Citrus Sinensis ID: 005355
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 700 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C9L5 | 792 | Wall-associated receptor | yes | no | 0.897 | 0.792 | 0.416 | 1e-140 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.905 | 0.847 | 0.429 | 1e-138 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.917 | 0.879 | 0.423 | 1e-136 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.908 | 0.835 | 0.416 | 1e-133 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.874 | 0.85 | 0.424 | 1e-132 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.914 | 0.852 | 0.420 | 1e-131 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.888 | 0.808 | 0.409 | 1e-130 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.91 | 0.872 | 0.414 | 1e-127 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.6 | 0.532 | 0.545 | 1e-126 | |
| Q9M092 | 786 | Wall-associated receptor | no | no | 0.921 | 0.820 | 0.410 | 1e-125 |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 500 bits (1287), Expect = e-140, Method: Compositional matrix adjust.
Identities = 306/735 (41%), Positives = 418/735 (56%), Gaps = 107/735 (14%)
Query: 15 LCQYSCGNVTINYPFGIGDGCYFDKRYEVICDDSSGSPKAFLAGVNNLELL--------N 66
LCQ CG + I YPFG+G GCY +K YE+ C+ S+ V N E++
Sbjct: 30 LCQPDCGGIKIPYPFGMGKGCYLEKWYEITCNTSTSGKLVPYLSVINKEVVGISLPTEGR 89
Query: 67 SDRYDGNLLRVNI--PVISLK--TTGHPNG--VNLSGIPLTFSRWHNRFAAIGC------ 114
RY+ VNI P+ S + + G G +NL+G P S+ HN A+GC
Sbjct: 90 GSRYNNPYQSVNIKNPIASKECSSNGEELGSLLNLTGTPFYVSQ-HNELVAVGCNNTASL 148
Query: 115 -------------------------------RNYNTIVKRANDSTVFG-------GCLTI 136
+NYN K N+ + C I
Sbjct: 149 TNVKPSIVQCTSSCSTKPHTHIKDYLAVLNCQNYNGYEKNCNEDSSMDESIMDETSCNGI 208
Query: 137 STCALSSRG--CYDFVCALPPN-LTQDFNASML-----YHFSQSIPQKCQS--VLMVEEN 186
C RG V N +T+ + L Y ++S PQK + VE
Sbjct: 209 GCCNAYMRGGSIQQIVGVTIENTITRGCKVAFLTNKAEYLSNKSDPQKLHARGYSTVELG 268
Query: 187 WLQSEFLTNANVLRDHQQFPAVLEFAEDRGNCVEEYNSRTTCNKDNRCSIQLTSGYSCLC 246
W TN + ++ + +V E+ +R + + T+C D+ + S C C
Sbjct: 269 WFI--HTTNHSFIKSLGCY-SVKEYNNERYTSTQRRINITSCICDDNAYL---SYARCSC 322
Query: 247 HRSFNGLNDGYCVGDLLCDSASSPYNCSGCPNGYLLDDTDSCYQN---TTAKTDTISPSP 303
R F G +PY GC D + C + T T+
Sbjct: 323 TRGFQG----------------NPYRLGGC------KDINECKEEEGMTYCGTNKCVNLQ 360
Query: 304 SPYEVVHENSNVLFIIIGCSVGAGLPFFLFMIG--RLHEIVERRRVIKLKQNFFKRNGGL 361
++ V+ N L I +G S G+ +F++G L++ ++++R + K+ FFKRNGGL
Sbjct: 361 GHFKCVYNNHRPLAIGLGASFGS----LIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGL 416
Query: 362 LLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKK 421
LLQQ+ S G EKT +F+S ELE AT+NF++NRILGQGGQGTVYKGML +GRIVA+KK
Sbjct: 417 LLQQQLISTVGMVEKTIVFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKK 476
Query: 422 SKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQT 481
SK+VDE +E+FINEV ILSQINHRN+VKLLGCCLET+VP+LVYEFIPNG L++++HD+
Sbjct: 477 SKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEF 536
Query: 482 EE-FPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540
+E TW IRLRIAI+++ AL YLHS+AS PIYHRD+KS NI+LD+KYRAKVSDFG SR
Sbjct: 537 DENIMATWNIRLRIAIDIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSR 596
Query: 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
+V +D THLTT V GT GY+DPEYF+SSQFT+KSDVYSFGVVLVEL+TG+K I S+E
Sbjct: 597 TVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQE 656
Query: 601 DKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660
+++L YF+ AMKEN+LF+++DAR+ ++ A +A++CLN+ G+KRP+M+E +
Sbjct: 657 NRTLATYFILAMKENKLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSM 716
Query: 661 ELGGIRASIGDSIMQ 675
EL IR GD +Q
Sbjct: 717 ELDSIRMPCGDMQLQ 731
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 492 bits (1266), Expect = e-138, Method: Compositional matrix adjust.
Identities = 296/689 (42%), Positives = 411/689 (59%), Gaps = 55/689 (7%)
Query: 14 DLCQYSCGNVTINYPFGIG-DGCYFDKRYEVICDDSSGSPKAFLAGVNNLELLNSDRYDG 72
D C CG ++I +PFGIG CY + YEV+C+ ++ P FL+ +N EL+N
Sbjct: 33 DRCNRVCGEISIPFPFGIGGKDCYLNPWYEVVCNSTNSVP--FLSRINR-ELVNISL--N 87
Query: 73 NLLRVNIPVIS--------LKTTGHPNGVNLSGIPLTFSRWHNRFAAIGCRNYNTIVKRA 124
++ + PV S T P V G P F N A+GC+ +
Sbjct: 88 GVVHIKAPVTSSGCSTGTSQPLTPPPLNVAGQGSPY-FLTDKNLLVAVGCKFKAVMAGIT 146
Query: 125 ND-STVFGGCLTISTCALSSRG--CYDFVCA---LPPNLTQDFNASMLYHFSQSIPQKCQ 178
+ ++ C ++ + R C + C +P Q + + IPQ
Sbjct: 147 SQITSCESSCNERNSSSQEGRNKICNGYKCCQTRIPEGQPQVISVDI------EIPQGNN 200
Query: 179 SVLMVEENWLQSEFLTNANV----LRDHQQFPAVLEFAEDRGNCVEEYNSRTT----CNK 230
+ E + FLT+ + + ++F A + G + +SR T C K
Sbjct: 201 TT---GEGGCRVAFLTSDKYSSLNVTEPEKFHGHGYAAVELGWFFDTSDSRDTQPISC-K 256
Query: 231 DNRCSIQLTSGYSCLCHRSFNGLNDGYCVGDLLCDSAS---SPYNCSGCPNGYLLDDTDS 287
+ + TS C C G G+ D C+S +P+ GC D D
Sbjct: 257 NASDTTPYTSDTRCSCSY---GYFSGFSYRDCYCNSPGYKGNPFLPGGCV------DVDE 307
Query: 288 CYQN---TTAKTDTISPSPSPYEVVHENSNVL-FIIIGCSVGAGLPFFLFMIGRLHEIVE 343
C + K + P ++ + L +I G +G+ L F F I L++ V+
Sbjct: 308 CKLDIGRNQCKDQSCVNLPGWFDCQPKKPEQLKRVIQGVLIGSALLLFAFGIFGLYKFVQ 367
Query: 344 RRRVIKLKQNFFKRNGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQ 403
+RR + + FF+RNGG+LL+Q+ + EGN E +++F+S ELE ATDNFN NR+LGQGGQ
Sbjct: 368 KRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQ 427
Query: 404 GTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463
GTVYKGML +GRIVA+K+SK VDE +E+FINEV +L+QINHRN+VKLLGCCLETEVP+L
Sbjct: 428 GTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVL 487
Query: 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANI 523
VYEF+PNG L + +HD+++++ +TWE+RL IAIE++ AL YLHSAAS PIYHRDIK+ NI
Sbjct: 488 VYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNI 547
Query: 524 LLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVL 583
LLD++ RAKVSDFG SRSV IDQTHLTT+V GTFGY+DPEYF+SS+FTEKSDVYSFGVVL
Sbjct: 548 LLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVL 607
Query: 584 VELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKR 643
VELLTG+KP SEE++ L +F+EA+KENR+ +++D R+ E +++++VA LA+R
Sbjct: 608 VELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQVMSVANLARR 667
Query: 644 CLNMIGKKRPTMKEAAFELGGIRASIGDS 672
CLN GKKRP M+E + EL IR+S DS
Sbjct: 668 CLNRKGKKRPNMREVSIELEMIRSSHYDS 696
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 485 bits (1249), Expect = e-136, Method: Compositional matrix adjust.
Identities = 297/702 (42%), Positives = 415/702 (59%), Gaps = 60/702 (8%)
Query: 7 PMKTSSEDLCQYSCGNVTINYPFGIG-DGCYFDKRYEVICDDSSGSPKAF--LAGVNNLE 63
P ++S C +CG ++I +PFGIG CY + YEVIC+ ++ L + N E
Sbjct: 30 PPISNSSTSCNKTCGGISIPFPFGIGGKDCYLNGWYEVICNTTTSDSNTTVPLLSMINRE 89
Query: 64 LLNSDRYDGN----LLRVNIPVISLKTTGHPNGVNLSGIPLT---------FSRWHNRFA 110
++N D N L+++ PV SL + + + + +P+ F NR
Sbjct: 90 VVNISLPDSNEPYGLVQIKGPVTSLGCSSNTSEGPQNSLPVLNVTGKGSPYFLTDENRLV 149
Query: 111 AIGCRNYNTIVKRANDSTVFGGCLTISTCALSSRG-------CYDFVCA---LPPNLTQD 160
A+GC + +S + G S+C G C + C LP Q
Sbjct: 150 AVGCGIKALMTD--TESEILG---CESSCEHRKSGEEVTNLICTGYRCCQARLPVGRPQA 204
Query: 161 FNASMLYHFSQSIPQKCQSVLMVEENWLQSEFLTNANVLRDHQQFPAVLEFAEDRGNCVE 220
++ S + C+ + ++ + S H VLE
Sbjct: 205 ITVNI--ENSSGGEETCKVAFLTDKRYSPSNVTEPEQF---HNNGYVVLELGWYFATSNS 259
Query: 221 EYNSRTTCNKDNRCSIQLTSGYS---CLC-HRSFNGLNDGYCVGDLLCDSASSPYNCSGC 276
+ S C +R SG+S C C + F+G++ C D +PY GC
Sbjct: 260 RFKSLLGCTNMSRKG----SGFSDDNCSCEYDYFSGMSYRNCYCDY--GYTGNPYLRGGC 313
Query: 277 PNGYLLDDTDSCYQNTTAKTDTISPS-PSPYEVVHENSNVLF-----IIIGCSVG-AGLP 329
DTDSC N D + P P + N + ++ G +G +GL
Sbjct: 314 V------DTDSCEGNHNCGEDAHCVNMPGPMSMCRPNPKITKPTKPPVLQGILIGLSGLV 367
Query: 330 FFLFMIGRLHEIVERRRVIKLKQNFFKRNGGLLLQQESSSNEGNSEKTKLFTSMELEMAT 389
FF+ + L +++++RR I + FFKRNGGLLL+Q+ ++ +GN E +K+F+S EL AT
Sbjct: 368 FFVGLFW-LFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKAT 426
Query: 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVV 449
DNF+ +R+LGQGGQGTVYKGML +G IVA+K+SK+VDE +E+FINE+ +LSQINHRN+V
Sbjct: 427 DNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIV 486
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA 509
KLLGCCLETEVP+LVYE+IPNG L++ +HD+++++ +TWE+RLRIAIE++ AL Y+HSAA
Sbjct: 487 KLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAA 546
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ 569
S PI+HRDIK+ NILLD+KYRAKVSDFG SRSV +DQTHLTT V GTFGY+DPEYF SSQ
Sbjct: 547 SFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQ 606
Query: 570 FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEA 629
+T KSDVYSFGVVLVEL+TG+KP+ SEE + L +FLEAMKENR+ +++D R+ E+
Sbjct: 607 YTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDES 666
Query: 630 KEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGD 671
K E+++ VA LA++CLN GK RP MKE + EL IR+S D
Sbjct: 667 KLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSSPED 708
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 476 bits (1224), Expect = e-133, Method: Compositional matrix adjust.
Identities = 286/687 (41%), Positives = 398/687 (57%), Gaps = 51/687 (7%)
Query: 15 LCQYSCGNVTINYPFGIGDG-CYFDKRYEVICDDSSGSPKAFLAGVNNLELLN------S 67
LC CG ++I +PFGIG CY + YEV+C+ ++ P FL+ +N EL+N +
Sbjct: 32 LCNRVCGGISIPFPFGIGGKECYLNPWYEVVCNTTTSVP--FLSRINR-ELVNIYLPDPT 88
Query: 68 DRYDGNLLRVNIPVIS--------LKTTGHPNGVNLSGIPLTFSRWHNRFAAIGCRNYNT 119
+ Y ++ + PV S T P V G P F N A+GC N
Sbjct: 89 EYYSNGVVHIKGPVTSSGCSTGTSQPLTPQPLNVAGQGSPY-FLTDKNLLMAVGC-NVKA 146
Query: 120 IVKRANDSTVFGGCLTISTCA---LSSRGCYDFVCA--------LPPNLTQDFNASMLYH 168
++ + GC S+C SS+ + +C+ +P Q ++
Sbjct: 147 VMMDVKSQII--GCE--SSCDERNSSSQVVRNKICSGNKCCQTRIPEGQPQVIGVNIEIP 202
Query: 169 FSQSIPQKCQSVLMVEENWLQSEFLTNANVLRDHQQFPAVLEFAEDRGNCVEEYNSRTTC 228
+++ + V + N S +T H AV+E S C
Sbjct: 203 ENKNTTEGGCKVAFLTSNKYSSLNVTEPEEF--HSDGYAVVELGWYFDTSDSRVLSPIGC 260
Query: 229 NKDNRCSIQLTSGYSCLCHRSFNGLNDGYCVGDLLCDS---ASSPYNCSGCPNGYLLDDT 285
+ S G +C S+ G G+ C+S A +P+ GC D
Sbjct: 261 MNVSDASQDGGYGSETICVCSY-GYFSGFSYRSCYCNSMGYAGNPFLPGGCV------DI 313
Query: 286 DSC---YQNTTAKTDTISPSPSPYEV-VHENSNVLFIIIGCSVGAGLPFFLFMIGRLHEI 341
D C K + P + + + + G +G+ L F F I L++
Sbjct: 314 DECKLEIGRKRCKDQSCVNKPGWFTCEPKKPGQIKPVFQGVLIGSALLLFAFGIFGLYKF 373
Query: 342 VERRRVIKLKQNFFKRNGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQG 401
++++R + FF+RNGG+LL+Q+ + EGN E +K+F+S ELE ATDNFNTNR+LGQG
Sbjct: 374 IKKQRRSSRMRVFFRRNGGMLLKQQLARKEGNVEMSKIFSSNELEKATDNFNTNRVLGQG 433
Query: 402 GQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461
GQGTVYKGML +GRIVA+K+SK +DE +E+FINEV +L+QINHRN+VKLLGCCLETEVP
Sbjct: 434 GQGTVYKGMLVDGRIVAVKRSKAMDEDKVEEFINEVVVLAQINHRNIVKLLGCCLETEVP 493
Query: 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSA 521
+LVYEF+PNG L + + D+ +++ +TWE+RL IAIE++ AL YLHSAAS PIYHRDIK+
Sbjct: 494 VLVYEFVPNGDLCKRLRDECDDYIMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTT 553
Query: 522 NILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGV 581
NILLD+KY+ KVSDFG SRSV IDQTHLTT+V GTFGY+DPEYF+SS+FT+KSDVYSFGV
Sbjct: 554 NILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTDKSDVYSFGV 613
Query: 582 VLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLA 641
VLVEL+TG+ P SEE++ +F+ A+KENR +++D R+ E ++++ VA LA
Sbjct: 614 VLVELITGKNPSSRVQSEENRGFAAHFVAAVKENRFLDIVDERIKDECNLDQVMAVAKLA 673
Query: 642 KRCLNMIGKKRPTMKEAAFELGGIRAS 668
KRCLN GKKRP M+E + EL IR+S
Sbjct: 674 KRCLNRKGKKRPNMREVSVELERIRSS 700
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 473 bits (1217), Expect = e-132, Method: Compositional matrix adjust.
Identities = 286/673 (42%), Positives = 394/673 (58%), Gaps = 61/673 (9%)
Query: 16 CQYSCGNVTINYPFGIGDGCYFDKRYEVICDDSSGSPKAFL-----AGVNNLELLNSDRY 70
C CGNV++ YPFGIG GCY +K +E++C SS L V + L D +
Sbjct: 33 CSDHCGNVSVPYPFGIGKGCYKNKWFEIVCKSSSDQQPILLLPRIRRAVTSFNL--GDPF 90
Query: 71 DGNLLRVNIPVISLKTTGHPN-------GVNLSGIPLTFSRWHNRFAAIGCRNYNTIVKR 123
++ LK +G PN +NL G P S +N+F A+GC N +
Sbjct: 91 SISVYNKFYIQSPLKHSGCPNRDGYSSSSLNLKGSPFFISE-NNKFTAVGCNN-KAFMNV 148
Query: 124 ANDSTVFGGCLT-----ISTCALSSRGCYDFVC---ALPPNLT-QDFNASMLYHFSQSIP 174
V GC T I + ++ C + C +PP L Q F+A++ +
Sbjct: 149 TGLQIV--GCETTCGNEIRSYKGANTSCVGYKCCQMTIPPLLQLQVFDATV--EKLEPNK 204
Query: 175 QKCQSVLMVEENWLQSEFLTNANVLRDHQQFPAVLEFAEDRGNCVEEYNSRTTCNKDNRC 234
Q CQ V + + L T ++ + LE+ D + R C +
Sbjct: 205 QGCQ-VAFLTQFTLSGSLFTPPELMEYSEYTTIELEWRLDLSYMTSK---RVLCKGNTF- 259
Query: 235 SIQLTSGYSCLCHRSFNGLNDGYCVGDLLCDSASSPYNCSGCPNGYLLDDTDSCYQNTTA 294
Y C CH + G +PY GC + +D+ + N
Sbjct: 260 ---FEDSYQCSCHNGYEG----------------NPYIPGGCQD---IDECRDPHLNKCG 297
Query: 295 KTDTISPSPSPYEVVHENSNVLFIIIGCSVGAGLPFFLFMIGRLHEIVERRRVIKLKQNF 354
K ++ S + I+ ++ +GL +F + L + +R+V K K+ F
Sbjct: 298 KRKCVNVLGS-----YRCEKTWPAILSGTLSSGLLLLIFGMWLLCKANRKRKVAKQKRKF 352
Query: 355 FKRNGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNG 414
F+RNGGLLLQQ++S G+ +TK+F+S +LE ATD FN +RILGQGGQGTVYKGML +G
Sbjct: 353 FQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASRILGQGGQGTVYKGMLEDG 412
Query: 415 RIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLY 474
IVA+KKSK + E N+E+FINE+ +LSQINHRNVVK+LGCCLETEVP+LVYEFIPN L+
Sbjct: 413 MIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLF 472
Query: 475 QYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVS 534
++H+ +E+FP++WE+RL IA EV+DAL YLHSA SIPIYHRD+KS NILLD+K+RAKVS
Sbjct: 473 DHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVS 532
Query: 535 DFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIR 594
DFG SRSV ID THLTT VQGT GY+DPEY +S+ FT KSDVYSFGV+L+ELLTG+KP+
Sbjct: 533 DFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKPVS 592
Query: 595 STDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT 654
+E + L YFLEAM+ +RL E+LDAR+ +E EE++ VA LA+RCL++ + RPT
Sbjct: 593 LLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPT 652
Query: 655 MKEAAFELGGIRA 667
M++ EL +++
Sbjct: 653 MRDVFIELDRMQS 665
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 469 bits (1207), Expect = e-131, Method: Compositional matrix adjust.
Identities = 290/690 (42%), Positives = 410/690 (59%), Gaps = 50/690 (7%)
Query: 11 SSEDLCQYSCGNVTINYPFGIGD-GCYFDKRYEVICDD--SSGSPKAFLAGVN----NLE 63
SS C CG + I +PFGIG C+ + YEV+C+ S S FL +N ++
Sbjct: 32 SSSTSCNRICGGIEIPFPFGIGRRDCFLNDWYEVVCNSTTSGKSLAPFLYKINRELVSIT 91
Query: 64 LLNSDRYDGNLLRVNIPVISLKTTGHPNG---VNLSGI--PLTFSRWHNRFAAIGCRNYN 118
L +S ++ + PV S + P +NL+G P F NR ++GC N
Sbjct: 92 LRSSIDSSYGVVHIKSPVTSSGCSQRPVKPLPLNLTGKGSPF-FITDSNRLVSVGCDNRA 150
Query: 119 TIVKRANDSTVFGGCLTISTC----ALSSRGCYDFVC---ALPPNLTQDFNASMLYHFSQ 171
I + T GC S+C + + C + C +P + Q +
Sbjct: 151 LITDIESQIT---GCE--SSCDGDKSRLDKICGGYTCCQAKIPADRPQVIGVDLESSGGN 205
Query: 172 SIPQ-KCQSVLMVEENWLQSEFLTNANVLRDHQQFPAVLEFAEDRGNCVEEYNSRTT--- 227
+ C+ + E + + ANV Q + E G + +SR T
Sbjct: 206 TTQGGNCKVAFLTNETY------SPANVTEPEQFYTNGFTVIE-LGWYFDTSDSRLTNPV 258
Query: 228 -CNKDNRCSIQLTSGYSCLC-HRSFNGLNDGYCVGDLLCDSASSPYNCSGCPNGYLLDDT 285
C I TS SC+C + +F+G C + + +PY GC D
Sbjct: 259 GCVNLTETGI-YTSAPSCVCEYGNFSGFGYSNCYCNQI-GYRGNPYLPGGC------IDI 310
Query: 286 DSCYQN---TTAKTDTISPSPSPYEV-VHENSNVLFIIIGCSVGAGLPFFLFMIGRLHEI 341
D C + ++ T P + ++ + + G +G L F + I L +
Sbjct: 311 DECEEGKGLSSCGELTCVNVPGSWRCELNGVGKIKPLFPGLVLGFPLLFLVLGIWGLIKF 370
Query: 342 VERRRVIKLKQNFFKRNGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQG 401
V++RR I K+ FFKRNGGLLL+Q+ ++ GN + +K+F+S ELE ATDNFN NR+LGQG
Sbjct: 371 VKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLGQG 430
Query: 402 GQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461
GQGTVYKGML +GRIVA+K+SK++DE +E+FINEV +LSQINHRN+VKL+GCCLETEVP
Sbjct: 431 GQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVP 490
Query: 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSA 521
+LVYE IPNG L++ +H ++++ +TW++RLRI++E++ AL YLHSAAS P+YHRD+K+
Sbjct: 491 ILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTT 550
Query: 522 NILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGV 581
NILLD+KYRAKVSDFG SRS+ +DQTHLTT V GTFGYLDPEYF++SQFT+KSDVYSFGV
Sbjct: 551 NILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGV 610
Query: 582 VLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLA 641
VLVEL+TG+KP EE++ LV +F EAMK+NR+ +++D+R+ + E+++ VA LA
Sbjct: 611 VLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAKLA 670
Query: 642 KRCLNMIGKKRPTMKEAAFELGGIRASIGD 671
+RCL++ GKKRP M+E + EL IR+S D
Sbjct: 671 RRCLSLKGKKRPNMREVSVELERIRSSPED 700
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 465 bits (1196), Expect = e-130, Method: Compositional matrix adjust.
Identities = 292/713 (40%), Positives = 411/713 (57%), Gaps = 91/713 (12%)
Query: 16 CQYSCGNVTINYPFGIGDGCYFDKRYEVICDDSSGSPKAFLAGVNN--LELLNSDRYDGN 73
C +CG + I YPFGIG GCY +K YE+IC ++S FL+ +N + + SD Y
Sbjct: 27 CPKTCGGIDIPYPFGIGTGCYLEKWYEIICVNNS---VPFLSIINREVVSISFSDMYRRF 83
Query: 74 L------LRVNIPVIS--LKTTGHPNG--VNLSGIPLTFSRWHNRFAAIGCRNYNTIVKR 123
+R+ P+ S + G G +N++G P +N A+GC N ++
Sbjct: 84 FNVGYGSIRIRNPIASKGCSSGGQEFGSLLNMTGYPFYLGD-NNMLIAVGCNNTASL--- 139
Query: 124 ANDSTVFGGCLTISTCALSSR-GCYDFVCALPPN-------------LTQDFNASMLYHF 169
N GC STC+ + D++ L N + D + + +
Sbjct: 140 TNVEPSIVGCE--STCSTNQDIPINDYLGVLYCNARYGDSEYCKNISIMNDTSCNGIGCC 197
Query: 170 SQSIPQKCQSVLMVEENWLQSE-------FLTNANVLRDHQQFPAVLE------------ 210
S+P + Q ++ VE + +E F+T+ + P L
Sbjct: 198 KASLPARYQQIIGVEIDDSNTESKGCKVAFITDEEYFLSNGSDPERLHANGYDTVDLRWF 257
Query: 211 -------FAEDRG-NCVEEYNSRTTCNKDNRCSIQLTSGYSCLCHRSFNGLNDGYCVGDL 262
F G ++EY T +DNR G CLC +N GY
Sbjct: 258 IHTANHSFIGSLGCKSIDEY---TILRRDNR-----EYGIGCLC--DYNSTTTGYATCSC 307
Query: 263 LCDSASSPYNCSGCPNGYLLDDTDSCYQNTTAKTDTISPSPSPYEVVH-------ENSNV 315
+PY C D + C + +P + + V+ E +N
Sbjct: 308 ASGFEGNPYIPGECK------DINECVRGIDG-----NPVCTAGKCVNLLGGYTCEYTNH 356
Query: 316 LFIIIGCSVGAGLPFFLFMIGRLHEIVERRRVIKLKQNFFKRNGGLLLQQESSSNEGNSE 375
++IG S F+ I L++ + R+R + K+ FFKRNGGLLLQQ+ ++ EGN +
Sbjct: 357 RPLVIGLSTSFSTLVFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVD 416
Query: 376 KTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFIN 435
T++F S ELE AT+NF+ RILG+GGQGTVYKGML +GRIVA+KKSK+VDE +E+FIN
Sbjct: 417 STRVFNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFIN 476
Query: 436 EVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPIT-WEIRLRI 494
EV ILSQINHRN+VKLLGCCLET+VP+LVYEFIPNG L++++HD ++++ +T WE+RLRI
Sbjct: 477 EVVILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRI 536
Query: 495 AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQ 554
A++++ AL YLHSAAS PIYHRDIKS NI+LD+K+RAKVSDFG SR+V +D THLTT V
Sbjct: 537 AVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVS 596
Query: 555 GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE 614
GT GY+DPEYF+SSQFT+KSDVYSFGVVL EL+TG+K + S+E ++L YF AMKE
Sbjct: 597 GTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKE 656
Query: 615 NRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667
NRL +++DAR+ K ++ A +A++CLNM G+KRP+M++ + EL IR+
Sbjct: 657 NRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRS 709
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 455 bits (1171), Expect = e-127, Method: Compositional matrix adjust.
Identities = 285/688 (41%), Positives = 400/688 (58%), Gaps = 51/688 (7%)
Query: 16 CQYSCGNVTINYPFGIG-DGCYFDKRYEVICDDS-SGSPKA--FLAGVN----NLELLNS 67
C + G ++I +PFGIG CY + YEV+C+ + SGS K FL +N N+ L S
Sbjct: 37 CNRTFGGISIPFPFGIGGKDCYLNSWYEVVCNSTTSGSCKTVPFLTRINREVVNISLPKS 96
Query: 68 DRYDG-NLLRVNIPVISLKTTGH---------PN-GVNLSGIPLTFSRWHNRFAAIGCRN 116
D + ++ + PV SL + + P+ + G P F NR A+GC
Sbjct: 97 DFFSPYGVVHIKGPVTSLGCSSNISQGLQKTLPDLNITGRGSPY-FLTDENRLVAVGCGT 155
Query: 117 YNTIVKRANDSTVFG---GCLTISTCALSSRGCYDFVCA---LPPNLTQDFNASMLYHFS 170
+ +S + G C + + + C + C LP Q ++ + +
Sbjct: 156 KALMTDI--ESEILGCESSCKDTKSNEVGNSLCNGYKCCQARLPVERPQAVGVNIESN-N 212
Query: 171 QSIPQKCQSVLMVEENWLQSEFLTNANVLRDHQQFPAVLEFAEDRGNCVEEYNSRTTCNK 230
+ + C++ + + S D AV+E + + C
Sbjct: 213 DTRGEGCKAAFLTSMKYFPSNITKPEWFQADGY---AVVELGWYFDTSDSRFRNPLGCTN 269
Query: 231 DNRCSIQLTSGYSCLCHRS-FNGLNDGYCVGDLLCDSA--SSPYNCSGCPNGYLLDDTDS 287
R S CLC F+ ++ C C S +PY GC + + +
Sbjct: 270 LTRSSGSYFLTDICLCRYGYFSRMSYRSC----YCGSGYRGNPYIRGGCIDIDECEVPNK 325
Query: 288 CYQNT----TAKTDTISPSPSPYEVVHENSNVLFIIIGCSVGAGLPFFLFMIGRLHEIVE 343
C ++T + + P ++ H VL GL FF+ I L++ +
Sbjct: 326 CGEDTCVNMAGRYSCVPKITKPAKLAHVLRGVL------IGLLGLLFFVIGIFGLYKFIR 379
Query: 344 RRRVIKLKQNFFKRNGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQ 403
+RR I FFKRNGGLLL+Q+ ++ +G+ E +K+F+S ELE ATDNF+ +R+LGQGGQ
Sbjct: 380 KRRRIIRSMKFFKRNGGLLLKQQLTTKDGSVEMSKIFSSRELEKATDNFSIDRVLGQGGQ 439
Query: 404 GTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463
GTVYK ML +G IVA+K+SK+VDE +E+FINE+ +LSQINHRN+VKLLGCCLETEVP+L
Sbjct: 440 GTVYKRMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPIL 499
Query: 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANI 523
VYE+IPNG L++ +HD+ +++ +TWE+RLRIA+E++ AL Y+HSAAS PI+HRDIK+ NI
Sbjct: 500 VYEYIPNGDLFKRLHDEYDDYMMTWEVRLRIAVEIAGALSYMHSAASFPIFHRDIKTTNI 559
Query: 524 LLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVL 583
LLD+KYRAK+SDFG SRSV DQTHLTT V GTFGY+DPEYF SSQ+T KSDVYSFGVVL
Sbjct: 560 LLDEKYRAKISDFGTSRSVATDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVL 619
Query: 584 VELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKR 643
VEL+TG+KP+ SEE L YFLEAMKENR +++D R+ E+K +++ VA LA+R
Sbjct: 620 VELITGEKPMSRVRSEEGIGLATYFLEAMKENRAVDIIDIRIKDESK--QVMAVAKLARR 677
Query: 644 CLNMIGKKRPTMKEAAFELGGIRASIGD 671
CLN G KRP M+E + +L IR+S D
Sbjct: 678 CLNRKGNKRPNMREVSIKLERIRSSPKD 705
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 453 bits (1166), Expect = e-126, Method: Compositional matrix adjust.
Identities = 239/438 (54%), Positives = 314/438 (71%), Gaps = 18/438 (4%)
Query: 258 CVGDLLCDSASSPYNCSGCPNGYL--------LDDTDSCYQNTTAK------TDTISPSP 303
C+ + + S + NC GC GY D + C +N+ + +DT P
Sbjct: 306 CICNNVTISGTDYANC-GCSQGYEGNPYLPGGCKDINECLRNSYGQRQNCRESDTCVNLP 364
Query: 304 SPYEVVHENSNVLFIIIGCSVGAGLPFFLFMIGRLHEIVERRRVIKLKQNFFKRNGGLLL 363
+ + + V I +G + G + + I L + +++RR+ K K+ FFKRNGGLLL
Sbjct: 365 GTFNCIGNKTRVTMIGVGSAFG--ILVLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLL 422
Query: 364 QQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSK 423
QQ+ ++N+GN EKT++F+S ELE ATDNF+ +RILGQGGQGTVYKGML +GR VA+KKSK
Sbjct: 423 QQQLNTNKGNVEKTRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSK 482
Query: 424 LVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEE 483
+VDE +E+FINEV ILSQINHR+VVKLLGCCLETEVP LVYEFIPNG L+Q+IH+++++
Sbjct: 483 VVDEDKLEEFINEVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDD 542
Query: 484 FPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543
+ TW +RLRIA++++ AL YLHSAAS PIYHRDIKS NILLD+KYR KVSDFG SRSV
Sbjct: 543 YTKTWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVT 602
Query: 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP-IRSTDSEEDK 602
ID TH TT + GT GY+DPEY+ SSQ+T+KSDVYSFGVVLVEL+TG+KP I ++S+E +
Sbjct: 603 IDHTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIR 662
Query: 603 SLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662
L +F AMKENR FE++DAR+ K E+++ VA LA+RCLN GKKRP M++ +L
Sbjct: 663 GLADHFRVAMKENRFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDL 722
Query: 663 GGIRASIGDSIMQHNCDD 680
I AS DS++ DD
Sbjct: 723 EKILASQEDSLVNIENDD 740
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M092|WAKLM_ARATH Wall-associated receptor kinase-like 17 OS=Arabidopsis thaliana GN=WAKL17 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 447 bits (1151), Expect = e-125, Method: Compositional matrix adjust.
Identities = 288/701 (41%), Positives = 405/701 (57%), Gaps = 56/701 (7%)
Query: 20 CGNVTINYPFGIGDGCYFDKRYEVICDDSSGSPKAFLAGVNN--LELLNSDRYDGNLLRV 77
CG + I YPFGIG GCY +K YE+ C ++SG FL+ ++ + + R +RV
Sbjct: 42 CGGIAIPYPFGIGKGCYLEKSYEIECLNTSGKLVPFLSVISKEVVSIHLPGRQSFGSVRV 101
Query: 78 NIPVISL--KTTGHPNG--VNLSGIPLTFSRWHNRFAAIGCRNYNTIVKRANDSTVFGGC 133
P+ S + G + +NL+ P S +N +GC + ++ + GC
Sbjct: 102 RSPITSAGCSSDGKDSAPVMNLTDSPFFVSDINN-LVGVGCSSKVSLEHIKQNMV---GC 157
Query: 134 -LTISTCALSSR---------GC---YDFVCALPPNLTQDFNASMLYHFSQSIPQKCQSV 180
L ST S GC Y F N +D S+P++ Q V
Sbjct: 158 ELNCSTTNASDSNSIPFFDKTGCSFSYTFAQVCTGNKPEDMGCDGRGCCQASLPREPQQV 217
Query: 181 L--MVEEN-------------WLQSEFLTNANVLRD---HQQFPAVLEFAEDRGNCVEEY 222
+ +E N +L EF + + + + H + A L +
Sbjct: 218 IGIRIESNDGKSTTSGDCRVAFLTDEFFSLSKLTKPEQLHAKRYATLSLGWIMQTRNTSF 277
Query: 223 NSRTTCN--KDNRCSIQLTSGYSCLCHRSFNGLND-GYCVGDLLCDSASSPYNCSGCPNG 279
+ C KD + C+C + + ++D Y + +PY+ GC
Sbjct: 278 VNSLACKIRKDTDTAYSNDQSIKCICDYTMSIISDIRYANCECNLGYKGNPYDSDGC--- 334
Query: 280 YLLDDTDSCYQNTT--AKTDTISPSPSPYEVVHENSNVLFIIIGCSVGAGLPFFLFMIGR 337
D D C +N +TDT Y V + + I+IG G G+ + +
Sbjct: 335 ---RDIDECKENPKYCKETDTCVNFEGGYRCVGDKTKA--IMIGAGTGFGVLVLVGGVWW 389
Query: 338 LHEIVERRRVIKLKQNFFKRNGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRI 397
L + + +RR+ K K+ FFKRNGGLLLQQE ++ +G EK ++FTS ELE AT+NF+ NR+
Sbjct: 390 LRKFLVKRRMAKRKKKFFKRNGGLLLQQELNTRQGVVEKARIFTSKELEKATENFSENRV 449
Query: 398 LGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLE 457
LG GGQGTVYKGML +GR VA+KKSK++DE +++FINEV ILSQINHR+VVKLLGCCLE
Sbjct: 450 LGHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLE 509
Query: 458 TEVPLLVYEFIPNGTLYQYIH-DQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHR 516
TEVP+LVYEFI NG L+++IH ++ +++ + W +RLRIA++++ AL YLHSAAS PIYHR
Sbjct: 510 TEVPILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIYHR 569
Query: 517 DIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDV 576
DIKS NILLD+KYRAKV+DFG SRSV IDQTH TT + GT GY+DPEY+RSSQ+TEKSDV
Sbjct: 570 DIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKSDV 629
Query: 577 YSFGVVLVELLTGQKP-IRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEII 635
YSFGV+L EL+TG KP I +++E +L +F AMKE RL +++DAR+ ++K E+++
Sbjct: 630 YSFGVILAELITGDKPVIMVQNTQEIIALAEHFRVAMKERRLSDIMDARIRDDSKPEQVM 689
Query: 636 TVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSIMQH 676
VA LA +CL+ G+ RP M+E EL I S DS +Q+
Sbjct: 690 AVANLAMKCLSSRGRNRPNMREVFTELERICTSPEDSQVQN 730
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 700 | ||||||
| 255545828 | 694 | kinase, putative [Ricinus communis] gi|2 | 0.921 | 0.929 | 0.524 | 0.0 | |
| 255545824 | 727 | kinase, putative [Ricinus communis] gi|2 | 0.951 | 0.916 | 0.528 | 0.0 | |
| 255541802 | 743 | kinase, putative [Ricinus communis] gi|2 | 0.897 | 0.845 | 0.531 | 1e-178 | |
| 359475622 | 867 | PREDICTED: wall-associated receptor kina | 0.904 | 0.730 | 0.490 | 1e-170 | |
| 359475620 | 822 | PREDICTED: wall-associated receptor kina | 0.904 | 0.770 | 0.503 | 1e-169 | |
| 147765961 | 679 | hypothetical protein VITISV_007744 [Viti | 0.891 | 0.918 | 0.478 | 1e-166 | |
| 224053054 | 722 | predicted protein [Populus trichocarpa] | 0.887 | 0.860 | 0.482 | 1e-158 | |
| 224103351 | 685 | predicted protein [Populus trichocarpa] | 0.918 | 0.938 | 0.468 | 1e-157 | |
| 225455808 | 718 | PREDICTED: wall-associated receptor kina | 0.874 | 0.852 | 0.485 | 1e-155 | |
| 224075946 | 729 | predicted protein [Populus trichocarpa] | 0.901 | 0.865 | 0.474 | 1e-152 |
| >gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 669 bits (1725), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/700 (52%), Positives = 461/700 (65%), Gaps = 55/700 (7%)
Query: 1 MALLFWPMKTSSEDLCQYSCGNVTINYPFGIGDGCYFDKRYEVICDDSSGSPKAFLAGVN 60
+ L+ W + S + C+ CGNV I +PFGIG GCY D+ +EV C+ SS PK FL +N
Sbjct: 17 LFLILWLAQARSVEPCESYCGNVPIEFPFGIGKGCYMDESFEVTCNSSSEPPKPFLTSIN 76
Query: 61 NLELLNSDRYDGNLLRVNIPVI---SLKTTGHPNGVNLSGIPLTFSRWHNRFAAIGCRNY 117
+ELL + N ++VN PVI T + V+LSG P TFS NRF A GC NY
Sbjct: 77 -MELL--EVLSPNQVQVNNPVIYSNCSHKTSTASRVSLSGTPFTFSNASNRFTAKGCNNY 133
Query: 118 NTIVKRANDSTVFGGCLTISTCALSSRGCYDFVC---ALPPNLTQDFNASMLYHFSQSIP 174
+++ D+ GGCL+I +S GCY C +PP + + F A+M FS +
Sbjct: 134 AILMQDIGDTV--GGCLSICRDEANSSGCYGINCWQTTIPPYM-KSFEANMTNPFSDNT- 189
Query: 175 QKCQSVLMVEENWL--QSEFLTNANVLRDHQQFPAVLEFAEDRGNC-VEEYNSRTTCNKD 231
C+S MV+++W QS + + L PAVL++A +G C + EY + T
Sbjct: 190 NNCKSAFMVDQSWFAFQSSSSRSLDDLNYKDHVPAVLDWANYQGYCDISEYYNITCTTDS 249
Query: 232 NRCSIQLTSGYSCLCHRSFNGLNDGYCVGDLLCDSASSPYNCS------------GCPNG 279
+ C +L C+C C C SS YNC CP G
Sbjct: 250 SYCWKELNRSQVCICQ----------CEDPNKCPDQSSNYNCRLFCMYRPGGYNCPCPRG 299
Query: 280 Y-LLDDTDSCYQNTTAKTDTISPSPSPYEVVHENSNVLFIIIGCSVGAGLPFFLFMIGRL 338
+ ++++ CY N+ + + + S L ++IG I L
Sbjct: 300 HGKYENSNRCYPNSVFWGKSRTKTKSIIIGCGSGIGFLLLLIG-------------IWSL 346
Query: 339 HEIVERRRVIKLKQNFFKRNGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRIL 398
++I++RRR +KLKQNFFKRNGGLLL+Q+ SS E E+TK+FTS ELE ATD+++TNRIL
Sbjct: 347 YKIIKRRRAMKLKQNFFKRNGGLLLEQQLSSTENYVEQTKVFTSKELEKATDDYHTNRIL 406
Query: 399 GQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLET 458
GQGGQGTVYKGML +GR+VAIKKSK+VDE ++QFINEV ILSQINHRNVVKL+GCCLET
Sbjct: 407 GQGGQGTVYKGMLIDGRVVAIKKSKVVDEDKLDQFINEVVILSQINHRNVVKLIGCCLET 466
Query: 459 EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDI 518
EVPLLVYEFIPNGTLYQYIH+ EEFP+TWE+RLRIA EV+ AL YLH+AAS+PIYHRDI
Sbjct: 467 EVPLLVYEFIPNGTLYQYIHNPNEEFPVTWEMRLRIATEVAGALAYLHAAASMPIYHRDI 526
Query: 519 KSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYS 578
KS+NILLD+KYRAKV+DFG S+S+ IDQTH+TTRVQGTFGYLDPEYF+SSQFTEKSDVYS
Sbjct: 527 KSSNILLDEKYRAKVADFGTSKSISIDQTHVTTRVQGTFGYLDPEYFQSSQFTEKSDVYS 586
Query: 579 FGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVA 638
FGVVLVELLTGQKPI S S E++SL YFL M+E+RLFE+LDARVLKE EEII +A
Sbjct: 587 FGVVLVELLTGQKPISSYRSVEERSLATYFLMTMEESRLFEILDARVLKEGGREEIIAMA 646
Query: 639 MLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSIMQHNC 678
LA++CLN+ GKKRP MK A EL GIR+S G + H C
Sbjct: 647 KLAEKCLNLNGKKRPKMKTVAIELEGIRSSQGHN---HTC 683
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545824|ref|XP_002513972.1| kinase, putative [Ricinus communis] gi|223547058|gb|EEF48555.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 662 bits (1707), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/708 (52%), Positives = 466/708 (65%), Gaps = 42/708 (5%)
Query: 8 MKTSSEDLCQYSCGNVTINYPFGIGDGCYFDKRYEVICDDSSGSPKAFLAGVNNLELLNS 67
+ T++ +CQ SCG++T +PFGIG GCY + +E++C+DS PK FL +N +ELL+
Sbjct: 24 LATAAGPVCQESCGDITFPFPFGIGKGCYMSEMFEIVCNDSFTPPKPFLTSIN-MELLHD 82
Query: 68 DRYDGNLLRVNIPVISLKTTGHPNG---VNLSGIPLTFSRWHNRFAAIGCRNYNTIVKRA 124
+ VN PVIS + + V+L G FS NRF IGC +Y + +
Sbjct: 83 PSIGSERITVNSPVISSNCSNKSSTSTEVSLLGTSFLFSNESNRFTTIGCDSYAMLTQSG 142
Query: 125 NDSTVFGGCLTISTCALSSRGCYDFVC---ALPPNLTQDFNASMLYHFSQSIP--QKCQS 179
N GGCL+I SS GCY C +PP + Q F ++ F+ +C+S
Sbjct: 143 N---TVGGCLSICR-DNSSSGCYGLNCCQTTIPPYV-QSFEVNITNPFNSDGDGRDRCKS 197
Query: 180 VLMVEENWLQSEFLTNANVLRDHQQFPAVLEFAEDRGNCVEEYNSRTTCNKDNRCSIQLT 239
MV +NWL S+ TN + +R PAVL++A D+G C N TC C QLT
Sbjct: 198 AFMVSQNWLASKS-TNLDEVRQMDHVPAVLDWANDQGYCDISKNPNITCT-SRYCWAQLT 255
Query: 240 SGYSCLCH------RSFNGLNDGYCVGDLLCDSASSPYNCSGCPNGYLLDDTDSCYQNTT 293
C+C + N N YC L C YNC CP + + CY
Sbjct: 256 ENQFCICRQCEDVGKCTNPKNYYYC--QLKCMYNRGGYNCP-CPVEHH-KEYSICY---- 307
Query: 294 AKTDTISPSPSPYEVVHENSNVLFIIIGCSVGAGLPFFLFMIGRLHEIVERRRVIKLKQN 353
P S + I+IGC G GL + I ++I++RRR KLKQ
Sbjct: 308 -----------PDSAFAGKSRIKTILIGCGSGLGLLLLIIGIWLSYKIIKRRRATKLKQK 356
Query: 354 FFKRNGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTN 413
FFKRNGGLLL+Q+ SS E + E+TK+FTS ELE ATDN++T+RILGQGGQGTVYKGMLT+
Sbjct: 357 FFKRNGGLLLEQQLSSTESHVEQTKVFTSKELEKATDNYHTSRILGQGGQGTVYKGMLTD 416
Query: 414 GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 473
GR+VAIKKSKLVDE ++QFINEV ILSQINHRNVVKL GCCLETEVPLLVYEFIPNGTL
Sbjct: 417 GRVVAIKKSKLVDEDKLDQFINEVVILSQINHRNVVKLTGCCLETEVPLLVYEFIPNGTL 476
Query: 474 YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKV 533
+QYI + +EFPITWE+RLRIA EV+ AL YLHSAAS+PIYHRDIKS+NILLD+KYRAKV
Sbjct: 477 FQYIQNPNKEFPITWEMRLRIATEVAGALAYLHSAASMPIYHRDIKSSNILLDEKYRAKV 536
Query: 534 SDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
+DFG S+S+ I+QTH+TT VQGTFGYLDPEYF+SSQFTEKSDVYSFGVVLVELLTGQKPI
Sbjct: 537 ADFGTSKSIAIEQTHVTTLVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPI 596
Query: 594 RSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRP 653
S S E++SL YFL M+ENRLFE+LDARVLKE EEII +A +A++CLN+ GKKRP
Sbjct: 597 SSLRSVEERSLATYFLMTMEENRLFEILDARVLKEGGREEIIAMAKMAEKCLNLNGKKRP 656
Query: 654 TMKEAAFELGGIRASIG-DSIMQHNCDDIDFVAGHNTGHSEIGSSSTG 700
MK A EL GIR+S G S +Q + +++D+V G T ++ SSSTG
Sbjct: 657 KMKTVAIELEGIRSSQGVSSTIQQDYEEVDYVVGDYTASWDVASSSTG 704
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541802|ref|XP_002511965.1| kinase, putative [Ricinus communis] gi|223549145|gb|EEF50634.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 633 bits (1632), Expect = e-178, Method: Compositional matrix adjust.
Identities = 357/672 (53%), Positives = 443/672 (65%), Gaps = 44/672 (6%)
Query: 16 CQYSCGNVTINYPFGIGDGCYFDKRYEVICDDSSGSPKAFLAGVNNLELLNSDRYDGNLL 75
C CGNVTI YPFGIG+GCY D + V C+ +S + +L +N LELL + L+
Sbjct: 32 CSDRCGNVTIPYPFGIGEGCYMDSGFAVTCNKTSLPYRPYLTSIN-LELLRVS-LESTLV 89
Query: 76 RVNIPVISLKTTGHPNGVNLSGIPLTFSRW-HNRFAAIGCRNYNTIVKRANDSTVFGGCL 134
RVN PV++ P +LS FS +NRF A+GC N I ++ V GGCL
Sbjct: 90 RVNNPVLNSNCQDRPPVSDLSFSGSPFSFSDNNRFTALGCNNLALIYRQ---DMVIGGCL 146
Query: 135 TISTCALSSRGCYDFVC---ALPPNLTQDFNASMLYHFSQSIPQKCQSVLMVEENWLQSE 191
+I ++ CY C ++PP L + NAS L ++C+ MV+ W S
Sbjct: 147 SICNVTVTESSCYGINCCQTSIPPYL-KFINAS-LRSIDPVPDEQCRVAFMVDREWFSSN 204
Query: 192 FLTNANVLRDHQQFPAVLEFAEDRGNCVEE---YNSRTTCNKDNRCSIQLTSGYSCLCHR 248
N + L +Q PAVLE+ G C + NS C + CS+++ Y C C++
Sbjct: 205 ASDNISALLGAKQVPAVLEWGISNGTCADSPGAENSTDICGSNASCSVKVGINYQCSCNQ 264
Query: 249 SFNGLNDGYCVG------------DLLCDSASSPYNCSGCPNGYLLDDTDSCYQNTTAKT 296
+ G C ++C + Y CS CP+GY+ ++CY T T
Sbjct: 265 GYEGNPYLSCQDINECEDSQKNKCSMICVNTPGSYKCS-CPDGYI-SMGNNCYL-TDGYT 321
Query: 297 DTISPSPSPYEVVHENSNVLFIIIGCSVGAGLPFFLFMIGRLHEIVERRRVIKLKQNFFK 356
+ P I I S G G+PF L L+++ +RR+ KL+Q FFK
Sbjct: 322 ERFRP---------------VIAIVLSAGLGIPFLLIGTWWLYKVQKRRKDAKLRQRFFK 366
Query: 357 RNGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRI 416
RNGGLLLQQ+ SS+E + EKT +FT+ ELE ATD++N NRILGQGGQGTVYKGMLT+G++
Sbjct: 367 RNGGLLLQQQLSSSESSIEKTNMFTAKELEKATDHYNENRILGQGGQGTVYKGMLTDGKV 426
Query: 417 VAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQY 476
VAIKKSK+ DES EQFINEV ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQ+
Sbjct: 427 VAIKKSKIADESKTEQFINEVVILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQH 486
Query: 477 IHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 536
+HD +EEFPITWE+RLRIAIE AL YLHSAAS+PIYHRDIKS NILLDDKYRAKVSDF
Sbjct: 487 LHDPSEEFPITWEMRLRIAIETGSALSYLHSAASVPIYHRDIKSTNILLDDKYRAKVSDF 546
Query: 537 GASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRST 596
G S+S+ +DQTH+TTRVQGTFGYLDPEYF+SSQFTEKSDVYSFGVVLVELLTGQKPI S
Sbjct: 547 GTSKSIAVDQTHVTTRVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSA 606
Query: 597 DSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMK 656
+ E++SL YFL +M++NRLFE+LDARVLKE +EEI+ VA LA+RCLN+ GKKRPTM+
Sbjct: 607 RAVEERSLAMYFLLSMEQNRLFEILDARVLKEGGKEEILAVAKLARRCLNLNGKKRPTMR 666
Query: 657 EAAFELGGIRAS 668
E+ IRAS
Sbjct: 667 TVVTEVERIRAS 678
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475622|ref|XP_003631717.1| PREDICTED: wall-associated receptor kinase-like 10-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 606 bits (1563), Expect = e-170, Method: Compositional matrix adjust.
Identities = 347/707 (49%), Positives = 441/707 (62%), Gaps = 74/707 (10%)
Query: 10 TSSEDLCQYSCGNVTINYPFGIGD-GCYFDKRYEVICDDSSGSPKAFLAGVNNLELLNSD 68
T ++ CQ CG+V I YPFGIG GCYFD+ +EV C++S+ PK FL GVN LE+LN
Sbjct: 31 TQAKPGCQERCGDVDIPYPFGIGSAGCYFDEWFEVTCNNSTDPPKPFLKGVN-LEVLNVS 89
Query: 69 RYDGNLLRVNIPVI-SLKTTGHPNGVN--LSGIPLTFSRWHNRFAAIGCRNYNTIVKRAN 125
DG + RVN PV+ S +G P+ G P +FS + RF A+GC + +V
Sbjct: 90 -LDGTI-RVNNPVLLSQNCSGKPSNDTQWWEGGPFSFSNTYTRFTAVGC---SALVYIMQ 144
Query: 126 DSTVFGGCLTI---STCALSSRGCYDFVCA---LPPNLTQDFNASM--LYHFSQSIPQKC 177
D TV GGC+T A CY C +PP L F A++ S ++C
Sbjct: 145 DDTVIGGCMTFCKKDATAAKKASCYGLECCQTQVPPGLL-SFTANLGTFSDGSADEQEQC 203
Query: 178 QSVLMVEENWLQSEFLTNANVLRDHQQFPAVLEFAEDRGNCVEEYNSRTT----CNKDNR 233
+ MV++ W S + + + ++D + PAVL++ C ++ T C ++
Sbjct: 204 KFAFMVDQEWFISN-VPDPHTVKDMEYVPAVLDWRIYNATCAASTSNLNTSTSFCGENTL 262
Query: 234 CSIQL-TSGYSCLCHRSFNGLNDGYCVGDLLCDSASSPYNCSGCPNGYLLDDTDSCYQNT 292
CS TS C C + G +PY GC ++D
Sbjct: 263 CSTDTQTSSLICSCFPVYEG----------------NPYLPQGCQGTQSIED-------- 298
Query: 293 TAKTDTISPSPSPYEVVHENSNVLFIIIGCSVGAGLPFFLFMIGRLHEIVERRRVIKLKQ 352
I IG G + L+ +++RR+ IK K+
Sbjct: 299 ----------------------CAVITIG---ALGTLLLVLCAWWLYIVLKRRKKIKYKE 333
Query: 353 NFFKRNGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLT 412
F RNGGLLL+Q+ SS EGN +KTKLFTS ELE ATD +N NR++GQGG+GTVYKGML
Sbjct: 334 KCFNRNGGLLLEQQLSSTEGNIDKTKLFTSKELEKATDRYNENRVIGQGGEGTVYKGMLM 393
Query: 413 NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 472
+GRIVA+KK K++ +S +EQFINEV IL QINHRNVVKLLGCCLETEVPLLVYEFIPNGT
Sbjct: 394 DGRIVAVKKLKIMSDSKLEQFINEVVILCQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 453
Query: 473 LYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAK 532
L ++IH Q EEFPITWEIRLRIA EV+ AL YLHSAAS+PIYHRDIKS NILLDDKYRAK
Sbjct: 454 LSEHIHGQNEEFPITWEIRLRIATEVAGALSYLHSAASVPIYHRDIKSTNILLDDKYRAK 513
Query: 533 VSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
V+DFG S+ V IDQTHLTT+VQGTFGYLDPEYF+SSQFTEKSDVYSFG+VL+ELLTG+KP
Sbjct: 514 VADFGISKFVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKP 573
Query: 593 IRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKR 652
I ST SEE KSL YF+ +M E+RL ++LDA+V+KE+++EEI +A LA+RC+N+ GKKR
Sbjct: 574 ILSTASEEGKSLASYFILSMNEDRLSDLLDAQVVKESRKEEINAIAFLARRCINLNGKKR 633
Query: 653 PTMKEAAFELGGIRASIGDSIMQHNCDDIDFVAGHNTGHSEIGSSST 699
PTM E A EL IR GD Q N ++I++ G ++ S ST
Sbjct: 634 PTMMEVAMELERIRKCQGDFGAQENSEEIEYNTIELIGPWDVTSIST 680
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 600 bits (1547), Expect = e-169, Method: Compositional matrix adjust.
Identities = 350/695 (50%), Positives = 442/695 (63%), Gaps = 62/695 (8%)
Query: 1 MALLFWPMK----TSSEDLCQYSCGNVTINYPFGIGD-GCYFDKRYEVICDDSSGS--PK 53
++LL W + T + C +CG+V I YPFGIG GCYFD+ +EV C++S PK
Sbjct: 134 ISLLLWLSRGLAATQGKSGCLETCGDVDIPYPFGIGSAGCYFDEWFEVTCNNSIHPHIPK 193
Query: 54 AFLAGVNNLELLNSDRYDGNLLRVNIPVIS-LKTTGHP--NGVNLSGIPLTFSRWHNRFA 110
FL + NLE+LN + + +RVN PV+ + +G P + + G P +FS + RF
Sbjct: 194 PFLK-ILNLEVLNVS-LNRSTIRVNNPVLGYMNCSGKPSNDAQSWEGGPFSFSDTYTRFT 251
Query: 111 AIGCRNYNTIVKRANDSTVFGGCLTI---STCALSSRGCYDFVCA---LPPNLTQDFNAS 164
A+GC I + NDS V GGC++ T A + CY C PP L + +
Sbjct: 252 AVGCSTLAYITQ--NDS-VIGGCMSYCKQGTTAAKNGSCYGLKCCQTQFPPGL--QYFTT 306
Query: 165 MLYHF-SQSIPQ-KCQSVLMVEENWLQSEFLTNANVLRDHQQFPAVLEFAEDRGNC---- 218
ML F S S Q +C+ MV++ W S + + ++D PAVL++ C
Sbjct: 307 MLGDFPSNSDDQDECKYAFMVDQEWFIS-MEQDPDKVKDVGHAPAVLDWRIYNATCKSVG 365
Query: 219 ----VEEYNSRTTCNKDNRCSIQL-TSGYSCLCHRSFNGLNDGYCVGDLLCDSASSPYNC 273
S + C + CS T +C C R + G +PY
Sbjct: 366 WNNTSTSNTSTSFCGANAICSADTQTPSLTCRCPRGYEG----------------NPYLT 409
Query: 274 SGCP-NGYLLDDTDSCYQNTTA-----KTDTISPSPSPYEVVHENSNVLFIIIGCSVGAG 327
GC Y L + + N A D + P P +V I +G G G
Sbjct: 410 EGCEGTNYKLYENGTVCINRNANFSCYPVDKLIVDPRPRRMVLPG-----ICVGILAGVG 464
Query: 328 LPFFLFMIGRLHEIVERRRVIKLKQNFFKRNGGLLLQQESSSNEGNSEKTKLFTSMELEM 387
+ L+++++RR+ IK K+ FKRNGGLLL+Q+ SS+EGN +KTKLFTS ELE
Sbjct: 465 TLLLVICAWWLYKVLKRRQKIKYKEKCFKRNGGLLLEQQLSSSEGNVDKTKLFTSKELEK 524
Query: 388 ATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRN 447
ATD +N NR++GQGGQGTVYKGML +GRIVA+KK K+V + +EQFINEV ILSQINHRN
Sbjct: 525 ATDRYNENRVIGQGGQGTVYKGMLMDGRIVAVKKLKIVGDGKVEQFINEVVILSQINHRN 584
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
VVKLLGCCLET VPLLVYEFIPNGTL ++IHDQ EEFPITWE+RLRIAIEV+ AL YLHS
Sbjct: 585 VVKLLGCCLETAVPLLVYEFIPNGTLSEHIHDQNEEFPITWEMRLRIAIEVAGALSYLHS 644
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS 567
AASIPIYHRDIKS NILLDDKYRAKV+DFG S+SV IDQTHLTT+VQGTFGYLDPEYF+S
Sbjct: 645 AASIPIYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHLTTQVQGTFGYLDPEYFQS 704
Query: 568 SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627
SQFTEKSDVYSFG+VL+ELLTG+KPI ST SEE KSL YF+ +M E+RL ++LDA+V+K
Sbjct: 705 SQFTEKSDVYSFGIVLIELLTGKKPILSTASEEGKSLASYFILSMNEDRLSDLLDAQVVK 764
Query: 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662
E K+EEI +A LA+RC+N+ GKKRPTM E A EL
Sbjct: 765 EGKKEEINAIAFLARRCINLNGKKRPTMMEVAMEL 799
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147765961|emb|CAN70207.1| hypothetical protein VITISV_007744 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1522), Expect = e-166, Method: Compositional matrix adjust.
Identities = 339/708 (47%), Positives = 441/708 (62%), Gaps = 84/708 (11%)
Query: 10 TSSEDLCQYSCGNVTINYPFGIGD-GCYFDKRYEVICDDSSGSPKAFLAGVNNLELLNSD 68
T ++ CQ CG+V I YPFGIG GCYFD+ +EV C++S+ PK FL GV NLE+LN
Sbjct: 24 TQAKPGCQEWCGDVDIPYPFGIGSSGCYFDEWFEVTCNNSTDPPKPFLKGV-NLEVLNVS 82
Query: 69 RYDGNLLRVNIPV-ISLKTTGHPNGVN--LSGIPLTFSRWHNRFAAIGCRNYNTIVKRAN 125
+ +RVN PV +S +G P+ G P +FS + RF A+GC + +
Sbjct: 83 LH--GTVRVNNPVLLSQNCSGKPSNDTQWWEGGPFSFSNTYTRFTAVGC---SAMAYFMQ 137
Query: 126 DSTVFGGCLTIS----TCALSSRGCYDFVCA---LPPNLTQDFNASM--LYHFSQSIPQK 176
D TV GGC+T+ A + CY C +PP L F A++ S +
Sbjct: 138 DDTVIGGCMTLCKKDVATAAKNASCYGLECCQTQVPPGLL-SFTANLDTFPEGSADEQEP 196
Query: 177 CQSVLMVEENWLQSEFLTNANVLRDHQQFPAVLEFAEDRGNC---VEEYNSRTT-CNKDN 232
C+ MV++ W S + + + ++D + PAVL++ C N+ T+ C ++
Sbjct: 197 CKYAFMVDQEWFISN-VPDPHTVKDMEYVPAVLDWRIYNATCDASTSNLNTSTSFCGENT 255
Query: 233 RCSIQL-TSGYSCLCHRSFNGLNDGYCVGDLLCDSASSPYNCSGCPNGYLLDDTDSCYQN 291
CS TS +C C + G +PY GC
Sbjct: 256 FCSTDTQTSSLTCSCPLLYEG----------------NPYLPQGC--------------- 284
Query: 292 TTAKTDTISPSPSPYEVVHENSNVLFIIIGCSVGAGLPFFLFMIGRLHEIVERRRVIKLK 351
+V+ S +++ C+ ++L++ ++RR+ IK K
Sbjct: 285 ---------------QVITIGSLGTLLLVLCA------WWLYI------XLKRRKKIKYK 317
Query: 352 QNFFKRNGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGML 411
+ F RNGGLLL+Q+ SS+EGN +KTKLFTS ELE ATD +N NR++GQG QGT YKGML
Sbjct: 318 EKCFNRNGGLLLEQQLSSSEGNIDKTKLFTSKELEKATDRYNENRVIGQGXQGTXYKGML 377
Query: 412 TNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 471
+GRIVA+KK K++ +S +EQFINEV IL QINHRNVVKLLGCCLETEVPLLVYEFIPNG
Sbjct: 378 MDGRIVAVKKLKIMSDSKLEQFINEVVILCQINHRNVVKLLGCCLETEVPLLVYEFIPNG 437
Query: 472 TLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRA 531
TL ++IH Q EEFPITWE+RLRIA EV AL YLHS ASIPIYHRDIKS NILLBDKYRA
Sbjct: 438 TLSEHIHGQNEEFPITWEMRLRIATEVXGALSYLHSXASIPIYHRDIKSTNILLBDKYRA 497
Query: 532 KVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQK 591
KV+DFG S+ V IDQTHLTT+VQGTFGYLDPEYF+SSQFTEKSDVYSFG+VL+ELLTG+K
Sbjct: 498 KVADFGISKFVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKK 557
Query: 592 PIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKK 651
PI S SEE KSL YF+ +M E+RL ++LDA+V+KE+++EEI +A LA+RC+N+ GKK
Sbjct: 558 PILSIASEEGKSLASYFILSMNEDRLSDLLDAQVVKESRKEEINAIAFLARRCINLNGKK 617
Query: 652 RPTMKEAAFELGGIRASIGDSIMQHNCDDIDFVAGHNTGHSEIGSSST 699
RPTM E A EL IR GD Q N ++I++ G ++ S ST
Sbjct: 618 RPTMMEVAMELERIRKCQGDFRAQENFEEIEYNTTELIGPWDVTSIST 665
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053054|ref|XP_002297684.1| predicted protein [Populus trichocarpa] gi|222844942|gb|EEE82489.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 565 bits (1456), Expect = e-158, Method: Compositional matrix adjust.
Identities = 323/670 (48%), Positives = 438/670 (65%), Gaps = 49/670 (7%)
Query: 16 CQYSCGNVTINYPFGIGDGCYFDKRYEVICDDSSG-SP-KAFLAGVNNLELLNSDRYDGN 73
C +CGN+TI +PFGIG GCY + + V C++++ SP +AFL+ +N +E+ + +
Sbjct: 32 CTETCGNITIPFPFGIGTGCYMNDWFSVHCNETTADSPSRAFLSRIN-MEVFKIS-LESS 89
Query: 74 LLRVNIPVISLKTTGHPN--GVNLSGIPLTFSRWHNRFAAIGCRNYNTIVKRANDSTVFG 131
++RVN P+IS +G +N++G P +FS N F A+GC N ++ V
Sbjct: 90 VVRVNSPIISSGCSGRGANLAINMTGSPFSFSS-SNIFTAMGCNN-RALLNGIEPEIV-- 145
Query: 132 GCLTISTCALSSRGCYDFVCA-------LPPNLTQDFNASM---LYHFSQSIPQKCQSVL 181
GC STC S+ G + C+ P+ Q NAS+ + + +C+
Sbjct: 146 GC--TSTCGASTEGKENSYCSGNNCCQTTIPSSLQVVNASLGTPEHPINDQGRNQCKVAF 203
Query: 182 MVEENWLQSEFLTNANVLRDHQQFPAVLEFAEDRGNCVEEYNSRTTCNKDNRCSIQLTSG 241
+V+E W ++ +++ V++D Q P +L++ D C N T + ++ L S
Sbjct: 204 IVQEKWFRNN-ISSPEVVQDMQYVPVILDWNSDAMYCDPPMN--LTSGRSGLRTVTLYSN 260
Query: 242 YS-CLCHRSFNGLNDGYCVGDLLCDSASSPYNCSGCPNGYLLDDTDSCYQNTTAKTDTIS 300
+ C C+ ++G +PY GC + +D+ N+ +
Sbjct: 261 STICSCNWGYDG----------------NPYLPDGCTD---IDECKIPRGNSCSGMTKCV 301
Query: 301 PSPSPYEVVHENSNVLFIIIGCSVGAGLPFFLFMIGRLHEIVERRRVIKLKQNFFKRNGG 360
P ++ + + + F+ S GL L I RL+++V++R+ I+LK+ FFKRNGG
Sbjct: 302 NVPGGFKCELDKAKITFL----SAATGLLLLLVGIWRLYKLVKKRKNIELKKKFFKRNGG 357
Query: 361 LLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIK 420
LLLQQ+ SS++G+ +KTK+FTS ELE ATD FN NRILGQGGQGTVYKGM +G IVA+K
Sbjct: 358 LLLQQQLSSSDGSIQKTKIFTSKELEKATDRFNDNRILGQGGQGTVYKGMQADGMIVAVK 417
Query: 421 KSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ 480
KS LVDE +E+FINEV ILSQ+NHRNVVKLLGCCLETEVPLLVYEFIPNG L++YIHDQ
Sbjct: 418 KSILVDEEKLEEFINEVVILSQVNHRNVVKLLGCCLETEVPLLVYEFIPNGNLFEYIHDQ 477
Query: 481 TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540
EEF +WE+RLRIA EV+ AL YLHSAASIP+YHRDIKS NI+LD+K+RAKVSDFG SR
Sbjct: 478 KEEFEFSWEMRLRIATEVARALSYLHSAASIPVYHRDIKSTNIMLDEKFRAKVSDFGTSR 537
Query: 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
S+ IDQTHLTT VQGTFGYLDPEYF+SSQFT KSDVYSFGVVL ELL+GQKPI SEE
Sbjct: 538 SIAIDQTHLTTHVQGTFGYLDPEYFQSSQFTGKSDVYSFGVVLAELLSGQKPISYERSEE 597
Query: 601 DKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660
SL +F+ ++EN++F++LD R++ + +EEE+I VA LA+RCLN+IG+KRPTM+E A
Sbjct: 598 RGSLATHFILLVEENKIFDILDERLMGQDREEEVIAVANLARRCLNLIGRKRPTMREVAI 657
Query: 661 ELGGIRASIG 670
EL IR S G
Sbjct: 658 ELEQIRLSKG 667
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103351|ref|XP_002334062.1| predicted protein [Populus trichocarpa] gi|222869636|gb|EEF06767.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 563 bits (1452), Expect = e-157, Method: Compositional matrix adjust.
Identities = 329/702 (46%), Positives = 440/702 (62%), Gaps = 59/702 (8%)
Query: 16 CQYSCGNVTINYPFGIGDGCYFDKRYEVICDDSSGSPK--AFLAGVNNLELLNSDRYDGN 73
C+ +CGN++I +PFGIG GCY + + V C+ ++ + AFL+ +N L S R +
Sbjct: 6 CKDTCGNISIPFPFGIGTGCYLNYWFSVHCNKTTADSRSRAFLSSINMEVLEISLRR--S 63
Query: 74 LLRVNIPVISLKTTGHPN--GVNLSGIPLTFSRWHNRFAAIGCRNYNTIVKRANDSTVFG 131
++RVN P+IS +G ++++G P FS N F A+GC N ++ R V
Sbjct: 64 VVRVNSPIISSGCSGRGANISIDMTGSPFAFSS-SNIFIAMGCNN-RALLSRIEPEIV-- 119
Query: 132 GCLTISTCALSSRGCYDFVCA--------LPPNLTQDFNASM---LYHFSQSIPQKCQSV 180
GC T + S+ G + C+ +P NL Q FNAS+ + + +C+
Sbjct: 120 GCTTTGS---STEGKENSYCSGNNCCQTTIPSNL-QVFNASLGTTEHPINDQGRNQCKVA 175
Query: 181 LMVEENWLQSEFLTNANVLRDHQQFPAVLEFAEDRGNCVEEYNSRTTCNKDNRCSIQLTS 240
+VEE W ++ +++ V++D Q P +L + G + E + + S +T
Sbjct: 176 FIVEEEWFRNN-ISSPEVVQDMQYVPVILRWLMYYGTDIPEGVTLWGLSTVTLYSNSIT- 233
Query: 241 GYSCLCHRSFNGLNDGYCVGDLLCDSASSPYNCSGCPNGYLLDDTDSCY---QNTTAKTD 297
C C ++G PY GC D D C N +
Sbjct: 234 ---CWCSPGYDG----------------HPYLPDGC------TDIDQCKIPGVNWCSGMT 268
Query: 298 TISPSPSPYEVVHENSNVLFIIIGCSVGAGLPFFLFMIGRLHEIVERRRVIKLKQNFFKR 357
P Y+ + + + F+ S GL L I RL+++V++R+ I+LK+ FFKR
Sbjct: 269 KCVNVPGWYKCELDKAKITFL----SAATGLLLLLVGIWRLYKLVKKRKNIELKKKFFKR 324
Query: 358 NGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIV 417
NGGLLLQQ+ SS++G+ +KTK+FTS ELE ATD FN NRILGQGGQGTVYKGM +G IV
Sbjct: 325 NGGLLLQQQLSSSDGSIQKTKIFTSKELEKATDRFNDNRILGQGGQGTVYKGMQADGMIV 384
Query: 418 AIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYI 477
A+KKS LVDE +E+FINEV ILSQ+NHRNVVKLLGCCLETEVPLLVYEFIPNG L++YI
Sbjct: 385 AVKKSILVDEEKLEEFINEVVILSQVNHRNVVKLLGCCLETEVPLLVYEFIPNGNLFEYI 444
Query: 478 HDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537
HDQ EEF +WE+RLRIA EV+ AL YLHSAASIP+YHRDIKS NI+LD+K+RAKVSDFG
Sbjct: 445 HDQKEEFEFSWEMRLRIATEVARALSYLHSAASIPVYHRDIKSTNIMLDEKFRAKVSDFG 504
Query: 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 597
SRS+ IDQTHLTT VQGTFGYLDPEYF+SSQFT KSDVYSFGVVL ELL+GQKPI
Sbjct: 505 TSRSIAIDQTHLTTHVQGTFGYLDPEYFQSSQFTGKSDVYSFGVVLAELLSGQKPISYER 564
Query: 598 SEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657
E+ +SL +F+ M+EN++F++LD R++ + +EEE+I VA LA+RCLN+ G+KRPTM+E
Sbjct: 565 PEDRRSLATHFILLMEENKIFDILDERLMGQDREEEVIAVANLARRCLNLNGRKRPTMRE 624
Query: 658 AAFELGGIRASIGDSIMQHNCDDIDFVAGHNTGHSEIGSSST 699
A EL IR S G Q +C D++ + EI +T
Sbjct: 625 VAIELEQIRVSKGAPHAQQSCKDLENIRDEVPNVWEIAGPTT 666
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455808|ref|XP_002274809.1| PREDICTED: wall-associated receptor kinase-like 9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 556 bits (1433), Expect = e-155, Method: Compositional matrix adjust.
Identities = 325/669 (48%), Positives = 425/669 (63%), Gaps = 57/669 (8%)
Query: 17 QYSCGNVTINYPFGIGDGCYFDKRYEVICDDSSGSPKAFLAGVNNLELLN--SDRYDGNL 74
Q CG++ I YPFG+G CY D+ + + C S PK L+ +N LE+L+ DR+ ++
Sbjct: 35 QDHCGDILIPYPFGMGKSCYKDEWFSISCSHSFDPPKPILSKLN-LEVLSIEMDRFQKSV 93
Query: 75 LRVNIPVIS------LKTTGHP-NGVNLSGIPLTFSRWHNRFAAIGCRNYNTIVKRANDS 127
+ VN P+ S ++ T P +L G P +S HN +GC N ++ R +
Sbjct: 94 M-VNSPIYSNCENGEVEVTSSPWQSRDLWGSPFLYS-LHNDLVGVGCHN---VLLRDRNE 148
Query: 128 TVFGGCLTISTCALSSRGC-YDFVCALPPNLTQDFNASMLYHFSQSIPQKCQSVLMVEEN 186
+ GC + +++++GC Y C L L +D + Y S + +
Sbjct: 149 EIMAGCASTCDKSITTKGCLYGINCCLT-RLQEDLD---FYSLSTTASSSERGDPDCTYA 204
Query: 187 WLQSEFLTNANV---LRDHQQFPAVLEF----AEDRGNCVEEYNSRTTCNKDNRCSIQLT 239
+L + +NV +RD + P ++ + D NCV++ + N N
Sbjct: 205 FLAYNYNNVSNVTTIVRDAKYAPLLISWLIPEQVDPQNCVDDTVYTSRGNYPN------- 257
Query: 240 SGYSCLCHRSFNGLNDGYCVGDLLCDSASSPYNCSGCPNGYLLDDTDSCYQNTTAKTDTI 299
Y C C+ + G L C+ C G D Y ++T K D
Sbjct: 258 --YRCACNWAEEG-------NPYLAHGCQVVRECANCRWG-----CDGRYNSSTYKYDFY 303
Query: 300 SPSPSPYEVVHENSNVLFIIIGCSVGAGLPFFLFMIGRLHEIVERRRVIKLKQNFFKRNG 359
+ + + +I+GCS+ GL L L+++V ++ I++K+ FFKRNG
Sbjct: 304 CSTKNKSKA---------LILGCSISGGLLLLLIFSFGLYKVVRKQLDIRVKKRFFKRNG 354
Query: 360 GLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAI 419
GLLLQQ+ SS++ EKTK+FTS ELE ATDNFN NRILGQGGQGTVYKGML +GRIVA+
Sbjct: 355 GLLLQQQISSDKIAFEKTKIFTSDELEKATDNFNKNRILGQGGQGTVYKGMLNDGRIVAV 414
Query: 420 KKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHD 479
KKSK+VDE+ +E FINE+ ILSQINHRNVV +LGCCLETEVPLLVYEFI NGTL+Q IHD
Sbjct: 415 KKSKIVDENQLEHFINEIVILSQINHRNVVGILGCCLETEVPLLVYEFISNGTLFQLIHD 474
Query: 480 QTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539
Q EFP++WE+RLRIA+EVS AL YLHSA SIPIYHRDIKS NILLDDKY+AKVSDFG S
Sbjct: 475 QNSEFPLSWEMRLRIALEVSGALSYLHSACSIPIYHRDIKSTNILLDDKYKAKVSDFGTS 534
Query: 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSE 599
RS+ IDQTHLTT VQGTFGYLDPEYF+SSQFTEKSDVYSFGVVLVELLTGQKPI ST S
Sbjct: 535 RSISIDQTHLTTIVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLTGQKPISSTRSP 594
Query: 600 EDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAA 659
E+KSL +F+ +++E+RLF++LDARV+KE ++E+I+T A LA RCLN+ G+KRPTMKE
Sbjct: 595 EEKSLATHFILSLQESRLFDILDARVVKEGRKEDIMTFAKLAGRCLNLNGRKRPTMKEVT 654
Query: 660 FELGGIRAS 668
E+ IR S
Sbjct: 655 TEIDNIRVS 663
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075946|ref|XP_002304841.1| predicted protein [Populus trichocarpa] gi|222842273|gb|EEE79820.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 546 bits (1407), Expect = e-152, Method: Compositional matrix adjust.
Identities = 328/691 (47%), Positives = 427/691 (61%), Gaps = 60/691 (8%)
Query: 16 CQYSCGNVTINYPFGIGDGCYFDKRYEVICDDSS--GSPKAFLAGVNNLELLNSDRYDGN 73
CQ CGN++I YPFG CY ++ ++++C +++ +P+AF++ +N +E+LN DG
Sbjct: 32 CQNRCGNISIPYPFGTAQDCYANEMFKIVCRETTNESAPRAFISMIN-MEVLNIT--DGA 88
Query: 74 LLRVNIPVISLKTTGHPN---GVNLSGIPLTFSRWHNRFAAIGCRNYNTIVKRANDSTVF 130
+ VN P++S + + +NL+G P FS + N F A+GC N ++ V
Sbjct: 89 AI-VNGPIMSSNCSDRQSNLPALNLTGSPFFFS-FGNVFTAVGC-NVRALLTGIGRQVV- 144
Query: 131 GGCLTISTCALSSRG------------CYDFVC--ALPPNLTQDFNASMLYHFSQSIPQK 176
GC STC+ S C D C A P Q F S+
Sbjct: 145 -GC--DSTCSADSNQKTLLYGQEINSLCADGNCCVARAPYRMQVFQPSLDTKNGSEDSSG 201
Query: 177 CQSVLMVEENWLQSEFLTNANVLRDHQQFPAVLEFAEDRGNCVEEYNSRTTCNKD--NRC 234
C+ + +E +TN L+ + P VL + D + Y+ T K
Sbjct: 202 CKLAFLTDETNFSFLNITNPQALQGWRSVPLVLAWMMDYS--IWRYDKSTMDCKYFLYES 259
Query: 235 SIQLTSGYSCLCHRSFNGLNDGYCVGDLLCDSASSPYNCSGCPNGYLLDDTDSCYQNTTA 294
S+ SGY C C + G +PY GC D + C
Sbjct: 260 SVSNVSGYECSCSNGYEG----------------NPY--LGCT------DINECKDPNRH 295
Query: 295 KTDTISPSPSPYEVVHENSNVLFII-IGCSVGAGLPFFLFMIGRLHEIVERRRVIKLKQN 353
I+ + N +I+ I V AG+ L I L+++ ++R+ I+LK+
Sbjct: 296 SCLGITKCVNTLGSYKCEVNKYWIVPILVVVIAGILSLLAGISWLYKLAKKRKNIELKRK 355
Query: 354 FFKRNGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTN 413
FFKRNGGLLLQQ+ SSN G+ +KTK+FTS ELE ATD FN NRILGQGGQGTVYKGML +
Sbjct: 356 FFKRNGGLLLQQQLSSNHGSVQKTKIFTSKELETATDRFNENRILGQGGQGTVYKGMLED 415
Query: 414 GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 473
GRIVA+K+S +V E +E+FINEV ILSQINHRNVVKL GCCLETEVPLLVYEFI NG L
Sbjct: 416 GRIVAVKRSTIVGEEKLEEFINEVVILSQINHRNVVKLFGCCLETEVPLLVYEFISNGNL 475
Query: 474 YQYIHD--QTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRA 531
+QY+H+ Q E+F ++WE+RL+IAIEV+ AL YLHSAASIPIYHRDIKSANILLDDKYRA
Sbjct: 476 FQYLHNFYQNEDFILSWEMRLQIAIEVAGALSYLHSAASIPIYHRDIKSANILLDDKYRA 535
Query: 532 KVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQK 591
KVSDFG+SRS+ IDQTHLTT VQGTFGYLDPEYF+SSQFT+KSDVYSFGVVLVELL+G+K
Sbjct: 536 KVSDFGSSRSMAIDQTHLTTNVQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLVELLSGKK 595
Query: 592 PIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKK 651
PI S+ S+E +SL +F+ M+ENRLF++LD +V ++ EEEI+ VA LAKRCLN+ K
Sbjct: 596 PIISSTSQETRSLATHFIVLMEENRLFDILDVQVKEDCLEEEIMAVANLAKRCLNVSRKH 655
Query: 652 RPTMKEAAFELGGIRASIGDSIMQHNCDDID 682
RPTMKE + EL I SI+Q N +D +
Sbjct: 656 RPTMKEVSAELERIGLLHRKSIVQQNEEDTN 686
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 700 | ||||||
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.765 | 0.676 | 0.444 | 4.1e-134 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.647 | 0.574 | 0.519 | 1.3e-130 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.927 | 0.889 | 0.424 | 2.8e-130 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.614 | 0.597 | 0.509 | 6.2e-129 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.925 | 0.866 | 0.428 | 3.6e-128 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.612 | 0.557 | 0.508 | 8.9e-128 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.532 | 0.488 | 0.569 | 1.2e-125 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.918 | 0.856 | 0.417 | 4.3e-125 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.632 | 0.563 | 0.5 | 6.4e-125 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.6 | 0.529 | 0.514 | 1.3e-123 |
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1164 (414.8 bits), Expect = 4.1e-134, Sum P(2) = 4.1e-134
Identities = 261/587 (44%), Positives = 370/587 (63%)
Query: 110 AAIGCRNYNTIVKRAN-DSTVFGGCLTISTCALSSRGCYDFVCALPPNLTQDFNASMLYH 168
A + C+NYN K N DS++ + ++C + GC + ++ Q ++
Sbjct: 175 AVLNCQNYNGYEKNCNEDSSMDESIMDETSC--NGIGCCNAYMR-GGSIQQIVGVTI--- 228
Query: 169 FSQSIPQKCQSVLMVEENWLQSEFLTN-ANVLRDHQQFPAVLE-----------FAEDRG 216
+I + C+ + + +E+L+N ++ + H + + +E F + G
Sbjct: 229 -ENTITRGCKVAFLTNK----AEYLSNKSDPQKLHARGYSTVELGWFIHTTNHSFIKSLG 283
Query: 217 NC--VEEYNSRTTCNKDNRCSIQLTSGYSCLCHRSFNGLNDGYCVGDLLCDSASSPYNCS 274
C V+EYN+ + R I +TS C+C + L+ C +PY
Sbjct: 284 -CYSVKEYNNERYTSTQRR--INITS---CICDDNAY-LSYARC--SCTRGFQGNPYRLG 334
Query: 275 GCPNGYLLDDTDSCYQN---TTAKTDTISPSPSPYEVVHENSNVLFIIIGCSVGAGLPFF 331
GC D + C + T T+ ++ V+ N L I +G S G+
Sbjct: 335 GCK------DINECKEEEGMTYCGTNKCVNLQGHFKCVYNNHRPLAIGLGASFGS----L 384
Query: 332 LFMIG--RLHEIVERRRVIKLKQNFFKRNGGLLLQQXXXXXXXXXXKTKLFTSMELEMAT 389
+F++G L++ ++++R + K+ FFKRNGGLLLQQ KT +F+S ELE AT
Sbjct: 385 IFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFSSRELEKAT 444
Query: 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVV 449
+NF++NRILGQGGQGTVYKGML +GRIVA+KKSK+VDE +E+FINEV ILSQINHRN+V
Sbjct: 445 ENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIV 504
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEE-FPITWEIRLRIAIEVSDALCYLHSA 508
KLLGCCLET+VP+LVYEFIPNG L++++HD+ +E TW IRLRIAI+++ AL YLHS+
Sbjct: 505 KLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAGALSYLHSS 564
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS 568
AS PIYHRD+KS NI+LD+KYRAKVSDFG SR+V +D THLTT V GT GY+DPEYF+SS
Sbjct: 565 ASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSS 624
Query: 569 QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE 628
QFT+KSDVYSFGVVLVEL+TG+K I S+E+++L YF+ AMKEN+LF+++DAR+
Sbjct: 625 QFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDARIRDG 684
Query: 629 AKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSIMQ 675
++ A +A++CLN+ G+KRP+M+E + EL IR GD +Q
Sbjct: 685 CMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRMPCGDMQLQ 731
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1158 (412.7 bits), Expect = 1.3e-130, Sum P(2) = 1.3e-130
Identities = 243/468 (51%), Positives = 323/468 (69%)
Query: 219 VEEYNSRTTCNKDNRC-SIQLTSGYSCLCHR-SFNGLNDGYCVGDLLCDSA--SSPYNCS 274
V + + T DN +I+L + SC+C+ + +G + C G C +PY
Sbjct: 282 VNSLSCKNTKEYDNSTYNIKLVT--SCICNNVTISGTDYANC-G---CSQGYEGNPYLPG 335
Query: 275 GCPN-GYLLDDTDSCYQNTTAKTDTISPSPSPYEVVHENSNVLFIIIGCSVGAGLPFFLF 333
GC + L ++ QN ++DT P + + + V I +G + G + +
Sbjct: 336 GCKDINECLRNSYGQRQNCR-ESDTCVNLPGTFNCIGNKTRVTMIGVGSAFG--ILVLVV 392
Query: 334 MIGRLHEIVERRRVIKLKQNFFKRNGGLLLQQXXXXXXXXXXKTKLFTSMELEMATDNFN 393
I L + +++RR+ K K+ FFKRNGGLLLQQ KT++F+S ELE ATDNF+
Sbjct: 393 GIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEKTRIFSSRELEKATDNFS 452
Query: 394 TNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLG 453
+RILGQGGQGTVYKGML +GR VA+KKSK+VDE +E+FINEV ILSQINHR+VVKLLG
Sbjct: 453 ESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVILSQINHRHVVKLLG 512
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPI 513
CCLETEVP LVYEFIPNG L+Q+IH++++++ TW +RLRIA++++ AL YLHSAAS PI
Sbjct: 513 CCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIAGALSYLHSAASSPI 572
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 573
YHRDIKS NILLD+KYR KVSDFG SRSV ID TH TT + GT GY+DPEY+ SSQ+T+K
Sbjct: 573 YHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYGSSQYTDK 632
Query: 574 SDVYSFGVVLVELLTGQKPIRS-TDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEE 632
SDVYSFGVVLVEL+TG+KP+ + ++S+E + L +F AMKENR FE++DAR+ K E
Sbjct: 633 SDVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKENRFFEIMDARIRDGCKPE 692
Query: 633 EIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSIMQHNCDD 680
+++ VA LA+RCLN GKKRP M++ +L I AS DS++ DD
Sbjct: 693 QVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILASQEDSLVNIENDD 740
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1278 (454.9 bits), Expect = 2.8e-130, P = 2.8e-130
Identities = 303/713 (42%), Positives = 417/713 (58%)
Query: 7 PMKTSSEDLCQYSCGNVTINYPFGIGD-GCYFDKRYEVICDDSSGSPKAF--LAGVNNLE 63
P+ SS C +CG ++I +PFGIG CY + YEVIC+ ++ L + N E
Sbjct: 31 PISNSSTS-CNKTCGGISIPFPFGIGGKDCYLNGWYEVICNTTTSDSNTTVPLLSMINRE 89
Query: 64 LLNSDRYDGN----LLRVNIPVISL----KTTGHPNG----VNLSG--IPLTFSRWHNRF 109
++N D N L+++ PV SL T+ P +N++G P F NR
Sbjct: 90 VVNISLPDSNEPYGLVQIKGPVTSLGCSSNTSEGPQNSLPVLNVTGKGSPY-FLTDENRL 148
Query: 110 AAIGCRNYNTIVKRANDSTVFGGCLTISTCALSSRG-------CYDFVCA---LPPNLTQ 159
A+GC ++ +S + G C S+C G C + C LP Q
Sbjct: 149 VAVGC-GIKALMTDT-ESEILG-CE--SSCEHRKSGEEVTNLICTGYRCCQARLPVGRPQ 203
Query: 160 DFNASMLYHFSQSIPQKCQSVLMVEENWLQSEFLTNANVLRDHQQFPAVLEFAEDRGNCV 219
++ S + C+ + ++ + S +T H VLE
Sbjct: 204 AITVNI--ENSSGGEETCKVAFLTDKRYSPSN-VTEPEQF--HNNGYVVLELGWYFATSN 258
Query: 220 EEYNSRTTCNKDNRCSIQLTSGYS---CLCHRS-FNGLNDGYCVGDLLCDSASSPYNCSG 275
+ S C +R SG+S C C F+G++ C D +PY G
Sbjct: 259 SRFKSLLGCTNMSRKG----SGFSDDNCSCEYDYFSGMSYRNCYCDY--GYTGNPYLRGG 312
Query: 276 CPNGYLLDDTDSCYQNTTAKTDTISPS-PSPYEVVHENSNVLF-----IIIGCSVG-AGL 328
C DTDSC N D + P P + N + ++ G +G +GL
Sbjct: 313 CV------DTDSCEGNHNCGEDAHCVNMPGPMSMCRPNPKITKPTKPPVLQGILIGLSGL 366
Query: 329 PFFLFMIGRLHEIVERRRVIKLKQNFFKRNGGLLLQQXXXXXXXXXXKTKLFTSMELEMA 388
FF+ + L +++++RR I + FFKRNGGLLL+Q +K+F+S EL A
Sbjct: 367 VFFVGLFW-LFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKA 425
Query: 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNV 448
TDNF+ +R+LGQGGQGTVYKGML +G IVA+K+SK+VDE +E+FINE+ +LSQINHRN+
Sbjct: 426 TDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNI 485
Query: 449 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
VKLLGCCLETEVP+LVYE+IPNG L++ +HD+++++ +TWE+RLRIAIE++ AL Y+HSA
Sbjct: 486 VKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSA 545
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS 568
AS PI+HRDIK+ NILLD+KYRAKVSDFG SRSV +DQTHLTT V GTFGY+DPEYF SS
Sbjct: 546 ASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSS 605
Query: 569 QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE 628
Q+T KSDVYSFGVVLVEL+TG+KP+ SEE + L +FLEAMKENR+ +++D R+ E
Sbjct: 606 QYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDE 665
Query: 629 AKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGD-SIMQHNCDD 680
+K E+++ VA LA++CLN GK RP MKE + EL IR+S D + N D+
Sbjct: 666 SKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSSPEDLDVRTENEDE 718
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1107 (394.7 bits), Expect = 6.2e-129, Sum P(2) = 6.2e-129
Identities = 226/444 (50%), Positives = 300/444 (67%)
Query: 221 EYNSRTTCNKDNRCSIQLTSGYSCLCHRSFNGLNDGYCVGDLLCDSA--SSPYNCSGCPN 278
EY+ TT + R + + LC + D Y C + +PY GC +
Sbjct: 229 EYSEYTTIELEWRLDLSYMTSKRVLC-KGNTFFEDSY---QCSCHNGYEGNPYIPGGCQD 284
Query: 279 GYLLDDTDSCYQNTTAKTDTISPSPSPYEVVHENSNVLFIIIGCSVGAGLPFFLFMIGRL 338
+D+ + N K ++ S + I+ ++ +GL +F + L
Sbjct: 285 ---IDECRDPHLNKCGKRKCVNVLGS-----YRCEKTWPAILSGTLSSGLLLLIFGMWLL 336
Query: 339 HEIVERRRVIKLKQNFFKRNGGLLLQQXXXXXXXXXXKTKLFTSMELEMATDNFNTNRIL 398
+ +R+V K K+ FF+RNGGLLLQQ +TK+F+S +LE ATD FN +RIL
Sbjct: 337 CKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASRIL 396
Query: 399 GQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLET 458
GQGGQGTVYKGML +G IVA+KKSK + E N+E+FINE+ +LSQINHRNVVK+LGCCLET
Sbjct: 397 GQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLET 456
Query: 459 EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDI 518
EVP+LVYEFIPN L+ ++H+ +E+FP++WE+RL IA EV+DAL YLHSA SIPIYHRD+
Sbjct: 457 EVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYHRDV 516
Query: 519 KSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYS 578
KS NILLD+K+RAKVSDFG SRSV ID THLTT VQGT GY+DPEY +S+ FT KSDVYS
Sbjct: 517 KSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYS 576
Query: 579 FGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVA 638
FGV+L+ELLTG+KP+ +E + L YFLEAM+ +RL E+LDAR+ +E EE++ VA
Sbjct: 577 FGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDREEVLAVA 636
Query: 639 MLAKRCLNMIGKKRPTMKEAAFEL 662
LA+RCL++ + RPTM++ EL
Sbjct: 637 KLARRCLSLNSEHRPTMRDVFIEL 660
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1258 (447.9 bits), Expect = 3.6e-128, P = 3.6e-128
Identities = 296/691 (42%), Positives = 417/691 (60%)
Query: 14 DLCQYSCGNVTINYPFGIGD-GCYFDKRYEVICDDSSGSPKAFLAGVNNLELLNSDRYDG 72
D C CG ++I +PFGIG CY + YEV+C+ ++ P FL+ +N EL+N +G
Sbjct: 33 DRCNRVCGEISIPFPFGIGGKDCYLNPWYEVVCNSTNSVP--FLSRINR-ELVNIS-LNG 88
Query: 73 NLLRVNIPVISLK-TTGH-----PNGVNLSG--IPLTFSRWHNRFAAIGCRNYNTIVKRA 124
++ + PV S +TG P +N++G P F N A+GC+ + ++
Sbjct: 89 -VVHIKAPVTSSGCSTGTSQPLTPPPLNVAGQGSPY-FLTDKNLLVAVGCK-FKAVMAGI 145
Query: 125 ND--STVFGGCLTISTCALSSRG--CYDFVCA---LPPNLTQDFNASMLYHFSQSIPQKC 177
++ C ++ + R C + C +P Q + + Q
Sbjct: 146 TSQITSCESSCNERNSSSQEGRNKICNGYKCCQTRIPEGQPQVISVDI--EIPQGNNTTG 203
Query: 178 QSVLMVEENWLQSEFLTNANVLRDHQQFPAVLEFAEDRGNCVEEYNSRTT----CNKDNR 233
+ V +L S+ ++ NV + ++F A + G + +SR T C K+
Sbjct: 204 EGGCRVA--FLTSDKYSSLNVT-EPEKFHGHGYAAVELGWFFDTSDSRDTQPISC-KNAS 259
Query: 234 CSIQLTSGYSCLCHRSFNGLNDGYCVGDLLCDSASSPYNCSGCPNGYLLDDTDSCYQN-- 291
+ TS C C S+ G G+ D C+S N P G + D D C +
Sbjct: 260 DTTPYTSDTRCSC--SY-GYFSGFSYRDCYCNSPGYKGN-PFLPGGCV--DVDECKLDIG 313
Query: 292 -TTAKTDTISPSPSPYEVVHENSNVLFIII-GCSVGAGLPFFLFMIGRLHEIVERRRVIK 349
K + P ++ + L +I G +G+ L F F I L++ V++RR +
Sbjct: 314 RNQCKDQSCVNLPGWFDCQPKKPEQLKRVIQGVLIGSALLLFAFGIFGLYKFVQKRRKLI 373
Query: 350 LKQNFFKRNGGLLLQQXXXXXXXXXXKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKG 409
+ FF+RNGG+LL+Q +++F+S ELE ATDNFN NR+LGQGGQGTVYKG
Sbjct: 374 RMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKG 433
Query: 410 MLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIP 469
ML +GRIVA+K+SK VDE +E+FINEV +L+QINHRN+VKLLGCCLETEVP+LVYEF+P
Sbjct: 434 MLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVP 493
Query: 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY 529
NG L + +HD+++++ +TWE+RL IAIE++ AL YLHSAAS PIYHRDIK+ NILLD++
Sbjct: 494 NGDLCKRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERN 553
Query: 530 RAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTG 589
RAKVSDFG SRSV IDQTHLTT+V GTFGY+DPEYF+SS+FTEKSDVYSFGVVLVELLTG
Sbjct: 554 RAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTG 613
Query: 590 QKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIG 649
+KP SEE++ L +F+EA+KENR+ +++D R+ E +++++VA LA+RCLN G
Sbjct: 614 EKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKG 673
Query: 650 KKRPTMKEAAFELGGIRASIGDSIMQHNCDD 680
KKRP M+E + EL IR+S DS + DD
Sbjct: 674 KKRPNMREVSIELEMIRSSHYDSGIHIEDDD 704
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1125 (401.1 bits), Expect = 8.9e-128, Sum P(2) = 8.9e-128
Identities = 232/456 (50%), Positives = 304/456 (66%)
Query: 219 VEEYNSRTTCNKDNRCSIQLTSGYSCLCHRSFNGLNDGYCVGDLLCDSASSPY---NCSG 275
++EY T +DNR G CLC +N GY +PY C
Sbjct: 274 IDEY---TILRRDNR-----EYGIGCLC--DYNSTTTGYATCSCASGFEGNPYIPGECKD 323
Query: 276 ---CPNGYLLDDTDSCYQNTTAKTDTISPSPSPYEVVHENSNVLFIIIGCSVGAGLPFFL 332
C G +D C T K + Y + N L +IG S F+
Sbjct: 324 INECVRG--IDGNPVC---TAGKCVNLLGG---YTCEYTNHRPL--VIGLSTSFSTLVFI 373
Query: 333 FMIGRLHEIVERRRVIKLKQNFFKRNGGLLLQQXXXXXXXXXXKTKLFTSMELEMATDNF 392
I L++ + R+R + K+ FFKRNGGLLLQQ T++F S ELE AT+NF
Sbjct: 374 GGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKATENF 433
Query: 393 NTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLL 452
+ RILG+GGQGTVYKGML +GRIVA+KKSK+VDE +E+FINEV ILSQINHRN+VKLL
Sbjct: 434 SLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLL 493
Query: 453 GCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPIT-WEIRLRIAIEVSDALCYLHSAASI 511
GCCLET+VP+LVYEFIPNG L++++HD ++++ +T WE+RLRIA++++ AL YLHSAAS
Sbjct: 494 GCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASS 553
Query: 512 PIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFT 571
PIYHRDIKS NI+LD+K+RAKVSDFG SR+V +D THLTT V GT GY+DPEYF+SSQFT
Sbjct: 554 PIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFT 613
Query: 572 EKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKE 631
+KSDVYSFGVVL EL+TG+K + S+E ++L YF AMKENRL +++DAR+ K
Sbjct: 614 DKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARIRDGCKL 673
Query: 632 EEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667
++ A +A++CLNM G+KRP+M++ + EL IR+
Sbjct: 674 NQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRS 709
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1102 (393.0 bits), Expect = 1.2e-125, Sum P(2) = 1.2e-125
Identities = 218/383 (56%), Positives = 281/383 (73%)
Query: 324 VGAGLPFFLFMIGR----LHEIVERRRVIKLKQNFFKRNGGLLLQQXXXXXXXXXXKTKL 379
+G G FF+ ++G +++ +RR+ K+ FFKRNGGLLLQQ KTKL
Sbjct: 382 LGLGAGFFVLIVGGGIWWWRKLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKL 441
Query: 380 FTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAI 439
F+S ELE ATDNFN NR++GQGGQGTVYKGML +GR VA+KKS +VDE +++FINEV I
Sbjct: 442 FSSRELEKATDNFNDNRVIGQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVII 501
Query: 440 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVS 499
LSQINHR+VVKLLGCCLETEVP+LVYEFIPNG L+Q++H++ +++ W +R+RIA+++S
Sbjct: 502 LSQINHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDIS 561
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY 559
A YLH+AA PIYHRDIKS NILLD+KYRAKVSDFG SRSV ID TH TT + GT GY
Sbjct: 562 GAFSYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGY 621
Query: 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRS-TDSEEDKSLVGYFLEAMKENRLF 618
+DPEY+ SS FTEKSDVYSFGVVLVEL+TG+KP+ + ++++E L YF AM+ENRLF
Sbjct: 622 VDPEYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSETQEITGLADYFRLAMRENRLF 681
Query: 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSIMQHNC 678
E++DAR+ + K E++I VA LA RCL GK RP M+E + L I ++ D +Q
Sbjct: 682 EIIDARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTALERICSAPEDFQVQIQI 741
Query: 679 DDID----FVAGHNTGHSEIGSS 697
D+ D G++ G +EI S
Sbjct: 742 DEEDETTKLFRGYS-GSTEIARS 763
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1229 (437.7 bits), Expect = 4.3e-125, P = 4.3e-125
Identities = 287/687 (41%), Positives = 407/687 (59%)
Query: 11 SSEDLCQYSCGNVTINYPFGIGD-GCYFDKRYEVICDDS-SGSPKA-FLAGVN----NLE 63
SS C CG + I +PFGIG C+ + YEV+C+ + SG A FL +N ++
Sbjct: 32 SSSTSCNRICGGIEIPFPFGIGRRDCFLNDWYEVVCNSTTSGKSLAPFLYKINRELVSIT 91
Query: 64 LLNSDRYDGNLLRVNIPVISLKTTGHPNG---VNLSG--IPLTFSRWHNRFAAIGCRNYN 118
L +S ++ + PV S + P +NL+G P F NR ++GC N
Sbjct: 92 LRSSIDSSYGVVHIKSPVTSSGCSQRPVKPLPLNLTGKGSPF-FITDSNRLVSVGCDNRA 150
Query: 119 TIVKRANDSTVFGGCLTISTC----ALSSRGCYDFVCA---LPPNLTQDFNASMLYHFSQ 171
I + T GC S+C + + C + C +P + Q +
Sbjct: 151 LITDIESQIT---GCE--SSCDGDKSRLDKICGGYTCCQAKIPADRPQVIGVDLESSGGN 205
Query: 172 SIPQ-KCQSVLMVEENWLQSEFLTNANVLRDHQQFPAVLEFAEDRGNCVEEYNSRTT--- 227
+ C+ + E + + ANV Q + E G + +SR T
Sbjct: 206 TTQGGNCKVAFLTNETY------SPANVTEPEQFYTNGFTVIE-LGWYFDTSDSRLTNPV 258
Query: 228 -CNKDNRCSIQLTSGYSCLC-HRSFNGLNDGYCVGDLLCDSASSPYNCSGCPNGYLLDDT 285
C I TS SC+C + +F+G C + + +PY GC + +D+
Sbjct: 259 GCVNLTETGIY-TSAPSCVCEYGNFSGFGYSNCYCNQI-GYRGNPYLPGGCID---IDEC 313
Query: 286 DSCYQNTTAKTDTISPSPSPYEV-VHENSNVLFIIIGCSVGAGLPFFLFMIGRLHEIVER 344
+ ++ T P + ++ + + G +G L F + I L + V++
Sbjct: 314 EEGKGLSSCGELTCVNVPGSWRCELNGVGKIKPLFPGLVLGFPLLFLVLGIWGLIKFVKK 373
Query: 345 RRVIKLKQNFFKRNGGLLLQQXXXXXXXXXXKTKLFTSMELEMATDNFNTNRILGQGGQG 404
RR I K+ FFKRNGGLLL+Q +K+F+S ELE ATDNFN NR+LGQGGQG
Sbjct: 374 RRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLGQGGQG 433
Query: 405 TVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464
TVYKGML +GRIVA+K+SK++DE +E+FINEV +LSQINHRN+VKL+GCCLETEVP+LV
Sbjct: 434 TVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILV 493
Query: 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANIL 524
YE IPNG L++ +H ++++ +TW++RLRI++E++ AL YLHSAAS P+YHRD+K+ NIL
Sbjct: 494 YEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNIL 553
Query: 525 LDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLV 584
LD+KYRAKVSDFG SRS+ +DQTHLTT V GTFGYLDPEYF++SQFT+KSDVYSFGVVLV
Sbjct: 554 LDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLV 613
Query: 585 ELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRC 644
EL+TG+KP EE++ LV +F EAMK+NR+ +++D+R+ + E+++ VA LA+RC
Sbjct: 614 ELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAKLARRC 673
Query: 645 LNMIGKKRPTMKEAAFELGGIRASIGD 671
L++ GKKRP M+E + EL IR+S D
Sbjct: 674 LSLKGKKRPNMREVSVELERIRSSPED 700
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1113 (396.9 bits), Expect = 6.4e-125, Sum P(2) = 6.4e-125
Identities = 228/456 (50%), Positives = 307/456 (67%)
Query: 230 KDNRCSIQLTSGYSCLCHRSFNGLND-GYCVGDLLCDSASSPYNCSGCPNGYLLDDTDSC 288
KD + C+C + + ++D Y + +PY+ GC D D C
Sbjct: 287 KDTDTAYSNDQSIKCICDYTMSIISDIRYANCECNLGYKGNPYDSDGCR------DIDEC 340
Query: 289 YQNTT--AKTDTISPSPSPYEVVHENSNVLFIIIGCSVGAGLPFFLFMIGRLHEIVERRR 346
+N +TDT Y V + + I+IG G G+ + + L + + +RR
Sbjct: 341 KENPKYCKETDTCVNFEGGYRCVGDKTKA--IMIGAGTGFGVLVLVGGVWWLRKFLVKRR 398
Query: 347 VIKLKQNFFKRNGGLLLQQXXXXXXXXXXKTKLFTSMELEMATDNFNTNRILGQGGQGTV 406
+ K K+ FFKRNGGLLLQQ K ++FTS ELE AT+NF+ NR+LG GGQGTV
Sbjct: 399 MAKRKKKFFKRNGGLLLQQELNTRQGVVEKARIFTSKELEKATENFSENRVLGHGGQGTV 458
Query: 407 YKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466
YKGML +GR VA+KKSK++DE +++FINEV ILSQINHR+VVKLLGCCLETEVP+LVYE
Sbjct: 459 YKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETEVPILVYE 518
Query: 467 FIPNGTLYQYIHDQ-TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL 525
FI NG L+++IH++ +++ + W +RLRIA++++ AL YLHSAAS PIYHRDIKS NILL
Sbjct: 519 FIINGNLFKHIHEEEADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILL 578
Query: 526 DDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVE 585
D+KYRAKV+DFG SRSV IDQTH TT + GT GY+DPEY+RSSQ+TEKSDVYSFGV+L E
Sbjct: 579 DEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKSDVYSFGVILAE 638
Query: 586 LLTGQKP-IRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRC 644
L+TG KP I +++E +L +F AMKE RL +++DAR+ ++K E+++ VA LA +C
Sbjct: 639 LITGDKPVIMVQNTQEIIALAEHFRVAMKERRLSDIMDARIRDDSKPEQVMAVANLAMKC 698
Query: 645 LNMIGKKRPTMKEAAFELGGIRASIGDSIMQHNCDD 680
L+ G+ RP M+E EL I S DS +Q+ D+
Sbjct: 699 LSSRGRNRPNMREVFTELERICTSPEDSQVQNRIDE 734
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1085 (387.0 bits), Expect = 1.3e-123, Sum P(3) = 1.3e-123
Identities = 224/435 (51%), Positives = 299/435 (68%)
Query: 258 CVGDLLCDSASSPYNCSGCPNGY-----LLD---DTDSCYQNTT--AKTDTISPSPSPYE 307
C + S +S NC GC GY +L+ D D C KT+T Y
Sbjct: 312 CTCGRITISETSYANC-GCTYGYTGNPYVLNGCKDIDECKVKFEYCGKTETCVNFEGGYR 370
Query: 308 VVHENSNVLFIIIGCSVGAGLPFFLFMIGRLHEIVERRRVIKLKQNFFKRNGGLLLQQXX 367
V + + I+IG G G+ + + L + + +RR+ K K+ FFKRNGGLLL Q
Sbjct: 371 CVRDKTKA--IMIGAGTGFGVLVLVGGLWWLRKFLIKRRITKRKKKFFKRNGGLLLLQEL 428
Query: 368 XXXXXXXXKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDE 427
KT++F S ELE AT+NF+ NR+LG GGQGTVYKGML +GR VA+KKSK++DE
Sbjct: 429 NTREGYVEKTRVFNSRELEKATENFSENRVLGHGGQGTVYKGMLVDGRTVAVKKSKVIDE 488
Query: 428 SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ-TEEFPI 486
+++FINEV ILSQINHR+VVKLLGCCLETEVP+LVYEFI NG L+++IH++ ++++ +
Sbjct: 489 DKLQEFINEVVILSQINHRHVVKLLGCCLETEVPMLVYEFIINGNLFKHIHEEESDDYTM 548
Query: 487 TWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546
W +RLRIA++++ AL YLHS+AS PIYHRDIKS NILLD+KYRAKV+DFG SRSV IDQ
Sbjct: 549 LWGMRLRIAVDIAGALSYLHSSASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQ 608
Query: 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP-IRSTDSEEDKSLV 605
TH TT + GT GY+DPEY++SSQ+TEKSDVYSFGV+L EL+TG KP I +++E +L
Sbjct: 609 THWTTVISGTVGYVDPEYYQSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIVALA 668
Query: 606 GYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665
+F AMKE RL +++DAR+ + K E+++ VA +A +CL+ GKKRP M+E EL I
Sbjct: 669 EHFRVAMKEKRLTDIIDARIRNDCKPEQVMAVAKVAMKCLSSKGKKRPNMREVFTELERI 728
Query: 666 RASIGDSIMQHNCDD 680
S DS + + D+
Sbjct: 729 CTSPEDSQVHNRIDE 743
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 700 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-54 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-52 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-42 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-35 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-32 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-29 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-29 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-27 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-27 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-25 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-23 | |
| pfam13947 | 106 | pfam13947, GUB_WAK_bind, Wall-associated receptor | 2e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-23 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-23 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-21 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-19 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-15 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-13 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-13 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 1e-55
Identities = 88/271 (32%), Positives = 134/271 (49%), Gaps = 21/271 (7%)
Query: 392 FNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIE--QFINEVAILSQINHRNV 448
+ R LG G GTVYK G+IVA+K K E + + E+ IL +++H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 449 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
V+L+ + + LV E+ G L+ Y+ P++ + +IA+++ L YLHS
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHSN 117
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE-YFRS 567
I HRD+K NILLD+ K++DFG ++ ++ + LTT V GT Y+ PE
Sbjct: 118 G---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGG 173
Query: 568 SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627
+ + K DV+S GV+L ELLTG+ P + + L E + +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQL--IRRILGPPLEFDEPKWSSGSE 231
Query: 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
EAK+ L K+CLN KRPT +E
Sbjct: 232 EAKD--------LIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 1e-54
Identities = 72/193 (37%), Positives = 106/193 (54%), Gaps = 10/193 (5%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKK-SKLVDESNIEQFINEVAILSQINHRNVVKLLGCC 455
LG+GG GTVY G+ VAIK K S +E+ + E+ IL ++NH N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 456 LETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515
+ LV E+ G+L + + E ++ + LRI +++ + L YLH S I H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 516 RDIKSANILLD-DKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ-FTEK 573
RD+K NILLD D + K++DFG S+ + L + GT Y+ PE ++EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKL-LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 574 SDVYSFGVVLVEL 586
SD++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 2e-52
Identities = 84/268 (31%), Positives = 126/268 (47%), Gaps = 29/268 (10%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNI-EQFINEVAILSQINHRNVVKLLG 453
LG+G G VY G++VAIK K E+ + E+ IL ++ H N+V+L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSDALCYLHSAAS 510
+ + LV E+ G L+ + + +E+ E R ++ AL YLHS
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSED-----EAR-FYLRQILSALEYLHSK-- 116
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQF 570
I HRD+K NILLD+ K++DFG +R + LTT V GT Y+ PE +
Sbjct: 117 -GIVHRDLKPENILLDEDGHVKLADFGLAR-QLDPGEKLTTFV-GTPEYMAPEVLLGKGY 173
Query: 571 TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAK 630
+ D++S GV+L ELLTG+ P D L+ F + K F + + EAK
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPF-----PGDDQLLELFKKIGKPKPPFPPPEWDISPEAK 228
Query: 631 EEEIITVAMLAKRCLNMIGKKRPTMKEA 658
+ L ++ L +KR T +EA
Sbjct: 229 D--------LIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 5e-52
Identities = 81/272 (29%), Positives = 125/272 (45%), Gaps = 31/272 (11%)
Query: 395 NRILGQGGQGTVYKGMLTNG-----RIVAIKKSKL-VDESNIEQFINEVAILSQINHRNV 448
+ LG+G G VYKG L VA+K K E IE+F+ E I+ +++H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 449 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
VKLLG C E E ++V E++P G L Y+ ++ L A++++ + YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS 568
S HRD+ + N L+ + K+SDFG SR + D + + ++ PE +
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 569 QFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLV--GYFLEAMKENRLFEVLDARV 625
+FT KSDV+SFGV+L E+ T G++P + E + GY L
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPN----------- 228
Query: 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657
E+ L +C + RPT E
Sbjct: 229 ----CPPEL---YKLMLQCWAEDPEDRPTFSE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 9e-52
Identities = 82/272 (30%), Positives = 125/272 (45%), Gaps = 32/272 (11%)
Query: 395 NRILGQGGQGTVYKGMLT-----NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNV 448
+ LG+G G VYKG L VA+K K E IE+F+ E I+ +++H NV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 449 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
VKLLG C E E +V E++ G L Y+ + ++ L A++++ + YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE-- 119
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS 568
S HRD+ + N L+ + K+SDFG SR + D + + ++ PE +
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 569 QFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLV--GYFLEAMKENRLFEVLDARV 625
+FT KSDV+SFGV+L E+ T G++P +EE + GY L
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPN----------- 227
Query: 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657
E+ L +C + RPT E
Sbjct: 228 ----CPPEL---YDLMLQCWAEDPEDRPTFSE 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 1e-49
Identities = 68/208 (32%), Positives = 111/208 (53%), Gaps = 17/208 (8%)
Query: 395 NRILGQGGQGTVYKGMLT-----NGRIVAIKKSKL-VDESNIEQFINEVAILSQINHRNV 448
+ LG+G G VYKG L VA+K K E E+F+ E +I+ +++H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 449 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
V+LLG C + E +V E++P G L ++ E+ + L++A++++ + YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE-- 119
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFG---YLDPEYF 565
S HRD+ + N L+ + K+SDFG SR + D + G ++ PE
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESL 176
Query: 566 RSSQFTEKSDVYSFGVVLVELLT-GQKP 592
+ +FT KSDV+SFGV+L E+ T G++P
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 5e-49
Identities = 84/278 (30%), Positives = 123/278 (44%), Gaps = 38/278 (13%)
Query: 396 RILGQGGQGTVYKGMLTNG----RIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVK 450
+ LG+G G VYKG L VA+K K E + F+ E ++ ++ H NVV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 451 LLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFP------ITWEIRLRIAIEVSDALCY 504
LLG C E E LV E++ G L Y+ FP ++ + L AI+++ + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDP 562
L S HRD+ + N L+ + K+SDFG SR V D + G ++ P
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-GGKLPIRWMAP 176
Query: 563 EYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLV--GYFLEAMKENRLFE 619
E + FT KSDV+SFGV+L E+ T G P +EE + GY L
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKP------- 229
Query: 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657
+ +E + L C + + RPT E
Sbjct: 230 -------EYCPDE----LYELMLSCWQLDPEDRPTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 63/203 (31%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLL 452
+LG+G G+VY + G ++A+K +L E +E E+ ILS + H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 453 GCCL-ETEVPLLVY-EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAAS 510
G E + L ++ E++ G+L + + P IR + ++ + L YLHS
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKF-GKLPEP-VIR-KYTRQILEGLAYLHSNG- 121
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSV-MIDQTHLTTRVQGTFGYLDPEYFRSSQ 569
I HRDIK ANIL+D K++DFG ++ + I+ T V+GT ++ PE R +
Sbjct: 122 --IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 570 FTEKSDVYSFGVVLVELLTGQKP 592
+ +D++S G ++E+ TG+ P
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 82/266 (30%), Positives = 120/266 (45%), Gaps = 32/266 (12%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL 456
+G+GG G VYK G+ VAIK KL + E+ INE+ IL + H N+VK G L
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 457 ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIA---IEVSDALCYLHSAASIPI 513
+ + +V EF G+L + + + IA E+ L YLHS I
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLHSNG---I 119
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 573
HRDIK+ANILL K+ DFG S + T + GT ++ PE + K
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGL--SAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 574 SDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL--DARVLKEAKE 631
+D++S G+ +EL G+ P L MK LF++ L+ ++
Sbjct: 178 ADIWSLGITAIELAEGKPPYSE-------------LPPMKA--LFKIATNGPPGLRNPEK 222
Query: 632 EEIITVAMLAKRCLNMIGKKRPTMKE 657
L K+CL +KRPT ++
Sbjct: 223 WSDEFKDFL-KKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 4e-39
Identities = 78/266 (29%), Positives = 122/266 (45%), Gaps = 24/266 (9%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLL 452
+ +G+G G VY ++G++ +K+ L + E E +NEV IL ++NH N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 453 GCCLETEVPLLVYEFIPNGTLYQYIHDQTEEF-PITWEIRLRIAIEVSDALCYLHSAASI 511
E +V E+ G L Q I Q +E P E L +++ AL YLHS
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-- 123
Query: 512 PIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFT 571
I HRDIK NI L K+ DFG S+ + T V GT YL PE ++ +
Sbjct: 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYLSPELCQNKPYN 181
Query: 572 EKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKE 631
KSD++S G VL EL T + P +L+ L+ +K + + ++ E +
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPFEGE------NLLELALKILKGQ--YPPIPSQYSSELRN 233
Query: 632 EEIITVAMLAKRCLNMIGKKRPTMKE 657
L L ++RP++ +
Sbjct: 234 --------LVSSLLQKDPEERPSIAQ 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 68/206 (33%), Positives = 108/206 (52%), Gaps = 12/206 (5%)
Query: 391 NFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRN 447
N+ ++G+G G VYKG+ L G VAIK+ L + E ++ + E+ +L + H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAI-EVSDALCYLH 506
+VK +G ++ ++ E+ NG+L Q I + FP E + + + +V L YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIK-KFGPFP---ESLVAVYVYQVLQGLAYLH 116
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR 566
I HRDIK+ANIL K++DFG + + + D + V GT ++ PE
Sbjct: 117 EQGVI---HRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 567 SSQFTEKSDVYSFGVVLVELLTGQKP 592
S + SD++S G ++ELLTG P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 136 bits (342), Expect = 7e-35
Identities = 77/281 (27%), Positives = 118/281 (41%), Gaps = 22/281 (7%)
Query: 391 NFNTNRILGQGGQGTVYKGMLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINH-R 446
++ R LG+G G VY ++VA+K K +E+F+ E+ IL+ +NH
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH 506
N+VKL + LV E++ G+L + + P++ L I ++ AL YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 507 SAASIPIYHRDIKSANILLD-DKYRAKVSDFGASRSVMIDQTHLTTRVQ-----GTFGYL 560
S I HRDIK NILLD D K+ DFG ++ + + + GT GY+
Sbjct: 119 SKGII---HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 561 DPEYFRSSQF---TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617
PE + SD++S G+ L ELLTG P + S +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ----TLKIILELP 231
Query: 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
L + + E + L K+ L K R +
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272
|
Length = 384 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 81/290 (27%), Positives = 120/290 (41%), Gaps = 47/290 (16%)
Query: 397 ILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQF----INEVAILSQINHRNVVKL 451
LG+G G VYK G IVA+KK +L ++ E + E+++L ++ H N+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 452 LGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASI 511
L LV+E+ L +Y+ + I+ I ++ L Y HS
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPN-LIK-SIMYQLLRGLAYCHSHR-- 118
Query: 512 PIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE-YFRSSQF 570
I HRD+K NIL++ K++DFG +R+ I T V T Y PE S +
Sbjct: 119 -ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHY 176
Query: 571 TEKSDVYSFGVVLVELLTGQKPIRSTDSEED--------------------KSLVGY--F 608
+ D++S G + E++TG KP+ DSE D L Y
Sbjct: 177 STAVDIWSVGCIFAEMITG-KPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235
Query: 609 LEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
L +VL + E I L + L KR + KEA
Sbjct: 236 FPKFPPKDLEKVL------PRLDPEGID---LLSKMLQYNPAKRISAKEA 276
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 72/208 (34%), Positives = 107/208 (51%), Gaps = 13/208 (6%)
Query: 398 LGQGGQGTVYKGMLTN-GRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKLLG 453
LG+G G V + G++ A+K K K++ +E + E ILS+INH +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 454 CCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIP 512
+TE L LV E+ P G L+ ++ + F R A E+ AL YLHS
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEER-ARFYAA-EIVLALEYLHSLG--- 113
Query: 513 IYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTE 572
I +RD+K NILLD K++DFG ++ + + + T GT YL PE + +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGK 172
Query: 573 KSDVYSFGVVLVELLTGQKPIRSTDSEE 600
D +S GV+L E+LTG+ P + D +E
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 71/259 (27%), Positives = 127/259 (49%), Gaps = 24/259 (9%)
Query: 398 LGQGGQGTVYKGML-TNGRIVAIKKSKLVDESNIEQ--FINEVAILSQINHRNVVKLLGC 454
+G+G G V+K + + R+ A+K+ L + E+ I+E +L++++ +++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIY 514
L+ +V E+ NG L++ + Q P+ + R I++ L +LHS I
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSKK---IL 123
Query: 515 HRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKS 574
HRDIKS N+ LD K+ D G ++ ++ D T+ + GT YL PE + EKS
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAK-LLSDNTNFANTIVGTPYYLSPELCEDKPYNEKS 182
Query: 575 DVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEI 634
DV++ GVVL E TG+ P D+ +L+ L+ ++ +F + ++
Sbjct: 183 DVWALGVVLYECCTGKHPF---DANNQGALI---LKIIRG--VFPPVSQMYSQQ------ 228
Query: 635 ITVAMLAKRCLNMIGKKRP 653
+A L +CL ++RP
Sbjct: 229 --LAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 61/190 (32%), Positives = 101/190 (53%), Gaps = 12/190 (6%)
Query: 398 LGQGGQGTVYKGMLTNGRIVAIKKSKLVDESN-IEQFINEVAILSQINHRNVVKLLGCCL 456
+G+G G V G G+ VA+K K D+S + F+ E ++++ + H N+V+LLG L
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLK--DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 457 ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHR 516
+ +V E++ G+L Y+ + IT +L A++V + + YL HR
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHR 126
Query: 517 DIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDV 576
D+ + N+L+ + AKVSDFG ++ Q V+ T PE R +F+ KSDV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDV 182
Query: 577 YSFGVVLVEL 586
+SFG++L E+
Sbjct: 183 WSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 72/277 (25%), Positives = 117/277 (42%), Gaps = 34/277 (12%)
Query: 390 DNFNTNRILGQGGQGTVYKGML-TNGRIVAIKKSKLVDESNIEQFI-NEVAILSQINHRN 447
+ ++LGQG G VYK G+I A+KK + + + + E+ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRL-RIAIEVSDALCYLH 506
VVK G + +V E++ G+L + + + P E L IA ++ L YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIP---EPVLAYIARQILKGLDYLH 116
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV--MIDQTHLTTRVQGTFGYLDPEY 564
+ I HRDIK +N+L++ K K++DFG S+ + +DQ + T V GT Y+ PE
Sbjct: 117 TKRHI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPER 171
Query: 565 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624
+ ++ +D++S G+ L+E G+ P + FE++ A
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFP----------------FLPPGQPSFFELMQAI 215
Query: 625 VLKEAKE-EEIITVAMLA---KRCLNMIGKKRPTMKE 657
CL KKRP+ E
Sbjct: 216 CDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 69/223 (30%), Positives = 108/223 (48%), Gaps = 35/223 (15%)
Query: 396 RILGQGGQGTVYKGMLTNGR------IVAIKKSK-LVDESNIEQFINEVAILSQINHRNV 448
R LG+G G V+ G + +VA+K K + F E +L+ H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 449 VKLLGCCLETEVPLLVYEFIPNGTLYQYI--HD---------QTEEFPITWEIRLRIAIE 497
VK G C E + P++V+E++ +G L +++ H + +T L+IA++
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 498 VSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTT---RVQ 554
++ + YL AS HRD+ + N L+ K+ DFG SR V TT RV
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY------TTDYYRVG 181
Query: 555 GT----FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
G ++ PE +FT +SDV+SFGVVL E+ T G++P
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 65/229 (28%), Positives = 103/229 (44%), Gaps = 30/229 (13%)
Query: 390 DNFNTNRILGQGGQGTVYKGML-TNGRIVAIK---KSKLVDESNIEQFINEVAILSQIN- 444
D+F +I+G+G TV + AIK K +L+ E ++ E +L+++N
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCY 504
H ++KL + E V E+ PNG L QYI R A E+ AL Y
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS-LDEKC-TRFYAA-EILLALEY 117
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQ---------- 554
LHS I HRD+K NILLD K++DFG ++ + + + + +
Sbjct: 118 LHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 555 ---------GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIR 594
GT Y+ PE + SD+++ G ++ ++LTG+ P R
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 78/278 (28%), Positives = 114/278 (41%), Gaps = 54/278 (19%)
Query: 398 LGQGGQGTVYKGMLTN-GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL 456
+G+G G VYK G+ VAIKK +L + N E INE+ I+ H N+V L
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 457 ETEVPLLVYEFIPNGTL----YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIP 512
+ +V E++ G+L Q E +I + EV L YLHS I
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEP-----QIA-YVCREVLQGLEYLHSQNVI- 138
Query: 513 IYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQ------GTFGYLDPEYFR 566
HRDIKS NILL K++DFG + LT GT ++ PE +
Sbjct: 139 --HRDIKSDNILLSKDGSVKLADFGFA-------AQLTKEKSKRNSVVGTPYWMAPEVIK 189
Query: 567 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF----LEAMKENRLFEVLD 622
+ K D++S G++ +E+ G+ P Y L A+ L
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPP--------------YLREPPLRALF---LITTKG 232
Query: 623 ARVLKEAKE--EEIITVAMLAKRCLNMIGKKRPTMKEA 658
LK ++ E +CL +KRP+ +E
Sbjct: 233 IPPLKNPEKWSPEFKDF---LNKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 71/213 (33%), Positives = 114/213 (53%), Gaps = 15/213 (7%)
Query: 396 RILGQGGQGTVYKGMLT----NGRIVAIKK-SKLVDESNIEQFINEVAILSQINHRNVVK 450
R++G+G G VY G L A+K +++ D +EQF+ E I+ +H NV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 451 LLGCCLETE-VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA 509
LLG CL +E PL+V ++ +G L +I +T P ++ + ++V+ + YL A
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN-PTVKDL-IGFGLQVAKGMEYL---A 115
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM---IDQTHLTTRVQGTFGYLDPEYFR 566
S HRD+ + N +LD+ + KV+DFG +R + H T + ++ E +
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 567 SSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDS 598
+ +FT KSDV+SFGV+L EL+T G P DS
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 68/199 (34%), Positives = 106/199 (53%), Gaps = 16/199 (8%)
Query: 398 LGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNI--EQFINEVAILSQINHRNVVKLLGCC 455
LG G G V+ G VAIK ++ E + + FI E ++ +++H N+V+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 456 LETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515
+ +V E++ NG L Y+ ++ + E L + +V +A+ YL S I H
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGT--EWLLDMCSDVCEAMEYLESNGFI---H 123
Query: 516 RDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGT---FGYLDPEYFRSSQFTE 572
RD+ + N L+ + KVSDFG +R V+ DQ T QGT + PE F S+F+
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 573 KSDVYSFGVVLVELLTGQK 591
KSDV+SFGV++ E+ + K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 69/229 (30%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 391 NFNTNRILGQGGQGTVYK-GMLTNGRIVAIKKSKLVDESNIEQF--INEVAILSQINHRN 447
+F + LG+G G+VYK L++ + A+K+ L S E+ +NE+ IL+ +NH N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 448 VVK-----LLGCCLETEVPLLVYEFIPNGTLYQYI-HDQTEEFPITWEIRLRIAIEVSDA 501
++ L G L +V E+ P G L + I + + I + RI I++
Sbjct: 61 IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
L LH I HRD+KSANILL K+ D G S+ ++ + T++ GT Y+
Sbjct: 116 LQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISK--VLKKNMAKTQI-GTPHYMA 169
Query: 562 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE--DKSLVGYF 608
PE ++ ++ KSD++S G +L E+ T P + ++ K G +
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY 218
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 17/212 (8%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLVDE--SNIEQFINEVAILSQINHRNVVKLLGC 454
+G G G VY + L G ++A+K+ ++ D I++ +E+ +L + H N+VK G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAASIPI 513
+ E + E+ GTL + + E I E +R+ +++ + L YLHS I
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTLQLLEGLAYLHSHG---I 120
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFG---YLDPEYFRSSQF 570
HRDIK ANI LD K+ DFG + + + T + VQ G Y+ PE +
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 571 TEK---SDVYSFGVVLVELLTGQKPIRSTDSE 599
+D++S G V++E+ TG++P D+E
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 6/208 (2%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINH 445
E + F R LG G G V++G+ N VAIK K D + F EV L ++ H
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
++++ L C E ++ E + G+L ++ E + + +A +V++ + YL
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYL 120
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF 565
SI HRD+ + NIL+ + KV+DFG +R ++ + +L++ + + + PE
Sbjct: 121 EEQNSI---HRDLAARNILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIPYKWTAPEAA 176
Query: 566 RSSQFTEKSDVYSFGVVLVELLT-GQKP 592
F+ KSDV+SFG++L E+ T GQ P
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 69/204 (33%), Positives = 111/204 (54%), Gaps = 7/204 (3%)
Query: 398 LGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLE 457
+G G G V+ G R VAIK + S E FI E ++ +++H +V+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 458 TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRD 517
LV+EF+ +G L Y+ Q +F + E L + ++V + + YL S+ I HRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKF--SQETLLGMCLDVCEGMAYLESSNVI---HRD 125
Query: 518 IKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVY 577
+ + N L+ + KVSDFG +R V+ DQ +T + + PE F S+++ KSDV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 578 SFGVVLVELLT-GQKPIRSTDSEE 600
SFGV++ E+ + G+ P + + E
Sbjct: 186 SFGVLMWEVFSEGKTPYENRSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 17/205 (8%)
Query: 398 LGQGGQGTVYKGMLTN--GRI--VAIK--KSKLVDESNIEQFINEVAILSQINHRNVVKL 451
LG G G V +G + G++ VA+K KS + + ++ F+ E AI+ ++H N+++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLIRL 61
Query: 452 LGCCLETEVPLLVYEFIPNGTLYQYIHD-QTEEFPITWEIRLRIAIEVSDALCYLHSAAS 510
G L T ++V E P G+L + F I+ A+++++ + YL S
Sbjct: 62 YGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLIS--TLCDYAVQIANGMRYLESKRF 118
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGT--FGYLDPEYFRSS 568
I HRD+ + NILL + K+ DFG R++ ++ H F + PE R+
Sbjct: 119 I---HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 569 QFTEKSDVYSFGVVLVELLT-GQKP 592
F+ SDV+ FGV L E+ T G++P
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 66/212 (31%), Positives = 119/212 (56%), Gaps = 23/212 (10%)
Query: 397 ILGQGGQGTVYKGM-LTNGRIVAIKKSKL--VDESN-------IEQFINEVAILSQINHR 446
++G G G+VY GM ++G ++A+K+ +L V S+ ++ E+A+L ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAI-EVSDALCYL 505
N+V+ LG L+ + + E++P G++ + + F E +R + ++ L YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFE---ETLVRNFVRQILKGLNYL 122
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTR-----VQGTFGYL 560
H+ I HRDIK ANIL+D+K K+SDFG S+ + + T +QG+ ++
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 561 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
PE + + +T K+D++S G ++VE+LTG+ P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 71/242 (29%), Positives = 114/242 (47%), Gaps = 26/242 (10%)
Query: 396 RILGQGGQGTVYKGMLTN-----GRIVAIKKSKLVDESN-IEQFINEVAILSQINHRNVV 449
+ LG+G G V G VA+K E F E+ IL ++H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 450 KLLGCCLET--EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
K G C + L+ E++P+G+L Y+ ++ I + L + ++ + YL S
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDYLGS 127
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG---TFGYLDPEY 564
I HRD+ + NIL++ + K+SDFG ++ + D+ + + G F Y PE
Sbjct: 128 QRYI---HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 565 FRSSQFTEKSDVYSFGVVLVELLT--------GQKPIRSTDSEEDKSLVGYFLEAMKEN- 615
R+S+F+ SDV+SFGV L EL T + +R + + +V LE +KE
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE 243
Query: 616 RL 617
RL
Sbjct: 244 RL 245
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 75/279 (26%), Positives = 131/279 (46%), Gaps = 38/279 (13%)
Query: 396 RILGQGGQGTVYKGMLT----NGRI-VAIKKSKLVDES---NIEQFINEVAILSQINHRN 447
++LG G GTVYKG+ +I VAIK L +E+ ++ ++E +++ ++H +
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKV--LREETSPKANKEILDEAYVMASVDHPH 70
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
VV+LLG CL + L+ + +P G L Y+ + + I + L ++++ + YL
Sbjct: 71 VVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEE 127
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG---TFGYLDPEY 564
+ HRD+ + N+L+ K++DFG ++ + +D+ +G ++ E
Sbjct: 128 KR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALES 182
Query: 565 FRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623
+T KSDV+S+GV + EL+T G KP + E L+ K RL
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL------EKGERL------ 230
Query: 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662
I V M+ +C + + RPT KE E
Sbjct: 231 ----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 395 NRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNI--EQFINEVAILSQINHRNVVKLL 452
R LG G G V+ G VA+K K + E F+ E I+ ++ H +V+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKLVQLY 67
Query: 453 GCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIP 512
C E E +V E++ G+L ++ + + + +A ++++ + YL S I
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIAEGMAYLESRNYI- 125
Query: 513 IYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDPEYFRSSQF 570
HRD+ + NIL+ + K++DFG +R +I+ T R F + PE +F
Sbjct: 126 --HRDLAARNILVGENLVCKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAANYGRF 181
Query: 571 TEKSDVYSFGVVLVELLT-GQKP 592
T KSDV+SFG++L E++T G+ P
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 17/206 (8%)
Query: 398 LGQGGQGTVYKG--MLTNGRI--VAIKKSKLVDESNIEQ-FINEVAILSQINHRNVVKLL 452
LG G G+V KG ++ +G+ VA+K K + ++ F+ E ++++Q++H +V+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 453 GCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAASI 511
G C E +LV E P G L +Y+ + L+ A +V+ + YL S +
Sbjct: 63 GVCKG-EPLMLVMELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 512 PIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDPEYFRSSQ 569
HRD+ + N+LL ++++AK+SDFG SR++ + G + + PE +
Sbjct: 118 ---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 570 FTEKSDVYSFGVVLVELLT-GQKPIR 594
F+ KSDV+S+GV L E + G KP
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYG 200
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 68/214 (31%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLT---NGRI-VAIKKSKL-VDESNIEQFINEVAIL 440
E+ ++ R +G+G G VY+G+ N +I VA+K K S E+F+ E I+
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 441 SQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVS 499
Q +H ++VKL+G TE P+ +V E P G L Y+ Q ++ + + + ++S
Sbjct: 62 RQFDHPHIVKLIGVI--TENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLS 117
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY 559
AL YL S HRDI + N+L+ K+ DFG SR + + + ++ + +
Sbjct: 118 TALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKW 174
Query: 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
+ PE +FT SDV+ FGV + E+L G KP
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 8e-27
Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 19/213 (8%)
Query: 397 ILGQGGQGTVYKGMLTNGRIVAIKK------SKLVDESNIEQFINEVAILSQINHRNVVK 450
+LG+G GTVY G+ G+++A+K+ + L E E+ EV +L + H N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 451 LLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEF-PITWEIRLRIAIEVSDALCYLHSAA 509
LG CL+ + EF+P G++ + F P+ + + ++ D + YLH+
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT-----TRVQGTFGYLDPEY 564
+ HRDIK N++L K+ DFG +R + H T + GT ++ PE
Sbjct: 123 VV---HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 565 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 597
S + KSD++S G + E+ TG+ P+ S D
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 76/274 (27%), Positives = 121/274 (44%), Gaps = 35/274 (12%)
Query: 397 ILGQGGQGTVYKGM-LTNGRIVAIKK---SKLVDESNIEQFINEVAILSQINHRNVVKLL 452
+G+G GTV K ++G+I+ K+ + E +Q ++EV IL ++ H N+V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 453 GCCL--ETEVPLLVYEFIPNGTLYQYIHDQTEEF-PITWEIRLRIAIEVSDALCYLH--S 507
+ + +V E+ G L Q I +E I E RI ++ AL H S
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS 567
+ HRD+K ANI LD K+ DFG ++ + D + T V GT Y+ PE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNH 184
Query: 568 SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLV--GYF--LEAMKENRLFEVLDA 623
+ EKSD++S G ++ EL P + + + S + G F + + L EV+
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVI-- 242
Query: 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657
K LN+ KRP+ +E
Sbjct: 243 ------------------KSMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCC 455
+G G VY + L N VAIK+ L ++++++ EV +SQ NH NVVK
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 456 LETEVPLLVYEFIPNGTL-----YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAAS 510
+ + LV ++ G+L Y +E I ++ EV L YLHS
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK-----EVLKGLEYLHSNGQ 123
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSV---MIDQTHLTTRVQGTFGYLDPEYFRS 567
I HRDIK+ NILL + K++DFG S S+ + GT ++ PE
Sbjct: 124 I---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 568 SQ-FTEKSDVYSFGVVLVELLTGQKP 592
+ K+D++SFG+ +EL TG P
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 79/293 (26%), Positives = 132/293 (45%), Gaps = 51/293 (17%)
Query: 398 LGQGGQGTVYKGMLT--NGR-------IVAIKKSKLVDESNIEQFINEVAILSQINHRNV 448
LG+G G VYKG LT N R I +K++ +F E ++S + H N+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ--EFRQEAELMSDLQHPNI 70
Query: 449 VKLLGCCLETEVPLLVYEFIPNGTLYQYI-----HDQTEEFPITWEIR--------LRIA 495
V LLG C + + +++E++ +G L++++ H ++ L IA
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 496 IEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG 555
I+++ + YL +S HRD+ + N L+ + K+SDFG SR + + RVQ
Sbjct: 131 IQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY---SADYYRVQS 184
Query: 556 T----FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLE 610
++ PE +FT +SD++SFGVVL E+ + G +P ++E
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---------- 234
Query: 611 AMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663
+ E++ +R L E+ V L C N I +RP K+ L
Sbjct: 235 ------VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 24/214 (11%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFIN--EVAILSQINHRNVVKLLGC 454
+G+G G VYK G IVAIKK KL ES E+ +L ++NH N++KLL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFP------ITWEIRLRIAIEVSDALCYLHSA 508
LV+EF+ + LY+ I D+ P +++ L+ L + HS
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQL-LQ-------GLAFCHSH 117
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE-YFRS 567
I HRD+K N+L++ + K++DFG +RS T V T Y PE
Sbjct: 118 G---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGD 173
Query: 568 SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
++ D++S G + ELL+ + P+ SE D
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR-PLFPGKSEID 206
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 63/222 (28%), Positives = 114/222 (51%), Gaps = 12/222 (5%)
Query: 396 RILGQGGQGTVYKGMLTNGRIVAIK--KSKLVDESNIEQFINEVAILSQINHRNVVKLLG 453
+G+G G VYKG+L VA+K +S L + +F+ E IL Q +H N+VKL+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIG 59
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPI 513
C++ + +V E +P G+L ++ + + + L+++++ + + YL S I
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLESKNCI-- 115
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTT-RVQGTFGYLDPEYFRSSQFTE 572
HRD+ + N L+ + K+SDFG SR ++ Q + PE ++T
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 573 KSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLV--GYFLEA 611
+SDV+S+G++L E + G P +++ + + GY + A
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA 216
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 69/245 (28%), Positives = 117/245 (47%), Gaps = 35/245 (14%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTN------GRIVAIKKSKLVDESNIEQ---FINE 436
E+ + R LGQG G VY+G+ VAIK + + +++ + F+NE
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKT--VNENASMRERIEFLNE 59
Query: 437 VAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEE-------FPITWE 489
+++ + N +VV+LLG + L+V E + G L Y+ + E P T +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 490 IRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM------ 543
+++A E++D + YL A+ HRD+ + N ++ + K+ DFG +R +
Sbjct: 120 KFIQMAAEIADGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 544 -IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEED 601
+ L R ++ PE + FT KSDV+SFGVVL E+ T ++P + +EE
Sbjct: 177 KGGKGLLPVR------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV 230
Query: 602 KSLVG 606
V
Sbjct: 231 LKFVI 235
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 63/216 (29%), Positives = 112/216 (51%), Gaps = 24/216 (11%)
Query: 396 RILGQGGQGTVYKGMLT--NGRI--VAIKKSKL--VDESNIEQFINEVAILSQINHRNVV 449
+ILG+G G+V +G L+ +G VA+K KL S IE+F++E A + +H NV+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 450 KLLGCCLETE------VPLLVYEFIPNGTLYQY-----IHDQTEEFPITWEIRLRIAIEV 498
KL+G C E P+++ F+ +G L+ + + E+ P+ + L+ +++
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDI 122
Query: 499 SDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRV-QGTF 557
+ + YL + I HRD+ + N +L + V+DFG S+ + + R+ +
Sbjct: 123 ALGMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 558 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
++ E +T KSDV++FGV + E+ T GQ P
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 80/270 (29%), Positives = 126/270 (46%), Gaps = 29/270 (10%)
Query: 398 LGQGGQGTVYKGMLTN-GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL 456
LG G G VY+G+ VA+K K D +E+F+ E A++ +I H N+V+LLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 457 ETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515
E P ++ EF+ G L Y+ + + + + L +A ++S A+ YL I H
Sbjct: 73 R-EPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKNFI---H 127
Query: 516 RDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDPEYFRSSQFTEK 573
RD+ + N L+ + + KV+DFG SR +M T+ T F + PE ++F+ K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSR-LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 574 SDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEE 632
SDV++FGV+L E+ T G P D + ++E+L+ E E
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEKGYRMERPEG 229
Query: 633 EIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662
V L + C RP+ E
Sbjct: 230 CPPKVYELMRACWQWNPSDRPSFAEIHQAF 259
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 60/210 (28%), Positives = 113/210 (53%), Gaps = 22/210 (10%)
Query: 395 NRILGQGGQGTVYKGMLT-NGR---IVAIK--KSKLVDESNIEQFINEVAILSQINHRNV 448
+++G G G V +G L G+ VAIK K+ D+ ++ F+ E +I+ Q +H N+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNI 67
Query: 449 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
++L G ++ +++ E++ NG+L +++ + +F T + + ++ + YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF--TVGQLVGMLRGIASGMKYLSEM 125
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTR-----VQGTFGYLDPE 563
+ HRD+ + NIL++ KVSDFG SR + + TT+ ++ T PE
Sbjct: 126 NYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APE 178
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
+FT SDV+SFG+V+ E+++ G++P
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 81/303 (26%), Positives = 129/303 (42%), Gaps = 51/303 (16%)
Query: 391 NFNTNRILGQGGQGTVYKGMLTN--GR----IVAIKKSKL-VDESNIEQFINEVAILSQI 443
N + LG+G G V K GR VA+K K S + ++E +L Q+
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 444 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIH---------------------DQTE 482
NH +V+KL G C + LL+ E+ G+L ++ D +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 483 EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542
E +T + A ++S + YL A + + HRD+ + N+L+ + + K+SDFG SR V
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 543 MIDQTHLTTRVQGTF--GYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSE 599
+ +++ R +G ++ E +T +SDV+SFGV+L E++T G P E
Sbjct: 178 YEEDSYV-KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236
Query: 600 EDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAA 659
RLF +L E E + L C KRPT + +
Sbjct: 237 ----------------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280
Query: 660 FEL 662
EL
Sbjct: 281 KEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 59/206 (28%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESN-----IEQFINEVAILSQINHRNVV 449
+LG G G+VY+G+ L +G A+K+ L D+ ++Q E+A+LS++ H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 450 KLLGCCLETEVPLLVY-EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIE-VSDALCYLHS 507
+ LG E + L ++ E +P G+ + +++ E +R+ + L YLH
Sbjct: 66 QYLGTEREED-NLYIFLELVPGGS----LAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS 567
++ HRDIK ANIL+D K++DFG ++ V+ +G+ ++ PE
Sbjct: 121 RNTV---HRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIAQ 175
Query: 568 S-QFTEKSDVYSFGVVLVELLTGQKP 592
+ +D++S G ++E+ TG+ P
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 72/246 (29%), Positives = 115/246 (46%), Gaps = 32/246 (13%)
Query: 396 RILGQG--GQGTVYKGMLTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKL 451
R+LG+G G+ T+Y+ + +V K+ L + E +NE+ ILS + H N++
Sbjct: 6 RVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 452 LGCCLETEVPLLVYEFIPNGTLYQYI-HDQTEEFPITWEIRLRIAIEVSDALCYLHSAAS 510
++ L+ E+ GTLY I + + F E+ L ++ A+ Y+H A
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE--EEMVLWYLFQIVSAVSYIHKAG- 121
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQF 570
I HRDIK+ NI L K+ DFG S+ ++ + + V GT Y+ PE + ++
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAETVVGTPYYMSPELCQGVKY 178
Query: 571 TEKSDVYSFGVVLVELLTGQK--------------------PIRSTDSEEDKSLVGYFLE 610
KSD+++ G VL ELLT ++ P+ S S E SLV L+
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQ 238
Query: 611 AMKENR 616
E R
Sbjct: 239 QDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 38/289 (13%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESN---IEQFINEVAILSQINHRNVVKL 451
+G+G G VYK G +VA+KK ++ +E I I E+ +L ++ H N+V+L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPI-TAIREIKLLQKLRHPNIVRL 63
Query: 452 LGCCLETEVP--LLVYEFIP---NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH 506
+V+E++ G L TE +I+ ++ + L YLH
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES-----QIK-CYMKQLLEGLQYLH 117
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPE-Y 564
S I HRDIK +NIL+++ K++DFG +R + T RV T Y PE
Sbjct: 118 SNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELL 173
Query: 565 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDK-----SLVGYFLEA----MKEN 615
++++ + D++S G +L EL G KPI +E ++ L G + + +
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLG-KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232
Query: 616 RLFEVLD-----ARVLKEAKEEEIITVAM-LAKRCLNMIGKKRPTMKEA 658
FE L R L+E + I A+ L + L + KKR + +A
Sbjct: 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 56/198 (28%), Positives = 100/198 (50%), Gaps = 6/198 (3%)
Query: 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCC 455
R LG G G V++G+ N VA+K K + + F+ E I+ ++ H +++L C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 456 LETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515
E +V E + G+L +Y+ + + +A +V+ + YL + I H
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQNYI---H 126
Query: 516 RDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSD 575
RD+ + N+L+ + KV+DFG +R + D + + PE ++F+ KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 576 VYSFGVVLVELLT-GQKP 592
V+SFG++L E++T G+ P
Sbjct: 187 VWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL 456
+GQG GTVY + + G+ VAIK+ L + E INE+ ++ + H N+V L L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 457 ETEVPLLVYEFIPNGTLYQYIHD-QTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515
+ +V E++ G+L + + +E I R E AL +LHS I H
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQVI---H 138
Query: 516 RDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSD 575
RDIKS NILL K++DFG + +Q+ +T V GT ++ PE + K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 576 VYSFGVVLVELLTGQKP 592
++S G++ +E++ G+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 74/256 (28%), Positives = 114/256 (44%), Gaps = 40/256 (15%)
Query: 391 NFNTNRILGQGGQGTVYKGML-TNGRIVAIK---KSKLVDESNIEQFINEVAILSQINHR 446
+F R++G+G G V ++ A+K K K V++ ++ +NE IL ++NH
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSDALC 503
+V L + E LV + + G L ++ + +EE +++ I E+ AL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-----QVKFWIC-EIVLALE 114
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE 563
YLHS I HRDIK NILLD++ ++DF + V D LTT GT GY+ PE
Sbjct: 115 YLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPE 169
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLTGQKPIR----------------------STDSEED 601
++ D +S GV E L G++P R +T S E
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEA 229
Query: 602 KSLVGYFLEAMKENRL 617
+ LE + RL
Sbjct: 230 IDAINKLLERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 83/272 (30%), Positives = 129/272 (47%), Gaps = 20/272 (7%)
Query: 396 RILGQGGQGTV--YKGMLTN---GRIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVV 449
R+LG+G G V Y N G +VA+K K + N + E+ IL + H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 450 KLLGCCLET--EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
K GCC E + L+ E++P G+L Y+ + L A ++ + + YLHS
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHS 125
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG---TFGYLDPEY 564
I HRD+ + N+LLD+ K+ DFG +++V + R G F Y E
Sbjct: 126 QHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-VEC 181
Query: 565 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624
+ ++F+ SDV+SFGV L ELLT +S + ++ ++G M RL E+L+
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIELLERG 240
Query: 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMK 656
+ + V +L K C K RPT +
Sbjct: 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 9/209 (4%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSK---LVDESNIEQFINEVAILSQIN 444
NF + +G+G VYK + L +GR+VA+KK + ++D + + E+ +L Q++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYI-HDQTEEFPITWEIRLRIAIEVSDALC 503
H NV+K L +E +V E G L + I H + ++ I + +++ AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE 563
++HS I HRDIK AN+ + K+ D G R T + V GT Y+ PE
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
+ + KSD++S G +L E+ Q P
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 1e-23
Identities = 81/278 (29%), Positives = 138/278 (49%), Gaps = 36/278 (12%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIKKS-KLVDES-----NIEQFINEVAILSQINHRNV 448
++LG G GTVYKG+ + G V I + K+++E+ N+E F++E I++ ++H ++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHL 71
Query: 449 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
V+LLG CL + LV + +P+G L Y+H+ + I ++ L ++++ + YL
Sbjct: 72 VRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER 128
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTR-VQGTFGYLDPEYFRS 567
+ HRD+ + N+L+ K++DFG +R + D+ + ++ E
Sbjct: 129 R---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 568 SQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626
+FT +SDV+S+GV + EL+T G KP + E L LE K RL
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL----LE--KGERL--------- 230
Query: 627 KEAKEEEIIT--VAMLAKRCLNMIGKKRPTMKEAAFEL 662
+ I T V M+ +C + RP KE A E
Sbjct: 231 ---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEF 265
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 68/217 (31%), Positives = 97/217 (44%), Gaps = 27/217 (12%)
Query: 398 LGQGGQGTVYKGMLTN-GRIVAIKKSKLVDESNIEQFIN-----EVAILSQINHRNVVKL 451
LG+G VYK GRIVAIKK KL + + IN E+ +L ++ H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 452 LGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLR------IAIEVSDALCYL 505
L LV+EF+ L + I D+ I L + L YL
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDK--------SIVLTPADIKSYMLMTLRGLEYL 118
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE-Y 564
HS I HRD+K N+L+ K++DFG +RS +T +V T Y PE
Sbjct: 119 HSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELL 174
Query: 565 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
F + + D++S G + ELL + P DS+ D
Sbjct: 175 FGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDID 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 74/269 (27%), Positives = 133/269 (49%), Gaps = 33/269 (12%)
Query: 397 ILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL 456
I+G+G G V +G T G+ VA+K K + + F+ E A++++++H+N+V+LLG L
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 457 ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHR 516
+ +V E + G L ++ + ++ L+ +++V++ + YL S + HR
Sbjct: 70 HNGL-YIVMELMSKGNLVNFLRTRGRALVSVIQL-LQFSLDVAEGMEYLESKK---LVHR 124
Query: 517 DIKSANILLDDKYRAKVSDFGASR--SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKS 574
D+ + NIL+ + AKVSDFG +R S+ +D + L + + PE + +F+ KS
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKS 178
Query: 575 DVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEE 633
DV+S+GV+L E+ + G+ P M + E ++ E E
Sbjct: 179 DVWSYGVLLWEVFSYGRAP----------------YPKMSLKEVKECVEKGYRMEPPEGC 222
Query: 634 IITVAMLAKRCLNMIGKKRPTMKEAAFEL 662
V +L C KKRP+ + +L
Sbjct: 223 PADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 37/216 (17%)
Query: 392 FNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVK 450
F+ LG+G G+VYK + G++VAIK + E ++++ I E++IL Q + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62
Query: 451 LLGCCLETEVPLLVYEF-----------IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVS 499
G + +V E+ I N TL TEE IA +
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL-------TEE---------EIAAILY 106
Query: 500 DA---LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGT 556
L YLHS I HRDIK+ NILL+++ +AK++DFG S + D V GT
Sbjct: 107 QTLKGLEYLHSNKKI---HRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGT 162
Query: 557 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
++ PE + + K+D++S G+ +E+ G+ P
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 2e-23
Identities = 37/105 (35%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 16 CQYSCGNVTINYPFGIGDGCYFDKRYEVICDDSSGSPKAFLAGVNNLELLNSDRYDGNLL 75
C CGNV+I YPFGIG GC D +E+ C++++ P+ L G N E+L+ +
Sbjct: 4 CPDRCGNVSIPYPFGIGPGCARDPGFELTCNNTTSPPRLLL-GNGNYEVLSIS-LANGTV 61
Query: 76 RVNIPVISL---KTTGHPNGVNLS-GIPLTFSRWHNRFAAIGCRN 116
RV P+ S + + +LS G P FS N+F +GC
Sbjct: 62 RVLDPISSNCYNSSGKRTDNGSLSLGGPFFFSSSRNKFVVVGCNT 106
|
This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 11/206 (5%)
Query: 398 LGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLE 457
LG G G V G VAIK K S ++FI E ++ +++H +V+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 458 TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRD 517
+V E++ NG L Y+ + + F L + +V + + YL S I HRD
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRF--QPSQLLEMCKDVCEGMAYLESKQFI---HRD 125
Query: 518 IKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDPEYFRSSQFTEKSD 575
+ + N L+DD+ KVSDFG SR V+ D+ T+ V F + PE S+F+ KSD
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 576 VYSFGVVLVELLT-GQKPIRSTDSEE 600
V++FGV++ E+ + G+ P ++ E
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSE 209
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 67/224 (29%), Positives = 117/224 (52%), Gaps = 15/224 (6%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGML-TNGR---IVAIKKSKL-VDESNIEQFINEVAIL 440
E+ + +++G G G V++G+L GR VAIK K E + F++E +I+
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 441 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEF-PITWEIRLRIAIEVS 499
Q +H N+++L G + + +++ E++ NG L +Y+ D EF LR ++
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIA 117
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID--QTHLTTRVQGTF 557
+ YL + + HRD+ + NIL++ KVSDFG SR + D T+ T+ +
Sbjct: 118 AGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174
Query: 558 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600
+ PE +FT SDV+SFG+V+ E+++ G++P + E
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 79/285 (27%), Positives = 113/285 (39%), Gaps = 64/285 (22%)
Query: 398 LGQGGQGTVYKG-MLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL 456
+G G G VYK + G +VAIK KL + E E+++L + H N+V G L
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 457 ETEVPLLVYEFIPNGTL---YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPI 513
+ +V E+ G+L YQ E I + R E L YLH I
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAYLHETGKI-- 123
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQ------GTFGYLDPEYF-- 565
HRDIK ANILL + K++DFG S LT + GT ++ PE
Sbjct: 124 -HRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPYWMAPEVAAV 175
Query: 566 -RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624
R + K D+++ G+ +EL Q P +F++ R
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPP------------------------MFDLHPMR 211
Query: 625 VL----KEA------KEEEIITVAM--LAKRCLNMIGKKRPTMKE 657
L K K++E + K+CL KKRPT +
Sbjct: 212 ALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATK 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 84/287 (29%), Positives = 130/287 (45%), Gaps = 32/287 (11%)
Query: 398 LGQGGQGTV----YKGMLTN-GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLL 452
LG+G G+V Y + N G +VA+KK + ++ F E+ IL + H N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 453 GCCLETEVP--LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAAS 510
G C LV E++P G+L Y+ E + L A ++ + YL S
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYLGSKRY 129
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG---TFGYLDPEYFRS 567
+ HRD+ + NIL++ + R K+ DFG ++ + D+ + R G F Y PE
Sbjct: 130 V---HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PESLTE 185
Query: 568 SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR--------LFE 619
S+F+ SDV+SFGVVL EL T S++ S F+ M ++ L E
Sbjct: 186 SKFSVASDVWSFGVVLYELF--------TYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237
Query: 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666
+L A + + K C N +RP+ E A ++ IR
Sbjct: 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 63/198 (31%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESN--IEQFINEVAILSQINHRNVVKLLGC 454
+G+G G VYK + ++VAIK L +E+ IE E+ LSQ + K G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDL-EEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIY 514
L+ ++ E+ G+ D + + I EV L YLH I
Sbjct: 68 FLKGSKLWIIMEYCGGGSCL----DLLKPGKLDETYIAFILREVLLGLEYLHEEGKI--- 120
Query: 515 HRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKS 574
HRDIK+ANILL ++ K++DFG S + + T V GT ++ PE + S + EK+
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKA 179
Query: 575 DVYSFGVVLVELLTGQKP 592
D++S G+ +EL G+ P
Sbjct: 180 DIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 75/292 (25%), Positives = 124/292 (42%), Gaps = 33/292 (11%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNI--EQFINEVAILSQINHR 446
+ + ++G+G G V K G IVAIKK K ++ + + EV +L Q+ H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFP--ITWEIRLRIAIEVSDALCY 504
N+V L LV+E++ + + E P + + ++ A+ Y
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERT-----LLELLEASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID-QTHLTTRVQGTFGYLDPE 563
HS I HRDIK NIL+ + K+ DFG +R++ + LT V T Y PE
Sbjct: 116 CHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE 171
Query: 564 YF-RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDK-----SLVGYFLEAMKE--- 614
+ + + DV++ G ++ ELL G+ P+ DS+ D+ +G + +E
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230
Query: 615 -------NRLFEVLDARVLKEAKEEEIITVAM-LAKRCLNMIGKKRPTMKEA 658
E L+ ++ + A+ K CL M K+R T E
Sbjct: 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDEL 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 63/210 (30%), Positives = 115/210 (54%), Gaps = 13/210 (6%)
Query: 398 LGQGGQGTVYKGM--LTNGRI-VAIKKSKLVDESNI-EQFINEVAILSQINHRNVVKLLG 453
LG G G V KG+ + +I VAIK K +E ++ ++ + E I+ Q+++ +V+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPI 513
C E E +LV E G L +++ + +E ++ + L +VS + YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVEL--MHQVSMGMKYLEGKNFV-- 117
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDPEYFRSSQFT 571
HRD+ + N+LL +++ AK+SDFG S+++ D ++ R G + + PE +F+
Sbjct: 118 -HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 572 EKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600
+SDV+S+G+ + E + GQKP + E
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 7e-23
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 398 LGQGGQGTVYKGMLTN------GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKL 451
LG+G G V+ N +VA+K K ES + F E +L+ + H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 452 LGCCLETEVPLLVYEFIPNGTLYQY---------IHDQTEEFP---ITWEIRLRIAIEVS 499
G C E L+V+E++ +G L ++ I E+ +T L IA +++
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM-IDQTHLTTRVQGTFG 558
+ YL AS+ HRD+ + N L+ K+ DFG SR + D + R
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 559 YLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
++ PE +FT +SD++SFGVVL E+ T G++P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 7e-23
Identities = 59/194 (30%), Positives = 101/194 (52%), Gaps = 8/194 (4%)
Query: 397 ILGQGGQGTVYKGMLTNGRIVAIK--KSKLVDESNIEQFINEVAILSQINHRNVVKLLGC 454
+LG+G G V+KG L + VA+K K L E I +F++E IL Q +H N+VKL+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIGV 60
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIY 514
C + + +V E +P G ++ + +E + ++ A++ + + YL S I
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAAAGMAYLESKNCI--- 115
Query: 515 HRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKS 574
HRD+ + N L+ + K+SDFG SR + Q + PE +++ +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 575 DVYSFGVVLVELLT 588
DV+S+G++L E +
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-22
Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 11/203 (5%)
Query: 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNI--EQFINEVAILSQINHRNVVKLLG 453
+ LG G G V+ G VAIK ++E + E FI E ++ +++H +V+L G
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPI 513
C + + +V EF+ NG L Y+ + + + ++ L + +V + + YL + I
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKL--SKDMLLSMCQDVCEGMEYLERNSFI-- 122
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 573
HRD+ + N L+ KVSDFG +R V+ D+ ++ + + PE F S+++ K
Sbjct: 123 -HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 574 SDVYSFGVVLVELLT-GQKPIRS 595
SDV+SFGV++ E+ T G+ P
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEK 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 66/228 (28%), Positives = 110/228 (48%), Gaps = 20/228 (8%)
Query: 397 ILGQGGQGTVYKGM-LTNGRIVAIKKSKL-VDESNIEQFINEVAILSQINH---RNVVKL 451
++G+G G VY+G + GR+VA+K L + ++ EVA+LSQ+ N+ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 452 LGCCLETEVPLLVYEFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAAS 510
G L+ ++ E+ G++ + E I+ IR EV AL Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIHKV-- 120
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ- 569
+ HRDIK+ANIL+ + K+ DFG + + + + +T V GT ++ PE +
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 570 FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617
+ K+D++S G+ + E+ TG P S+ D + K RL
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPY----SDVDAFRAMMLIPKSKPPRL 222
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 75/220 (34%), Positives = 112/220 (50%), Gaps = 30/220 (13%)
Query: 396 RILGQGGQGTVYKGMLTN------GRI-VAIK--KSKLVDESNIEQFINEVAILSQINHR 446
LG G G VY+G T+ G I VA+K + D+ E F+ E ++S NH
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-FLKEAHLMSNFNHP 59
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHD-QTEEFP---ITWEIRLRIAIEVSDAL 502
N+VKLLG CL E ++ E + G L Y+ D + E F +T + L I ++V+
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 503 CYLHSAASIPIYHRDIKSANILLDDK-YRA----KVSDFGASRSVMIDQTHLTTRVQG-- 555
YL I HRD+ + N L+ +K Y A K+ DFG +R + + R +G
Sbjct: 120 VYLEQMHFI---HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEG 173
Query: 556 --TFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
++ PE +FT +SDV+SFGV++ E+LT GQ+P
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 61/208 (29%), Positives = 108/208 (51%), Gaps = 19/208 (9%)
Query: 398 LGQGGQGTVYKGML--TNGRIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGC 454
LG G G V K +L G+I+A+K +L ++E+ +Q + E+ IL + N +V G
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 455 CL-ETEVPLLVYEFIPNGTL---YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAAS 510
++ + + E++ G+L + + + E + +IA+ V L YLH
Sbjct: 68 FYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKHK 121
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQF 570
I HRD+K +NIL++ + + K+ DFG S +++ T GT Y+ PE + + +
Sbjct: 122 I--IHRDVKPSNILVNSRGQIKLCDFGVSG-QLVNSLAKTF--VGTSSYMAPERIQGNDY 176
Query: 571 TEKSDVYSFGVVLVELLTGQKPIRSTDS 598
+ KSD++S G+ L+EL TG+ P +
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPEND 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 391 NFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDES-----NIEQFINEVAILSQIN 444
N+ ++LGQG G VY + GR +A+K+ +S + E+ +L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEF-PITWEIRLRIAIEVSDALC 503
H +V+ GC + E + E++P G+ + DQ + + +T + + ++ + +
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGS----VKDQLKAYGALTETVTRKYTRQILEGVE 118
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT--TRVQGTFGYLD 561
YLHS I HRDIK ANIL D K+ DFGAS+ + + T V GT ++
Sbjct: 119 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 562 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
PE + K+DV+S G +VE+LT + P
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 8e-22
Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 390 DNFNTNRILGQGGQGTVYKGML----TNGRIVAIK---KSKLVDESNIEQFINEVAILSQ 442
D+F + LG G G V ML +G+ A+K K+K+V +E +NE IL
Sbjct: 1 DDFEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 443 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDAL 502
I H +V L G + LV E++P G L+ + ++ FP R A +V AL
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPV-ARFYAA-QVVLAL 114
Query: 503 CYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQ---GTFGY 559
YLHS I +RD+K N+LLD K++DFG ++ + R GT Y
Sbjct: 115 EYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK-------RVKGRTYTLCGTPEY 164
Query: 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
L PE S + + D ++ G+++ E+L G P
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 9e-22
Identities = 63/212 (29%), Positives = 110/212 (51%), Gaps = 15/212 (7%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINH 445
E+ + + LG G G V+ G VAIK K S E F+ E ++ Q+ H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQH 60
Query: 446 RNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEE-FPITWEIRLRIAIEVSDALC 503
+V+L T+ P+ ++ E++ NG+L ++ +T E +T + +A ++++ +
Sbjct: 61 PRLVRLYAVV--TQEPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLD 561
++ I HRD+++ANIL+ + K++DFG +R +I+ T R F +
Sbjct: 117 FIERKNYI---HRDLRAANILVSETLCCKIADFGLAR--LIEDNEYTAREGAKFPIKWTA 171
Query: 562 PEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
PE FT KSDV+SFG++L E++T G+ P
Sbjct: 172 PEAINYGTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 56/189 (29%), Positives = 96/189 (50%), Gaps = 23/189 (12%)
Query: 415 RIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 473
+VA+K + ++ E F+ EV ILS+++ N+ +LLG C ++ E++ NG L
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 474 YQYIHDQTEEF----------PITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANI 523
Q++ Q +++ L +A +++ + YL S+ HRD+ + N
Sbjct: 107 NQFL--QKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNC 161
Query: 524 LLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGT----FGYLDPEYFRSSQFTEKSDVYSF 579
L+ Y K++DFG SR++ + RVQG ++ E +FT KSDV++F
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSSDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218
Query: 580 GVVLVELLT 588
GV L E+LT
Sbjct: 219 GVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 61/199 (30%), Positives = 111/199 (55%), Gaps = 13/199 (6%)
Query: 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCC 455
+ +G+G G V G G VA+K K +++ + F+ E ++++Q+ H N+V+LLG
Sbjct: 12 QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 456 LETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIY 514
+E + L +V E++ G+L Y+ + + + L+ +++V +A+ YL + +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANNFV--- 124
Query: 515 HRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKS 574
HRD+ + N+L+ + AKVSDFG ++ Q V+ T PE R +F+ KS
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKS 180
Query: 575 DVYSFGVVLVELLT-GQKP 592
DV+SFG++L E+ + G+ P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 10/215 (4%)
Query: 383 MELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILS 441
+E E D +LG+G G VY L+ +AIK+ D ++ E+A+ S
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 442 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDA 501
+ HRN+V+ LG E + E +P G+L + + + + ++ +
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGASRSVMIDQTHLTTRVQGTFGY 559
L YLH I HRDIK N+L+ + Y K+SDFG S+ + T GT Y
Sbjct: 121 LKYLHDNQ---IVHRDIKGDNVLV-NTYSGVVKISDFGTSKR-LAGINPCTETFTGTLQY 175
Query: 560 LDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKP 592
+ PE + +D++S G +VE+ TG+ P
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 398 LGQGGQGTVY--KGMLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKLL 452
+ +G G V+ K T G I AIK K+ ++ ++ ++Q + E ILSQ VVKL
Sbjct: 1 ISKGAYGRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 453 GCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASI 511
+ + L LV E++P G L + R+ IA E+ AL YLHS
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDV-ARIYIA-EIVLALEYLHS---N 112
Query: 512 PIYHRDIKSANILLDDKYRAKVSDFGASR-------SVMIDQTHLTTRVQGTFGYLDPEY 564
I HRD+K NIL+D K++DFG S+ + D R+ GT Y+ PE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 565 FRSSQFTEKSDVYSFGVVLVELLTGQKP 592
++ D +S G +L E L G P
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 3e-21
Identities = 73/276 (26%), Positives = 131/276 (47%), Gaps = 36/276 (13%)
Query: 391 NFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFI--------NEVAILSQ 442
+ R++G+G G V+ L + A +K ++ + +EQ NE +L
Sbjct: 1 KYEKIRVVGRGAFGIVH---LCRRK--ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKL 55
Query: 443 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDAL 502
++H N+++ LE + ++V E+ P GTL +YI + + + L +++ AL
Sbjct: 56 LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLAL 114
Query: 503 CYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
++H+ I HRD+K+ NILLD K K+ DFG S+ ++ ++ T V GT Y+
Sbjct: 115 HHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISK-ILSSKSKAYT-VVGTPCYIS 169
Query: 562 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621
PE + +KSD+++ G VL EL + + R+ ++ +LV L+ M F +
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLK---RAFEAANLPALV---LKIMSGT--FAPI 221
Query: 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657
R + + L LN+ KRP + +
Sbjct: 222 SDRYSPDLR--------QLILSMLNLDPSKRPQLSQ 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 10/197 (5%)
Query: 398 LGQGGQGTVYK-GMLTNGRIVAIKK--SKLVDESNIEQFINEVAILSQINHRNVVKLLGC 454
+G+G G V+K G VA+KK + ++ Q + E+ L H VVKLL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIY 514
+LV E++P L + + D EE P+ + + Y+H+ I
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRD--EERPLPEAQVKSYMRMLLKGVAYMHANG---IM 121
Query: 515 HRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE-YFRSSQFTEK 573
HRD+K AN+L+ K++DFG +R ++ L + T Y PE + + ++
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181
Query: 574 SDVYSFGVVLVELLTGQ 590
D+++ G + ELL G
Sbjct: 182 VDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 18/218 (8%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIK---KSKLVDESNIEQ----FINEVA 438
E+ D+ R LG G G VY+G+ A++ K + ES EQ F+ E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 439 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHD----QTEEFPITWEIRLRI 494
I+S+ NH+N+V+L+G E ++ E + G L ++ + +T + L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 495 AIEVSDALCYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGASRSVM-IDQTHLT 550
A +V+ YL I HRDI + N LL K AK++DFG +R +
Sbjct: 122 ARDVAKGCKYLEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 588
R ++ PE F FT K+DV+SFGV+L E+ +
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 63/211 (29%), Positives = 111/211 (52%), Gaps = 15/211 (7%)
Query: 398 LGQGGQGTVYKG---MLTNGRIVAIK--KSKLVDESNIEQFINEVAILSQINHRNVVKLL 452
LG G GTV KG M + + VA+K K+ D + ++ + E ++ Q+++ +V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 453 GCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIP 512
G C E E +LV E G L +++ +T + + +VS + YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMGMKYLEETNFV- 117
Query: 513 IYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDPEYFRSSQF 570
HRD+ + N+LL ++ AK+SDFG S+++ D+ + + G + + PE +F
Sbjct: 118 --HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 571 TEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600
+ KSDV+SFGV++ E + GQKP + E
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 3e-21
Identities = 88/365 (24%), Positives = 158/365 (43%), Gaps = 34/365 (9%)
Query: 297 DTISPSPSPYEVVHENSNVLFIIIGCSVGAGLPFFLFMIGRLHEIVERRRVIKLKQNFFK 356
DT S P P + V + + F I C++GA L L G + + R ++LK+
Sbjct: 611 DTTSGLP-PCKRVRKTPSWWFYI-TCTLGAFLVLALVAFGFV--FIRGRNNLELKR---- 662
Query: 357 RNGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKG-MLTNGR 415
++ E + E +K+ S+ + + ++ +G +G YKG + NG
Sbjct: 663 ------VENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGM 716
Query: 416 IVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQ 475
+K+ V+ S I + + ++ H N+VKL+G C + L++E+I L +
Sbjct: 717 QFVVKEINDVN-SIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSE 772
Query: 476 YIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535
+ + ++WE R +IAI ++ AL +LH S + ++ I++D K +
Sbjct: 773 VLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR- 825
Query: 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRS 595
+ D + Y+ PE + TEKSD+Y FG++L+ELLTG+ P
Sbjct: 826 LSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSP-AD 879
Query: 596 TDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEA--KEEEIITVAMLAKRCLNMIGKKRP 653
+ S+V + + L +D + + + EI+ V LA C RP
Sbjct: 880 AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939
Query: 654 TMKEA 658
+
Sbjct: 940 CANDV 944
|
Length = 968 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 52/213 (24%), Positives = 101/213 (47%), Gaps = 17/213 (7%)
Query: 391 NFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQ------FINEVAILSQI 443
+ + LG G + Y+ + G ++A+K+ V ++ EQ E+ +++++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 444 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC 503
NH +++++LG E L E++ G++ + + + ++ L
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLS 117
Query: 504 YLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGASRSVMIDQT---HLTTRVQGTFGY 559
YLH I HRD+K AN+L+D R +++DFGA+ + T ++ GT +
Sbjct: 118 YLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
+ PE R Q+ DV+S G V++E+ T + P
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 71/233 (30%), Positives = 107/233 (45%), Gaps = 32/233 (13%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNV 448
DNF +G+G G V + GR VA+KK L + E NEV I+ H N+
Sbjct: 22 DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 449 VKLLGCCLETEVPLLVYEFIPNGTLYQYI-HDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
V++ L + +V EF+ G L + H + E I + + V AL +LH+
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLAVLKALSFLHA 133
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS 567
I HRDIKS +ILL R K+SDFG V + + V GT ++ PE
Sbjct: 134 QGVI---HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISR 189
Query: 568 SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF----LEAMKENR 616
+ + D++S G++++E++ G+ P YF L+AMK R
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPP--------------YFNEPPLQAMKRIR 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 78/279 (27%), Positives = 130/279 (46%), Gaps = 39/279 (13%)
Query: 398 LGQGGQGTVYKGMLTNG--RIVAIK----------KSKLVDESNIEQFINEVAIL-SQIN 444
LG G G VYK N ++A+K K K + +I ++EV I+ Q+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 445 HRNVVKLLGCCLETEVPLLVYEFI---PNGTLYQYIHDQTEEFPITWEIRL-RIAIEVSD 500
H N+V+ LE + +V + I P G + + ++ + F E R+ I +++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT---EERIWNIFVQMVL 124
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYL 560
AL YLH I HRD+ NI+L + + ++DFG ++ ++ LT+ V GT Y
Sbjct: 125 ALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVV-GTILYS 180
Query: 561 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620
PE ++ + EK+DV++FG +L ++ T Q P ST+ SL +EA+ E
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKIVEAVYEP----- 232
Query: 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAA 659
L E E +T + CL + RP + + +
Sbjct: 233 -----LPEGMYSEDVT--DVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 68/281 (24%), Positives = 125/281 (44%), Gaps = 32/281 (11%)
Query: 397 ILGQGGQGTVYKGMLTNG------RIVAIKKSKLVDESNIEQ-FINEVAILSQINHRNVV 449
LG+G G V+ +V +K + + N++ F E+ + +++H+NVV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQYI------HDQTEEFPITWEIRLRIAIEVSDALC 503
+LLG C E E ++ E+ G L Q++ ++ + P++ + ++ + +++ +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE 563
+L +A + HRD+ + N L+ + KVS S+ V + + +L PE
Sbjct: 132 HLSNARFV---HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622
+ F+ KSDV+SFGV++ E+ T G+ P EE L ++ +L
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAGKL----- 236
Query: 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663
L E + L RC + K RP+ E LG
Sbjct: 237 --ELPVP-EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 66/218 (30%), Positives = 109/218 (50%), Gaps = 11/218 (5%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINH 445
E+ ++ + LG G G V+ G VA+K K S E F+ E I+ ++ H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRH 60
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
+V+L E + +V E++ G+L ++ D E + + +A +V+ + Y+
Sbjct: 61 DKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDPE 563
I HRD++SANIL+ D K++DFG +R +I+ T R F + PE
Sbjct: 119 ERMNYI---HRDLRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPE 173
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600
+FT KSDV+SFG++L EL+T G+ P ++ E
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE 211
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 16/216 (7%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRN 447
++ T LG G G+V K V KK + S +Q + E+ I+ +
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY 64
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
+V G L + EF+ G+L + + PI EI +IA+ V + L YL++
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM--IDQTHLTTRVQGTFGYLDPEYF 565
I HRDIK +NIL++ + + K+ DFG S ++ I T + GT Y+ PE
Sbjct: 122 VHRI--MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERI 174
Query: 566 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
+ ++T KSDV+S G+ ++EL G+ P S D
Sbjct: 175 QGGKYTVKSDVWSLGISIIELALGKFPF--AFSNID 208
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 26/213 (12%)
Query: 397 ILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESN----------IEQFINEVAILSQINH 445
++G+G G VY + +T G ++A+K+ +L ++ +E+ L ++H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 446 RNVVKLLGCCLETEVPLLVY-EFIPNGTLYQYI--HDQTEEFPITWEIRLRIAIEVSDAL 502
N+V+ LG TE L ++ E++P G++ + + + EE + + +V + L
Sbjct: 68 LNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-----QVLEGL 121
Query: 503 CYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR-SVMIDQTHLTTRVQGTFGYLD 561
YLHS I HRD+K+ N+L+D K+SDFG S+ S I +QG+ ++
Sbjct: 122 AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 562 PEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKP 592
PE S ++ K D++S G V++E+ G++P
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 67/236 (28%), Positives = 121/236 (51%), Gaps = 29/236 (12%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRI-------VAIKKSKLVDES-----NIEQF 433
E+A + +R LGQG G VY+G + G + VAIK V+E+ IE F
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKT---VNEAASMRERIE-F 56
Query: 434 INEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYI-------HDQTEEFPI 486
+NE +++ + N +VV+LLG + + L++ E + G L Y+ + + P
Sbjct: 57 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116
Query: 487 TWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM-ID 545
+ + +++A E++D + YL++ + HRD+ + N ++ + + K+ DFG +R + D
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
Query: 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600
+ ++ PE + FT SDV+SFGVVL E+ T ++P + +E+
Sbjct: 174 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 19/202 (9%)
Query: 398 LGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLE 457
LGQG G V+ G VAIK K S E F+ E ++ ++ H +V+L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 458 TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRL----RIAIEVSDALCYLHSAASIPI 513
+ +V E++ G+L ++ + ++ +RL +A +++ + Y+ +
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVERMNYV-- 124
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDPEYFRSSQFT 571
HRD+++ANIL+ + KV+DFG +R +I+ T R F + PE +FT
Sbjct: 125 -HRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 572 EKSDVYSFGVVLVELLT-GQKP 592
KSDV+SFG++L EL T G+ P
Sbjct: 182 IKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIK--KSKLVDESNIEQFIN--EVAILSQIN-HRNVVKL 451
LG G G+VY G +VAIK K K + E+ +N EV L ++N H N+VKL
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKF---YSWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 452 LGCCLETEVPLLVYEFIPNGTLYQYIHDQTEE-FPITWEIRLR-IAIEVSDALCYLHSAA 509
E + V+E++ G LYQ + D+ + F E +R I ++ L ++H
Sbjct: 64 KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS---ESVIRSIIYQILQGLAHIHKHG 119
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF-RSS 568
+HRD+K N+L+ K++DFG +R + + T V T Y PE RS+
Sbjct: 120 ---FFHRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDYV-STRWYRAPEILLRST 174
Query: 569 QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
++ D+++ G ++ EL T +P+ SE D
Sbjct: 175 SYSSPVDIWALGCIMAELYTL-RPLFPGSSEID 206
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 398 LGQGGQGTVYKGMLTNGR-IVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCC 455
+G+G G VYKG+ + +VAIK L + E IE E+ +LSQ + + + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 456 LETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515
L+ ++ E++ G+ D + P+ I E+ L YLHS I H
Sbjct: 72 LKGTKLWIIMEYLGGGSAL----DLLKPGPLEETYIATILREILKGLDYLHSERKI---H 124
Query: 516 RDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSD 575
RDIK+AN+LL ++ K++DFG + + Q T V GT ++ PE + S + K+D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKAD 183
Query: 576 VYSFGVVLVELLTGQKP 592
++S G+ +EL G+ P
Sbjct: 184 IWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 4e-20
Identities = 63/198 (31%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 398 LGQGGQGTVYKGMLTNGR-IVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCC 455
+G+G G V+KG+ + +VAIK L + E IE E+ +LSQ + V K G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 456 LETEVPLLVYEFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASIPIY 514
L+ ++ E++ G+ + +EF I ++ E+ L YLHS I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----EILKGLDYLHSEKKI--- 123
Query: 515 HRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKS 574
HRDIK+AN+LL ++ K++DFG + + Q T V GT ++ PE + S + K+
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKA 182
Query: 575 DVYSFGVVLVELLTGQKP 592
D++S G+ +EL G+ P
Sbjct: 183 DIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 66/236 (27%), Positives = 117/236 (49%), Gaps = 23/236 (9%)
Query: 369 SNEGNS----EKTKLFTSMELEMATDNFNTNRILGQGGQGTVYK----GMLTNGRI--VA 418
S GN + T+L ++ E +N + + LG G G V + G+ + + VA
Sbjct: 10 SINGNEYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVA 69
Query: 419 IKKSK-LVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQY 476
+K K S E ++E+ I+S + NH N+V LLG C L++ E+ G L +
Sbjct: 70 VKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNF 129
Query: 477 IHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 536
+ + E F ++ L + +V+ + +L S I HRD+ + N+LL K+ DF
Sbjct: 130 LRRKRESFLTLEDL-LSFSYQVAKGMAFLASKNCI---HRDLAARNVLLTHGKIVKICDF 185
Query: 537 GASRSVMIDQTHLTTRVQGT----FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 588
G +R +M D ++ V+G ++ PE + +T +SDV+S+G++L E+ +
Sbjct: 186 GLARDIMNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 73/287 (25%), Positives = 133/287 (46%), Gaps = 51/287 (17%)
Query: 398 LGQGGQGTVYKGML-----TNGRIVAIKKSKLVDESNIEQ---FINEVAILSQINHRNVV 449
LG+ G +YKG L + ++VAIK K D +N +Q F E +++++++H N+V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQYI--------------HDQTEEFPITWEIRLRIA 495
LLG + + +++E++ G L++++ D T + + L IA
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 496 IEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG 555
I+++ + YL S + H+D+ + NIL+ ++ K+SD G SR + + RVQ
Sbjct: 131 IQIAAGMEYLSSHFFV---HKDLAARNILIGEQLHVKISDLGLSREIYSADYY---RVQP 184
Query: 556 T----FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLE 610
++ PE +F+ SD++SFGVVL E+ + G +P ++E
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---------- 234
Query: 611 AMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657
+ E++ R L E+ + L C +RP K+
Sbjct: 235 ------VIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKD 275
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 65/214 (30%), Positives = 108/214 (50%), Gaps = 20/214 (9%)
Query: 391 NFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDES-----NIEQFINEVAILSQIN 444
N+ ++LGQG G VY GR +A+K+ + ES + E+ +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 445 HRNVVKLLGCCLET-EVPLLVY-EFIPNGTLYQYIHDQTEEF-PITWEIRLRIAIEVSDA 501
H +V+ GC + E L ++ E +P G+ I DQ + + +T + + ++ +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQILEG 118
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR---SVMIDQTHLTTRVQGTFG 558
+ YLHS I HRDIK ANIL D K+ DFGAS+ ++ + T + + V GT
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPY 174
Query: 559 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
++ PE + K+D++S G +VE+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 10/210 (4%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINH 445
E+ ++ + LG G G V+ G N VA+K K S ++ F+ E ++ + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQH 60
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
+V+L + E ++ E++ G+L ++ E + + + ++++ + Y+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDPE 563
I HRD+++AN+L+ + K++DFG +R +I+ T R F + PE
Sbjct: 120 ERKNYI---HRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPE 174
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
FT KSDV+SFG++L E++T G+ P
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 61/197 (30%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 398 LGQGGQGTVYKGML-TNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL 456
+G+G G V + ++G++VA+KK L + E NEV I+ H NVV++ L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 457 ETEVPLLVYEFIPNGTLYQYI-HDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515
+ +V EF+ G L + H + E I + + V AL LH+ I H
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQGVI---H 139
Query: 516 RDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSD 575
RDIKS +ILL R K+SDFG V + + V GT ++ PE + + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVD 198
Query: 576 VYSFGVVLVELLTGQKP 592
++S G++++E++ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 6e-20
Identities = 79/296 (26%), Positives = 142/296 (47%), Gaps = 44/296 (14%)
Query: 392 FNTNRILGQGGQGTVYKGMLT----NGRIVAIK--KSKLVDESNIEQFINEVAILSQINH 445
F R+LG+G G+V + L + + VA+K K+ + S+IE+F+ E A + + +H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 446 RNVVKLLGCCLETE------VPLLVYEFIPNGTLYQYI---HDQTEEFPITWEIRLRIAI 496
NV+KL+G L + +P+++ F+ +G L+ ++ E F + + +R I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 497 EVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGT 556
+++ + YL S I HRD+ + N +L++ V+DFG S+ + + QG
Sbjct: 121 DIASGMEYLSSKNFI---HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR----QGC 173
Query: 557 FG-----YLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLE 610
+L E + +T SDV++FGV + E++T GQ P ++ E + Y +
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLI- 229
Query: 611 AMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666
K NRL + D L++ E L +C + K RP+ + +L I
Sbjct: 230 --KGNRLKQPPDC--LEDVYE--------LMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 6e-20
Identities = 79/262 (30%), Positives = 118/262 (45%), Gaps = 26/262 (9%)
Query: 398 LGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCC 455
+G+G G V+KG+ ++VAIK L + E IE E+ +LSQ + V K G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 456 LETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515
L+ ++ E++ G+ D E P+ I E+ L YLHS I H
Sbjct: 72 LKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSEKKI---H 124
Query: 516 RDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSD 575
RDIK+AN+LL + K++DFG + + Q T V GT ++ PE + S + K+D
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKAD 183
Query: 576 VYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEII 635
++S G+ +EL G+ P E + FL E ++ LKE
Sbjct: 184 IWSLGITAIELAKGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKE------- 231
Query: 636 TVAMLAKRCLNMIGKKRPTMKE 657
+ CLN RPT KE
Sbjct: 232 ----FVEACLNKEPSFRPTAKE 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 8e-20
Identities = 63/196 (32%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 398 LGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL 456
+G+G G V +GR VA+K L + E NEV I+ H+NVV++ L
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 457 ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHR 516
E ++ EF+ G L D + + E + V ALCYLHS I HR
Sbjct: 89 VGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQGVI---HR 141
Query: 517 DIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDV 576
DIKS +ILL R K+SDFG + D + V GT ++ PE + + + D+
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDI 200
Query: 577 YSFGVVLVELLTGQKP 592
+S G++++E++ G+ P
Sbjct: 201 WSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 1e-19
Identities = 63/197 (31%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL 456
+GQG GTVY + + G+ VAIK+ L + E INE+ ++ + + N+V L L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 457 ETEVPLLVYEFIPNGTLYQYIHDQ-TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515
+ +V E++ G+L + + +E I R E AL +LHS I H
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALDFLHSNQVI---H 138
Query: 516 RDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSD 575
RDIKS NILL K++DFG + +Q+ +T V GT ++ PE + K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 576 VYSFGVVLVELLTGQKP 592
++S G++ +E++ G+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 1e-19
Identities = 65/214 (30%), Positives = 109/214 (50%), Gaps = 20/214 (9%)
Query: 391 NFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDES-----NIEQFINEVAILSQIN 444
N+ ++LGQG G VY + GR +A K+ + ES + E+ +L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 445 HRNVVKLLGCCLE-TEVPLLVY-EFIPNGTLYQYIHDQTEEF-PITWEIRLRIAIEVSDA 501
H +V+ GC + E L ++ E++P G+ + DQ + + +T + + ++ +
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGS----VKDQLKAYGALTESVTRKYTRQILEG 118
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR---SVMIDQTHLTTRVQGTFG 558
+ YLHS I HRDIK ANIL D K+ DFGAS+ ++ + T + + V GT
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPY 174
Query: 559 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
++ PE + K+DV+S G +VE+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 63/232 (27%), Positives = 113/232 (48%), Gaps = 21/232 (9%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGM---LTNGRIVAIKKSKLVDES-----NIEQFINEV 437
E++ + R LGQG G VY+G + G K V+ES IE F+NE
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEA 60
Query: 438 AILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYI-------HDQTEEFPITWEI 490
+++ +VV+LLG + + L+V E + +G L Y+ + P T +
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 491 RLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM-IDQTHL 549
+++A E++D + YL++ + HRD+ + N ++ + K+ DFG +R + D
Sbjct: 121 MIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 177
Query: 550 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600
+ ++ PE + FT SD++SFGVVL E+ + ++P + +E+
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 77/302 (25%), Positives = 128/302 (42%), Gaps = 52/302 (17%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGML-----TNGRI-VAIKKSKL-VDESNIEQFINE 436
E E+ D + LG+G G V K N VA+K K E ++ ++E
Sbjct: 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE 65
Query: 437 VAILSQI-NHRNVVKLLGCCLETEVPLLVYEFI-------------PNGTLYQYIHDQTE 482
+ ++ I H+N++ LLG C + +V E+ P G +
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 483 EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542
E +T + + A +V+ + +L S I HRD+ + N+L+ + + K++DFG +R +
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCI---HRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 543 M-IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600
ID TT + ++ PE +T +SDV+SFGV+L E+ T G P EE
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242
Query: 601 DKSLVGYFLEAMKENRLFEVLDARVLKEAKEEE-----IITVAMLAKRCLNMIGKKRPTM 655
LF+ +LKE E + L + C + + +RPT
Sbjct: 243 ----------------LFK-----LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTF 281
Query: 656 KE 657
K+
Sbjct: 282 KQ 283
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL 456
LG G G VYK G A K ++ E +E F+ E+ ILS+ H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 457 ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITW-EIRLRIAIEVSDALCYLHSAASIPIYH 515
++ EF G L I + E +T +IR + ++ +AL +LHS I H
Sbjct: 73 YENKLWILIEFCDGGAL-DSIMLELER-GLTEPQIRY-VCRQMLEALNFLHSHKVI---H 126
Query: 516 RDIKSANILLDDKYRAKVSDFGAS-RSVMIDQTHLTTRVQGTFGYLDPEY-----FRSSQ 569
RD+K+ NILL K++DFG S ++ Q T GT ++ PE F+ +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNP 184
Query: 570 FTEKSDVYSFGVVLVELLTGQKP 592
+ K+D++S G+ L+EL + P
Sbjct: 185 YDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 77/273 (28%), Positives = 126/273 (46%), Gaps = 37/273 (13%)
Query: 398 LGQGGQGTVYKGMLTN-GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL 456
+G+G G V + G+ VA+KK L + E NEV I+ +H NVV + L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 457 ETEVPLLVYEFIPNGTLYQYI-HDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515
+ +V EF+ G L + H + E I + + V AL YLH+ I H
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQGVI---H 141
Query: 516 RDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSD 575
RDIKS +ILL R K+SDFG V + + V GT ++ PE + + D
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVD 200
Query: 576 VYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF----LEAMKENRLFEVLDARVLKEAKE 631
++S G++++E++ G+ P YF L+AM+ R+ + L RV
Sbjct: 201 IWSLGIMVIEMIDGEPP--------------YFNEPPLQAMR--RIRDNLPPRV------ 238
Query: 632 EEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664
++ V+ + + L+++ + P+ + A EL
Sbjct: 239 KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL 456
+GQG GTV+ + + G+ VAIK+ L + E INE+ ++ ++ + N+V L L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 457 ETEVPLLVYEFIPNGTLYQYIHDQ-TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515
+ +V E++ G+L + + +E I R E AL +LH+ I H
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR-----ECLQALEFLHANQVI---H 138
Query: 516 RDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSD 575
RDIKS N+LL K++DFG + +Q+ +T V GT ++ PE + K D
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 576 VYSFGVVLVELLTGQKP 592
++S G++ +E++ G+ P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 15/203 (7%)
Query: 396 RILGQGGQGTV----YKGMLTN-GRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVV 449
R LG+G G V Y N G VA+K K ++I E+ IL + H N+V
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 450 KLLGCCLET--EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
K G C E L+ EF+P+G+L +Y+ + I + +L+ A+++ + YL S
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK--INLKQQLKYAVQICKGMDYLGS 127
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTR--VQGTFGYLDPEYF 565
+ HRD+ + N+L++ +++ K+ DFG ++++ D+ + T + + + PE
Sbjct: 128 RQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 566 RSSQFTEKSDVYSFGVVLVELLT 588
S+F SDV+SFGV L ELLT
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 21/220 (9%)
Query: 391 NFNTNRILGQGGQGTVYKGMLTN------GRIVAIKKSKLVDESNIEQFINEVAILSQIN 444
N R LG+G G V+ N +VA+K K ++ + F E +L+ +
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ-------TEEFP---ITWEIRLRI 494
H ++VK G C+E + ++V+E++ +G L +++ E +T L I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 495 AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM-IDQTHLTTRV 553
A +++ + YL AS HRD+ + N L+ + K+ DFG SR V D +
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 554 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
++ PE +FT +SDV+S GVVL E+ T G++P
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 396 RILGQGGQGTV----YKGMLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNV 448
++LG+G G V KG + A+K K ++ + ++E + E +L+
Sbjct: 1 KVLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57
Query: 449 VKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLH 506
+ L C +T+ L V E++ G L +I ++ F E R R A E+ L +LH
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFD---EPRARFYAAEIVLGLQFLH 113
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID-QTHLTTRVQGTFGYLDPEYF 565
I +RD+K N+LLD + K++DFG + ++ T T+ GT Y+ PE
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEIL 168
Query: 566 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
+ D ++ GV+L E+L GQ P D +E
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 76/266 (28%), Positives = 123/266 (46%), Gaps = 33/266 (12%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL 456
+GQG GTVY M + G+ VAI++ L + E INE+ ++ + + N+V L L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 457 ETEVPLLVYEFIPNGTLYQYIHDQ-TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515
+ +V E++ G+L + + +E I R E AL +LHS I H
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQVI---H 139
Query: 516 RDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSD 575
RDIKS NILL K++DFG + +Q+ +T V GT ++ PE + K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 576 VYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN--RLFEVLDARVLKEAKEEE 633
++S G++ +E++ G+ P + EN R ++ E + E
Sbjct: 199 IWSLGIMAIEMIEGEPPY------------------LNENPLRALYLIATNGTPELQNPE 240
Query: 634 IITVAM--LAKRCLNMIGKKRPTMKE 657
++ RCL+M +KR + KE
Sbjct: 241 KLSAIFRDFLNRCLDMDVEKRGSAKE 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 63/198 (31%), Positives = 102/198 (51%), Gaps = 11/198 (5%)
Query: 398 LGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLE 457
LGQG G V+ G VAIK K E F+ E I+ ++ H +V L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 458 TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRD 517
+ +V EF+ G+L ++ + ++ + + +A +++D + Y+ I HRD
Sbjct: 73 EPI-YIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIERMNYI---HRD 127
Query: 518 IKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDPEYFRSSQFTEKSD 575
+++ANIL+ D K++DFG +R +I+ T R F + PE +FT KSD
Sbjct: 128 LRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 576 VYSFGVVLVELLT-GQKP 592
V+SFG++L EL+T G+ P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 78/278 (28%), Positives = 132/278 (47%), Gaps = 36/278 (12%)
Query: 396 RILGQGGQGTVYKGMLT----NGRI-VAIK--KSKLVDESNIEQFINEVAILSQINHRNV 448
++LG G GTVYKG+ N +I VAIK + ++N ++ ++E +++ + V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN-KEILDEAYVMAGVGSPYV 71
Query: 449 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
+LLG CL + V L V + +P G L Y+ + + I + L ++++ + YL
Sbjct: 72 CRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDR--IGSQDLLNWCVQIAKGMSYLEE- 127
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG---TFGYLDPEYF 565
+ + HRD+ + N+L+ K++DFG +R + ID+T G ++ E
Sbjct: 128 --VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEY--HADGGKVPIKWMALESI 183
Query: 566 RSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624
+FT +SDV+S+GV + EL+T G KP + E L LE K RL +
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL----LE--KGERLPQPPIC- 236
Query: 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662
I V M+ +C + + RP +E E
Sbjct: 237 ---------TIDVYMIMVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 10/209 (4%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGC 454
+G+G G VYKG G+IVA+KK +L +E I E+++L ++ H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIY 514
++ L++EF+ + L +Y+ + + E+ ++ + + HS +
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VL 123
Query: 515 HRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ-FTEK 573
HRD+K N+L+D+K K++DFG +R+ I T V T Y PE S ++
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYSTP 182
Query: 574 SDVYSFGVVLVELLTGQKPIRSTDSEEDK 602
D++S G + E+ T +KP+ DSE D+
Sbjct: 183 VDIWSIGTIFAEMAT-KKPLFHGDSEIDQ 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 8e-19
Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 397 ILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIE-QFINEVAILSQINHRNVVKLLGC 454
ILG G GTVYK L RI+A+K L ++ Q ++E+ IL + + ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIY 514
+ EF+ G+L Y I + RIA+ V L YL S + I
Sbjct: 68 FFVENRISICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS---LKIL 117
Query: 515 HRDIKSANILLDDKYRAKVSDFGASRSVM--IDQTHLTTRVQGTFGYLDPEYFRSSQFTE 572
HRD+K +N+L++ + + K+ DFG S ++ I +T++ GT Y+ PE Q+
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQYGI 172
Query: 573 KSDVYSFGVVLVELLTGQKP 592
SDV+S G+ +EL G+ P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 8e-19
Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 41/281 (14%)
Query: 396 RILGQGGQGTVYKG-MLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKL 451
R+LG+G G V + +GR+ A+K K ++ + ++E + E ILS + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 452 LGCCLET-EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAA 509
L CC +T + V EF+ G L +I ++ F E R R A E++ AL +LH
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFD---EARARFYAAEITSALMFLHDKG 116
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ 569
I +RD+K N+LLD + K++DFG + + + T+ GT Y+ PE +
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTSTFCGTPDYIAPEILQEML 172
Query: 570 FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEA 629
+ D ++ GV+L E+L G P EA E+ LFE +L
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAP----------------FEAENEDDLFEA----ILN-- 210
Query: 630 KEEEIITVAML---AKRCLNMIGKKRPTMKEAAFELGGIRA 667
+E++ L A L K PTM+ + LGG A
Sbjct: 211 --DEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEA 249
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 21/214 (9%)
Query: 395 NRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESN---IEQFINEVAILSQINHRNVVK 450
NRI G+G G VY+ T+G IVA+KK ++ +E + I + E+ +L + H N+V+
Sbjct: 13 NRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS-LREITLLLNLRHPNIVE 70
Query: 451 LL----GCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH 506
L G L++ LV E+ L + + F + +++ + +++ L YLH
Sbjct: 71 LKEVVVGKHLDS--IFLVMEYCEQ-DLASLLDNMPTPFSES-QVKC-LMLQLLRGLQYLH 125
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE-YF 565
I HRD+K +N+LL DK K++DFG +R+ + +T +V T Y PE
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLL 181
Query: 566 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSE 599
+ +T D+++ G +L ELL KP+ SE
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAH-KPLLPGKSE 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 60/223 (26%), Positives = 113/223 (50%), Gaps = 23/223 (10%)
Query: 396 RILGQGGQGTVYKGMLTNGRI---VAIKKSKLV--DESNIEQFINEVAILSQINHRNVVK 450
+ LG+G G+V +G L VA+K K+ S +E F++E + + +H NV++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 451 LLGCCLETE------VPLLVYEFIPNGTLYQY-----IHDQTEEFPITWEIRLRIAIEVS 499
L+G CL+T P+++ F+ +G L+ + + D + P ++ ++ +++
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT--QMLVKFMTDIA 122
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRV-QGTFG 558
+ YL S + I HRD+ + N +L++ V+DFG S+ + + R+ +
Sbjct: 123 SGMEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 559 YLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600
++ E +T KSDV+SFGV + E+ T GQ P ++ E
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 37/282 (13%)
Query: 397 ILGQGGQGTVYKGMLTN-GRIVAIKKSKLVDESNIEQFI--NEVAILSQINHRNVVKLLG 453
++G+G G V K G+IVAIKK ++ + + I E+ +L Q+ H N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFP--ITWEIRLRIAIEVSDALCYLHSAASI 511
+ LV+EF+ + L D E++P + + ++ + + HS
Sbjct: 68 VFRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN-- 120
Query: 512 PIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF-RSSQF 570
I HRDIK NIL+ K+ DFG +R++ T V T Y PE +++
Sbjct: 121 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTKY 178
Query: 571 TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDK---------SLVGYFLEAMKENRLFEVL 621
D+++ G ++ E+LTG+ P+ DS+ D+ +L+ E ++N LF +
Sbjct: 179 GRAVDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 622 DARVLKEAKEEEII---------TVAMLAKRCLNMIGKKRPT 654
L E KE E + V LAK+CL + RP+
Sbjct: 238 ---RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 31/219 (14%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNI--EQFINEVAILSQINHRN 447
+ LG+G G+V K L N ++ K+ D + +Q + E+ I
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 448 VVKLLGCCL---ETEVPLLVYEFIPNGTL---YQYIHDQ---TEEFPITWEIRLRIAIEV 498
+VK G L + + + + E+ G+L Y+ + + E + +IA V
Sbjct: 61 IVKYYGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVL-----GKIAESV 114
Query: 499 SDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFG 558
L YLHS I HRDIK +NILL K + K+ DFG S L + GTF
Sbjct: 115 LKGLSYLHSRKII---HRDIKPSNILLTRKGQVKLCDFGVS-------GELVNSLAGTFT 164
Query: 559 ----YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
Y+ PE + ++ SDV+S G+ L+E+ + P
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 73/302 (24%), Positives = 135/302 (44%), Gaps = 51/302 (16%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGM---LTNGR---IVAIKKSKLVDESNIE---QFINE 436
E +N R +GQG G V++ L +VA+K K +E++ + F E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQRE 58
Query: 437 VAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQT--------------- 481
A++++ +H N+VKLLG C + L++E++ G L +++ ++
Sbjct: 59 AALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118
Query: 482 ----EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537
P++ +L IA +V+ + YL + HRD+ + N L+ + K++DFG
Sbjct: 119 KCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFG 175
Query: 538 ASRSV-MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRS 595
SR++ D + ++ PE +++T +SDV+++GVVL E+ + G +P
Sbjct: 176 LSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235
Query: 596 TDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTM 655
EE V Y+ V D VL + + + L + C + + RP+
Sbjct: 236 MAHEE----VIYY-----------VRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSF 279
Query: 656 KE 657
Sbjct: 280 AS 281
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 20/214 (9%)
Query: 391 NFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKL-VDESNIEQFIN----EVAILSQIN 444
N+ ++LG+G G VY GR +A+K+ D + +N E+ +L +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 445 HRNVVKLLGCCLE-TEVPLLVY-EFIPNGTLYQYIHDQTEEF-PITWEIRLRIAIEVSDA 501
H +V+ GC + E L ++ E++P G+ I DQ + + +T + R ++
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQILQG 118
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR---SVMIDQTHLTTRVQGTFG 558
+ YLHS I HRDIK ANIL D K+ DFGAS+ ++ + T + + V GT
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPY 174
Query: 559 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
++ PE + K+DV+S +VE+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGC 454
+G+G G VYK G IVA+KK +L DE I E+++L ++NH N+V+LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIY 514
LV+EF+ + L +Y+ D + + + ++ + Y HS +
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VL 121
Query: 515 HRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE-YFRSSQFTEK 573
HRD+K N+L+D + K++DFG +R+ + T V T Y PE S Q++
Sbjct: 122 HRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYSTP 180
Query: 574 SDVYSFGVVLVELLTGQKPIRSTDSEED 601
D++S G + E++ ++P+ DSE D
Sbjct: 181 VDIWSIGCIFAEMVN-RRPLFPGDSEID 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 4e-18
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 10/223 (4%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKK--SKLVDESNIEQFINEVAILSQI 443
E+ D+F LG G G V K ++ +K + + Q I E+ +L +
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 444 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC 503
N +V G + E + G+L Q + + I EI +++I V L
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLA 117
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE 563
YL I HRD+K +NIL++ + K+ DFG S +ID + GT Y+ PE
Sbjct: 118 YLREKHQI--MHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDS--MANSFVGTRSYMSPE 172
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVG 606
+ + ++ +SD++S G+ LVEL G+ PI D++E +++ G
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG 215
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-18
Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 18/224 (8%)
Query: 392 FNTNRILGQGGQGTVYKGMLT----NGRI-VAIKKSKLVDESNIEQFI-NEVAILSQINH 445
F ++LG G GTVYKG+ +I VAIK+ + + I +E +++ +++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
+V +LLG CL + V L + + +P G L Y+ + + + L ++++ + YL
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYL 125
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG---TFGYLDP 562
+ HRD+ + N+L+ K++DFG ++ + D+ +G ++
Sbjct: 126 EERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY--HAEGGKVPIKWMAL 180
Query: 563 EYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLV 605
E +T +SDV+S+GV + EL+T G KP + E S++
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 52/187 (27%), Positives = 100/187 (53%), Gaps = 20/187 (10%)
Query: 416 IVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLY 474
+VA+K + V ++ F+ E+ I+S++ + N+++LLG C+ + ++ E++ NG L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 475 QYIHDQ--------TEEFP-ITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL 525
Q++ + P ++ L +A++++ + YL AS+ HRD+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 526 DDKYRAKVSDFGASRSVMIDQTHLTTRVQG----TFGYLDPEYFRSSQFTEKSDVYSFGV 581
+ Y K++DFG SR++ + R+QG ++ E +FT SDV++FGV
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 582 VLVELLT 588
L E+ T
Sbjct: 220 TLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 70/223 (31%), Positives = 116/223 (52%), Gaps = 27/223 (12%)
Query: 396 RILGQGGQGTVY---------KGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHR 446
++LGQG G V+ G L ++ +KK+ L + E IL+++NH
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKV--LKKATLKVRDRVRT-KMERDILAEVNHP 58
Query: 447 NVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSDAL 502
+VKL +TE L L+ +F+ G L+ + + TEE +++ +A E++ AL
Sbjct: 59 FIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-----DVKFYLA-ELALAL 111
Query: 503 CYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDP 562
+LHS + I +RD+K NILLD++ K++DFG S+ ID GT Y+ P
Sbjct: 112 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYSFCGTVEYMAP 167
Query: 563 EYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLV 605
E T+ +D +SFGV++ E+LTG P + D +E +++
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 72/234 (30%), Positives = 113/234 (48%), Gaps = 33/234 (14%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGM--LTNGRIVAIKKSKLVDESNIEQF----INEVAI 439
+ D F+ +G+G G VYK T G +VA+KK +L +E E F I E+ I
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDT-GELVALKKVRLDNEK--EGFPITAIREIKI 59
Query: 440 LSQINHRNVVKLLGCCLETEVPL----------LVYEFIPN---GTLYQYIHDQTEEFPI 486
L Q+NHRN+V L + + L LV+E++ + G L + +E+
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED--- 116
Query: 487 TWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546
I+ ++ + L Y H + HRDIK +NILL++K + K++DFG +R ++
Sbjct: 117 --HIK-SFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170
Query: 547 THLTTRVQGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDSE 599
+ T T Y PE + + DV+S G +L EL T +KPI + E
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQE 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 8e-18
Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 397 ILGQGGQGTVYKGM-LTNGRIVAIKKSKL-VDESNIEQF-INEVAILSQI---NHRNVVK 450
+G+G GTVYK L GR VA+KK ++ + E I + E+A+L Q+ H N+V+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 451 LLGCC----LETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
LL C + E+ L LV+E + + L Y+ + I+ + ++ + +L
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRGVDFL 123
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF 565
HS I HRD+K NIL+ + K++DFG +R + + LT+ V T Y PE
Sbjct: 124 HSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMALTSVVV-TLWYRAPEVL 178
Query: 566 RSSQFTEKSDVYSFGVVLVEL 586
S + D++S G + EL
Sbjct: 179 LQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 8e-18
Identities = 62/193 (32%), Positives = 90/193 (46%), Gaps = 25/193 (12%)
Query: 414 GRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKLL--GCCLETEVPLL--VYE 466
G VAIK +E +F E A+ +++ H N+V LL G E LL V+E
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSG---EAPPGLLFAVFE 59
Query: 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL- 525
++P TL + + + R+ ++V DAL H+ I HRD+K NI++
Sbjct: 60 YVPGRTLREVLAADG---ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVS 113
Query: 526 --DDKYRAKVSDFGAS------RSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVY 577
+ AKV DFG R + TT V GT Y PE R T SD+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 578 SFGVVLVELLTGQ 590
++G++ +E LTGQ
Sbjct: 174 AWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 67/226 (29%), Positives = 110/226 (48%), Gaps = 12/226 (5%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL-VDESNIEQFINEVAILSQINHRN 447
D+F LG G G V K + +G I+A K L + + Q I E+ +L + N
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 448 VVKLLGCCL-ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH 506
+V G + E+ + + E + G+L Q + I I +I+I V L YL
Sbjct: 61 IVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGR---IPENILGKISIAVLRGLTYLR 116
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR 566
I HRD+K +NIL++ + K+ DFG S +ID + GT Y+ PE +
Sbjct: 117 EKHKI--MHRDVKPSNILVNSRGEIKLCDFGVS-GQLIDS--MANSFVGTRSYMSPERLQ 171
Query: 567 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAM 612
+ +T +SD++S G+ LVE+ G+ PI D++E +++ G +
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEG 217
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 397 ILGQGGQGTVYKGMLTN-GR---IVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKL 451
++G G G V +G L G+ VAIK K E F++E +I+ Q +H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 452 LGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASI 511
G ++ +++ EF+ NG L ++ +F + + + I + + YL + +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGI--AAGMKYL---SEM 125
Query: 512 PIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFG------YLDPEYF 565
HRD+ + NIL++ KVSDFG SR + D + T + G + PE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT--YTSSLGGKIPIRWTAPEAI 183
Query: 566 RSSQFTEKSDVYSFGVVLVELLT-GQKP 592
+FT SDV+S+G+V+ E+++ G++P
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 9/207 (4%)
Query: 391 NFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSK---LVDESNIEQFINEVAILSQINHR 446
NF + +G+G VY+ L +G VA+KK + L+D I E+ +L Q+NH
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYI-HDQTEEFPITWEIRLRIAIEVSDALCYL 505
NV+K +E +V E G L + I H + ++ I + + +++ AL ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF 565
HS + HRDIK AN+ + K+ D G R +T + GT Y+ PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYMSPERI 178
Query: 566 RSSQFTEKSDVYSFGVVLVELLTGQKP 592
+ + KSD++S G +L E+ Q P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 13/205 (6%)
Query: 396 RILGQGGQGTVYKGML-TNGR---IVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVK 450
+++G G G V G L G+ VAIK K E F++E +I+ Q +H N++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 451 LLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAAS 510
L G +++ ++V E++ NG+L ++ +F + + + I + + YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGI--ASGMKYLSDMGY 127
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFG--YLDPEYFRSS 568
+ HRD+ + NIL++ KVSDFG SR + D T G + PE
Sbjct: 128 V---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 569 QFTEKSDVYSFGVVLVELLT-GQKP 592
+FT SDV+S+G+V+ E+++ G++P
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 81/268 (30%), Positives = 122/268 (45%), Gaps = 31/268 (11%)
Query: 392 FNTNRILGQGGQGTVYKGML-TNGRIVAIKK--SKLVDESNIEQF-INEVAILSQINHRN 447
F R+LG+GG G V + G++ A KK K + + E +NE IL ++N R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 448 VVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEE-FPITWEIRLRIAIEVSDALCYL 505
VV L ET+ L LV + G L +I+ E F R ++ C L
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE-----EGRAVFYAAEICCGL 115
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF 565
I +RD+K NILLDD ++SD G + V QT + RV GT GY+ PE
Sbjct: 116 EDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVV 173
Query: 566 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625
++ ++T D ++ G +L E++ GQ P F + K+ + EV R+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSP---------------FQQRKKKIKREEV--ERL 216
Query: 626 LKEAKEEEIITVAMLAKRCLNMIGKKRP 653
+KE +EE + A+ M+ K P
Sbjct: 217 VKEVQEEYSEKFSPDARSLCKMLLCKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 396 RILGQGGQGTVYKGMLTN------GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVV 449
R LG+G G V+ N +VA+K K + + F E +L+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIR-------------LRIAI 496
K G C + + ++V+E++ +G L +++ + I + + L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 497 EVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG- 555
+++ + YL AS HRD+ + N L+ K+ DFG SR V + RV G
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVGGH 184
Query: 556 ---TFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
++ PE +FT +SDV+SFGV+L E+ T G++P
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-17
Identities = 67/227 (29%), Positives = 109/227 (48%), Gaps = 10/227 (4%)
Query: 386 EMATDNFNTNRILGQGGQGTVYK-GMLTNGRIVAIKKSKLVDESNIE-QFINEVAILSQI 443
E+ D+F LG G G V+K +G I+A K L + I Q I E+ +L +
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 444 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC 503
N +V G + E + G+L Q + I +I +++I V L
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLT 117
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE 563
YL I HRD+K +NIL++ + K+ DFG S +ID + GT Y+ PE
Sbjct: 118 YLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDS--MANSFVGTRSYMSPE 172
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLE 610
+ + ++ +SD++S G+ LVE+ G+ PI D++E + + G +E
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVE 219
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 9/207 (4%)
Query: 391 NFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSK---LVDESNIEQFINEVAILSQINHR 446
NF + +G+G VY+ L + + VA+KK + ++D + + E+ +L Q+NH
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYI-HDQTEEFPITWEIRLRIAIEVSDALCYL 505
NV+K L +E +V E G L Q I + + ++ I + +++ A+ ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF 565
HS + HRDIK AN+ + K+ D G R T + V GT Y+ PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 566 RSSQFTEKSDVYSFGVVLVELLTGQKP 592
+ + KSD++S G +L E+ Q P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 64/231 (27%), Positives = 93/231 (40%), Gaps = 43/231 (18%)
Query: 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIK--KSKLVDESNIEQFINEVAILSQIN 444
T F ++G+G G VYK G++VAIK +E I++ N + S N
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS--N 61
Query: 445 HRNVVKLLGCCLETEVPL------LVYEFIPNGT---LYQYIHDQTEEFPITWEIRLRIA 495
H N+ G ++ P LV E G+ L + + + + W IA
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IA 116
Query: 496 I---EVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTR 552
E L YLH I HRDIK NILL K+ DFG S L +
Sbjct: 117 YILRETLRGLAYLHENKVI---HRDIKGQNILLTKNAEVKLVDFGVSA-------QLDST 166
Query: 553 VQ------GTFGYLDPEYFRSSQ-----FTEKSDVYSFGVVLVELLTGQKP 592
+ GT ++ PE + + +SDV+S G+ +EL G+ P
Sbjct: 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 13/217 (5%)
Query: 391 NFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESN--IEQFINEVAILSQINHRN 447
NF +G+G G VYK G +VA+KK +L E+ I E+++L ++NH N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 448 VVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH 506
+VKLL + TE L LV+EF+ + L +++ D + I + ++ L + H
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR 566
S + HRD+K N+L++ + K++DFG +R+ + T V T Y PE
Sbjct: 118 SHRVL---HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 173
Query: 567 SSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDK 602
++ + D++S G + E++T ++ + DSE D+
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 76/305 (24%), Positives = 131/305 (42%), Gaps = 44/305 (14%)
Query: 386 EMATDNFNTNRILGQGGQGTVY--------KGMLTNGRIVAIKKSK-LVDESNIEQFINE 436
E + D + LG+G G V K VA+K K E ++ ++E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 437 VAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------------DQTE 482
+ ++ I H+N++ LLG C + ++ E+ G L +Y+ +
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 483 EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542
+ +T++ + +V+ + YL S I HRD+ + N+L+ + K++DFG +R V
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 543 M-IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600
ID TT + ++ PE +T +SDV+SFGV++ E+ T G P EE
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247
Query: 601 DKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660
+ +KE R+ K A + M+ + C + I RPT K+
Sbjct: 248 -------LFKLLKEGH-------RMDKPANCTN--ELYMMMRDCWHAIPSHRPTFKQLVE 291
Query: 661 ELGGI 665
+L I
Sbjct: 292 DLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 23/221 (10%)
Query: 397 ILGQGGQGTVYKGMLTNG-----RIVAIKKSKLVDESNIEQ---FINEVAILSQINHRNV 448
+L +G G ++ G+L + V +K + D ++ Q + E +L ++H+N+
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKT--VKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 449 VKLLGCCLE-TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLR------IAIEVSDA 501
+ +L C+E E P ++Y ++ G L ++ Q L +AI+++
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQ-QCRLGEANNPQALSTQQLVHMAIQIACG 129
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYL 560
+ YLH + H+DI + N ++D++ + K++D SR + H L ++
Sbjct: 130 MSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM 186
Query: 561 DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600
E + +++ SDV+SFGV+L EL+T GQ P D E
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 391 NFNTNRILGQGGQGTVY--KGMLTNGRIVAIKKSKL----VDESNIEQFINEVAILSQIN 444
+ + +G+G G +Y K + V IK+ L V E + EV +L+++
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASK--KEVILLAKMK 57
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ-----TEEFPITWEIRLRIAIEVS 499
H N+V E +V E+ G L + I+ Q +E+ ++W +++S
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQIS 111
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYR-AKVSDFGASRSVMIDQTHLTTRVQGTFG 558
L ++H I HRDIKS NI L AK+ DFG +R + D L GT
Sbjct: 112 LGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPY 167
Query: 559 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 597
YL PE ++ + K+D++S G VL EL T + P +
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQF---INEVAILSQINHRNVVKL 451
R +G G G VY +VAIKK + + E++ I EV L Q+ H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 452 LGCCLETEVPLLVYEF-IPNGTLYQYIHDQ-TEEFPITWEIRLRIAIEVSDALCYLHSAA 509
GC L LV E+ + + + +H + +E I I L YLHS
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIA-----AICHGALQGLAYLHSHE 135
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS-- 567
I HRDIK+ NILL + K++DFG++ V + + GT ++ PE +
Sbjct: 136 RI---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMD 187
Query: 568 -SQFTEKSDVYSFGVVLVELLTGQKPI 593
Q+ K DV+S G+ +EL + P+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 27/216 (12%)
Query: 398 LGQGGQGTVYKGMLTN--GRIVAIKKSKL-VDESNIEQFINEV-AILSQINHRNVVKLLG 453
+G+G GTV K ML G I+A+K+ + VDE ++ + ++ ++ + +VK G
Sbjct: 12 IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 454 CCLETEVPLLVYEF--IPNGTLYQYIHD-QTEEFPITWEIRLRIAIEVSDALCYLHSAAS 510
+ E I Y+Y+++ P EI +IA+ AL YL
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLKSVIP--EEILGKIAVATVKALNYLKE--E 126
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT-----TRVQGTFGYLDPEYF 565
+ I HRD+K +NILLD K+ DFG S L TR G Y+ PE
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGIS-------GQLVDSIAKTRDAGCRPYMAPERI 179
Query: 566 RSSQ---FTEKSDVYSFGVVLVELLTGQKPIRSTDS 598
S + +SDV+S G+ L E+ TG+ P +S
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS 215
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 66/218 (30%), Positives = 94/218 (43%), Gaps = 19/218 (8%)
Query: 392 FNTNRILGQGGQGTV----YKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQIN--- 444
F +LG+G G V YK I A+KK ++ +E + E I N
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALC 503
H +V L C + V E+ G L +IH T+ F E R A V L
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH--TDVFS---EPRAVFYAACVVLGLQ 115
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM-IDQTHLTTRVQGTFGYLDP 562
YLH I +RD+K N+LLD + K++DFG + M T+ GT +L P
Sbjct: 116 YLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAP 170
Query: 563 EYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
E + +T D + GV++ E+L G+ P D EE
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 57/213 (26%), Positives = 108/213 (50%), Gaps = 11/213 (5%)
Query: 398 LGQGGQGTVYKGML-TNGRIVAIKKSKLVDESNIE-QFINEVAILSQINHRNVVKLLGCC 455
+G+G G V+ G L + VA+K + +++ +F+ E IL Q +H N+V+L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 456 LETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515
+ + +V E + G ++ +TE + + +++ + + YL S I H
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKHCI---H 117
Query: 516 RDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTT--RVQGTFGYLDPEYFRSSQFTEK 573
RD+ + N L+ +K K+SDFG SR D + +T Q + PE +++ +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 574 SDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLV 605
SDV+SFG++L E + G P + +++ + +
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 77/307 (25%), Positives = 137/307 (44%), Gaps = 44/307 (14%)
Query: 386 EMATDNFNTNRILGQG--GQGTVYKGMLTN----GRI--VAIKKSKL-VDESNIEQFINE 436
E+ D + LG+G GQ + + + + R+ VA+K K E ++ I+E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 437 VAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------------DQTE 482
+ ++ I H+N++ LLG C + ++ E+ G L +Y+ Q
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 483 EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542
E ++++ + A +V+ + YL S I HRD+ + N+L+ + K++DFG +R +
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 543 M-IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600
ID TT + ++ PE +T +SDV+SFGV+L E+ T G P EE
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250
Query: 601 DKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660
LF++L + + M+ + C + + +RPT K+
Sbjct: 251 ----------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294
Query: 661 ELGGIRA 667
+L I A
Sbjct: 295 DLDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 13/219 (5%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINH 445
E+ ++ + LG G G V+ VA+K K S +E F+ E ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQH 60
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-DQTEEFPITWEIRLRIAIEVSDALCY 504
+VKL + E ++ EF+ G+L ++ D+ + P+ I + ++++ + +
Sbjct: 61 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAF 117
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDP 562
+ I HRD+++ANIL+ K++DFG +R +I+ T R F + P
Sbjct: 118 IEQRNYI---HRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAP 172
Query: 563 EYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600
E FT KSDV+SFG++L+E++T G+ P + E
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 1e-16
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 55/227 (24%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIE--QFINEVAILSQINHRNVVKLL 452
+ +G G G V + GR VAIKK V + I+ + + E+ +L + H N++ LL
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 453 GCCLETEVPL-----------LVYEFIPNGT-LYQYIHDQTEEFPITWEIRLRIAIEVSD 500
++ +V E + T L++ I P+T + ++
Sbjct: 66 ------DILRPPSPEDFNDVYIVTELME--TDLHKVIKSPQ---PLTDDHIQYFLYQILR 114
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID---QTHLT----TRV 553
L YLHSA + HRD+K +NIL++ K+ DFG +R V D + LT TR
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR- 170
Query: 554 QGTFGYLDPEYFR-------SSQFTEKSDVYSFGVVLVELLTGQKPI 593
++R SS++T+ D++S G + ELLT KP+
Sbjct: 171 ----------WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 59/215 (27%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCC 455
LG+G TVYKG T G IVA+K+ L +E I E++++ ++ H N+V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV- 66
Query: 456 LETEVPL-LVYEFIPNGTLYQYIHDQTEEFPI--------TWEIRLRIAIEVSDALCYLH 506
+ TE L LV+E++ + L +Y+ + T+++ IA C+ +
Sbjct: 67 IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA------FCHEN 119
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR 566
+ HRD+K N+L++ + K++DFG +R+ I + V T Y P+
Sbjct: 120 R-----VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLL 173
Query: 567 SSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
S+ ++ D++S G ++ E++TG+ T++E+
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 40/274 (14%)
Query: 417 VAIK--KSKLVDESNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVPLLV-YEFIPNGT 472
VA+K K D+ ++ I+E+ ++ I H+N++ LLG C + E PL V E+ G
Sbjct: 47 VAVKMLKDNATDK-DLADLISEMELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGN 104
Query: 473 LYQYIH-----------DQTE--EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIK 519
L +++ D T+ E ++++ + A +V+ + YL S I HRD+
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI---HRDLA 161
Query: 520 SANILLDDKYRAKVSDFGASRSVM-IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYS 578
+ N+L+ + K++DFG +R V ID T+ + ++ PE +T +SDV+S
Sbjct: 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWS 221
Query: 579 FGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITV 637
FG+++ E+ T G P EE LF++L + +
Sbjct: 222 FGILMWEIFTLGGSPYPGIPVEE----------------LFKLLREGHRMDKPSNCTHEL 265
Query: 638 AMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGD 671
ML + C + + +RPT K+ L + A++ +
Sbjct: 266 YMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 68/224 (30%), Positives = 111/224 (49%), Gaps = 18/224 (8%)
Query: 391 NFNTNRILGQGGQGTVY----KGMLTNGRIVAIK---KSKLVDES-NIEQFINEVAILSQ 442
NF R+LG G G V+ G G++ A+K K+ +V ++ E E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 443 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDA 501
+ + L +T+ L L+ +++ G L+ +++ Q E F + E+R+ IA E+ A
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFTES-EVRVYIA-EIVLA 117
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
L +LH + I +RDIK NILLD + ++DFG S+ + ++ GT Y+
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 562 PEYFR--SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKS 603
PE R S + D +S GV+ ELLTG P + D E++
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF-TVDGEQNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 51/244 (20%)
Query: 395 NRILGQGGQGTVYKGMLTN-GRIVAIKKSKLVDESN----IEQFINEVAI---------- 439
LG+G G V K T G+IVAIKK K+++ SN Q + I
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 440 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLR------ 493
+++I H N++ L+ +E + LV + I L + + + IRL
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVVDRK---------IRLTESQVKC 123
Query: 494 IAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID-------- 545
I +++ + L LH HRD+ ANI ++ K K++DFG +R
Sbjct: 124 ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 546 ------QTHLTTRVQGTFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDS 598
+ +T++V T Y PE + ++ D++S G + ELLTG KP+ ++
Sbjct: 181 DETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFPGEN 238
Query: 599 EEDK 602
E D+
Sbjct: 239 EIDQ 242
|
Length = 335 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 77/245 (31%), Positives = 113/245 (46%), Gaps = 50/245 (20%)
Query: 367 SSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV 425
SSS G++ S ELE NRI G G GTVYK + GR+ A+K V
Sbjct: 59 SSSASGSAPSAAKSLS-ELE------RVNRI-GSGAGGTVYKVIHRPTGRLYALK----V 106
Query: 426 -----DESNIEQFINEVAILSQINHRNVVKLLGCCLET-----EVPLLVYEFIPNGTLYQ 475
+++ Q E+ IL +NH NVVK C + E+ +L+ EF+ G+L
Sbjct: 107 IYGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSL-- 159
Query: 476 YIHDQTEEFPITWEIRLR-IAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVS 534
E I E L +A ++ + YLH I HRDIK +N+L++ K++
Sbjct: 160 ------EGTHIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIA 210
Query: 535 DFGASRSVMIDQTH--LTTRVQGTFGYLDPEYFRSSQFTEK-----SDVYSFGVVLVELL 587
DFG SR ++ QT + V GT Y+ PE + D++S GV ++E
Sbjct: 211 DFGVSR--ILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFY 267
Query: 588 TGQKP 592
G+ P
Sbjct: 268 LGRFP 272
|
Length = 353 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 3e-16
Identities = 50/175 (28%), Positives = 92/175 (52%), Gaps = 26/175 (14%)
Query: 433 FINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-----DQTEE---- 483
F+ EV ILS++ N+++LLG C++ + ++ E++ NG L Q++ D+ E
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125
Query: 484 -------FPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 536
I++ L +A++++ + YL +S+ HRD+ + N L+ + K++DF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADF 182
Query: 537 GASRSVMIDQTHLTTRVQG----TFGYLDPEYFRSSQFTEKSDVYSFGVVLVELL 587
G SR++ + R+QG ++ E +FT SDV++FGV L E+L
Sbjct: 183 GMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKL-VDESNI-EQFINEVAILSQINHR 446
D + +G+G G VYK G++VA+KK++L +DE I + E+++L ++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 447 N-VVKLLGCCLETEVPL------LVYEFIPNGTLYQYI--HDQTEEFPITWEIRLRIAIE 497
+V+LL E LV+E++ + L +++ + + P+ + +
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 498 VSDALCYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGASRSVMIDQTHLTTRVQGT 556
+ + + H + HRD+K N+L+D K K++D G R+ I T + T
Sbjct: 119 LLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-T 174
Query: 557 FGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSE 599
Y PE S+ ++ D++S G + E+ Q P+ DSE
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ-PLFPGDSE 217
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 58/214 (27%), Positives = 108/214 (50%), Gaps = 21/214 (9%)
Query: 391 NFNTNRILGQG--GQGTVYKGMLTNGRIVAIKKSKL-VDESNIEQFINEVAILSQINHRN 447
+N R++G+G G+ + + + ++ + A+K+ +L S +E E +L+++ H N
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 448 VVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ-----TEEFPITWEIRLRIAIEVSDA 501
+V E + L +V E+ G L Q I Q E+ + W +++ + ++
Sbjct: 60 IVAFKES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ---- 114
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
++H + HRDIKS NI L + K+ DFG++R + + T V GT Y+
Sbjct: 115 --HIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVP 168
Query: 562 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRS 595
PE + + + KSD++S G +L EL T + P ++
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 14/211 (6%)
Query: 396 RILGQGGQGTVY----KGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKL 451
++LG+G G V KG I A+KK ++++ ++E + E +L+ +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 452 LGCCLETEVPLL-VYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAA 509
L C +T+ L V E++ G L +I + F E R R A E+ L +LH
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQ-SSGRFD---EARARFYAAEIICGLQFLHKKG 116
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ 569
I +RD+K N+LLD K++DFG + M + +T GT Y+ PE + +
Sbjct: 117 II---YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQK 172
Query: 570 FTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
+ E D +SFGV+L E+L GQ P D +E
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 5e-16
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 396 RILGQGGQGTVYKGMLTNGR-----IVAIKKSKLVDESNIEQFINEVAILSQINHRNVVK 450
++LG+G G V L G+ + A+KK ++ + ++E + E +L+ +
Sbjct: 1 KVLGKGSFGKVLLAEL-KGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 451 LLGCCLETEVPLL-VYEFIPNGTLYQYIHDQT--EEFPITWEIRLRIAIEVSDALCYLHS 507
L C +T+ L V EF+ G L +I D+ + + T+ A E+ L +LHS
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQFLHS 114
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS 567
I +RD+K N++LD K++DFG + + +T GT Y+ PE +
Sbjct: 115 KGII---YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQG 170
Query: 568 SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
++T D +SFGV+L E+L GQ P D +E
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 14/211 (6%)
Query: 398 LGQGGQGTVYKGM--LTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLG 453
+G+G G VYK +TN +A+KK +L DE I E+++L ++ H N+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPI 513
+ LV+E++ + L +++ D + +F + ++ + Y HS +
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHM-DSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---V 123
Query: 514 YHRDIKSANILLDDKYRA-KVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS-QFT 571
HRD+K N+L+D + A K++DFG +R+ I T V T Y PE S ++
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRHYS 182
Query: 572 EKSDVYSFGVVLVELLTGQKPIRSTDSEEDK 602
D++S G + E++ QKP+ DSE D+
Sbjct: 183 TPVDIWSVGCIFAEMVN-QKPLFPGDSEIDE 212
|
Length = 294 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 62/199 (31%), Positives = 87/199 (43%), Gaps = 18/199 (9%)
Query: 400 QGGQGTVY--KGMLTNGRIVAIK---KSKLVDESNIEQFINEVAIL-SQINHRNVVKLLG 453
+G G+VY K T G AIK KS ++ ++ + E AI+ Q V KL
Sbjct: 6 KGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPI 513
+ LV E++ G I P W + IA EV + LH I
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLIK-TLGGLPEDW-AKQYIA-EVVLGVEDLHQRG---I 118
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 573
HRDIK N+L+D K++DFG SR+ + ++ + GT YL PE +
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPETILGVGDDKM 173
Query: 574 SDVYSFGVVLVELLTGQKP 592
SD +S G V+ E L G P
Sbjct: 174 SDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 67/277 (24%), Positives = 126/277 (45%), Gaps = 34/277 (12%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIKKS-KLVDESNIEQFINEVA----ILSQINHRNVV 449
++LG G GTV+KG+ + G + I + K + + + Q E+ + ++H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA 509
+LLG C + L V + P G+L ++ + + + L ++++ + YL
Sbjct: 73 RLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI-DQTHLTTRVQGTFGYLDPEYFRSS 568
+ HR++ + NILL +++DFG + + D+ + + + ++ E
Sbjct: 130 MV---HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 569 QFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627
++T +SDV+S+GV + E+++ G +P E L LE K RL
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL----LE--KGERL---------- 230
Query: 628 EAKEEEIIT--VAMLAKRCLNMIGKKRPTMKEAAFEL 662
+ +I T V M+ +C + RPT KE A E
Sbjct: 231 --AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEF 265
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 8e-16
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 21/198 (10%)
Query: 402 GQGTVYKGML----TNGRIVAIKKSKLVDESNIE--QFINEVAILSQINHRNVVKLLGCC 455
G+G+ K +L +G+ IK+ + S E + EVA+LS + H N+V+
Sbjct: 9 GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF 68
Query: 456 LETEVPLLVYEFIPNGTLYQYIHDQ-----TEEFPITWEIRLRIAIEVSDALCYLHSAAS 510
E +V ++ G LY+ I+ Q E+ + W +++ +A++ ++H
Sbjct: 69 EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK------HVHDRK- 121
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQF 570
I HRDIKS NI L K+ DFG +R V+ L GT YL PE + +
Sbjct: 122 --ILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYYLSPEICENRPY 178
Query: 571 TEKSDVYSFGVVLVELLT 588
KSD+++ G VL E+ T
Sbjct: 179 NNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTNGR-IVAIKK---SKLVDESNIEQFINEVAILSQINH 445
D+ + +G G G V+ A+K +++ + NE +L +++H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIH------DQTEEFPITWEIRLRIAIEVS 499
+++L + ++ E++P G L+ Y+ + T F A E+
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF---------YASEIV 111
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY 559
AL YLHS I +RD+K NILLD + K++DFG ++ + D+T + GT Y
Sbjct: 112 CALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTW---TLCGTPEY 164
Query: 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIR 594
L PE +S + D ++ G+++ E+L G P
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 70/248 (28%), Positives = 115/248 (46%), Gaps = 23/248 (9%)
Query: 355 FKRNGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNG 414
F +N L +++S S + K K M ++FN R LG G G V N
Sbjct: 3 FLKNLQLHKKKDSDSTKEPKRKNK--------MKYEDFNFIRTLGTGSFGRVILATYKNE 54
Query: 415 RI--VAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIP 469
VAIK KSK++ + ++ +E IL+ INH V L G + LV EF+
Sbjct: 55 DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI 114
Query: 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY 529
G + ++ + + FP ++ A ++ YL S+ I +RD+K N+LLD
Sbjct: 115 GGEFFTFLR-RNKRFPN--DVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDG 168
Query: 530 RAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTG 589
K++DFG ++ V T T + GT Y+ PE + + +D ++ G+ + E+L G
Sbjct: 169 FIKMTDFGFAKVV---DTR-TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
Query: 590 QKPIRSTD 597
P + +
Sbjct: 225 CPPFYANE 232
|
Length = 340 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 66/239 (27%), Positives = 99/239 (41%), Gaps = 51/239 (21%)
Query: 388 ATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQF----INEVAILSQ 442
++ LG+G G VYK + GR+VA+KK + +E + F + E+ IL +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKK 63
Query: 443 INHRNVVKLLGCCLE-----TEVPLLVYEFIPNGTLYQYIHDQTE--EFPITWEIRLRIA 495
+ H NVV L+ +E VY P Y HD + E P +
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP----YM-DHDLSGLLENP-------SVK 111
Query: 496 IEVSDALC----------YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545
+ S C YLH I HRDIK+ANIL+D++ K++DFG +R
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
Query: 546 QTHLT----------TRVQGTFGYLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
+ T + T Y PE ++T D++ G V E+ T +PI
Sbjct: 169 PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 80/272 (29%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 392 FNTNRILGQGGQGTVYKGML-TNGRIVAIKK--SKLVDESNIEQF-INEVAILSQINHRN 447
F R+LG+GG G V + G++ A KK K + + E +NE IL ++N R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 448 VVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEE-FPITWEIR-LRIAIEVSDALCY 504
VV L ET+ L LV + G L +I++ F E R + A E++ L
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVFYAAEITCGLED 117
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEY 564
LH I +RD+K NILLDD ++SD G + + +T + RV GT GY+ PE
Sbjct: 118 LHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEV 172
Query: 565 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624
++ ++T D + G ++ E++ G+ P R KE E ++ R
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSPFR----------------QRKEKVKREEVERR 216
Query: 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMK 656
V KE +EE + A+ + K P +
Sbjct: 217 V-KEDQEEYSEKFSEAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 23/231 (9%)
Query: 391 NFNTNRILGQGGQGTVY----KGMLTNGRIVAIK---KSKLVD-ESNIEQFINEVAILSQ 442
NF ++LG G G V+ G++ A+K K+ LV +E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 443 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAI-EVSD 500
+ + L +TE L L+ +++ G ++ +++ Q + F E +R E+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFS---EDEVRFYSGEIIL 116
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYL 560
AL +LH + I +RDIK NILLD + ++DFG S+ + ++ T GT Y+
Sbjct: 117 ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 561 DPEYFRSSQFTEKS-DVYSFGVVLVELLTGQKPI-----RSTDSEEDKSLV 605
PE R K+ D +S G+++ ELLTG P R+T SE + ++
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL 224
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 398 LGQGGQGTVYK-GMLTNGRIVAIKK--SKLVDESNIEQF-INEVAILSQINHRNVVKLLG 453
LG+GG G V + G++ A KK K + + EQ +NE IL +++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 454 CCLETEVPL-LVYEFIPNGTLYQYIHDQTEE-FPITWEIRLRI-AIEVSDALCYLHSAAS 510
ET+ L LV + G L +I++ E FP E R A ++ L +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP---EARAIFYAAQIICGLEHLHQRR- 115
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQF 570
I +RD+K N+LLDD ++SD G + + + R GT GY+ PE + +
Sbjct: 116 --IVYRDLKPENVLLDDHGNVRISDLGLAVE-LKGGKKIKGRA-GTPGYMAPEVLQGEVY 171
Query: 571 TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDK 602
D ++ G L E++ G+ P R + +K
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 12/210 (5%)
Query: 396 RILGQGGQGTVY----KGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKL 451
++LG+G G V+ KG I A+KK ++ + ++E + E +LS +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 452 LGCCLETEVPLL-VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAAS 510
L C +T+ L V E++ G L +I +F + R ++ +C L S
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQ-SCHKFDLP-----RATFYAAEIICGLQFLHS 114
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQF 570
I +RD+K NILLD K++DFG + M+ T GT Y+ PE ++
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQKY 173
Query: 571 TEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
D +SFGV+L E+L GQ P D EE
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 69/244 (28%), Positives = 106/244 (43%), Gaps = 40/244 (16%)
Query: 390 DNFNTNRILGQGGQGTVYKG-MLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINH 445
D+F +++G+G G V+ G++ A+K KS ++ + I E IL+ +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 446 RNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCY 504
+VKL + E L LV E++P G L + + + FP R IA E+ AL
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEET-ARFYIA-ELVLALDS 116
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS--------RSVMIDQTHLT---TRV 553
+H I HRDIK NIL+D K++DFG R ++ +H V
Sbjct: 117 VHKLGFI---HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 554 Q-----------------GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRST 596
GT Y+ PE R + + + D +S GV+L E+L G P S
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233
Query: 597 DSEE 600
+E
Sbjct: 234 TLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 79/278 (28%), Positives = 119/278 (42%), Gaps = 29/278 (10%)
Query: 392 FNTNRILGQGGQGTVYKGML-TNGRIVAIKK--SKLVDESNIEQF-INEVAILSQINHRN 447
F R+LG+GG G V + G++ A K+ K + + E +NE IL ++N +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIR-LRIAIEVSDALCYLH 506
VV L + LV + G L +I++ P E R L A E+ L LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLH 119
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR 566
++ +RD+K NILLDD ++SD G + V I + GT GY+ PE
Sbjct: 120 RENTV---YRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLN 174
Query: 567 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626
+ ++T D + G ++ E++ GQ P R KE E +D RVL
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSPFR----------------GRKEKVKREEVDRRVL 218
Query: 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664
E +E + AK M+ K P + E G
Sbjct: 219 -ETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGA 255
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 69/254 (27%), Positives = 113/254 (44%), Gaps = 45/254 (17%)
Query: 397 ILGQGGQGT---VYKGMLTN---GRIVAIKKSKLVDESNIEQF----INEVAILSQINHR 446
I G G+GT VYK N G+ AIKK K D+ E+A+L ++ H
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFK-GDKEQYTGISQSACREIALLRELKHE 62
Query: 447 NVVKLLGCCLE-TEVPL-LVYEFIPNGTLYQYIHDQTE----EFP------ITWEIRLRI 494
NVV L+ LE + + L++++ + L+Q I + P + W+I
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQIL--- 118
Query: 495 AIEVSDALCYLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGASRSV--MIDQTH 548
+ + YLHS + HRD+K ANIL+ ++ K+ D G +R +
Sbjct: 119 -----NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 549 LTTRVQGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGY 607
V T Y PE ++ +T+ D+++ G + ELLT +PI + K +
Sbjct: 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGREAKIKKSNPF 229
Query: 608 FLEAMKENRLFEVL 621
+ ++ R+FEVL
Sbjct: 230 QRDQLE--RIFEVL 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 64/212 (30%), Positives = 108/212 (50%), Gaps = 15/212 (7%)
Query: 396 RILGQGGQGTVY----KGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKL 451
++LG+G G V KG I +KK ++ + +++ + E IL+ +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 452 LGCCLETEVPLL-VYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAA 509
L CC +T+ L V E++ G L I ++ +F E R R A EV+ AL +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQ-RSRKFD---EPRSRFYAAEVTLALMFLHRHG 116
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ 569
I +RD+K NILLD + K++DFG + +++ TT GT Y+ PE + +
Sbjct: 117 VI---YRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGTPDYIAPEILQELE 172
Query: 570 FTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
+ D ++ GV++ E++ GQ P + D+E+D
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPPFEA-DNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 398 LGQGGQGTVYKGMLTNGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGC 454
LG G G VYK N A+ +K+++ E +E ++ E+ IL+ NH +VKLLG
Sbjct: 20 LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 455 CLETEVPLLVYEFIPNGTLYQYIH--DQTEEFPITWEIRLRIAIEVSDALCYLHSAASIP 512
++ EF P G + + D+ P +I++ I ++ +AL YLHS +
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHS---MK 130
Query: 513 IYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQ--GTFGYLDPEY-----F 565
I HRD+K+ N+LL K++DFG S + L R GT ++ PE
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAK---NVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 566 RSSQFTEKSDVYSFGVVLVELLTGQKP 592
+ + + K+D++S G+ L+E+ + P
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 391 NFNTNRILGQGGQGTVYKGMLTNGR-------IVAIKKSKLVDESNI-EQFINEVAILSQ 442
NF ++LG G G V+ +G + +KK+ +V ++ E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 443 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDA 501
I + L +T+ L L+ ++I G L+ ++ Q E F E+++ E+ A
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFK-EQEVQIYSG-EIVLA 117
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
L +LH + I +RDIK NILLD ++DFG S+ D+ GT Y+
Sbjct: 118 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 562 PEYFR--SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
P+ R + D +S GV++ ELLTG P + D E++
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF-TVDGEKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 70/212 (33%), Positives = 99/212 (46%), Gaps = 16/212 (7%)
Query: 396 RILGQGGQGTVYKGMLT-NGRIVAIK--KSKLVDESNIEQFI--NEVAILSQINHRNVVK 450
+++G+G G V +G+ A+K + K+V ++ I +L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 451 LLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEE-FPITWEIRLRI-AIEVSDALCYLHSA 508
L TE V +F+ G L+ H Q E FP E R R A E++ AL YLHS
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFP---EPRARFYAAEIASALGYLHS- 114
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS 568
I I +RD+K NILLD + ++DFG + I Q+ TT GT YL PE R
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 569 QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
+ D + G VL E+L G P D E
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 64/247 (25%), Positives = 116/247 (46%), Gaps = 35/247 (14%)
Query: 427 ESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ----- 480
+ ++ ++E+ ++ I H+N++ LLG C + ++ E+ G L +Y+ +
Sbjct: 58 DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGM 117
Query: 481 -----TEEFP---ITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAK 532
T + P +T++ + A +V+ + YL S I HRD+ + N+L+ + K
Sbjct: 118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI---HRDLAARNVLVTEDNVMK 174
Query: 533 VSDFGASRSVM-IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQ 590
++DFG +R V ID TT + ++ PE +T +SDV+SFGV+L E+ T G
Sbjct: 175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 234
Query: 591 KPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGK 650
P EE + +KE R+ K A + M+ + C + +
Sbjct: 235 SPYPGIPVEE-------LFKLLKEGH-------RMDKPANCTH--ELYMIMRECWHAVPS 278
Query: 651 KRPTMKE 657
+RPT K+
Sbjct: 279 QRPTFKQ 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 60/210 (28%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNV 448
++F + +G G G VYK + G + AIK KL + E+ ++ H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 449 VKLLGCCLETEVPLLVYEFIPNGTLYQYIH--DQTEEFPITWEIRLRIAIEVSDALCYLH 506
V G L + + EF G+L H E I + R E L YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR-----ETLQGLYYLH 123
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF- 565
S + HRDIK ANILL D K++DFG S + + + GT ++ PE
Sbjct: 124 SKGKM---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAA 179
Query: 566 --RSSQFTEKSDVYSFGVVLVELLTGQKPI 593
R + + D+++ G+ +EL Q P+
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 14/216 (6%)
Query: 391 NFNTNRILGQGGQGTVY----KGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHR 446
+FN +LG+G G V KG I +KK ++ + ++E + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 447 NVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
+ L C +T L V E++ G L I Q F + A E++ L +L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEPHAVFY--AAEIAIGLFFL 117
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRV-QGTFGYLDPEY 564
HS I +RD+K N++LD + K++DFG + M D +TT+ GT Y+ PE
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEI 172
Query: 565 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
+ + D ++FGV+L E+L GQ P D +E
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 398 LGQGGQGTVYKGMLTN-GRIVAIK--KSKLVDESNIEQFI-NEVAILSQINHRNVVKLLG 453
LG GG G V + + R A+K K + + E+ ++ I +E IL + NH +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHD--QTEEFPITWEIRLRIAIEVSDALCYLHSAASI 511
+ + ++ E+ G L+ + D +E + R IA V A YLH+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE----YTARFYIACVVL-AFEYLHN---R 112
Query: 512 PIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFT 571
I +RD+K N+LLD K+ DFG ++ + Q T GT Y+ PE + +
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--FCGTPEYVAPEIILNKGYD 170
Query: 572 EKSDVYSFGVVLVELLTGQKPIRSTD 597
D +S G++L ELLTG+ P D
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 397 ILGQGGQGTVYKGMLT---NGRIVAIKKSK-LVDESNIEQFINEVAILSQI-NHRNVVKL 451
++G+G G V + M+ AIK K E++ F E+ +L ++ +H N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 452 LGCCLETEVPLLVYEFIPNGTLYQYIHDQT--EEFP-----------ITWEIRLRIAIEV 498
LG C + E+ P G L ++ E P +T + L+ A +V
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 499 SDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR--SVMIDQTHLTTRVQGT 556
+ + YL I HRD+ + N+L+ + +K++DFG SR V + +T V+
Sbjct: 129 ATGMQYLSEKQFI---HRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR-- 183
Query: 557 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 588
++ E S +T KSDV+SFGV+L E+++
Sbjct: 184 --WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 8e-15
Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 24/221 (10%)
Query: 391 NFNTNRILGQGGQGTVYKGMLTNGR-------IVAIKKSKLVDESNIEQFINEVAILSQI 443
+FN +LG+G G V ML + I +KK ++ + ++E + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57
Query: 444 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEF--PITWEIRLRIAIEVSD 500
+ L C +T L V E++ G L +I Q +F P + A E++
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPHA----VFYAAEIAI 112
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRV-QGTFGY 559
L +LHS I +RD+K N++LD + K++DFG + + TTR GT Y
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDY 167
Query: 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
+ PE + + D ++FGV+L E+L GQ P D +E
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 8e-15
Identities = 85/318 (26%), Positives = 140/318 (44%), Gaps = 97/318 (30%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFIN---------EVAILSQI-NHR 446
LG+G G V+K + +VA+KK + F N E+ L ++ +H
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGDHP 67
Query: 447 NVVKLLGC--------------CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRL 492
N+VKLL +ET++ + I L + +H + I +++ L
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYMETDL----HAVIRANIL-EDVHKRY----IMYQL-L 117
Query: 493 RIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM-IDQTH--- 548
+ AL Y+HS I HRD+K +NILL+ R K++DFG +RS+ +++
Sbjct: 118 K-------ALKYIHSGNVI---HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167
Query: 549 -LTTRVQGTFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPI---RST------- 596
LT V T Y PE S+++T+ D++S G +L E+L G KP+ ST
Sbjct: 168 VLTDYV-ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTSTLNQLEKI 225
Query: 597 ------DSEEDKSLVGYFLEAMKE---NRLFEVLDAR-------VLKEAKEEEIITVAML 640
S ED +E++K + + L +R +L +A ++ + L
Sbjct: 226 IEVIGPPSAED-------IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDAL----DL 274
Query: 641 AKRCLNMIGKKRPTMKEA 658
K+ L KR T +EA
Sbjct: 275 LKKLLVFNPNKRLTAEEA 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 46/168 (27%), Positives = 91/168 (54%), Gaps = 18/168 (10%)
Query: 433 FINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIH--------DQTEEF 484
F+ E+ I+S++ N+++LL C+ ++ ++ E++ NG L Q++ ++ +
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 485 PITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544
I++ + +A +++ + YL +S+ HRD+ + N L+ Y K++DFG SR++
Sbjct: 126 TISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 545 DQTHLTTRVQG----TFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 588
+ R+QG ++ E +FT SDV++FGV L E+LT
Sbjct: 183 GDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-14
Identities = 56/231 (24%), Positives = 97/231 (41%), Gaps = 32/231 (13%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIKKSK--LVDESNI-EQFINEVAILSQINHRNVVKL 451
R++G+GG G VY R VA+KK + L + + ++F+ E I + + H +V +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 452 LGCCLETEVPLLVYEFIPNGTLYQYIHD--QTEEFPITWEIR------LRIAIEVSDALC 503
C + + +I TL + Q E + L I ++ +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTT------------ 551
Y+HS + HRD+K NILL + D+GA+ +++ L
Sbjct: 128 YVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 552 -----RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 597
++ GT Y+ PE +E +D+Y+ GV+L ++LT P R
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235
|
Length = 932 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 90/327 (27%), Positives = 148/327 (45%), Gaps = 52/327 (15%)
Query: 385 LEMATDNFNTNRILGQGGQGTV----YKGMLTNGRIVAIK---KSKLVDESNIEQFINEV 437
L+M ++++ +++G+G G V +K ++ ++ A+K K +++ S+ F E
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 438 AILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAI 496
I++ N VV+L C + + L +V E++P G L + + + P W + A
Sbjct: 95 DIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWA-KFYTA- 149
Query: 497 EVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT---HLTTRV 553
EV AL +HS I HRD+K N+LLD K++DFG + +D+T T V
Sbjct: 150 EVVLALDAIHSMGLI---HRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCDTAV 204
Query: 554 QGTFGYLDPEYFRSS----QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL 609
GT Y+ PE +S + + D +S GV L E+L G P + SLVG +
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA------DSLVGTYS 257
Query: 610 EAMK-ENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIG------KKRPTMKEAAFEL 662
+ M +N L D + K AK + A L R + + K+ P K +
Sbjct: 258 KIMDHKNSLNFPEDVEISKHAKN---LICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNW 314
Query: 663 GGIRAS-------IGDSIMQHNCDDID 682
IR + + I N DDI+
Sbjct: 315 DNIRETAAPVVPELSSDIDSSNFDDIE 341
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 14/216 (6%)
Query: 391 NFNTNRILGQGGQGTVYKG-MLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINHR 446
+FN +LG+G G V + AIK K ++ + ++E + E +L+ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 447 NVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
+ L C +T L V E++ G L +I Q +F + A E+S L +L
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPQAVFY--AAEISVGLFFL 117
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRV-QGTFGYLDPEY 564
H I +RD+K N++LD + K++DFG + M+D +TTR GT Y+ PE
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEI 172
Query: 565 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
+ + D +++GV+L E+L GQ P D +E
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 28/222 (12%)
Query: 397 ILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQF----INEVAILSQINHRNVVKL 451
+GQG G V+K +IVA+KK + +E E F + E+ IL + H NVV L
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNL 76
Query: 452 LGCCLETEVP--------LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC 503
+ C P LV+EF + L + ++ +F ++ EI+ ++ + + L
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS-EIK-KVMKMLLNGLY 133
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI----DQTHLTTRVQGTFGY 559
Y+H I HRD+K+ANIL+ K++DFG +R+ + T RV T Y
Sbjct: 134 YIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWY 189
Query: 560 LDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
PE + D++ G ++ E+ T + PI ++E+
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQ 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 398 LGQGGQGTVYK-GMLTNGRIVAIKK---SKLVDESNIEQFINEVAILSQINHRNVVKLLG 453
LG+GG G V M G++ A KK +L E + E IL++++ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 454 CCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIR-LRIAIEVSDALCYLHSAASI 511
+T+ L LV + G L +I++ EE P E R ++ L +LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117
Query: 512 PIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFT 571
I +RD+K N+LLD+ ++SD G + + Q+ T GT G++ PE + ++
Sbjct: 118 -IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYD 175
Query: 572 EKSDVYSFGVVLVELLTGQKPIRS 595
D ++ GV L E++ + P R+
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRA 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQ-INHRNVVK 450
+++G+G G V +G+ A+K K ++ + + + E +L + + H +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 451 LLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEE-FPITWEIRLRI-AIEVSDALCYLHSA 508
L + V +++ G L+ H Q E FP E R R A E++ AL YLHS
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELF--FHLQRERSFP---EPRARFYAAEIASALGYLHS- 114
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS 568
+ I +RD+K NILLD + ++DFG + I+ + T+ GT YL PE R
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 569 QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
+ D + G VL E+L G P S D+ E
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 398 LGQGGQGTVYKG--MLTNGRIVAIKKSKL--VDESNIEQFINEVAILSQIN---HRNVVK 450
+G+G G V+K + GR VA+K+ ++ +E I EVA+L + H NVV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 451 LLGCCL------ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCY 504
L C ET++ L V+E + + L Y+ D+ E + E + ++ L +
Sbjct: 69 LFDVCTVSRTDRETKLTL-VFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEY 564
LHS + HRD+K NIL+ + K++DFG +R + T V T Y PE
Sbjct: 126 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVVVTLWYRAPEV 180
Query: 565 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDK 602
S + D++S G + E+ +KP+ S+ D+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 64/242 (26%), Positives = 106/242 (43%), Gaps = 30/242 (12%)
Query: 403 QGTVYKGMLTNGRIVA--IKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEV 460
G ++GM + R+V ++ S DE F+ EV ++NH NV++ LG C+E+
Sbjct: 13 LGEAHRGM-SKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVLQCLGQCIESIP 69
Query: 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRL--RIAIEVSDALCYLHSAASIPIYHRDI 518
LLV EF P G L Y+ + + R+A EV+ L +LH A I H D+
Sbjct: 70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI---HSDL 126
Query: 519 KSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFG--YLDPEYFRSSQ------- 569
N L K+ D+G + + + T+ +L PE
Sbjct: 127 ALRNCQLTADLSVKIGDYGLALE-QYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKD 185
Query: 570 FTEKSDVYSFGVVLVEL----------LTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619
T+KS+++S GV + EL L+ ++ ++ E+D L L+ +R +E
Sbjct: 186 QTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE 245
Query: 620 VL 621
V+
Sbjct: 246 VM 247
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 80/275 (29%), Positives = 121/275 (44%), Gaps = 39/275 (14%)
Query: 392 FNTNRILGQGGQGTVYKGML-TNGRIVAIKK--SKLVDESNIEQF-INEVAILSQINHRN 447
F R+LG+GG G V + G++ A KK K + + E +NE IL ++N R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 448 VVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ-----TEEFPITWEIRLRIAIEVSDA 501
VV L ET+ L LV + G L +I++ E+ R ++
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ---------RAIFYAAEL 111
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
C L I +RD+K NILLDD+ ++SD G + + +T + RV GT GY+
Sbjct: 112 CCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMA 169
Query: 562 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621
PE + ++T D + G ++ E++ GQ P R KE E +
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK----------------RKERVKREEV 213
Query: 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMK 656
D RV KE +EE + AK M+ K P +
Sbjct: 214 DRRV-KEDQEEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 31/221 (14%)
Query: 395 NRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQF----INEVAILSQINHRNVV 449
NRI +G G VY+ G IVA+KK K+ E E F + E+ IL ++ H N+V
Sbjct: 11 NRI-EEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSLREINILLKLQHPNIV 67
Query: 450 KLLGCCLETEVPL--------LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDA 501
+ EV + +V E++ + L + + F + E++ + +++
Sbjct: 68 TV------KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS-EVKC-LMLQLLSG 118
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
+ +LH I HRD+K++N+LL+++ K+ DFG +R T V T Y
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRA 174
Query: 562 PE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
PE + +++ D++S G + ELLT +KP+ SE D
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGKSEID 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 75/259 (28%), Positives = 121/259 (46%), Gaps = 26/259 (10%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIV-AIK---KSKLVDESNIEQFINEVAI 439
+L M ++F+ +++G+G G V + + V A+K K +++ S+ F E I
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 440 LSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEV 498
++ N +V+L + + L +V E++P G L + + + P W R A EV
Sbjct: 97 MAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWA-RFYTA-EV 151
Query: 499 SDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID-QTHLTTRVQGTF 557
AL +HS I HRD+K N+LLD K++DFG + + T V GT
Sbjct: 152 VLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTP 207
Query: 558 GYLDPEYFRS----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK 613
Y+ PE +S + + D +S GV L E+L G P SLVG + + M
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY------ADSLVGTYSKIMD 261
Query: 614 -ENRLFEVLDARVLKEAKE 631
+N L D + K+AK+
Sbjct: 262 HKNSLTFPDDIEISKQAKD 280
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL 456
+G G G VYK L G + A+K KL + E+ ++ + H N+V G L
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 457 ETEVPLLVYEFIPNGTLYQYIH--DQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIY 514
E + E+ G+L H E I + R E L YLHS +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSKGKM--- 128
Query: 515 HRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF---RSSQFT 571
HRDIK ANILL D K++DFG + + + + GT ++ PE ++ +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYN 187
Query: 572 EKSDVYSFGVVLVELLTGQKPI 593
+ D+++ G+ +EL Q P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 11/207 (5%)
Query: 396 RILGQGGQGTV-YKGMLTNGRIVAIKKSKLVDESNIEQFI--NEVAILSQINHRNVVKLL 452
R++G+G G V T+G+ IKK L + S E+ E +LSQ+ H N+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 453 GCCLETEVPLL--VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAAS 510
E E LL V F G LY + +Q + ++ + ++++ AL YLH
Sbjct: 66 ES-WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQV-VEWFVQIAMALQYLHEKH- 122
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQF 570
I HRD+K+ N+ L KV D G +R V+ +Q + + + GT Y+ PE F + +
Sbjct: 123 --ILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPELFSNKPY 179
Query: 571 TEKSDVYSFGVVLVELLTGQKPIRSTD 597
KSDV++ G + E+ T + + D
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKD 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 392 FNTNRILGQGGQGTVY--KGMLTNGRIVAIKKSKLVDESNIEQF---INEVAILSQINHR 446
F R +G G G VY + + TN +VAIKK + + E++ I EV L +I H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85
Query: 447 NVVKLLGCCLETEVPLLVYEF-IPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCY 504
N ++ GC L LV E+ + + + +H + +E I I L Y
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AITHGALQGLAY 140
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEY 564
LHS I HRDIK+ NILL + + K++DFG++ + + GT ++ PE
Sbjct: 141 LHSHNMI---HRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEV 192
Query: 565 FRS---SQFTEKSDVYSFGVVLVELLTGQKPI 593
+ Q+ K DV+S G+ +EL + P+
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 67/237 (28%), Positives = 110/237 (46%), Gaps = 30/237 (12%)
Query: 397 ILGQGGQGTVYKGMLTNGRI---VAIKKSK-LVDESNIEQFINEVAILSQIN-HRNVVKL 451
++G+G G V K + + AIK+ K + + F E+ +L ++ H N++ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 452 LGCCLETEVPLLVYEFIPNGTLYQYIHDQT--EEFP-----------ITWEIRLRIAIEV 498
LG C L E+ P+G L ++ E P ++ + L A +V
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 499 SDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR--SVMIDQTHLTTRVQGT 556
+ + YL I HRD+ + NIL+ + Y AK++DFG SR V + +T V+
Sbjct: 134 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-- 188
Query: 557 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE--DKSLVGYFLE 610
++ E S +T SDV+S+GV+L E+++ G P E +K GY LE
Sbjct: 189 --WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 243
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 398 LGQGGQGTVYKGMLTN-GRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKLLG 453
+GQGG G V+ + G IVA+K KS L + + + E IL+ +VKLL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 454 CCLETEVPLLVYEFIPNG---TLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAAS 510
+ E L E++P G TL + +E+ R +A E+ +A+ LH
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-----HARFYMA-EMFEAVDALHELGY 122
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQF 570
I HRD+K N L+D K++DFG S+ ++ V G+ Y+ PE R +
Sbjct: 123 I---HRDLKPENFLIDASGHIKLTDFGLSKGIV----TYANSVVGSPDYMAPEVLRGKGY 175
Query: 571 TEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
D +S G +L E L G P + E
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 58/271 (21%), Positives = 117/271 (43%), Gaps = 42/271 (15%)
Query: 400 QGGQGTVYKGMLTNGRIV--AIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLE 457
+ Q ++YKG+ N ++ KK + I+ NE+ L +I+ N++K+ G ++
Sbjct: 30 ENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID 89
Query: 458 TEVPL----LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPI 513
L L+ E+ G L + + +E ++++ +L +AI+ L L+ + P
Sbjct: 90 IVDDLPRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP- 145
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS--SQFT 571
++++ S + L+ + Y+ K+ G + I + V Y + S++T
Sbjct: 146 -YKNLTSVSFLVTENYKLKIICHGLEK---ILSSPPFKNVN-FMVYFSYKMLNDIFSEYT 200
Query: 572 EKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKE 631
K D+YS GVVL E+ TG+ P + ++ E+ D ++ +
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFENLTTK-------------------EIYDL-IINKNNS 240
Query: 632 EEIITVAML-----AKRCLNMIGKKRPTMKE 657
++ L + C + KRP +KE
Sbjct: 241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKE 271
|
Length = 283 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 12/204 (5%)
Query: 390 DNFNTNRILGQGGQGTVYKGML-TNGRIVAIKKSKLVDESNIE-QFINEVAILSQINHRN 447
D++ LG+G TVYKG NG++VA+K +L +E I E ++L + H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEF-PITWEIRLRIAIEVSDALCYLH 506
+V L E LV+E++ + L QY+ P ++ L ++ L Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL---FQLLRGLSYIH 120
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE-YF 565
I HRD+K N+L+ D K++DFG +R+ + +H + T Y P+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLL 176
Query: 566 RSSQFTEKSDVYSFGVVLVELLTG 589
S++++ D++ G + VE++ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQF---INEVAILSQINHRNVVKLLG 453
+G G G VY +VA+KK + E++ I EV L Q+ H N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 454 CCLETEVPLLVYEF-IPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASI 511
C L+ LV E+ + + + +H + +E I I L YLHS I
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AITHGALQGLAYLHSHNMI 143
Query: 512 PIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS---S 568
HRDIK+ NILL + + K++DFG++ + + GT ++ PE +
Sbjct: 144 ---HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEG 195
Query: 569 QFTEKSDVYSFGVVLVELLTGQKPI 593
Q+ K DV+S G+ +EL + P+
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 56/183 (30%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 418 AIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYI 477
I+K+ +V S + + E +L+Q+N +V L E LV FI G L+
Sbjct: 25 TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFH-- 82
Query: 478 HDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537
H Q E R A + LC L + + +RD+K NILLD + + DFG
Sbjct: 83 HLQREGRFDLSRARFYTA----ELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFG 138
Query: 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 597
+ M D T GT YL PE +T+ D ++ GV+L E+LTG P +
Sbjct: 139 LCKLNMKD-DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197
Query: 598 SEE 600
E
Sbjct: 198 VNE 200
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-13
Identities = 78/240 (32%), Positives = 115/240 (47%), Gaps = 40/240 (16%)
Query: 395 NRILGQGGQGTV-YKGMLTNGRIVAIKKSKLVD-ESNIEQFIN----EVAILSQINHRNV 448
+R+LG G GTV +++G A+K +VD E E N EV L + ++
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVK---VVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 449 VKLLGCCLE------------TEVPLLVYEFIPNGTLYQYIHD--QTEEFPITWEIRLRI 494
VK C E + LV ++ G L Q I +T E L +
Sbjct: 94 VK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL-L 148
Query: 495 AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQ 554
I+V A+ ++HS I HRDIKSANILL K+ DFG S+ M T ++ V
Sbjct: 149 FIQVLLAVHHVHSKHMI---HRDIKSANILLCSNGLVKLGDFGFSK--MYAAT-VSDDVG 202
Query: 555 GTFG----YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE--DKSLVGYF 608
TF Y+ PE +R +++K+D++S GV+L ELLT ++P + EE K+L G +
Sbjct: 203 RTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262
|
Length = 496 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 71/263 (26%), Positives = 124/263 (47%), Gaps = 22/263 (8%)
Query: 396 RILGQGGQGTVYKGMLT-NGRIVAIK--KSKLV-DESNIEQFINEVAILSQINHRNVVKL 451
R++G+G V L RI A+K K +LV D+ +I+ E + Q ++ +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 452 LGCCLETEVPLL-VYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAA 509
L C +TE L V E++ G L ++ Q + P E R + E+S AL YLH
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLP---EEHARFYSAEISLALNYLHERG 116
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ 569
I +RD+K N+LLD + K++D+G + + T+ GT Y+ PE R
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-RPGDTTSTFCGTPNYIAPEILRGED 172
Query: 570 FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEA 629
+ D ++ GV++ E++ G+ P S ++ + E+ LF+V+ + ++
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-------DQNTEDYLFQVILEKQIRIP 225
Query: 630 KEEEIITVAMLAKRCLNMIGKKR 652
+ + ++L K LN K+R
Sbjct: 226 RSLSVKAASVL-KSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 42/122 (34%), Positives = 61/122 (50%), Gaps = 14/122 (11%)
Query: 485 PITWEIRLRIAIEVSDALCYL---HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541
PI +I ++ + + AL YL H + HRD+K +NILLD K+ DFG S
Sbjct: 110 PIPEDILGKMTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGR 164
Query: 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEK----SDVYSFGVVLVELLTGQKPIRSTD 597
++ + TR G Y+ PE K +DV+S G+ LVEL TGQ P ++
Sbjct: 165 LVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222
Query: 598 SE 599
+E
Sbjct: 223 TE 224
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 51/232 (21%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQF----INEVAIL---SQINHRNVV 449
+G G GTVYK +G VA+K ++ ++N + + EVA+L +H N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRV--QTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 450 KLLGCCL------ETEVPLLVYEFI------------PNGTLYQYIHDQTEEFPITWEIR 491
+L+ C ET+V L V+E + P G + I D +F
Sbjct: 66 RLMDVCATSRTDRETKVTL-VFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQF------- 117
Query: 492 LRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT- 550
LR L +LH+ I HRD+K NIL+ + K++DFG +R I +
Sbjct: 118 LR-------GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMAL 164
Query: 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDK 602
T V T Y PE S + D++S G + E+ +KP+ +SE D+
Sbjct: 165 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 77/281 (27%), Positives = 126/281 (44%), Gaps = 28/281 (9%)
Query: 362 LLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTV----YKGMLTNGRIV 417
L + ++ N N K + +L M +++ +++G+G G V +K + ++
Sbjct: 15 LRKNKNIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVY 71
Query: 418 AIK---KSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLY 474
A+K K +++ S+ F E I++ N VV+L + +V E++P G L
Sbjct: 72 AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV 131
Query: 475 QYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVS 534
+ + + P W R A EV AL +HS I HRD+K N+LLD K++
Sbjct: 132 NLMSNY--DVPEKWA-RFYTA-EVVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLA 184
Query: 535 DFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS----QFTEKSDVYSFGVVLVELLTGQ 590
DFG + + GT Y+ PE +S + + D +S GV L E+L G
Sbjct: 185 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244
Query: 591 KPIRSTDSEEDKSLVGYFLEAMK-ENRLFEVLDARVLKEAK 630
P + SLVG + + M +N L D + KEAK
Sbjct: 245 TPFYA------DSLVGTYSKIMNHKNSLTFPDDNDISKEAK 279
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 42/287 (14%)
Query: 397 ILGQGGQGTVYKGMLTNGRI---VAIKKSK-LVDESNIEQFINEVAILSQINHR-NVVKL 451
++G+G G V K + + AIK+ K + + F E+ +L ++ H N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 452 LGCCLETEVPLLVYEFIPNGTLYQYIHDQT--EEFP-----------ITWEIRLRIAIEV 498
LG C L E+ P+G L ++ E P ++ + L A +V
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 499 SDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR--SVMIDQTHLTTRVQGT 556
+ + YL I HRD+ + NIL+ + Y AK++DFG SR V + +T V+
Sbjct: 122 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-- 176
Query: 557 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR 616
++ E S +T SDV+S+GV+L E++ SL G M
Sbjct: 177 --WMAIESLNYSVYTTNSDVWSYGVLLWEIV---------------SLGGTPYCGMTCAE 219
Query: 617 LFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663
L+E L E V L ++C +RP+ + L
Sbjct: 220 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 398 LGQGGQGTVYKGMLTNGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGC 454
LG G G VYK ++A +K++D E +E ++ E+ IL+ +H N+VKLL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLA--AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVS-DALCYLHSAASIPI 513
++ EF G + + + E P+T E ++R+ + + +AL YLH I
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLEL--ERPLT-EPQIRVVCKQTLEALNYLHENK---I 124
Query: 514 YHRDIKSANILLDDKYRAKVSDFGAS----RSVMIDQTHLTTRVQGTFGYLDPEYF---- 565
HRD+K+ NIL K++DFG S R++ + + GT ++ PE
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCET 179
Query: 566 -RSSQFTEKSDVYSFGVVLVELLTGQKP 592
+ + K+DV+S G+ L+E+ + P
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 30/209 (14%)
Query: 396 RILGQGGQGTVYKGMLTNGRI-VAIKKSKLVDESNI--EQFINEVAILSQINHRNVVKLL 452
+G G G V T VAIKK +S I ++ E+ +L ++H NV+ LL
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 453 GC-----CLE--TEVPLLVYEFIPNGTLYQYIHDQ--TEEFPITWEIRLRIAIEVSDALC 503
LE +V LV + L + Q +++ I+ + ++ L
Sbjct: 81 DVFTPASSLEDFQDV-YLVTHLM-GADLNNIVKCQKLSDD-----HIQF-LVYQILRGLK 132
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDP 562
Y+HSA I HRD+K +NI +++ K+ DFG +R + T ++ TR Y P
Sbjct: 133 YIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAP 184
Query: 563 E-YFRSSQFTEKSDVYSFGVVLVELLTGQ 590
E + + D++S G ++ ELLTG+
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIE-QFINEVAILSQINHRNVVKLLGCC 455
LG+G TVYKG+ NG++VA+K + E + I E ++L + H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 456 LETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515
E V+E++ + L QY+ + +RL ++ L Y+H I H
Sbjct: 73 HTKETLTFVFEYM-HTDLAQYMIQHPGGLH-PYNVRL-FMFQLLRGLAYIHGQH---ILH 126
Query: 516 RDIKSANILLDDKYRAKVSDFGASRSVMI-DQTHLTTRVQGTFGYLDPEYFR-SSQFTEK 573
RD+K N+L+ K++DFG +R+ I QT+ + V T Y P+ ++ ++
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYSSA 184
Query: 574 SDVYSFGVVLVELLTGQ 590
D++ G + +E+L GQ
Sbjct: 185 LDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 65/241 (26%), Positives = 114/241 (47%), Gaps = 27/241 (11%)
Query: 396 RILGQGGQGTVYKGML-TNGRIVAIK--KSKLV-DESNIEQFINEVAILSQINHRNVVKL 451
R++G+G V L RI A+K K +LV D+ +I+ E + ++ +
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 452 LGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAA 509
L C +TE L V EF+ G L ++ Q + P E R + E+S AL +LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLP---EEHARFYSAEISLALNFLHERG 116
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ 569
I +RD+K N+LLD + K++D+G + I T+ GT Y+ PE R
Sbjct: 117 ---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 570 FTEKSDVYSFGVVLVELLTGQKP---IRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626
+ D ++ GV++ E++ G+ P + +D+ + + E+ LF+V+ + +
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNT----------EDYLFQVILEKQI 222
Query: 627 K 627
+
Sbjct: 223 R 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 392 FNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQF---INEVAILSQINHRN 447
F+ R +G G G VY + N +VAIKK + + E++ I EV L ++ H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 448 VVKLLGCCLETEVPLLVYEF-IPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYL 505
++ GC L LV E+ + + + +H + +E I + L YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AVTHGALQGLAYL 131
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF 565
HS I HRD+K+ NILL + K+ DFG S S+M GT ++ PE
Sbjct: 132 HSHNMI---HRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXFV----GTPYWMAPEVI 183
Query: 566 RS---SQFTEKSDVYSFGVVLVELLTGQKPI 593
+ Q+ K DV+S G+ +EL + P+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 67/243 (27%), Positives = 110/243 (45%), Gaps = 19/243 (7%)
Query: 396 RILGQGGQGTVYKGMLT-NGRIVAIK--KSKLV-DESNIEQFINEVAILSQINHRNVVKL 451
R++G+G V L N +I A+K K +LV D+ +I+ E + Q + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 452 LGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAA 509
L C +T L LV E++ G L ++ Q + P E R A E+ AL +LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLP---EEHARFYAAEICIALNFLHERG 116
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ 569
I +RD+K N+LLD K++D+G + + T+ GT Y+ PE R +
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 570 FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN-----RLFEVLDAR 624
+ D ++ GV++ E++ G+ P D + Y + + E R V +
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASH 232
Query: 625 VLK 627
VLK
Sbjct: 233 VLK 235
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 384 ELEM----ATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAI 439
+ EM T +F RI G G Y I +KK +++ ++ E +I
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYA-------IKCLKKREILKMKQVQHVAQEKSI 71
Query: 440 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVS 499
L +++H +V ++ + + EF+ G L+ ++ + FP ++ E+
Sbjct: 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR-KAGRFPN--DVAKFYHAELV 128
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY 559
A YLHS I +RD+K N+LLD+K KV+DFG ++ V T + GT Y
Sbjct: 129 LAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEY 181
Query: 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
L PE +S + D ++ GV+L E + G P
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 29/220 (13%)
Query: 392 FNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNV 448
F ++G G G VYKG + G++ AIK + +E I+Q IN + S +HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS--HHRNI 65
Query: 449 VKLLGCCLETEVP------LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDAL 502
G ++ P LV EF G++ I + T+ + E I E+ L
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGL 124
Query: 503 CYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS----RSVMIDQTHLTTRVQGTFG 558
+LH I HRDIK N+LL + K+ DFG S R+V T + GT
Sbjct: 125 SHLHQHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPY 176
Query: 559 YLDPEYFRSSQ-----FTEKSDVYSFGVVLVELLTGQKPI 593
++ PE + + KSD++S G+ +E+ G P+
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 28/204 (13%)
Query: 398 LGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIE--------QFINEVAILSQINHRNVV 449
LG+G GTVY ++ + + VA ++ K++ E + Q E +LS+++H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQYIHD--QTEE-FP----ITWEIRLRIAIEVSDAL 502
K LE + ++ E+ L + + T + W I+L + +
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH----- 120
Query: 503 CYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDP 562
Y+H I HRD+K+ NI L + K+ DFG SR +M L T GT Y+ P
Sbjct: 121 -YMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDLATTFTGTPYYMSP 174
Query: 563 EYFRSSQFTEKSDVYSFGVVLVEL 586
E + + KSD++S G +L E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 59/227 (25%), Positives = 108/227 (47%), Gaps = 28/227 (12%)
Query: 391 NFNTNRILGQGGQ---GTVYKGML------TNGRIVAIKKSKLVDESNI-EQFINEVAIL 440
N +T R + + G+ G VYKG L + VAIK K E + E+F +E +
Sbjct: 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 441 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYI-------------HDQTEEFPIT 487
S++ H N+V LLG + + +++ + + L++++ D+T + +
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 488 WEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM-IDQ 546
+ I +++ + +L S + H+D+ + N+L+ DK K+SD G R V D
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
L ++ PE +F+ SD++S+GVVL E+ + G +P
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 71/258 (27%), Positives = 111/258 (43%), Gaps = 59/258 (22%)
Query: 390 DNFNTNRILGQGGQGTV-YKGMLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINH 445
D+F + +++G+G G V G I A+K KS+++++ + E IL++ ++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 446 RNVVKLLGCCLETEVPL-LVYEFIPNG---TLYQYIHDQTEEFPITWEIRLRIAIEVSDA 501
VVKL + E L L+ E++P G TL TEE E R IA E A
Sbjct: 61 PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-----ETRFYIA-ETILA 113
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQ------- 554
+ +H I HRDIK N+LLD K K+SDFG + ++H T +
Sbjct: 114 IDSIHKLGYI---HRDIKPDNLLLDAKGHIKLSDFGLCTGL--KKSHRTEFYRILSHALP 168
Query: 555 --------------------------------GTFGYLDPEYFRSSQFTEKSDVYSFGVV 582
GT Y+ PE F + + ++ D +S GV+
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228
Query: 583 LVELLTGQKPIRSTDSEE 600
+ E+L G P S + +E
Sbjct: 229 MYEMLVGYPPFCSDNPQE 246
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 59/220 (26%), Positives = 112/220 (50%), Gaps = 28/220 (12%)
Query: 398 LGQGGQGTVYKGMLTN-GRIVAIKKS----KLVDESN---IEQFINEVAILSQINHRNVV 449
LGQG ++KG+ G + K+ K++D+S+ E F +++SQ++H+++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA 509
G C+ + ++V E++ G+L Y+ I+W +L +A +++ AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 510 SIPIYHRDIKSANILL----DDKYRA----KVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
+ H ++ + N+LL D K K+SD G S +V+ + L R+ ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI-LLERIP----WVP 172
Query: 562 PEYFRSSQ-FTEKSDVYSFGVVLVELLTG-QKPIRSTDSE 599
PE + Q + +D +SFG L E+ +G KP+ + DS+
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 37/224 (16%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKK-SKLVDE-SNIEQFINEVAILSQINHR 446
+ +G G G V + T +G+ VAIKK D + ++ + E+ IL H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 447 NVVKLLGCCLETEVPL-----LVYEFIPNGTLYQYIH-DQTEEFPITWE-IR------LR 493
N++ + L +V + + + L+ IH DQ P+T E IR LR
Sbjct: 65 NIIAIRDI-LRPPGADFKDVYVVMDLMES-DLHHIIHSDQ----PLTEEHIRYFLYQLLR 118
Query: 494 IAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM---IDQTHLT 550
L Y+HSA + HRD+K +N+L+++ ++ DFG +R + + +
Sbjct: 119 -------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 551 TRVQGTFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
T T Y PE ++T D++S G + E+L G++ +
Sbjct: 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKK---SKLVDESNIEQF-INEVAILSQINHRNVVKLL 452
+G+G G V+K G+IVAIKK S+ D+ I++ + E+ +L Q+ H N+V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESE--DDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 453 GCCLETEVPLLVYEFIPNGTLY---QYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA 509
LV+E+ + L + E I+ +I + A+ + H
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH-----LIK-KIIWQTLQAVNFCHKHN 120
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF-RSS 568
I HRD+K NIL+ + + K+ DFG +R + T V T Y PE +
Sbjct: 121 CI---HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDT 176
Query: 569 QFTEKSDVYSFGVVLVELLTGQ 590
Q+ DV++ G V ELLTGQ
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 396 RILGQGGQGT---VYKGM-LTNGRIVAIKKSKLVDESNIEQFIN--EVAILSQIN-HRNV 448
+ILG+ G+GT V K G+ AIK K +S +EQ N E+ L +++ H N+
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQVNNLREIQALRRLSPHPNI 60
Query: 449 VKLLGCCLE--TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH 506
++L+ + T LV+E + + LY+ I + P R+ + L L
Sbjct: 61 LRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLP-----EKRVKSYMYQLLKSLD 114
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR 566
I+HRDIK NIL+ D K++DFG+ R I T T Y PE
Sbjct: 115 HMHRNGIFHRDIKPENILIKD-DILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLL 171
Query: 567 SSQF-TEKSDVYSFGVVLVELLT 588
+ + K D+++ G V E+L+
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 9e-13
Identities = 67/267 (25%), Positives = 108/267 (40%), Gaps = 68/267 (25%)
Query: 390 DNFNTNRILGQGGQGTV-YKGMLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINH 445
++F+T +++G+G G V G+I A+K KS++ + + E +L++ +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEI------RLRIAIEVS 499
VV L + + L+ EF+P G L + I ++ R +A E
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMA-ECV 111
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS-------------------- 539
A+ +H I HRDIK NIL+D K+SDFG S
Sbjct: 112 LAIEAVHKLGFI---HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168
Query: 540 --------RSVMIDQTHLT--TRVQ----------------GTFGYLDPEYFRSSQFTEK 573
SV +D +LT ++ Q GT Y+ PE F + ++
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228
Query: 574 SDVYSFGVVLVELLTGQKPIRSTDSEE 600
D +S G ++ E L G P S +S E
Sbjct: 229 CDWWSLGAIMFECLIGWPPFCSENSHE 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 84/360 (23%), Positives = 123/360 (34%), Gaps = 113/360 (31%)
Query: 386 EMATDNFNTNRILGQGGQGTVYK------GMLTNGRIVAIKKSKL-VDESNIEQFINEVA 438
E D + LG+G G V + + R VA+K K S + + E+
Sbjct: 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK 62
Query: 439 ILSQI-NHRNVVKLLGCCLETEVPLLV-YEFIPNGTLYQYIHDQTEEF------------ 484
IL I +H NVV LLG C + PL+V E+ G L Y+ + E F
Sbjct: 63 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKRE 122
Query: 485 ---PITWEIRL---------------------------------RIAIEVSDALCY---- 504
+ RL + + + D + Y
Sbjct: 123 MKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQV 182
Query: 505 ---LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
+ AS HRD+ + NILL + K+ DFG +R + Y D
Sbjct: 183 ARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI----------------YKD 226
Query: 562 PEYFRSSQ-----------------FTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKS 603
P+Y R +T +SDV+SFGV+L E+ + G P +E+
Sbjct: 227 PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-- 284
Query: 604 LVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663
F +KE R+ I ML C + + RPT E LG
Sbjct: 285 ----FCRRLKEG-------TRMRAPEYATPEIYSIMLD--CWHNNPEDRPTFSELVEILG 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCC 455
LG+G G+VYK + G +A+K+ +L +DES Q I E+ IL + +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 456 LETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515
+ E++ G+L + I ++ RI V L +L +I H
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI--IH 126
Query: 516 RDIKSANILLDDKYRAKVSDFGASRSVM--IDQTHLTTRVQGTFGYLDPEYFRS------ 567
RD+K N+L++ + K+ DFG S +++ + +T++ G Y+ PE +S
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQN 181
Query: 568 SQFTEKSDVYSFGVVLVELLTGQKP 592
+T +SDV+S G+ ++E+ G+ P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 45/223 (20%)
Query: 396 RILGQGGQGTVYKGMLTN-GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGC 454
R LG G G V+ + ++ + VA+KK L D +++ + E+ I+ +++H N+VK
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK---- 66
Query: 455 CLETEVPLLVYEFI-PNGT-LYQYIHDQT--------------------EEFPITWE-IR 491
VYE + P+G+ L + + T E+ P++ E R
Sbjct: 67 ---------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 492 LRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGASRSVMIDQTHLT 550
L ++ L Y+HSA + HRD+K AN+ ++ + K+ DFG +R V +H
Sbjct: 118 L-FMYQLLRGLKYIHSANVL---HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKG 173
Query: 551 TRVQG--TFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQ 590
+G T Y P S + +T+ D+++ G + E+LTG+
Sbjct: 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 14/209 (6%)
Query: 398 LGQGGQGTVYKG--MLTNGRIVAIKKSKLVDESNIE-QFINEVAILSQINHRNVVKLLGC 454
LG+G TVYKG LT+ +VA+K+ +L E I EV++L + H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 455 CLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPI 513
+ TE L LV+E++ + L QY+ D + ++L + ++ L Y H +
Sbjct: 73 -IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-NVKLFL-FQLLRGLNYCHRRK---V 125
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE-YFRSSQFTE 572
HRD+K N+L++++ K++DFG +R+ I + V T Y P+ S+ ++
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 573 KSDVYSFGVVLVELLTGQKPIRSTDSEED 601
+ D++ G + E+ TG+ + EE
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 402 GQGTVYKGML----TNGRIVA---IKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGC 454
G+GT K +L +G+ A +KK ++ + + + E +L H + L
Sbjct: 4 GKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS 63
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAASIPI 513
+ V E++ G L+ ++ + + E R R E+ AL YLHS I
Sbjct: 64 FQTKDRLCFVMEYVNGGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGK---I 116
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 573
+RD+K N++LD K++DFG + + D + T GT YL PE + +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYGRA 175
Query: 574 SDVYSFGVVLVELLTGQKPIRSTDSEE 600
D + GVV+ E++ G+ P + D E+
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEK 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 72/283 (25%), Positives = 108/283 (38%), Gaps = 67/283 (23%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGML------TNGRIVAIKKSKL-VDESNIEQFINEVA 438
E D ++LG G G V + ++ VA+K K S + ++E+
Sbjct: 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELK 62
Query: 439 ILSQI-NHRNVVKLLGCCLETEVPLLV-YEFIPNGTLYQYIHDQTEEFPITWE------I 490
IL I NH NVV LLG C + PL+V EF G L ++ + E F E
Sbjct: 63 ILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRG 122
Query: 491 RLRIAIEVS-------------------------------------------DALCY--- 504
R R +E S D +CY
Sbjct: 123 RFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQ 182
Query: 505 ----LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTT-RVQGTFGY 559
+ AS HRD+ + NILL + K+ DFG +R + D ++ + +
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242
Query: 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEED 601
+ PE +T +SDV+SFGV+L E+ + G P E+
Sbjct: 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 65/232 (28%), Positives = 100/232 (43%), Gaps = 55/232 (23%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQF---------INEVAI 439
+ +G+G G V G VAIKK I F + E+ I
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--------ISPFEHQTFCQRTLREIKI 56
Query: 440 LSQINHRNVVKLLGC----CLET--EVPLLVYEFIPNGTLYQYI------HDQTEEFPIT 487
L + H N++ +L E+ +V +V E + LY+ I +D + F
Sbjct: 57 LRRFKHENIIGILDIIRPPSFESFNDV-YIVQELMET-DLYKLIKTQHLSNDHIQYF--L 112
Query: 488 WEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547
++I LR L Y+HSA + HRD+K +N+LL+ K+ DFG +R D
Sbjct: 113 YQI-LR-------GLKYIHSANVL---HRDLKPSNLLLNTNCDLKICDFGLARI--ADPE 159
Query: 548 H-----LTTRVQGTFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
H LT V T Y PE S +T+ D++S G +L E+L+ +P+
Sbjct: 160 HDHTGFLTEYV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 45/178 (25%), Positives = 86/178 (48%), Gaps = 24/178 (13%)
Query: 436 EVAILSQINHRNVVKLLGCCLETEVPLLVYEFIP--NGTLYQYIHDQTEEFPITWEIRLR 493
E +L +NH +V+++ + + +V +P + LY Y+ ++ PI + L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPI--DQALI 161
Query: 494 IAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRV 553
I ++ + L YLH+ I HRD+K+ NI ++D + + D GA++ ++ L +
Sbjct: 162 IEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216
Query: 554 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELL------------TGQKPIRSTDSE 599
GT PE ++ K+D++S G+VL E+L T ++ ++S S
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH 274
|
Length = 357 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 29/212 (13%)
Query: 396 RILGQGGQGTVYKGMLT----NGRIVAIK---KSKLV-DESNIEQFINEVAILSQINHRN 447
++LG+GG G V++ G+I A+K K+ +V ++ + E IL + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 448 VVKLLGCCLETEVPL-LVYEFIPNGTLYQYIH------DQTEEFPITWEIRLRIAIEVSD 500
+V L+ +T L L+ E++ G L+ ++ + T F ++ E+S
Sbjct: 62 IVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS---------EISL 111
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYL 560
AL +LH I +RD+K NILLD + K++DFG + + + T +T GT Y+
Sbjct: 112 ALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYM 167
Query: 561 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
PE S + D +S G ++ ++LTG P
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 56/209 (26%), Positives = 106/209 (50%), Gaps = 13/209 (6%)
Query: 398 LGQGGQGTVYKG--MLTNGRIVAIKKSKLVDESNIE-QFINEVAILSQINHRNVVKLLGC 454
LG+G TV+KG LT +VA+K+ +L E I EV++L + H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIY 514
+ LV+E++ + L QY+ D + +++ + ++ L Y H +
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMH-NVKIFL-YQILRGLAYCHRRK---VL 126
Query: 515 HRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR-SSQFTEK 573
HRD+K N+L++++ K++DFG +R+ + + V T Y P+ SS+++ +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQ 185
Query: 574 SDVYSFGVVLVELLTGQKPIRSTDSEEDK 602
D++ G + E+ +G +P+ + ED+
Sbjct: 186 IDMWGVGCIFFEMASG-RPLFPGSTVEDE 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 29/220 (13%)
Query: 392 FNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNV 448
F ++G G G VYKG + G++ AIK + + E I+ IN + S +HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYS--HHRNI 75
Query: 449 VKLLGCCLETEVP------LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDAL 502
G ++ P LV EF G++ + + T+ + + I E+ L
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN-TKGNALKEDWIAYICREILRGL 134
Query: 503 CYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS----RSVMIDQTHLTTRVQGTFG 558
+LH+ I HRDIK N+LL + K+ DFG S R+V T + GT
Sbjct: 135 AHLHAHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPY 186
Query: 559 YLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPI 593
++ PE + + +SD++S G+ +E+ G P+
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 14/213 (6%)
Query: 398 LGQGGQGTVYKG--MLTNGRIVAIKKSKLVDESNIE-QFINEVAILSQINHRNVVKLLGC 454
LG+G TV+KG LT +VA+K+ +L E I EV++L + H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 455 CLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPI 513
+ TE L LV+E++ + L QY+ D +++ ++ L Y H I
Sbjct: 72 -IHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKI-FMFQLLRGLSYCHKRK---I 124
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE-YFRSSQFTE 572
HRD+K N+L+++K K++DFG +R+ + + V T Y P+ S++++
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 573 KSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLV 605
D++ G +L E+ TG+ + +E+ L+
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 28/232 (12%)
Query: 390 DNFNTNRILGQG--GQGTVYKGMLTNGRIVA---IKKSKLVDESNIEQFINEVAILSQIN 444
+F+ ++G+G G+ V + T G I A +KKS L+ + + F E ILS N
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIH---DQTEEFPITWEIRLRIAIEVSDA 501
+ +L + + LV E+ P G L ++ DQ +E + +A E+ A
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDED----MAQFYLA-ELVLA 114
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
+ +H + HRDIK N+L+D K++DFG++ + ++ + GT Y+
Sbjct: 115 IHSVHQMGYV---HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 562 PEYFRSSQFTEKS------DVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGY 607
PE + K D +S GV+ E++ G+ P E S Y
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF-----HEGTSAKTY 218
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 50/215 (23%), Positives = 84/215 (39%), Gaps = 19/215 (8%)
Query: 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIE-QFI-NEVAILSQINHRNVVKLLG 453
+ + K +VA+KK L S + + + E+ Q+ H N++ +
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHDQ-TEEFPITWEIRLRIAIEVSDALCYLHSAASIP 512
+ +V + G+ + E P I I +V +AL Y+HS I
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL-AIAF-ILKDVLNALDYIHSKGFI- 123
Query: 513 IYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG-------TFGYLDPEYF 565
HR +K+++ILL + +S S S MI V +L PE
Sbjct: 124 --HRSVKASHILLSGDGKVVLSGLRYSVS-MIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180
Query: 566 RSS--QFTEKSDVYSFGVVLVELLTGQKPIRSTDS 598
+ + + EKSD+YS G+ EL G P + +
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 59/190 (31%), Positives = 94/190 (49%), Gaps = 13/190 (6%)
Query: 417 VAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQY 476
V K L DE +E+ L+ +H +VK + LL+ E+ G L +
Sbjct: 96 VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQ 155
Query: 477 IHDQTEE-FPIT-WEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVS 534
I + +E P +E+ L + ++ AL +HS + HRD+KSANI L K+
Sbjct: 156 IKQRLKEHLPFQEYEVGL-LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLG 211
Query: 535 DFGASR----SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQ 590
DFG S+ SV +D + + GT YL PE + ++++K+D++S GV+L ELLT
Sbjct: 212 DFGFSKQYSDSVSLD---VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLH 268
Query: 591 KPIRSTDSEE 600
+P + E
Sbjct: 269 RPFKGPSQRE 278
|
Length = 478 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 398 LGQGGQGTVYKGMLTN-GRIVAIKK---SKLVDESNIEQFINEVAILSQINHRNVVKLLG 453
LG+GG G V + N G++ A KK +L +S + + E IL ++N +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 454 CCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIP 512
E++ L LV + G L +I++ E + E + + +++ + +LHS +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 513 IYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTE 572
I +RD+K N+LLDD+ ++SD G + V + T+ GT GY+ PE + ++
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPYSY 173
Query: 573 KSDVYSFGVVLVELLTGQKPIRSTDSEEDK 602
D ++ G + E++ G+ P + + K
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 12/158 (7%)
Query: 444 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC 503
++ N +KL + +L+ ++I +G L+ + + E E++ I ++ +AL
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSEAEVKK-IIRQLVEALN 123
Query: 504 YLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDP 562
LH I H DIK N+L D K R + D+G + + + GT Y P
Sbjct: 124 DLHKHNII---HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSP 175
Query: 563 EYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
E + + D ++ GV+ ELLTG+ P + + EE
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 50/215 (23%), Positives = 97/215 (45%), Gaps = 15/215 (6%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGR---IVAIKKSKLVDESNIEQ---FINEVA 438
E+ + RILG G G + +G L + VAI L + +Q F+ E
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHT--LRAGCSDKQRRGFLAEAL 58
Query: 439 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEV 498
L Q +H N+V+L G ++V E++ NG L ++ + E + + + +
Sbjct: 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGL 116
Query: 499 SDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFG 558
+ + YL + H+ + + +L++ K+S F + + + T +
Sbjct: 117 ASGMKYLSEMGYV---HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL 173
Query: 559 YLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
+ PE + F+ SDV+SFG+V+ E+++ G++P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 402 GQGTVYKGML----TNGRIVAIK----KSKLVDESNIEQFINEVAILSQINHRNVVKLLG 453
G+G+ K +L ++G A+K K+ L + +L + H +V L
Sbjct: 4 GKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHY 63
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAASIP 512
E V +++ G L+ H Q E E R R A EV+ A+ YLHS +
Sbjct: 64 SFQTAEKLYFVLDYVNGGELF--FHLQRER--CFLEPRARFYAAEVASAIGYLHS---LN 116
Query: 513 IYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTE 572
I +RD+K NILLD + ++DFG + + + T+ GT YL PE R +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGV-EPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 573 KSDVYSFGVVLVELLTGQKPIRSTD 597
D + G VL E+L G P S D
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 402 GQGTVYKGML----TNGRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKLLGC 454
G+GT K +L GR A+K K ++ + + + E +L H + L
Sbjct: 4 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 63
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAASIPI 513
+ V E+ G L+ ++ + + E R R E+ AL YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---V 116
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 573
+RDIK N++LD K++DFG + + D + T GT YL PE + +
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRA 175
Query: 574 SDVYSFGVVLVELLTGQKPIRSTDSE 599
D + GVV+ E++ G+ P + D E
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 73/271 (26%), Positives = 134/271 (49%), Gaps = 38/271 (14%)
Query: 353 NFFKRNGGLLLQQESS--SNEGNSEKTKLFTSMELEMATD-NFNTNRILGQGGQGTVYKG 409
F+ N L ++E S +N G E + ++ + + ++ I+G G G VY+
Sbjct: 26 GKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEA 85
Query: 410 M-LTNGRIVAIKKSKLVDESNIEQFIN-EVAILSQINHRNVVKL-----LGCCLETEVPL 462
+ + VAIKK L D Q+ N E+ I+ +NH N++ L C + E +
Sbjct: 86 ICIDTSEKVAIKKV-LQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140
Query: 463 ---LVYEFIPNGTLYQYIH---DQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHR 516
+V EFIP T+++Y+ P+ + ++L + ++ AL Y+HS I HR
Sbjct: 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPL-FLVKL-YSYQLCRALAYIHSKF---ICHR 194
Query: 517 DIKSANILLDDK-YRAKVSDFGASRSVMIDQ---THLTTRVQGTFGYLDPE-YFRSSQFT 571
D+K N+L+D + K+ DFG++++++ Q +++ +R Y PE ++ +T
Sbjct: 195 DLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYT 249
Query: 572 EKSDVYSFGVVLVELLTGQKPIRSTDSEEDK 602
D++S G ++ E++ G PI S S D+
Sbjct: 250 THIDLWSLGCIIAEMILGY-PIFSGQSSVDQ 279
|
Length = 440 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 396 RILGQGGQGTVYKGMLTN-GRIVAIKK--SKLVDESNIEQFINEVAILSQINHRNVVKLL 452
+ +G G QG V T G VA+KK ++++ ++ E+ +L +NH+N++ LL
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 453 GCCL------ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC--- 503
E + LV E + + L Q IH + + R++ + LC
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDH--------ERMSYLLYQMLCGIK 137
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE 563
+LHSA I HRD+K +NI++ K+ DFG +R+ + + T T Y PE
Sbjct: 138 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPE 192
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 597
+ E D++S G ++ EL+ G + TD
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 69/289 (23%), Positives = 125/289 (43%), Gaps = 55/289 (19%)
Query: 398 LGQGGQGTVYKGML-------TNGRIVAIK------KSKLVDESNIEQFINEVAILSQIN 444
LGQG +YKG+L G + S D F +++SQ++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDS---LAFFETASLMSQLS 59
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCY 504
H+++VKL G C+ E ++V E++ G L ++H + + W +L +A +++ AL Y
Sbjct: 60 HKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHY 116
Query: 505 LHSAASIPIYHRDIKSANILL-----DDKYR--AKVSDFGASRSVMIDQTHLTTRVQGTF 557
L + H ++ NIL+ ++ Y K+SD G +V+ + R+
Sbjct: 117 LEDKKLV---HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL-SREERVERIP--- 169
Query: 558 GYLDPEYFR--SSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKE 614
++ PE R + T +D +SFG L+E+ + G++P+ + S E +
Sbjct: 170 -WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE------------ 216
Query: 615 NRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663
R ++ D L E+ A L +C KRP+ + +L
Sbjct: 217 -RFYQ--DQHRLPMPDCAEL---ANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 54/206 (26%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 402 GQGTVYKGML----TNGRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKLLGC 454
G+GT K +L G+ A+K K ++ + + + E +L H + L
Sbjct: 4 GKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS 63
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAASIPI 513
+ V E+ G L+ ++ + + E R R E+ AL YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCD---V 116
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 573
+RD+K N++LD K++DFG + + D + T GT YL PE + +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRA 175
Query: 574 SDVYSFGVVLVELLTGQKPIRSTDSE 599
D + GVV+ E++ G+ P + D E
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 52/163 (31%), Positives = 76/163 (46%), Gaps = 9/163 (5%)
Query: 439 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIE 497
+L + H +V L + V ++I G L+ H Q E + E R R A E
Sbjct: 49 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELF--YHLQRERCFL--EPRARFYAAE 104
Query: 498 VSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF 557
++ AL YLHS + I +RD+K NILLD + ++DFG + I+ T+ GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTP 160
Query: 558 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
YL PE + D + G VL E+L G P S ++ E
Sbjct: 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 389 TDNFNTNRILGQGGQGTV--YKGMLTNGRIVAIKK--SKLVDESNIEQFINEVAILSQIN 444
T+ + + +G G G V + LT G+ VAIKK ++ E+ +L +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 445 HRNVVKLLGCCLE-TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC 503
H N++ L + E V E + GT +H P+ + ++ L
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELL--GT---DLHRLLTSRPLEKQFIQYFLYQILRGLK 122
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE 563
Y+HSA + HRD+K +NIL+++ K+ DFG +R I +T GY+
Sbjct: 123 YVHSAGVV---HRDLKPSNILINENCDLKICDFGLAR---IQDPQMT-------GYVSTR 169
Query: 564 YFRSSQ-------FTEKSDVYSFGVVLVELLTGQKPI 593
Y+R+ + + + D++S G + E+L G KP+
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 66/237 (27%), Positives = 101/237 (42%), Gaps = 40/237 (16%)
Query: 390 DNFNTNRILGQGGQGTVY----KGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINH 445
++F T +++ G G VY K + I K L+ + I+Q E IL+ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 446 RNVVKLLGCCLETEVPL-LVYEFIPNG---TLYQYIHDQTEEFPITWEI-RLRIAIEVSD 500
VV + C ET+ L +V E++ G TL + I + ++ R+ A E
Sbjct: 61 PFVVSMF-CSFETKRHLCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFA-ETVL 112
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTR-------- 552
AL YLH+ I HRD+K N+L+ K++DFG S+ I LTT
Sbjct: 113 ALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK---IGLMSLTTNLYEGHIEK 166
Query: 553 ---------VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
V GT Y+ PE + + D ++ G++L E L G P EE
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 73/283 (25%), Positives = 120/283 (42%), Gaps = 42/283 (14%)
Query: 402 GQGTVYKGML----TNGRIVA---IKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGC 454
G+GT K +L GR A +KK +V + + + E +L H + L
Sbjct: 4 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 63
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAASIPI 513
+ V E+ G L+ ++ + + E R R E+ AL YLHS ++
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKNV-- 117
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 573
+RD+K N++LD K++DFG + + D + T GT YL PE + +
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGRA 176
Query: 574 SDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEE 633
D + GVV+ E++ G+ P + D E +LFE++ ++ +
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHE----------------KLFELILMEEIRFPR--- 217
Query: 634 IITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSIMQH 676
T++ AK L+ + KK P + LGG IMQH
Sbjct: 218 --TLSPEAKSLLSGLLKKDPKQR-----LGG-GPDDAKEIMQH 252
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 66/252 (26%), Positives = 106/252 (42%), Gaps = 50/252 (19%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTN-GRIVAIK---KSKLVDESNIEQFINEVAILSQINH 445
D+F + +++G+G G V + G I A+K K+ ++++ + E IL + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSDAL 502
VVK+ + L+ EF+P G + + + +EE + IA E A+
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE-----ATQFYIA-ETVLAI 114
Query: 503 CYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG-------ASRSVMI-DQTH------ 548
+H I HRDIK N+LLD K K+SDFG A R+ + TH
Sbjct: 115 DAIHQLGFI---HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 549 --------------------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 588
L GT Y+ PE F + + + D +S GV++ E+L
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 589 GQKPIRSTDSEE 600
G P S +E
Sbjct: 232 GYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 73/261 (27%), Positives = 111/261 (42%), Gaps = 39/261 (14%)
Query: 398 LGQGGQGTVYKGMLTN-GRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKLLG 453
+G+G G VY+ + RI A+K K ++V + + I E IL + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 454 CCLETEVP---LLVYEFIPNGTLYQYIHDQTE-EFPITWEIRLRIAI-EVSDALCYLHSA 508
+ LV +++ G L+ H Q E F E R + I E+ AL +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFW--HLQKEGRFS---EDRAKFYIAELVLALEHLHKY 115
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS 568
I +RD+K NILLD + DFG S++ + D T GT YL PE
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPEVLLDE 171
Query: 569 Q-FTEKSDVYSFGVVLVELLTGQKPIRSTD--------------------SEEDKSLVGY 607
+ +T+ D +S GV++ E+ G P + D S+E + V
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKG 231
Query: 608 FLEAMKENRLFEVLDARVLKE 628
L ++RL DA LKE
Sbjct: 232 LLNRNPQHRLGAHRDAVELKE 252
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 20/209 (9%)
Query: 397 ILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE--SNIEQFINEVAILSQINHRNVVKLLG 453
++G+G G V + T G VAIKK V E S+ + + E+ +L + H ++V++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 454 CCL-----ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
L E + +V+E + L+Q I + P + L ++ AL Y+H+A
Sbjct: 67 IMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFL---YQLLRALKYIHTA 122
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID--QTHLTTRVQGTFGYLDPEYFR 566
++HRD+K NIL + + K+ DFG +R D T T Y PE
Sbjct: 123 N---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 567 S--SQFTEKSDVYSFGVVLVELLTGQKPI 593
S S++T D++S G + E+LTG KP+
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 65/226 (28%), Positives = 95/226 (42%), Gaps = 34/226 (15%)
Query: 398 LGQGGQGTVYKGMLTNGRIVA--IKKSKLVDESNIEQ--FINEVAILSQINHRNVVKLLG 453
+G G G V G + +G A + K V S EQ F+ E + H N+++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRL--RIAIEVSDALCYLHSAASI 511
C E LLV EF P G L Y+ + +T + R+A E++ L +LH I
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFI 122
Query: 512 PIYHRDIKSANILLDDKYRAKVSDFGASRS-------VMIDQTHLTTR---------VQG 555
H D+ N LL K+ D+G S + V DQ + R V G
Sbjct: 123 ---HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 556 TFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600
+D T++S+V+S GV + EL G +P R E+
Sbjct: 180 NLLVVDQ--------TKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 31/220 (14%)
Query: 390 DNFNTNRILGQGGQGTVYKGML--TNGRIVAIKKSKL-VDESNIEQFINEVAILSQINH- 445
D+ LG+G G V K M G I+A+K+ + V+ ++ + ++ I +
Sbjct: 1 DDLEVIEELGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDC 59
Query: 446 RNVVKLLGC---------CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAI 496
V G C+E L +F Y T I +I +IA+
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMDTSL-DKFYKK----VYDKGLT----IPEDILGKIAV 110
Query: 497 EVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGT 556
+ AL YLHS S+ HRD+K +N+L++ + K+ DFG S ++D T G
Sbjct: 111 SIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGIS-GYLVDSVAKTIDA-GC 166
Query: 557 FGYLDPEYF----RSSQFTEKSDVYSFGVVLVELLTGQKP 592
Y+ PE + KSDV+S G+ ++EL TG+ P
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 11/209 (5%)
Query: 398 LGQGGQGTVYKGMLTN-GRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGC 454
+G+G GTV+K IVA+K+ +L DE + E+ +L ++ H+N+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIY 514
+ LV+E+ + L +Y + I EI ++ L + HS +
Sbjct: 68 LHSDKKLTLVFEYC-DQDLKKYFDSCNGD--IDPEIVKSFMFQLLKGLAFCHSHN---VL 121
Query: 515 HRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE-YFRSSQFTEK 573
HRD+K N+L++ K++DFG +R+ I + V T Y P+ F + ++
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTS 180
Query: 574 SDVYSFGVVLVELLTGQKPIRSTDSEEDK 602
D++S G + EL +P+ + +D+
Sbjct: 181 IDMWSAGCIFAELANAGRPLFPGNDVDDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 30/209 (14%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIKK--SKLVDESNIEQFINEVAILSQINHRNVVKLL 452
+ +G G QG V G+ VAIKK + ++ ++ E+ ++ +NH+N++ LL
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 453 GC-----CLET--EVPLLVYEFIPNGTLYQYIH-DQTEEFPITWEIRLRIAIEVSDALC- 503
LE +V LV E + + L Q I D E R++ + LC
Sbjct: 82 NVFTPQKSLEEFQDV-YLVMELM-DANLCQVIQMDLDHE---------RMSYLLYQMLCG 130
Query: 504 --YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
+LHSA I HRD+K +NI++ K+ DFG +R+ +T V T Y
Sbjct: 131 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVV-TRYYRA 185
Query: 562 PEYFRSSQFTEKSDVYSFGVVLVELLTGQ 590
PE + E D++S G ++ E++ G
Sbjct: 186 PEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 28/223 (12%)
Query: 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDE-SNIEQFIN-EVAILSQI-NH 445
TD + +G+G G VYK +TN + ++ K++D S++++ I E IL + NH
Sbjct: 21 TDTWEIIETIGKGTYGKVYK--VTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNH 78
Query: 446 RNVVKLLGCCLETEVPL-----LVYEFIPNGTLYQYIHD-----QTEEFPITWEIRLRIA 495
NVVK G + + + LV E G++ + + Q + + I+
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM-------IS 131
Query: 496 IEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG 555
+ AL L + I HRD+K NILL + K+ DFG S + + T V G
Sbjct: 132 YILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-G 190
Query: 556 TFGYLDPEYFRSSQ-----FTEKSDVYSFGVVLVELLTGQKPI 593
T ++ PE Q + + DV+S G+ +EL G P+
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 61/224 (27%), Positives = 95/224 (42%), Gaps = 36/224 (16%)
Query: 391 NFNTNRILGQGGQGTV----YKGMLTNGRIVAIKKSKLVDESNI--EQFINEVAILSQI- 443
+ + LGQG G V VAIKK V I ++ + E+ +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEET-VAIKKITNVFSKKILAKRALRELKLLRHFR 59
Query: 444 NHRNVVKLLGCCLETEVP-------LLVYEFIPNGTLYQYIHD--QTEEFPITWEIRLRI 494
H+N+ C + ++ L +YE + L+Q I + I
Sbjct: 60 GHKNIT----CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI---- 111
Query: 495 AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID----QTHLT 550
++ L Y+HSA + HRD+K N+L++ K+ DFG +R + +T
Sbjct: 112 -YQILCGLKYIHSANVL---HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167
Query: 551 TRVQGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPI 593
V T Y PE S Q +T+ DV+S G +L ELL G+KP+
Sbjct: 168 EYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 43/163 (26%), Positives = 78/163 (47%), Gaps = 14/163 (8%)
Query: 432 QFINEVAILSQINHRNVVKL---LGCCLETEVPLLVYEFIPNGTLYQYIHD---QTEEFP 485
Q NE+ L ++NH N++K+ L T + Y+F LY +++D ++ P
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRP 264
Query: 486 ITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545
+ + R I ++ A+ Y+H I HRDIK NI L+ + + DFG + +
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDKKLI---HRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 588
+ GT PE + E +D++S G++L+++L+
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 28/223 (12%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHR 446
+D + +G+G G V+K + NG A+K + + + E+ E IL + +H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHP 75
Query: 447 NVVKLLGCCLETEVP-----LLVYEFIPNGTLYQYIH------DQTEEFPITWEIRLRIA 495
NVVK G + +V LV E G++ + ++ EE I + I
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----IL 130
Query: 496 IEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG 555
E L +LH +I HRD+K NILL + K+ DFG S + + T V G
Sbjct: 131 HEALMGLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-G 186
Query: 556 TFGYLDPEYFRSSQ-----FTEKSDVYSFGVVLVELLTGQKPI 593
T ++ PE Q + + DV+S G+ +EL G P+
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 64/248 (25%), Positives = 107/248 (43%), Gaps = 46/248 (18%)
Query: 390 DNFNTNRILGQGGQGTVY----KGMLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQ 442
+F ++LG+G G V+ KG G++ A+K K +++ + +++ + E IL+
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILAT 57
Query: 443 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEE-FPITWEIRLRIAIEVSD 500
++H + L +TE L LV ++ P G L++ + Q + R A EV
Sbjct: 58 LDHPFLPTLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE-VARFYAA-EVLL 114
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF-------------------GASRS 541
AL YLH I +RD+K NILL + +SDF G+ RS
Sbjct: 115 ALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 542 VMIDQTHLT------TRVQ---GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
+ T R GT Y+ PE D ++ G++L E+L G P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
Query: 593 IRSTDSEE 600
+ ++ +E
Sbjct: 232 FKGSNRDE 239
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 60/230 (26%), Positives = 107/230 (46%), Gaps = 37/230 (16%)
Query: 433 FINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRL 492
F +++ Q++H+++V L G C+ ++V EF+ G L ++H +++ W +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108
Query: 493 RIAIEVSDALCYLHSAASIPIYHRDIKSANILL-----DDKYRA--KVSDFGASRSVMID 545
++A +++ AL YL + H ++ + NILL D + K+SD G +V+
Sbjct: 109 KVAKQLASALSYLEDKDLV---HGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR 165
Query: 546 QTHLTTRVQGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVEL-LTGQKPIRSTDSEEDKS 603
Q R+ ++ PE S+ + +D +SFG L E+ G+ P++ DK+
Sbjct: 166 Q-ECVERIP----WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK------DKT 214
Query: 604 LVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRP 653
L A KE R +E V KE +A L C+N +RP
Sbjct: 215 L------AEKE-RFYEGQCMLVTPSCKE-----LADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 53/213 (24%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 397 ILGQGGQGTVYKGMLTN-GRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKLL 452
I+G+GG G VY + G++ A+K K ++ + +NE +LS ++ + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 453 GCCLETEVP---LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSA 508
P + + + G L H + + E +R A E+ L ++H+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDL----HYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF-RS 567
+ +RD+K ANILLD+ ++SD G + + H + GT GY+ PE +
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKG 170
Query: 568 SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
+ + +D +S G +L +LL G P R +++
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIE-QFINEVAILSQINHRNVVKLLGCC 455
LG+G TVYKG G++VA+K+ +L E I E ++L + H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 456 LETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515
+ LV+E++ + L QY+ D +RL ++ L Y H + H
Sbjct: 73 HTKKTLTLVFEYL-DTDLKQYM-DDCGGGLSMHNVRL-FLFQLLRGLAYCHQRR---VLH 126
Query: 516 RDIKSANILLDDKYRAKVSDFGASRSVMI-DQTHLTTRVQGTFGYLDPEYFR-SSQFTEK 573
RD+K N+L+ ++ K++DFG +R+ + +T+ V T Y P+ S++++
Sbjct: 127 RDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLGSTEYSTS 184
Query: 574 SDVYSFGVVLVELLTGQKPI--RSTDSEE 600
D++ G + E+ TG+ P+ STD E+
Sbjct: 185 LDMWGVGCIFYEMATGR-PLFPGSTDVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 64/252 (25%), Positives = 106/252 (42%), Gaps = 50/252 (19%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTN-GRIVAIK---KSKLVDESNIEQFINEVAILSQINH 445
++F + +++G+G G V + G + A+K K+ ++++ + E IL + +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSDAL 502
VVK+ + L+ EF+P G + + + TEE E + IA E A+
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE-----ETQFYIA-ETVLAI 114
Query: 503 CYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG-------ASRSVMI----------- 544
+H I HRDIK N+LLD K K+SDFG A R+
Sbjct: 115 DSIHQLGFI---HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 545 ----------------DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 588
++ L GT Y+ PE F + + + D +S GV++ E+L
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 589 GQKPIRSTDSEE 600
G P S +E
Sbjct: 232 GYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 37/119 (31%), Positives = 66/119 (55%), Gaps = 11/119 (9%)
Query: 479 DQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGA 538
D + +P+ + LR + +V+ + +L S I HRD+ + N+LL D AK+ DFG
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGL 258
Query: 539 SRSVMIDQTHLTTRVQGT----FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
+R +M D ++ V+G ++ PE +T +SDV+S+G++L E+ + G+ P
Sbjct: 259 ARDIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 61/244 (25%), Positives = 110/244 (45%), Gaps = 38/244 (15%)
Query: 374 SEKTKLFTSMELEMAT----DNFNTNRILGQGGQGTV---YKGMLTNGRIVAIKK--SKL 424
S++ F S+E+ +T + + +G G QG V Y +L R VAIKK
Sbjct: 4 SKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPF 61
Query: 425 VDESNIEQFINEVAILSQINHRNVVKLLGC-----CLETEVPLLVYEFIPNGTLYQYIHD 479
++++ ++ E+ ++ +NH+N++ LL LE + + + + L Q I
Sbjct: 62 QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM 121
Query: 480 QTEEFPITWEIRLRIAIEVSDALC---YLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 536
+ + R++ + LC +LHSA I HRD+K +NI++ K+ DF
Sbjct: 122 ELDH--------ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 170
Query: 537 GASRSV---MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
G +R+ + ++ TR Y PE + E D++S G ++ E++ G
Sbjct: 171 GLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225
Query: 594 RSTD 597
TD
Sbjct: 226 PGTD 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 10/216 (4%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTNGR-IVAIKKSKLVDESN--IEQFINEVAILSQINHR 446
+ F ++G+G G V K + IVAIKK K +E+ E + E+ +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH 506
N+V+L LV+E++ L + EE P ++ + + +H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNML-----ELLEEMP-NGVPPEKVRSYIYQLIKAIH 114
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR 566
I HRDIK N+L+ K+ DFG +R++ T T Y PE
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174
Query: 567 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDK 602
+ + + D++S G +L EL GQ P+ +SE D+
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ-PLFPGESEIDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-09
Identities = 38/104 (36%), Positives = 53/104 (50%), Gaps = 12/104 (11%)
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT-HLTTRVQGTFGYL 560
L YLHSA I HRDIK N+L++ K+ DFG +R D++ H+T V + Y
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171
Query: 561 DPEYFRSSQ-FTEKSDVYSFGVVLVELLTG------QKPIRSTD 597
PE S+ +T D++S G + ELL Q PI+ D
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD 215
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 5e-09
Identities = 62/254 (24%), Positives = 110/254 (43%), Gaps = 44/254 (17%)
Query: 427 ESNIEQFINEVAILSQINHRNVVKLLGCCLE--TEVPLLVYEFIPNGTLYQYIHDQTEEF 484
E Q + EV ++ ++ H+N+V+ + L + ++ EF G L + I + F
Sbjct: 53 EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF 112
Query: 485 -PITWEIRLRIAIEVSDALCYLHSAASIP----IYHRDIKSANILLDDKYR--------- 530
I + I ++ AL Y H+ P + HRD+K NI L R
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172
Query: 531 --------AKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF--RSSQFTEKSDVYSFG 580
AK+ DFG S+++ I+ + GT Y PE + + +KSD+++ G
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 581 VVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAML 640
++ EL +G+ P ++ F + + E L D + ++KE + +L
Sbjct: 231 CIIYELCSGKTPFHKANN---------FSQLISE--LKRGPDLPIKGKSKE-----LNIL 274
Query: 641 AKRCLNMIGKKRPT 654
K LN+ K+RP+
Sbjct: 275 IKNLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 39/218 (17%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNI--EQFINEVAILSQINHRNVVKLLGC 454
+G G G+V + G VAIKK +S I ++ E+ +L + H NV+ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL-- 80
Query: 455 CLETEVPLLVYEFIPNGTL---YQYI-------HDQTEEFPITWEIRLRIAIEVSDALC- 503
+ + + + L Y H +E+ ++ V LC
Sbjct: 81 --DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED---------KVQYLVYQMLCG 129
Query: 504 --YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT-HLTTRVQGTFGYL 560
Y+HSA I HRD+K N+ +++ K+ DFG +R + T ++ TR Y
Sbjct: 130 LKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYR 181
Query: 561 DPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTD 597
PE + + + D++S G ++ E+LTG+ + D
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 34/213 (15%)
Query: 398 LGQGGQGTV--YKGMLTNGRIVAIKKSKLVDESNIE--QFINEVAILSQINHRNVVKLLG 453
+G+G G V K TN + VAIKK ++ I+ + + E+ +L ++H NV+ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEK-VAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD 71
Query: 454 CCLET-----EVPLLVYEFIPNGTLYQYI-------HDQTEEFPITWEIRLRIAIEVSDA 501
+VYE + + L+Q I D + F +++ LR
Sbjct: 72 IMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYF--LYQL-LR-------G 120
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
L Y+HSA + HRD+K +N+LL+ K+ DFG +R+ +T V T Y
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRA 176
Query: 562 PE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
PE S++T DV+S G + ELL G+KP+
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 30/204 (14%)
Query: 398 LGQGGQGTV---YKGMLTNGRIVAIKK--SKLVDESNIEQFINEVAILSQINHRNVVKLL 452
+G G QG V Y +L R VAIKK ++++ ++ E+ ++ +NH+N++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 453 GCCL------ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC--- 503
E + LV E + + L Q I + + R++ + LC
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDH--------ERMSYLLYQMLCGIK 133
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE 563
+LHSA I HRD+K +NI++ K+ DFG +R+ + + T T Y PE
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 188
Query: 564 YFRSSQFTEKSDVYSFGVVLVELL 587
+ E D++S G ++ E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 55/239 (23%), Positives = 107/239 (44%), Gaps = 20/239 (8%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTNG-RIVAIK---KSKLVDESNIEQFINEVAILSQINH 445
++F +++G+G G V L N ++ A+K K +++ + F E +L ++
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
+ + L + LV ++ G L + + P E R + ++ + +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP---EDMARFYL--AEMVIAI 115
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF 565
S + HRDIK NIL+D +++DFG+ +M D T ++ GT Y+ PE
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 566 RS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619
++ ++ + D +S GV + E+L G+ P + +SLV + + M F+
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHKERFQ 228
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 50/167 (29%), Positives = 78/167 (46%), Gaps = 24/167 (14%)
Query: 436 EVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT--LYQYIHDQTEEFP----ITWE 489
E+ IL I+HR ++ L+ +V +P L+ Y+ D++ P IT +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYV-DRSGPLPLEQAITIQ 191
Query: 490 IRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549
RL +AL YLH I HRD+K+ NI LD+ A + DFGA + +D
Sbjct: 192 RRLL------EALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA--ACKLDAHPD 240
Query: 550 TTRVQGTFGYLD---PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
T + G G L+ PE + K+D++S G+VL E+ +
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 57/239 (23%), Positives = 106/239 (44%), Gaps = 20/239 (8%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTNG-RIVAIK---KSKLVDESNIEQFINEVAILSQINH 445
D+F +++G+G G V + + RI A+K K +++ + F E +L +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
+ + L + LV ++ G L + + P E R I ++ + +
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLP---EDMARFYI--AEMVLAI 115
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF 565
HS + HRDIK N+LLD +++DFG+ + D T ++ GT Y+ PE
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 566 RS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619
++ ++ + D +S GV + E+L G+ P + +SLV + + M F+
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHEERFQ 228
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 397 ILGQGGQGTVYKGMLTN-GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCC 455
I+G+GG G VY + G++ A+K +D+ I+ E L N R ++ L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLAL---NERIMLSLVST- 53
Query: 456 LETEVPLLV---YEF-----------IPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSD 500
+ P +V Y F + NG Y Q F E +R A E+
Sbjct: 54 --GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EAEMRFYAAEIIL 108
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYL 560
L ++H+ + +RD+K ANILLD+ ++SD G + + H + GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 561 DPEYF-RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
PE + + +D +S G +L +LL G P R +++
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 70/295 (23%), Positives = 129/295 (43%), Gaps = 66/295 (22%)
Query: 398 LGQGGQGTVYKGML-----------------------TNGRIVAIKKSKLVDESNIE--- 431
LGQG + +Y G L NGR + + K++D S+ +
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVV-LKVLDPSHRDIAL 61
Query: 432 QFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIR 491
F +++SQ++H ++ + G C+ ++V EF+ +G L + + P+ W+I
Sbjct: 62 AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKI- 120
Query: 492 LRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRA-------KVSDFGASRSVMI 544
+A +++ AL YL + H ++ + NILL A K+SD G S + +
Sbjct: 121 -TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176
Query: 545 DQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVEL-LTGQKPIRS-TDSEED 601
+ RV+ ++ PE + + +D +SFG L+E+ G+ P++ T SE++
Sbjct: 177 RE----ERVE-RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231
Query: 602 KSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMK 656
+ F E K++RL E +A L +CL +RP+ +
Sbjct: 232 R-----FYE--KKHRL------------PEPSCKELATLISQCLTYEPTQRPSFR 267
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 48/167 (28%), Positives = 71/167 (42%), Gaps = 13/167 (7%)
Query: 434 INEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIP--NGTLYQYIHDQTEEFPITWEIR 491
E IL INH ++++L G + L+ +P LY Y+ + I +I
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAK-RNIAIC-DI- 184
Query: 492 LRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS-RSVMIDQTHLT 550
L I V A+ YLH I HRDIK+ NI ++ + DFGA+ V I+
Sbjct: 185 LAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 597
GT PE + D++S G+VL E+ T + D
Sbjct: 242 GWA-GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287
|
Length = 391 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 63/242 (26%), Positives = 116/242 (47%), Gaps = 27/242 (11%)
Query: 398 LGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIE-QFINEVAILSQINHRNVVKLLGCCL 456
+G+G G VYK +G+ K ++ + I E+A+L ++ H NV+ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 457 ---ETEVPLLVYEFIPNGTLYQYIH----DQTEEFPITWEIRL--RIAIEVSDALCYLHS 507
+ +V LL +++ + L+ I + + P+ + + ++ D + YLH+
Sbjct: 69 SHADRKVWLL-FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 508 AASIPIYHRDIKSANILL----DDKYRAKVSDFGASR---SVMIDQTHLTTRVQGTFGYL 560
+ HRD+K ANIL+ ++ R K++D G +R S + L V TF Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYR 182
Query: 561 DPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619
PE ++ +T+ D+++ G + ELLT + PI E+ K+ Y + + +R+F
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTSNPYHHDQL--DRIFN 239
Query: 620 VL 621
V+
Sbjct: 240 VM 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 52/213 (24%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 390 DNFNTNRILGQG--GQGTVYKGMLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQIN 444
D+F +++G+G G+ V K M G++ A+K K +++ + F E +L +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVK-MKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD 59
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCY 504
R + L + LV ++ G L + + P E R + ++ +
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP---EDMARFYL--AEMVLA 114
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEY 564
+ S + HRDIK N+LLD +++DFG+ ++ D T + GT Y+ PE
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 565 FRS-----SQFTEKSDVYSFGVVLVELLTGQKP 592
++ ++ + D +S GV + E+L G+ P
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 40/219 (18%)
Query: 398 LGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNI--EQFINEVAILSQINHRNVVKLLGC 454
+G G GTV + G VAIKK +S + ++ E+ +L + H NV+ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITW-------------EIRLRIAI-EVSD 500
F P+ +L ++ HD P E R++ + ++
Sbjct: 83 ------------FTPDLSLDRF-HDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK 129
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT-HLTTRVQGTFGY 559
L Y+H+A I HRD+K N+ +++ K+ DFG +R + T ++ TR Y
Sbjct: 130 GLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WY 181
Query: 560 LDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTD 597
PE + +T+ D++S G ++ E+LTG+ + D
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 5/110 (4%)
Query: 485 PITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544
+T E + + +V+ + +L S I HRD+ + NILL + K+ DFG +R +
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 545 DQTHLTT-RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
D ++ + ++ PE +T +SDV+SFGV+L E+ + G P
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 62/242 (25%), Positives = 116/242 (47%), Gaps = 27/242 (11%)
Query: 398 LGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIE-QFINEVAILSQINHRNVVKLLGCCL 456
+G+G G VYK +G+ K ++ + I E+A+L ++ H NV+ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 457 ---ETEVPLLVYEFIPNGTLYQYIH----DQTEEFPITWEIRL--RIAIEVSDALCYLHS 507
+ +V LL +++ + L+ I + + P+ + + ++ D + YLH+
Sbjct: 69 SHSDRKVWLL-FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 508 AASIPIYHRDIKSANILL----DDKYRAKVSDFGASR---SVMIDQTHLTTRVQGTFGYL 560
+ HRD+K ANIL+ ++ R K++D G +R S + L V TF Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYR 182
Query: 561 DPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619
PE ++ +T+ D+++ G + ELLT + PI E+ K+ + + + +R+F
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTSNPFHHDQL--DRIFS 239
Query: 620 VL 621
V+
Sbjct: 240 VM 241
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 42/220 (19%)
Query: 398 LGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNI--EQFINEVAILSQINHRNVVKLL-- 452
+G G G+V T G VA+KK +S I ++ E+ +L + H NV+ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 453 ---GCCLE--TEVPLLVYEF---IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCY 504
LE +V L+ + + N Q + D +F I +R L Y
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR---------GLKY 135
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEY 564
+HSA I HRD+K +N+ +++ K+ DFG +R + T GY+ +
Sbjct: 136 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT----------GYVATRW 182
Query: 565 FRSSQ-------FTEKSDVYSFGVVLVELLTGQKPIRSTD 597
+R+ + + + D++S G ++ ELLTG+ TD
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 54/221 (24%)
Query: 419 IKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIH 478
++K +++ + + E IL++ ++ VVKL + + V ++IP G + +
Sbjct: 34 LRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL- 92
Query: 479 DQTEEFPITWEIRLRIAI-EVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537
+ E FP E+ R I E++ A+ +H I HRDIK NIL+D K++DFG
Sbjct: 93 IRMEVFP---EVLARFYIAELTLAIESVHKMGFI---HRDIKPDNILIDLDGHIKLTDFG 146
Query: 538 ----------------------------------------------ASRSVMIDQTHLTT 551
R+ Q L
Sbjct: 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206
Query: 552 RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
+ GT Y+ PE +T+ D +S GV+L E+L GQ P
Sbjct: 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 43/156 (27%), Positives = 62/156 (39%), Gaps = 24/156 (15%)
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH 506
N+V L + + LV + G L+ +I I E R A E+ AL LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN---IPEECVKRWAAEMVVALDALH 102
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV-------MIDQTHLTTRVQGTFGY 559
I RD+ NILLDD+ +++ F V ++ Y
Sbjct: 103 REG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----------Y 148
Query: 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRS 595
PE S+ TE D +S G +L ELLTG+ +
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 28/83 (33%), Positives = 48/83 (57%), Gaps = 5/83 (6%)
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF---GYLDPEYF 565
AS HRD+ + N+L+ + K+ DFG +R +M D +++ TF ++ PE
Sbjct: 256 ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK--GSTFLPLKWMAPESI 313
Query: 566 RSSQFTEKSDVYSFGVVLVELLT 588
++ +T SDV+SFG++L E+ T
Sbjct: 314 FNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 52/199 (26%), Positives = 79/199 (39%), Gaps = 48/199 (24%)
Query: 436 EVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIA 495
E IL++ ++ VVKL + + V ++IP G + + + F R IA
Sbjct: 51 ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL-IRLGIFEEDLA-RFYIA 108
Query: 496 IEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG------------------ 537
E++ A+ +H I HRDIK NIL+D K++DFG
Sbjct: 109 -ELTCAIESVHKMGFI---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164
Query: 538 ---------ASRSVMIDQTHLTT----------RVQ-----GTFGYLDPEYFRSSQFTEK 573
+ ID+ L R GT Y+ PE + +T+
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 224
Query: 574 SDVYSFGVVLVELLTGQKP 592
D +S GV+L E+L GQ P
Sbjct: 225 CDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 42/213 (19%)
Query: 398 LGQGGQGTVYKGMLTNGR-IVAIKKSKLVDESNIE--QFINEVAILSQINHRNVVKLL-- 452
+G G G+V T R VA+KK +S I + E+ +L + H NV+ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 453 ---GCCLE--TEVPL---LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCY 504
+E EV L L+ + N Q + D+ +F I +R L Y
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR---------GLKY 133
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEY 564
+HSA I HRD+K +N+ +++ ++ DFG +R + T GY+ +
Sbjct: 134 IHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT----------GYVATRW 180
Query: 565 FRSSQ-------FTEKSDVYSFGVVLVELLTGQ 590
+R+ + + + D++S G ++ ELL G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 50/236 (21%), Positives = 87/236 (36%), Gaps = 64/236 (27%)
Query: 419 IKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIH 478
++K ++ + + E IL++ ++ VV+L + + V ++IP G + +
Sbjct: 34 LRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLL- 92
Query: 479 DQTEEFPITWEIRLRIAIE------VSDALCYLHSAASIPIYHRDIKSANILLDDKYRAK 532
IR+ I E +++ C + S + HRDIK NIL+D K
Sbjct: 93 -----------IRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIK 141
Query: 533 VSDFG----------------------------------------------ASRSVMIDQ 546
++DFG R+ Q
Sbjct: 142 LTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQ 201
Query: 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDK 602
L + GT Y+ PE + +T+ D +S GV+L E+L GQ P + E +
Sbjct: 202 RCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 57/250 (22%), Positives = 101/250 (40%), Gaps = 32/250 (12%)
Query: 398 LGQGGQGTVYKGMLTNGRIVA------IKKSKLVDESNIEQFINEVAILSQINHRNVVKL 451
+G G G V + VA +K + E N +F+ + + H N+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN--EFLQQGDPYRILQHPNILQC 60
Query: 452 LGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRL-RIAIEVSDALCYLHSAAS 510
LG C+E LLV+E+ G L Y+ + + + L R+A E++ + ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFG--YLDPEYFRS- 567
+ H D+ N L KV D+G S + ++ T +L PE
Sbjct: 121 L---HSDLALRNCFLTSDLTVKVGDYGIGPS-RYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 568 ------SQFTEKSDVYSFGVVLVEL----------LTGQKPIRSTDSEEDKSLVGYFLEA 611
++ T+ S+V++ GV L EL L+ ++ + ++ L LE
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL 236
Query: 612 MKENRLFEVL 621
R +EVL
Sbjct: 237 PYSERWYEVL 246
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 33/127 (25%), Positives = 63/127 (49%), Gaps = 9/127 (7%)
Query: 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANIL 524
Y+ + + + D E T ++ L +V+ + +L S + HRD+ + N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDL-LSFTYQVARGMEFLASKNCV---HRDLAARNVL 269
Query: 525 LDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF---GYLDPEYFRSSQFTEKSDVYSFGV 581
L K+ DFG +R +M D +++ TF ++ PE + +T SDV+S+G+
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSK--GSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 582 VLVELLT 588
+L E+ +
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 34/118 (28%), Positives = 61/118 (51%), Gaps = 11/118 (9%)
Query: 480 QTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539
+ +E + E L + +V+ + +L S I HRD+ + NILL K+ DFG +
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLA 261
Query: 540 RSVMIDQTHLTTRVQGT----FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
R + D ++ V+G ++ PE + +T +SDV+S+G++L E+ + G P
Sbjct: 262 RDIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 40/154 (25%), Positives = 69/154 (44%), Gaps = 22/154 (14%)
Query: 400 QGGQGTVYKGML-TNGRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKLLGCC 455
+G G VY G N ++ A+K K+ +++++ + Q E L+ +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 456 LETEVPLLVYEFIPNGTL------YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA 509
LV E++ G + Y Y ++ I+ EV+ AL YLH
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS---------EVALALDYLHRHG 124
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543
I HRD+K N+L+ ++ K++DFG S+ +
Sbjct: 125 ---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 49/183 (26%), Positives = 74/183 (40%), Gaps = 44/183 (24%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTN------GRIVAIKKSKLVDESNIEQFINEVAILSQI 443
D+F + LG+G G VYK L N G+ V +KK+ + +E ++NE +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKAT--EYGAVEIWMNERV---RR 185
Query: 444 NHRN-VVKLLGCCLET-----EVPL-LVYEFIPNGTLYQYIHDQTEEFPITWE------- 489
N + LE E LV+ + TL + Q++EFP E
Sbjct: 186 ACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLM--QSKEFPYNVEPYLLGKV 243
Query: 490 ------------IRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRA-KVSDF 536
I I ++ AL LHS I HRD+K NI+ + + K+ D
Sbjct: 244 QDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDL 300
Query: 537 GAS 539
GA+
Sbjct: 301 GAA 303
|
Length = 566 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 32/103 (31%), Positives = 45/103 (43%), Gaps = 17/103 (16%)
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF---------GASRSVMIDQTHLTT 551
L YLH I HR+IK+++IL+ +S G V+ D +T
Sbjct: 113 GLNYLHQNGYI---HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169
Query: 552 RVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKP 592
V +L PE R + KSD+YS G+ EL TG+ P
Sbjct: 170 SVLP---WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 32/144 (22%), Positives = 57/144 (39%), Gaps = 15/144 (10%)
Query: 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVV--KLLG 453
++L G VY + V ++ E EVAIL + + + K+L
Sbjct: 4 KLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADRE---REVAILQLLARKGLPVPKVLA 60
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPI 513
L+ E+I TL + ++ E+ IA ++++ L LH + +
Sbjct: 61 SGESDGWSYLLMEWIEGETLDEVSEEEKED----------IAEQLAELLAKLHQLPLLVL 110
Query: 514 YHRDIKSANILLDDKYRAKVSDFG 537
H D+ NIL+DD + D+
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 12/126 (9%)
Query: 371 EGNS----EKTKLFTSMELEMATDNFNTNRILGQGGQGTVYK------GMLTNGRIVAIK 420
EGN+ + T+L + + E DN + LG G G V + G N VA+K
Sbjct: 15 EGNNYTFIDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVK 74
Query: 421 KSKLVDESN-IEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIH 478
K ++ E ++E+ ILS + H+N+V LLG C L++ E+ G L ++
Sbjct: 75 MLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 134
Query: 479 DQTEEF 484
+ E F
Sbjct: 135 KKAETF 140
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 8/107 (7%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGM---LTNGR---IVAIKKSKLVDESNIEQ-FINEVA 438
E D RILG G G V +G L+ + VA+K K S+ +Q ++E+
Sbjct: 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELK 92
Query: 439 ILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEF 484
I++ + H N+V LLG C ++ ++ E+ G L Y+H + F
Sbjct: 93 IMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNF 139
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 12/131 (9%)
Query: 366 ESSSNEGNS----EKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGM---LTNGRI-- 416
ES S++G+ + +L EM DN R LG G G V + L++ +
Sbjct: 9 ESVSSDGHEYIYVDPMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTM 68
Query: 417 -VAIKKSKLVDESNIEQ-FINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTL 473
VA+K K S+ +Q ++E+ I+S + H N+V LLG C + ++ E+ G L
Sbjct: 69 KVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDL 128
Query: 474 YQYIHDQTEEF 484
Y+H F
Sbjct: 129 VDYLHRNKHTF 139
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 29/114 (25%), Positives = 48/114 (42%), Gaps = 22/114 (19%)
Query: 493 RIAIEVSDALCYLHSAASIPIYHRDIKSANILLD----------------DKYRAKVSDF 536
+I + AL Y H+ + + H D+K NIL++ D R ++ D
Sbjct: 235 QIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 537 GASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQ 590
G D+ H T + T Y PE + +D++S G ++ EL TG+
Sbjct: 293 GGC----CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 21/160 (13%)
Query: 434 INEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIP--NGTLYQYIHDQTEEFPITWEIR 491
++E +L +++H V+ LL + + LV +P LY Y+ + P+
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLR--PLGLAQV 262
Query: 492 LRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGA------SRSVMID 545
+A ++ A+ Y+H I HRDIK+ N+L++ + DFGA S S
Sbjct: 263 TAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS---- 315
Query: 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVE 585
T + GT PE +T D++S G+V+ E
Sbjct: 316 -TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 700 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| PF08488 | 103 | WAK: Wall-associated kinase; InterPro: IPR013695 T | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.98 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.83 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.58 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.56 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.53 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.51 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.4 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.27 | |
| KOG1219 | 4289 | consensus Uncharacterized conserved protein, conta | 98.24 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.22 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.1 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.08 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.02 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.99 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.96 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.96 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.93 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.85 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.79 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.63 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.56 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.56 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.56 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.53 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.46 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.04 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.98 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.97 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.89 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.8 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.74 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.63 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.61 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.58 | |
| PLN02236 | 344 | choline kinase | 96.51 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.37 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.35 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.34 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.07 | |
| KOG1219 | 4289 | consensus Uncharacterized conserved protein, conta | 95.8 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.63 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.36 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.19 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.01 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.78 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.45 | |
| PF12947 | 36 | EGF_3: EGF domain; InterPro: IPR024731 This entry | 94.15 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 93.79 | |
| PF00008 | 32 | EGF: EGF-like domain This is a sub-family of the P | 93.61 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=443.03 Aligned_cols=292 Identities=46% Similarity=0.757 Sum_probs=259.1
Q ss_pred cccccchHHHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEE
Q 005355 376 KTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCC 455 (700)
Q Consensus 376 ~~~~~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 455 (700)
..+.|++.+++.+|++|...++||+|+||.||+|.+.++..||||++.........+|.+|++++.+++|||+|+|+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999998899999988765443135599999999999999999999999
Q ss_pred EeCC-cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEe
Q 005355 456 LETE-VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVS 534 (700)
Q Consensus 456 ~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~ 534 (700)
.+.+ ..+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||....++|+|||||++|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 499999999999999999987654 69999999999999999999999988889999999999999999999999
Q ss_pred ecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh
Q 005355 535 DFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE 614 (700)
Q Consensus 535 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 614 (700)
|||+++..........+...||.+|+|||++..+..+.|+|||||||+|+||++|+.+.+.........+..|+...+..
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 99999765431222221117999999999999999999999999999999999999998876655566699999999999
Q ss_pred cchhhhcchhhh-hccCH-HHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 615 NRLFEVLDARVL-KEAKE-EEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 615 ~~~~~~~d~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
+++.+++|+.+. .+... .+...+..++.+|++.+|++||+|.||+++|+.+...
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999987 55554 6888899999999999999999999999999666544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=372.90 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=211.8
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc-ceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEV-PLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~E 466 (700)
++++.++.||+|..|+||+++++ +++.+|+|.+.. .++...+++.+|+++++..+||+||+++|+|..... ..|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 45566689999999999999987 688999999854 456667899999999999999999999999999985 999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||++|+|++++..... +++..+.+++.++++||.|||+ ++ ||||||||+||||+..|++||+|||.+..+...
T Consensus 159 YMDgGSLd~~~k~~g~---i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGR---IPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999999987643 9999999999999999999996 66 999999999999999999999999999876433
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
...+..||..|||||.+.+..|+.++||||||++++|+++|+.||....... ....+ .+. .+++...
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~-~~~~~-Ll~--------~Iv~~pp 299 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY-LDIFE-LLC--------AIVDEPP 299 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC-CCHHH-HHH--------HHhcCCC
Confidence 5667789999999999999999999999999999999999999998652111 11111 111 1222111
Q ss_pred hhccCH-HHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 626 LKEAKE-EEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 626 ~~~~~~-~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
...+. ..++++..++..||+.||.+||+++|+++.
T Consensus 300 -P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 300 -PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 12223 367789999999999999999999999873
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=389.22 Aligned_cols=264 Identities=35% Similarity=0.553 Sum_probs=217.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC-cceEEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDE--SNIEQFINEVAILSQINHRNVVKLLGCCLETE-VPLLVY 465 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 465 (700)
...+...+.||+|+||+||+|.|+....||||++...+. ...+.|.+|+.+|.+++|||||+++|++.+.. ...+||
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 444555567999999999999998555599999876432 22679999999999999999999999999988 789999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEeecCCCccccc
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGASRSVMI 544 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~-~~kl~DfGl~~~~~~ 544 (700)
||+++|+|.++++.. .+..+++..++.++.|||+||.|||+++. |||||||++||||+.++ ++||+|||+++....
T Consensus 120 Ey~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 999999999999885 33459999999999999999999999984 89999999999999997 999999999986543
Q ss_pred CCceeeeeeecccccccccccc--cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFR--SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
.. ...+...||+.|||||++. ...++.|+||||||++||||++|+.||......+. +......+.
T Consensus 197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~------~~~v~~~~~------ 263 (362)
T KOG0192|consen 197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV------ASAVVVGGL------ 263 (362)
T ss_pred cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcCC------
Confidence 22 2233367999999999999 56999999999999999999999999986654221 111111111
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCC
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGD 671 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~ 671 (700)
....+...+..+..|+.+||..||..||++.+++..|+.+......
T Consensus 264 ---Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 264 ---RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ---CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 1222333667889999999999999999999999999999876553
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=389.60 Aligned_cols=262 Identities=30% Similarity=0.457 Sum_probs=224.7
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++....++..+.||+|-||.||.|.++....||+|.++.... ..+.|.+|+++|++|+|+|||++++++..++..+||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 3444555667789999999999999999778999999886533 347899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
||||+.|+|.++|+.. .+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||++....
T Consensus 280 tE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999999999973 2334899999999999999999999999 99999999999999999999999999996655
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
+.........-+..|+|||.+....++.|||||||||+||||+| |+.|+......+ +.+.++.+
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-------v~~~le~G-------- 420 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-------VLELLERG-------- 420 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-------HHHHHhcc--------
Confidence 66656666667789999999999999999999999999999999 889987766544 23333332
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
..-..+...+..+.+|+..||..+|++|||++.+...|+.+..
T Consensus 421 -yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 421 -YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred -CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 2233456678899999999999999999999999999988754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=381.71 Aligned_cols=247 Identities=25% Similarity=0.421 Sum_probs=215.0
Q ss_pred cCCCccceEeeeCCeEEEEEEE-cCCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGML-TNGRIVAIKKSKL---VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
.+|...+.||+|||+.+|+++. ..|+.||+|++.. ......+.+.+|++|.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 6789999999999999999997 6899999998764 44566789999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
|++.+++|..++++. +++++.++..+++||+.||.|||+++ |+|||||..|+||+++.+|||+|||||..+..+
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999999843 35999999999999999999999999 999999999999999999999999999877544
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
.+...+.+||+.|+|||++.....+..+||||+|||||-||.|++||+...-.+ ....++....
T Consensus 172 -~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~Ik~~~Y-------- 235 (592)
T KOG0575|consen 172 -GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKIKLNEY-------- 235 (592)
T ss_pred -ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHHHhcCc--------
Confidence 344567889999999999999999999999999999999999999997654333 2222222221
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+...+.+..+||.++|+.+|.+|||+++|+.
T Consensus 236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 123345567889999999999999999999997
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=362.17 Aligned_cols=249 Identities=28% Similarity=0.435 Sum_probs=204.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
..+|...+.||+|.|++||+|+++ ++..||||.+... .....+.+..|+++|+.++|||||++++++...+..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888889999999999999976 6789999987654 6677788999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC------CcEEEeecCCC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK------YRAKVSDFGAS 539 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~------~~~kl~DfGl~ 539 (700)
||+.+|+|.+||+.... +++..+..++.||+.||++||+++ ||||||||.||||+.. ..+||+|||++
T Consensus 89 EyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999998754 999999999999999999999999 9999999999999764 56999999999
Q ss_pred cccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
+.+. ......+.+|++-|||||++...+|+.|+|+||+|+|||+|++|+.||......|-. ..++.+.
T Consensus 163 R~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~-------~~~~k~~--- 230 (429)
T KOG0595|consen 163 RFLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELL-------LYIKKGN--- 230 (429)
T ss_pred hhCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHH-------HHHhccc---
Confidence 9774 444566788999999999999999999999999999999999999999876655421 1222211
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAA 659 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl 659 (700)
.+....+......+.+|+...++.+|.+|-+..+-.
T Consensus 231 ----~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 231 ----EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred ----cccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 111112222333344566666666666666554443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=365.36 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=209.6
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-------hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-------ESNIEQFINEVAILSQINHRNVVKLLGCCLETE 459 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 459 (700)
..+.|.+.+.||+|+||.|-+|..+ +++.||||+++... ........+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4567888999999999999999965 79999999876421 112334679999999999999999999999999
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC---CcEEEeec
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDF 536 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~---~~~kl~Df 536 (700)
..||||||+++|+|.+.+-.+.. +.+..-..+++|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999987654 778888899999999999999999 9999999999999765 78999999
Q ss_pred CCCcccccCCceeeeeeecccccccccccccCCC---CcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHH
Q 005355 537 GASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQF---TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK 613 (700)
Q Consensus 537 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 613 (700)
|+++... ....+.+.+||+.|.|||++.+... ..|+|+||+||+||-+|+|.+||.....+. . +.+.+.
T Consensus 324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s----l~eQI~ 395 (475)
T KOG0615|consen 324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S----LKEQIL 395 (475)
T ss_pred chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c----HHHHHh
Confidence 9998654 5567788999999999999977543 358899999999999999999997654332 1 223333
Q ss_pred hcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 614 ENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 614 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.+++... .....+..++..+||.+||..||++|||+.|+++
T Consensus 396 ~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 3433211 1123456678889999999999999999999987
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=396.67 Aligned_cols=271 Identities=28% Similarity=0.464 Sum_probs=234.7
Q ss_pred hHHHHHHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCceeeEEeE
Q 005355 382 SMELEMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVDES-NIEQFINEVAILSQINHRNVVKLLGC 454 (700)
Q Consensus 382 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~ 454 (700)
....+..+.+.+..+.||+|.||+||+|+.. +...||||.++..... ..++|++|++++..++|||||+|+|+
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 3445667788888999999999999999954 2457999999986665 78999999999999999999999999
Q ss_pred EEeCCcceEEEeeCCCCCHHHHHhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 005355 455 CLETEVPLLVYEFIPNGTLYQYIHDQTE-----------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANI 523 (700)
Q Consensus 455 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NI 523 (700)
|.+++..++|+|||..|+|.+||+.... ..+|+..+.+.||.|||.||.||-++. +|||||..+|+
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNC 634 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNC 634 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhc
Confidence 9999999999999999999999975422 224889999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeecCCCcccccCCceeee-eeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhh
Q 005355 524 LLDDKYRAKVSDFGASRSVMIDQTHLTT-RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEED 601 (700)
Q Consensus 524 Ll~~~~~~kl~DfGl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~ 601 (700)
||.++..|||+||||++.....+++... ...-+.+||+||.+..+++|.+||||||||+|||+++ |+.||.+...+|
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E- 713 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE- 713 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-
Confidence 9999999999999999988766555443 5567889999999999999999999999999999999 999998877665
Q ss_pred hhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCC
Q 005355 602 KSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGD 671 (700)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~ 671 (700)
+++.+..+++. +.+...+.++.+|+..||+.+|++||+++||-..|+..-+....
T Consensus 714 ------VIe~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~ 768 (774)
T KOG1026|consen 714 ------VIECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK 768 (774)
T ss_pred ------HHHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence 45566666552 33556778999999999999999999999999999887655443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=346.40 Aligned_cols=259 Identities=26% Similarity=0.395 Sum_probs=212.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEE-cCCcEEEEEEcc--ccChhhHHHHHHHHHHHhhcCCCceeeEEe-EEEeCCc-ceE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGML-TNGRIVAIKKSK--LVDESNIEQFINEVAILSQINHRNVVKLLG-CCLETEV-PLL 463 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~l 463 (700)
..+|++.++||+|.||+||++.. .+|..||.|.++ ..+....++...|+.+|++|+|||||++++ .+.+++. ..|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 35678889999999999999995 489999999866 456667888999999999999999999998 4555555 789
Q ss_pred EEeeCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 464 VYEFIPNGTLYQYIHDQTE-EFPITWEIRLRIAIEVSDALCYLHSAAS-IPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~-~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
|||++..|+|...++..+. +..+++..+++++.|++.||.++|+.-+ ..|+||||||.||+|+.+|.|||+||||++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999987543 3458999999999999999999998221 1289999999999999999999999999997
Q ss_pred cccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
+... .......+|||.||+||.+.+..|+.||||||+||++|||..-+.||.+.+-.+ +...++++....+.
T Consensus 178 l~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-------L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 178 LSSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-------LCKKIEQGDYPPLP 249 (375)
T ss_pred hcch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-------HHHHHHcCCCCCCc
Confidence 6433 334556789999999999999999999999999999999999999998763222 33445555432221
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
+ .-++.++.+||..|+..||+.||+...+++.+.
T Consensus 250 ~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 250 D--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred H--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1 456778999999999999999999655555443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=349.56 Aligned_cols=243 Identities=28% Similarity=0.423 Sum_probs=207.6
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL---VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
..++|+++++||+|+||+|+.++.+ .++.+|+|.++. ......+....|..+|.+++||.||+++-.|++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 4678999999999999999999965 588999998764 344567888999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
|+||+.||.|..+|.+... +++..+..++.+|+.||.|||+++ ||||||||+|||||.+|+++|+||||++...
T Consensus 103 Vld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999999999987654 999999999999999999999999 9999999999999999999999999998653
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
.. .....+.+||+.|||||++.+..|+..+|.||||+++|||++|.+||...+..+ ..+.+..+++
T Consensus 177 ~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-------~~~~I~~~k~------ 242 (357)
T KOG0598|consen 177 KD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-------MYDKILKGKL------ 242 (357)
T ss_pred cC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-------HHHHHhcCcC------
Confidence 33 334455789999999999999999999999999999999999999998766433 2222222221
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCC
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRP 653 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 653 (700)
...+.-...+..+++.++|..+|++|.
T Consensus 243 ---~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 ---PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 112222455788899999999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=334.17 Aligned_cols=264 Identities=24% Similarity=0.341 Sum_probs=211.1
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE--SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
+.|+.+.++|+|+||.||+.+.+ .|+.||||++...++ .-.+-..+|+++|++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 46778889999999999999977 699999999876443 334567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|++.. +.+-|.+...+ ++.+.+..++.|+++|+.|+|+++ ++||||||+||||+.++.+||+|||+|+.+.. .
T Consensus 82 ~~dhT-vL~eLe~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p 154 (396)
T KOG0593|consen 82 YCDHT-VLHELERYPNG--VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-P 154 (396)
T ss_pred ecchH-HHHHHHhccCC--CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence 99764 44455555443 899999999999999999999999 99999999999999999999999999998754 3
Q ss_pred ceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHH--------HHHHHHhcch
Q 005355 547 THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGY--------FLEAMKENRL 617 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~ 617 (700)
....+..+.|.+|.|||.+.+ .+|...+||||+||++.||++|.+.|.+...-+...++.. ..+....+.+
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 444556678999999999887 7899999999999999999999999987765443222211 1122222222
Q ss_pred h------hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 F------EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ~------~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+ +.-+.+..+..-+....-+.+|++.||..||.+|++-++++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1 222222222233444556899999999999999999999885
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=343.97 Aligned_cols=273 Identities=24% Similarity=0.355 Sum_probs=216.4
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhh--cCCCceeeEEeEEEeCC-
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQ--INHRNVVKLLGCCLETE- 459 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~- 459 (700)
...+....+.++.+.||+|.||.||+|.|+ |+.||||++...++ +.+++|.+|++. |+|+||+.+++.-..++
T Consensus 204 LVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 204 LVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred HhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 445566788999999999999999999998 89999999987655 558999999987 59999999999876543
Q ss_pred ---cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeeecCCCCCcEEECCCCcE
Q 005355 460 ---VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH-----SAASIPIYHRDIKSANILLDDKYRA 531 (700)
Q Consensus 460 ---~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-----~~~~~~ivH~Dik~~NILl~~~~~~ 531 (700)
+++||.+|.+.|||.|||.+.. ++.+..++++..+|.||+||| .+|+|.|.|||||++|||+..++..
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 5689999999999999998754 999999999999999999999 4788999999999999999999999
Q ss_pred EEeecCCCcccccCCce---eeeeeecccccccccccccCC------CCcccceehHHHHHHHHHhC----------CCC
Q 005355 532 KVSDFGASRSVMIDQTH---LTTRVQGTFGYLDPEYFRSSQ------FTEKSDVYSFGVVLVELLTG----------QKP 592 (700)
Q Consensus 532 kl~DfGl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwSlG~il~elltg----------~~p 592 (700)
.|+|+||+.....+... .....+||.+|||||++.+.- .-..+||||||+++||+.-. +.|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 99999999866544322 234467999999999997642 22479999999999999862 466
Q ss_pred CCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 593 IRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
|...-+.+ ...+.+.+..-..++...+..+ ....+....+.+|++.||..+|..|.|+-.+.+.|.++.+.
T Consensus 436 yyd~Vp~D--Ps~eeMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 436 YYDVVPSD--PSFEEMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred cccCCCCC--CCHHHHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 65433211 1112222222223333322222 23456788899999999999999999999999999888753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=351.98 Aligned_cols=266 Identities=26% Similarity=0.342 Sum_probs=213.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC--CcceE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLET--EVPLL 463 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 463 (700)
.+.|+.+++||+|+||.||+|+.. +|+.||+|++.... +.......+||.||++|+||||++|.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 466788899999999999999954 79999999877544 55567778999999999999999999999877 67899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
|+|||+. +|.-++....- .+++.++..++.||+.||.|+|+++ |+|||||..|||||.+|.+||+||||++.+.
T Consensus 196 VFeYMdh-DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999965 88888876433 3999999999999999999999999 9999999999999999999999999999877
Q ss_pred cCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh----
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF---- 618 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---- 618 (700)
.......+..+.|++|.|||.+.+ ..|+.++|+||.||||.||+.|++.|.+..+.+....+-.+--...+..|.
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 776666777889999999999887 579999999999999999999999999877554332221111101111111
Q ss_pred ---hhcch-----hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 619 ---EVLDA-----RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 619 ---~~~d~-----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+.+ +...+.-...+....+|+..+|..||.+|.|+.++++
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 01110 1111112233456888999999999999999999886
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=357.50 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=217.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
...|...++||+|..|.||.|... .++.||||++........+-+++|+.+|+..+|+|||.+++.+...+..|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 456777889999999999999954 6889999999988777888899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
|++|+|.|.+.... +++.++..|.+++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999998765 999999999999999999999999 99999999999999999999999999987755544
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
...+.+||+.|||||++....|..|.||||||++++||+-|++||-..++.. ++..+..+-..++
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-------AlyLIa~ng~P~l------- 489 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGTPKL------- 489 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-------HHHHHhhcCCCCc-------
Confidence 4556779999999999999999999999999999999999999997644332 2222222221111
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+...+..+.+++.+||+.|+++||+++|+|+
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 223456678999999999999999999999998
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=382.91 Aligned_cols=274 Identities=27% Similarity=0.483 Sum_probs=228.2
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcC--Cc----EEEEEEccc-cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTN--GR----IVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCCLETE 459 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 459 (700)
....+.+..+.||+|.||.||+|...+ +. .||||.++. .+.+...+|.+|..+|+.++|||||+++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 346677888999999999999999653 33 489998875 45677899999999999999999999999999999
Q ss_pred cceEEEeeCCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEee
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTE----EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~D 535 (700)
.++|++|||++|+|..||++.+. ...++...++.++.|||+|+.||++++ +|||||..+|+||++...|||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence 99999999999999999998622 235899999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccccCCceeeee-eecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHH
Q 005355 536 FGASRSVMIDQTHLTTR-VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMK 613 (700)
Q Consensus 536 fGl~~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 613 (700)
||+++.+...+.+.... ..-+..|||||.+..+.++.|+|||||||+|||+++ |..||...+..+. +....+
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~~ 919 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVLE 919 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHHh
Confidence 99999665444443332 244569999999999999999999999999999999 8999987665442 222333
Q ss_pred hcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCCccCCCCC
Q 005355 614 ENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSIMQHNCD 679 (700)
Q Consensus 614 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~~~~~~ 679 (700)
.+++ +.+..++..+.+|+..||+.+|++||++..+++.++.+.+.+.......-.+
T Consensus 920 ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~~a 975 (1025)
T KOG1095|consen 920 GGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPLPA 975 (1025)
T ss_pred CCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCccccccc
Confidence 3332 3355677789999999999999999999999999999887665555444333
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=337.81 Aligned_cols=265 Identities=25% Similarity=0.365 Sum_probs=215.1
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
.....+.|++.+.||.|.-++||+|+.. .++.||||++.... ....+.+++|+..|+.++||||++.+..|..++..|
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 3445688999999999999999999954 67999999988643 333688999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+||.||.+|++.++++..-..+ +++..+..|++++++||.|||++| .||||||+.||||+.+|.|||+|||.+..+
T Consensus 101 vVmpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred EeehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeee
Confidence 9999999999999998764433 999999999999999999999999 999999999999999999999999988766
Q ss_pred ccCCce---eeeeeeccccccccccccc--CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 543 MIDQTH---LTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 543 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
...... ......||+.|||||++.. ..|+.|+||||||++..||.+|..||....+.+. +...+ ++..
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------Ll~tL-qn~p 249 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------LLLTL-QNDP 249 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------HHHHh-cCCC
Confidence 443222 1245689999999999543 5799999999999999999999999987655431 11111 2222
Q ss_pred hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
....-..+..+........+.+++..||+.||++|||+++++.
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111111122223344557999999999999999999999886
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=319.36 Aligned_cols=265 Identities=26% Similarity=0.288 Sum_probs=211.5
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChh--hHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDES--NIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
++|...++||+|.||.||+|++. .|+.||||+++..+.. -.....+|++.|+.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46788899999999999999965 7999999998865433 24567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|| ..+|...|++... .++..++..++.++++||+|||++. |+||||||.|+||+.+|.+||+|||+++.+....
T Consensus 82 fm-~tdLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ec-cccHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 99 5699999987654 4899999999999999999999999 9999999999999999999999999999876544
Q ss_pred ceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh---hcc
Q 005355 547 THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE---VLD 622 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~d 622 (700)
... +..+.|..|.|||.+.+ ..|+..+||||.|||+.||+-|.+-|.+..+-+....+-..+.......|.+ +.|
T Consensus 156 ~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 156 RIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred ccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 333 33368999999999877 5699999999999999999999988887765443222221111111222211 111
Q ss_pred hh--------hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 623 AR--------VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 623 ~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
-. .....-.....+..+|+.+||..||.+|++++|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 1111223445667999999999999999999999874
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=348.39 Aligned_cols=267 Identities=26% Similarity=0.350 Sum_probs=211.9
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChh-hHHHHHHHHHHHhhcC-CCceeeEEeEEEeCC-cce
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDES-NIEQFINEVAILSQIN-HRNVVKLLGCCLETE-VPL 462 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~ 462 (700)
...++|.++++||.|+||.||+|+-. .++.||||+++..-.. +.-.=++|+..|++|+ ||||+++.+++.+.+ .++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 34678999999999999999999954 6899999998753322 2233468999999998 999999999999988 999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+||||| ..+|.+++++. +..+++..+..|+.||++||+|+|++| +.|||+||+|||+..+..+||+|||+++..
T Consensus 87 fVfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 999999 56999999887 456999999999999999999999999 999999999999999889999999999976
Q ss_pred ccCCceeeeeeecccccccccccc-cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch----
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFR-SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL---- 617 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 617 (700)
.... ..+..+.|.+|+|||++. ..-|+.+.|||++|||++|+.+-++.|.+.++.+....+..++..-....+
T Consensus 161 ~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 161 RSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 4332 345566899999999874 567999999999999999999999999887754433222222111111111
Q ss_pred --hhhcch-------hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 618 --FEVLDA-------RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 618 --~~~~d~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
...+.- .-....-.....+.++|+.+||++||.+|||++|++++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111 11111223367789999999999999999999999984
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=343.00 Aligned_cols=255 Identities=30% Similarity=0.462 Sum_probs=207.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC--cceEEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETE--VPLLVY 465 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 465 (700)
..++...+.||+|.||.||++... +|+..|||.....+....+.+.+|+.+|++++|||||+.+|.....+ ...++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 456778899999999999999976 48999999877654444677999999999999999999999855444 588999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEeecCCCccccc
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGASRSVMI 544 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~-~~~~kl~DfGl~~~~~~ 544 (700)
||+++|+|.+++.+... .+++..+..+++||++||+|||+++ |+|+||||+||||+. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999998764 4999999999999999999999999 999999999999999 79999999999987653
Q ss_pred --CCceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 545 --DQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 545 --~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
..........||+.|||||++... ....++|||||||++.||+||+.||... .............+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~------ 239 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED------ 239 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC------
Confidence 222234457799999999999863 3335999999999999999999999753 11111111111111
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L 662 (700)
.....+...+.+..+++.+|++.+|++|||++++++..
T Consensus 240 ---~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 240 ---SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ---CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11133444666788999999999999999999999865
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=321.76 Aligned_cols=237 Identities=28% Similarity=0.398 Sum_probs=205.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|+.++.||.|+||+|.+++.+ +|..+|+|+++.. ...+.+...+|..+|+.+.||.++++++.+.+.+..+||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 357888899999999999999976 6889999988753 345567788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++|.|..++++..+ +++..+..+|.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+++...
T Consensus 123 meyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~- 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS- 195 (355)
T ss_pred EeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-
Confidence 999999999999998654 999999999999999999999999 9999999999999999999999999998763
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
....+.+||+.|+|||+++...+..++|.|+|||++|||+.|.+||...++.. ..+.+-++++
T Consensus 196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~KI~~~~v------- 258 (355)
T KOG0616|consen 196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYEKILEGKV------- 258 (355)
T ss_pred ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHHHHHhCcc-------
Confidence 23667899999999999999999999999999999999999999998776532 1222222222
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCC
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKR 652 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~R 652 (700)
.++.-....+.+|+..+|+.|-.+|
T Consensus 259 ---~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 ---KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2344455678899999999998888
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=353.99 Aligned_cols=271 Identities=25% Similarity=0.453 Sum_probs=220.3
Q ss_pred cchHHHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe
Q 005355 380 FTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLE 457 (700)
Q Consensus 380 ~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 457 (700)
....++++..+.+.+.+.||+|.||+||+|.|.. .||||+++.. .++..+.|++|+.+|++-+|.||+-+.|++..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3457788889999999999999999999999863 5999998764 45578899999999999999999999999999
Q ss_pred CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 458 TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 458 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
... .||+.++++-+|+.+|+....+ +.....+.||+||++||.|||.++ |||||||.+||+|.++++|||+|||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etk--fdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETK--FDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhh--hhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccc
Confidence 888 9999999999999999987644 888999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccC-Cceeeeeeeccccccccccccc---CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHH
Q 005355 538 ASRSVMID-QTHLTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK 613 (700)
Q Consensus 538 l~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 613 (700)
|+..-..- ........-|...|||||+++. .+|+..+||||||+++|||++|..||.....+.. +-+.-
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-------ifmVG 606 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-------IFMVG 606 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-------EEEec
Confidence 98743211 1111222347788999999854 5799999999999999999999999984433321 11111
Q ss_pred hcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 614 ENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 614 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
.+.+. +++ .......+.++.+|+..||..++++||.+.+|+..|+.+..++.
T Consensus 607 rG~l~----pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 607 RGYLM----PDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred ccccC----ccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 11111 111 11224456789999999999999999999999999988877543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=346.15 Aligned_cols=253 Identities=29% Similarity=0.388 Sum_probs=213.5
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCc
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL---VDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEV 460 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 460 (700)
....++|...+.||+|+|++|++|+.. .++.+|||++.. ..+...+-+..|-.+|.+| .||.|++|+-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 444678999999999999999999965 689999998764 2344456678899999999 89999999999999999
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
+|+|+||.++|+|.++|++... +++.....++.||+.||+|||++| ||||||||+|||||+++++||+|||-++
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 9999999999999999998754 999999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCce----------e--eeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH
Q 005355 541 SVMIDQTH----------L--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF 608 (700)
Q Consensus 541 ~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 608 (700)
.+...... . ....+||..|.+||++.....+..+|+|+||||||+|+.|.+||.+.++.- .|
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------iF 296 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------IF 296 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH------HH
Confidence 77532211 1 144789999999999999999999999999999999999999998765321 12
Q ss_pred HHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 609 LEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 609 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
...+. - .-+++...++.+.+|+++.|..||.+|++.++|-+.
T Consensus 297 qkI~~---------l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 297 QKIQA---------L--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHH---------h--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11111 1 113344455678899999999999999999888774
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=353.48 Aligned_cols=264 Identities=28% Similarity=0.461 Sum_probs=209.5
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhc-CCCceeeEEeEEEe
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVD-ESNIEQFINEVAILSQI-NHRNVVKLLGCCLE 457 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 457 (700)
.+..++|++.++||+|+||.||+|.+. .++.||||+++... ....+.+.+|+.++..+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 345678999999999999999999742 35689999987532 33456789999999999 89999999998876
Q ss_pred CC-cceEEEeeCCCCCHHHHHhccCC------------------------------------------------------
Q 005355 458 TE-VPLLVYEFIPNGTLYQYIHDQTE------------------------------------------------------ 482 (700)
Q Consensus 458 ~~-~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------ 482 (700)
.+ ..++||||+++|+|.+++.....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 54 56899999999999999975321
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce-eeeeeecc
Q 005355 483 -----EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGT 556 (700)
Q Consensus 483 -----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt 556 (700)
..++++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........ ......++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 124788899999999999999999999 999999999999999999999999999865332221 12223456
Q ss_pred cccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHH
Q 005355 557 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEII 635 (700)
Q Consensus 557 ~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 635 (700)
..|+|||++.+..++.++||||||++||||++ |..||......+. +...+..+... ..+...+.
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~ 304 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTRM---------RAPENATP 304 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCCC---------CCCCCCCH
Confidence 78999999999999999999999999999997 9999976543221 11222222111 11223345
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 636 TVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 636 ~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
.+.+|+.+||+.+|++|||+.|++++|+++..
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 78899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=362.74 Aligned_cols=261 Identities=24% Similarity=0.417 Sum_probs=220.5
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEcC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLTN----GRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEV 460 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 460 (700)
++......+.++||.|.||.|++|.++- ...||||.++.. .+.++.+|+.|+.||.++.||||++|.|+......
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 3345566788999999999999999862 357999999974 45677899999999999999999999999999999
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.+||.|||++|+|+.||+.+..+ +++.++.-+++.|+.||.||.+.+ +|||||.++|||++.+...||+||||++
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEecccccee
Confidence 99999999999999999987654 899999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCceeeeee--ecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 541 SVMIDQTHLTTRV--QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 541 ~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
.+..+.....+.. .-+.+|.|||.+...+++.+|||||||++|||.++ |+.||-.....+ .+..++++
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-------VIkaIe~g-- 850 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VIKAIEQG-- 850 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-------HHHHHHhc--
Confidence 7654432222222 23569999999999999999999999999999877 999987655443 22333322
Q ss_pred hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 618 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
..-..+.+.+..|.+|++.||++|-.+||.+.+|+..|+++..
T Consensus 851 -------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 851 -------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred -------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 2223355677889999999999999999999999999999764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=335.34 Aligned_cols=271 Identities=25% Similarity=0.372 Sum_probs=206.2
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhh--cCCCceeeEEeEEEeCC----cce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQ--INHRNVVKLLGCCLETE----VPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~ 462 (700)
....++.++||+|+||.||+|+++ ++.||||++. ....+.|.+|-+|++. |+|+||+++++.-.... .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 345566788999999999999997 6999999987 4556779999999887 58999999999876555 789
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh------cCCCCeeecCCCCCcEEECCCCcEEEeec
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS------AASIPIYHRDIKSANILLDDKYRAKVSDF 536 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~------~~~~~ivH~Dik~~NILl~~~~~~kl~Df 536 (700)
||+||.+.|+|.++|+.+. ++|....+++..+++||+|||. +.+++|+|||||++||||..|++..|+||
T Consensus 285 LVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999999876 9999999999999999999996 34678999999999999999999999999
Q ss_pred CCCcccccCCce-eeeeeecccccccccccccCC-CC-----cccceehHHHHHHHHHhCCCCCCCCCchhh--------
Q 005355 537 GASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQ-FT-----EKSDVYSFGVVLVELLTGQKPIRSTDSEED-------- 601 (700)
Q Consensus 537 Gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~s-----~ksDVwSlG~il~elltg~~p~~~~~~~~~-------- 601 (700)
||+..+...... .....+||.+|||||++.+.- +. .+.||||+|++||||++.-..+......+-
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999887644322 233467999999999997642 22 368999999999999997554431111110
Q ss_pred --hhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 602 --KSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 602 --~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
....+.+....-..+.+..+..... ....+..+.+.+..||..|++.|.|+.=+.+.+.++.....
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~---~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWR---KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhh---cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 0011111111111111111111111 12456678999999999999999999999888877765443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=347.25 Aligned_cols=257 Identities=28% Similarity=0.480 Sum_probs=214.8
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
.+++..+.+..++-||.|+.|.||+|++. ++.||||+.+... ..+|+.|++|+|+||+.|.|+|...--++|
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence 34555666677789999999999999997 7899999876432 246788999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+..|.|..+|+..+ +++...+..|..+||.||.|||.+. |||||||.-||||+.+..|||+|||-++...
T Consensus 190 iMEfCa~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred eeeccccccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhh
Confidence 999999999999998765 3899999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
.. ...-.+.||..|||||++.+.+.++|+|||||||+|||||||..||...+.... +..+-..
T Consensus 264 ~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------------IwGVGsN 326 (904)
T KOG4721|consen 264 DK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------------IWGVGSN 326 (904)
T ss_pred hh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---------------EEeccCC
Confidence 33 223346799999999999999999999999999999999999999976543221 1111111
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCC
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGD 671 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~ 671 (700)
.+.-..+...+..+.-|+++||+..|..||++++++..|+-..+.+..
T Consensus 327 sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~ 374 (904)
T KOG4721|consen 327 SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLS 374 (904)
T ss_pred cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhc
Confidence 222233456677889999999999999999999999999887766543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=346.55 Aligned_cols=256 Identities=26% Similarity=0.376 Sum_probs=212.6
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc----Ch-hhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCC
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV----DE-SNIEQFINEVAILSQIN-HRNVVKLLGCCLETE 459 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 459 (700)
...++|.+.+.||+|.||+|++|... .++.||+|++... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 44678999999999999999999865 6899999976542 11 33456778999999998 999999999999999
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEeecCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGA 538 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~-~~~kl~DfGl 538 (700)
..++||||+.+|+|.+++.... .+.+.++..+++||+.|++|||+++ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999998843 3899999999999999999999999 9999999999999999 9999999999
Q ss_pred CcccccCCceeeeeeecccccccccccccCC-CC-cccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcc
Q 005355 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ-FT-EKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR 616 (700)
Q Consensus 539 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 616 (700)
+.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||...+... +...+..+.
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-------l~~ki~~~~ 239 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-------LYRKIRKGE 239 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-------HHHHHhcCC
Confidence 98664 3444566778999999999999977 76 78999999999999999999998633221 111122222
Q ss_pred hhhhcchhhhhccCHHH-HHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 617 LFEVLDARVLKEAKEEE-IITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 617 ~~~~~d~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
+ ..+... ..++..|+.+||..+|.+|+++.+++ .-.-++.
T Consensus 240 ~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 240 F----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred c----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 1 111222 66789999999999999999999999 5555554
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=335.13 Aligned_cols=246 Identities=22% Similarity=0.382 Sum_probs=201.3
Q ss_pred ceEeeeCCeEEEEEEEcCCcEEEEEEccccChhh---HHHHHHHHHHHhhcCCCceeeEEeEEEe----CCcceEEEeeC
Q 005355 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESN---IEQFINEVAILSQINHRNVVKLLGCCLE----TEVPLLVYEFI 468 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~E~~ 468 (700)
..||+|+++.||+|++ +++.||||+++...... .+.|.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999998 48999999987543322 5778899999999999999999999877 34678999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
++|+|.+++.... .+++...+.++.|++.||+|||+. + ++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999997653 389999999999999999999985 6 7899999999999999999999999987543221
Q ss_pred eeeeeeeccccccccccccc--CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ...+..+...
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-------~~~i~~~~~~------- 240 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-------YDLIINKNNS------- 240 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhcCCC-------
Confidence 23457889999999976 6899999999999999999999999986543221 1111111100
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
...+...+..+.+|+.+||+.||++|||++|+++.|+.++.
T Consensus 241 -~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 241 -LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 01122345678999999999999999999999999998875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=349.62 Aligned_cols=268 Identities=29% Similarity=0.457 Sum_probs=220.8
Q ss_pred hHHHHHHhcCCCccceEeeeCCeEEEEEEEcC--C--cE-EEEEEccc---cChhhHHHHHHHHHHHhhcCCCceeeEEe
Q 005355 382 SMELEMATDNFNTNRILGQGGQGTVYKGMLTN--G--RI-VAIKKSKL---VDESNIEQFINEVAILSQINHRNVVKLLG 453 (700)
Q Consensus 382 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 453 (700)
...++...++..+.++||+|+||.||+|+++. + .. ||||..+. .......+|.+|+++|++++|||||+++|
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34456666777788999999999999999763 2 23 89998774 45777899999999999999999999999
Q ss_pred EEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEE
Q 005355 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKV 533 (700)
Q Consensus 454 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl 533 (700)
+.......++|||++.+|+|.++|++... .++..+++.++.++|.||+|||+++ ++||||.++|+|++.+..+||
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKI 303 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKI 303 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEe
Confidence 99999999999999999999999998765 3999999999999999999999999 999999999999999999999
Q ss_pred eecCCCcccccCCceeee-eeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHH
Q 005355 534 SDFGASRSVMIDQTHLTT-RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEA 611 (700)
Q Consensus 534 ~DfGl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 611 (700)
+|||+++... ...... ...-+..|+|||.+....++.++|||||||++||+++ |..||.+....+ ....
T Consensus 304 SDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-------v~~k 374 (474)
T KOG0194|consen 304 SDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-------VKAK 374 (474)
T ss_pred CccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-------HHHH
Confidence 9999997542 111111 2235679999999999999999999999999999999 888998766543 1222
Q ss_pred HHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCC
Q 005355 612 MKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGD 671 (700)
Q Consensus 612 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~ 671 (700)
+..+. .....+...+..+..++.+|+..+|++||+|.++.+.|+.+......
T Consensus 375 I~~~~--------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 375 IVKNG--------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHhcC--------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 21111 11122234556788899999999999999999999999998876554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=336.90 Aligned_cols=255 Identities=26% Similarity=0.353 Sum_probs=209.0
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
+...++|++++.||+|+||.||+++.+ .|+.+|+|+++.. ...+.+.++.|-.+|....+++||+|+..|.+.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 445789999999999999999999965 6999999998763 345678889999999999999999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
||||||++||++..+|.+.. .|++..+..++.+++-|+..||+.| +|||||||+|+|||..|++||+||||+..
T Consensus 217 YLiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999998765 4999999999999999999999999 99999999999999999999999999864
Q ss_pred ccc-----------------------CCc-----e------------------eeeeeecccccccccccccCCCCcccc
Q 005355 542 VMI-----------------------DQT-----H------------------LTTRVQGTFGYLDPEYFRSSQFTEKSD 575 (700)
Q Consensus 542 ~~~-----------------------~~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~s~ksD 575 (700)
+.. +.. . .....+|||.|||||++.+..|+...|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 321 000 0 011245999999999999999999999
Q ss_pred eehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCC-
Q 005355 576 VYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT- 654 (700)
Q Consensus 576 VwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs- 654 (700)
.||||||+||||.|.+||....+.+--..+..+...+. .........+..+||.++|. ||++|.-
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-------------fP~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-------------FPEEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-------------CCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 99999999999999999998877653211111111111 01112233678899999999 9999976
Q ss_pred --HHHHHH
Q 005355 655 --MKEAAF 660 (700)
Q Consensus 655 --~~evl~ 660 (700)
++||-+
T Consensus 437 ~G~~EIK~ 444 (550)
T KOG0605|consen 437 KGAEEIKK 444 (550)
T ss_pred ccHHHHhc
Confidence 555544
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=334.64 Aligned_cols=268 Identities=24% Similarity=0.376 Sum_probs=219.7
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDES-NIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
.+.+.+...+.++||+|-||.|.+.+...+.+||||+++..... .+.+|.+|+++|.+++||||++++|+|..++...+
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 45667788899999999999999999988899999999875544 45899999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
|+|||++|+|.++|..+.... +......+|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||+++.+.
T Consensus 613 I~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999998875332 455666789999999999999999 9999999999999999999999999999776
Q ss_pred cCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh--CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 544 IDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT--GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 544 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
..+.+ .....+-+.+|||+|.+..++++.++|||+||++|||+++ .+.||.....+.. ++.......... ..
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~-~~- 763 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQG-RQ- 763 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCC-cc-
Confidence 55544 3345566889999999999999999999999999999866 7889865443321 221111111111 11
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
..-..+.-.+..+.+++.+||+.+.++||+++++...|.+.
T Consensus 764 ----~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 ----VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ----eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11122445667888999999999999999999999988654
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=331.79 Aligned_cols=256 Identities=21% Similarity=0.354 Sum_probs=208.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc----CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT----NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
.++|++.++||+|+||.||+|.+. .+..||+|.++... ......+.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 467899999999999999999864 35689999987643 3445678999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++|+|.+++..... .+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999986532 4899999999999999999999999 9999999999999999999999999876532
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
...........++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ....+..+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~----- 226 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGFR----- 226 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCC-----
Confidence 221111112334678999999999999999999999999999875 999997654322 1222222211
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
...+...+..+.+++.+||+.+|.+||+++++++.|+++
T Consensus 227 ----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 ----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011233456789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=326.81 Aligned_cols=247 Identities=25% Similarity=0.424 Sum_probs=213.2
Q ss_pred hcCCCccceEeeeCCeEEEEEEE-cCCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGML-TNGRIVAIKKSKL---VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
..+|++.+.||+|.||.|-+|.. ..|+.||||.++. .++++.-.+++|++||..|+||||+.++.+|...+..+||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 46788889999999999999995 6899999997653 5566777899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||..+|.|.||+..... |++.++..+++||+.|+.|+|+++ ++|||||.+|||||.|+++||+||||+..+.
T Consensus 132 MEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~- 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA- 204 (668)
T ss_pred EEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc-
Confidence 999999999999987654 999999999999999999999999 9999999999999999999999999997653
Q ss_pred CCceeeeeeecccccccccccccCCCC-cccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
......+++|++-|.+||++.+.+|. ..+|-||||++||.|+.|..||++.+... +...+..+...+.
T Consensus 205 -~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-------lvrQIs~GaYrEP--- 273 (668)
T KOG0611|consen 205 -DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-------LVRQISRGAYREP--- 273 (668)
T ss_pred -cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-------HHHHhhcccccCC---
Confidence 33445678899999999999999885 78999999999999999999998775332 3344454444332
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
+.+....-||++||..||++|.|+.+|...
T Consensus 274 --------~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 274 --------ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred --------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 223345569999999999999999998764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=336.52 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=213.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
...|+.++.||+|.||.||+|.+. .++.||+|++.... ....+++.+|+.+|.+++++||.+.++.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 456777789999999999999975 68899999988643 4457889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+.+|++.+.|+... .+.+..+..++++++.||.|||.++ .+|||||+.|||+..+|.+||+|||.+..+....
T Consensus 92 y~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999998654 2588888899999999999999999 9999999999999999999999999998765444
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
... .+.+||+.|||||++....|+.|+||||||++.+||++|.+|+....+.. ..-++.+..+
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~P 228 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAP 228 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCC
Confidence 433 67789999999999998899999999999999999999999997654421 1222222222
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..........+.+++..||..||+.||++.++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 3333466777999999999999999999999886
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.40 Aligned_cols=264 Identities=24% Similarity=0.385 Sum_probs=205.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcC-----------------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTN-----------------GRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVK 450 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 450 (700)
.++|++.++||+|+||.||++.+.+ +..||+|.+... .......|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 5678999999999999999998542 336999988754 3444678999999999999999999
Q ss_pred EEeEEEeCCcceEEEeeCCCCCHHHHHhccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 005355 451 LLGCCLETEVPLLVYEFIPNGTLYQYIHDQTE----------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIY 514 (700)
Q Consensus 451 l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iv 514 (700)
+++++.+.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999999865321 124788999999999999999999999 99
Q ss_pred ecCCCCCcEEECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh--CCC
Q 005355 515 HRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT--GQK 591 (700)
Q Consensus 515 H~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt--g~~ 591 (700)
||||||+|||++.++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999765332221 2223345788999999998899999999999999999987 567
Q ss_pred CCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 592 PIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 592 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
||......+. ............. ......+...+..+.+|+.+||+.+|++|||+.+|.+.|++
T Consensus 241 p~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDEQV---IENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHHHH---HHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7765443221 1111111111000 00011122345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=338.08 Aligned_cols=246 Identities=27% Similarity=0.424 Sum_probs=211.0
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
++|.+.+.||+|.||.||||+-+ +.+.||+|.+.. ..+...+.+++|++|++.++||||+.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999965 688999998765 344567889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+.+ +|..+|..... ++++.+..++.+++.||.|||+.+ |+|||+||.|||++..+.+|++|||+++.+.. .
T Consensus 82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N 153 (808)
T ss_pred hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence 9966 99999987654 999999999999999999999999 99999999999999999999999999997643 4
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
....+.+.||+-|||||.+.+..|+..+|+||+|||+|||+.|++||-..... ...+.+..+..
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~-------~Lv~~I~~d~v--------- 217 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT-------QLVKSILKDPV--------- 217 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH-------HHHHHHhcCCC---------
Confidence 55667788999999999999999999999999999999999999999633211 11122211111
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+......+..+++..|..||.+|.+..+++.
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 113356678899999999999999999999886
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=327.92 Aligned_cols=257 Identities=22% Similarity=0.412 Sum_probs=210.6
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
..++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++.+.+.+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 4578899999999999999999988888999998765332 357899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.++++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999999999976432 24889999999999999999999999 99999999999999999999999999986543322
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
.......++..|+|||++....++.++||||||+++|+|++ |..||......+ ....+......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~-------- 223 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGYRM-------- 223 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCC--------
Confidence 22223345678999999998899999999999999999998 999997543322 11111111100
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
......+..+.+++.+||..+|++||+++++++.|+++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 -PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=345.25 Aligned_cols=264 Identities=26% Similarity=0.410 Sum_probs=209.4
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhc-CCCceeeEEeEE
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVD-ESNIEQFINEVAILSQI-NHRNVVKLLGCC 455 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 455 (700)
++....++|++.+.||+|+||.||+|++. .+..||||+++... ....+.+.+|+.++..+ +||||+++++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 34555678999999999999999999742 35689999987432 33456789999999999 899999999999
Q ss_pred EeCCcceEEEeeCCCCCHHHHHhccCC-----------------------------------------------------
Q 005355 456 LETEVPLLVYEFIPNGTLYQYIHDQTE----------------------------------------------------- 482 (700)
Q Consensus 456 ~~~~~~~lv~E~~~~gsL~~~l~~~~~----------------------------------------------------- 482 (700)
.+.+..++||||+++|+|.++++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 999999999999999999999975321
Q ss_pred -------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 483 -------------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 483 -------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 124788999999999999999999999 9999999999999999999999999997654
Q ss_pred cCCcee-eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 544 IDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 544 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
...... .....++..|+|||++.+..++.++||||||+++|||++ |..||........ +...+..+..
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~------~~~~~~~~~~---- 335 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK------FYKMIKEGYR---- 335 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH------HHHHHHhCcc----
Confidence 322211 112334567999999999999999999999999999998 8889875433221 1122222111
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
...+...+.++.+|+.+||+.||++||++.|++++|++.
T Consensus 336 -----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 -----MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 011112345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=343.61 Aligned_cols=246 Identities=28% Similarity=0.385 Sum_probs=209.2
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCC
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQIN-HRNVVKLLGCCLETE 459 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 459 (700)
.....++|.++++||+|.||+|+++..+ +++.+|||.++.. ...+.+....|.+|+...+ ||.++.++.+|...+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3455688999999999999999999987 5789999988763 3556788899999998875 999999999999999
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
+.++||||+.||++..+.+.. .+++..+..++..|+.||+|||+++ |||||||.+|||||.+|.+||+|||++
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred eEEEEEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence 999999999999954444433 2999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
+..... ...+.+.+||+.|||||++.+..|+.++|.|||||+|||||.|+.||.+.++++. ...+...
T Consensus 516 Ke~m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-------FdsI~~d---- 583 (694)
T KOG0694|consen 516 KEGMGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-------FDSIVND---- 583 (694)
T ss_pred cccCCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHhcC----
Confidence 875433 3356778999999999999999999999999999999999999999998876652 1111111
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCH
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTM 655 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~ 655 (700)
. -.++...+.+.+.|++++|..+|++|.-+
T Consensus 584 ----~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 ----E--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----C--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1 12344556778899999999999999876
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=329.71 Aligned_cols=251 Identities=25% Similarity=0.329 Sum_probs=203.0
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|+||+++++.+.+.+..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4778899999999999999965 78999999876422 2234567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999988865432 24899999999999999999999999 9999999999999999999999999997643221
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
......|+..|+|||++.+..++.++||||||+++|||++|+.||.......... ......... .
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~~~----------~ 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVKED----------Q 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhhcc----------c
Confidence 2233468999999999999999999999999999999999999998654322111 111111110 0
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPT-----MKEAAF 660 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~ 660 (700)
...+...+..+.+|+.+||+.||++||+ ++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1122334567889999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.10 Aligned_cols=265 Identities=23% Similarity=0.253 Sum_probs=204.0
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
++|++.+.||+|+||.||+++++ +++.||||+++... ....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999986 57899999876532 3345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|++++.|..+.... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99987776554332 23899999999999999999999999 9999999999999999999999999998654333
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH--------HH-HHhcch
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL--------EA-MKENRL 617 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~-~~~~~~ 617 (700)
........+++.|+|||++.+..++.++||||||+++|||++|+.||......+......... .. ......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 333334568999999999999899999999999999999999999998654332211111100 00 000000
Q ss_pred hhhcchhh------hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 FEVLDARV------LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ~~~~d~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.....+.. ........+..+.+|+++||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 00011123457999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=340.61 Aligned_cols=254 Identities=28% Similarity=0.479 Sum_probs=214.1
Q ss_pred CccceEeeeCCeEEEEEEEc-CC----cEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 393 NTNRILGQGGQGTVYKGMLT-NG----RIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 393 ~~~~~lG~G~fg~Vy~~~~~-~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
+..++||+|+||+||+|.|- .+ -+||||++.. ...+..+++++|+-+|.+++|||+++|++++.... +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 45689999999999999964 33 3689997654 34455688999999999999999999999998776 789999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
||+.|+|.|+++.++.+ +-.+..+.|..|||+||.|||.++ ++||||..+|||+..-..+||.|||+++.+..+.
T Consensus 778 ~mP~G~LlDyvr~hr~~--igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDN--IGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHhhcc--ccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999987654 888999999999999999999999 9999999999999999999999999999887665
Q ss_pred ceeeee-eecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 547 THLTTR-VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 547 ~~~~~~-~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
...... ..-.+.|||-|.+....++.++|||||||++|||+| |..|+.+...++..++.+ .+
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~g--------- 916 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------KG--------- 916 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------cc---------
Confidence 554332 334668999999999999999999999999999999 999999887766433322 11
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
..-..+.....++..++.+||..|+..||+++++..++.++...
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 11223455677899999999999999999999999998776543
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=324.44 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=205.8
Q ss_pred cCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCC
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIP 469 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 469 (700)
++|++.+.||+|+||.||++.++++..+|+|.+.... ...+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 5688889999999999999999888899999876432 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee
Q 005355 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549 (700)
Q Consensus 470 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~ 549 (700)
+|+|.++++.... .+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999976432 3899999999999999999999999 9999999999999999999999999987653322222
Q ss_pred eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhc
Q 005355 550 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE 628 (700)
Q Consensus 550 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 628 (700)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+..+.. ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~-------~~~i~~~~~--~~------- 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV-------VEMISRGFR--LY------- 221 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCC--CC-------
Confidence 222335668999999998899999999999999999999 8999975543221 111221111 00
Q ss_pred cCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 629 AKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 629 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
.+...+..+.+|+.+||+.+|++||++.|+++.|.
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11123456899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=326.41 Aligned_cols=256 Identities=28% Similarity=0.442 Sum_probs=209.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
..+|++.+.||+|+||.||+|.++ .++.||+|++... ....+.+.+|++++++++|+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 456888899999999999999976 5889999987753 33457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++..... ..+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999976432 34899999999999999999999999 99999999999999999999999999976543322
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
........+..|+|||++.+..++.++||||||+++|||++ |..||.....++. ....... ..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~---------~~ 223 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKG---------YR 223 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCC---------CC
Confidence 22222334668999999999999999999999999999998 9999876543321 1111111 01
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
.+.+...+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 112233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=324.87 Aligned_cols=258 Identities=24% Similarity=0.407 Sum_probs=210.6
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
...++|++.+.||+|++|.||+|.+.+++.||+|.++... ...+.+.+|+.++++++|+||+++++++...+..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 3457799999999999999999998778899999987543 234678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999997654 234899999999999999999999999 9999999999999999999999999998664222
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
.........+..|+|||++.+..++.++||||||++++||++ |+.||......+ ....+.....
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~-------- 222 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGYR-------- 222 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC--------
Confidence 111111223457999999999999999999999999999999 999997554222 1111211110
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
...+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 223 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 -MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 011223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.28 Aligned_cols=264 Identities=27% Similarity=0.450 Sum_probs=209.5
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEE
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLV-DESNIEQFINEVAILSQI-NHRNVVKLLGCCL 456 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 456 (700)
+....++|++.+.||+|+||.||++++. ++..||||+++.. .....+.+.+|+++++.+ +|+||+++++++.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3455678999999999999999999853 2357999998753 334456789999999999 8999999999999
Q ss_pred eCCcceEEEeeCCCCCHHHHHhccCC------------------------------------------------------
Q 005355 457 ETEVPLLVYEFIPNGTLYQYIHDQTE------------------------------------------------------ 482 (700)
Q Consensus 457 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------ 482 (700)
+.+..++||||+++|+|.++++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 99999999999999999999864321
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce-
Q 005355 483 -------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH- 548 (700)
Q Consensus 483 -------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~- 548 (700)
..++++..+++++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 124788999999999999999999999 999999999999999999999999999765332221
Q ss_pred eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 549 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......++..|+|||++....++.++||||||+++|||++ |+.||........ +......+. ..
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~---------~~ 334 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGY---------QM 334 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHccc---------Cc
Confidence 1122335668999999999999999999999999999997 9999975433221 111111110 00
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
..+...+.++.+++.+||+.+|.+||++.+++++|+++.
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 111123467889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=327.49 Aligned_cols=262 Identities=26% Similarity=0.320 Sum_probs=208.2
Q ss_pred cchHHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--------------hhhHHHHHHHHHHHhhcC
Q 005355 380 FTSMELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--------------ESNIEQFINEVAILSQIN 444 (700)
Q Consensus 380 ~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~ 444 (700)
+...+-.+..++|++.+.||+|.||.|-+|+.. +++.||||++.... ....++..+|+.+|++++
T Consensus 87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 344455566799999999999999999999965 78999999865421 123568999999999999
Q ss_pred CCceeeEEeEEEe--CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 005355 445 HRNVVKLLGCCLE--TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSAN 522 (700)
Q Consensus 445 h~niv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~N 522 (700)
|+|||+|+++..+ .+..|||+||+..|.+...--.... +++.++++++++++.||.|||.++ |+||||||.|
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~e---ls~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsN 240 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPE---LSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSN 240 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCccc---ccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhh
Confidence 9999999999875 4688999999998877654333221 899999999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCCCcccccC----CceeeeeeecccccccccccccCC----CCcccceehHHHHHHHHHhCCCCCC
Q 005355 523 ILLDDKYRAKVSDFGASRSVMID----QTHLTTRVQGTFGYLDPEYFRSSQ----FTEKSDVYSFGVVLVELLTGQKPIR 594 (700)
Q Consensus 523 ILl~~~~~~kl~DfGl~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlG~il~elltg~~p~~ 594 (700)
+||+++|++||+|||.+..+... .........||+.|+|||...+.. -+.+.||||+||+||.|+.|+.||.
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 99999999999999999765221 111223367999999999987632 3468899999999999999999997
Q ss_pred CCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005355 595 STDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662 (700)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L 662 (700)
+....+- ...++...+......++..++.+||++||..||+.|.+..+|....
T Consensus 321 ~~~~~~l---------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 321 DDFELEL---------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred cchHHHH---------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 5543221 1223333332333345667899999999999999999999998765
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.53 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=214.2
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.+..+|++.++||+|+||.||+|.+.+++.+++|.+..........+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567899999999999999999998899999999887766667789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|.+++..... ..+++..++.++.||+.||+|||+++ ++|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999987532 34899999999999999999999999 9999999999999999999999999997653322
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
. ......++..|+|||++....++.++||||||+++++|++ |+.||......+. ...+..+.
T Consensus 159 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~-------~~~~~~~~--------- 221 (261)
T cd05148 159 Y-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV-------YDQITAGY--------- 221 (261)
T ss_pred c-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH-------HHHHHhCC---------
Confidence 1 1223335678999999998899999999999999999998 8999975542221 11111110
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
....+...+..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0111233456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.76 Aligned_cols=265 Identities=22% Similarity=0.261 Sum_probs=208.4
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChh--hHHHHHHHHHHHhhcCCCceeeEEeEEEeC--CcceE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDES--NIEQFINEVAILSQINHRNVVKLLGCCLET--EVPLL 463 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 463 (700)
.++|+.++.|++|+||.||+|+++ +++.||+|+++...+. ..-.-++|+.+|.+.+|||||.+..+.... +..||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 356788899999999999999976 7899999998864432 233468999999999999999999987643 57899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||++. +|..++..... ++...++.-++.|+++|++|||++. |+|||||++|+|+++.|.+||+|||+|+.+.
T Consensus 155 VMe~~Eh-DLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999955 89999988763 4889999999999999999999999 9999999999999999999999999999875
Q ss_pred cCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch-----
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL----- 617 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 617 (700)
.. ....+..+.|++|.|||.+.+ ..|+++.|+||+|||+.||+.+++.|.+....+..+.+-..+....+..|
T Consensus 229 sp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 229 SP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred CC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 44 334566778999999999887 46999999999999999999999999887654433222211111111111
Q ss_pred ---------hhhcchhhhhccCHH-HHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 ---------FEVLDARVLKEAKEE-EIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ---------~~~~d~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.......+...+... ....-.+|+..+|..||.+|.|++|.|+
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 111111122222221 3456788999999999999999999886
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=337.30 Aligned_cols=247 Identities=27% Similarity=0.398 Sum_probs=212.8
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
+-|++.+.||+|+-|.|-+|++. .|+.+|||++... .......+.+|+.||+.+.|||++++++++.+..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45788899999999999999975 7999999987643 3344567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++|.|+++|-.+.. +++.++.+++.||+.|+.|+|+.+ |+||||||+|+|||...++||+|||+|..- .
T Consensus 92 Eyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe--~ 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE--V 163 (786)
T ss_pred EecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc--c
Confidence 99999999999987653 999999999999999999999999 999999999999999999999999999753 3
Q ss_pred CceeeeeeecccccccccccccCCCC-cccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
......+.+|.+-|.|||++.+..|. .++||||.|||||.||+|+.||++.+.. .++..++.|.+
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir-------~LLlKV~~G~f------- 229 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR-------VLLLKVQRGVF------- 229 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH-------HHHHHHHcCcc-------
Confidence 44556677899999999999999885 7999999999999999999999854322 23333444443
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
+.+...+.+..+|+.+||..||++|.|++||++.
T Consensus 230 ---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 ---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2244566788999999999999999999999984
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.74 Aligned_cols=265 Identities=23% Similarity=0.321 Sum_probs=202.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.++|++.++||+|+||.||+|..+ +++.||+|+++... ......+.+|++++++++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 357899999999999999999976 68899999876432 2334567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|++ ++|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 84 YLD-SDLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCC-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 997 599999875432 3789999999999999999999999 9999999999999999999999999987543222
Q ss_pred ceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch--------
Q 005355 547 THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL-------- 617 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 617 (700)
. ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+................+
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 1 2233457899999999865 56899999999999999999999999876544322211111000000000
Q ss_pred -hhhcchhh----hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 -FEVLDARV----LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 -~~~~d~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.....+.. ..........+..+|+.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000 00001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=336.74 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=206.6
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.+.||+|+||.||+|++. +++.||||+++.. .......+.+|++++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999976 5889999987643 2234567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999997653 3899999999999999999999999 99999999999999999999999999975432
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
......||+.|+|||++.+..++.++||||||+++|||++|..||......+.... +... ...+....
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~-------i~~~--~~~~~~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN-------LKYW--KETLQRPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH-------HHhc--cccccCCC
Confidence 23345689999999999999999999999999999999999999986554332111 1110 00011000
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
........+.++.+|+.+||..+|.+||+++++++.
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 010012345678899999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=336.92 Aligned_cols=265 Identities=28% Similarity=0.442 Sum_probs=230.2
Q ss_pred hHHHHHHhcCCCccceEeeeCCeEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc
Q 005355 382 SMELEMATDNFNTNRILGQGGQGTVYKGMLTN-GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEV 460 (700)
Q Consensus 382 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 460 (700)
.++++....++.+..+||-|-||.||.|.|+. .-.||||.++.. ....++|+.|+.+|+.++|||+|+|+|+|..+-.
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 36677778888999999999999999999973 567999998864 4456899999999999999999999999999999
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.|||.|||..|+|.+||+...+. .++.-.++.++.||..||.||..++ +|||||..+|+|+.++..|||+||||++
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999999987543 3788889999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
.+..+.........-+..|.|||-+....++.|+|||+|||+|||+.| |..||.+.+..+. ..
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV----------------Y~ 477 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------------YG 477 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH----------------HH
Confidence 887766665555566789999999999999999999999999999998 8899987654332 22
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
++......+.+..+++.+.+|+++||++.|.+||++.|+-+.|+.+-.
T Consensus 478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 333333345567788899999999999999999999999999977643
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=335.09 Aligned_cols=246 Identities=26% Similarity=0.337 Sum_probs=203.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|++.+.||+|+||.||++++. +++.||||.+... .....+.+.+|+.++++++||||+++++.+.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 467899999999999999999976 5889999987643 223456788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++.....
T Consensus 97 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999998653 3889999999999999999999999 99999999999999999999999999976532
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
. .....|++.|+|||++.+..++.++||||||+++|||++|..||......+ ....+..+.+
T Consensus 171 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~~------- 232 (329)
T PTZ00263 171 R----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-------IYEKILAGRL------- 232 (329)
T ss_pred C----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-------HHHHHhcCCc-------
Confidence 2 223468999999999999999999999999999999999999997544321 1112222211
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPT-----MKEAAFE 661 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~ 661 (700)
..+......+.+|+.+||+.||.+||+ +++++..
T Consensus 233 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 ---KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111123456789999999999999997 6777643
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.44 Aligned_cols=245 Identities=24% Similarity=0.351 Sum_probs=203.5
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47889999999999999999976 68899999876432 234567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999997654 3899999999999999999999999 999999999999999999999999998765321
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
.....|++.|+|||++.+..++.++||||||+++|+|++|+.||......+. ...+..+..
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-------~~~i~~~~~-------- 215 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI-------YEKILAGKL-------- 215 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCc--------
Confidence 2234589999999999999999999999999999999999999976543221 111111111
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPT-----MKEAAFE 661 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~~ 661 (700)
..+......+.+|+++||+.||.+||+ ++|+++.
T Consensus 216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 112223456889999999999999995 7777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=318.81 Aligned_cols=267 Identities=25% Similarity=0.346 Sum_probs=210.6
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcc--ccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe-----CC
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSK--LVDESNIEQFINEVAILSQINHRNVVKLLGCCLE-----TE 459 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 459 (700)
....|...+.||+|+||.|..+..+ +|+.||||++. -......++..+|+.+|+.++|+||+.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456666899999999999999976 78999999987 3455667889999999999999999999999875 35
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
..|+|+|+| ..+|...|+.... ++.++...++.||++||.|+|+.+ ++||||||.|+|++.+..+||+|||++
T Consensus 100 DvYiV~elM-etDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 679999999 6799999986643 999999999999999999999999 999999999999999999999999999
Q ss_pred cccccC-Cceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH--------
Q 005355 540 RSVMID-QTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL-------- 609 (700)
Q Consensus 540 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-------- 609 (700)
+..... .....+..+.|.+|.|||++.. ..|+.+.||||.||||.||++|++-|.+.+......+.....
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 976432 2233456678999999998754 689999999999999999999999999887554333332221
Q ss_pred HHHHhcchhhhcc------hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 610 EAMKENRLFEVLD------ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 610 ~~~~~~~~~~~~d------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..+...+....+. +......-....+...+|+.+||..||.+|+|++|+++.
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111111111111 000011112344568899999999999999999999874
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=334.89 Aligned_cols=261 Identities=28% Similarity=0.409 Sum_probs=207.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.++|++.+.||+|+||.||++++. ++..||+|.+... .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 578999999999999999999976 6788999987753 33445789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
|+++++|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999997654 389999999999999999999985 5 999999999999999999999999998755322
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHH---h--------
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK---E-------- 614 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~-------- 614 (700)
......++..|+|||++.+..++.++||||||+++|||++|+.||...+..+..... ..... .
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF---GRPVVDGEEGEPHSISP 231 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh---cccccccccCCccccCc
Confidence 223346899999999999999999999999999999999999999755432211100 00000 0
Q ss_pred -------------------cchhhhcchh----hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 615 -------------------NRLFEVLDAR----VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 615 -------------------~~~~~~~d~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
....+..+.. ...........++.+|+.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 0000112345679999999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=332.97 Aligned_cols=241 Identities=24% Similarity=0.320 Sum_probs=199.4
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 471 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 471 (700)
+.||+|+||.||++... +++.||||+++.. .......+.+|++++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999975 6899999987642 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeee
Q 005355 472 TLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTT 551 (700)
Q Consensus 472 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~ 551 (700)
+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~ 153 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMK 153 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCccc
Confidence 9999997653 3899999999999999999999999 999999999999999999999999998753222 22233
Q ss_pred eeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCH
Q 005355 552 RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKE 631 (700)
Q Consensus 552 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 631 (700)
...||+.|+|||++.+..++.++||||||+++|||++|..||...+.... ...+..+.. ..+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-------~~~~~~~~~----------~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEEI----------RFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH-------HHHHHcCCC----------CCCC
Confidence 45699999999999999999999999999999999999999975443221 111111111 1123
Q ss_pred HHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005355 632 EEIITVAMLAKRCLNMIGKKRP-----TMKEAAF 660 (700)
Q Consensus 632 ~~~~~l~~li~~cl~~~p~~RP-----s~~evl~ 660 (700)
.....+.+|+.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 3456788999999999999999 7888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.30 Aligned_cols=249 Identities=37% Similarity=0.619 Sum_probs=197.1
Q ss_pred ccceEeeeCCeEEEEEEEc-----CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 394 TNRILGQGGQGTVYKGMLT-----NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 394 ~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+.+.||.|.||.||+|.+. .+..|+||.++.. .....+.|.+|++++++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 2568999999653 344578999999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++|+|.++|.... ...+++..++.++.||++||+|||+++ ++|++|+++|||+++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999999872 223899999999999999999999999 99999999999999999999999999986632222
Q ss_pred -eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 548 -HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 548 -~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
...........|+|||.+....++.++||||||+++|||++ |+.||......+ +...+.++....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-------~~~~~~~~~~~~------ 225 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-------IIEKLKQGQRLP------ 225 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-------HHHHHHTTEETT------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccccce------
Confidence 22333457789999999999999999999999999999999 788986553322 122222222111
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L 662 (700)
.+...+..+.+++.+||..+|++||++++++++|
T Consensus 226 ---~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ---IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1122355688899999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=304.77 Aligned_cols=267 Identities=25% Similarity=0.357 Sum_probs=217.0
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEE-EcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC----
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETE---- 459 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 459 (700)
+.+..++|++.+.||+|||+-||+++ ..+++.+|+|++......+.+..++|++..++++|||+++++++...+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 34557899999999999999999999 4578999999998877788899999999999999999999998876544
Q ss_pred -cceEEEeeCCCCCHHHHHhccCCCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 460 -VPLLVYEFIPNGTLYQYIHDQTEEF-PITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 460 -~~~lv~E~~~~gsL~~~l~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
..||+++|...|+|.+.+.....++ .+++.+.++|+.+|++||.+||... +|++||||||.|||+++.+.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence 3799999999999999998754433 5999999999999999999999988 469999999999999999999999999
Q ss_pred CCcccccCCceee--------eeeeccccccccccccc---CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHH
Q 005355 538 ASRSVMIDQTHLT--------TRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVG 606 (700)
Q Consensus 538 l~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~ 606 (700)
.+......-.... ....-|..|.|||.+.- ...++++|||||||+||+|+.|..||+..-..
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~------- 247 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ------- 247 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-------
Confidence 9876542211110 11235789999999854 46789999999999999999999999643221
Q ss_pred HHHHHHHhcch-hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 607 YFLEAMKENRL-FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 607 ~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
.+.+ ..+...++........++.+.+|+++||+.||.+||++.+++..++.+.
T Consensus 248 -------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 -------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111 1222323333333447788999999999999999999999999998764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=325.66 Aligned_cols=258 Identities=29% Similarity=0.483 Sum_probs=210.4
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcC------CcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTN------GRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
.++|++.+.||+|+||.||+|.+.. ...||+|.+.... ......|.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 3578899999999999999998643 2579999886533 34456789999999999999999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC
Q 005355 462 LLVYEFIPNGTLYQYIHDQTE-------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK 528 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~ 528 (700)
+++|||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence 999999999999999976421 134889999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHH
Q 005355 529 YRAKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVG 606 (700)
Q Consensus 529 ~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~ 606 (700)
+.+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------ 234 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------ 234 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH------
Confidence 9999999999976533222 12233446788999999998899999999999999999998 999997654332
Q ss_pred HHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 607 YFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 607 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
....+..+.. ...+...+..+.+|+.+||+.+|.+||+++||++.|+.+
T Consensus 235 -~~~~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 235 -VIEMIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -HHHHHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1122222211 112334567899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=301.14 Aligned_cols=250 Identities=26% Similarity=0.369 Sum_probs=210.6
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
..++|++.+.||+|.||.||.|+.+ ++-.||+|++.... .....++++|++|-+.|+||||++++++|.+....+|
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4578999999999999999999966 67889999876422 2335678999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
++||.++|+|...|...... .+++.....++.|+|.||.|+|..+ ++||||||+|+|++.++.+||+|||.+....
T Consensus 100 ilEya~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999854332 3888999999999999999999999 9999999999999999999999999986432
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
.....+.+||..|++||+..+...+.++|+|++|++.||++.|.+||......+ ..+.+..- ++
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-------tYkrI~k~---~~--- 239 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-------TYKRIRKV---DL--- 239 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-------HHHHHHHc---cc---
Confidence 444566789999999999999999999999999999999999999997554222 11111111 11
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..+...+...+++|.+||..+|.+|.+..|+++.
T Consensus 240 ----~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 ----KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1234456678899999999999999999998863
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=320.73 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=205.7
Q ss_pred cCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCC
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIP 469 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 469 (700)
++|++.+.||+|+||.||+|.+.++..+|+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 56788899999999999999988777899998775332 34679999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee
Q 005355 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549 (700)
Q Consensus 470 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~ 549 (700)
+++|.+++..... .+++..++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999976433 4899999999999999999999999 9999999999999999999999999987654332222
Q ss_pred eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhc
Q 005355 550 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE 628 (700)
Q Consensus 550 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 628 (700)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||......+ ....+..+... .
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLRL---------Y 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCCC---------C
Confidence 222335678999999998889999999999999999998 999987554322 11111111111 0
Q ss_pred cCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 629 AKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 629 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
.+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11123467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=325.07 Aligned_cols=257 Identities=28% Similarity=0.480 Sum_probs=209.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcC------CcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTN------GRIVAIKKSKLVDES-NIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
.++|.+.+.||+|+||.||+|.+.+ ++.||||+++..... ..+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4568888999999999999998643 478999998765444 457899999999999999999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTE-----------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR 530 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~ 530 (700)
++||||+++++|.+++..... ...+++..+..++.|++.||+|||+++ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 999999999999999976421 234789999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHH
Q 005355 531 AKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYF 608 (700)
Q Consensus 531 ~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 608 (700)
+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||......+ .
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------~ 233 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------V 233 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------H
Confidence 99999999975433221 11223345788999999999999999999999999999998 999987554332 1
Q ss_pred HHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 609 LEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 609 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
...+..+... ..+...+..+.+++.+||+.+|++||++.|+++.|++
T Consensus 234 ~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 IECITQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1222222211 1122345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=320.02 Aligned_cols=256 Identities=24% Similarity=0.418 Sum_probs=208.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTN----GRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
.++|++.+.||+|+||.||+|.+.. ...||||.++.. .......|.+|+.++++++|+||+++++.+.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 4678999999999999999999752 457999987753 34445788999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
+|||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||++....
T Consensus 83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999976543 4899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 544 IDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 544 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+ ....+......
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~--- 227 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGYRL--- 227 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCC---
Confidence 22221 1122334678999999999999999999999999999998 999986543222 11122111110
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
..+...+..+.+|+.+||+.+|++||+++|+++.|+++
T Consensus 228 ------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=369.90 Aligned_cols=271 Identities=26% Similarity=0.429 Sum_probs=214.6
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
+.....+...++||+|+||.||+|++. ++..||||++...... ...|++++++++||||+++++++.+.+..++|
T Consensus 686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 333456788899999999999999974 7899999988653322 23468889999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++|+|.++++. ++|..+.+++.|+++||+|||+...++|+||||||+||+++.++..++. |+.......
T Consensus 762 ~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 762 HEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 999999999999963 8899999999999999999996644559999999999999999888875 665543221
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
. ....+++.|+|||++.+..++.|+||||||+++|||++|+.||..... .......|.............+++.
T Consensus 835 ~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 835 D-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred C-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcc
Confidence 1 123578999999999999999999999999999999999999954322 2233444444444334444455555
Q ss_pred hhh--ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCCc
Q 005355 625 VLK--EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSI 673 (700)
Q Consensus 625 ~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~ 673 (700)
+.. ..+.++..++.+++.+||+.+|++||+|+|++++|+++.+....+.
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~~ 959 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCV 959 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccccc
Confidence 432 2345667788999999999999999999999999998866544333
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.34 Aligned_cols=261 Identities=25% Similarity=0.420 Sum_probs=214.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
..+|.+.+.||+|+||.||+++.. ++..+++|.+........+.+.+|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 356888899999999999999853 34568999988766666778999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC
Q 005355 463 LVYEFIPNGTLYQYIHDQTE-------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY 529 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~ 529 (700)
+||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence 99999999999999976421 234899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHH
Q 005355 530 RAKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGY 607 (700)
Q Consensus 530 ~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 607 (700)
.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------- 233 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------- 233 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence 999999999975533221 12233446788999999999999999999999999999999 999987554332
Q ss_pred HHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 608 FLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 608 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
....+..+.... .+...+..+.+++.+||+.+|++||++++|+++|+++.+.
T Consensus 234 ~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 234 VIECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 112222222211 1122355788999999999999999999999999999664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.39 Aligned_cols=252 Identities=26% Similarity=0.363 Sum_probs=217.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc-ceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEV-PLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv 464 (700)
.++|..++++|+|+||.++..+++ +++.+++|++... .....+...+|+.++++++|||||.+.+.+.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 467889999999999999999876 6789999987653 33445578899999999999999999999999988 8999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|+|++||+|.+.|.+.+ ...++++.+..++.||+.|+.|||++. |+|||||+.|||++.+..|||+|||+++.+..
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999998876 345999999999999999999999888 99999999999999999999999999998765
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
+. ....+..||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+..+- +. +.. ..
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L---i~---ki~----------~~ 221 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL---IL---KIN----------RG 221 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH---HH---HHh----------hc
Confidence 54 345667899999999999999999999999999999999999999987765442 11 111 11
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.....+..+..++..|+..||+.+|+.||++.+++.+
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1234456778889999999999999999999999986
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.87 Aligned_cols=261 Identities=26% Similarity=0.442 Sum_probs=213.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 467889999999999999999852 34568999988766666788999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEE
Q 005355 463 LVYEFIPNGTLYQYIHDQT----------EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAK 532 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~k 532 (700)
+||||+++++|.+++.... ....+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999997543 1234899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHH
Q 005355 533 VSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLE 610 (700)
Q Consensus 533 l~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 610 (700)
|+|||++......... ......++..|+|||++.+..++.++||||||+++++|++ |..||......+ ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~ 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIE 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH
Confidence 9999999765332211 1222335778999999999999999999999999999998 899987554322 122
Q ss_pred HHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 611 AMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 611 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
.+..+.... .+...+..+.+|+.+||+.+|.+|||++|+++.|+++...
T Consensus 234 ~i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 CITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 222222111 1112345689999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=319.69 Aligned_cols=251 Identities=28% Similarity=0.436 Sum_probs=204.3
Q ss_pred cCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCC
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIP 469 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 469 (700)
.+|++.+.||+|+||.||++.++++..+|+|++..... ..+.+.+|++++++++|+||+++++++.+.+..++|+||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 45788899999999999999988777899998764322 23568899999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee
Q 005355 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549 (700)
Q Consensus 470 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~ 549 (700)
+++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999976543 4899999999999999999999999 9999999999999999999999999987653222211
Q ss_pred eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhc
Q 005355 550 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE 628 (700)
Q Consensus 550 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 628 (700)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+. ........ . ..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~-----~----~~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-------VESVSAGY-----R----LY 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-------HHHHHcCC-----c----CC
Confidence 122224467999999999999999999999999999999 8999975543221 11111110 0 01
Q ss_pred cCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005355 629 AKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662 (700)
Q Consensus 629 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L 662 (700)
.+...+..+.+|+.+||+.+|++|||+.|++++|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1223456789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.58 Aligned_cols=257 Identities=23% Similarity=0.411 Sum_probs=209.0
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
+..++|++.++||+|+||.||+|...+++.||+|.+..... ..+++.+|+.++++++|+|++++++.+ ..+..++++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEE
Confidence 44678999999999999999999988889999998875433 346789999999999999999999886 4567899999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|.+++..... ..+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999999876432 34899999999999999999999999 9999999999999999999999999997654222
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
........++..|+|||++....++.++||||||++++||++ |+.||......+ ....+..+..
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~-------- 221 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-------VIQNLERGYR-------- 221 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHHcCCC--------
Confidence 222223345678999999998899999999999999999999 999997554322 1111111110
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
...+...+..+.+++.+||+.+|++||+++++++.|+.+
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 222 -MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 011222345799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.49 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=206.6
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
..++|++.++||+|+||.||++...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3567899999999999999999988888899998875433 3467999999999999999999999875 4567999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999999999976432 24899999999999999999999999 99999999999999999999999999976543322
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||......+ ....+.... .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~---------~ 221 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-------VLEQVERGY---------R 221 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC---------C
Confidence 22222335678999999988899999999999999999999 899997543222 111111110 0
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
...+...+..+.+|+.+||..+|++|||+.++++.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.92 Aligned_cols=258 Identities=25% Similarity=0.478 Sum_probs=206.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGR----IVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
..+|++.+.||+|+||.||+|++. +++ .||||.++.. .....+.+.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 467899999999999999999964 333 4899998753 344567899999999999999999999998764 568
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+++||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999987543 3889999999999999999999999 999999999999999999999999999866
Q ss_pred ccCCceee-eeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 543 MIDQTHLT-TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 543 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
........ .....+..|+|||++.+..++.++||||||+++|||++ |..||......+. ......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~-- 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGERL-- 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHhCCCCC--
Confidence 43332221 12234678999999999999999999999999999998 9999975543221 1111111110
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
..+......+.+++.+||+.+|.+||++.+++..|..+...
T Consensus 231 -------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 231 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred -------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 01112345688899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.15 Aligned_cols=273 Identities=24% Similarity=0.410 Sum_probs=214.2
Q ss_pred cCCCccceEeeeCCeEEEEEEEcC-C--cEEEEEEccc-cChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLTN-G--RIVAIKKSKL-VDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~~-~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 464 (700)
++|++.+.||+|+||.||+|.+++ + ..+++|.++. ......+.+.+|++++.++ +||||+++++++.+.+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999999753 3 3578888774 3344557789999999999 799999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcE
Q 005355 465 YEFIPNGTLYQYIHDQTE-------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRA 531 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~ 531 (700)
+||+++++|.+++..... ...+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999975321 124889999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHH
Q 005355 532 KVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLE 610 (700)
Q Consensus 532 kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 610 (700)
||+|||++...... ........+..|+|||++....++.++||||||+++|||++ |..||......+. ..
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-------~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-------YE 229 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HH
Confidence 99999998643211 11111223557999999999899999999999999999997 9999975543221 11
Q ss_pred HHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCCccCCCCCccce
Q 005355 611 AMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSIMQHNCDDIDF 683 (700)
Q Consensus 611 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~~~~~~~~~~ 683 (700)
....+ .....+...+..+.+|+.+||+.+|.+||++.++++.|+.+.........+...+.-.+
T Consensus 230 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~~~~~~~~~~~ 293 (297)
T cd05089 230 KLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYVNMALFENFTY 293 (297)
T ss_pred HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccccchhhhhhcc
Confidence 11111 01111223445788999999999999999999999999998877666555444444333
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=323.18 Aligned_cols=259 Identities=27% Similarity=0.459 Sum_probs=207.3
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETE 459 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 459 (700)
...++|++.+.||+|+||.||+|.+. .+..||||++.... .....++.+|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999999854 24679999876432 334567899999999999999999999999999
Q ss_pred cceEEEeeCCCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEE
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTE-------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAK 532 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~k 532 (700)
..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 99999999999999999976322 124678899999999999999999999 99999999999999999999
Q ss_pred EeecCCCcccccCCcee-eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHH
Q 005355 533 VSDFGASRSVMIDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLE 610 (700)
Q Consensus 533 l~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 610 (700)
|+|||++.......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+ ...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~ 232 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLR 232 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH
Confidence 99999987553322211 112345778999999999999999999999999999999 788987554322 111
Q ss_pred HHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 611 AMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 611 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
........ ..+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 233 ~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 22221111 1122334578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.63 Aligned_cols=265 Identities=25% Similarity=0.395 Sum_probs=211.2
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcC-CCceeeEEeEEE
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVD-ESNIEQFINEVAILSQIN-HRNVVKLLGCCL 456 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 456 (700)
++...++|++.++||+|+||.||+|++. .+..||||++.... ....+.+.+|+++++++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 4455788999999999999999999863 13479999987533 344578999999999996 999999999999
Q ss_pred eCCcceEEEeeCCCCCHHHHHhccCC------------------------------------------------------
Q 005355 457 ETEVPLLVYEFIPNGTLYQYIHDQTE------------------------------------------------------ 482 (700)
Q Consensus 457 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------ 482 (700)
+.+..+|||||+++|+|.++|+....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999999999999875321
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 005355 483 ---------------------------------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANI 523 (700)
Q Consensus 483 ---------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NI 523 (700)
...+++..++.++.||++||+|||+.+ |+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence 123788889999999999999999999 99999999999
Q ss_pred EECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhh
Q 005355 524 LLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEED 601 (700)
Q Consensus 524 Ll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~ 601 (700)
|++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||........
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 9999999999999999765332221 1222346778999999999999999999999999999997 9999875432221
Q ss_pred hhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 602 KSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
+...+..+.. ...+...+..+.+++.+||+.+|++||++.+|.++|+++..
T Consensus 349 ------~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 ------FYNKIKSGYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ------HHHHHhcCCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1111221110 11122345678999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=336.05 Aligned_cols=260 Identities=23% Similarity=0.286 Sum_probs=199.6
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
...+|++.+.||+|+||.||++.+. .++.||+|+.. .+.+.+|++++++++||||+++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3467999999999999999999975 68899999754 2457899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
++. ++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 164 ~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 164 RYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred cCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 994 78988887643 3899999999999999999999999 9999999999999999999999999997533222
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhh----hhHHHHHHHHHHh--------
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED----KSLVGYFLEAMKE-------- 614 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~----~~~~~~~~~~~~~-------- 614 (700)
........||+.|+|||++.+..++.++||||||+++|||++|..||........ .............
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 2223345699999999999999999999999999999999999988754321110 0011111100000
Q ss_pred --cchhhhc---------ch--hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 615 --NRLFEVL---------DA--RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 615 --~~~~~~~---------d~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+.... .+ ..........+.++.+|+.+||+.||++|||++|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 00 0000001134567899999999999999999999986
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.97 Aligned_cols=239 Identities=26% Similarity=0.319 Sum_probs=195.7
Q ss_pred EeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCH
Q 005355 398 LGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 473 (700)
Q Consensus 398 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 473 (700)
||+|+||.||++... +++.||+|++... .......+.+|+.++++++||||+++++.+.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 5789999987642 344556788999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeeee
Q 005355 474 YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRV 553 (700)
Q Consensus 474 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~ 553 (700)
.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 153 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF 153 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence 99997643 3899999999999999999999999 9999999999999999999999999987542222 223345
Q ss_pred ecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHH
Q 005355 554 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEE 633 (700)
Q Consensus 554 ~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 633 (700)
.||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+ ..+.... ...+...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~-~~~~~~~----------~~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MY-RKILQEP----------LRFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HH-HHHHcCC----------CCCCCcC
Confidence 68999999999999999999999999999999999999997544322 11 1111111 0122334
Q ss_pred HHHHHHHHHHHhccCCCCCCC---HHHHHH
Q 005355 634 IITVAMLAKRCLNMIGKKRPT---MKEAAF 660 (700)
Q Consensus 634 ~~~l~~li~~cl~~~p~~RPs---~~evl~ 660 (700)
...+.+|+.+||+.||++||+ +.|++.
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 567889999999999999986 455544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.55 Aligned_cols=265 Identities=29% Similarity=0.453 Sum_probs=205.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-----CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe--CCcc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-----NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLE--TEVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 461 (700)
.++|++.+.||+|+||.||++..+ +++.||+|++........+.+.+|++++++++|+||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 357888999999999999999843 578999999887777777889999999999999999999998754 3467
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++|+||+++++|.+++..... .+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++..
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 899999999999999976432 3899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCcee--eeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcc---
Q 005355 542 VMIDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR--- 616 (700)
Q Consensus 542 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 616 (700)
........ .....++..|+|||++.+..++.++||||||++++||++|..++....... ...+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--------~~~~~~~~~~~ 229 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF--------MRMMGNDKQGQ 229 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh--------hhhcccccccc
Confidence 54332211 111223446999999998899999999999999999999877764332110 00000000
Q ss_pred -----hhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 617 -----LFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 617 -----~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
+.+.+............+..+.+|+.+||+.+|++|||++|+++.|+.++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred cchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 00011110001112234457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.58 Aligned_cols=251 Identities=24% Similarity=0.306 Sum_probs=200.9
Q ss_pred CCCccceEeeeCCeEEEEEEEc----CCcEEEEEEcccc----ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcc
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT----NGRIVAIKKSKLV----DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 461 (700)
+|++.+.||+|+||.||+++.. .++.||+|++... .....+.+..|+.+++.+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788999999999999998853 5789999987642 223356788999999999 599999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999997643 3899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
.............||+.|+|||++.+. .++.++||||||+++|||++|+.||.......... .+...+...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~~----- 226 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRILKC----- 226 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHhcC-----
Confidence 543333333445699999999999875 47889999999999999999999997543222111 111111110
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRP-----TMKEAAF 660 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~ 660 (700)
++ ..+......+.+++.+||+.||++|| +++++++
T Consensus 227 -~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 -DP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -CC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11 11223455688999999999999999 6777775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.44 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=206.8
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
..++|++.++||+|+||.||+|++.+...||+|+++.... ..+.+.+|++++++++|+||+++++.+. .+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 3567999999999999999999987777899999875332 3467899999999999999999999874 4567999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++..... ..+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 82 MSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999999976432 24799999999999999999999999 99999999999999999999999999976543322
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
.......++..|+|||++.+..++.++||||||+++|||++ |..||......+. ...+.....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-------~~~~~~~~~--------- 221 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQVERGYR--------- 221 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-------HHHHhcCCC---------
Confidence 22223346678999999998999999999999999999999 8888875543221 111111100
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
.......+..+.+|+.+|++.+|++||++.++++.|+..
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011234456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=321.58 Aligned_cols=263 Identities=23% Similarity=0.410 Sum_probs=212.7
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcC-----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe-CC
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTN-----GRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLE-TE 459 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 459 (700)
+..++|++.++||+|+||.||+|.+.+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.+ ..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 346789999999999999999999765 688999987753 34456778999999999999999999998776 46
Q ss_pred cceEEEeeCCCCCHHHHHhccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEe
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEE-----FPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVS 534 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~ 534 (700)
..++++||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999999764322 45899999999999999999999999 9999999999999999999999
Q ss_pred ecCCCcccccCCcee-eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHH
Q 005355 535 DFGASRSVMIDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAM 612 (700)
Q Consensus 535 DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 612 (700)
|||+++.+....... .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+ . ...+
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~ 232 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---M----AAYL 232 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---H----HHHH
Confidence 999998654333221 222345778999999998899999999999999999999 999997554322 1 1111
Q ss_pred HhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 613 KENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 613 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
..+.. .......+..+.+++.+||+.+|++|||+.++++.|+.+.+.
T Consensus 233 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 233 KDGYR---------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HcCCC---------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11110 001122345788999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=329.90 Aligned_cols=259 Identities=24% Similarity=0.415 Sum_probs=216.0
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc--CCc--EEEEEEccccChh-hHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT--NGR--IVAIKKSKLVDES-NIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
..+.+.+.++||+|.||.|++|.|+ +|+ .||||.++..... ...+|++|+.+|.+|+|+|+++|+|+..+ ....
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 3455567789999999999999987 343 6899998875554 67899999999999999999999999998 6778
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
||+|+.+.|+|.+.|++ ..+..+....+..++.|||.||+||.+++ +|||||..+|+||-....|||+||||++.+
T Consensus 187 MV~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred HHhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceecc
Confidence 99999999999999998 34456888999999999999999999999 999999999999998889999999999988
Q ss_pred ccCCcee--eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 543 MIDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 543 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
...+... .......+.|+|||.+....++.++|||+|||+||||++ |+.||.+-.... +.+
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~ 326 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILK 326 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHH
Confidence 7654432 122335678999999999999999999999999999999 889998765432 122
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
.+|..-.-..+..+++++.++++.||..+|.+|||+..|.+.+--.++
T Consensus 327 ~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 327 NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 233322334466788899999999999999999999999866543333
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=323.55 Aligned_cols=264 Identities=27% Similarity=0.435 Sum_probs=212.0
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEcC------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCceeeEEeEE
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTN------GRIVAIKKSKLV-DESNIEQFINEVAILSQI-NHRNVVKLLGCC 455 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 455 (700)
+++...++|++.+.||+|+||.||++.+.. ...+|+|.+... .......+.+|+++++++ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345566789999999999999999998642 367999987753 334456789999999999 799999999999
Q ss_pred EeCCcceEEEeeCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 005355 456 LETEVPLLVYEFIPNGTLYQYIHDQT-------------EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSAN 522 (700)
Q Consensus 456 ~~~~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~N 522 (700)
...+..+++|||+++++|.++++... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceee
Confidence 99999999999999999999997531 2245899999999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchh
Q 005355 523 ILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600 (700)
Q Consensus 523 ILl~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~ 600 (700)
||+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 99999999999999999865432221 1222335678999999999999999999999999999997 999987554332
Q ss_pred hhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 601 DKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
. ...+..+.. ...+......+.+|+.+||..+|++|||+.|+++.|+.+.
T Consensus 243 ~-------~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 L-------FKLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H-------HHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 111111111 1112233557889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=328.07 Aligned_cols=242 Identities=24% Similarity=0.329 Sum_probs=199.0
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 471 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 471 (700)
++||+|+||.||++... +++.||||++... .......+.+|+.+++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999975 6899999987642 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeee
Q 005355 472 TLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTT 551 (700)
Q Consensus 472 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~ 551 (700)
+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 153 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMK 153 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccc
Confidence 9999987653 3899999999999999999999999 999999999999999999999999998753222 12223
Q ss_pred eeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCH
Q 005355 552 RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKE 631 (700)
Q Consensus 552 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 631 (700)
...||+.|+|||++.+..++.++||||||+++|+|++|+.||......+. ...+..... ..+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-------~~~~~~~~~----------~~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEDI----------KFPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-------HHHhccCCc----------cCCC
Confidence 45689999999999999999999999999999999999999975543221 111111110 1122
Q ss_pred HHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005355 632 EEIITVAMLAKRCLNMIGKKRP-----TMKEAAFE 661 (700)
Q Consensus 632 ~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~ 661 (700)
.....+.+|+.+||+.||++|| ++.|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3455788999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=313.02 Aligned_cols=272 Identities=24% Similarity=0.326 Sum_probs=209.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCc-eeeEEeEEEeCC-----
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE--SNIEQFINEVAILSQINHRN-VVKLLGCCLETE----- 459 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 459 (700)
...|..+++||+|+||+||+|+.+ +|+.||+|++....+ .......+|+.+|++++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 455677788999999999999965 789999999876433 24466789999999999999 999999999877
Q ss_pred -cceEEEeeCCCCCHHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 460 -VPLLVYEFIPNGTLYQYIHDQTEE-FPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 460 -~~~lv~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
..++|+||+ .-+|.+++...... ..++...+..++.||+.||+|||+++ |+||||||.||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 778999999 56999999876532 33777899999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcc
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR 616 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 616 (700)
+++....+... .+..++|..|.|||++.+. .|+...||||+|||+.||+++++.|.+....+....+-..+....+..
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 99976533332 4556799999999999886 799999999999999999999999987765322111111111111111
Q ss_pred hhhhc-------------chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhc
Q 005355 617 LFEVL-------------DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE--LGGI 665 (700)
Q Consensus 617 ~~~~~-------------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~--L~~l 665 (700)
|..+. .+......-........+++.+||+.+|.+|.|++.++++ +..+
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 11111 0000000001112468899999999999999999999986 5544
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=328.43 Aligned_cols=241 Identities=25% Similarity=0.325 Sum_probs=198.3
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 471 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 471 (700)
+.||+|+||.||++... +++.||+|++... .......+.+|+++++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999975 6899999987642 2344567789999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeee
Q 005355 472 TLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTT 551 (700)
Q Consensus 472 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~ 551 (700)
+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~ 153 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccc
Confidence 9999987653 3899999999999999999999999 9999999999999999999999999987532221 2223
Q ss_pred eeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCH
Q 005355 552 RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKE 631 (700)
Q Consensus 552 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 631 (700)
...|++.|+|||++.+..++.++||||||+++|||++|+.||...+..+. ...+..... ..+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-------~~~~~~~~~----------~~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-------FELILMEEI----------RFPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHhcCCC----------CCCC
Confidence 35689999999999999999999999999999999999999975543221 111111110 1122
Q ss_pred HHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005355 632 EEIITVAMLAKRCLNMIGKKRP-----TMKEAAF 660 (700)
Q Consensus 632 ~~~~~l~~li~~cl~~~p~~RP-----s~~evl~ 660 (700)
.....+.+|+.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 3455788999999999999998 8888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.22 Aligned_cols=261 Identities=25% Similarity=0.376 Sum_probs=197.3
Q ss_pred cCCCccceEeeeCCeEEEEEEEc--CCcEEEEEEccccC--hhhHHHHHHHHHHHhhc---CCCceeeEEeEEE-----e
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT--NGRIVAIKKSKLVD--ESNIEQFINEVAILSQI---NHRNVVKLLGCCL-----E 457 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 457 (700)
++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47899999999999999999863 46889999876432 22334566787777765 6999999999885 2
Q ss_pred CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 458 TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 458 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
....++|+||++ ++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346789999996 699999976533 24899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHH---h
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK---E 614 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~ 614 (700)
++...... .......+++.|+|||++.+..++.++||||||+++|||++|.+||......+.... ...... .
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~---i~~~~~~~~~ 230 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---ILDVIGLPGE 230 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHHhCCCCh
Confidence 99754322 223345689999999999988999999999999999999999999987654332111 111100 0
Q ss_pred cchh-------hhcc---hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 615 NRLF-------EVLD---ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 615 ~~~~-------~~~d---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+. .... ..............+.+|+.+||+.+|++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 0000 00001111223456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=330.26 Aligned_cols=247 Identities=25% Similarity=0.332 Sum_probs=203.4
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcC--CcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTN--GRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
..++|++.+.||+|+||.||+|.++. +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34679999999999999999998653 368999987542 2334567889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 108 lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999997654 3899999999999999999999999 999999999999999999999999999764
Q ss_pred ccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
... .....||+.|+|||++.+..++.++||||||+++|||++|..||....... ....+..+..
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~~i~~~~~----- 245 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------IYQKILEGII----- 245 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCC-----
Confidence 321 234568999999999999899999999999999999999999997654321 1111111111
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRP-----TMKEAAFE 661 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~ 661 (700)
..+......+.+++++||+.+|++|+ +++++++.
T Consensus 246 -----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11222345678899999999999995 88888764
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.04 Aligned_cols=264 Identities=27% Similarity=0.416 Sum_probs=204.3
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
..++|++.++||+|+||.||++.+. ++..+|+|.+... .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3578999999999999999999986 5788999987653 3344577999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
||+++++|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999997643 388999999999999999999975 6 99999999999999999999999999875432
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH--------------
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLE-------------- 610 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-------------- 610 (700)
. ......++..|+|||++.+..++.++||||||+++|||++|+.||......+..........
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 1 12234588999999999998999999999999999999999999975443221100000000
Q ss_pred ------HHHh-----cchhhhcchhhhhc---c-CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 611 ------AMKE-----NRLFEVLDARVLKE---A-KEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 611 ------~~~~-----~~~~~~~d~~~~~~---~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.... .....+.+...... . ......++.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0000 00000000000000 0 0113456889999999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=343.92 Aligned_cols=263 Identities=22% Similarity=0.360 Sum_probs=219.0
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEcCC-cEEEEEEccccChhhHHHHHHHHHHHhhcC-CCceeeEEeE-EEe----
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLTNG-RIVAIKKSKLVDESNIEQFINEVAILSQIN-HRNVVKLLGC-CLE---- 457 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~---- 457 (700)
+.+...++++.+.|.+|||+.||.|....+ ..+|+|++...++...+.+++|+++|++|. |+|||.+++. ...
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 445567788899999999999999998765 999999998889999999999999999996 9999999993 221
Q ss_pred --CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEee
Q 005355 458 --TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535 (700)
Q Consensus 458 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~D 535 (700)
.-+.+|+|||+.+|.|-|++...-... |++.++++|+.|+++|+++||... +||||||||-+||||+.+++.||+|
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence 124579999999999999998654433 999999999999999999999987 6799999999999999999999999
Q ss_pred cCCCcccccCCcee--------eeeeeccccccccccc---ccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhH
Q 005355 536 FGASRSVMIDQTHL--------TTRVQGTFGYLDPEYF---RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSL 604 (700)
Q Consensus 536 fGl~~~~~~~~~~~--------~~~~~gt~~y~aPE~~---~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~ 604 (700)
||.+.......... .-...-|+.|+|||++ .+...++|+|||+|||+||-|+....||+....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------ 263 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------ 263 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence 99887543222110 0112368999999986 567899999999999999999999999975421
Q ss_pred HHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 605 VGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 605 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
..|++..........+...|.+||+.||+.||++||++-+|++.+-.+...
T Consensus 264 -------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 264 -------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 234454444444567889999999999999999999999999999877653
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.98 Aligned_cols=270 Identities=26% Similarity=0.392 Sum_probs=201.1
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC-----cce
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETE-----VPL 462 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 462 (700)
+|++.++||+|+||.||+|... +++.||||++... .......+.+|++++++++||||+++++++...+ ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5788999999999999999975 6899999987642 2334467889999999999999999999886432 468
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+||||++ ++|.+++.... .+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68999887543 3899999999999999999999999 999999999999999999999999999754
Q ss_pred ccCCc--eeeeeeeccccccccccccc--CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH--------HH
Q 005355 543 MIDQT--HLTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF--------LE 610 (700)
Q Consensus 543 ~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~ 610 (700)
..... .......+++.|+|||++.+ ..++.++||||||+++|||++|+.||............... ..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32221 11234568999999999876 67899999999999999999999999765432211111000 00
Q ss_pred HHHhcchhhhcc---hhhh---hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhchh
Q 005355 611 AMKENRLFEVLD---ARVL---KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE--LGGIRA 667 (700)
Q Consensus 611 ~~~~~~~~~~~d---~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~--L~~l~~ 667 (700)
.+........+. .... ..........+.+++.+||+.+|++|||++|+++. ++++..
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 000000000000 0000 00001224567899999999999999999999974 444433
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.94 Aligned_cols=255 Identities=24% Similarity=0.317 Sum_probs=204.6
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
...++|++.++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34678999999999999999999976 6889999987642 2334456789999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+||||+++|+|.+++.... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~~----l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNYD----IPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999997543 888899999999999999999999 999999999999999999999999999765
Q ss_pred ccCCceeeeeeecccccccccccccC----CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSS----QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
............||+.|+|||++.+. .++.++||||||+++|||++|+.||........ +..........
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~~~~ 266 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMDHKNSL 266 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH------HHHHHcCCCcC
Confidence 43322223345699999999998653 478899999999999999999999976543221 11111110000
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKK--RPTMKEAAFE 661 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~ 661 (700)
. -......+..+.+|+.+||+.+|.+ ||+++|+++.
T Consensus 267 ~-------~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 T-------FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred C-------CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 0011234567889999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=322.77 Aligned_cols=263 Identities=24% Similarity=0.370 Sum_probs=200.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE-SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 478999999999999999999976 688999998875332 233567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|++ ++|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 688888875432 3889999999999999999999999 9999999999999999999999999987542221
Q ss_pred ceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc---chhh---
Q 005355 547 THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN---RLFE--- 619 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~--- 619 (700)
.......+++.|+|||++.+ ..++.++||||||+++|||++|..||........ ............ .+..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchhh
Confidence 22233458899999999865 4588999999999999999999999986543211 111111110000 0000
Q ss_pred --hcch---------hhhhcc-CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 620 --VLDA---------RVLKEA-KEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 620 --~~d~---------~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...+ .+.... .......+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 000000 0012346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=344.09 Aligned_cols=252 Identities=24% Similarity=0.298 Sum_probs=207.1
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-C-CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-N-GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
..|.+.+.||+|+||.||+|... + ++.||+|............+.+|+.+++.++||||+++++.+...+..+|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34889999999999999999865 3 678899987766666667788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 468 IPNGTLYQYIHDQ-TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 468 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
+++|+|.++++.. ....++++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999998653 23345899999999999999999999999 9999999999999999999999999998654322
Q ss_pred c-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 547 T-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 547 ~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .......+...
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-------~~~~~~~~~~~------- 289 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-------IMQQVLYGKYD------- 289 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC-------
Confidence 1 12334568999999999999999999999999999999999999997543321 11111111110
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+...+..+.+|+.+||+.+|++||+++++++
T Consensus 290 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 --PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 112234467899999999999999999999875
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.94 Aligned_cols=263 Identities=29% Similarity=0.464 Sum_probs=208.5
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeC
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVD-ESNIEQFINEVAILSQI-NHRNVVKLLGCCLET 458 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 458 (700)
.+.++|++.+.||+|+||.||+|.+. .++.||+|+++... ....+.+..|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 44578999999999999999999743 24789999987532 33456788999999999 899999999988654
Q ss_pred -CcceEEEeeCCCCCHHHHHhccCC-------------------------------------------------------
Q 005355 459 -EVPLLVYEFIPNGTLYQYIHDQTE------------------------------------------------------- 482 (700)
Q Consensus 459 -~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------- 482 (700)
...++++||+++++|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 567899999999999999865321
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee-eeeeecccc
Q 005355 483 ---EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL-TTRVQGTFG 558 (700)
Q Consensus 483 ---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~gt~~ 558 (700)
...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++..+....... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 125899999999999999999999999 9999999999999999999999999998654332221 223345678
Q ss_pred cccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHH
Q 005355 559 YLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITV 637 (700)
Q Consensus 559 y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l 637 (700)
|+|||++.+..++.++||||||++|+||++ |..||......+. +...+..+... ..+......+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~ 305 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRM---------RAPEYATPEI 305 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCC---------CCCccCCHHH
Confidence 999999999999999999999999999998 9999976443221 11222221111 1122334578
Q ss_pred HHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 638 AMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 638 ~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
.+++.+||+.+|++||++.|++++|+++..
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=316.91 Aligned_cols=260 Identities=24% Similarity=0.347 Sum_probs=210.8
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL---VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.+.||+|+||.||+|+.. +++.||||.+.. .+......+.+|+++++.++||||+++++.+.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999975 689999997653 23444567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 466 EFIPNGTLYQYIHDQTE-EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
||+++++|.+++..... ...+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999999865322 234889999999999999999999999 99999999999999999999999999876532
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
... ......+++.|+|||.+.+..++.++||||||+++|||++|..||....... .. +...+......
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~-~~~~~~~~~~~------ 226 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FS-LCQKIEQCDYP------ 226 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HH-HHHHHhcCCCC------
Confidence 221 1223457889999999998889999999999999999999999986443221 11 11111111111
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
.......+..+.+++.+||+.+|++||++.++++.|++++
T Consensus 227 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 --PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1111234567899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=331.55 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=204.6
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.+.||+|+||+||++... +++.||+|+++.. .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47889999999999999999976 6889999988753 2334567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++++|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999987532 3899999999999999999999999 999999999999999999999999999866444
Q ss_pred Cceeeeeeecccccccccccc------cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFR------SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
.........||+.|+|||++. ...++.++||||||+++|||++|..||......+. +...........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~ 229 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQRFLK 229 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCCccC
Confidence 333334456899999999986 45678999999999999999999999976543221 111111111100
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. ......+..+.+|+.+||+ +|++||+++++++
T Consensus 230 ~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 230 F-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 0111245568889999998 9999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=320.32 Aligned_cols=256 Identities=25% Similarity=0.455 Sum_probs=206.3
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-----CCcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-----NGRIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
++|++.+.||+|+||.||+|.+. .++.|++|.+.. ........+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 56888899999999999999852 467899999874 334445788999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC
Q 005355 464 VYEFIPNGTLYQYIHDQTE--------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY 529 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~ 529 (700)
+|||+++++|.+++..... ...+++..++.++.|++.||+|||+++ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999964321 234789999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHH
Q 005355 530 RAKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGY 607 (700)
Q Consensus 530 ~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 607 (700)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999976543221 12223345678999999988889999999999999999998 999987544322
Q ss_pred HHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 608 FLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 608 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
........... ..+...+..+.+++.+||+.+|.+||++.+++++|+.
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11222221111 1122334578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.22 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=206.0
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.+.||+|+||+||+|+.. +++.||||++... .......+.+|++++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999976 6899999997642 2244567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999999998762 3899999999999999999999999 999999999999999999999999999765433
Q ss_pred C----------------------------ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCC
Q 005355 546 Q----------------------------THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 597 (700)
Q Consensus 546 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~ 597 (700)
. ........||+.|+|||++.+..++.++||||||++||||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 112234568999999999999999999999999999999999999998665
Q ss_pred chhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCC-HHHHHHH
Q 005355 598 SEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT-MKEAAFE 661 (700)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~evl~~ 661 (700)
..+. ......... ..........+..+.+|+.+||. +|.+||+ ++++++.
T Consensus 235 ~~~~------~~~i~~~~~-------~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQET------YNKIINWKE-------SLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHH------HHHHhccCC-------cccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 3221 111111000 00000011145678899999998 9999999 9999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.47 Aligned_cols=272 Identities=24% Similarity=0.394 Sum_probs=212.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCc--EEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGR--IVAIKKSKLV-DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 463 (700)
.++|++.+.||+|+||.||+|.++ ++. .+++|.++.. .......+.+|++++.++ +|+||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 467889999999999999999975 343 4678876643 344557889999999999 89999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc
Q 005355 464 VYEFIPNGTLYQYIHDQTE-------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR 530 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~ 530 (700)
|+||+++++|.++++.... ...+++..++.++.||+.||+|||+++ ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 9999999999999975421 124889999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHH
Q 005355 531 AKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFL 609 (700)
Q Consensus 531 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 609 (700)
+||+|||++...... ........+..|+|||++.+..++.++||||||++++||++ |..||......+. .
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~ 233 (303)
T cd05088 163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------Y 233 (303)
T ss_pred EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-------H
Confidence 999999998632111 11111224567999999988889999999999999999998 9999975443221 1
Q ss_pred HHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCCccCCCCCcc
Q 005355 610 EAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSIMQHNCDDI 681 (700)
Q Consensus 610 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~~~~~~~~ 681 (700)
....... ....+...+..+.+|+.+||+.+|++||++.+++++|+++.........+.--++.
T Consensus 234 ~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~~~~~~~~ 296 (303)
T cd05088 234 EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKF 296 (303)
T ss_pred HHHhcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhhhhhhccC
Confidence 1111110 00111223456889999999999999999999999999887666555544433333
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=329.11 Aligned_cols=262 Identities=28% Similarity=0.478 Sum_probs=222.5
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEcC---C--cEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTN---G--RIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCCLE 457 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~---~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 457 (700)
..+.........++||.|-||.||+|.+.+ | -.||||.-+. .+....+.|..|+.+|++++||||++++|++.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 445556667778899999999999999643 3 3589998876 556668999999999999999999999999976
Q ss_pred CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 458 TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 458 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
. ..+||||+.+-|.|..||...+.. ++...+..++.||..||+|||+.. .|||||..+|||+....-|||+|||
T Consensus 463 ~-P~WivmEL~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 463 Q-PMWIVMELAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred c-ceeEEEecccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccc
Confidence 5 559999999999999999987654 899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcc
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENR 616 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 616 (700)
+++.+..+..+......-+..|||||.+.-.+++.++|||.|||.+||++. |..||.+....+.
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--------------- 601 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--------------- 601 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce---------------
Confidence 999887666666666566789999999999999999999999999999987 9999987654321
Q ss_pred hhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 617 LFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 617 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
...+...-.-..++.+++.+..|+.+||..+|.+||.+.|+...|+.+..
T Consensus 602 -I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 -IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11122222233456788899999999999999999999999999988776
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=332.75 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=203.5
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL---VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
....++|++.+.||+|+||.||++... +++.||+|.+.. ......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344678999999999999999999976 578999998753 2233445688999999999999999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++||||+++|+|.+++.... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~----~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYD----VPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999997542 889999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCceeeeeeecccccccccccccCC----CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQ----FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
.............||+.|+|||++.... ++.++||||||++||||++|..||......+. +.........
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~i~~~~~~ 265 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSKIMDHKNS 265 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCcc
Confidence 5433322234556999999999987643 78899999999999999999999976543221 1111111110
Q ss_pred hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 005355 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKK--RPTMKEAAFE 661 (700)
Q Consensus 618 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~ 661 (700)
.. .......+..+.+++.+||..++.+ ||++.|+++.
T Consensus 266 ~~-------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 LN-------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cC-------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00 0111234566788999999865544 8999999885
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=314.86 Aligned_cols=254 Identities=27% Similarity=0.391 Sum_probs=205.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
.++|++.+.||+|+||.||++.+..+..+|+|++..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 466889999999999999999988777899998765332 3467889999999999999999998875 45679999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
++++|.++++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999976432 34899999999999999999999999 999999999999999999999999999765332222
Q ss_pred eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 549 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......++..|+|||++.+..++.++||||||+++|||++ |..||......+. ...+..+.. .
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~---------~ 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV-------LEQVERGYR---------M 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC---------C
Confidence 2222345678999999998899999999999999999999 8999975443221 111111100 0
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
..+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=319.45 Aligned_cols=267 Identities=29% Similarity=0.444 Sum_probs=203.8
Q ss_pred CCccceEeeeCCeEEEEEEE-----cCCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC--CcceE
Q 005355 392 FNTNRILGQGGQGTVYKGML-----TNGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLET--EVPLL 463 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 463 (700)
|+..+.||+|+||+||++.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 48889999999999988653 257789999887543 33457788999999999999999999988754 35789
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
+|||+++++|.+++.... +++..++.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~~~----l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHHcC----CCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999997643 899999999999999999999999 9999999999999999999999999997654
Q ss_pred cCCce--eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 544 IDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 544 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
..... ......++..|+|||.+.+..++.++||||||++++||++|..||........ ..............+.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhh
Confidence 32211 11122356679999999988999999999999999999999999865432110 0000000000000111111
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
+.......+...+..+.+++.+||+.+|++|||+++++++|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111122334568999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=325.23 Aligned_cols=242 Identities=25% Similarity=0.367 Sum_probs=197.4
Q ss_pred cceEeeeCCeEEEEEEEc----CCcEEEEEEcccc----ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 395 NRILGQGGQGTVYKGMLT----NGRIVAIKKSKLV----DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
+++||+|+||.||+++.. .++.||||.++.. .......+.+|+++++.++||||+++++.+...+..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999853 5789999987642 22334567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 81 YLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999997653 3788999999999999999999999 9999999999999999999999999987543222
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+..+..
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-------~~~~~~~~~~--------- 217 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-------TIDKILKGKL--------- 217 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC---------
Confidence 22233568999999999999899999999999999999999999997654322 1111111111
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRP-----TMKEAAF 660 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~ 660 (700)
..+......+.+|+.+||+.+|++|| +++++++
T Consensus 218 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 -NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11223345688999999999999999 7888776
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=315.91 Aligned_cols=257 Identities=26% Similarity=0.416 Sum_probs=210.0
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
...++|++.++||+|+||.||+|..++++.||||.+..... ..+++.+|+.++++++|+|++++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 45678999999999999999999988788999998875433 34779999999999999999999999998889999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|.+++..... ..+++..+..++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999987532 24899999999999999999999999 9999999999999999999999999987654322
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
.........+..|+|||.+.+..++.++||||||+++++|++ |+.||....... ....+..+. .
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------~~~~~~~~~-~------- 222 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-------VLEQVERGY-R------- 222 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC-C-------
Confidence 222222234568999999998899999999999999999998 999996543221 111111110 0
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
...+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 -MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=313.34 Aligned_cols=247 Identities=26% Similarity=0.422 Sum_probs=198.6
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCH
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 473 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 473 (700)
+.||+|+||.||+|++. +++.||+|..... .......+.+|++++++++|+||+++++++...+..++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999975 6889999987643 344557799999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee-ee
Q 005355 474 YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT-TR 552 (700)
Q Consensus 474 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~-~~ 552 (700)
.+++..... .+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++........... ..
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999975432 3899999999999999999999999 99999999999999999999999999875432111100 11
Q ss_pred eecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCH
Q 005355 553 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKE 631 (700)
Q Consensus 553 ~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 631 (700)
...+..|+|||.+.+..++.++||||||+++|||++ |..||......+. ....... .....+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~~~~~~---------~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------REAIEQG---------VRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HHHHHcC---------CCCCCcc
Confidence 123457999999999999999999999999999998 8888865433221 1111111 0111122
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 632 EEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 632 ~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
..+..+.+|+.+||+.+|++|||+.+++++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 34567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=332.67 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=201.9
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.++||+|+||+||+++.. +++.||||++... .......+.+|++++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999976 6889999998642 2344567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999997653 3899999999999999999999999 999999999999999999999999998754221
Q ss_pred Cce-------------------------------------eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh
Q 005355 546 QTH-------------------------------------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 588 (700)
Q Consensus 546 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt 588 (700)
... ......||+.|+|||++....++.++||||||+++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0112358999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCC---HHHHHH
Q 005355 589 GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT---MKEAAF 660 (700)
Q Consensus 589 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~evl~ 660 (700)
|..||......+. ............. ......+..+.+|+.+||. +|.+|++ ++|+++
T Consensus 235 G~~Pf~~~~~~~~------~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQET------YRKIINWKETLQF-------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHHH------HHHHHcCCCccCC-------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999976543321 1111110000000 0011234567889999997 9999998 888877
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=324.81 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=198.2
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
++||+|+||.||++.+. +++.||||+++.. .....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999976 6889999988742 233456788999999988 799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT 153 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-CCcc
Confidence 99999987553 3999999999999999999999999 999999999999999999999999998743221 1223
Q ss_pred eeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchh--hhhHHHHHHHHHHhcchhhhcchhhhhc
Q 005355 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE--DKSLVGYFLEAMKENRLFEVLDARVLKE 628 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 628 (700)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+ ......+....+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------C
Confidence 34568999999999999999999999999999999999999997433221 11111222222222211 1
Q ss_pred cCHHHHHHHHHHHHHHhccCCCCCCC------HHHHHH
Q 005355 629 AKEEEIITVAMLAKRCLNMIGKKRPT------MKEAAF 660 (700)
Q Consensus 629 ~~~~~~~~l~~li~~cl~~~p~~RPs------~~evl~ 660 (700)
.+......+.+++.+||+.||.+||+ ++++++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 12233456889999999999999997 567764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=315.03 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=204.1
Q ss_pred CCccceEeeeCCeEEEEEEEcC----CcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc-----
Q 005355 392 FNTNRILGQGGQGTVYKGMLTN----GRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEV----- 460 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 460 (700)
|++.+.||+|+||.||+|.+.. +..||||+++.. .....+.+.+|+++++.++|+||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999999652 367999988753 33445789999999999999999999998876554
Q ss_pred -ceEEEeeCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeec
Q 005355 461 -PLLVYEFIPNGTLYQYIHDQT---EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 536 (700)
Q Consensus 461 -~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~Df 536 (700)
.++++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999986542 2235899999999999999999999999 999999999999999999999999
Q ss_pred CCCcccccCCcee-eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHh
Q 005355 537 GASRSVMIDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKE 614 (700)
Q Consensus 537 Gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 614 (700)
|+++......... ......+..|+|||++.+..++.++||||||+++|||++ |..||......+ .......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-------~~~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-------IYDYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc
Confidence 9998654332221 112234678999999998999999999999999999999 889986544322 1111221
Q ss_pred cchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 615 NRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 615 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
+... ..+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 231 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 11233456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=332.45 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=199.4
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.|++++.||+|+||+||+|+.. +++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999975 6789999988642 23445678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999997654 3899999999999999999999999 9999999999999999999999999975431100
Q ss_pred c----------------------------------------------eeeeeeecccccccccccccCCCCcccceehHH
Q 005355 547 T----------------------------------------------HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFG 580 (700)
Q Consensus 547 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG 580 (700)
. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001234699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhc--cCCCCCCCHHHH
Q 005355 581 VVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLN--MIGKKRPTMKEA 658 (700)
Q Consensus 581 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~--~~p~~RPs~~ev 658 (700)
+++|||++|..||......+.. ......... +..........++.+|+.+|+. .++..||+++|+
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~------~~i~~~~~~-------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQ------LKVINWENT-------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHH------HHHHccccc-------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 9999999999999765433211 111110000 0001111234567888988554 455569999999
Q ss_pred HHH
Q 005355 659 AFE 661 (700)
Q Consensus 659 l~~ 661 (700)
+..
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=313.88 Aligned_cols=257 Identities=23% Similarity=0.408 Sum_probs=209.0
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
+..++|++.++||+|+||.||++.+..+..+++|.+.... ...+.+.+|++++++++|+||+++++.+.+ ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4567899999999999999999998778889999877532 345788999999999999999999999887 77899999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999999976432 34889999999999999999999999 9999999999999999999999999987654322
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
........++..|+|||++....++.++|+||||+++++|++ |..||....... ....+..+...
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~------- 222 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYRM------- 222 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCCCC-------
Confidence 222222345678999999998889999999999999999998 999997543322 11112211110
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
......+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 223 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 223 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred --CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 11223445788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=312.27 Aligned_cols=251 Identities=29% Similarity=0.466 Sum_probs=208.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
.++|++.+.||+|+||.||++... ++.||+|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 567889999999999999999876 78999999876544 5678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
++++|.+++..... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 99999999976542 24899999999999999999999999 9999999999999999999999999997652221
Q ss_pred eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 549 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
.....+..|+|||++....++.++||||||++++||++ |..||......+ .......+.. .
T Consensus 157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~ 218 (256)
T cd05039 157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYR---------M 218 (256)
T ss_pred --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCC---------C
Confidence 12335668999999998899999999999999999997 999987554322 1111111110 1
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
..+...+..+.+++.+||..+|++||+++|++++|+++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11223456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=311.13 Aligned_cols=247 Identities=26% Similarity=0.449 Sum_probs=201.0
Q ss_pred ceEeeeCCeEEEEEEEcCCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCHH
Q 005355 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLY 474 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 474 (700)
++||+|+||.||+|...+++.+|+|++.... ......+.+|++++++++|+||+++++.+...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4689999999999998888999999877543 333457899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeeeee
Q 005355 475 QYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQ 554 (700)
Q Consensus 475 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~~ 554 (700)
+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++...............
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 99976533 3889999999999999999999999 999999999999999999999999998754322221112223
Q ss_pred cccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHH
Q 005355 555 GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEE 633 (700)
Q Consensus 555 gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 633 (700)
++..|+|||++.+..++.++||||||+++|+|++ |..||........ ......+.. ...+...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~-------~~~~~~~~~---------~~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA-------REQVEKGYR---------MSCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH-------HHHHHcCCC---------CCCCCCC
Confidence 4667999999998999999999999999999998 9999975533221 111111110 0112234
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 634 IITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 634 ~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
+..+.+++.+||+.+|++||++.|++++|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=318.51 Aligned_cols=257 Identities=26% Similarity=0.438 Sum_probs=208.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
..+|+..++||+|+||.||++... ++..+|+|.+........+.+.+|+++++.++|+||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 467888999999999999999742 35689999988777777788999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc
Q 005355 463 LVYEFIPNGTLYQYIHDQTE------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR 530 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~ 530 (700)
+++||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999976432 124889999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHH
Q 005355 531 AKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYF 608 (700)
Q Consensus 531 ~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 608 (700)
+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|||++ |..||......+.
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------- 233 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------- 233 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-------
Confidence 999999998755332211 1222335678999999999999999999999999999998 8999865433221
Q ss_pred HHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 609 LEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 609 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
......+.. ...+...+..+.+|+.+||+.+|.+||+++||++.|+.
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 234 IECITQGRE---------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHcCcc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111111110 01112344568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=318.84 Aligned_cols=258 Identities=28% Similarity=0.427 Sum_probs=207.2
Q ss_pred CCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
+|++.+.||+|+||.||+|... ....+++|.+.... ....+++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4788899999999999999853 23578898876533 3445789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 005355 464 VYEFIPNGTLYQYIHDQTE---------------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSAN 522 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~N 522 (700)
++||+.+++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999999875321 134889999999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCCCcccccCCcee-eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchh
Q 005355 523 ILLDDKYRAKVSDFGASRSVMIDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600 (700)
Q Consensus 523 ILl~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~ 600 (700)
||+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||++++||++ |..||......+
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999997653332211 122345678999999988899999999999999999998 999997654332
Q ss_pred hhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 601 DKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
. ........ ....+...+..+.+++.+||+.+|++||++.|+++.|+++-.
T Consensus 238 ~-------~~~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 L-------FNLLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H-------HHHHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 11111111 011122344578899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.17 Aligned_cols=259 Identities=26% Similarity=0.408 Sum_probs=212.0
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL---VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.+.||+|+||.||+|... +++.||+|.++. .+....+.+.+|++++++++|+|++++++.+.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67999999999999999999987 789999998753 33344678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 466 EFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999997532 2345899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ... .......+..
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~~------- 225 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEKCDY------- 225 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHH-HHhhhhcCCC-------
Confidence 221 123345788999999999999999999999999999999999998644321 111 1111111111
Q ss_pred hhhccC-HHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 625 VLKEAK-EEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 625 ~~~~~~-~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
...+ ...+..+.+++.+||..+|++||++.+|+++|+++.
T Consensus 226 --~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 --PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1111 144557889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=324.73 Aligned_cols=244 Identities=26% Similarity=0.363 Sum_probs=196.6
Q ss_pred CCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHH---hhcCCCceeeEEeEEEeCCcceEE
Q 005355 392 FNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAIL---SQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
|++.+.||+|+||.||++.+. +++.||||+++.. .....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999976 6899999998643 233345677776665 456799999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++++|..+++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999988653 3899999999999999999999999 99999999999999999999999999875322
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
.. .......|++.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+..+..
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-------~~~i~~~~~------- 218 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-------FDSIVNDEV------- 218 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC-------
Confidence 22 223345689999999999999999999999999999999999999976543321 111111111
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRP-----TMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~ 660 (700)
..+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11223355688999999999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=315.18 Aligned_cols=256 Identities=27% Similarity=0.452 Sum_probs=207.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CC---cEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NG---RIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
.++|+..+.||+|+||.||+|... ++ ..+++|+.+.. .....+.+.+|++++++++|+|++++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 567888999999999999999975 23 37999988754 34456789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++++|.+++..... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999976432 3899999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCceeee--eeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 544 IDQTHLTT--RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 544 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
........ ....+..|+|||++....++.++||||||+++|||++ |..||......+ ....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i~~~~~--- 228 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDGFR--- 228 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhcCCC---
Confidence 32221111 1223457999999998899999999999999999997 999996543321 1122221110
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
.......+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 229 ------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 ------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=317.64 Aligned_cols=257 Identities=27% Similarity=0.409 Sum_probs=205.1
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcC------CcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTN------GRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEV 460 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 460 (700)
..++|++.+.||+|+||.||+|.+.. +..|++|...... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45779999999999999999999753 5678999876433 3445679999999999999999999999999999
Q ss_pred ceEEEeeCCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC---cEEE
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTE----EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY---RAKV 533 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~---~~kl 533 (700)
.++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976532 124899999999999999999999999 99999999999998654 6999
Q ss_pred eecCCCcccccCCcee-eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHH
Q 005355 534 SDFGASRSVMIDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEA 611 (700)
Q Consensus 534 ~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 611 (700)
+|||+++......... ......+..|+|||++.+..++.++||||||+++|||++ |..||......+. ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~-------~~~ 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV-------MEF 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHH
Confidence 9999998653221111 112223568999999999999999999999999999997 9999976543321 111
Q ss_pred HHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 612 MKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 612 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
+..... ...+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111100 1112234567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=323.08 Aligned_cols=264 Identities=27% Similarity=0.439 Sum_probs=210.9
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEE
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT--------NGRIVAIKKSKLV-DESNIEQFINEVAILSQI-NHRNVVKLLGCCL 456 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 456 (700)
...++|.+.+.||+|+||.||++.+. ....+|+|.++.. .......+.+|+++++.+ +|+||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 33578999999999999999999853 2346999988753 234456788999999999 7999999999999
Q ss_pred eCCcceEEEeeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 005355 457 ETEVPLLVYEFIPNGTLYQYIHDQTE-------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANI 523 (700)
Q Consensus 457 ~~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NI 523 (700)
..+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHhe
Confidence 99999999999999999999976432 124899999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeecCCCcccccCCcee-eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhh
Q 005355 524 LLDDKYRAKVSDFGASRSVMIDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEED 601 (700)
Q Consensus 524 Ll~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~ 601 (700)
|+++++.+||+|||++.......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||.....++
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~- 250 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 250 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-
Confidence 99999999999999987553221111 112224568999999999899999999999999999998 888886544322
Q ss_pred hhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 602 KSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
+...+..... .+.+...+..+.+|+.+||..+|.+||++.++++.|+++.+..
T Consensus 251 ------~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 251 ------LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred ------HHHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1112222111 1122334567889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=330.60 Aligned_cols=249 Identities=26% Similarity=0.346 Sum_probs=196.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.++|+..++||+|+||.||++++. +++.||||++... .....+.+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 345667789999999999999976 6899999997643 33445778999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|.+.. ...+..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||++.......
T Consensus 153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 99999986532 2567788899999999999999999 9999999999999999999999999997653221
Q ss_pred ceeeeeeeccccccccccccc-----CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 547 THLTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
.......||..|+|||++.. ...+.++||||||+++|||++|+.||......+..... .......
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~----~~~~~~~----- 292 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM----CAICMSQ----- 292 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH----HHHhccC-----
Confidence 12234568999999998853 23456899999999999999999999743322211111 1110000
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
...........+.+|+.+||+.+|++||++.|+++.
T Consensus 293 ----~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ----PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011223345678999999999999999999999874
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.25 Aligned_cols=243 Identities=27% Similarity=0.412 Sum_probs=194.0
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
++||+|+||.||++... +++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999976 5789999987642 334456678899988876 899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTT 153 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccc
Confidence 99999887653 3899999999999999999999999 9999999999999999999999999987532221 122
Q ss_pred eeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchh--hhhHHHHHHHHHHhcchhhhcchhhhhc
Q 005355 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE--DKSLVGYFLEAMKENRLFEVLDARVLKE 628 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 628 (700)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......+....+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence 34568999999999999999999999999999999999999996422211 11111222222222111 1
Q ss_pred cCHHHHHHHHHHHHHHhccCCCCCCCH
Q 005355 629 AKEEEIITVAMLAKRCLNMIGKKRPTM 655 (700)
Q Consensus 629 ~~~~~~~~l~~li~~cl~~~p~~RPs~ 655 (700)
.+......+.+|+.+||+.||++||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 222344568899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=314.75 Aligned_cols=260 Identities=25% Similarity=0.355 Sum_probs=210.5
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL---VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.+.||+|+||.||++... +++.++||.+.. .+....+.+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46888899999999999999964 789999997654 23344568899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 466 EFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
||+++++|.+++.... ....+++..++.++.||++||+|||+++ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999987532 2345899999999999999999999999 99999999999999999999999999875532
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
... ......++..|+|||++.+..++.++||||||+++|+|++|..||........ .......... .+
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~-----~~- 226 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----SLCKKIEQCD-----YP- 226 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-----HHhhhhhcCC-----CC-
Confidence 221 12234588899999999999999999999999999999999999965432211 1111111111 01
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
.......+..+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 227 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 227 --PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1111235567899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.85 Aligned_cols=246 Identities=28% Similarity=0.433 Sum_probs=198.7
Q ss_pred eEeeeCCeEEEEEEEc---CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCC
Q 005355 397 ILGQGGQGTVYKGMLT---NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 471 (700)
Q Consensus 397 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 471 (700)
.||+|+||.||+|.++ +++.+|+|+++... ....+.+.+|+.+++.++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 57889999876433 345678999999999999999999999875 45678999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee-
Q 005355 472 TLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT- 550 (700)
Q Consensus 472 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~- 550 (700)
+|.+++.... .+++..++.++.|++.||+|||+++ ++||||||.||++++++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999997543 3899999999999999999999999 99999999999999999999999999986543332211
Q ss_pred -eeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhc
Q 005355 551 -TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE 628 (700)
Q Consensus 551 -~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 628 (700)
....++..|+|||.+....++.++||||||+++|||++ |..||......+ ....+..+... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~i~~~~~~---------~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMIESGERM---------E 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCCC---------C
Confidence 12234578999999988889999999999999999998 999997654322 12222222111 1
Q ss_pred cCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 629 AKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 629 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
.+...+..+.+|+.+||+.+|++||++.+|.+.|++.
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1223456788999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=328.57 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=198.8
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.+.||+|+||+||++... +++.||||++... .......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999976 5889999988642 2334567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999997653 3899999999999999999999999 999999999999999999999999998754321
Q ss_pred Cc----------------------------------eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCC
Q 005355 546 QT----------------------------------HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQK 591 (700)
Q Consensus 546 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~ 591 (700)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 00123469999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhcc--CCCCCCCHHHHHHH
Q 005355 592 PIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNM--IGKKRPTMKEAAFE 661 (700)
Q Consensus 592 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~--~p~~RPs~~evl~~ 661 (700)
||......+. ...+........+ ... ......+.+++.+++.. ++..||+++|+++.
T Consensus 235 Pf~~~~~~~~-------~~~i~~~~~~~~~----p~~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQET-------YKKVMNWKETLIF----PPE--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHHH-------HHHHHcCcCcccC----CCc--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9976543321 1111111000000 011 11334677788886652 33356899999885
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=325.98 Aligned_cols=242 Identities=24% Similarity=0.318 Sum_probs=197.9
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 471 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 471 (700)
+.||+|+||.||++... +++.||+|++... .......+.+|+++++.++|+||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999965 6889999987642 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 472 TLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 472 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
+|.+++.... .+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATM 153 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccc
Confidence 9999987653 38999999999999999999997 68 9999999999999999999999999987532222 222
Q ss_pred eeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccC
Q 005355 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAK 630 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 630 (700)
....||+.|+|||++.+..++.++||||||+++|||++|..||.....++. ...+..... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-------~~~i~~~~~----------~~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEEI----------RFP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH-------HHHHhcCCC----------CCC
Confidence 345689999999999999999999999999999999999999976543221 111111110 112
Q ss_pred HHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005355 631 EEEIITVAMLAKRCLNMIGKKRP-----TMKEAAFE 661 (700)
Q Consensus 631 ~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~ 661 (700)
......+.+|+.+||+.||++|+ ++.++++.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 22345688999999999999996 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.98 Aligned_cols=255 Identities=25% Similarity=0.465 Sum_probs=200.9
Q ss_pred CCccceEeeeCCeEEEEEEEcC-Cc--EEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC------Cc
Q 005355 392 FNTNRILGQGGQGTVYKGMLTN-GR--IVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLET------EV 460 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 460 (700)
|.+.++||+|+||.||+|.+.. +. .||+|.++.. .....+.+.+|+++++.++|+||+++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999999764 32 6899987653 345567899999999999999999999987532 24
Q ss_pred ceEEEeeCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 461 PLLVYEFIPNGTLYQYIHDQT---EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
.++++||+++|+|.+++.... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999885321 2234899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCcee-eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhc
Q 005355 538 ASRSVMIDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKEN 615 (700)
Q Consensus 538 l~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 615 (700)
+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcC
Confidence 998654332211 122335678999999999999999999999999999999 889987543321 11122222
Q ss_pred chhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 616 RLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 616 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
.... .+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111 1123345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=330.08 Aligned_cols=263 Identities=24% Similarity=0.310 Sum_probs=201.5
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC-----cce
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETE-----VPL 462 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 462 (700)
+|++.++||+|+||.||++... +++.||||++... +....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999975 6899999987642 3344577899999999999999999999998776 789
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+|+||+. ++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 68888876543 3899999999999999999999999 999999999999999999999999999765
Q ss_pred ccCCceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH-------------
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF------------- 608 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~------------- 608 (700)
............++..|+|||++.+. .++.++||||||+++|||++|+.||......+........
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 43333333344578899999998774 5789999999999999999999999866543321111100
Q ss_pred ---HHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 609 ---LEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 609 ---~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
...+....... ................+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKP-PSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCC-CchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000 00000001112234578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.42 Aligned_cols=252 Identities=26% Similarity=0.340 Sum_probs=203.4
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
+|++.++||+|+||+||++... +++.||+|++.... ......+.+|+.++++++|+||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999975 68899999876432 2233567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999999875432 34899999999999999999999999 9999999999999999999999999987643222
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
. .....|+..|+|||++.+..++.++||||||+++|||++|..||......... ..+...+... .
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~----------~ 221 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKED----------Q 221 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhc----------c
Confidence 1 22345899999999999999999999999999999999999999765432211 1111111111 0
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRP-----TMKEAAFE 661 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~ 661 (700)
...+...+..+.+|+.+||+.||++|| +++++++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 112234566788999999999999999 78888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=331.76 Aligned_cols=265 Identities=25% Similarity=0.417 Sum_probs=211.0
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcC-CCceeeEEeEE
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVD-ESNIEQFINEVAILSQIN-HRNVVKLLGCC 455 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 455 (700)
+++...++|.+.++||+|+||.||+|++. .++.||||+++... ....+.+.+|+++|.++. |+||+++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 35666778999999999999999999864 24689999987542 333457889999999997 99999999999
Q ss_pred EeCCcceEEEeeCCCCCHHHHHhccCC-----------------------------------------------------
Q 005355 456 LETEVPLLVYEFIPNGTLYQYIHDQTE----------------------------------------------------- 482 (700)
Q Consensus 456 ~~~~~~~lv~E~~~~gsL~~~l~~~~~----------------------------------------------------- 482 (700)
...+..++|+||+++|+|.++++....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999975421
Q ss_pred ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 005355 483 ------------------------------------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKS 520 (700)
Q Consensus 483 ------------------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~ 520 (700)
...+++..++.++.||+.||+|||+.+ ++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence 123678889999999999999999998 99999999
Q ss_pred CcEEECCCCcEEEeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCc
Q 005355 521 ANILLDDKYRAKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDS 598 (700)
Q Consensus 521 ~NILl~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~ 598 (700)
+|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999975432221 11223346788999999998899999999999999999998 8899865433
Q ss_pred hhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 599 EEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
.+. ....+..+.. ...+......+.+|+.+||+.+|.+||+++||++.|+++.
T Consensus 348 ~~~------~~~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQ------FYNAIKRGYR---------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHH------HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 221 1111111100 0112233567899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.81 Aligned_cols=256 Identities=23% Similarity=0.421 Sum_probs=203.2
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCc----EEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGR----IVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
++|++.+.||+|+||+||+|.+. +++ .+++|++.... .....++..|+.++++++|+||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 56788899999999999999974 343 47888875432 234467888888999999999999999875 445689
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
++||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999976533 4899999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 544 IDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 544 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
..... ......++..|+|||++.+..++.++||||||+++|||++ |..||......+. ...+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~~-- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLEKGERLA-- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCcCC--
Confidence 33221 2233446778999999998899999999999999999998 9999976543321 11122221111
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
. +......+.+++.+||..+|++|||+.|++++|..+..
T Consensus 232 ~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 Q-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred C-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0 11123457789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=322.86 Aligned_cols=236 Identities=27% Similarity=0.399 Sum_probs=193.7
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
++||+|+||.||+++.+ +++.||||++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999976 5889999987642 234456778888888876 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT 153 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence 99999997654 3899999999999999999999999 9999999999999999999999999987532221 223
Q ss_pred eeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccC
Q 005355 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAK 630 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 630 (700)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+..+.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------~~~i~~~~~----------~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-------FEAILNDEV----------VYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-------HHHHhcCCC----------CCC
Confidence 345689999999999999999999999999999999999999976543321 111211111 111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCH
Q 005355 631 EEEIITVAMLAKRCLNMIGKKRPTM 655 (700)
Q Consensus 631 ~~~~~~l~~li~~cl~~~p~~RPs~ 655 (700)
......+.+|+.+||+.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 2234578899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.33 Aligned_cols=241 Identities=25% Similarity=0.367 Sum_probs=196.5
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCC-CceeeEEeEEEeCCcceEEE
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINH-RNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 465 (700)
+|++.+.||+|+||.||+|+.. +++.||||++... .....+.+..|++++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999976 5789999987642 23445678889999999976 46888999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999997654 3899999999999999999999999 999999999999999999999999998743222
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+.....
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-------~~~i~~~~~-------- 218 (324)
T cd05587 155 G-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------FQSIMEHNV-------- 218 (324)
T ss_pred C-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCC--------
Confidence 2 223345689999999999999999999999999999999999999976543221 111111110
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTM 655 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~ 655 (700)
..+......+.+++.+||..+|.+|++.
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 --SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1122334568899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=320.96 Aligned_cols=264 Identities=26% Similarity=0.440 Sum_probs=211.6
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEE
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT--------NGRIVAIKKSKLV-DESNIEQFINEVAILSQI-NHRNVVKLLGCCL 456 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 456 (700)
...++|.+.+.||+|+||.||++++. ++..||+|..... .......+.+|+.+++.+ +|+||+++++.+.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44677889999999999999999742 2457999988643 344567899999999999 8999999999999
Q ss_pred eCCcceEEEeeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 005355 457 ETEVPLLVYEFIPNGTLYQYIHDQTE-------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANI 523 (700)
Q Consensus 457 ~~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NI 523 (700)
.....+++|||+++++|.+++..... ...+++..++.++.||++||+|||+++ ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999976421 134788999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeecCCCcccccCCcee-eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhh
Q 005355 524 LLDDKYRAKVSDFGASRSVMIDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEED 601 (700)
Q Consensus 524 Ll~~~~~~kl~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~ 601 (700)
|+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||......+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~- 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-
Confidence 99999999999999998664322221 222345678999999999899999999999999999998 788886544322
Q ss_pred hhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 602 KSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
....+..+... ..+...+..+.+|+.+||+.+|.+||++.|+++.|+++....
T Consensus 248 ------~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 248 ------LFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred ------HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 11122221110 112234567889999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=318.04 Aligned_cols=261 Identities=26% Similarity=0.433 Sum_probs=207.3
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLET 458 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 458 (700)
++..++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++|+||+++++.+.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 345788999999999999999999754 24579999876433 23345688999999999999999999999999
Q ss_pred CcceEEEeeCCCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcE
Q 005355 459 EVPLLVYEFIPNGTLYQYIHDQTE-------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRA 531 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~ 531 (700)
+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcE
Confidence 999999999999999999975321 133577889999999999999999999 9999999999999999999
Q ss_pred EEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHH
Q 005355 532 KVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFL 609 (700)
Q Consensus 532 kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 609 (700)
||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....++ ..
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-------~~ 231 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VL 231 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HH
Confidence 99999998755332211 1122235678999999999999999999999999999998 788987544322 11
Q ss_pred HHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 610 EAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 610 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
.....+... ..+...+..+.+++.+||+.+|++|||+.++++.|+..
T Consensus 232 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 232 KFVMDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111111110 11122346799999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=341.99 Aligned_cols=258 Identities=26% Similarity=0.327 Sum_probs=207.7
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC--
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETE-- 459 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 459 (700)
.+...++|++.++||+|+||+||++... +++.||||++... .......+.+|+.++..++|+|++++...+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3445679999999999999999999865 6899999987643 3455677889999999999999999988775432
Q ss_pred ------cceEEEeeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEE
Q 005355 460 ------VPLLVYEFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAK 532 (700)
Q Consensus 460 ------~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~k 532 (700)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 2579999999999999997542 2345899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCcccccCC-ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHH
Q 005355 533 VSDFGASRSVMIDQ-THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEA 611 (700)
Q Consensus 533 l~DfGl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 611 (700)
|+|||+++...... ........||+.|+|||++.+..++.++||||||++||||++|+.||......+ ....
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-------~~~~ 256 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-------VMHK 256 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHH
Confidence 99999997654322 122334568999999999999999999999999999999999999997654322 1111
Q ss_pred HHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 612 MKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 612 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
...+.. ...+...+..+.+|+.+||+.+|.+||++.++++.
T Consensus 257 ~~~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111 11223345678999999999999999999999863
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=319.41 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=205.8
Q ss_pred cCCCccceEeeeCCeEEEEEEEcC------CcEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLTN------GRIVAIKKSKLVDE-SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
.+|++.+.||+|+||.||+|.+.+ ++.||||+++.... ...+.+.+|+.++..++|+||+++++.+.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 457778899999999999998642 47899999875433 33567889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC
Q 005355 463 LVYEFIPNGTLYQYIHDQT-------------EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY 529 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~ 529 (700)
+++||+++++|.+++.... .+..+++..++.++.|++.||+|||+++ |+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999986321 1234888999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHH
Q 005355 530 RAKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGY 607 (700)
Q Consensus 530 ~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 607 (700)
.+||+|||+++....... .......+++.|+|||++....++.++||||||+++|||++ |..||......+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------- 234 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999876533222 12223345778999999988889999999999999999998 888887544322
Q ss_pred HHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 608 FLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 608 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
....+...... ..+...+..+.+|+.+||+.+|++||+++++++.|+.
T Consensus 235 ~~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 12222222211 1123345668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=296.17 Aligned_cols=254 Identities=27% Similarity=0.413 Sum_probs=210.0
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--------hhhHHHHHHHHHHHhhc-CCCceeeEEeEE
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--------ESNIEQFINEVAILSQI-NHRNVVKLLGCC 455 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 455 (700)
+.-.+.|...++||.|..+.|-+..++ .++.+|+|++.... ....+.-++|+.||+++ .||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 334567788899999999999988865 68889999865421 12245567899999997 699999999999
Q ss_pred EeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEee
Q 005355 456 LETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535 (700)
Q Consensus 456 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~D 535 (700)
......++|+|.|+.|.|.|+|..... ++++...+|++|+++|+.|||.++ ||||||||+|||++++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~Vt---lSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKVT---LSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhhee---ecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 999999999999999999999987654 999999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccccCCceeeeeeeccccccccccccc------CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 005355 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS------SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL 609 (700)
Q Consensus 536 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 609 (700)
||++..+.. .......+||++|+|||.+.. ..|+..+|+|++|||||.|+.|.+||-... . ..++
T Consensus 167 FGFa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----Q--mlML 237 (411)
T KOG0599|consen 167 FGFACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----Q--MLML 237 (411)
T ss_pred cceeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----H--HHHH
Confidence 999987643 334566889999999999854 357889999999999999999999995321 1 1234
Q ss_pred HHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 610 EAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 610 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.++.+++.. .......+......+||.+||+.||.+|.|++|+++
T Consensus 238 R~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 238 RMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 555555542 112223556778899999999999999999999987
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.51 Aligned_cols=266 Identities=26% Similarity=0.435 Sum_probs=211.0
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEcC--------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCceeeEEeE
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLTN--------GRIVAIKKSKLV-DESNIEQFINEVAILSQI-NHRNVVKLLGC 454 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 454 (700)
++....+|++.+.||+|+||.||++.... ...||+|.++.. .....+.+.+|+++++++ +|+||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 34445678999999999999999997531 236899987753 344567899999999999 79999999999
Q ss_pred EEeCCcceEEEeeCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 005355 455 CLETEVPLLVYEFIPNGTLYQYIHDQT-------------EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSA 521 (700)
Q Consensus 455 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~ 521 (700)
+.+.+..++++||+++++|.+++.... ....+++..++.++.|++.||+|||+++ ++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence 999999999999999999999997632 1234889999999999999999999999 999999999
Q ss_pred cEEECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCch
Q 005355 522 NILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSE 599 (700)
Q Consensus 522 NILl~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~ 599 (700)
|||+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||.....+
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999999765332211 1122234567999999999999999999999999999998 88898755433
Q ss_pred hhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 600 EDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
+ +...+..+.. .+.+......+.+|+.+||+.+|++||++.|+++.|+.+....
T Consensus 244 ~-------~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 244 E-------LFKLLKEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred H-------HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 2 1112221111 1112233457889999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=331.32 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=199.5
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.++||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47889999999999999999875 6889999987542 2334567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999997643 3899999999999999999999999 999999999999999999999999998633210
Q ss_pred Cce----------------------------------------------eeeeeecccccccccccccCCCCcccceehH
Q 005355 546 QTH----------------------------------------------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSF 579 (700)
Q Consensus 546 ~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSl 579 (700)
... ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0012458999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCC---CCHH
Q 005355 580 GVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKR---PTMK 656 (700)
Q Consensus 580 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Ps~~ 656 (700)
||++|||++|..||......+. +............ .. .......+.+|+.+||. +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~-----p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHET------YRKIINWRETLYF-----PD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHH------HHHHHccCCccCC-----CC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 9999999999999976543221 1111110000000 00 11234568889999998 66665 5999
Q ss_pred HHHHH
Q 005355 657 EAAFE 661 (700)
Q Consensus 657 evl~~ 661 (700)
|+++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.78 Aligned_cols=251 Identities=26% Similarity=0.423 Sum_probs=204.0
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-----hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-----ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
++|.+.+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999965 68999999865422 2234678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
|+||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999997653 3889999999999999999999999 9999999999999999999999999987553
Q ss_pred cCCceee--eeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 544 IDQTHLT--TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 544 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
....... ....++..|+|||++.+..++.++||||||+++|||++|+.||......+. ....... .
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~-~----- 223 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQ-P----- 223 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHHHhcc-C-----
Confidence 2221111 234577899999999999999999999999999999999999965432211 1111110 0
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.....+......+.+++.+||..+|.+||++.++++.
T Consensus 224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 ---TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111223345578899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=310.46 Aligned_cols=247 Identities=26% Similarity=0.435 Sum_probs=197.8
Q ss_pred eEeeeCCeEEEEEEEc---CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCC
Q 005355 397 ILGQGGQGTVYKGMLT---NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 472 (700)
Q Consensus 397 ~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 472 (700)
.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999864 35579999887643 334567999999999999999999999875 457799999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee--
Q 005355 473 LYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT-- 550 (700)
Q Consensus 473 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~-- 550 (700)
|.+++..... .+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999975432 4899999999999999999999999 99999999999999999999999999975543322211
Q ss_pred eeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhcc
Q 005355 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEA 629 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 629 (700)
....++..|+|||.+....++.++||||||+++|||++ |..||......+ +...+..+.. ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKR---------LDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCC---------CCC
Confidence 11223578999999998889999999999999999996 999997554322 1111111111 112
Q ss_pred CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 630 KEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 630 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
+...+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 233456788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.28 Aligned_cols=242 Identities=24% Similarity=0.350 Sum_probs=197.0
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
++||+|+||.||+|+.. +++.||||+++.. .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999976 5789999987642 234456678899998876 799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~ 153 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTT 153 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC-Cccc
Confidence 99999997654 3899999999999999999999999 999999999999999999999999998753222 2223
Q ss_pred eeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccC
Q 005355 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAK 630 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 630 (700)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+..+.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-------~~~i~~~~~----------~~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-------FESILHDDV----------LYP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCC----------CCC
Confidence 345689999999999999999999999999999999999999986553321 111111111 011
Q ss_pred HHHHHHHHHHHHHHhccCCCCCC-------CHHHHHHH
Q 005355 631 EEEIITVAMLAKRCLNMIGKKRP-------TMKEAAFE 661 (700)
Q Consensus 631 ~~~~~~l~~li~~cl~~~p~~RP-------s~~evl~~ 661 (700)
......+.+|+.+||+.+|++|| +++++++.
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 12345688999999999999999 77888753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=329.78 Aligned_cols=261 Identities=23% Similarity=0.325 Sum_probs=206.3
Q ss_pred hHHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe
Q 005355 382 SMELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL---VDESNIEQFINEVAILSQINHRNVVKLLGCCLE 457 (700)
Q Consensus 382 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 457 (700)
..++....++|++.+.||+|+||.||++.+. +++.||+|++.. ......+.+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3455666789999999999999999999976 578999998753 223344567899999999999999999999999
Q ss_pred CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 458 TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 458 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
.+..++||||+++|+|.+++.... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 999999999999999999997543 888999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccCC----CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHH
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ----FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK 613 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 613 (700)
++...............||+.|+|||++.... ++.++||||||+++|||++|..||....... .+.....
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~ 261 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMN 261 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHHHc
Confidence 99865433322334566999999999987543 7889999999999999999999997654322 1111111
Q ss_pred hcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHHH
Q 005355 614 ENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKK--RPTMKEAAFEL 662 (700)
Q Consensus 614 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~L 662 (700)
....... ......+..+.+++.+||...+.+ ||+++|+++..
T Consensus 262 ~~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 HKNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1111111 111234566888999999844433 78999988853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.46 Aligned_cols=261 Identities=28% Similarity=0.437 Sum_probs=209.9
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhc-CCCceeeEEeEEEe
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVD-ESNIEQFINEVAILSQI-NHRNVVKLLGCCLE 457 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 457 (700)
....++|.+.+.||+|+||.||++.+. .+..||||+++... ....+.+.+|+.+++++ +|+||+++++.+..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 444577999999999999999999752 24579999877543 34457789999999999 79999999999999
Q ss_pred CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 458 TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 458 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
.+..+++|||+++++|.++++.... ..+++.+++.++.|++.||+|||+++ |+|+||||+|||++.++.+||+|||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999999976432 23899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhc
Q 005355 538 ASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKEN 615 (700)
Q Consensus 538 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 615 (700)
+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......+. +......+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~~~~~ 260 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEG 260 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHHHHcC
Confidence 99865433221 1222345678999999999999999999999999999998 9999875543221 11111111
Q ss_pred chhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 616 RLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 616 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
. ....+......+.+++.+||+.+|++||++.|+++.|+++
T Consensus 261 ~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 Y---------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1 0011122345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.84 Aligned_cols=266 Identities=25% Similarity=0.445 Sum_probs=211.5
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCceeeEEeEE
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT--------NGRIVAIKKSKLV-DESNIEQFINEVAILSQI-NHRNVVKLLGCC 455 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 455 (700)
....++|.+.+.||+|+||.||+++.. ....+|+|+++.. .......+.+|+++++++ +|+||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344578889999999999999999752 2457999987753 334567789999999999 699999999999
Q ss_pred EeCCcceEEEeeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 005355 456 LETEVPLLVYEFIPNGTLYQYIHDQTE-------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSAN 522 (700)
Q Consensus 456 ~~~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~N 522 (700)
.+.+..++++||+++++|.+++..... ...+++..+..++.||+.||.|||+++ ++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccccee
Confidence 999999999999999999999976421 234899999999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchh
Q 005355 523 ILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600 (700)
Q Consensus 523 ILl~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~ 600 (700)
||+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999865422211 1112224467999999999999999999999999999999 889986554322
Q ss_pred hhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 601 DKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
+...+..+... ..+...+..+.+|+.+||+.+|++||++.|+++.|+++.....
T Consensus 245 -------~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 245 -------LFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred -------HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 11222221111 1122334578899999999999999999999999999876553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=330.91 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=198.0
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.|+++++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999975 68899999876432 3345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999997653 3889999999999999999999999 9999999999999999999999999975321100
Q ss_pred ----------------------------------------------ceeeeeeecccccccccccccCCCCcccceehHH
Q 005355 547 ----------------------------------------------THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFG 580 (700)
Q Consensus 547 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG 580 (700)
........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001224689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCC---HHH
Q 005355 581 VVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT---MKE 657 (700)
Q Consensus 581 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~e 657 (700)
|+||||++|+.||......+.. ........ ...........+.+.+++.+|+ .+|++|++ +.|
T Consensus 236 vil~elltG~~Pf~~~~~~~~~------~~i~~~~~-------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQ------MKVINWQT-------SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHH------HHHHccCC-------CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 9999999999999865433211 11111000 0000111223456777888876 59999997 777
Q ss_pred HHH
Q 005355 658 AAF 660 (700)
Q Consensus 658 vl~ 660 (700)
+++
T Consensus 302 i~~ 304 (382)
T cd05625 302 IKA 304 (382)
T ss_pred Hhc
Confidence 765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=316.17 Aligned_cols=259 Identities=28% Similarity=0.446 Sum_probs=209.1
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcC------CcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTN------GRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETE 459 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 459 (700)
...++|++.+.||+|+||.||+|.+.. +..||+|.+.... ......+.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 345788999999999999999998652 3689999976543 344567899999999999999999999999999
Q ss_pred cceEEEeeCCCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEE
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTE-------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAK 532 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~k 532 (700)
..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence 99999999999999999975422 124788999999999999999999999 99999999999999999999
Q ss_pred EeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHH
Q 005355 533 VSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLE 610 (700)
Q Consensus 533 l~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 610 (700)
|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+. ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-------~~ 232 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-------LK 232 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH-------HH
Confidence 999999876543322 12223346788999999998899999999999999999998 9999875443321 11
Q ss_pred HHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 611 AMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 611 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
....+... ..+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 233 ~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 233 FVIDGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111111 1122235678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=321.14 Aligned_cols=243 Identities=26% Similarity=0.378 Sum_probs=196.0
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
++||+|+||.||++... +++.||+|+++.. .....+.+.+|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999976 5789999988742 234456788999999888 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT 153 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCce
Confidence 99999987543 3999999999999999999999999 999999999999999999999999998743222 1223
Q ss_pred eeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccC
Q 005355 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAK 630 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 630 (700)
....||+.|+|||++.+..++.++||||||++||||++|..||......+...........+..... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CCC
Confidence 3456899999999999999999999999999999999999999754433322222222222222111 112
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCH
Q 005355 631 EEEIITVAMLAKRCLNMIGKKRPTM 655 (700)
Q Consensus 631 ~~~~~~l~~li~~cl~~~p~~RPs~ 655 (700)
...+..+.+++.+||+.||++||++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 2234567889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.42 Aligned_cols=241 Identities=25% Similarity=0.358 Sum_probs=193.6
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhh-cCCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQ-INHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
+.||+|+||.||+|+.. +++.||||.++.. .....+.+..|..++.. .+||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999976 5789999987642 23334556677777765 4899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 99999997653 3899999999999999999999999 9999999999999999999999999997543222 223
Q ss_pred eeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccC
Q 005355 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAK 630 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 630 (700)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+. ...+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~-------~~~i~~~~----------~~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-------FDSILNDR----------PHFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCC----------CCCC
Confidence 345689999999999999999999999999999999999999986543221 11111111 0112
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 005355 631 EEEIITVAMLAKRCLNMIGKKRPTMK-EAAF 660 (700)
Q Consensus 631 ~~~~~~l~~li~~cl~~~p~~RPs~~-evl~ 660 (700)
......+.+|+.+||+.+|++||++. ++++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 22345678899999999999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.52 Aligned_cols=258 Identities=28% Similarity=0.434 Sum_probs=208.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcC----CcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTN----GRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
.++|.+.+.||+|+||.||+|.+.+ ...|+||...... ....+.+.+|+.++++++|+||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4568888999999999999998653 2468999877644 4566789999999999999999999998865 55789
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999976533 3899999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
...........++..|+|||.+....++.++||||||++++||++ |..||......+. ...+..+...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------~~~~~~~~~~---- 227 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-------IGRIENGERL---- 227 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHcCCcC----
Confidence 332222223334568999999988899999999999999999996 9999976543221 1111111110
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
..+...+..+.+++.+|+..+|.+|||+.++++.|+.++..
T Consensus 228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11223456788999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=309.12 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=206.7
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+|.+.+.||+|++|.||++... +++.|++|.+.. ......+.+.+|++++++++|+|++++++.+.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999976 688999998764 2345567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999998752 234899999999999999999999999 99999999999999999999999999876543322
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......+++.|+|||++.+..++.++||||||+++++|++|+.||......+ .......+.. .
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~---------~ 219 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-------LILKIIRGVF---------P 219 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC---------C
Confidence 2233457889999999999999999999999999999999999997554221 1111111111 1
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.........+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1122345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=311.68 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=207.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-C---CcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-N---GRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
..+|++.+.||+|+||.||+|.+. + +..+|+|.++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 457888999999999999999864 2 3479999876532 3445788999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++++|.+++..... .+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999986543 3899999999999999999999999 9999999999999999999999999998664
Q ss_pred cCCceeee--eeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 544 IDQTHLTT--RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 544 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
........ ...++..|+|||++.+..++.++||||||++++|+++ |..||......+ ....+..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~~--- 227 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-------VIKAIEEGYR--- 227 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-------HHHHHhCCCc---
Confidence 33322221 1223567999999999899999999999999999886 999997554322 1111221110
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
.......+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 228 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 ------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011123455788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=308.68 Aligned_cols=270 Identities=27% Similarity=0.327 Sum_probs=203.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC-----cce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETE-----VPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 462 (700)
.-.|...+++|.|.||.||+|+.. .++.||||+.....+. --+|+++|+.+.|||||+++-+|.... ...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 345667789999999999999976 5789999987654332 247999999999999999999887443 234
Q ss_pred EEEeeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEeecCCCc
Q 005355 463 LVYEFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGASR 540 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~-~~~kl~DfGl~~ 540 (700)
||||||+. +|.++++... .+..++...+.-++.||++||+|||+.+ |+||||||.|+|+|.+ +.+||+|||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999965 8999998531 2234888889999999999999999999 9999999999999976 999999999999
Q ss_pred ccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH-----HHHHh
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL-----EAMKE 614 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~ 614 (700)
.+...+.. ...+-|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.........+..++ +.+..
T Consensus 175 ~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 175 VLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 87655443 34456788999999877 579999999999999999999999999865443222221111 11111
Q ss_pred cch--hhhcchhhh-----hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH--HHHhchhh
Q 005355 615 NRL--FEVLDARVL-----KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF--ELGGIRAS 668 (700)
Q Consensus 615 ~~~--~~~~d~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~~~ 668 (700)
... .+...+++. .-......++..+|+.++|+.+|.+|.++.|++. .++.++..
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 000 011111111 1123445678999999999999999999999986 45666654
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.82 Aligned_cols=253 Identities=29% Similarity=0.488 Sum_probs=204.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
..+|++.+.||+|+||.||++.+.+++.+|+|++..... ....+.+|++++++++|+|++++++++......++|+||+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 357888899999999999999987788999998764332 2367899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
++++|.+++..... .++++.++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 82 EHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999976533 3889999999999999999999999 999999999999999999999999998755332221
Q ss_pred eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 549 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......++..|+|||++.+..++.++||||||+++|||++ |..||......+ ....+..+. ....
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~--~~~~----- 222 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VVETINAGF--RLYK----- 222 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHhCCC--CCCC-----
Confidence 1222335678999999998899999999999999999998 999987544322 111111110 0011
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
+...+..+.+|+.+||+.+|++||++.|++++|.
T Consensus 223 --~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 --PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1113457889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=320.09 Aligned_cols=241 Identities=26% Similarity=0.369 Sum_probs=196.4
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEE
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 465 (700)
+|++.+.||+|+||.||+|... +++.||||++... .....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788999999999999999976 5789999987642 223345677788888877 5899999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999997653 3899999999999999999999999 999999999999999999999999998754322
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+.....
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-------~~~i~~~~~-------- 218 (323)
T cd05616 155 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-------FQSIMEHNV-------- 218 (323)
T ss_pred C-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC--------
Confidence 2 123345689999999999999999999999999999999999999976543221 111111111
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTM 655 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~ 655 (700)
..+.....++.+|+.+||+.+|.+|++.
T Consensus 219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 --AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1122345578899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.64 Aligned_cols=264 Identities=23% Similarity=0.347 Sum_probs=201.7
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
++|.+.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 67899999999999999999976 67889999876533 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++ +|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 974 88888876533 3789999999999999999999999 99999999999999999999999999875432221
Q ss_pred eeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc----
Q 005355 548 HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD---- 622 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d---- 622 (700)
......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||......+................+..+..
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1223457899999999865 5688999999999999999999999987654432222111100000000000000
Q ss_pred --hhhhh-------ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 623 --ARVLK-------EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 623 --~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..... .........+.+|+.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 011123456789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=309.32 Aligned_cols=250 Identities=26% Similarity=0.449 Sum_probs=203.2
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEE-eCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL-ETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~ 467 (700)
.++|++.+.||+|+||.||++... +..||+|..+... ..+.+.+|+.++++++|+|++++++++. +.+..++++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 457889999999999999999876 7889999876432 3467899999999999999999999765 45678999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++..... ..+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 999999999976532 24889999999999999999999999 9999999999999999999999999987543221
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+..+..
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~--------- 217 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYK--------- 217 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCC---------
Confidence 22334568999999999999999999999999999997 999986543222 1111211110
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
.......+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 111223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.97 Aligned_cols=264 Identities=24% Similarity=0.378 Sum_probs=204.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcC---------------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTN---------------GRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLL 452 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~ 452 (700)
.++|++.+.||+|+||.||++.... ...||+|+++.. .....+.|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4689999999999999999987532 235899988653 344556799999999999999999999
Q ss_pred eEEEeCCcceEEEeeCCCCCHHHHHhccCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 005355 453 GCCLETEVPLLVYEFIPNGTLYQYIHDQTE---------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANI 523 (700)
Q Consensus 453 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NI 523 (700)
+++...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999965321 123788999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh--CCCCCCCCCchh
Q 005355 524 LLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT--GQKPIRSTDSEE 600 (700)
Q Consensus 524 Ll~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt--g~~p~~~~~~~~ 600 (700)
++++++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++++|++ +..||......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999765332211 1222335678999999998899999999999999999998 667776544332
Q ss_pred hhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 601 DKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
.... ........ ........+...+..+.+|+.+||+.+|++||++.+|++.|++
T Consensus 241 ~~~~---~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIEN---TGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHH---HHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111 11111100 0000011122234679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=323.83 Aligned_cols=239 Identities=27% Similarity=0.351 Sum_probs=194.8
Q ss_pred cceEeeeCCeEEEEEEE----cCCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 395 NRILGQGGQGTVYKGML----TNGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
++.||+|+||.||+++. ..++.||+|++.... ......+.+|++++++++||||+++++.+.+.+..++||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999875 257899999887532 223456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 81 RGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 9999999997543 3899999999999999999999999 9999999999999999999999999987543221 2
Q ss_pred eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhc
Q 005355 549 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE 628 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 628 (700)
......|++.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+..... .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-------~~~i~~~~~----------~ 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET-------MTMILKAKL----------G 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH-------HHHHHcCCC----------C
Confidence 23345689999999999998999999999999999999999999976543221 111111111 1
Q ss_pred cCHHHHHHHHHHHHHHhccCCCCCCCHHH
Q 005355 629 AKEEEIITVAMLAKRCLNMIGKKRPTMKE 657 (700)
Q Consensus 629 ~~~~~~~~l~~li~~cl~~~p~~RPs~~e 657 (700)
.+......+.+|+.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 12233456889999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=298.93 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=205.2
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
.+.|++-+.||+|.|+.|++.... .|+.+|+|++.. ......+++.+|++|-+.|+||||+++.+...+....+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 467788889999999999998865 688888887543 33446788999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC---CCCcEEEeecCCCccc
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGASRSV 542 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~---~~~~~kl~DfGl~~~~ 542 (700)
|+|.+++|..-|-.. ...++..+-..++||++||.|+|.++ |||||+||+|+|+- ...-+||+|||++..+
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999998766543 23788889999999999999999999 99999999999994 3456999999999877
Q ss_pred ccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
. .........||+.|||||++...+|+..+|||+.|||||-|+.|.+||.+.+... +.+.+..+...
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-------lye~I~~g~yd---- 230 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYEQIKAGAYD---- 230 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-------HHHHHhccccC----
Confidence 5 3334445679999999999999999999999999999999999999998644322 23333333221
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+.........++..+|+++||..||.+|.|+.|.|.
T Consensus 231 --~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 --YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111122345567889999999999999999988764
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.09 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=204.2
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.++|++.+.||+|+||.||+|+.. +++.||+|+...........+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 467999999999999999999974 6889999998765555566788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.++++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 88 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 99999999997543 3899999999999999999999999 9999999999999999999999999997653221
Q ss_pred eeeeeeecccccccccccc---cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 548 HLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
.......++..|+|||.+. ...++.++||||||+++|||++|+.||......+.. . .+....+ ..+.
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~------~-~~~~~~~---~~~~ 230 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------F-LMSKSNF---QPPK 230 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh------e-eeecCCC---CCCC
Confidence 1122345888999999884 345788999999999999999999998644322110 0 0000000 0000
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L 662 (700)
. ......+..+.+++.+||+.+|++||+++++++.|
T Consensus 231 ~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 L--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 01123456788999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.59 Aligned_cols=252 Identities=33% Similarity=0.550 Sum_probs=202.2
Q ss_pred CCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHH--HHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 392 FNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIE--QFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
|++.+.||+|+||+||+++.. +++.||+|++......... ...+|+.++++++|+||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999987 5678999998876554433 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
++++|.+++.... .+++..++.++.||++||++||+.+ ++|+||||+||+++.++.++|+|||.+... .....
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNE 153 (260)
T ss_dssp TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTS
T ss_pred ccccccccccccc---ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc-ccccc
Confidence 9999999998332 3899999999999999999999999 999999999999999999999999998754 22233
Q ss_pred eeeeeecccccccccccc-cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 549 LTTRVQGTFGYLDPEYFR-SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......++..|+|||++. +..++.++||||||+++++|++|..||............... .. ... ......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~---~~-~~~----~~~~~~ 225 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKI---LK-RPL----PSSSQQ 225 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHH---HH-THH----HHHTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhc---cc-ccc----cccccc
Confidence 344556899999999998 889999999999999999999999999866322221111111 10 000 000000
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.......+.+++.+||+.+|++||++.++++
T Consensus 226 --~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 --SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011267899999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=331.65 Aligned_cols=252 Identities=23% Similarity=0.297 Sum_probs=199.8
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++++.||+|+||.||+++.. +++.||||++.... ......+.+|++++++++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999975 58899999876422 234567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999997653 3889999999999999999999999 999999999999999999999999997532100
Q ss_pred C------------------------------------------ceeeeeeecccccccccccccCCCCcccceehHHHHH
Q 005355 546 Q------------------------------------------THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVL 583 (700)
Q Consensus 546 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il 583 (700)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001134689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCC---CHHHHHH
Q 005355 584 VELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRP---TMKEAAF 660 (700)
Q Consensus 584 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---s~~evl~ 660 (700)
|||++|+.||......+... .+..... . ............+.+++.+|+ .+|.+|+ ++.|+++
T Consensus 235 yell~G~~Pf~~~~~~~~~~-------~i~~~~~--~----~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQL-------KVINWET--T----LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHHHH-------HHhccCc--c----ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999999998665432110 1111000 0 000011123456777888876 5999999 8899887
Q ss_pred H
Q 005355 661 E 661 (700)
Q Consensus 661 ~ 661 (700)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=315.82 Aligned_cols=250 Identities=27% Similarity=0.416 Sum_probs=206.4
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
..+|++.+.||+|+||.||+|... +++.|++|.+........+.+.+|+.+++.++|+||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 467888999999999999999965 6889999988766555667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 9999999999653 2889999999999999999999999 99999999999999999999999999875432221
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||........ .......... . .
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~~~~~~~-~-------~ 236 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP-E-------L 236 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHHhcCCCC-C-------C
Confidence 12234588899999999988899999999999999999999999975543221 1111111100 0 0
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+......+.+++.+||..+|++||+++|+++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 112334567889999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=306.76 Aligned_cols=269 Identities=25% Similarity=0.300 Sum_probs=218.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcC-CcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTN-GRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.+.|++++.||+|.-|+||++.+++ +..+|+|++... ......+...|-+||+.+.||.++.|++.+..++..+|+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 4567778999999999999999874 589999998753 344456778899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||++||+|..+++++..+ .+++..+..++.+++-||+|||-.| ||+|||||+||||.++|++-|+||.|+.....
T Consensus 156 meyCpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EecCCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999999987654 4999999999999999999999999 99999999999999999999999998764311
Q ss_pred ---------------------------------CCc----------------------eeeeeeecccccccccccccCC
Q 005355 545 ---------------------------------DQT----------------------HLTTRVQGTFGYLDPEYFRSSQ 569 (700)
Q Consensus 545 ---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~ 569 (700)
... ......+||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 0112246899999999999999
Q ss_pred CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCC
Q 005355 570 FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIG 649 (700)
Q Consensus 570 ~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p 649 (700)
.+.++|+|+||++||||+.|..||.+.+..+- +..++.+.+.-......+..+.+||+++|..||
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence 99999999999999999999999998876542 233333333222233667789999999999999
Q ss_pred CCCCC----HHHHHH--HHHhchhhcCCCccCC
Q 005355 650 KKRPT----MKEAAF--ELGGIRASIGDSIMQH 676 (700)
Q Consensus 650 ~~RPs----~~evl~--~L~~l~~~~~~~~~~~ 676 (700)
.+|.- +.||-+ .+++++=.+..+..+.
T Consensus 377 ~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP 409 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKRHPFFEGVNWALIRCARPP 409 (459)
T ss_pred hhhhccccchHHhhcCccccCCChhheeccCCC
Confidence 99998 777765 4555554444444443
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=311.32 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=204.7
Q ss_pred cCCCccceEeeeCCeEEEEEEEcC-C---cEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLTN-G---RIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
..|++.+.||+|+||.||+|.+.. + ..||||.++.. .....+.|..|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457888999999999999999753 3 36999998754 445567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++++|.+++..... .+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999976533 3899999999999999999999999 99999999999999999999999999875533
Q ss_pred CCceee--eeee--cccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 545 DQTHLT--TRVQ--GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 545 ~~~~~~--~~~~--gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
...... .... .+..|+|||++....++.++||||||+++|||++ |..||......+ ....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-------~~~~i~~~~~-- 229 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VINAIEQDYR-- 229 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCc--
Confidence 221111 1111 2457999999999999999999999999999886 999997544322 1111111100
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
...+.+.+..+.+++.+||+.+|.+||++++++..|+++
T Consensus 230 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 -------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011123345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=312.98 Aligned_cols=259 Identities=26% Similarity=0.468 Sum_probs=206.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGR----IVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
.++|++.++||+|+||+||+|++. +++ .||+|.++.. .....+.+.+|+.+++.++|+||+++++.+... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 467888999999999999999864 344 4899987653 344467789999999999999999999998754 568
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+++||+++|+|.++++.... .+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999976533 3899999999999999999999999 999999999999999999999999999866
Q ss_pred ccCCcee-eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 543 MIDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 543 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||........ ...+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~-- 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI-------PDLLEKGERL-- 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCcC--
Confidence 4332221 112234678999999999999999999999999999998 8999865433221 1111111111
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
..+...+..+.+++.+||+.||++||++.++++.|+.+....
T Consensus 231 -------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 -------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 111234457889999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.71 Aligned_cols=241 Identities=24% Similarity=0.368 Sum_probs=197.2
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
+.||+|+||+||++.+. +++.||||+++.. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999976 5789999987742 233456678899999887 799999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTT 153 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccc
Confidence 99999987653 3899999999999999999999999 9999999999999999999999999987532222 222
Q ss_pred eeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccC
Q 005355 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAK 630 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 630 (700)
....|++.|+|||++.+..++.++||||||+++|+|++|+.||......+ ....+..... ..+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~-------~~~~i~~~~~----------~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE-------LFQSILEDEV----------RYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCC----------CCC
Confidence 33568999999999999999999999999999999999999997554322 1111111111 112
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCH-----HHHHH
Q 005355 631 EEEIITVAMLAKRCLNMIGKKRPTM-----KEAAF 660 (700)
Q Consensus 631 ~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~ 660 (700)
...+..+.+|+.+||+.||++||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 2334578899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=310.39 Aligned_cols=250 Identities=26% Similarity=0.439 Sum_probs=198.2
Q ss_pred ceEeeeCCeEEEEEEEcC-Cc--EEEEEEccc-cChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLTN-GR--IVAIKKSKL-VDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
++||+|+||.||+|.+.+ +. .+++|..+. ......+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999753 43 568888774 3345567899999999999 799999999999999999999999999
Q ss_pred CCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 471 GTLYQYIHDQTE-------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 471 gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999975421 124789999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcc
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENR 616 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 616 (700)
++...... ........+..|+|||++....++.++||||||++++||++ |..||......+ ....+..+.
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~ 228 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQGY 228 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-------HHHHHhCCC
Confidence 98632211 11111223567999999998899999999999999999997 999996543221 111111111
Q ss_pred hhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 617 LFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 617 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
. .+.+......+.+|+.+||+.+|.+|||+.++++.|+++.
T Consensus 229 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 R---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 0111223456889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=307.94 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=205.2
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
+|++.++||+|+||.||++... +++.+|+|.++. ......+.+.+|+.++++++|+||+++++.+.+.+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999976 688999998764 23445678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
++++|.+++..... ..+++..++.++.|++.||.|||+++ |+|+||||+||++++++.++|+|||++...... ..
T Consensus 81 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GA 155 (255)
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc-cc
Confidence 99999999875432 34789999999999999999999999 999999999999999999999999998755322 22
Q ss_pred eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhc
Q 005355 549 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE 628 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 628 (700)
......+++.|+|||++.+..++.++|+||||+++|+|++|..||....... .......+... .
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN-------LILKVCQGSYK---------P 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH-------HHHHHhcCCCC---------C
Confidence 2234558889999999999999999999999999999999999997543221 11111122111 1
Q ss_pred cCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 629 AKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 629 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.+...+..+.+|+.+||+.+|++||++.|++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=307.60 Aligned_cols=248 Identities=28% Similarity=0.447 Sum_probs=199.7
Q ss_pred ceEeeeCCeEEEEEEEcC----CcEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLTN----GRIVAIKKSKLVDE-SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
++||+|+||.||+|++.. +..+|+|.+..... ...+.+.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998642 26899998775443 34578999999999999999999999875 4567999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
++|.+++.... .+++..++.++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999998654 4899999999999999999999999 99999999999999999999999999986643332211
Q ss_pred e--eeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 551 T--RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 551 ~--~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
. ...++..|+|||.+.+..++.++||||||+++|+|++ |..||......+ +...+..... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-------VIAMLESGER---------L 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCCc---------C
Confidence 1 1223467999999999999999999999999999998 999997554322 1112222111 0
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
..+...+..+.+++.+||..+|++||++.++++.|+++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 112234457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=320.63 Aligned_cols=255 Identities=21% Similarity=0.339 Sum_probs=200.5
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL---VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.+.||+|+||.||+++.. +++.||+|++.. ......+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999976 588999998764 22334566889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++|+|.+++.+... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999976432 3899999999999999999999999 999999999999999999999999998765433
Q ss_pred Cceeeeeeeccccccccccccc-----CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
.........||+.|+|||++.. ..++.++||||||+++|||++|+.||......+. +...........+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~~ 229 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKEHFQF 229 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCcccC
Confidence 3323333568999999999863 4578899999999999999999999975443221 1111111110000
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKK--RPTMKEAAFE 661 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~ 661 (700)
.......+..+.+++++||...+++ ||+++++++.
T Consensus 230 ------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 ------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0111124557788999988654443 7899999885
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.18 Aligned_cols=246 Identities=22% Similarity=0.292 Sum_probs=196.2
Q ss_pred EeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCH
Q 005355 398 LGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 473 (700)
Q Consensus 398 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 473 (700)
||+|+||+||++.+. +++.||+|++.... ....+.+..|++++++++|+||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999976 68899999876422 22345678899999999999999999999999999999999999999
Q ss_pred HHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeee
Q 005355 474 YQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTR 552 (700)
Q Consensus 474 ~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~ 552 (700)
.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 99886432 2345899999999999999999999999 99999999999999999999999999876533222 2233
Q ss_pred eecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHH
Q 005355 553 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEE 632 (700)
Q Consensus 553 ~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 632 (700)
..|++.|+|||++.+..++.++||||||+++|||++|+.||.......... ...... .... ...+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~--------~~~~--~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---ELKQRI--------LNDS--VTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH---HHHHhh--------cccC--CCCccc
Confidence 468999999999999999999999999999999999999997544321110 000000 0000 011233
Q ss_pred HHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005355 633 EIITVAMLAKRCLNMIGKKRP-----TMKEAAF 660 (700)
Q Consensus 633 ~~~~l~~li~~cl~~~p~~RP-----s~~evl~ 660 (700)
.+..+.+++.+||+.+|++|| +++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 556788999999999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=317.43 Aligned_cols=241 Identities=27% Similarity=0.355 Sum_probs=194.1
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhh-cCCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQ-INHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
+.||+|+||.||+|.+. +++.||||+++.. .....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999976 5789999987653 12334566778888876 4899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKT 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cce
Confidence 99999997643 3899999999999999999999999 9999999999999999999999999987532222 123
Q ss_pred eeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccC
Q 005355 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAK 630 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 630 (700)
....||..|+|||++.+..++.++||||||+++|||++|..||......+. ...+..... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-------~~~i~~~~~----------~~~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-------FQSIRMDNP----------CYP 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC----------CCC
Confidence 345689999999999999999999999999999999999999976543221 111111110 011
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 005355 631 EEEIITVAMLAKRCLNMIGKKRPTMK-EAAF 660 (700)
Q Consensus 631 ~~~~~~l~~li~~cl~~~p~~RPs~~-evl~ 660 (700)
......+.+|+.+||+.+|++||++. ++++
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 22345678899999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=318.78 Aligned_cols=240 Identities=25% Similarity=0.366 Sum_probs=193.7
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
++||+|+||.||++++. +++.||+|.++.. .....+.+..|..++..+ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999976 6889999987642 123445677788888764 899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence 99999987643 3899999999999999999999999 9999999999999999999999999987432221 223
Q ss_pred eeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccC
Q 005355 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAK 630 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 630 (700)
....||+.|+|||++.+..++.++||||||+++|||++|..||......+ ....+.... + ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-------~~~~~~~~~------~----~~~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-------LFESIRVDT------P----HYP 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCC------C----CCC
Confidence 34568999999999999999999999999999999999999997654322 111111111 0 111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHH-HHH
Q 005355 631 EEEIITVAMLAKRCLNMIGKKRPTMK-EAA 659 (700)
Q Consensus 631 ~~~~~~l~~li~~cl~~~p~~RPs~~-evl 659 (700)
......+.+|+.+||+.||++||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 22345678899999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=305.34 Aligned_cols=247 Identities=27% Similarity=0.458 Sum_probs=201.2
Q ss_pred ceEeeeCCeEEEEEEEcCCcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCHH
Q 005355 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDES-NIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLY 474 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 474 (700)
++||+|+||.||++.+.+++.|++|+....... ..+.+.+|++++++++|+||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999987764433 5678999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee-eee
Q 005355 475 QYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT-TRV 553 (700)
Q Consensus 475 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~-~~~ 553 (700)
+++..... .+++..++.++.+++.||+|||+++ ++||||||+|||++.++.+||+|||++........... ...
T Consensus 81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99976433 3889999999999999999999999 99999999999999999999999999875532211111 112
Q ss_pred ecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHH
Q 005355 554 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEE 632 (700)
Q Consensus 554 ~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 632 (700)
..+..|+|||.+.+..++.++||||||++++||++ |..||........ ...+.... ....+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~-------~~~~~~~~---------~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT-------RERIESGY---------RMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH-------HHHHhcCC---------CCCCCcc
Confidence 24567999999998899999999999999999999 8888865543221 11111110 0011223
Q ss_pred HHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 633 EIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 633 ~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
.+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 4557899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=315.14 Aligned_cols=258 Identities=25% Similarity=0.450 Sum_probs=207.3
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEV 460 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 460 (700)
..++|++.+.||+|+||.||++.+. ++..||+|++.... ......+.+|+.++++++|+||+++++++.+.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 4578999999999999999999864 36789999887543 3445679999999999999999999999999999
Q ss_pred ceEEEeeCCCCCHHHHHhccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTE-------------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSA 521 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~-------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~ 521 (700)
.++++||+++++|.+++..... ...+++..++.++.|++.||+|||+++ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 9999999999999999975321 124788999999999999999999999 999999999
Q ss_pred cEEECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCch
Q 005355 522 NILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSE 599 (700)
Q Consensus 522 NILl~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~ 599 (700)
||+++.++.+||+|||++......... .......+..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999998754322211 1122234667999999998999999999999999999997 88888654432
Q ss_pred hhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 600 EDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
+ ....+..+... ..+...+..+.+|+.+||+.+|++|||+.|+++.|++
T Consensus 240 ~-------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 E-------VIYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H-------HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 2 11222222211 1112345678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=313.62 Aligned_cols=265 Identities=25% Similarity=0.407 Sum_probs=207.6
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcC-----------------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCcee
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTN-----------------GRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVV 449 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 449 (700)
..++|++.+.||+|+||.||++.+.. +..||+|.+... .....+.+.+|++++++++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 35688999999999999999988642 245899987753 334567899999999999999999
Q ss_pred eEEeEEEeCCcceEEEeeCCCCCHHHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 005355 450 KLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTE--------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSA 521 (700)
Q Consensus 450 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~ 521 (700)
++++++...+..++++|++++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence 999999999999999999999999999976541 124899999999999999999999999 999999999
Q ss_pred cEEECCCCcEEEeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh--CCCCCCCCCc
Q 005355 522 NILLDDKYRAKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT--GQKPIRSTDS 598 (700)
Q Consensus 522 NILl~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt--g~~p~~~~~~ 598 (700)
||+++.++.++|+|||+++....... .......++..|+|||++....++.++||||||+++|||++ +..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999876533221 12233446778999999998899999999999999999998 6777764432
Q ss_pred hhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 599 EEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
.+ ............. .......+...+.++.+|+.+||+.+|++|||+.||++.|++
T Consensus 240 ~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 QQ---VIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HH---HHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 22 1111111111100 011111122334678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=320.53 Aligned_cols=237 Identities=26% Similarity=0.384 Sum_probs=190.7
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHH-HHhhcCCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVA-ILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
++||+|+||+||+|... +++.||||++.... ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999976 68999999876421 223344555555 45779999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTT 153 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcc
Confidence 99999997643 3899999999999999999999999 999999999999999999999999998753222 2223
Q ss_pred eeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccC
Q 005355 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAK 630 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 630 (700)
....||+.|+|||++.+..++.++||||||+++|||++|..||...+..+. ...+..... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~~----------~~~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-------YDNILNKPL----------RLK 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH-------HHHHHcCCC----------CCC
Confidence 345689999999999999999999999999999999999999976543221 111111111 111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHH
Q 005355 631 EEEIITVAMLAKRCLNMIGKKRPTMK 656 (700)
Q Consensus 631 ~~~~~~l~~li~~cl~~~p~~RPs~~ 656 (700)
...+..+.+++.+||+.+|.+||+++
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 22356788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=310.20 Aligned_cols=251 Identities=26% Similarity=0.403 Sum_probs=200.4
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
++|++.++||+|+||.||+|.+. +++.||+|..... .....+.+.+|++++++++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36788899999999999999964 6889999987643 334456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999997653 2788899999999999999999999 999999999999999999999999999755322
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......++..|+|||++.+..++.++||||||+++|+|++|+.||......+...........+..... + .
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~---~ 219 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-----P---V 219 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-----C---C
Confidence 223346889999999999999999999999999999999999999754322211111111111111100 0 0
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
........++.+++.+||+.+|++||+++|+++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0112234578899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=311.32 Aligned_cols=251 Identities=29% Similarity=0.352 Sum_probs=201.5
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.|+..+.||+|+||.||++.+. +++.||||.+.... ....+.+.+|+.++++++|+|++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677889999999999999976 68899999876422 2234567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999999865432 24899999999999999999999999 9999999999999999999999999987543222
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
. .....|+..|+|||++.+..++.++||||||+++|+|++|+.||..............+... ..
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-------------~~ 221 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-------------VQ 221 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-------------hh
Confidence 1 22346899999999999999999999999999999999999999764322111111111000 00
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPT-----MKEAAF 660 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~ 660 (700)
...+......+.+|+.+||+.||++||| ++|+++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1112234456889999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=313.80 Aligned_cols=265 Identities=24% Similarity=0.382 Sum_probs=205.6
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-----------------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCcee
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-----------------NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVV 449 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 449 (700)
+.++|++.++||+|+||.||++.+. +...||+|++... .....+.+.+|+++++.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3467999999999999999998643 2346899988753 344567899999999999999999
Q ss_pred eEEeEEEeCCcceEEEeeCCCCCHHHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 005355 450 KLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTE--------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSA 521 (700)
Q Consensus 450 ~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~ 521 (700)
++++++...+..+++|||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence 999999999999999999999999999976431 124788899999999999999999999 999999999
Q ss_pred cEEECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh--CCCCCCCCCc
Q 005355 522 NILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT--GQKPIRSTDS 598 (700)
Q Consensus 522 NILl~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt--g~~p~~~~~~ 598 (700)
|||++.++.++|+|||++......... ......++..|+|||+.....++.++||||||+++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999999765332211 1122334678999999888889999999999999999998 7788865443
Q ss_pred hhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 599 EEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
.+.. ............ ......+...+..+.+|+.+||+.+|++||++.||++.|++
T Consensus 240 ~~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQVI---ENTGEFFRDQGR------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHH---HHHHHHHhhccc------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 2211 111111110000 00001122344678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.86 Aligned_cols=262 Identities=27% Similarity=0.411 Sum_probs=204.6
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-----CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC--Ccc
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-----NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLET--EVP 461 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 461 (700)
..|++.+.||+|+||.||++++. +++.||+|.++... ....+.+.+|++++++++|+|++++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 45788999999999999999842 47889999987543 44457899999999999999999999998875 567
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 899999999999999976432 3899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCce--eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchh--------hhhHHHHHHHH
Q 005355 542 VMIDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE--------DKSLVGYFLEA 611 (700)
Q Consensus 542 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~--------~~~~~~~~~~~ 611 (700)
....... ......++..|+|||++.+..++.++||||||+++|||+++..|........ ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 5433221 1223446778999999998899999999999999999999876643211100 00001111111
Q ss_pred HHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 612 MKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 612 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
...+.. ...+...+..+.+|+.+||+.+|++||+++++++.|+.+
T Consensus 239 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGKR---------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCcc---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111 111223456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=322.52 Aligned_cols=263 Identities=28% Similarity=0.432 Sum_probs=205.7
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEE------cCCcEEEEEEccccC-hhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeC
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGML------TNGRIVAIKKSKLVD-ESNIEQFINEVAILSQI-NHRNVVKLLGCCLET 458 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 458 (700)
...++|++.+.||+|+||.||+|.+ ..++.||||+++... ......+.+|+.++.++ +|+||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3467899999999999999999974 246789999987532 33456788999999999 689999999988654
Q ss_pred -CcceEEEeeCCCCCHHHHHhccCC-------------------------------------------------------
Q 005355 459 -EVPLLVYEFIPNGTLYQYIHDQTE------------------------------------------------------- 482 (700)
Q Consensus 459 -~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------- 482 (700)
...+++|||+++|+|.++++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 456899999999999999975321
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce-eeee
Q 005355 483 ---------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH-LTTR 552 (700)
Q Consensus 483 ---------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~-~~~~ 552 (700)
...+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 123688889999999999999999999 999999999999999999999999998765322211 1122
Q ss_pred eecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCH
Q 005355 553 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKE 631 (700)
Q Consensus 553 ~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 631 (700)
..++..|+|||++.+..++.++||||||+++|+|++ |..||......+. +......+.... .+.
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~~---------~~~ 305 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMR---------APD 305 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCCCC---------CCC
Confidence 335678999999999999999999999999999997 9999875433221 111122211110 111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 632 EEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 632 ~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
.....+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 123468899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.35 Aligned_cols=271 Identities=24% Similarity=0.357 Sum_probs=205.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++|+||+++++++...+..++|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 357889999999999999999976 57899999876432 3334567899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|++ ++|.+++..... .+++..+..++.||++||+|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 85 YLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 996 689998876533 3889999999999999999999999 9999999999999999999999999987543222
Q ss_pred ceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch--
Q 005355 547 THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA-- 623 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-- 623 (700)
. ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+................+..++..
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 1 1223346889999999865 45788999999999999999999999866543321111111000000111111100
Q ss_pred -------hh----hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH--HHHhch
Q 005355 624 -------RV----LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF--ELGGIR 666 (700)
Q Consensus 624 -------~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~ 666 (700)
.. ...........+.+|+.+||+.||.+|||++|+++ .++.++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 00 00011123456889999999999999999999987 444444
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=310.87 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=196.3
Q ss_pred EeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCH
Q 005355 398 LGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 473 (700)
Q Consensus 398 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 473 (700)
||+|+||.||++..+ +++.||+|.+.... ......+..|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999975 68999999876321 22234566799999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeeee
Q 005355 474 YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRV 553 (700)
Q Consensus 474 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~ 553 (700)
.+++..... ..+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++...... ......
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~ 154 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQR 154 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeecc
Confidence 999865432 34899999999999999999999999 999999999999999999999999998765322 222334
Q ss_pred ecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHH
Q 005355 554 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEE 633 (700)
Q Consensus 554 ~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 633 (700)
.++..|+|||++.+..++.++||||||+++|||++|+.||.......... . ......... +. ......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~-~~~~~~~~~--------~~-~~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--E-LKRRTLEDE--------VK-FEHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--H-HHHHhhccc--------cc-cccccC
Confidence 68999999999999899999999999999999999999997543321110 0 111111111 00 001124
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 634 IITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 634 ~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
+.++.+|+.+||+.||++||+++|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 556889999999999999999988775553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=310.19 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=208.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVDES-NIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
.++|++.+.||+|+||.||+|+.+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 367889999999999999999964 2467999987764443 567899999999999999999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEee
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEE------FPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~D 535 (700)
++||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence 9999999999999999865422 14899999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHh
Q 005355 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKE 614 (700)
Q Consensus 536 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 614 (700)
||++...............++..|+|||.+.+..++.++||||||+++++|++ |..||....... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~~~ 233 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQA 233 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHHHc
Confidence 99987543333223333456778999999988889999999999999999999 888886443221 1112222
Q ss_pred cchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 615 NRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 615 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
+.+.. ......+..+.+++.+||+.+|++||++.|++++|.
T Consensus 234 ~~~~~--------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLEL--------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 22111 111233457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=333.22 Aligned_cols=261 Identities=23% Similarity=0.333 Sum_probs=195.3
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC-------
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLET------- 458 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 458 (700)
....+|++.++||+|+||.||+|... .++.||||++.... ....+|+.+++.++|+||+++++++...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 34578999999999999999999975 68899999875422 2345799999999999999999886432
Q ss_pred -CcceEEEeeCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEee
Q 005355 459 -EVPLLVYEFIPNGTLYQYIHDQ-TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY-RAKVSD 535 (700)
Q Consensus 459 -~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~-~~kl~D 535 (700)
...++||||++ ++|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence 23568999997 4787777542 22345899999999999999999999999 99999999999998664 799999
Q ss_pred cCCCcccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh
Q 005355 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE 614 (700)
Q Consensus 536 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 614 (700)
||+++....... .....+|+.|+|||++.+ ..++.++||||||++||||++|.+||.+....+.... ..+....
T Consensus 215 FGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~---i~~~~~~ 289 (440)
T PTZ00036 215 FGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVR---IIQVLGT 289 (440)
T ss_pred cccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCC
Confidence 999986543222 223457999999999876 4689999999999999999999999986554322111 1111000
Q ss_pred c---------------chhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 615 N---------------RLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 615 ~---------------~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. .+..+....+....+...+.++.+|+.+||+.+|.+|||+.|+++
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0 000001111111122234567899999999999999999999985
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=307.56 Aligned_cols=259 Identities=26% Similarity=0.379 Sum_probs=206.0
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
|++.+++++.....||+|+||.||+|++. ++..|++|.+........+.+.+|+.++++++|+||+++++++...+..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34566777777889999999999999965 57789999888766667788999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEeecCCCcc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGASRS 541 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~-~~~~kl~DfGl~~~ 541 (700)
+|+||+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 99999999999999986533212388889999999999999999999 999999999999976 67999999999875
Q ss_pred cccCCceeeeeeecccccccccccccCC--CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
...... ......+++.|+|||++.... ++.++||||||+++|+|++|..||......... . ......
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~-~~~~~~------ 227 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---M-FKVGMF------ 227 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---H-hhhhhh------
Confidence 432221 122334788999999986643 788999999999999999999999654322110 0 000000
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
......+.....++.+++.+||+.+|.+|||+.|+++
T Consensus 228 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 ----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0011122334567889999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=306.32 Aligned_cols=249 Identities=33% Similarity=0.502 Sum_probs=205.5
Q ss_pred ceEeeeCCeEEEEEEEcC----CcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLTN----GRIVAIKKSKLVDES-NIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
+.||+|+||.||++.... +..|++|.+...... ..+.+.+|+++++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999764 788999998765443 368899999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 471 GTLYQYIHDQTE------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 471 gsL~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
++|.+++..... ...+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999987521 245999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 545 DQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 545 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
... .......++..|+|||.+....++.++||||||+++++|++ |..||......+ +......+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC-----
Confidence 321 12233457889999999998899999999999999999999 699997663322 1112221110
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
...+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1122334567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=316.27 Aligned_cols=263 Identities=29% Similarity=0.422 Sum_probs=203.6
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
++|++.+.||+|+||.||++.+. ++..+|+|.+... ......++.+|++++++++||||+++++.+.+.+..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46899999999999999999976 5788999987653 334456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
+++++|.+++.... .+++..+..++.|+++||.|||+ .+ ++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999997653 38999999999999999999997 47 999999999999999999999999998754322
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh------------
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE------------ 614 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 614 (700)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.................
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 123346889999999998888999999999999999999999999654422211111000000000
Q ss_pred -----cchhhhcchhhh----hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 615 -----NRLFEVLDARVL----KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 615 -----~~~~~~~d~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
....+..+.... ..........+.+|+.+||+.+|++||+++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 00001234568999999999999999999999885
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.66 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=213.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
..-|.+.+.||+|.|..|-+|++- .|++||||++.. .+......+++|++-|+.++|||||+|+++.......|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 456788889999999999999854 799999999875 33445678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-CCCcEEEeecCCCccccc
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~-~~~~~kl~DfGl~~~~~~ 544 (700)
|+=++|+|+|||-++... +.++...+++.||+.|+.|+|+.. +|||||||+||.+- .-|-|||+|||++..+.+
T Consensus 97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999999887665 999999999999999999999999 99999999999885 568899999999986643
Q ss_pred CCceeeeeeecccccccccccccCCCC-cccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
. ...++.+|.+.|.|||++.+..|. +++||||||||||.|++|++||+..+..| .+..++|-
T Consensus 172 G--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImDC 234 (864)
T KOG4717|consen 172 G--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMDC 234 (864)
T ss_pred c--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhcc
Confidence 3 345667899999999999998886 57899999999999999999998665443 23334444
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.. ..+.....+..+||..||..||++|.+.+|+..
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 32 345667888999999999999999999999875
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=310.31 Aligned_cols=251 Identities=25% Similarity=0.316 Sum_probs=200.9
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.|+..+.||+|+||+||++.+. +++.||+|.+.... ......+.+|++++++++|+|++++.+.+...+..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677889999999999999975 68899999876432 2334567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred eccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999999876432 24999999999999999999999999 9999999999999999999999999986543221
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||............ ........
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~---~~~~~~~~---------- 221 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV---DRRVLETE---------- 221 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhhhccc----------
Confidence 123346899999999999999999999999999999999999999765432221111 11111100
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPT-----MKEAAF 660 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~ 660 (700)
..........+.+|+.+||+.+|++||+ +.++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0112233456789999999999999999 556665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=312.28 Aligned_cols=260 Identities=24% Similarity=0.352 Sum_probs=195.3
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhc---CCCceeeEEeEEEeC-----C
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQI---NHRNVVKLLGCCLET-----E 459 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 459 (700)
+|++.+.||+|+||+||+|... +++.||+|.++... ......+.+|+++++++ +|+||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5788999999999999999976 68899999876432 22234566777777665 799999999988642 4
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
..++++||++ ++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 5689999997 589998876532 23899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHH---hcc
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK---ENR 616 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 616 (700)
...... .......++..|+|||++.+..++.++||||||+++|+|++|.+||......+.. ........ ...
T Consensus 156 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDLIGLPPEDD 230 (288)
T ss_pred ccccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH---HHHHHHhCCCChhh
Confidence 765322 1223345789999999999999999999999999999999999999755432211 11111110 000
Q ss_pred hhh-------hc---chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 617 LFE-------VL---DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 617 ~~~-------~~---d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+.. .. ...............+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00 000001111234556889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=318.64 Aligned_cols=255 Identities=20% Similarity=0.314 Sum_probs=200.7
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.++||+|+||.||+++++ .++.+|+|++... .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999976 5778999987532 2233456888999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++|+|.+++.+... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999986433 3899999999999999999999999 999999999999999999999999998765433
Q ss_pred Cceeeeeeecccccccccccc-----cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
.........||+.|+|||++. ...++.++||||||+++|||++|+.||......+. +...........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~~- 228 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKERFQ- 228 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCCCcccc-
Confidence 333333456999999999986 34678999999999999999999999975543221 111111110000
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKK--RPTMKEAAFE 661 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~ 661 (700)
. .......+..+.+|+++||..++.+ |++++|+++.
T Consensus 229 ----~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 ----F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0111234567888999998765444 6899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=311.44 Aligned_cols=263 Identities=25% Similarity=0.362 Sum_probs=201.4
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+|++.+.||+|++|.||+|+.. +++.||||+++.. .....+.+.+|+.++++++|+||+++++.+.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999976 6889999987643 233356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
++ ++|.+++........+++..++.++.||++||+|||+.+ ++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 689999876554456899999999999999999999999 9999999999999999999999999987543222
Q ss_pred eeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHH--hcc--------
Q 005355 548 HLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK--ENR-------- 616 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~-------- 616 (700)
.......+++.|+|||++.+. .++.++||||||+++++|++|+.||........ ....+..... ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhhH
Confidence 122234568899999988654 578899999999999999999999976543221 1110000000 000
Q ss_pred -hhhhcc---hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 617 -LFEVLD---ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 617 -~~~~~d---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...... .............++.+++.+||+.||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 00000111123567789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=318.52 Aligned_cols=255 Identities=21% Similarity=0.315 Sum_probs=200.4
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.+.||+|+||.||+++.. +++.||+|.+... .......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999976 5788999987642 2334456888999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++|+|.+++..... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999986432 3899999999999999999999999 999999999999999999999999999765433
Q ss_pred Cceeeeeeeccccccccccccc-----CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
.........|++.|+|||++.+ ..++.++||||||++||||++|+.||......+. +...........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~~- 228 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHEERFQ- 228 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCCCccc-
Confidence 3333334569999999999875 4678899999999999999999999975543221 111111100000
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKK--RPTMKEAAFE 661 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~ 661 (700)
+ .......+..+.+++.+||...+++ |++++++++.
T Consensus 229 ~-----p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 F-----PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred C-----CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0111223567888999999866544 4688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.01 Aligned_cols=243 Identities=25% Similarity=0.351 Sum_probs=192.1
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHH-HHHhhcCCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEV-AILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
+.||+|+||.||++++. +++.||+|++.... ......+..|. .+++.++|+||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999976 57889999876422 12223444444 456788999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
++|.+++.... .+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~ 153 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTT 153 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCc
Confidence 99999997643 3788899999999999999999999 9999999999999999999999999987543222 223
Q ss_pred eeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccC
Q 005355 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAK 630 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 630 (700)
....||+.|+|||++.+..++.++||||||+++|||++|..||......+. ...+..... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~i~~~~~----------~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-------YDNILNKPL----------QLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH-------HHHHHhCCc----------CCC
Confidence 345689999999999999999999999999999999999999976543221 111111110 111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005355 631 EEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662 (700)
Q Consensus 631 ~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L 662 (700)
......+.+++.+||+.+|.+||++.+.+.++
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 23455688999999999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=306.47 Aligned_cols=250 Identities=30% Similarity=0.469 Sum_probs=195.4
Q ss_pred ceEeeeCCeEEEEEEEc----CCcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCceeeEEeEEE-eCCcceEEEeeCC
Q 005355 396 RILGQGGQGTVYKGMLT----NGRIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCCL-ETEVPLLVYEFIP 469 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~E~~~ 469 (700)
+.||+|+||.||+|.+. ....||+|++.. ......+.+.+|+.+++.++|||++++++.+. .....++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999864 235799998754 33455678899999999999999999999776 4556789999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce-
Q 005355 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH- 548 (700)
Q Consensus 470 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~- 548 (700)
+++|.+++..... .+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999976533 2678888999999999999999999 999999999999999999999999999755322111
Q ss_pred --eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhC-CCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 549 --LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTG-QKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 549 --~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
......++..|+|||++.+..++.++||||||+++|||++| .+||......+ .. .....+...
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~----~~~~~~~~~------- 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---IT----VYLLQGRRL------- 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHhcCCCC-------
Confidence 11123456789999999989999999999999999999995 56665433221 11 111111100
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
..+...+..+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 222 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 --LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 001123456889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=323.98 Aligned_cols=245 Identities=25% Similarity=0.417 Sum_probs=199.8
Q ss_pred CccceEeeeCCeEEEEEEEc-CCcEEEEEEcc----ccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc--ceEEE
Q 005355 393 NTNRILGQGGQGTVYKGMLT-NGRIVAIKKSK----LVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEV--PLLVY 465 (700)
Q Consensus 393 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 465 (700)
+...+||+|+|-+||+|.+. +|..||--.++ ...+...++|..|+++|+.|+|+||++++..+.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45678999999999999976 57777633222 1345567899999999999999999999999987766 67899
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEeecCCCccccc
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGASRSVMI 544 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~-~~~kl~DfGl~~~~~~ 544 (700)
|++..|+|..|+++.+. +..+.+..|++||++||.|||++. |||+|||||-+||+|+.+ |.|||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999998865 889999999999999999999988 679999999999999864 8999999999986532
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
.....++|||.|||||++. ..|.+.+||||||+.|+||+|+..||. |..+..+.+..... |.....+..
T Consensus 199 ---s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-----EC~n~AQIYKKV~S-GiKP~sl~k- 267 (632)
T KOG0584|consen 199 ---SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-----ECTNPAQIYKKVTS-GIKPAALSK- 267 (632)
T ss_pred ---cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-----hhCCHHHHHHHHHc-CCCHHHhhc-
Confidence 2234478999999999997 889999999999999999999999996 44444444433332 222211111
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
-..+++.++|.+||.. .++|||+.|+|+
T Consensus 268 -------V~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 -------VKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred -------cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1134688899999999 999999999987
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=321.80 Aligned_cols=263 Identities=25% Similarity=0.332 Sum_probs=198.8
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC-----
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLETE----- 459 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 459 (700)
..++|++.+.||+|+||.||++... .++.||||++.. ........+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4588999999999999999999975 588999998764 23344577889999999999999999999986543
Q ss_pred -cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 005355 460 -VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGA 538 (700)
Q Consensus 460 -~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl 538 (700)
..++||||+++ +|.+.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46899999964 67776643 2788999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHH------------H
Q 005355 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLV------------G 606 (700)
Q Consensus 539 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~------------~ 606 (700)
++..... .......+|..|+|||++.+..++.++||||||+++|+|++|+.||...+..+..... .
T Consensus 170 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 170 ARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred ccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 9754222 2223356899999999999999999999999999999999999999866432210000 0
Q ss_pred HHH----HHHHhc-ch-----hhhcchhh---hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 607 YFL----EAMKEN-RL-----FEVLDARV---LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 607 ~~~----~~~~~~-~~-----~~~~d~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
... ...... .. .+...... ...........+.+|+.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 000000 00 00000000 000011124568899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=316.38 Aligned_cols=252 Identities=27% Similarity=0.369 Sum_probs=215.4
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcC-CcEEEEEEccccCh---hhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcce
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTN-GRIVAIKKSKLVDE---SNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 462 (700)
....|++.+.||+|.||.||+++.+. |+.+|+|.+..... ...+.+.+|+.+|+++. ||||+.+.+.+.+.+..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 35678888999999999999999874 99999998765332 34578999999999998 999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC----CCcEEEeecCC
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGA 538 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~----~~~~kl~DfGl 538 (700)
+|||++.+|.|.+.|... . +++..+..++.|++.|+.|||+.+ |+||||||+|+|+.. ++.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~--~--~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK--H--YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc--c--CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999877 2 999999999999999999999999 999999999999953 35799999999
Q ss_pred CcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 539 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
+..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||......+... .+..+.+
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~- 255 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF- 255 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC-
Confidence 987654 455677889999999999999999999999999999999999999998776544211 2222222
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
....+........+.++++++|..||.+|+|+.++++.
T Consensus 256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 12233345567788999999999999999999999993
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=316.26 Aligned_cols=241 Identities=25% Similarity=0.374 Sum_probs=195.6
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcceEEE
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 465 (700)
+|+..+.||+|+||.||++... +++.||||++... .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999976 6889999987642 2334566788999998885 577888999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999997653 3899999999999999999999999 999999999999999999999999998754322
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
. .......||+.|+|||++.+..++.++||||||+++|||++|..||........ ...+.....
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-------~~~i~~~~~-------- 218 (323)
T cd05615 155 G-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL-------FQSIMEHNV-------- 218 (323)
T ss_pred C-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC--------
Confidence 2 122345589999999999999999999999999999999999999976543221 111111111
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTM 655 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~ 655 (700)
..+...+..+.+++.+||+.+|.+|++.
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1122334567889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=319.64 Aligned_cols=242 Identities=26% Similarity=0.383 Sum_probs=192.5
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHH-HHhhcCCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVA-ILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
+.||+|+||+||+++.. +++.||+|++... .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999975 6899999987642 2233445556655 46778999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~ 153 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTT 153 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCc
Confidence 99999987543 3899999999999999999999999 999999999999999999999999998753221 1223
Q ss_pred eeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccC
Q 005355 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAK 630 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 630 (700)
....|++.|+|||++.+..++.++||||||+++|||++|..||...+..+. ...+..... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-------~~~~~~~~~----------~~~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM-------YDNILHKPL----------VLR 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH-------HHHHHcCCc----------cCC
Confidence 345689999999999999999999999999999999999999976543221 111111111 011
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 631 EEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 631 ~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
......+.+++.+||+.+|.+||++++.+++
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 1234567889999999999999998644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=305.55 Aligned_cols=248 Identities=27% Similarity=0.428 Sum_probs=201.6
Q ss_pred ceEeeeCCeEEEEEEEcC--C--cEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLTN--G--RIVAIKKSKLVDE-SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
++||+|++|.||+|.+.. + ..||||.+..... ...+.+.+|+.++++++|+||+++++.+.+ ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999753 2 3699999887555 567889999999999999999999999988 888999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce--
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH-- 548 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~-- 548 (700)
++|.+++..... ..+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999987542 35899999999999999999999999 999999999999999999999999999876432221
Q ss_pred eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 549 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......++..|+|||++.+..++.++||||||+++|||++ |..||......+. ... ....... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~---~~~~~~~---------~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKK---IDKEGER---------L 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH---HHhcCCc---------C
Confidence 1122346788999999999999999999999999999998 9999965443221 111 1100000 0
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 111234567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=309.61 Aligned_cols=253 Identities=25% Similarity=0.388 Sum_probs=200.5
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeC------
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLET------ 458 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 458 (700)
.+.+.|++.+.||+|+||.||+|... .++.||+|+..... .....+.+|+.+++++ +|+||+++++.+...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678899999999999999999975 57899999886543 3346788999999998 799999999998753
Q ss_pred CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 005355 459 EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGA 538 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl 538 (700)
...+++|||+++++|.+++..... ..+++..+..++.|++.||+|||+++ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 357899999999999999986432 34899999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCceeeeeeecccccccccccc-----cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHH
Q 005355 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK 613 (700)
Q Consensus 539 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 613 (700)
+....... .......|+..|+|||++. ...++.++||||||+++|||++|..||......... . ...
T Consensus 158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~--~~~ 229 (272)
T cd06637 158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----F--LIP 229 (272)
T ss_pred ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----H--HHh
Confidence 87543222 2233456889999999986 345788999999999999999999999644322111 0 001
Q ss_pred hcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 614 ENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 614 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
....... .....+..+.+|+.+||+.+|.+|||+.|+++
T Consensus 230 ~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 RNPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cCCCCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1110011 11223456889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=306.23 Aligned_cols=240 Identities=23% Similarity=0.418 Sum_probs=191.9
Q ss_pred ceEeeeCCeEEEEEEEcC-------------CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 396 RILGQGGQGTVYKGMLTN-------------GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
+.||+|+||.||+|++.. ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2358999877665566678899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc-------EEEee
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR-------AKVSD 535 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~-------~kl~D 535 (700)
+||||+++++|..++..... .+++..++.++.||++||+|||+++ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999999875432 3899999999999999999999999 999999999999987654 89999
Q ss_pred cCCCcccccCCceeeeeeecccccccccccc-cCCCCcccceehHHHHHHHHH-hCCCCCCCCCchhhhhHHHHHHHHHH
Q 005355 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFR-SSQFTEKSDVYSFGVVLVELL-TGQKPIRSTDSEEDKSLVGYFLEAMK 613 (700)
Q Consensus 536 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~ 613 (700)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ .|..||......+.. ...
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~~- 222 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RFY- 222 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HHH-
Confidence 9998654222 2234778899999987 467899999999999999998 588887654322211 000
Q ss_pred hcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 614 ENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 614 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
.... .. .......+.+|+.+||+.||++||+++++++.|+
T Consensus 223 ~~~~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQC-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcCc-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1110 00 1112356889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=311.95 Aligned_cols=263 Identities=28% Similarity=0.427 Sum_probs=208.2
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-----CCcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCceeeEEeEEEe--CCcc
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-----NGRIVAIKKSKLVDES-NIEQFINEVAILSQINHRNVVKLLGCCLE--TEVP 461 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 461 (700)
+.|++.+.||+|+||.||++.+. .++.+|||.+...... ..+.|.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46778899999999999999864 3678999998765443 56789999999999999999999999877 5578
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
+++|||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999986543 3899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCcee--eeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhh--------hHHHHHHHH
Q 005355 542 VMIDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDK--------SLVGYFLEA 611 (700)
Q Consensus 542 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~--------~~~~~~~~~ 611 (700)
........ .....++..|+|||.+.+..++.++||||||++++||++|..|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 64322211 11223456799999999889999999999999999999999998654322110 001111111
Q ss_pred HHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 612 MKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 612 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
+... .....+...+..+.+|+.+||+.+|++||++.||+++|+++.
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 239 LKEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1111 111112233467899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=340.36 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=206.6
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.++||+|+||.||+|.+. .++.||||++... .....+++.+|++++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999976 5899999987642 2334567999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 466 EFIPNGTLYQYIHDQTE--------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
||+++++|.+++..... ...+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999975211 123567788999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCc-----------------eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchh
Q 005355 538 ASRSVMIDQT-----------------HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600 (700)
Q Consensus 538 l~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~ 600 (700)
+++....... .......||+.|+|||++.+..++.++||||||+++|||++|..||......+
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 01122468999999999999999999999999999999999999997533221
Q ss_pred hhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhchh
Q 005355 601 DKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRP-TMKEAAFELGGIRA 667 (700)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~l~~ 667 (700)
.. .. .. ..++... ......+..+.+++.+||+.||++|| +++++++.|+....
T Consensus 239 i~-----~~-----~~---i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 IS-----YR-----DV---ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh-----hh-----hh---ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 10 00 00 0011000 00123455688999999999999995 67888888877654
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=308.93 Aligned_cols=250 Identities=25% Similarity=0.338 Sum_probs=202.4
Q ss_pred CCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 392 FNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
|++.+.||+|+||.||++... .+..+++|.+........+.+.+|+++++.++|+|++++++.+...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 577789999999999999976 4778899998776667778899999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
++|..++.+.. .++++..+..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++...... ....
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~ 160 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRR 160 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc-cccc
Confidence 99999887533 24899999999999999999999999 999999999999999999999999998754322 1222
Q ss_pred eeeecccccccccccc-----cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 551 TRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
....++..|+|||++. ...++.++||||||+++|||++|..||......+. ....... .....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~-~~~~~----- 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKS-EPPTL----- 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhhc-CCCCC-----
Confidence 3345889999999984 34578899999999999999999999975443221 1111111 10000
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..+...+..+.+|+.+||+.+|.+||++.++++.
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 --AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122344578899999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.41 Aligned_cols=257 Identities=26% Similarity=0.485 Sum_probs=207.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCc----EEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGR----IVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
..+|++.+.||+|+||.||+|.+. +++ .||+|...... ......+.+|+.++++++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 467888899999999999999965 232 68999876543 3456788999999999999999999999887 7889
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+|+||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999986543 3899999999999999999999999 999999999999999999999999999866
Q ss_pred ccCCceee-eeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 543 MIDQTHLT-TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 543 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
........ ....++..|+|||.+....++.++||||||+++|||++ |..||......+ +...+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~-- 230 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGERL-- 230 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCCC--
Confidence 43322211 11223568999999988899999999999999999998 999997654332 11122211110
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
..+......+.+++.+||..+|.+||++.++++.|+++..
T Consensus 231 -------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 -------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111233467889999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=308.58 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=205.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.+.|++.++||+|+||.||+|+.. +++.|++|.+...+....+.+.+|+.+++.++|+||+++++.+......++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367889999999999999999976 5889999998877777778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|..++..... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++...... .
T Consensus 91 ~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~ 164 (292)
T cd06644 91 CPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-L 164 (292)
T ss_pred CCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-c
Confidence 999999998865433 3899999999999999999999999 999999999999999999999999988653222 1
Q ss_pred eeeeeeecccccccccccc-----cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 548 HLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
.......+++.|+|||++. ...++.++||||||+++|||++|..||......+ ....... .....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~-~~~~~--- 234 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAK-SEPPT--- 234 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHHhc-CCCcc---
Confidence 1223445788999999984 3457889999999999999999999986543221 1111111 11000
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...+...+..+.+++.+||+.+|++||+++++++
T Consensus 235 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 235 ----LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ----CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0112234457889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=312.20 Aligned_cols=250 Identities=26% Similarity=0.392 Sum_probs=206.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
..+|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 477899999999999999999964 7899999998765555667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999999654 2889999999999999999999999 99999999999999999999999999875433222
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+...... .....+. ...
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~~--------~~~ 235 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT--------PEL 235 (297)
T ss_pred -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCCC--------CCC
Confidence 1223457889999999999999999999999999999999999997554322100 0000000 001
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+...+..+.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112334456788999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.11 Aligned_cols=250 Identities=26% Similarity=0.487 Sum_probs=202.8
Q ss_pred CCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccC------hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 391 NFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVD------ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
+|+..+.||+|+||.||+|...+++.+|||.+.... ....+.+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999998889999999876422 22346788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
+||+++++|.+++.+.. ++++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997643 3889999999999999999999999 99999999999999999999999999875422
Q ss_pred CC-----ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 545 DQ-----THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 545 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
.. ........++..|+|||++.+..++.++||||||+++++|++|..||...+..+.. .........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~~~~-- 226 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM------FYIGAHRGL-- 226 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH------HHhhhccCC--
Confidence 11 11122345888999999999999999999999999999999999999754322211 000000000
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
....+......+.+++++||+.+|.+||++.|+++
T Consensus 227 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 ------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01122334567889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=303.98 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=206.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTN-GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.++|+..+.||+|+||.||+|.+.+ ++.+++|.+..... .+.+.+|++++++++|+||+++++.+.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 4688999999999999999999874 78999999875433 67899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999999975432 4899999999999999999999999 99999999999999999999999999886543321
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......++..|+|||++.+..++.++||||||+++|+|++|+.||......+.. ........ . ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~-----~--~~ 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMIPNKPP-----P--TL 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhhccCCC-----C--CC
Confidence 223345788999999999999999999999999999999999999754332210 00000000 0 01
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+......+.+++.+||+.+|++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 112234467899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=323.40 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=199.0
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|+..+.||+|+||.||++... +++.||||++... .......+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46889999999999999999976 6889999988642 2334567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999997653 3899999999999999999999999 999999999999999999999999998754211
Q ss_pred Cc----------------------------------eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCC
Q 005355 546 QT----------------------------------HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQK 591 (700)
Q Consensus 546 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~ 591 (700)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 00123468999999999999999999999999999999999999
Q ss_pred CCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCC---HHHHHHH
Q 005355 592 PIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT---MKEAAFE 661 (700)
Q Consensus 592 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~evl~~ 661 (700)
||......+.. ..+.... ..+. .... ......+.+|+.+++ .+|.+|++ +.|+++.
T Consensus 235 Pf~~~~~~~~~-------~~i~~~~--~~~~--~p~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQETY-------RKVMNWK--ETLV--FPPE--VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHHHH-------HHHHcCC--Ccee--cCCC--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 99765543211 1111100 0000 0000 113456778888876 49999985 5666653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=302.70 Aligned_cols=253 Identities=24% Similarity=0.378 Sum_probs=193.9
Q ss_pred ceEeeeCCeEEEEEEEcC---CcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCC
Q 005355 396 RILGQGGQGTVYKGMLTN---GRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 471 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 471 (700)
+.||+|+||.||+|.+.+ +..+|+|+++... ......+.+|+.++++++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998653 4579999877543 333457889999999999999999999999999999999999999
Q ss_pred CHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee
Q 005355 472 TLYQYIHDQTE--EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549 (700)
Q Consensus 472 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~ 549 (700)
+|.++++.... ....++..+..++.|++.||+|||+.+ ++|+||||+||+++.++++||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999976432 234677888899999999999999999 9999999999999999999999999987543222211
Q ss_pred -eeeeecccccccccccccC-------CCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 550 -TTRVQGTFGYLDPEYFRSS-------QFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 550 -~~~~~gt~~y~aPE~~~~~-------~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
.....++..|+|||++... .++.++||||||+++|||++ |..||......+.. .. ... +.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~---~~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TY---TVR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HH---Hhh-cccCCC
Confidence 1234467889999998643 35789999999999999996 99999755433211 00 011 111111
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
.++.+ .......+.+++.+|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 1123345778999998 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=318.50 Aligned_cols=263 Identities=27% Similarity=0.362 Sum_probs=206.0
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-C-----CceeeEEeEEEeCCc
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQIN-H-----RNVVKLLGCCLETEV 460 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~ 460 (700)
..-+|.+++.||+|.||.|.++.+. +++.||||+++.... -..+...|+.+|..|+ | -|+|+++++|...++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 3448999999999999999999965 699999999986433 3466788999999997 4 489999999999999
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC--CCcEEEeecCC
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD--KYRAKVSDFGA 538 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~--~~~~kl~DfGl 538 (700)
.+||+|.+ ..+|.++|+.+.-+. ++...+..++.||+.||.+||+.+ |||.||||+||||.+ ...+||+|||.
T Consensus 263 lciVfELL-~~NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccc
Confidence 99999999 679999999876543 999999999999999999999999 999999999999964 34799999999
Q ss_pred CcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH--------HH
Q 005355 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF--------LE 610 (700)
Q Consensus 539 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~ 610 (700)
+.... .... ....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.+..+....+..+ +.
T Consensus 338 Sc~~~---q~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 338 SCFES---QRVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred ccccC---Ccce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 97542 1222 455788899999999999999999999999999999999999887754432222111 11
Q ss_pred HHHh-cchh-------------h-----------------hcchhhh-------hccCHHHHHHHHHHHHHHhccCCCCC
Q 005355 611 AMKE-NRLF-------------E-----------------VLDARVL-------KEAKEEEIITVAMLAKRCLNMIGKKR 652 (700)
Q Consensus 611 ~~~~-~~~~-------------~-----------------~~d~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~R 652 (700)
.... .++. . ..+...+ ..........+.+++++||.+||.+|
T Consensus 414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R 493 (586)
T KOG0667|consen 414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER 493 (586)
T ss_pred hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence 1100 0000 0 0000011 00112344568999999999999999
Q ss_pred CCHHHHHH
Q 005355 653 PTMKEAAF 660 (700)
Q Consensus 653 Ps~~evl~ 660 (700)
+|+.++++
T Consensus 494 ~tp~qal~ 501 (586)
T KOG0667|consen 494 ITPAQALN 501 (586)
T ss_pred CCHHHHhc
Confidence 99999987
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.95 Aligned_cols=251 Identities=27% Similarity=0.385 Sum_probs=207.1
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+|+..+.||+|+||.||.++.. +++.+++|.+... ......++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999865 5889999986643 345567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999998653 234899999999999999999999999 99999999999999999999999999876543332
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......+++.|+|||++.+..++.++||||||+++|||++|..||......+. ...+..+.+..
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~-------~~~~~~~~~~~-------- 220 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL-------VVKIVQGNYTP-------- 220 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHcCCCCC--------
Confidence 23345588999999999988899999999999999999999999975443221 11111222111
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L 662 (700)
.....+..+.+++.+||+.+|++||+++++++.+
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 -VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1123455788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.47 Aligned_cols=260 Identities=23% Similarity=0.382 Sum_probs=194.4
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
....+|++.+.||+|+||.||+|+.. .++.||+|+... .....|+.++++++|+||+++++++.+....++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34567999999999999999999976 567899997543 22456999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
|++ .++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~-~~~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHY-SSDLYTYLTKRSR--PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred Ecc-CCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 999 5689988876433 4899999999999999999999999 999999999999999999999999998743221
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCC-CCCCchhh---hhHHHHHHHHHHhcch-hh-
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPI-RSTDSEED---KSLVGYFLEAMKENRL-FE- 619 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~-~~~~~~~~---~~~~~~~~~~~~~~~~-~~- 619 (700)
.......||..|+|||++.+..++.++||||||+++|||+++..|+ ........ ......+...+..... ..
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 1223456899999999999999999999999999999999865554 32221110 1111111111111000 00
Q ss_pred hc---chhhhh------------------ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 620 VL---DARVLK------------------EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 620 ~~---d~~~~~------------------~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.. ...... .........+.+|+.+||+.||++|||++|+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 00 000000 000122345667999999999999999999986
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=316.00 Aligned_cols=237 Identities=24% Similarity=0.359 Sum_probs=189.7
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHH-HHhhcCCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVA-ILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
++||+|+||.||+|+.. +++.||+|++.... ......+..|.. +++.++|+||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999976 68899999876421 223344555554 57889999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 99999887543 3889999999999999999999999 9999999999999999999999999987532221 223
Q ss_pred eeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccC
Q 005355 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAK 630 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 630 (700)
....||+.|+|||++.+..++.++||||||+++|||++|..||...+..+ ....+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~----------~~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-------MYDNILHKP----------LQLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-------HHHHHhcCC----------CCCC
Confidence 34568999999999999999999999999999999999999997654222 111111111 1112
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHH
Q 005355 631 EEEIITVAMLAKRCLNMIGKKRPTMK 656 (700)
Q Consensus 631 ~~~~~~l~~li~~cl~~~p~~RPs~~ 656 (700)
......+.+++.+||+.+|.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 23455788999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=311.33 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=206.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
..+|++.+.||.|+||.||+|... +++.|++|.+........+.+.+|+.+++.++|+|++++++.+...+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 356899999999999999999864 6899999988765555667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++... .+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 9999999998754 3899999999999999999999999 99999999999999999999999999876543322
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..+.. ....... ... .
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~~~-~~~-------~ 235 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG-TPE-------L 235 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcC-Ccc-------c
Confidence 122345888999999999989999999999999999999999999765433211 1111110 000 0
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+...+..+.+++.+||..+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 112234456888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=320.38 Aligned_cols=264 Identities=22% Similarity=0.285 Sum_probs=200.0
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC-----
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLET----- 458 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 458 (700)
...++|++.+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34678999999999999999999865 5889999988643 334457788999999999999999999988643
Q ss_pred -CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 459 -EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 459 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
...++||||+++ +|.+.+.. .+++..+..++.|+++||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 346899999964 67777653 2889999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHH-HH---------
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLV-GY--------- 607 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~-~~--------- 607 (700)
+++.... ........+|..|+|||++.+..++.++||||||+++|+|++|+.||...+..+..... ..
T Consensus 165 ~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCC--ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9975422 22223456899999999999999999999999999999999999999765532211100 00
Q ss_pred ------HHHHHHhc-chhhhcchhh--------hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 608 ------FLEAMKEN-RLFEVLDARV--------LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 608 ------~~~~~~~~-~~~~~~d~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
........ .......+.. ...........+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 0000000000 000111234568899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=331.42 Aligned_cols=266 Identities=20% Similarity=0.270 Sum_probs=196.6
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCC------CceeeEEeEE
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINH------RNVVKLLGCC 455 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~ 455 (700)
.++....++|++.++||+|+||+||+|.+. .++.||||+++... .....+..|+++++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556789999999999999999999975 57889999986532 223456677777777654 4588898888
Q ss_pred EeC-CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCC----
Q 005355 456 LET-EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS-AASIPIYHRDIKSANILLDDKY---- 529 (700)
Q Consensus 456 ~~~-~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dik~~NILl~~~~---- 529 (700)
... ...++|||++ +++|.+++.+.. .+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 755 4678899988 778999887653 38999999999999999999998 48 99999999999998665
Q ss_pred ------------cEEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCC
Q 005355 530 ------------RAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 597 (700)
Q Consensus 530 ------------~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~ 597 (700)
.+||+|||++... ........||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDE----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccccccCCCCceEEECCCCccccC----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4999999987532 122334568999999999999999999999999999999999999998765
Q ss_pred chhhhhHHHHHHHH----HH--------------hcchhhhcchhhhhc-------cCHHHHHHHHHHHHHHhccCCCCC
Q 005355 598 SEEDKSLVGYFLEA----MK--------------ENRLFEVLDARVLKE-------AKEEEIITVAMLAKRCLNMIGKKR 652 (700)
Q Consensus 598 ~~~~~~~~~~~~~~----~~--------------~~~~~~~~d~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~R 652 (700)
..+........... +. .+.+....++..... ........+.+||.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 43322222111000 00 000000000000000 001123467899999999999999
Q ss_pred CCHHHHHH
Q 005355 653 PTMKEAAF 660 (700)
Q Consensus 653 Ps~~evl~ 660 (700)
||++|+++
T Consensus 430 ~ta~e~L~ 437 (467)
T PTZ00284 430 LNARQMTT 437 (467)
T ss_pred CCHHHHhc
Confidence 99999997
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.56 Aligned_cols=253 Identities=26% Similarity=0.352 Sum_probs=207.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.++|++.+.||+|+||.||++.+. +++.+|+|..........+.+.+|++++++++|+||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 567899999999999999999975 6889999998877777778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++..... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 999999999976433 4899999999999999999999999 9999999999999999999999999887543222
Q ss_pred eeeeeeecccccccccccc-----cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 548 HLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
.......++..|+|||++. ...++.++||||||+++|+|++|+.||......+. .. .+.......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~------~~-~~~~~~~~~--- 227 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV------LL-KILKSEPPT--- 227 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH------HH-HHhcCCCCC---
Confidence 2223456889999999974 34577899999999999999999999975533221 11 111111000
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
...+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 228 ----LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 01112344578899999999999999999999774
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.25 Aligned_cols=248 Identities=28% Similarity=0.397 Sum_probs=204.8
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
++|++.+.||.|+||.||+|.+. +++.||+|.+.... ......+.+|+++++.++|+|++++++.+.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999976 68899999876543 44456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999999765 4899999999999999999999999 9999999999999999999999999997664332
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
.......++..|+|||++.+..++.++||||||+++|+|++|..||......+ ....+....... +..
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-------~~~~~~~~~~~~-----~~~ 220 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------VLFLIPKNNPPS-----LEG 220 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-------HHHHhhhcCCCC-----Ccc
Confidence 12233457889999999999889999999999999999999999997544221 111111111111 100
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...+..+.+++.+||..+|++||+++++++
T Consensus 221 ---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 ---NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ---cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 114557889999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.83 Aligned_cols=239 Identities=23% Similarity=0.406 Sum_probs=189.9
Q ss_pred eEeeeCCeEEEEEEEcC-------------------------CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeE
Q 005355 397 ILGQGGQGTVYKGMLTN-------------------------GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKL 451 (700)
Q Consensus 397 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 451 (700)
.||+|+||.||+|.+.. ...|++|++..........+.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998521 13588998876555556788999999999999999999
Q ss_pred EeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC--
Q 005355 452 LGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY-- 529 (700)
Q Consensus 452 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~-- 529 (700)
++++.+....++||||+++++|..++..... .+++..++.++.||++||+|||+++ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999976433 3889999999999999999999999 99999999999997643
Q ss_pred -----cEEEeecCCCcccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHH-hCCCCCCCCCchhhh
Q 005355 530 -----RAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELL-TGQKPIRSTDSEEDK 602 (700)
Q Consensus 530 -----~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~ell-tg~~p~~~~~~~~~~ 602 (700)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||......+..
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 4899999988643221 12346788999998875 56899999999999999995 699998755433211
Q ss_pred hHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 603 SLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
. + ..... ..+......+.+++.+||+.+|++||+++++++.|.
T Consensus 232 ~----~---~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 232 R----F---YEKKH-----------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H----H---HHhcc-----------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 1 00000 001112346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=302.33 Aligned_cols=254 Identities=26% Similarity=0.381 Sum_probs=208.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.++|++.+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++|+||+++++.+.+.+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 467899999999999999999975 5788999998876666778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++..... .+++..+..++.|++.||+|||+++ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQVTRG--PLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 999999999876522 3899999999999999999999999 9999999999999999999999999987653221
Q ss_pred eeeeeeecccccccccccccC---CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSS---QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
.......++..|+|||.+... .++.++||||||+++|+|++|+.||......+... ......+. ...
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-------~~~~~~~~---~~~ 225 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-------LISKSNFP---PPK 225 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhccCC---Ccc
Confidence 122334578899999999776 88999999999999999999999997654322110 01111000 000
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.......+..+.+++.+||..+|.+||++.+++.
T Consensus 226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 --LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0112344567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.36 Aligned_cols=248 Identities=28% Similarity=0.511 Sum_probs=201.3
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh---------hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE---------SNIEQFINEVAILSQINHRNVVKLLGCCLETEV 460 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 460 (700)
+|.+.+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|+.++++++|+||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999975 578999998764322 123578899999999999999999999999999
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.++++||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999997653 3889999999999999999999999 9999999999999999999999999988
Q ss_pred ccccCCce-----eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc
Q 005355 541 SVMIDQTH-----LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN 615 (700)
Q Consensus 541 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 615 (700)
........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------IFK-IGEN 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------HHH-Hhcc
Confidence 66422111 11224578899999999998999999999999999999999999975432111 010 1100
Q ss_pred chhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 616 RLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 616 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.. ...+...+..+.+++++||+.+|.+||++.|+++
T Consensus 228 -----~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 -----AS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----CC----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11 1122334567889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.11 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=203.3
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
++|++.+.||+|+||.||++.+. .++.||+|.+... .......+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999976 6899999987653 344557899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
+++++|..++........+++..+..++.||+.||.|||+. + ++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999987653333589999999999999999999974 7 999999999999999999999999998754322
Q ss_pred ceeeeeeecccccccccccccC------CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSS------QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||........ .... ..+..+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~-~~~~~~~---- 226 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQL-SAIVDGD---- 226 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHH-HHHhhcC----
Confidence 22234578899999998554 358899999999999999999999965432211 1111 1111111
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
....+......+.+++.+||+.+|++||+++++++
T Consensus 227 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 -----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11223345677889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=301.90 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=211.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
..-|.++.+||+|.||.||+|.++ .|+.||||+... +.+.+++..|+.++++...+++|+++|.+.....+++||||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 344677889999999999999987 699999998775 45568899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+..|++.++++..+ .+|++.++..+++..++||+|||... -+|||||..|||++.+|.+||+|||.+..+.. .-
T Consensus 110 CGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TM 183 (502)
T KOG0574|consen 110 CGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TM 183 (502)
T ss_pred cCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh-hH
Confidence 99999999998754 35999999999999999999999988 79999999999999999999999999976532 22
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
....++.||+-|||||++..-.|..++||||||++..||.-|++||....+... .-++. ..+...-
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-------IFMIP-------T~PPPTF 249 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-------IFMIP-------TKPPPTF 249 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-------eEecc-------CCCCCCC
Confidence 334567899999999999999999999999999999999999999975543211 00011 1111112
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..+...+.++.+++++||..+|++|.|+.++++.
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2345567789999999999999999999888773
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.35 Aligned_cols=251 Identities=32% Similarity=0.528 Sum_probs=204.5
Q ss_pred CCccceEeeeCCeEEEEEEEcC-----CcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 392 FNTNRILGQGGQGTVYKGMLTN-----GRIVAIKKSKLVDES-NIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
|++.+.||.|+||.||++.+.+ +..||+|.+...... ..+.+.+|+++++.++|+||+++++.+.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999763 388999998765433 5678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++++|.+++...... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999865432 2899999999999999999999999 999999999999999999999999999866443
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
.........+++.|+|||.+.+..++.++||||||+++++|++ |..||......+ .......+...
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~------ 223 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-------VLEYLKKGYRL------ 223 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCCC------
Confidence 2222222336789999999988889999999999999999998 788886533222 11112211111
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L 662 (700)
..+...+..+.+++.+||..+|++|||+.|+++.|
T Consensus 224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11122456788999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=324.34 Aligned_cols=261 Identities=22% Similarity=0.331 Sum_probs=197.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
...|.+.+.||+|+||.||++.+. .++.||||.... ..+.+|++++++++|+||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999976 578899996432 3467899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+ .++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~-~~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 Y-RSDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred c-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 9 4789988875432 4999999999999999999999999 99999999999999999999999999976533221
Q ss_pred e-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCch-hhhhHHHHHHHHHHhcch-----hhh
Q 005355 548 H-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSE-EDKSLVGYFLEAMKENRL-----FEV 620 (700)
Q Consensus 548 ~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~-----~~~ 620 (700)
. ......||..|+|||++.+..++.++||||||++||||++|..|+...... ........+...+..... ...
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1 222356999999999999999999999999999999999987665332211 111111111112211110 000
Q ss_pred cchhhhh------------ccC-------HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 621 LDARVLK------------EAK-------EEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 621 ~d~~~~~------------~~~-------~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
....+.. ... ......+.+|+.+||+.||++|||+.|+++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000 000 0123468889999999999999999999874
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=304.36 Aligned_cols=248 Identities=28% Similarity=0.395 Sum_probs=205.7
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
..|+..+.||+|+||.||+|.+. .++.||+|.+.... ....+.+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45778889999999999999976 58899999876533 44567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++... ++++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 9999999998753 3889999999999999999999999 9999999999999999999999999997653322
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
.......++..|+|||++.+..++.++|+||||+++|||++|..||......... ...... ...
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~~---------~~~ 219 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-------FLIPKN---------NPP 219 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-------hhhhcC---------CCC
Confidence 1223345788999999999889999999999999999999999999754432211 011111 112
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
......+..+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2234566788999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=300.93 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=202.8
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC-CcceEEEe
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLET-EVPLLVYE 466 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E 466 (700)
+|++.+.||+|++|.||++... +++.||+|++... .....+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999976 5788999987643 334556789999999999999999999987644 45789999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|.+++.... ...+++.+++.++.|++.||++||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999998643 234899999999999999999999999 9999999999999999999999999987653222
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
.......+++.|+|||++.+..++.++||||||+++++|++|+.||...+.... . ..+..+..
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~-~~~~~~~~--------- 219 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------V-YRIIEGKL--------- 219 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------H-HHHHhcCC---------
Confidence 223344588999999999999999999999999999999999999975432211 1 11111111
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
...+......+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11223455678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.10 Aligned_cols=263 Identities=23% Similarity=0.310 Sum_probs=199.6
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC------
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLET------ 458 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 458 (700)
..++|++.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999975 5889999988642 334456788999999999999999999987543
Q ss_pred CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 005355 459 EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGA 538 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl 538 (700)
...++||||++ ++|.+++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 34689999996 477777753 2788999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHH--------HHH
Q 005355 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGY--------FLE 610 (700)
Q Consensus 539 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~--------~~~ 610 (700)
++..... .......+|..|+|||++.+..++.++||||||+++|+|++|+.||...+..+....... +..
T Consensus 173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9754321 222345689999999999999999999999999999999999999986654322111100 000
Q ss_pred H--------HHhcc-h-----hhhcchhh---hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 611 A--------MKENR-L-----FEVLDARV---LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 611 ~--------~~~~~-~-----~~~~d~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
. ..... . ........ ..+........+.+|+.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 00000 0 00000000 000111123568899999999999999999999884
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.49 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=203.2
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.++|++.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 457888899999999999999965 6889999998766555667788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...... .
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~ 160 (267)
T cd06645 88 CGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-I 160 (267)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-c
Confidence 99999999987553 3899999999999999999999999 999999999999999999999999998755322 1
Q ss_pred eeeeeeecccccccccccc---cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 548 HLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
.......|+..|+|||++. ...++.++||||||+++|+|++|..||......... . ........ .+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~-~~~~~~~~---~~~ 230 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------F-LMTKSNFQ---PPK 230 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------H-hhhccCCC---CCc
Confidence 1223346889999999974 456889999999999999999999998654322210 0 01111110 000
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
... ....+..+.+++.+||+.+|++||+++++++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000 1123456889999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=321.18 Aligned_cols=262 Identities=23% Similarity=0.300 Sum_probs=201.4
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc---CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT---NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
...+|++.+.||+|+||.||++... .++.||+|.+... ..+.+|++++++++|+||+++++.+......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3567999999999999999999754 3578999987642 2356899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
||++. ++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 165 ~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99995 6898888443 24899999999999999999999999 99999999999999999999999999976543
Q ss_pred CCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh-----
Q 005355 545 DQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF----- 618 (700)
Q Consensus 545 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 618 (700)
.... ......||+.|+|||++....++.++||||||+++|||++|+.||.........................
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 3221 2234569999999999999999999999999999999999999997665433222222222111110000
Q ss_pred -----hh---cchhhhhcc-------CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 619 -----EV---LDARVLKEA-------KEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 619 -----~~---~d~~~~~~~-------~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.. ......... ......++.+++++||+.+|++|||+.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000000000 01123467889999999999999999999874
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.18 Aligned_cols=264 Identities=25% Similarity=0.336 Sum_probs=201.8
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
++|+..+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++|+|++++++.+......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999986 58999999876432 2234568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|..++.... .+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999988888776543 3899999999999999999999999 9999999999999999999999999998654322
Q ss_pred ceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHH--------HHhcch
Q 005355 547 THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEA--------MKENRL 617 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~ 617 (700)
. ......++..|+|||++.+ ..++.++||||||+++|+|++|..||......+........... .....+
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 1 1223347789999999876 56789999999999999999999999865543321111100000 000000
Q ss_pred h---hhcchhh---hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 F---EVLDARV---LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ~---~~~d~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. ...++.. ........+..+.+|+.+||+.+|++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 0000000 00001123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=307.53 Aligned_cols=259 Identities=27% Similarity=0.402 Sum_probs=207.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.++|++.+.||+|+||+||++... +++.||+|+..... ....+.+.+|+++++.++|+||+++++.+...+..++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 467888899999999999999975 58899999876532 3446789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
|+++++|.+++.... .+++..+..++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999987643 38999999999999999999997 47 999999999999999999999999998654221
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhh-----hHHHHHHHHHHhcchhhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDK-----SLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 620 (700)
. .....++..|+|||++.+..++.++||||||+++|+|++|..||......++. .....+...+...
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 1 22346889999999998889999999999999999999999999865543211 1111111111100
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
.........+..+.+|+.+||+.+|++||++.|++++.--+
T Consensus 230 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 230 ----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred ----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 00000112456788999999999999999999999874333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=311.96 Aligned_cols=197 Identities=25% Similarity=0.402 Sum_probs=161.2
Q ss_pred cceEeeeCCeEEEEEEEc---CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe--CCcceEEEeeCC
Q 005355 395 NRILGQGGQGTVYKGMLT---NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLE--TEVPLLVYEFIP 469 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~ 469 (700)
.++||+|+||.||+|... +++.||+|.+.... ....+.+|++++++++||||+++++.+.. ....++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999965 46789999876432 23457889999999999999999999864 345689999985
Q ss_pred CCCHHHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----CCCCcEEEeecCCC
Q 005355 470 NGTLYQYIHDQT------EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGAS 539 (700)
Q Consensus 470 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl----~~~~~~kl~DfGl~ 539 (700)
++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888876431 1234899999999999999999999999 9999999999999 45678999999999
Q ss_pred cccccCCce--eeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCC
Q 005355 540 RSVMIDQTH--LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTD 597 (700)
Q Consensus 540 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~ 597 (700)
+........ ......+|+.|+|||++.+ ..++.++||||||+++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 865432211 2234568999999999877 458999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=302.28 Aligned_cols=247 Identities=28% Similarity=0.481 Sum_probs=200.7
Q ss_pred cCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCC
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIP 469 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 469 (700)
++|++.+.||+|+||.||++.. .++.||+|+.+... ..+.+.+|+.++++++|+|++++++.+... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 5688899999999999999986 57889999886532 346789999999999999999999998654 5799999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee
Q 005355 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549 (700)
Q Consensus 470 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~ 549 (700)
+++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 9999999976532 24899999999999999999999999 999999999999999999999999998754221
Q ss_pred eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhc
Q 005355 550 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE 628 (700)
Q Consensus 550 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 628 (700)
......+..|+|||++.+..++.++||||||+++|||++ |..||......+. ......+.. ..
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~---------~~ 217 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-------KECVEKGYR---------ME 217 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHHHhCCCC---------CC
Confidence 112234567999999998899999999999999999998 9999976543321 112221111 11
Q ss_pred cCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 629 AKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 629 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
.....+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=300.44 Aligned_cols=238 Identities=25% Similarity=0.455 Sum_probs=191.9
Q ss_pred ceEeeeCCeEEEEEEEcCCc-----------EEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 396 RILGQGGQGTVYKGMLTNGR-----------IVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999986432 5788876654433 6789999999999999999999999988 778999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-------cEEEeecC
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY-------RAKVSDFG 537 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~-------~~kl~DfG 537 (700)
+||+++++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999987543 4899999999999999999999999 99999999999999887 79999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccC--CCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHh
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS--QFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKE 614 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 614 (700)
++..... .....++..|+|||++... .++.++||||||+++|||++ |..||......+.... ...
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~-------~~~ 221 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-------YQD 221 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH-------Hhc
Confidence 9876432 2223467789999999876 78999999999999999999 5777765543221110 110
Q ss_pred cchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 615 NRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 615 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
.... +......+.+++.+||..+|.+||++.++++.|+
T Consensus 222 ~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHRL-----------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCC-----------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 0011167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=308.27 Aligned_cols=248 Identities=28% Similarity=0.420 Sum_probs=202.3
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++|+||+++++.+...+..++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34666788999999999999875 57889999876433 34557889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++... .+++..+..++.|+++||.|||+++ ++|+||+|+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999999998653 3899999999999999999999999 99999999999999999999999999876532221
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......++..|+|||++.+..++.++||||||+++|||++|..||........ ........ ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~---------~~ 219 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-------LFLIPKNS---------PP 219 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-------HhhhhcCC---------CC
Confidence 12234578899999999999999999999999999999999999864432221 11111111 01
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
......+..+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1122345678899999999999999999999983
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=303.99 Aligned_cols=250 Identities=29% Similarity=0.467 Sum_probs=198.9
Q ss_pred ceEeeeCCeEEEEEEEcC-------CcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 396 RILGQGGQGTVYKGMLTN-------GRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+.||+|+||.||+|++.+ ++.+|||.+.... ......+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998652 2578999875432 34467889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-----cEEEeecCC
Q 005355 468 IPNGTLYQYIHDQT----EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY-----RAKVSDFGA 538 (700)
Q Consensus 468 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~-----~~kl~DfGl 538 (700)
+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997542 1234789999999999999999999999 99999999999999877 899999999
Q ss_pred CcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcc
Q 005355 539 SRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENR 616 (700)
Q Consensus 539 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 616 (700)
+......... ......++..|+|||++.+..++.++||||||+++|||++ |..||......+. ...+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~-------~~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV-------LQHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH-------HHHHhcCC
Confidence 8755322211 1122335678999999999999999999999999999998 9999975433221 11111111
Q ss_pred hhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 617 LFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 617 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
. ...+...+..+.+++.+||+.+|.+||++.++++.|++
T Consensus 231 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 R---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred c---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 01122345678899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=311.16 Aligned_cols=262 Identities=20% Similarity=0.280 Sum_probs=198.2
Q ss_pred ccceEeee--CCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 394 TNRILGQG--GQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 394 ~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
++++||+| +|++||++..+ +++.||||++... .....+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 46789999 68999999975 6899999998753 2334567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
++++|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+++.||+...........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999975432 23899999999999999999999999 999999999999999999999999865433211110
Q ss_pred ------eeeeeeccccccccccccc--CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 549 ------LTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 549 ------~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||........ . .... .+.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~----~~~~-~~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--L----LEKL-NGTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--H----HHHh-cCCcccc
Confidence 1112346778999999976 4688999999999999999999999975432211 0 0000 0000000
Q ss_pred cch------------------------------------hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH--HH
Q 005355 621 LDA------------------------------------RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF--EL 662 (700)
Q Consensus 621 ~d~------------------------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L 662 (700)
++. ...........+.+.+|+.+||+.||++|||++|+++ .+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f 310 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 310 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhh
Confidence 000 0000112234567889999999999999999999987 34
Q ss_pred Hhch
Q 005355 663 GGIR 666 (700)
Q Consensus 663 ~~l~ 666 (700)
++++
T Consensus 311 ~~~~ 314 (327)
T cd08227 311 KQIK 314 (327)
T ss_pred hhcc
Confidence 4443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=304.74 Aligned_cols=240 Identities=24% Similarity=0.423 Sum_probs=192.3
Q ss_pred ceEeeeCCeEEEEEEEcC--------CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 396 RILGQGGQGTVYKGMLTN--------GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+.||+|+||.||+|.... ...|++|.+........+.+.+|+.+++.++|+|++++++.+...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 234888887665555667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc--------EEEeecCCC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR--------AKVSDFGAS 539 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~--------~kl~DfGl~ 539 (700)
+++|+|.++++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999986543 3899999999999999999999999 999999999999987665 699999988
Q ss_pred cccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCC-CCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQ-KPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
..... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+......... ..... .
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-------~~~~~-~- 221 (258)
T cd05078 156 ITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-------QFYED-R- 221 (258)
T ss_pred cccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-------HHHHc-c-
Confidence 65432 122457889999999987 45799999999999999999985 565433322110 00110 0
Q ss_pred hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 618 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
...+......+.+|+.+||+.+|++|||++++++.|+
T Consensus 222 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ---------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0112223356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.40 Aligned_cols=258 Identities=28% Similarity=0.510 Sum_probs=203.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCc----EEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGR----IVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
.++|+..+.||+|+||.||+|.+. +++ .||+|.+.... ......+.+|+.+++.++|+||+++++.+... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 456788899999999999999864 343 57889876533 33345788999999999999999999998754 467
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+++||+++|+|.+++..... .+++..++.++.|++.||+|||+++ |+|+||||+|||++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 99999999999999976533 3899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCcee-eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 543 MIDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 543 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
....... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+. ...+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~-- 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-------PDLLEKGERL-- 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHCCCCC--
Confidence 4322211 122335678999999999999999999999999999997 8999975543221 1111111110
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
..+......+.+++.+||..+|++||++++++++|+.+...
T Consensus 231 -------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 -------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01112345688999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=300.37 Aligned_cols=249 Identities=25% Similarity=0.424 Sum_probs=197.1
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC--Ccc
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-----DESNIEQFINEVAILSQINHRNVVKLLGCCLET--EVP 461 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 461 (700)
.+|+..+.||+|+||.||+|... .++.|++|++... .....+.+.+|+.++++++|+||+++++.+.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47899999999999999999975 5889999987532 123456788999999999999999999988753 567
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++++||+++++|.+++.... .+++...+.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999997643 3889999999999999999999999 99999999999999999999999999876
Q ss_pred cccCCc--eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 542 VMIDQT--HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 542 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
...... .......++..|+|||++.+..++.++||||||+++|||++|+.||......+. ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~~~---- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIATQP---- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhcCC----
Confidence 532211 111234578899999999999999999999999999999999999975432221 11111100
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.. ...+......+.+++ +||..+|++||+++|+++
T Consensus 226 -~~----~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 -TN----PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CC----CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 01 112233345566777 678889999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=299.83 Aligned_cols=249 Identities=25% Similarity=0.395 Sum_probs=198.8
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC--Ccc
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-----DESNIEQFINEVAILSQINHRNVVKLLGCCLET--EVP 461 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 461 (700)
.+|++.++||+|+||.||++... +++.||||.+... .....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57889999999999999999975 5889999986532 123456788999999999999999999998764 456
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++++||+++++|.+++.... .+++..++.++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 79999999999999997653 3788999999999999999999999 99999999999999999999999999875
Q ss_pred cccCCc--eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 542 VMIDQT--HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 542 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
...... .......++..|+|||++.+..++.++||||||+++|||++|+.||........ ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~---- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQP---- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------HHHHhcCC----
Confidence 532111 112234588899999999988899999999999999999999999965422211 11111100
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.....+......+.+++.+|+. +|++||+++|+++
T Consensus 226 -----~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 -----TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -----CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0112234455678889999995 9999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=302.61 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=203.1
Q ss_pred CCCccceEeeeCCeEEEEEEEcC--CcEEEEEEcccc----------ChhhHHHHHHHHHHHhh-cCCCceeeEEeEEEe
Q 005355 391 NFNTNRILGQGGQGTVYKGMLTN--GRIVAIKKSKLV----------DESNIEQFINEVAILSQ-INHRNVVKLLGCCLE 457 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 457 (700)
+|++.+.||+|+||.||++.+.. ++.+|+|.+... ......++.+|+.++.+ ++|+||+++++.+.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999764 688999976532 22345667889998875 799999999999999
Q ss_pred CCcceEEEeeCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEee
Q 005355 458 TEVPLLVYEFIPNGTLYQYIHDQ-TEEFPITWEIRLRIAIEVSDALCYLHS-AASIPIYHRDIKSANILLDDKYRAKVSD 535 (700)
Q Consensus 458 ~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dik~~NILl~~~~~~kl~D 535 (700)
.+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999998653 223358999999999999999999996 66 99999999999999999999999
Q ss_pred cCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc
Q 005355 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN 615 (700)
Q Consensus 536 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 615 (700)
||++....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .......
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~-------~~~~~~~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL-------ATKIVEA 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH-------HHHHhhc
Confidence 99997653322 23345688899999999988899999999999999999999999965432211 1111111
Q ss_pred chhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 616 RLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 616 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
..... ........+.+++.+||+.||++||++.|+.++|+
T Consensus 229 ~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYEPL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCcC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11110 01123457889999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=300.09 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=191.7
Q ss_pred ceEeeeCCeEEEEEEEcC---CcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCC
Q 005355 396 RILGQGGQGTVYKGMLTN---GRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 471 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 471 (700)
+.||+|+||.||+|.... ...+++|.+.... ......+.+|+++++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997543 3578888766432 334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhccCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce-
Q 005355 472 TLYQYIHDQTEE--FPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH- 548 (700)
Q Consensus 472 sL~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~- 548 (700)
+|.+++...... ...++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999775431 23567888999999999999999999 999999999999999999999999998654322211
Q ss_pred eeeeeeccccccccccccc-------CCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 549 LTTRVQGTFGYLDPEYFRS-------SQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
......++..|+|||++.. ..++.++||||||+++|||++ |..||......+. ........ ...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV------LKQVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HHHHhhcc-CccC
Confidence 1122345678999998743 456889999999999999999 7888865433221 11111111 1111
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
..+.+ ....+..+.+++..|+ .+|++||+++||++.|.
T Consensus 231 ~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 12211 2233455677888888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.44 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=196.5
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC------
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLET------ 458 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 458 (700)
..++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4678999999999999999999965 67899999876432 23446678999999999999999999987543
Q ss_pred CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 005355 459 EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGA 538 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl 538 (700)
...++++|++ +++|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3458999988 78998888643 3899999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc--
Q 005355 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN-- 615 (700)
Q Consensus 539 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 615 (700)
+...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+. ...........
T Consensus 165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 237 (343)
T cd07878 165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---LKRIMEVVGTPSP 237 (343)
T ss_pred ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCCCH
Confidence 9764322 223458999999999877 5689999999999999999999999976543221 11111000000
Q ss_pred ---------chhhhcc------hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 616 ---------RLFEVLD------ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 616 ---------~~~~~~d------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.....+. ............+.+.+|+.+||+.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000000001122357899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=305.71 Aligned_cols=262 Identities=24% Similarity=0.321 Sum_probs=204.3
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+|++.+.||+|+||.||+|.+. +++.|++|++.... ....+.+.+|+.++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999975 68999999877543 33457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+ +++|.+++.... .++++..++.++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999997654 34899999999999999999999999 99999999999999999999999999986644332
Q ss_pred eeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc-----------
Q 005355 548 HLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN----------- 615 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 615 (700)
.......++..|+|||++.+. .++.++||||||++++||++|.+||......+. ...........
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCc
Confidence 223345688999999998654 468999999999999999999888865443221 11111111000
Q ss_pred -chhhh----cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 616 -RLFEV----LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 616 -~~~~~----~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.+..+ ...........+....+.+|+.+||+.+|++||+++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 00000011112334788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=299.21 Aligned_cols=247 Identities=26% Similarity=0.432 Sum_probs=202.5
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-----hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-----ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
+|+..+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+++++.++|+||+++++.+.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999976 78999999876433 33557899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
+||+++++|.+++.... .+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999997653 3889999999999999999999999 99999999999999999999999999876533
Q ss_pred CCceeeeeeecccccccccccccCC-CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|..||......+. ..........
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~------ 220 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA------VFKIGRSKEL------ 220 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH------HHHHHhcccC------
Confidence 22 233455888999999987776 89999999999999999999999975442111 1111110111
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...+......+.+++++||+.+|.+||++++++.
T Consensus 221 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ---PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1112234567888999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=299.94 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=207.3
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
++|++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999965 67899999876432 33567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999986543345899999999999999999999999 99999999999999999999999999876654332
Q ss_pred e---eeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 548 H---LTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 548 ~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
. ......++..|+|||++... .++.++|+||||+++|+|++|+.||......+. +....... .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHhcCC------CC
Confidence 2 22334588999999998877 789999999999999999999999975543221 11111110 00
Q ss_pred hhhhcc-CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 624 RVLKEA-KEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 624 ~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...... ....+..+.+++.+||+.+|++||+++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 010110 1234567889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=299.18 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=204.4
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+|++.+.||+|+||.+|++... +++.||+|.+... .....+.+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5788999999999999999965 6889999987642 334456889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++..... ..+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999999976432 23789999999999999999999999 99999999999999999999999999975533221
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......+++.|+|||++.+..++.++|+||||+++++|++|..||......+ ...... .+.. .
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~-~~~~---------~ 219 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKII-RGSY---------P 219 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHh-cCCC---------C
Confidence 1223457889999999999999999999999999999999999987543222 111111 1111 1
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..+......+.+++.+||+.+|.+||++.+|++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1123345678999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=304.73 Aligned_cols=259 Identities=23% Similarity=0.354 Sum_probs=204.0
Q ss_pred chHHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEe-
Q 005355 381 TSMELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLE- 457 (700)
Q Consensus 381 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 457 (700)
+..++..+.+.|++.+.||+|+||.||+|.+. +++.+|+|...... .....+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44566667889999999999999999999975 67899999876543 3346788999999998 79999999999853
Q ss_pred -----CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEE
Q 005355 458 -----TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAK 532 (700)
Q Consensus 458 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~k 532 (700)
.+..+++|||+++++|.+++..... ..+++..+..++.||+.||+|||+.+ |+|+||+|+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 4567899999999999999976432 24888899999999999999999999 99999999999999999999
Q ss_pred EeecCCCcccccCCceeeeeeecccccccccccc-----cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHH
Q 005355 533 VSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGY 607 (700)
Q Consensus 533 l~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 607 (700)
|+|||++........ ......++..|+|||.+. ...++.++||||||+++|||++|..||......+..
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----- 235 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----- 235 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence 999999875432211 123345888999999985 346788999999999999999999999654322111
Q ss_pred HHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 608 FLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 608 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..... .. .........+..+.+|+.+||+.+|.+||++.|+++
T Consensus 236 -~~~~~-~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 -FLIPR-NP--------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hhHhh-CC--------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000 00 001111234567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.49 Aligned_cols=265 Identities=26% Similarity=0.326 Sum_probs=204.5
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
++|++.+.||+|+||.||+|.+. +++.|+||+++.. .....+.+.+|++++++++|+||+++++++...+..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46889999999999999999976 5789999987643 33345788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|++++.|..++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999877766554432 3899999999999999999999999 9999999999999999999999999988765443
Q ss_pred ceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH--------HHHh-c-
Q 005355 547 THLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLE--------AMKE-N- 615 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~-~- 615 (700)
........++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.......... .... .
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 3233345678899999999888 889999999999999999999999975543221111000000 0000 0
Q ss_pred ----chhhhcchhh-hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 616 ----RLFEVLDARV-LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 616 ----~~~~~~d~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
......+... ....+...+..+.+|+++||..+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000111100 11112223677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.20 Aligned_cols=268 Identities=23% Similarity=0.386 Sum_probs=224.3
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEcC------CcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCceeeEEeEE
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLTN------GRIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCC 455 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 455 (700)
.++.....+++...++-+|.||.||+|.|.+ .+.|.+|..+. .++-+...++.|.-++..+.|||++.+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 4556667788999999999999999998763 34677887664 4556678899999999999999999999998
Q ss_pred EeC-CcceEEEeeCCCCCHHHHHh-----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC
Q 005355 456 LET-EVPLLVYEFIPNGTLYQYIH-----DQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY 529 (700)
Q Consensus 456 ~~~-~~~~lv~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~ 529 (700)
.++ +.++.+|.++.-|+|+.+|. +....+.++..++..++.|++.|++|||+++ +||.||..+|.+||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 754 67899999999999999998 4444456888899999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHH
Q 005355 530 RAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGY 607 (700)
Q Consensus 530 ~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 607 (700)
++||+|-.+++.+.+.+.+ .......+..||+||.+.+..|+.++|||||||+||||++ |+.|+...++.|..
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~----- 508 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME----- 508 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-----
Confidence 9999999999988766554 3344557789999999999999999999999999999999 99999888776632
Q ss_pred HHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 608 FLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 608 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
..++.+ ..-..+.+.++++..++.-||...|++||++++++.-|...-..+
T Consensus 509 --~ylkdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 509 --HYLKDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred --HHHhcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 122222 112335567889999999999999999999999999998776544
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=305.97 Aligned_cols=262 Identities=24% Similarity=0.321 Sum_probs=203.8
Q ss_pred chHHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEE--
Q 005355 381 TSMELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCL-- 456 (700)
Q Consensus 381 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-- 456 (700)
....+..+.++|++.+.||+|+||.||++... .++.+|+|+...... ....+.+|+.+++.+ +|+||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34556677899999999999999999999975 578999998764322 235678899999999 6999999999874
Q ss_pred ---eCCcceEEEeeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEE
Q 005355 457 ---ETEVPLLVYEFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAK 532 (700)
Q Consensus 457 ---~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~k 532 (700)
..+..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEE
Confidence 3456799999999999999886432 2335889999999999999999999999 99999999999999999999
Q ss_pred EeecCCCcccccCCceeeeeeeccccccccccccc-----CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHH
Q 005355 533 VSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGY 607 (700)
Q Consensus 533 l~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 607 (700)
|+|||++....... .......+++.|+|||++.. ..++.++||||||+++|||++|+.||......+.
T Consensus 165 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~------ 237 (286)
T cd06638 165 LVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------ 237 (286)
T ss_pred EccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH------
Confidence 99999987653222 12233458999999999853 4578899999999999999999999975432211
Q ss_pred HHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 608 FLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 608 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
... ..........+ +......+.+|+.+||+.+|++|||++|+++.
T Consensus 238 ~~~-~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 LFK-IPRNPPPTLHQ-------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred Hhh-ccccCCCcccC-------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 00010000101 11123468899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=303.87 Aligned_cols=264 Identities=24% Similarity=0.332 Sum_probs=206.4
Q ss_pred ccchHHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEE
Q 005355 379 LFTSMELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCL 456 (700)
Q Consensus 379 ~~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 456 (700)
+++..++..+.++|++.+.||+|+||.||++... +++.+|+|....... ..+.+.+|+.+++++ +|+|++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3455666677899999999999999999999975 688999998765332 236678899999998 8999999999987
Q ss_pred eCC-----cceEEEeeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc
Q 005355 457 ETE-----VPLLVYEFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR 530 (700)
Q Consensus 457 ~~~-----~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~ 530 (700)
..+ ..++|+||+++++|.++++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 543 5789999999999999987532 2235899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCcccccCCceeeeeeecccccccccccccC-----CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHH
Q 005355 531 AKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS-----QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLV 605 (700)
Q Consensus 531 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~ 605 (700)
+||+|||++........ ......++..|+|||++... .++.++||||||+++|||++|+.||......+.
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~---- 241 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT---- 241 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH----
Confidence 99999999876532221 12234578899999998653 368899999999999999999999975433221
Q ss_pred HHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 606 GYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 606 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.. .+.......+.+ +......+.+|+.+||+.+|++||++.|+++.
T Consensus 242 --~~-~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 --LF-KIPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred --HH-HHhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11 111111111111 12334568899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=307.91 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=202.7
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh---hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE---SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|+..+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+++++.++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888999999999999999976 489999998765332 34567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+.+++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999987543 234899999999999999999999999 999999999999999999999999998754321
Q ss_pred Cce----------------------------eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCC
Q 005355 546 QTH----------------------------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 597 (700)
Q Consensus 546 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~ 597 (700)
... ......|+..|+|||++.+..++.++||||||+++|+|++|..||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 1112357889999999999999999999999999999999999997554
Q ss_pred chhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCC----HHHHHH
Q 005355 598 SEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT----MKEAAF 660 (700)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs----~~evl~ 660 (700)
..+. +..... .. .........+..+.+++.+||+.+|++||+ ++|+++
T Consensus 237 ~~~~------~~~~~~-~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDET------FSNILK-KE--------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHH------HHHHhc-CC--------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 3221 111111 11 101111124668999999999999999999 556555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=338.84 Aligned_cols=257 Identities=23% Similarity=0.390 Sum_probs=201.0
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC--Cc
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLET--EV 460 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 460 (700)
+...++|++++.||+|+||+||++.+. .++.||+|.+.. ........|..|+.++++++||||+++++++.+. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344678999999999999999999976 577899998764 2344567899999999999999999999988654 46
Q ss_pred ceEEEeeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeeecCCCCCcEEECC--------
Q 005355 461 PLLVYEFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAAS----IPIYHRDIKSANILLDD-------- 527 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~----~~ivH~Dik~~NILl~~-------- 527 (700)
.+|||||+++++|.++|.... ....+++..++.|+.||+.||+|||+.+. ..|+||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 789999999999999997632 22359999999999999999999998541 23999999999999964
Q ss_pred ---------CCcEEEeecCCCcccccCCceeeeeeeccccccccccccc--CCCCcccceehHHHHHHHHHhCCCCCCCC
Q 005355 528 ---------KYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRST 596 (700)
Q Consensus 528 ---------~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlG~il~elltg~~p~~~~ 596 (700)
.+.+||+|||++...... .......||+.|+|||++.. ..++.++||||||+|||||++|..||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 335899999999765322 22234568999999999854 45889999999999999999999999754
Q ss_pred CchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 597 DSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.... .+...+..... + .....+..+.+||.+||+.+|.+||++.+++.
T Consensus 247 ~~~~------qli~~lk~~p~-------l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFS------QLISELKRGPD-------L---PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHH------HHHHHHhcCCC-------C---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 3221 11111211110 0 01123457889999999999999999999984
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.46 Aligned_cols=264 Identities=25% Similarity=0.344 Sum_probs=201.4
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
++|++.++||+|+||.||++.++ +++.||+|++.... ....+.+.+|+++++.++|+||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999986 58899999865432 2235678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|.++..... .+++..++.++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999988776543 3899999999999999999999999 9999999999999999999999999987653332
Q ss_pred ceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH--------HHHHHhcch
Q 005355 547 THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF--------LEAMKENRL 617 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~ 617 (700)
.......++..|+|||++.+ ..++.++||||||+++|||++|.+||......+........ .........
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 22233457889999999875 45788999999999999999999999755432211000000 000000000
Q ss_pred ------hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 ------FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ------~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
................+..+.+|+.+||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000111234567999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.58 Aligned_cols=240 Identities=25% Similarity=0.302 Sum_probs=188.7
Q ss_pred EeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc---CCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 398 LGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQI---NHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 398 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
||+|+||+||+|+.. +++.||||++... .......+..|..++... +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999976 5899999987642 122334556677777665 699999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~ 153 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTT 153 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCc
Confidence 99999987643 3899999999999999999999999 9999999999999999999999999987532222 223
Q ss_pred eeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhcc
Q 005355 551 TRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEA 629 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 629 (700)
....||..|+|||++.+. .++.++||||||+++|+|++|..||......+ ....+..+... +.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~~------~~--- 217 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKVR------FP--- 217 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCCC------CC---
Confidence 345689999999998764 48999999999999999999999997654322 11112111110 00
Q ss_pred CHHHHHHHHHHHHHHhccCCCCCCC----HHHHHH
Q 005355 630 KEEEIITVAMLAKRCLNMIGKKRPT----MKEAAF 660 (700)
Q Consensus 630 ~~~~~~~l~~li~~cl~~~p~~RPs----~~evl~ 660 (700)
.......+.+++.+||+.+|.+||+ +.++++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0123456788999999999999984 556555
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=307.73 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=202.4
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCC
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIP 469 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 469 (700)
.|.....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444467999999999999975 688999999876666667789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee
Q 005355 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549 (700)
Q Consensus 470 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~ 549 (700)
+++|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||++++++.+||+|||++........ .
T Consensus 103 ~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 174 (292)
T cd06658 103 GGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K 174 (292)
T ss_pred CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence 99999998643 2889999999999999999999999 99999999999999999999999999875432221 2
Q ss_pred eeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhcc
Q 005355 550 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEA 629 (700)
Q Consensus 550 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 629 (700)
.....++..|+|||++.+..++.++||||||++++||++|..||......+. ...+.. .+...+..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~~-----~~~~~~~~-- 240 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-------MRRIRD-----NLPPRVKD-- 240 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHh-----cCCCcccc--
Confidence 2335688999999999988999999999999999999999999975443221 011111 11111111
Q ss_pred CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 630 KEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 630 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.......+.+++.+||..+|.+|||++|+++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234568889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=300.70 Aligned_cols=255 Identities=27% Similarity=0.465 Sum_probs=200.8
Q ss_pred CCccceEeeeCCeEEEEEEEc----CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC------
Q 005355 392 FNTNRILGQGGQGTVYKGMLT----NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETE------ 459 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 459 (700)
|.+.+.||+|+||.||+|.+. .++.||||++... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999864 3678999987643 3445678899999999999999999999886542
Q ss_pred cceEEEeeCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeec
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQT---EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 536 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~Df 536 (700)
..++++||+.+|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999999875432 2234789999999999999999999999 999999999999999999999999
Q ss_pred CCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHh
Q 005355 537 GASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKE 614 (700)
Q Consensus 537 Gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 614 (700)
|+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||......+. ...+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~-------~~~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI-------YNYLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH-------HHHHHc
Confidence 998865432211 1122335678999999998899999999999999999999 8899875443221 111111
Q ss_pred cchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 615 NRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 615 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
.... ..+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 231 ~~~~---------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRL---------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1100 01122345789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=298.64 Aligned_cols=251 Identities=27% Similarity=0.421 Sum_probs=204.0
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe--CCcceEEE
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLE--TEVPLLVY 465 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 465 (700)
+|++.+.||.|+||.||++... +++.||+|.+.. ......+.+.+|++++++++|+||+++++.+.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999965 678999998764 334456778999999999999999999998764 34568999
Q ss_pred eeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 466 EFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLH-----SAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH-----~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
||+++++|.+++.... ....+++..++.++.||++||+||| +.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999997642 2345899999999999999999999 666 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
........ ......++..|+|||++.+..++.++||||||+++++|++|..||......+ +.+.+..+..
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~-- 227 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-------LASKIKEGKF-- 227 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-------HHHHHhcCCC--
Confidence 86543322 1233468999999999999889999999999999999999999997654221 1122222211
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
...+...+..+.+++.+||+.+|++||++++|++.
T Consensus 228 -------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 12233455678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.60 Aligned_cols=252 Identities=24% Similarity=0.452 Sum_probs=203.0
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC------hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD------ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
+|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++.+.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999964 68899999876432 1235788999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEeecCCCccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGASRSV 542 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~-~~kl~DfGl~~~~ 542 (700)
|+||+++++|.+++.+.. ++++..+..++.|++.||.|||+++ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999997643 4899999999999999999999999 99999999999998775 6999999998765
Q ss_pred ccCCc---eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 543 MIDQT---HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 543 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
..... .......++..|+|||.+.+..++.++||||||+++++|++|..||......... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~------- 224 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIA------- 224 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHh-------
Confidence 43211 1122345788999999998888999999999999999999999999654322111 1110000
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
........+......+.+++.+||+.+|.+||++.|+++
T Consensus 225 --~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 225 --SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 001112233445677889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=304.70 Aligned_cols=263 Identities=24% Similarity=0.369 Sum_probs=198.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE-SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.++|++.+.||+|++|.||+|..+ +++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367899999999999999999976 688999998764322 223457789999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|++ ++|.+++.+... .+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~-~~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLD-TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCC-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 997 599999876543 4899999999999999999999999 9999999999999999999999999987543221
Q ss_pred ceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh---cchhh---
Q 005355 547 THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE---NRLFE--- 619 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 619 (700)
. ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||........ ........+.. ..+..
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhh
Confidence 1 1122346789999999875 4588999999999999999999999975542111 11111110000 00000
Q ss_pred ----------hc-chhhhhcc-CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 620 ----------VL-DARVLKEA-KEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 620 ----------~~-d~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.. ...+.... .......+.+++.+||+.+|++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00000000 0111256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.80 Aligned_cols=255 Identities=23% Similarity=0.302 Sum_probs=202.5
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+++++.++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46889999999999999999976 57899999876533 234567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999997653 3899999999999999999999999 999999999999999999999999988632110
Q ss_pred C--------------ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHH
Q 005355 546 Q--------------THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEA 611 (700)
Q Consensus 546 ~--------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 611 (700)
. ........++..|+|||++....++.++||||||+++|||++|..||.+....+ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-------~~~~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-------LFGQ 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH
Confidence 0 001112357889999999998899999999999999999999999997543322 1111
Q ss_pred HHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 612 MKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 612 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
...+... .+. .....+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 228 ~~~~~~~---~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDDIE---WPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhcccC---CCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1111110 000 011345568899999999999999997666666644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=312.30 Aligned_cols=246 Identities=28% Similarity=0.419 Sum_probs=203.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh---hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE---SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
...|.-++.||.|+||.||.|.+. +.+.||||++.-... ..+.+++.|+..|++++|||++.+.|++..+...|||
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 345677789999999999999965 788999999875443 3467889999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+ -|+-.|++.-... ++-+..+..|..+.+.||+|||+++ .||||||..|||+++.|.|||+|||.+....+
T Consensus 105 MEYC-lGSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 105 MEYC-LGSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHH-hccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 9999 5688888765543 4889999999999999999999999 99999999999999999999999998875533
Q ss_pred CCceeeeeeeccccccccccc---ccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 545 DQTHLTTRVQGTFGYLDPEYF---RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~---~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
...++||+.|||||++ ..+.|+-|+||||||++-.||.-.++|+...+... ++..+.++..
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------ALYHIAQNes---- 242 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQNES---- 242 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------HHHHHHhcCC----
Confidence 3446799999999987 46789999999999999999999999986554221 2222222221
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+.+ ...+.+..+..++..||+.-|.+|||.++++.
T Consensus 243 -PtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 -PTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -CCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 111 13566778999999999999999999987764
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=297.70 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=191.0
Q ss_pred ceEeeeCCeEEEEEEEcCC---cEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCC
Q 005355 396 RILGQGGQGTVYKGMLTNG---RIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 471 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 471 (700)
+.||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999985433 346677665433 345678999999999999999999999999999999999999999
Q ss_pred CHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC-cee
Q 005355 472 TLYQYIHDQTE-EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ-THL 549 (700)
Q Consensus 472 sL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~-~~~ 549 (700)
+|.++++.... ...+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999986432 233677788899999999999999999 9999999999999999999999999886432111 112
Q ss_pred eeeeeccccccccccccc-------CCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 550 TTRVQGTFGYLDPEYFRS-------SQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 550 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
.....++..|+|||++.. ..++.++||||||+++|||++ +..||......+ .+...+.. ......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~-~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIKD-QQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhh-cccccC
Confidence 223457889999999753 345789999999999999997 567775443221 11111221 112222
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
++.+.. .....+.+++.+|| .+|++||++++|++.|.
T Consensus 231 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 332222 23456778999999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=305.57 Aligned_cols=261 Identities=23% Similarity=0.341 Sum_probs=197.4
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+|+..+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++|+||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999976 68899999876432 22345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
++ ++|.+++..... .+++..++.++.||++||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 96 588888765432 3899999999999999999999999 99999999999999999999999999875532221
Q ss_pred eeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc---c---hhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN---R---LFEV 620 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~---~~~~ 620 (700)
......++..|+|||++.+. .++.++||||||+++|+|++|..|+......+. ............ . ....
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhhc
Confidence 12234578899999998764 478999999999999999999888643332211 111111100000 0 0000
Q ss_pred cchhh---------hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 621 LDARV---------LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 621 ~d~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.+... ........+..+.+|+.+||+.||.+|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 01111234567889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.34 Aligned_cols=251 Identities=27% Similarity=0.448 Sum_probs=203.0
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE--SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+|+..+.||+|+||.||++... +++.|++|.++.... ...+.+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999965 688999998776444 3678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999997643 3789999999999999999999999 99999999999999999999999999886643322
Q ss_pred eee---eeeecccccccccccccCC---CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 548 HLT---TRVQGTFGYLDPEYFRSSQ---FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 548 ~~~---~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
... ....++..|+|||++.... .+.++||||||+++|+|++|..||........ ... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-----~~~-~~~~~~~---- 224 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-----IMF-HVGAGHK---- 224 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-----HHH-HHhcCCC----
Confidence 221 1345788999999998766 88999999999999999999999975432111 000 0111100
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+.+.. .......+.+++.+||+.+|.+||++.|++.
T Consensus 225 -~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 -PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00100 1123556789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.38 Aligned_cols=249 Identities=25% Similarity=0.401 Sum_probs=202.7
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+|+..+.||+|+||.||++... +++.+|||.+... .....+.+.+|++++++++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788999999999999999975 6889999987643 334567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEeecCCCcccccCC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~-~~~kl~DfGl~~~~~~~~ 546 (700)
+++++|.+++.... ...+++..++.++.|+++||+|||+++ ++|+||+|+||+++++ ..+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999997643 234899999999999999999999999 9999999999999855 468999999997653322
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
......++..|+|||.+....++.++||||||+++|+|++|+.||...+.... .. ........
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~-~~~~~~~~-------- 219 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL------VL-KIMSGTFA-------- 219 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH------HH-HHHhcCCC--------
Confidence 22234588899999999988899999999999999999999999975543221 11 11111111
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..+......+.+++.+||+.+|++|||++|+++.
T Consensus 220 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 -PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1112245578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=307.16 Aligned_cols=197 Identities=25% Similarity=0.403 Sum_probs=160.7
Q ss_pred cceEeeeCCeEEEEEEEc---CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe--CCcceEEEeeCC
Q 005355 395 NRILGQGGQGTVYKGMLT---NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLE--TEVPLLVYEFIP 469 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~E~~~ 469 (700)
.++||+|+||.||+|+.. .+..||+|.+.... ....+.+|++++++++||||+++++++.. ....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 358999999999999965 35789999876532 23467899999999999999999999854 456789999986
Q ss_pred CCCHHHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----CCCCcEEEeecCCC
Q 005355 470 NGTLYQYIHDQT------EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGAS 539 (700)
Q Consensus 470 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl----~~~~~~kl~DfGl~ 539 (700)
++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 57888875321 1234889999999999999999999999 9999999999999 56679999999999
Q ss_pred cccccCCce--eeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCC
Q 005355 540 RSVMIDQTH--LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTD 597 (700)
Q Consensus 540 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~ 597 (700)
+........ ......+|+.|+|||++.+ ..++.++||||||+++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 865432221 2234568999999999876 458899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=303.74 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=206.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.++|.+.+.||+|+||.||++... +++.|++|.+........+.+.+|+.+++.++|||++++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 478899999999999999999864 6789999998765555567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++.... +++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~~----l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999997542 789999999999999999999999 99999999999999999999999998875543322
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......+++.|+|||.+....++.++||||||+++|+|++|+.||......+... .....+. ...
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~--------~~~ 235 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT--------PEL 235 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCC--------CCC
Confidence 2223458889999999988889999999999999999999999997554322110 0000000 001
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..+......+.+++.+||+.+|++||++.+++.+
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122344568899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.58 Aligned_cols=244 Identities=27% Similarity=0.374 Sum_probs=202.2
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.+.||+|+||.||++.+. +++.||+|.+... .....+.+.+|++++++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47889999999999999999976 5899999987642 2344577899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999997653 3899999999999999999999999 999999999999999999999999999765433
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
.....+++.|+|||.+.+...+.++||||||+++++|++|..||......+ .......+..
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~-------- 215 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-------IYEKILEGKV-------- 215 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCc--------
Confidence 233458899999999988889999999999999999999999997554211 1111111111
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRP-----TMKEAAF 660 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~ 660 (700)
..+......+.+++.+||..+|.+|| +++|+++
T Consensus 216 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 --RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11222356788999999999999999 6666664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=303.10 Aligned_cols=264 Identities=22% Similarity=0.298 Sum_probs=201.8
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC--CcceEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLET--EVPLLV 464 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 464 (700)
++|++.+.||+|+||.||+|++. +++.+++|.++... ......+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888999999999999999986 58899999886533 22334677899999999999999999998877 889999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
+||++ ++|.+++..... .+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99996 599999876543 4899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH--------------
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL-------------- 609 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-------------- 609 (700)
... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||......+.........
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred Ccc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 321 22334578899999998764 46899999999999999999999997654332111100000
Q ss_pred HHHHhcchhhhcchhhhhccCHH-HHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 610 EAMKENRLFEVLDARVLKEAKEE-EIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 610 ~~~~~~~~~~~~d~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.......+.......+....+.. ....+.+++++||+.+|++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000001111111111122221 3567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=298.65 Aligned_cols=248 Identities=28% Similarity=0.430 Sum_probs=203.1
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+-|+..+.||+|+||.||+|... +++.||||...... ....+.+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34678889999999999999865 68899999876433 34456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 84 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 9999999998753 3899999999999999999999999 9999999999999999999999999987553221
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||....... ....+..... .
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~---------~ 219 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-------VLFLIPKNNP---------P 219 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-------HHHHHhcCCC---------C
Confidence 11223457889999999998889999999999999999999999996543221 1111111111 1
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
......+..+.+++.+||+.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1122345678899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=314.20 Aligned_cols=244 Identities=28% Similarity=0.434 Sum_probs=204.7
Q ss_pred eEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCHHH
Q 005355 397 ILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQ 475 (700)
Q Consensus 397 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 475 (700)
+||+|.||+||-|++. +...+|||-+...+....+-+.+|+.+-++++|+|||+.+|.+.+.+..-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999976 466789998887777777889999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-CCCcEEEeecCCCcccccCCceeeee
Q 005355 476 YIHDQTEEFPI--TWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGASRSVMIDQTHLTTR 552 (700)
Q Consensus 476 ~l~~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~-~~~~~kl~DfGl~~~~~~~~~~~~~~ 552 (700)
+|+..=. ++ .+..+-.+.+||++||.|||.+. |||||||-+|+||+ -.|.+||+|||-++.+. .-+..+.+
T Consensus 662 LLrskWG--PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP~TET 735 (1226)
T KOG4279|consen 662 LLRSKWG--PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINPCTET 735 (1226)
T ss_pred HHHhccC--CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc-cCCccccc
Confidence 9986532 35 77888899999999999999999 99999999999995 57899999999988653 22334556
Q ss_pred eecccccccccccccC--CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccC
Q 005355 553 VQGTFGYLDPEYFRSS--QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAK 630 (700)
Q Consensus 553 ~~gt~~y~aPE~~~~~--~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 630 (700)
..||+.|||||++..+ .|..++|||||||++.||.||++||........ .+.+-+.+ ......+
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVGmy------KvHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVGMY------KVHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhcce------ecCCCCc
Confidence 6799999999999764 588999999999999999999999975544321 11121211 1223446
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 631 EEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 631 ~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.+...+...+|.+|+..+|.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 677788899999999999999999999987
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.71 Aligned_cols=260 Identities=24% Similarity=0.352 Sum_probs=199.1
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+|+..+.||+|++|.||+|+.. +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888999999999999999975 68899999876432 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+. ++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 689999876432 34899999999999999999999999 99999999999999999999999999875532221
Q ss_pred eeeeeeecccccccccccccCC-CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc-----------
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN----------- 615 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 615 (700)
......++..|+|||++.+.. ++.++||||||+++|||++|+.||......+. .... .......
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRI-FRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHH-HHHhCCCChhhhhhhhHH
Confidence 122334678999999887654 58899999999999999999999976543221 1111 1000000
Q ss_pred -----chhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 616 -----RLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 616 -----~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.+....... ...........+.+++.+||+.||.+||+++|+++
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYKPSFPKWARQD-FSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhhcccccccC-HHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000 00111123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=305.69 Aligned_cols=246 Identities=27% Similarity=0.399 Sum_probs=200.8
Q ss_pred ccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCC
Q 005355 394 TNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 472 (700)
Q Consensus 394 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 472 (700)
....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|||++++++.+...+..++++||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999975 688999999876555556778999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeee
Q 005355 473 LYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTR 552 (700)
Q Consensus 473 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~ 552 (700)
|.+++... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .....
T Consensus 105 L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~ 176 (297)
T cd06659 105 LTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKS 176 (297)
T ss_pred HHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccc
Confidence 99988653 2899999999999999999999999 9999999999999999999999999987543322 12233
Q ss_pred eecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHH
Q 005355 553 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEE 632 (700)
Q Consensus 553 ~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 632 (700)
..++..|+|||++.+..++.++||||||++++||++|+.||......+.. ..+....... ......
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-------~~~~~~~~~~-------~~~~~~ 242 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-------KRLRDSPPPK-------LKNAHK 242 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhccCCCC-------ccccCC
Confidence 56889999999999889999999999999999999999999754432211 1111110000 000112
Q ss_pred HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 633 EIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 633 ~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
....+.+++.+||+.+|++||+++++++.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 34568889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=295.32 Aligned_cols=252 Identities=27% Similarity=0.397 Sum_probs=208.5
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE-SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
++|++.+.||+|++|.||+++.. +++.|+||++..... ...+.+.+|+.++.+++|+|++++++.+...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999987 589999998876543 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
+++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999865 248999999999999999999999 99 9999999999999999999999999988654332
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||............ ..+.....
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~----~~~~~~~~--------- 220 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM----QAICDGPP--------- 220 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH----HHHhcCCC---------
Confidence 22 23455888999999999999999999999999999999999999765431111111 11111111
Q ss_pred hccCHH-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 627 KEAKEE-EIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 627 ~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
...+.. .+..+.+++.+||..+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111222 55679999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=308.86 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=207.7
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEcc--ccChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcc
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSK--LVDESNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVP 461 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 461 (700)
+.+....|+++++||+||.+.||++...+.+.+|+|+.. ..+.+...-|.+|+..|.+|+ |.+|++|+++-..++..
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 345567899999999999999999998888899998754 467777899999999999994 99999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
|||||+= ..+|..+|+..... ++.-.+..+..|++.|+.++|.+| |||-||||.|+|+-. |.+||+|||++..
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~a 508 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANA 508 (677)
T ss_pred EEEeecc-cccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcc
Confidence 9999975 67999999877543 343377889999999999999999 999999999999965 4899999999998
Q ss_pred cccCCce-eeeeeecccccccccccccCC-----------CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 005355 542 VMIDQTH-LTTRVQGTFGYLDPEYFRSSQ-----------FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL 609 (700)
Q Consensus 542 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-----------~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 609 (700)
+..+... .....+||+.||+||.+.... .+.++||||||||||+|+.|+.||..... ..
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~---- 579 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QI---- 579 (677)
T ss_pred cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HH----
Confidence 8766554 345678999999999985432 45789999999999999999999963321 11
Q ss_pred HHHHhcchhhhcchhhhhccCHH-HHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 610 EAMKENRLFEVLDARVLKEAKEE-EIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 610 ~~~~~~~~~~~~d~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.++..+.++.-..+++.- ...++.++++.||+.||++||+..|+|+
T Consensus 580 -----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 -----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 234455555443333211 1123899999999999999999999987
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.88 Aligned_cols=264 Identities=22% Similarity=0.344 Sum_probs=203.0
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE-SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
+|++.+.||+|++|.||+|+.. +++.||||.++.... ...+.+.+|++++++++|+||+++++.+.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999986 688999998875432 33467788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
+ ++|.+++........+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 7 489998876654456899999999999999999999999 99999999999999999999999999975432211
Q ss_pred eeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH--------HHHHHh-cch-
Q 005355 549 LTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF--------LEAMKE-NRL- 617 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~-~~~- 617 (700)
......++..|++||++.+. .++.++||||||+++|+|++|+.||......+........ ...+.. ..+
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 12234468899999998664 5788999999999999999999999866543321111000 000000 000
Q ss_pred ---hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 ---FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ---~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
....+ .............+.+++.+||+.+|.+||+++++++
T Consensus 236 ~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPP-QDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCCh-HHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 0011111233567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.97 Aligned_cols=254 Identities=23% Similarity=0.419 Sum_probs=200.4
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC----------hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD----------ESNIEQFINEVAILSQINHRNVVKLLGCCLETE 459 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 459 (700)
+|.+.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677899999999999999865 68899999865321 112356888999999999999999999999999
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
..++|+||+++++|.+++.... .+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999998753 4899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCce-eeeeeecccccccccccccCC--CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcc
Q 005355 540 RSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR 616 (700)
Q Consensus 540 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 616 (700)
......... ......++..|+|||++.... ++.++|+||||+++|+|++|..||......+. ....... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~-~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA------MFKLGNK-R 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH------HHHhhcc-c
Confidence 754322111 123345788999999987654 88999999999999999999999964332211 1111111 0
Q ss_pred hhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 617 LFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 617 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
....+ ..+.....+..+.+++.+||+.+|++||+++++++.
T Consensus 229 ~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPI----PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcC----CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 01111 111222345678999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.63 Aligned_cols=260 Identities=28% Similarity=0.341 Sum_probs=200.3
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChh-----hHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDES-----NIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
+|++.+.||+|+||.||+|... +++.||||++...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999976 6899999988754322 345677899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+ +++|.+++.... ..+++..++.++.||++||+|||+++ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999997654 24899999999999999999999999 99999999999999999999999999976543
Q ss_pred CCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh---c-----
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE---N----- 615 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~----- 615 (700)
... ......++..|+|||.+.+ ..++.++||||||++++||++|.+||......+.. ......... .
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL---GKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH---HHHHHHcCCCchhhhhhc
Confidence 321 1222346778999998865 46789999999999999999998887654432211 111110000 0
Q ss_pred -chhhhcchhh-----hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 616 -RLFEVLDARV-----LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 616 -~~~~~~d~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.......... ...........+.+++.+||+.+|++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000000 00111233567889999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.58 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=195.3
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHH-HhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAI-LSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
++|++.+.||+|+||.||++.+. +++.||+|+++... ......+..|+.+ ++.++|+|++++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47889999999999999999976 68999999876532 2233456666665 566789999999999999999999999
Q ss_pred eCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 467 FIPNGTLYQYIHDQ-TEEFPITWEIRLRIAIEVSDALCYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 467 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|++ ++|.+++... .....+++..++.++.||+.||+|||++ + ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 7898888653 2234589999999999999999999997 7 99999999999999999999999999876532
Q ss_pred CCceeeeeeeccccccccccccc----CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRS----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....... ........ +..
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~-~~~--- 225 (283)
T cd06617 157 S--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-----QQLKQVVE-EPS--- 225 (283)
T ss_pred c--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-----HHHHHHHh-cCC---
Confidence 2 11223457889999998865 456889999999999999999999996432211 11111111 110
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+.+ .....+..+.+++.+||..+|++||++.++++
T Consensus 226 --~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 --PQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001 01124567889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=299.64 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=204.5
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
++|+..+.||+|+||.||++.+. +++.|++|++.... ....+++.+|++++++++|+||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46788899999999999999986 68899999876543 34567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999998653 348999999999999999999999 88 9999999999999999999999999987553222
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
.. ...++..|+|||++.+..++.++||||||+++++|++|..||....... ......... +.....
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~-~~~~~~--------- 221 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQY-IVNEPP--------- 221 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHH-HhcCCC---------
Confidence 11 1558889999999999999999999999999999999999997543211 111111111 111110
Q ss_pred hccCHH-HHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 627 KEAKEE-EIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 627 ~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...+.. ....+.+++.+||..+|++|||+.+++.
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 011111 4567899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.47 Aligned_cols=255 Identities=26% Similarity=0.396 Sum_probs=202.2
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCC-----
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETE----- 459 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----- 459 (700)
.++++|++.+.||+|+||.||+|... +++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35689999999999999999999986 578999998776544 346789999999998 7999999999997654
Q ss_pred -cceEEEeeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 460 -VPLLVYEFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 460 -~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
..++||||+++++|.+++.... .+..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4799999999999999987643 2335899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCceeeeeeeccccccccccccc-----CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHH
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAM 612 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 612 (700)
++....... .......++..|+|||++.. ..++.++||||||++|++|++|..||......+. ... +
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~-~ 230 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA------LFK-I 230 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH------HHH-h
Confidence 987543222 22233458889999998753 3467899999999999999999999964332111 111 1
Q ss_pred HhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 613 KENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 613 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.......+ ..+......+.+|+.+||..||++|||+.++++
T Consensus 231 ~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNPPPTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccCCCCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111110 111234567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=299.54 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=202.7
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCC
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIP 469 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 469 (700)
.|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+||+++++.+...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3445579999999999999965 688999999876666666778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee
Q 005355 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549 (700)
Q Consensus 470 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~ 549 (700)
+++|.+++... .+++..+..++.|++.||+|||+++ ++||||+|+||+++.++.++|+|||++........ .
T Consensus 100 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 100 GGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred CCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 99999999763 3899999999999999999999999 99999999999999999999999998875433221 2
Q ss_pred eeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhcc
Q 005355 550 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEA 629 (700)
Q Consensus 550 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 629 (700)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||...+..+. . ........ +.+ ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~-~~~~~~~~-----~~~--~~ 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------M-KRIRDNLP-----PKL--KN 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------H-HHHHhcCC-----CCC--cc
Confidence 2334588999999999988899999999999999999999999975432211 1 11111100 000 01
Q ss_pred CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 630 KEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 630 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
....+..+.+++.+||+.+|++||+++++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1124457899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.29 Aligned_cols=263 Identities=24% Similarity=0.315 Sum_probs=201.4
Q ss_pred CCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC--CcceEEEe
Q 005355 392 FNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLET--EVPLLVYE 466 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~E 466 (700)
|++.+.||+|+||.||+|... +++.+|+|++.... ......+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999976 58899999987653 33456788999999999999999999999988 88999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|++ ++|.+++.... ..+++..++.++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 997 48999887653 24899999999999999999999999 9999999999999999999999999998664443
Q ss_pred ceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch--------
Q 005355 547 THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL-------- 617 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------- 617 (700)
........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......................+
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 222333456788999998765 46789999999999999999999999765543221111100000000000
Q ss_pred ------hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 ------FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ------~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.......+.......++..+.+++++||+.+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000111111111112567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=298.08 Aligned_cols=247 Identities=26% Similarity=0.431 Sum_probs=200.8
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcC---CCceeeEEeEEEeCCcceEEE
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQIN---HRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 465 (700)
.|+..+.||+|+||.||+|.+. +++.||+|.+... .....+.+.+|+.++++++ |+|++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4778899999999999999974 6889999987653 3445677889999999986 999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999998654 3899999999999999999999999 999999999999999999999999998765433
Q ss_pred Cceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......... ....... .+.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~~-----~~~ 221 (277)
T cd06917 155 SS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------MLIPKSK-----PPR 221 (277)
T ss_pred cc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------hccccCC-----CCC
Confidence 32 2233458889999999865 45789999999999999999999999754332210 0011000 011
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+.. ...+..+.+++.+||+.+|++||++.|++.
T Consensus 222 ~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 LED---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 114567889999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=300.76 Aligned_cols=247 Identities=27% Similarity=0.403 Sum_probs=198.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.+.|+..+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+++++.++|||++++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 456888999999999999999975 6889999987642 233456789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
+||++ |+|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99996 678777764432 4899999999999999999999999 99999999999999999999999999865432
Q ss_pred CCceeeeeeecccccccccccc---cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
. ....++..|+|||++. ...++.++||||||+++|||++|..||........ . .....+..
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~-~~~~~~~~---- 231 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------L-YHIAQNDS---- 231 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------H-HHHhcCCC----
Confidence 2 2245788999999874 45688999999999999999999999975433221 0 00111100
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
........+..+.+++.+||+.+|++||++.+++..
T Consensus 232 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 ----PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011112345678999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.13 Aligned_cols=264 Identities=24% Similarity=0.334 Sum_probs=197.9
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE-SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++|+||+++.+++...+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999875 688999998765332 22346788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+. ++|.+++..... .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9995 778777765432 3788889999999999999999999 999999999999999999999999998754322
Q ss_pred CceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh----------
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE---------- 614 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 614 (700)
.. ......+++.|+|||++.+. .++.++||||||+++|||++|..||........ ...........
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhhh
Confidence 11 12233478899999998764 578899999999999999999999975543211 00000000000
Q ss_pred ---cchhhhcc---hhhhhc--cCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 615 ---NRLFEVLD---ARVLKE--AKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 615 ---~~~~~~~d---~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
........ +..... ........+.+++.+|++.||++|||++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000 000000 00112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=290.47 Aligned_cols=249 Identities=31% Similarity=0.432 Sum_probs=206.6
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCC
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIP 469 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 469 (700)
.|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++.+...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999986 688999999887655567889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee
Q 005355 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549 (700)
Q Consensus 470 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~ 549 (700)
+++|.+++.... ..+++..+..++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999998753 24899999999999999999999999 99999999999999999999999999876644332
Q ss_pred eeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhcc
Q 005355 550 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEA 629 (700)
Q Consensus 550 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 629 (700)
.....++..|+|||.+.....+.++||||||+++++|++|..||......+.. .............
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~~~~~------- 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL-------FKIATNGPPGLRN------- 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH-------HHHHhcCCCCcCc-------
Confidence 33456889999999999888999999999999999999999999755322211 0111111111110
Q ss_pred CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 630 KEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 630 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
....+..+.+++.+||+.+|++|||+.|+++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112567899999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=323.03 Aligned_cols=267 Identities=20% Similarity=0.284 Sum_probs=191.2
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcC--CcEEEEE------------------EccccChhhHHHHHHHHHHHhhcCCCc
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTN--GRIVAIK------------------KSKLVDESNIEQFINEVAILSQINHRN 447 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 447 (700)
..++|++.+.||+|+||+||++.++. +...++| +.. ........+.+|+.+|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987542 2222222 111 12233467889999999999999
Q ss_pred eeeEEeEEEeCCcceEEEeeCCCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005355 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTE--EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL 525 (700)
Q Consensus 448 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl 525 (700)
|+++++++...+..++|+|++ .++|.+++..... ........+..++.||+.||+|||+++ |+||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 999999999999999999998 4678887765321 112346677889999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCC-CCCCCchhhhhH
Q 005355 526 DDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP-IRSTDSEEDKSL 604 (700)
Q Consensus 526 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p-~~~~~~~~~~~~ 604 (700)
+.++.+||+|||+++.+............||..|+|||++.+..++.++||||||++||||++|..+ +..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999986644333333445699999999999999999999999999999999998754 433322221111
Q ss_pred HHHHHHHHH--hc-------chhhhcchhhhhcc---------CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 605 VGYFLEAMK--EN-------RLFEVLDARVLKEA---------KEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 605 ~~~~~~~~~--~~-------~~~~~~d~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.... .... .. .+...++....... .......+.+++.+||+.||.+|||+.|+++
T Consensus 381 ~~~~-~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKII-DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHH-HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111 0000 00 00001100000000 0112345677899999999999999999987
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=297.95 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=207.2
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.++.|+..+.||+|+||.||++.+. +++.|++|.+..... ..+.+.+|++++++++|+|++++++.+...+..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4667888899999999999999987 688999999876544 56788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999998764 24999999999999999999999999 9999999999999999999999999886543222
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
.......++..|++||++.+..++.++||||||+++|+|++|..||......... .. +.........
T Consensus 171 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~------~~-~~~~~~~~~~----- 237 (286)
T cd06614 171 -SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL------FL-ITTKGIPPLK----- 237 (286)
T ss_pred -hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH------HH-HHhcCCCCCc-----
Confidence 1223345788999999999888999999999999999999999999755433211 11 1111111100
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.....+..+.+++.+||+.+|.+||++.++++
T Consensus 238 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 --NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred --chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11124457889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=311.16 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=205.5
Q ss_pred CCCccceEeeeCCeEEEEEEEcCC-cEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCC
Q 005355 391 NFNTNRILGQGGQGTVYKGMLTNG-RIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIP 469 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 469 (700)
-|.++..||.|+||.||+|..++. -..|.|.+........++|.-|++||....||+||+|++.|...+.++++.||+.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 345556799999999999997743 3456788888888889999999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee
Q 005355 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549 (700)
Q Consensus 470 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~ 549 (700)
||-.+.++-.-.. .|++.++..+.+|++.||.|||+++ |||||||+.|||++-+|.++|+|||.+..... ....
T Consensus 113 GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk 186 (1187)
T KOG0579|consen 113 GGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK 186 (1187)
T ss_pred CchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence 9999999876543 4999999999999999999999999 99999999999999999999999999865322 2233
Q ss_pred eeeeeccccccccccc-----ccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 550 TTRVQGTFGYLDPEYF-----RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 550 ~~~~~gt~~y~aPE~~-----~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
...++||+.|||||++ ...+|+.++||||||++|.||..+.+|-...++. ..++...+.... .
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RVllKiaKSePP------T 254 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEPP------T 254 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HHHHHHhhcCCC------c
Confidence 4567899999999986 4568999999999999999999999997644322 122222222111 0
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+ ..+......+.+++.+||..||+.||++.++++
T Consensus 255 L--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 255 L--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred c--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1 113445667899999999999999999999986
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=302.40 Aligned_cols=266 Identities=25% Similarity=0.326 Sum_probs=199.2
Q ss_pred CCCccceEeeeCCeEEEEEEEcC---CcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC--Ccce
Q 005355 391 NFNTNRILGQGGQGTVYKGMLTN---GRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLET--EVPL 462 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 462 (700)
+|++.++||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999999753 7899999887632 34456788999999999999999999999988 7889
Q ss_pred EEEeeCCCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC----CCcEEEeec
Q 005355 463 LVYEFIPNGTLYQYIHDQTE--EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDF 536 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~----~~~~kl~Df 536 (700)
+||||++ ++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 477777754322 235899999999999999999999999 999999999999999 999999999
Q ss_pred CCCcccccCCc--eeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhh------hHHHH
Q 005355 537 GASRSVMIDQT--HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDK------SLVGY 607 (700)
Q Consensus 537 Gl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~------~~~~~ 607 (700)
|++........ .......++..|+|||++.+ ..++.++||||||+++++|++|+.||......... .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543322 11233457889999998876 45789999999999999999999999765543210 00001
Q ss_pred HHHHHHhc------------chhh--------hcc-hhhhhccCH--HHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 608 FLEAMKEN------------RLFE--------VLD-ARVLKEAKE--EEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 608 ~~~~~~~~------------~~~~--------~~d-~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+...+... .... ... ..+...... .....+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11100000 0000 000 000000001 33456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=295.34 Aligned_cols=260 Identities=26% Similarity=0.316 Sum_probs=202.2
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC--CcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLET--EVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 465 (700)
++|+..+.||.|++|.||++... +++.+|+|.+.... ......+.+|++++++++|+||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999975 57899999877533 34457799999999999999999999998654 3678999
Q ss_pred eeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 466 EFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999876432 2334899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ....+ ............+ ...
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~-~~~~~~~~~~~~~-~~~ 231 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIE-LLSYIVNMPNPEL-KDE 231 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHH-HHHHHhcCCchhh-ccC
Confidence 21 123447889999999999999999999999999999999999997653311 11111 1111111111111 000
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. .........+.+++.+||..+|.+|||+.|+++
T Consensus 232 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 001123567899999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.93 Aligned_cols=263 Identities=22% Similarity=0.301 Sum_probs=198.1
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCc-----
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQIN-HRNVVKLLGCCLETEV----- 460 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 460 (700)
++|++.+.||+|+||.||+|.+. +++.||||+..... ......+.+|+.+++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999976 68899999876432 223467889999999995 6999999999887665
Q ss_pred ceEEEeeCCCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEeecC
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTE--EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFG 537 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~-~~~~kl~DfG 537 (700)
.++||||+++ +|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 89988865432 245899999999999999999999999 999999999999998 8899999999
Q ss_pred CCcccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc-
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN- 615 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 615 (700)
++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||......+.. ..+.......
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL---LHIFKLLGTPT 232 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHhCCCC
Confidence 9875532211 1122346788999998865 45789999999999999999999999765432211 0111110000
Q ss_pred --chhhh-----------cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 616 --RLFEV-----------LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 616 --~~~~~-----------~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.+... ..+.............+.+++.+||+.+|.+||+++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 0000011111234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=308.09 Aligned_cols=268 Identities=24% Similarity=0.351 Sum_probs=201.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC-----cc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETE-----VP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 461 (700)
.++|++.++||+|+||.||+|.+. +++.||||+++... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 578999999999999999999965 68999999886432 334567889999999999999999999876543 46
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++++||++ ++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 89999996 5888887653 3899999999999999999999999 99999999999999999999999999876
Q ss_pred cccCCce--eeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh---c
Q 005355 542 VMIDQTH--LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE---N 615 (700)
Q Consensus 542 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 615 (700)
....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+...... .+...... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~---~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN---LILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCCHH
Confidence 5332211 1223457889999998755 568999999999999999999999997654322111 11100000 0
Q ss_pred chhhhcchhh--------------hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhchh
Q 005355 616 RLFEVLDARV--------------LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE--LGGIRA 667 (700)
Q Consensus 616 ~~~~~~d~~~--------------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~--L~~l~~ 667 (700)
.+..+.+... ...........+.+++.+||+.+|++|||+.|+++. |+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000000000 000011235668899999999999999999999986 555543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=302.97 Aligned_cols=265 Identities=26% Similarity=0.325 Sum_probs=198.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC--CcceE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLET--EVPLL 463 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 463 (700)
.++|++.+.||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 478999999999999999999975 68999999876432 22234567899999999999999999998765 45799
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+. ++|.+++.... ..+++..++.++.||++||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 58988887643 34899999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh---
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE--- 619 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 619 (700)
.... ......++..|+|||++.+ ..++.++||||||+++|||++|..||......+................+..
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 160 LPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 3221 1222345788999999865 5678999999999999999999999976554332111111000000000000
Q ss_pred -------hcchhhh---hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 620 -------VLDARVL---KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 620 -------~~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.+..... ..........+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 0000113566789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=294.43 Aligned_cols=249 Identities=25% Similarity=0.375 Sum_probs=201.9
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788899999999999999976 5789999987643 223456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEeecCCCcccccCC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~-~~kl~DfGl~~~~~~~~ 546 (700)
+++++|.+++..... ..+++..+..++.|+++||+|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999976432 24799999999999999999999999 99999999999998885 56999999987654322
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
.......+++.|+|||++....++.++|+||||++++||++|..||......+ ...... ...+.
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~-------- 220 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKIC-QGYFA-------- 220 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHh-cccCC--------
Confidence 22233458889999999988889999999999999999999999996543221 111111 11111
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.........+.+++.+||+.+|++|||+.|+++
T Consensus 221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 -PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111233457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=300.52 Aligned_cols=265 Identities=27% Similarity=0.348 Sum_probs=200.9
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC---
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETE--- 459 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 459 (700)
+...++|++.+.||+|+||.||+|.++ +++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345688999999999999999999986 58899999886533 233456788999999999999999999987655
Q ss_pred -------cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEE
Q 005355 460 -------VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAK 532 (700)
Q Consensus 460 -------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~k 532 (700)
..++|+||+++ +|.+++.... ..+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 77899999975 7777776542 24899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCcccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHH
Q 005355 533 VSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEA 611 (700)
Q Consensus 533 l~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 611 (700)
|+|||++...............++..|+|||.+.+ ..++.++||||||++++||++|+.||......+. ...+...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~---~~~~~~~ 233 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ---LELISRL 233 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHH
Confidence 99999997654333222223346778999998865 4578899999999999999999999975443221 1111111
Q ss_pred HHhc---chhhh--------cc------hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 612 MKEN---RLFEV--------LD------ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 612 ~~~~---~~~~~--------~d------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.... .+..+ .+ ...... ....+..+.+++.+||+.+|.+||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1100 00000 00 000000 1123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=306.39 Aligned_cols=272 Identities=23% Similarity=0.319 Sum_probs=204.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC-----Cc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLET-----EV 460 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 460 (700)
.++|.+.+.||+|+||+||++... +++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999965 6899999987642 233456678899999999999999999987654 34
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.++|+||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 689999995 78998887543 3899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH--------H
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLE--------A 611 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------~ 611 (700)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+..+.......... .
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 653322 22233457889999998865 5688999999999999999999999976543221111110000 0
Q ss_pred HHhcchhhhc-------chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhchhhc
Q 005355 612 MKENRLFEVL-------DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE--LGGIRASI 669 (700)
Q Consensus 612 ~~~~~~~~~~-------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~--L~~l~~~~ 669 (700)
+........+ +... .......+..+.+|+++||+.+|++|||++|+++. |+.+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred cCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 0000000000 0000 01112345678899999999999999999999987 76655443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=297.91 Aligned_cols=260 Identities=25% Similarity=0.353 Sum_probs=198.7
Q ss_pred CCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 392 FNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
|++.+.||.|++|.||+|.+. +++.||+|++.... ....+.+.+|++++++++|+|++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677889999999999999975 68999999876432 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
+ ++|.+++..... ..+++..++.++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 4 699999876542 24899999999999999999999999 99999999999999999999999999975432221
Q ss_pred eeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh---c---------
Q 005355 549 LTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE---N--------- 615 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~--------- 615 (700)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||........ ....+ +.... .
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIF-RTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCChHHhhhhhhch
Confidence 12223468899999988664 578899999999999999999999976543221 11100 00000 0
Q ss_pred chhhhc---chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 616 RLFEVL---DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 616 ~~~~~~---d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...... ............+..+.+++.+||+.+|.+||+++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 000001111223467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=296.62 Aligned_cols=259 Identities=17% Similarity=0.249 Sum_probs=188.1
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcC----CcEEEEEEccccChhh-----------HHHHHHHHHHHhhcCCCceeeE
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTN----GRIVAIKKSKLVDESN-----------IEQFINEVAILSQINHRNVVKL 451 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l 451 (700)
...++|++.++||+|+||.||+|.+.+ +..+|+|+........ ......++..+..+.|+|++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 345789999999999999999999764 3466777543322211 0112233445566789999999
Q ss_pred EeEEEeCC----cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC
Q 005355 452 LGCCLETE----VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD 527 (700)
Q Consensus 452 ~~~~~~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~ 527 (700)
+++..... ..++++|++. .++.+.+.... ..++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~ 161 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG 161 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 99876544 2357777763 46766665432 2578889999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCcccccCCce------eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhh
Q 005355 528 KYRAKVSDFGASRSVMIDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601 (700)
Q Consensus 528 ~~~~kl~DfGl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~ 601 (700)
++.++|+|||+++........ ......||+.|+|||++.+..++.++||||||++|+||++|..||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999865432211 11224589999999999999999999999999999999999999986633221
Q ss_pred hhH--HHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 602 KSL--VGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 602 ~~~--~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
... ...+...+..+ .+. ....+..+.+++..|+..+|++||++.++++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~--------~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIKRLHEG--------KIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHHHhhhh--------hhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 100 00111111111 110 1123467889999999999999999999999773
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=294.22 Aligned_cols=260 Identities=23% Similarity=0.302 Sum_probs=194.6
Q ss_pred CCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeC--CcceEEEe
Q 005355 392 FNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQIN-HRNVVKLLGCCLET--EVPLLVYE 466 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~E 466 (700)
|++.+.||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999965 68899999876532 222334567888998885 99999999999987 88899999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||+|+||+++. +.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 58888887643 24899999999999999999999999 999999999999999 999999999997653322
Q ss_pred ceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH--------HHHHHhcch
Q 005355 547 THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF--------LEAMKENRL 617 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~ 617 (700)
. .....++..|+|||++.. ..++.++||||||+++|||++|..||...+..+........ .........
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 1 223457889999997644 56788999999999999999999999765543211111000 000000000
Q ss_pred hhhcchhh----hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 FEVLDARV----LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ~~~~d~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.....+.. ........+..+.+|+.+||+.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000 00111234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=290.43 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=199.8
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC--Ccc
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-----DESNIEQFINEVAILSQINHRNVVKLLGCCLET--EVP 461 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 461 (700)
.+|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57899999999999999999975 5889999986432 233456889999999999999999999998764 457
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++++||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999997543 3889999999999999999999999 99999999999999999999999999986
Q ss_pred cccCC--ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 542 VMIDQ--THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 542 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
..... ........++..|+|||++.+..++.++||||||+++++|++|+.||......+ ...+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~----- 224 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------AIFKIATQ----- 224 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------HHHHHHcC-----
Confidence 53211 111223458889999999998889999999999999999999999997543221 11111111
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
......+......+.+++.+||+ +|..||++.+++.
T Consensus 225 ----~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 ----PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11122344556778999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.59 Aligned_cols=263 Identities=23% Similarity=0.319 Sum_probs=200.2
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC------
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLET------ 458 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 458 (700)
..++|+..+.||+|+||.||++... +++.||||++.. ......+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4588999999999999999999975 689999998764 2344456788999999999999999999988644
Q ss_pred CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 005355 459 EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGA 538 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl 538 (700)
...++||||+. ++|.+.+... +++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 34689999995 5888888643 788999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHH--------HHHH
Q 005355 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVG--------YFLE 610 (700)
Q Consensus 539 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~--------~~~~ 610 (700)
++...... ......++..|+|||.+.+..++.++||||||+++++|++|+.||...+......... .+..
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 165 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred ceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 97653221 2233457889999999999999999999999999999999999997654321100000 0000
Q ss_pred --------HHHhcc------hhhhcchhh----hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 611 --------AMKENR------LFEVLDARV----LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 611 --------~~~~~~------~~~~~d~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
...... +........ ...........+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 000000000 000012345568899999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=293.42 Aligned_cols=247 Identities=27% Similarity=0.336 Sum_probs=203.6
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
+|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|++++++++||||+++++.+.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788999999999999999976 5889999987642 22456789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+.+++|.+++... .++++..+..++.||++||.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999999765 24899999999999999999999999 9999999999999999999999999987654332
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..+...... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~----------~~ 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQET----------AD 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhcc----------cc
Confidence 22345588899999999988899999999999999999999999986654211 111111111 00
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCH--HHHH
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTM--KEAA 659 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~--~evl 659 (700)
...+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11222344678899999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=289.70 Aligned_cols=250 Identities=30% Similarity=0.417 Sum_probs=206.8
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+|++.+.||.|+||.||++.+. +++.|++|++.... ....+.+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999976 68899999987543 35667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 468 IPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 468 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999998753 1235899999999999999999999999 9999999999999999999999999997654332
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
.......+++.|+|||.+....++.++||||||+++++|++|..||......+ ..........
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~--------- 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-------LALKILKGQY--------- 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-------HHHHHhcCCC---------
Confidence 23334568889999999998899999999999999999999999996554221 1111111111
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...+......+.+++.+||..+|++||++.|+++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1112234457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=288.11 Aligned_cols=250 Identities=27% Similarity=0.444 Sum_probs=206.6
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC--CcceEEE
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLET--EVPLLVY 465 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 465 (700)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|++++++++|+||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999987 68899999877544 25568899999999999999999999999988 8899999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999998764 4999999999999999999999999 999999999999999999999999998766443
Q ss_pred Cce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 546 QTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 546 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
... ......++..|+|||.+.....+.++||||||+++++|++|..||....... ....... ...
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~---------~~~ 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKIG---------SSG 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhcc---------ccC
Confidence 221 1233558889999999998889999999999999999999999997655111 1111111 001
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.....+...+..+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111222334678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=291.00 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=206.2
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+|++.+.||+|+||.||+++.. +++.+++|.+... .......+.+|++++++++|+||+++++.+.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999865 6789999987653 334456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 468 IPNGTLYQYIHDQTE-EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
+++++|.+++.+... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999876321 235899999999999999999999999 999999999999999999999999999765433
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
......++..|++||.+.+..++.++|+||||+++++|++|+.||...+..+ +......+..
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~--------- 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGKY--------- 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCC---------
Confidence 2223457889999999999999999999999999999999999997654332 1111222211
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.........++.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 12223455678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.91 Aligned_cols=251 Identities=27% Similarity=0.411 Sum_probs=199.8
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
..|+..+.||+|+||.||+++.. ++..||+|++... .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34778889999999999999965 6889999987642 2334567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+. |+|.+++..... ++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~-g~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 105 EYCL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred eCCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 9996 588888765432 4899999999999999999999999 99999999999999999999999998865432
Q ss_pred Cceeeeeeecccccccccccc---cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 546 QTHLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
.....++..|+|||++. ...++.++||||||+++|||++|..||......+. .. .+.....
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~-~~~~~~~----- 241 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LY-HIAQNES----- 241 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------HH-HHHhccC-----
Confidence 12345788999999974 45688999999999999999999999865432211 01 1111110
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
........+..+.+|+.+||+.+|.+||++.++++.+-.+.
T Consensus 242 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 242 ---PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ---CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 01112234556889999999999999999999998664433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=295.03 Aligned_cols=246 Identities=26% Similarity=0.339 Sum_probs=205.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.+.|+.-++||+|+||.|+-.+.+ .|+.+|.|++... ........++|-.||.+++.+.||.+-.++...+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 467888899999999999999866 6999999976532 223345578899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
+..|.||+|.-+|..... ..+++..++.++.+|+-||.+||+.+ ||+||+||+|||||+.|+++|+|+||+..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999988764 34999999999999999999999999 99999999999999999999999999987754
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
... ....+||.+|||||++.+..|+...|.|||||+||||+.|+.||........ .+-+|.+
T Consensus 340 g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----------------~eEvdrr 401 (591)
T KOG0986|consen 340 GKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----------------REEVDRR 401 (591)
T ss_pred CCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----------------HHHHHHH
Confidence 443 3334799999999999999999999999999999999999999975432211 1112222
Q ss_pred h---hhccCHHHHHHHHHHHHHHhccCCCCCCCHH
Q 005355 625 V---LKEAKEEEIITVAMLAKRCLNMIGKKRPTMK 656 (700)
Q Consensus 625 ~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ 656 (700)
+ ..+++...+++..+|.+..|+.||++|.--+
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 2 1234556677888999999999999996543
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=298.24 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=197.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc-----
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEV----- 460 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 460 (700)
.++|++.++||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 467999999999999999999976 68899999875432 2223456789999999999999999999876544
Q ss_pred ---ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 461 ---PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 461 ---~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
.++||||+. ++|.+++..... .+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNV--KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 489999996 588888865432 3899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCce---eeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHH
Q 005355 538 ASRSVMIDQTH---LTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK 613 (700)
Q Consensus 538 l~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 613 (700)
++......... ......++..|+|||.+.+. .++.++||||||+++|||++|..||..............+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99765432221 11234577889999988664 478899999999999999999999976654332222221110000
Q ss_pred hcchhhh-----cc---------hhhhhcc-CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 614 ENRLFEV-----LD---------ARVLKEA-KEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 614 ~~~~~~~-----~d---------~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...+... .+ ....... .......+.+|+.+||+.+|.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000 00 0000000 0011245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=289.42 Aligned_cols=242 Identities=27% Similarity=0.326 Sum_probs=196.2
Q ss_pred EeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCH
Q 005355 398 LGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 473 (700)
Q Consensus 398 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 473 (700)
||.|+||.||+++.. .++.|++|.+.... ....+.+.+|++++++++|+||+++++.+.+.+..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999976 48899999876422 23457799999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeeee
Q 005355 474 YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRV 553 (700)
Q Consensus 474 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~ 553 (700)
.+++.+.. .+++..+..++.||+.||+|||+++ ++|+||+|+||+++.++.+||+|||++....... .....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 99997653 3899999999999999999999999 9999999999999999999999999998654332 22334
Q ss_pred ecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHH
Q 005355 554 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEE 633 (700)
Q Consensus 554 ~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 633 (700)
.++..|++||.+....++.++|+||||+++|+|++|..||.....+. ......... .......+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~---------~~~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILK---------GNGKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhc---------cCCCCCCCccc
Confidence 57889999999988889999999999999999999999997655311 111111110 00001112223
Q ss_pred HHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 005355 634 IITVAMLAKRCLNMIGKKRPT-----MKEAAF 660 (700)
Q Consensus 634 ~~~l~~li~~cl~~~p~~RPs-----~~evl~ 660 (700)
...+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 567899999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=294.75 Aligned_cols=259 Identities=25% Similarity=0.334 Sum_probs=202.1
Q ss_pred CCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 392 FNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE--SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
|++.+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+||+++++.+...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999975 688999998765432 34577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
++ +|.+++.... ..+++..++.++.|+++||.|||+.+ ++|+||||+||+++.++.+||+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 65 8888887643 24899999999999999999999999 9999999999999999999999999987664433 1
Q ss_pred eeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh---cchhhhcc--
Q 005355 549 LTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE---NRLFEVLD-- 622 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d-- 622 (700)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+.... ....... ..+....+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccchhhh
Confidence 22234577889999998876 789999999999999999999999976554322111 1110000 00000000
Q ss_pred -----------hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 623 -----------ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 623 -----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..............+.+++.+||+.+|.+||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00001112345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=295.56 Aligned_cols=243 Identities=26% Similarity=0.402 Sum_probs=199.2
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCHH
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLY 474 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~ 474 (700)
.+||+|+||.||++... +++.||||++........+.+.+|+.+++.++|+|++++++.+...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999975 68999999987655556678999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeeeee
Q 005355 475 QYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQ 554 (700)
Q Consensus 475 ~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~~ 554 (700)
+++... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 106 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 177 (292)
T cd06657 106 DIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV 177 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence 988643 2899999999999999999999999 9999999999999999999999999887553322 1223345
Q ss_pred cccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHH
Q 005355 555 GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEI 634 (700)
Q Consensus 555 gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 634 (700)
++..|+|||.+.+..++.++|+||||+++|+|++|..||......+. ........ ..... ......
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-------~~~~~~~~-----~~~~~--~~~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDNL-----PPKLK--NLHKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhhC-----CcccC--CcccCC
Confidence 78899999999888899999999999999999999999975443221 11111110 00000 011234
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 635 ITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 635 ~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+.+++.+||+.+|.+||++.++++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 56788999999999999999999988
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.50 Aligned_cols=262 Identities=21% Similarity=0.314 Sum_probs=198.4
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
++|++.+.||+|++|.||+|..+ +++.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57889999999999999999976 68899999876432 2334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEeecCCCcccccC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGASRSVMID 545 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~-~~~~kl~DfGl~~~~~~~ 545 (700)
|++ ++|.+++..... ..+++..+..++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 995 588888765432 23688889999999999999999999 999999999999985 567999999999754322
Q ss_pred Cceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc---chh---
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN---RLF--- 618 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~--- 618 (700)
. .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||......+... ......... .+.
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 V-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF---KIFRILGTPNEETWPGVT 232 (294)
T ss_pred c-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChhhccccc
Confidence 1 11223456889999999876 457899999999999999999999997654322111 111110000 000
Q ss_pred ---------hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 619 ---------EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 619 ---------~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..................+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000001111233556889999999999999999999986
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=286.39 Aligned_cols=247 Identities=28% Similarity=0.446 Sum_probs=204.4
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE--SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+|++.+.||+|++|.||+++.. +++.|++|.+..... ...+.+.+|++++++++|+|++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999876 578999999876543 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999997653 4899999999999999999999999 99999999999999999999999999986643332
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
. .....++..|+|||.+.+...+.++|||+||+++++|++|..||........ ..... .... .
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~------~~~~~-~~~~---------~ 217 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA------LFRIV-QDDH---------P 217 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHh-ccCC---------C
Confidence 1 2334578899999999888889999999999999999999999975432111 11111 1110 1
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+......+.+++.+||..+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112233567889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=303.30 Aligned_cols=266 Identities=22% Similarity=0.328 Sum_probs=200.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEe----CCcc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLE----TEVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 461 (700)
.++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999975 68999999876532 2345678889999999999999999988763 3457
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++|+||+. ++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999995 68999987543 3899999999999999999999999 99999999999999999999999999876
Q ss_pred cccCCce---eeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH--------
Q 005355 542 VMIDQTH---LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL-------- 609 (700)
Q Consensus 542 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-------- 609 (700)
....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5332211 1223468889999999865 568899999999999999999999997654332211111000
Q ss_pred HHHHhcchhhhcch------hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 610 EAMKENRLFEVLDA------RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 610 ~~~~~~~~~~~~d~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.......+.+..+. ..........+..+.+++++||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000000 00001112345679999999999999999999998873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=292.21 Aligned_cols=242 Identities=22% Similarity=0.295 Sum_probs=188.6
Q ss_pred eEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhh---cCCCceeeEEeEEEeCCcceEEEeeCC
Q 005355 397 ILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQ---INHRNVVKLLGCCLETEVPLLVYEFIP 469 (700)
Q Consensus 397 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~E~~~ 469 (700)
+||+|+||.||++... +++.+|+|.+.... ......+.+|..+++. .+|+|++.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 58899999875421 2222334455544444 479999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee
Q 005355 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549 (700)
Q Consensus 470 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~ 549 (700)
+++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999987653 3999999999999999999999999 9999999999999999999999999987543221
Q ss_pred eeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhc
Q 005355 550 TTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE 628 (700)
Q Consensus 550 ~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 628 (700)
.....++..|+|||.+.+ ..++.++||||||+++++|++|..||.......... ...... .. ...
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~------~~----~~~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTL------TV----NVE 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhh------cC----CcC
Confidence 123458999999999864 568899999999999999999999997554322111 000000 00 111
Q ss_pred cCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005355 629 AKEEEIITVAMLAKRCLNMIGKKRP-----TMKEAAFE 661 (700)
Q Consensus 629 ~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~ 661 (700)
.+...+..+.+++.+||+.||.+|| +++|+++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2334556788999999999999999 59888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.60 Aligned_cols=255 Identities=26% Similarity=0.366 Sum_probs=195.8
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 466 (700)
++|...+.||+|+||.||++... +++.||+|++.... ......+.+|+.++.++. |+||+++++++...+..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 34556788999999999999976 58999999876432 344567889999999996 9999999999999999999999
Q ss_pred eCCCCCHHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 467 FIPNGTLYQYIHDQ--TEEFPITWEIRLRIAIEVSDALCYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 467 ~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
|+. ++|.++.... .....+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 985 4655543211 1123489999999999999999999975 7 9999999999999999999999999987543
Q ss_pred cCCceeeeeeecccccccccccccC---CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSS---QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||..... .......... +.
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~~---- 227 (288)
T cd06616 160 DSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-GD---- 227 (288)
T ss_pred cCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-CC----
Confidence 222 12233578899999999776 688999999999999999999999975431 1111111111 10
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.+.+........+..+.+|+.+||+.+|++|||++++++.
T Consensus 228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111112223356678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=292.16 Aligned_cols=244 Identities=25% Similarity=0.296 Sum_probs=193.9
Q ss_pred EeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCH
Q 005355 398 LGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 473 (700)
Q Consensus 398 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 473 (700)
||+|+||+||++... +++.||+|.+.... ......+.+|++++++++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 68899999875422 23345678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeeee
Q 005355 474 YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRV 553 (700)
Q Consensus 474 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~ 553 (700)
.+++..... ..+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++..... .......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGR 154 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCccccc
Confidence 999976543 34899999999999999999999999 99999999999999999999999999875432 1222334
Q ss_pred ecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHH
Q 005355 554 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEE 633 (700)
Q Consensus 554 ~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 633 (700)
.++..|+|||++.+..++.++||||||+++++|++|+.||........... +.... .. .....+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~----~~------~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE---LKRRT----LE------MAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH---HHhcc----cc------ccccCCccC
Confidence 578899999999888899999999999999999999999976543211110 00000 00 011122234
Q ss_pred HHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005355 634 IITVAMLAKRCLNMIGKKRP-----TMKEAAF 660 (700)
Q Consensus 634 ~~~l~~li~~cl~~~p~~RP-----s~~evl~ 660 (700)
...+.+++.+||+.+|.+|| ++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 56788999999999999999 5555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=302.46 Aligned_cols=266 Identities=27% Similarity=0.363 Sum_probs=200.5
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeC--Ccc
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQI-NHRNVVKLLGCCLET--EVP 461 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 461 (700)
..++|++.+.||+|+||.||+|.+. +++.+|||++.. ........+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3578889999999999999999976 588999998753 2334456678899999999 999999999998654 357
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++||||++ ++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999996 5999988764 3889999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCc----eeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH-------
Q 005355 542 VMIDQT----HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL------- 609 (700)
Q Consensus 542 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~------- 609 (700)
...... .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643322 12233458889999998765 567889999999999999999999997654332111110000
Q ss_pred -HHHHhcchhhhcch------hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 610 -EAMKENRLFEVLDA------RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 610 -~~~~~~~~~~~~d~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..+.......+++. ..........+..+.+++.+||+.+|.+|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000000 00001111245678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.04 Aligned_cols=256 Identities=24% Similarity=0.289 Sum_probs=202.3
Q ss_pred CCCccceEeeeCCeEEEEEEEc----CCcEEEEEEccccC----hhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcc
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT----NGRIVAIKKSKLVD----ESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 461 (700)
+|++.+.||+|+||.||+++.. +++.||||.++... ....+.+.+|++++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999853 46889999876422 22346688999999999 599999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++||||+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999987543 3889999999999999999999999 99999999999999999999999999876
Q ss_pred cccCCceeeeeeecccccccccccccCC--CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
.............++..|+|||.+.+.. .+.++||||||++++||++|..||........ .. .........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~-~~~~~~~~~---- 227 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QS-EISRRILKS---- 227 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HH-HHHHHHHcc----
Confidence 5444333333455889999999987755 78899999999999999999999964332111 00 111111100
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
. ...+......+.+++.+||+.+|++|||++++.+.|+..
T Consensus 228 --~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 --K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 111223445688999999999999999999888877553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=303.04 Aligned_cols=270 Identities=27% Similarity=0.350 Sum_probs=207.6
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC-----cce
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETE-----VPL 462 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 462 (700)
+|++.+.||+|+||.||+++.. .++.||||++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999976 48999999877543 445578999999999999999999999988775 789
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
++|||++ ++|.+++.... .+++..++.++.||+.||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 58999887643 4999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCc--eeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHH------
Q 005355 543 MIDQT--HLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK------ 613 (700)
Q Consensus 543 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 613 (700)
..... .......++..|+|||++.+. .++.++||||||+++++|++|..||......+.............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 43321 122334578899999999887 889999999999999999999999987664332111111000000
Q ss_pred --hcchhhhcc------hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhchh
Q 005355 614 --ENRLFEVLD------ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE--LGGIRA 667 (700)
Q Consensus 614 --~~~~~~~~d------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~--L~~l~~ 667 (700)
.......+. ...........+..+.+++.+||+.+|++||+++++++. |++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000000 000001112245678899999999999999999999984 665554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=320.64 Aligned_cols=265 Identities=28% Similarity=0.449 Sum_probs=219.2
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEc----C----CcEEEEEEccc-cChhhHHHHHHHHHHHhhc-CCCceeeEEe
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLT----N----GRIVAIKKSKL-VDESNIEQFINEVAILSQI-NHRNVVKLLG 453 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~ 453 (700)
.++...++..+.+.||+|.||.|++|... . ...||||.++. ....+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56777777788889999999999999844 1 34699999875 3446678999999999998 6999999999
Q ss_pred EEEeCCcceEEEeeCCCCCHHHHHhccC-C----------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 005355 454 CCLETEVPLLVYEFIPNGTLYQYIHDQT-E----------E--FPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKS 520 (700)
Q Consensus 454 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~-~----------~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~ 520 (700)
++......++|.||+..|+|.++|+..+ . . ..++...++.++.|||.||+||++.. ++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999998876 0 0 13889999999999999999999999 99999999
Q ss_pred CcEEECCCCcEEEeecCCCcccccCCceeeeeeec--ccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCC
Q 005355 521 ANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG--TFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTD 597 (700)
Q Consensus 521 ~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~ 597 (700)
+||||+++..+||+|||+++..............+ +..|||||.+....|+.|+||||||++||||++ |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999765555544333332 456999999999999999999999999999999 889997643
Q ss_pred chhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 598 SEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
..++ +.+.++.+.. .+.+.....++.++++.||+.+|++||++.++.+.|+.+.
T Consensus 527 ~~~~------l~~~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 527 PTEE------LLEFLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred cHHH------HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 2221 1223333332 2334455778889999999999999999999999999953
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=283.02 Aligned_cols=244 Identities=25% Similarity=0.343 Sum_probs=205.2
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL---VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
++..++|..+++||+|.||+|.+.+.+ .++.+|+|+++. ........-+.|-++|+..+||.+..+.-.|...+..
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 345688999999999999999999965 789999998875 3344556677899999999999999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++||||..+|.|.-+|.+.+ .+++.....+..+|+.||.|||+++ ||.||||.+|.|+|.+|++||+||||++.
T Consensus 244 CFVMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchh
Confidence 99999999999999998754 3899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
-. .......+.+||+.|+|||++....|..++|.|.+||++|||++|+.||...+.+.. ...+-.
T Consensus 318 ~I-~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-------FeLIl~------- 382 (516)
T KOG0690|consen 318 EI-KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-------FELILM------- 382 (516)
T ss_pred cc-cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH-------HHHHHh-------
Confidence 43 334456678999999999999999999999999999999999999999976654331 111111
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCC
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRP 653 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 653 (700)
.. -.++....++...|+..+|..||.+|.
T Consensus 383 -ed--~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 383 -ED--LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -hh--ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 11 122344455677799999999999995
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=291.08 Aligned_cols=245 Identities=28% Similarity=0.370 Sum_probs=198.3
Q ss_pred EeeeCCeEEEEEEEc-CCcEEEEEEccccCh---hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCH
Q 005355 398 LGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE---SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 473 (700)
Q Consensus 398 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 473 (700)
||+|+||.||++.+. +++.+++|.+..... ...+.+.+|++++++++|+||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 489999998765433 4567889999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc------
Q 005355 474 YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT------ 547 (700)
Q Consensus 474 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~------ 547 (700)
.+++.+.. .+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99998654 3899999999999999999999999 99999999999999999999999999875433211
Q ss_pred -eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 548 -HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 548 -~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
.......++..|+|||.+.....+.++||||||+++++|++|..||......+. ......+.... .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~------~ 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-------FQNILNGKIEW------P 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhcCCcCC------C
Confidence 122334578899999999888899999999999999999999999975543221 11111111100 0
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
. ....+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 222 ~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 E--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred c--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0 0112567889999999999999999966666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=297.49 Aligned_cols=267 Identities=20% Similarity=0.291 Sum_probs=198.2
Q ss_pred ceEeee--CCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQG--GQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
+.||+| +||+||++++. .++.||+|+.... .....+.+.+|+.+++.++|+||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 89999999975 6899999987643 334457889999999999999999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee-
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL- 549 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~- 549 (700)
++|.+++...... .+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999999865322 3899999999999999999999999 9999999999999999999999998654322111110
Q ss_pred -----eeeeecccccccccccccC--CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH-------------
Q 005355 550 -----TTRVQGTFGYLDPEYFRSS--QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL------------- 609 (700)
Q Consensus 550 -----~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~------------- 609 (700)
.....++..|+|||++.+. .++.++||||||+++|||++|..||......+.. .....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccccc
Confidence 0112245679999999763 4789999999999999999999999765432210 00000
Q ss_pred ---HHHH----------------hcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH--HHHhchhh
Q 005355 610 ---EAMK----------------ENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF--ELGGIRAS 668 (700)
Q Consensus 610 ---~~~~----------------~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~~~ 668 (700)
.... .+......+..+...........+.+|+++||+.||++|||++|+++ .++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 0000 00000011111111223345678999999999999999999999985 45555554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=306.62 Aligned_cols=272 Identities=26% Similarity=0.387 Sum_probs=208.8
Q ss_pred CCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC------CcceE
Q 005355 392 FNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCCLET------EVPLL 463 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 463 (700)
+...+.||+|+||.||+|+.+ .|+.||||.+.. ......+..-+|+++|++++|+|||+++++-.+. ..+++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 455678999999999999965 799999998775 3344567889999999999999999999986543 46789
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC----CCCcEEEeecCCC
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD----DKYRAKVSDFGAS 539 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~----~~~~~kl~DfGl~ 539 (700)
||||+.+|+|...|.+..+...|++.+++.++.++..||.|||.++ |+||||||.||++- ....-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998777777999999999999999999999999 99999999999993 3345799999999
Q ss_pred cccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
+.+.. ........||..|++||++.. ..|+..+|.||||+++|+.+||..||.............|....-+..-..
T Consensus 172 rel~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccCCC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 97743 336778889999999999995 788999999999999999999999997665443222222221111110000
Q ss_pred hhcchhh------------hhccCHHHHHHHHHHHHHHhccCCCCCC--CHHHHHHHHHhchhh
Q 005355 619 EVLDARV------------LKEAKEEEIITVAMLAKRCLNMIGKKRP--TMKEAAFELGGIRAS 668 (700)
Q Consensus 619 ~~~d~~~------------~~~~~~~~~~~l~~li~~cl~~~p~~RP--s~~evl~~L~~l~~~ 668 (700)
-...+.. ...........+...+..+|..+|++|- ...+....+..|...
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 0000000 1112233444566788888999999998 666666666665543
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=286.94 Aligned_cols=243 Identities=27% Similarity=0.304 Sum_probs=191.4
Q ss_pred ceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHH-hhcCCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAIL-SQINHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
+.||+|+||.||+|... +++.||||.+.... ......+..|..++ ...+|+|++++++.+...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999975 58899999876432 22233445555544 445899999999999999999999999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..... .
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 99999997643 3899999999999999999999999 99999999999999999999999998875432 2
Q ss_pred eeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccC
Q 005355 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAK 630 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 630 (700)
....++..|+|||.+.+..++.++||||||+++++|++|..||......+. ...+..+... ......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~------~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-------FDNILSRRIN------WPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhcccC------CCCccc
Confidence 234578899999999888899999999999999999999999975543221 1111111110 001111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005355 631 EEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662 (700)
Q Consensus 631 ~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L 662 (700)
...+..+.+++.+||+.+|++||++.++.+.|
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 23456789999999999999999887666544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=288.53 Aligned_cols=259 Identities=27% Similarity=0.382 Sum_probs=197.5
Q ss_pred CCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhc---CCCceeeEEeEEEeCCc-----
Q 005355 392 FNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQI---NHRNVVKLLGCCLETEV----- 460 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 460 (700)
|++.+.||+|+||.||+|+++ +++.||+|++.... ......+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999987 48999999886432 22235567788877766 59999999999988776
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.+++|||+. ++|.+++..... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999996 589998876432 24899999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc-c--h
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN-R--L 617 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~--~ 617 (700)
....... .....++..|+|||++.+..++.++||||||+++|||++|.+||......+. ...+.+..... . +
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKIFDVIGLPSEEEW 230 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHHHHHcCCCChHhc
Confidence 6533221 2233478899999999999999999999999999999999999876543321 11111111000 0 0
Q ss_pred ----------hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 ----------FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ----------~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...................+.+++.+||+.+|.+||+++|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000011112244567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=291.48 Aligned_cols=251 Identities=25% Similarity=0.316 Sum_probs=197.5
Q ss_pred CCCccceEeeeCCeEEEEEEEc----CCcEEEEEEccccC----hhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcc
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT----NGRIVAIKKSKLVD----ESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 461 (700)
+|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++++ +|+||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788899999999999999863 68899999876432 22346788999999999 599999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++|+||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999997653 3889999999999999999999999 99999999999999999999999999976
Q ss_pred cccCCceeeeeeecccccccccccccC--CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRSS--QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
.............++..|+|||.+... .++.++||||||+++|+|++|..||........ ... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~-~~~~~~~~~--- 228 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAE-ISRRILKSE--- 228 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHH-HHHHhhccC---
Confidence 543332223345588999999998753 467899999999999999999999964322111 111 111111000
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRP-----TMKEAAF 660 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~ 660 (700)
...+......+.+++.+||+.+|++|| ++++++.
T Consensus 229 -------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 -------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 011223456788999999999999997 6666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=293.09 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=198.4
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL---VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
+.|+..+.||+|+||.||+|+.. +++.+|+|.+.. ......+++.+|+++++.++|+|++++++++...+..++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44667789999999999999975 578899998753 23344567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+. ++|.+++..... .+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 688888765432 3899999999999999999999999 999999999999999999999999998754322
Q ss_pred Cceeeeeeecccccccccccc---cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 546 QTHLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
....++..|+|||++. ...++.++||||||+++|+|++|..||......+.. .....+..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------~~~~~~~~----- 231 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------YHIAQNES----- 231 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH-------HHHhhcCC-----
Confidence 2345788999999974 356788999999999999999999998654322211 01111111
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
...........+.+|+.+||+.+|++||++.++++..--+
T Consensus 232 ---~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 232 ---PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred ---CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 0111223455688999999999999999999999865433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=298.12 Aligned_cols=269 Identities=23% Similarity=0.299 Sum_probs=200.8
Q ss_pred chHHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe
Q 005355 381 TSMELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLE 457 (700)
Q Consensus 381 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 457 (700)
...++...+++|.+.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++|+||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34556777899999999999999999999864 6889999988643 23335678899999999999999999998864
Q ss_pred C------CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcE
Q 005355 458 T------EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRA 531 (700)
Q Consensus 458 ~------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~ 531 (700)
. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 3 3357788876 78998888653 2899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCcccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH--
Q 005355 532 KVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF-- 608 (700)
Q Consensus 532 kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~-- 608 (700)
||+|||++..... ......++..|+|||.+.+ ..++.++||||||+++++|++|+.||...............
T Consensus 160 kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 160 KILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred EEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999875422 1223457889999999876 56888999999999999999999999755432211110000
Q ss_pred ------HHHHHhcch---hhhcchhh---hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 609 ------LEAMKENRL---FEVLDARV---LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 609 ------~~~~~~~~~---~~~~d~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
...+..... ...+.... ..+........+.+++.+||+.+|.+||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000 00000000 000001134568899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.51 Aligned_cols=249 Identities=26% Similarity=0.360 Sum_probs=209.9
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
.....|.+.+.||+|.|++|.+|++. .+..||||.+.. .+...+..+.+|+++|+.++|||||+++.+......+++
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34678999999999999999999965 689999998775 334455679999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||..+|.+++++.+... +.+..+..++.|++.|++|||++. |+|||||++||||+.+.++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999988765 667888999999999999999999 9999999999999999999999999998653
Q ss_pred cCCceeeeeeecccccccccccccCCC-CcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
......+..|++.|.|||++.+..+ .+++|+||+|++||.|+.|..||++....+.. . +.+.
T Consensus 207 --~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-------~--------rvl~ 269 (596)
T KOG0586|consen 207 --YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-------P--------RVLR 269 (596)
T ss_pred --ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-------c--------hhee
Confidence 4455667789999999999998776 57999999999999999999999876543311 0 0111
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+ ..+.....+..+|++++|..+|.+|++++++.+
T Consensus 270 gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 270 GKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eee--cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 111 122334456778999999999999999999876
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=292.07 Aligned_cols=260 Identities=18% Similarity=0.249 Sum_probs=193.0
Q ss_pred cceEeeeCCeEEEEEEEcCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCC
Q 005355 395 NRILGQGGQGTVYKGMLTNGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 472 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gs 472 (700)
.+.+|.|+++.|+++.. +++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34445555555555544 5899999997653 45566789999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc-----
Q 005355 473 LYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT----- 547 (700)
Q Consensus 473 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~----- 547 (700)
|.+++..... ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999986532 23889999999999999999999999 99999999999999999999999998865432211
Q ss_pred -eeeeeeeccccccccccccc--CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHH----Hhcc----
Q 005355 548 -HLTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAM----KENR---- 616 (700)
Q Consensus 548 -~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~---- 616 (700)
.......++..|+|||++.. ..++.++||||||+++|||++|..||........ ..+...... ....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhh
Confidence 11123346778999999876 3588999999999999999999999975442211 111100000 0000
Q ss_pred ---hhh----hcch----hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 617 ---LFE----VLDA----RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 617 ---~~~----~~d~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
... ..+. .............+.+|+.+||+.+|++|||++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 0000 00111223345678899999999999999999999983
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=295.28 Aligned_cols=262 Identities=25% Similarity=0.331 Sum_probs=196.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC------
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE--SNIEQFINEVAILSQINHRNVVKLLGCCLETE------ 459 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 459 (700)
.++|++.++||+|+||.||+|.+. +++.+|||++..... .....+.+|++++++++|+||+++++.+.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999976 688999998754322 22346788999999999999999999876543
Q ss_pred --cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 460 --VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 460 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
..++|+||+.. +|...+.... ..+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999964 6777776543 24999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCce----------eeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHH
Q 005355 538 ASRSVMIDQTH----------LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVG 606 (700)
Q Consensus 538 l~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~ 606 (700)
++......... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~- 239 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI- 239 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-
Confidence 99765322211 1123457888999998765 45889999999999999999999999765543221111
Q ss_pred HHHHHHHhc---------chhhh--------cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 607 YFLEAMKEN---------RLFEV--------LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 607 ~~~~~~~~~---------~~~~~--------~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
....... .+... ....+ ..........+.+++.+||+.+|++|||+.|++.
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 --FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTL-EERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred --HHHhCCCChhhchhhhhcccccccccCCCCCccH-HHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1110000 00000 00000 0001122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=290.35 Aligned_cols=244 Identities=27% Similarity=0.406 Sum_probs=194.9
Q ss_pred CCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 392 FNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
|...+.||+|+||+||+|+.. +++.|++|++... .....+.+.+|+++++.++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999975 6889999987642 233446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+. ++|.+++..... ++++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 95 678888765432 4899999999999999999999999 99999999999999999999999998864321
Q ss_pred eeeeeeecccccccccccc---cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 548 HLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
.....++..|+|||++. ...++.++||||||+++|+|++|..||...+..... ..... ....
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~-~~~~------ 238 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-NDSP------ 238 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHh-cCCC------
Confidence 22345888999999984 456888999999999999999999998755432211 11111 1110
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..........+.+|+.+||+.+|.+||++.+++..
T Consensus 239 --~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 --TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112233468889999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=283.93 Aligned_cols=246 Identities=22% Similarity=0.289 Sum_probs=191.0
Q ss_pred HHHhcCCCccceE--eeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcc
Q 005355 386 EMATDNFNTNRIL--GQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 386 ~~~~~~~~~~~~l--G~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 461 (700)
....++|++.+.+ |+|+||.||++..+ +++.+|+|.......... |+.....+ +|+|++++++.+...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3334677777776 99999999999965 678899998764322111 22222223 799999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEeecCCCc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGASR 540 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~-~~kl~DfGl~~ 540 (700)
++||||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||++.
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 99999999999999997653 4999999999999999999999999 99999999999999988 99999999987
Q ss_pred ccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
..... ....++..|+|||++.+..++.++||||||++++||++|..||......+ ..... +.... ..
T Consensus 159 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~-~~~~~-~~----- 225 (267)
T PHA03390 159 IIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLES-LLKRQ-QK----- 225 (267)
T ss_pred ecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHH-HHHhh-cc-----
Confidence 54322 12357889999999999899999999999999999999999997443222 11111 11111 00
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCC-HHHHHH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT-MKEAAF 660 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~evl~ 660 (700)
........+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 226 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 -----KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -----cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00112245567899999999999999996 688874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=254.03 Aligned_cols=264 Identities=23% Similarity=0.336 Sum_probs=203.4
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.+|...++||+|.||+||+|+.. .++.||+|+....+ +.......+|+.+++.++|+|||++++....+....+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 35667789999999999999954 68899999876543 3345678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+ .-+|..+...-+.. ++.+....++.|+++||.|.|+++ +.|||+||.|.||+.+|++|++|||+++.+...-
T Consensus 82 ~c-dqdlkkyfdslng~--~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSLNGD--LDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred Hh-hHHHHHHHHhcCCc--CCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 99 45788887665443 899999999999999999999999 9999999999999999999999999999876543
Q ss_pred ceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh---c
Q 005355 547 THLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV---L 621 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 621 (700)
.- ......|..|.+|.++.+. -|+...|+||-|||+.||.. |++.|.+.+.++...-+-+.+....++.|..+ .
T Consensus 156 rc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred Ee-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 32 3345579999999999875 58889999999999999988 77777776654432222222222233333221 1
Q ss_pred chhhhhccC---------HHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 622 DARVLKEAK---------EEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 622 d~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
|-.....++ +.....-.+|+++.|.-+|.+|.++++.++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111111111 112223567889999999999999998876
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=296.76 Aligned_cols=266 Identities=23% Similarity=0.345 Sum_probs=197.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC------
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETE------ 459 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 459 (700)
.++|...+.||+|+||.||+|... +++.||||++... .......+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999965 6899999987642 2233456889999999999999999999987543
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
..++|+||+. .+|.+++.. .+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMGH-----PLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 3489999995 477766531 3899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHH--------HHH
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGY--------FLE 610 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~--------~~~ 610 (700)
+..... .....++..|+|||++.+ ..++.++||||||+++|||++|+.||.............. +..
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 754221 123457889999999876 4688999999999999999999999986543221100000 000
Q ss_pred HHHhcchhhhcch--hh-hh---ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhchh
Q 005355 611 AMKENRLFEVLDA--RV-LK---EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE--LGGIRA 667 (700)
Q Consensus 611 ~~~~~~~~~~~d~--~~-~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~--L~~l~~ 667 (700)
............. .. .. .........+.+|+.+||+.||++||++.|++.. ++.++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000000000000 00 00 0001234568899999999999999999999964 666653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=288.76 Aligned_cols=262 Identities=25% Similarity=0.333 Sum_probs=197.5
Q ss_pred CCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh-hhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcceEEEeeC
Q 005355 392 FNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE-SNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
|++.+.||+|+||+||+|+.. +++.|+||++..... .......+|+..+++++ |+|++++++.+.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 577889999999999999986 578899998764322 22334567999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
+++|.+++.... ...+++..++.++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 889999987654 224899999999999999999999999 9999999999999999999999999997553221
Q ss_pred eeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH----------HHHHHhcch
Q 005355 549 LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF----------LEAMKENRL 617 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~~~~ 617 (700)
......++..|+|||++.. ..++.++|+||||++++||++|+.||......+........ .........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 1223457889999998854 56789999999999999999999999766433211100000 000000000
Q ss_pred hhhcch---hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 FEVLDA---RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ~~~~d~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...+.. .............+.+++++||+.+|++||+++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000 0001111122467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=288.58 Aligned_cols=262 Identities=27% Similarity=0.356 Sum_probs=200.8
Q ss_pred CCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 392 FNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|+.++++++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999976 58999999877643 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
+ ++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||+|+||++++++.+||+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 7 59999998753 23899999999999999999999999 99999999999999999999999999976543222
Q ss_pred eeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh---------
Q 005355 549 LTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF--------- 618 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 618 (700)
......++..|+|||.+.+. .++.++||||||++++||++|..||......+................+.
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 22233467789999998776 88999999999999999999999997655332111110000000000000
Q ss_pred ---hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 619 ---EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 619 ---~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..................+.+++.+||+.+|++||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000111122567999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=296.43 Aligned_cols=260 Identities=25% Similarity=0.337 Sum_probs=196.8
Q ss_pred cCCC-ccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhh--------------HHHHHHHHHHHhhcCCCceeeEEe
Q 005355 390 DNFN-TNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESN--------------IEQFINEVAILSQINHRNVVKLLG 453 (700)
Q Consensus 390 ~~~~-~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~ 453 (700)
++|. +.+.||+|+||.||+|... .++.||||+++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 4577999999999999976 68999999876432211 125778999999999999999999
Q ss_pred EEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEE
Q 005355 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKV 533 (700)
Q Consensus 454 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl 533 (700)
++...+..++||||++ ++|.+++.... .+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999996 69999987543 3899999999999999999999999 999999999999999999999
Q ss_pred eecCCCcccccCC-------------ceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCch
Q 005355 534 SDFGASRSVMIDQ-------------THLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSE 599 (700)
Q Consensus 534 ~DfGl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~ 599 (700)
+|||++....... ........++..|+|||++.+. .++.++||||||+++|||++|..||...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999987654110 1111223467889999998764 4689999999999999999999999866543
Q ss_pred hhhhHHHHHHHHHHhcc---hhhh------------cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 600 EDKSLVGYFLEAMKENR---LFEV------------LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 600 ~~~~~~~~~~~~~~~~~---~~~~------------~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+.. ..+........ +... ..... ..........+.+++.+||+.+|++||+++|++.
T Consensus 241 ~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 DQL---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHH---HHHHHHhCCCchhhCcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 221 11111111000 0000 00000 0111223456889999999999999999999986
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=294.37 Aligned_cols=264 Identities=22% Similarity=0.311 Sum_probs=199.5
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe-CCcc
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLE-TEVP 461 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 461 (700)
...+++|++.+.||+|+||.||++... +++.||||++.. ......+.+.+|++++++++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999966 789999998653 223345678899999999999999999999875 5678
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++++||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 56899888643 3788889999999999999999999 99999999999999999999999999875
Q ss_pred cccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH--------HHHH
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF--------LEAM 612 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~ 612 (700)
.... .....++..|+|||++.+ ..++.++||||||+++++|++|+.||............... ....
T Consensus 158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 4221 122346888999999866 57899999999999999999999999765432211111100 0000
Q ss_pred Hhcchhhhcchh------hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 613 KENRLFEVLDAR------VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 613 ~~~~~~~~~d~~------~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
......+..... ...+........+.+++.+||+.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 0000011234678999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.32 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=196.4
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC---------
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLET--------- 458 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 458 (700)
..+|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++|+||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 478999999999999999999975 5889999998776666667899999999999999999999876543
Q ss_pred -----CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-CCCcEE
Q 005355 459 -----EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD-DKYRAK 532 (700)
Q Consensus 459 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~-~~~~~k 532 (700)
...++|+||++ ++|.+++... .+++..+..++.||++||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 34689999996 5898888643 3899999999999999999999999 99999999999997 456789
Q ss_pred EeecCCCcccccCCce--eeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 005355 533 VSDFGASRSVMIDQTH--LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL 609 (700)
Q Consensus 533 l~DfGl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 609 (700)
|+|||++......... ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||......+..... .
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~---~ 232 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI---L 232 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H
Confidence 9999998754322111 1122357889999998654 56888999999999999999999999765432211110 0
Q ss_pred HHHHh------cchhhhcchhh----------hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 610 EAMKE------NRLFEVLDARV----------LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 610 ~~~~~------~~~~~~~d~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..... ........... ..........++.+|+.+||+.+|++|||++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 00000000000 00011123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=288.79 Aligned_cols=248 Identities=27% Similarity=0.390 Sum_probs=203.3
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcceEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 464 (700)
++|.+.+.||+|+||.||+++.. +++.||+|+.... .....+.+.+|++++++++ |+||+++++.+...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47889999999999999999976 6899999987642 2344567889999999998 99999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
||++++++|.+++.+.. .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999998654 4999999999999999999999999 99999999999999999999999999876543
Q ss_pred CCc-------------------eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHH
Q 005355 545 DQT-------------------HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLV 605 (700)
Q Consensus 545 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~ 605 (700)
... .......++..|+|||++....++.++||||||+++++|++|..||.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----- 229 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----- 229 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-----
Confidence 221 12223457889999999998889999999999999999999999997554211
Q ss_pred HHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCH----HHHHH
Q 005355 606 GYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTM----KEAAF 660 (700)
Q Consensus 606 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~----~evl~ 660 (700)
.+.... .. ....+...+..+.+++.+||+.+|.+||++ +++++
T Consensus 230 -~~~~~~-~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 -TFQKIL-KL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -HHHHHH-hc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111111 10 011222335678899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=295.14 Aligned_cols=264 Identities=22% Similarity=0.314 Sum_probs=198.5
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC--
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETE-- 459 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 459 (700)
+....++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++|+||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445788999999999999999999865 6899999987542 2333467889999999999999999999987554
Q ss_pred ----cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEee
Q 005355 460 ----VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535 (700)
Q Consensus 460 ----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~D 535 (700)
..++||||+ +++|.+++... .+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 348999999 77999888643 3899999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHH--------
Q 005355 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVG-------- 606 (700)
Q Consensus 536 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~-------- 606 (700)
||++...... .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||.............
T Consensus 162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 162 FGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9999754322 123346889999999876 458899999999999999999999997554321100000
Q ss_pred HHHHHHHhcchhhhcc------hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 607 YFLEAMKENRLFEVLD------ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 607 ~~~~~~~~~~~~~~~d------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.+...+.......... ..............+.+++.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000000 00000111223456889999999999999999999994
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=290.27 Aligned_cols=253 Identities=25% Similarity=0.420 Sum_probs=196.1
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcC-CcEEEEEEccccC-hhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTN-GRIVAIKKSKLVD-ESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 464 (700)
..++|++.+.||+|+||.||+|.+.. ++.||||+++... ......+..|+.++.+. .|+||+++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34778889999999999999999874 8899999987532 33445677788777666 499999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
|||++ ++|.+++..... .+++..+..++.|++.||+|||+ .+ |+||||+|+||++++++.+||+|||++....
T Consensus 93 ~e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99984 577777765433 48999999999999999999997 47 9999999999999999999999999987553
Q ss_pred cCCceeeeeeecccccccccccccCC----CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQ----FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
.... .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||....... +......... ...
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~-~~~ 238 (296)
T cd06618 167 DSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLTKILQEE-PPS 238 (296)
T ss_pred CCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHHHHhcCC-CCC
Confidence 2221 22234778999999987654 7889999999999999999999996432211 1111111111 000
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
. ......+..+.+|+.+||+.+|.+||++.++++.
T Consensus 239 -----~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 -----L--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -----C--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0011234578999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=269.47 Aligned_cols=252 Identities=23% Similarity=0.396 Sum_probs=198.9
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc-cChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL-VDESNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 466 (700)
++++.+..||.|.-|.|++++.+ .|...|||.+.. .+....++++..+.++..-+ .|.||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34445567999999999999977 589999998775 45556778888888877664 8999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
.| ..-++.++++... ++++..+-++...+++||.||..+. .|+|||+||+|||+|+.|++|++|||++..+..
T Consensus 172 lM-s~C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd-- 244 (391)
T KOG0983|consen 172 LM-STCAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD-- 244 (391)
T ss_pred HH-HHHHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec--
Confidence 98 4456666665433 4999999999999999999998765 399999999999999999999999999976532
Q ss_pred ceeeeeeeccccccccccccc---CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 547 THLTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
+...+...|-+.|||||.+.- ..|+.++||||||+.|+||.||+.||.+-+.+-.. +..+.++. . +
T Consensus 245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~------ltkvln~e-P----P 313 (391)
T KOG0983|consen 245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV------LTKVLNEE-P----P 313 (391)
T ss_pred ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH------HHHHHhcC-C----C
Confidence 333455568999999999864 46889999999999999999999999876543211 11111100 0 1
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.+..+ ...++.+.+++..||+.|+.+||...++++.
T Consensus 314 ~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 314 LLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11111 2256789999999999999999999998873
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=284.10 Aligned_cols=241 Identities=22% Similarity=0.295 Sum_probs=187.4
Q ss_pred eEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHH---HhhcCCCceeeEEeEEEeCCcceEEEeeCC
Q 005355 397 ILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAI---LSQINHRNVVKLLGCCLETEVPLLVYEFIP 469 (700)
Q Consensus 397 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 469 (700)
+||+|+||.||++... .++.||+|.+.... ......+..|..+ ++...|+||+++++.+.+.+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 58899999875422 1222234444443 444579999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee
Q 005355 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549 (700)
Q Consensus 470 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~ 549 (700)
+++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999999987543 4999999999999999999999999 9999999999999999999999999987543221
Q ss_pred eeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhc
Q 005355 550 TTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE 628 (700)
Q Consensus 550 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 628 (700)
.....|+..|+|||++.+. .++.++||||||+++|||++|+.||.......... ....... .. ..
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~------~~----~~ 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------MA----VE 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc------cC----CC
Confidence 2234589999999998754 68999999999999999999999997653221110 0111110 01 11
Q ss_pred cCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005355 629 AKEEEIITVAMLAKRCLNMIGKKRP-----TMKEAAF 660 (700)
Q Consensus 629 ~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~ 660 (700)
.+...+..+.+++.+||..+|.+|| ++.++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1222356788999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=273.37 Aligned_cols=272 Identities=23% Similarity=0.283 Sum_probs=201.4
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcC-----CcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCceeeEEeEEEe-C
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTN-----GRIVAIKKSKLVDE--SNIEQFINEVAILSQINHRNVVKLLGCCLE-T 458 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 458 (700)
.....|+....||+|+||.||+|.-.+ .+.+|||+++.... .--....+|+.+++.++|+||+.+..++.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 345678899999999999999996432 23689998875422 123457899999999999999999999988 6
Q ss_pred CcceEEEeeCCCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC----CcEE
Q 005355 459 EVPLLVYEFIPNGTLYQYIHDQTE--EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK----YRAK 532 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~----~~~k 532 (700)
...+|++||.+. +|..+|+.++. ...++...+..|+.||+.|+.|||++= |+||||||.||||..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence 778999999965 89999875432 346899999999999999999999999 9999999999999876 9999
Q ss_pred EeecCCCcccccCCce--eeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhh---hHHH
Q 005355 533 VSDFGASRSVMIDQTH--LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDK---SLVG 606 (700)
Q Consensus 533 l~DfGl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~---~~~~ 606 (700)
|+|||+++.+...-.. ....++.|..|.|||.+.+ ..|+.+.|||+.|||+.||++-++.|.+....-.. ....
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 9999999987644332 2345778999999999987 46899999999999999999999888765432111 1111
Q ss_pred HHHHHHHh------cchhhh---cch-hhhhcc------C----------HHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 607 YFLEAMKE------NRLFEV---LDA-RVLKEA------K----------EEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 607 ~~~~~~~~------~~~~~~---~d~-~~~~~~------~----------~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
++....+- ..|..+ .+- ....++ + ..-.+.-.+|+.++|+.||.+|.|+++.++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 11111110 011000 000 000000 0 001123678999999999999999999987
Q ss_pred HH
Q 005355 661 EL 662 (700)
Q Consensus 661 ~L 662 (700)
..
T Consensus 337 h~ 338 (438)
T KOG0666|consen 337 HP 338 (438)
T ss_pred cc
Confidence 43
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=282.01 Aligned_cols=245 Identities=27% Similarity=0.384 Sum_probs=203.4
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCc
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEV 460 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 460 (700)
.+...+|..+.+||+|+||.|.+|.-+ ..+.+|||+++.. ...+.+--..|-++|... +-|.++++..++...+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 445678999999999999999999876 4678999988752 223334445677777776 57789999999999999
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
+++||||+.+|+|.-+|+.... +.+..+..+|.+||-||-+||+++ |+.||||.+||+||.+|.+||+|||+++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence 9999999999999999987654 888899999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
.-..+ ...+.+.+||+.|+|||++..++|...+|.|||||+||||+.|++||++.++++. .+.+.+
T Consensus 499 Eni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-------F~aI~e------ 564 (683)
T KOG0696|consen 499 ENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------FQAIME------ 564 (683)
T ss_pred ccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHH------
Confidence 64333 3345668899999999999999999999999999999999999999998876652 222222
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCC
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT 654 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs 654 (700)
... .++...+.+..++.+..|..+|.+|.-
T Consensus 565 --hnv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 565 --HNV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --ccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 111 234556677888999999999999953
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=283.84 Aligned_cols=249 Identities=24% Similarity=0.309 Sum_probs=196.0
Q ss_pred CCCccceEeeeCCeEEEEEEEcC-CcEEEEEEccc-----cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 391 NFNTNRILGQGGQGTVYKGMLTN-GRIVAIKKSKL-----VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
+|.+.+.||+|+||.||++.+.. +..+++|..+. .......++..|+.+++.++||||+++++.+.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998753 44455555432 1223345677899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 465 YEFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
+||+++++|.+++.... ....+++..++.++.|+++||.|||+.+ ++|+||+|+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999987532 2345899999999999999999999999 999999999999976 469999999987653
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||......+ .... ...+.
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~-~~~~~------- 221 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLR-IVEGP------- 221 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHH-HHcCC-------
Confidence 322 22233457889999999988889999999999999999999999986433211 1111 11111
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
....+...+..+.+++.+||+.+|++||++.|+++
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 --TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11123345668899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.98 Aligned_cols=263 Identities=24% Similarity=0.305 Sum_probs=193.2
Q ss_pred CCCccceEeeeCCeEEEEEEEc-C--CcEEEEEEcccc--ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeC----Cc
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-N--GRIVAIKKSKLV--DESNIEQFINEVAILSQI-NHRNVVKLLGCCLET----EV 460 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 460 (700)
+|++.+.||+|+||.||++... . +..||+|++... .....+.+.+|+++++++ +|+||+++++..... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999976 3 678999987642 223356788999999999 599999999875432 45
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.++++|++. ++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888885 68999986543 3899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCce---eeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH--------
Q 005355 541 SVMIDQTH---LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF-------- 608 (700)
Q Consensus 541 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~-------- 608 (700)
........ ......++..|+|||++.+ ..++.++||||||+++|+|++|..||...+...........
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65432211 1223468899999998765 46899999999999999999999999765432211100000
Q ss_pred HHHHHhcchhhhcc---h---hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 609 LEAMKENRLFEVLD---A---RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 609 ~~~~~~~~~~~~~d---~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...+.......... . .............+.+|+.+||+.+|++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000 0 0000011112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=324.98 Aligned_cols=254 Identities=25% Similarity=0.371 Sum_probs=204.8
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEE-cCCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGML-TNGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
...+-+++...+||.|.||.||.|.. .+|+..|+|-++. ......+.+.+|+.+|..++|||+|+.+|+-.+.+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 34456778888999999999999984 5799999996554 33444567889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
|.|||+++|+|.+++..... .++.....+..|++.|++|||++| ||||||||.||||+.+|.+|++|||.+..+
T Consensus 1311 IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 99999999999999987653 677777888999999999999999 999999999999999999999999999877
Q ss_pred ccCCce---eeeeeecccccccccccccC---CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcc
Q 005355 543 MIDQTH---LTTRVQGTFGYLDPEYFRSS---QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR 616 (700)
Q Consensus 543 ~~~~~~---~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 616 (700)
...... ......||+.|||||++.+. ....++|||||||++.||+||+.||...+.+= .+.+. ...+.
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~---V~~gh 1458 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYH---VAAGH 1458 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhH---HhccC
Confidence 544211 12245699999999999764 35568999999999999999999997554321 01110 11111
Q ss_pred hhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 617 LFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 617 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. ...+.....+-.+++.+||..||++|.++.|+++
T Consensus 1459 ~---------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1459 K---------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred C---------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1 1223446677888999999999999988887766
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=314.23 Aligned_cols=254 Identities=29% Similarity=0.422 Sum_probs=193.3
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC------
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLET------ 458 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 458 (700)
.-..+|+.+++||+||||.||+++.+ ||+.+|||++... .......+.+|+..|.+|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34577888999999999999999976 8999999998764 344457789999999999999999998533110
Q ss_pred --------------------------------------------------------------------------------
Q 005355 459 -------------------------------------------------------------------------------- 458 (700)
Q Consensus 459 -------------------------------------------------------------------------------- 458 (700)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 005355 459 ---------------------------------EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505 (700)
Q Consensus 459 ---------------------------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L 505 (700)
...||-|||++..+|.++++++... -.....++++++|++||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence 1125678888888888888765421 14678899999999999999
Q ss_pred HhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc-----------------cCCceeeeeeecccccccccccccC
Q 005355 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM-----------------IDQTHLTTRVQGTFGYLDPEYFRSS 568 (700)
Q Consensus 506 H~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~ 568 (700)
|++| ||||||||.||+|+++..|||+|||++.... .......+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999998721 0111123456799999999999765
Q ss_pred ---CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHh
Q 005355 569 ---QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCL 645 (700)
Q Consensus 569 ---~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl 645 (700)
.|+.|+|+||||+||+||+. ||.... |.. ..+...+.+.+..- .++.....+.-+.+|++|+
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa----~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERA----SILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchH--HHH----HHHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 49999999999999999996 554322 221 12222333332221 1223344455677999999
Q ss_pred ccCCCCCCCHHHHHH
Q 005355 646 NMIGKKRPTMKEAAF 660 (700)
Q Consensus 646 ~~~p~~RPs~~evl~ 660 (700)
+.||.+|||+.|+|.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999885
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=315.98 Aligned_cols=259 Identities=24% Similarity=0.330 Sum_probs=217.2
Q ss_pred hHHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe
Q 005355 382 SMELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL---VDESNIEQFINEVAILSQINHRNVVKLLGCCLE 457 (700)
Q Consensus 382 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 457 (700)
..+++...++|.++++||+|+||.|..++++ .++.+|+|++.. ........|..|-.+|..-+.+.|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4567777899999999999999999999986 588999998876 334556779999999999999999999999999
Q ss_pred CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 458 TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 458 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
..++|+|||||+||+|..++.+.. .++++.+..++..|+.||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999999876 3999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCceeeeeeeccccccccccccc-----CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHH
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAM 612 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 612 (700)
.+-.+..+..-.....+|||.|.+||++.. +.|....|.||+||++|||+.|..||... +++.-+...+
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KIm 294 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKIM 294 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHHh
Confidence 998877676667777889999999999853 56889999999999999999999999643 3333333333
Q ss_pred HhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCC---HHHHHH
Q 005355 613 KENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT---MKEAAF 660 (700)
Q Consensus 613 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~evl~ 660 (700)
.-.....+. .....+.+..+||.+.+. +|+.|.. ++++..
T Consensus 295 ~hk~~l~FP-------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 295 NHKESLSFP-------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred chhhhcCCC-------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 221111111 113467788899999876 7888887 887765
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=274.70 Aligned_cols=253 Identities=21% Similarity=0.327 Sum_probs=203.6
Q ss_pred ceEeeeCCeEEEEEE-EcCCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEEeeCCCCCH
Q 005355 396 RILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTL 473 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 473 (700)
++||+|+|+.|--+. ..++..+|||++.....-.+.++++|++++.+. .|+||++|+++|.++...|||||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 579999999999887 568999999999887777789999999999998 599999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC---cEEEeecCCCcccccCC----
Q 005355 474 YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY---RAKVSDFGASRSVMIDQ---- 546 (700)
Q Consensus 474 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~---~~kl~DfGl~~~~~~~~---- 546 (700)
..+|++... +++.++.++.++|+.||.|||.+| |.||||||+|||-.+.. -+||+||.|........
T Consensus 164 LshI~~~~~---F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKRKH---FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 999987654 999999999999999999999999 99999999999996543 48999998876543221
Q ss_pred --ceeeeeeecccccccccccc-----cCCCCcccceehHHHHHHHHHhCCCCCCCCCchh--------hhhHHHHHHHH
Q 005355 547 --THLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE--------DKSLVGYFLEA 611 (700)
Q Consensus 547 --~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~--------~~~~~~~~~~~ 611 (700)
.....+.+|+..|||||+.. ...|+.+.|.||||||||-||+|.+||.+.-..+ ...--+.+...
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 11223356888999999863 2457889999999999999999999998655322 11122223344
Q ss_pred HHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 612 MKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 612 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+.+++.. +. +......+.+..+|+..+|..++.+|.++..+++
T Consensus 318 IQEGkYe-FP-----dkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGKYE-FP-----DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccCCc-CC-----hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 4444431 11 1223445667788999999999999999999887
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=296.89 Aligned_cols=261 Identities=25% Similarity=0.338 Sum_probs=198.3
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc----
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEV---- 460 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 460 (700)
..++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999976 5789999987642 23344677889999999999999999988766554
Q ss_pred --ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 005355 461 --PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGA 538 (700)
Q Consensus 461 --~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl 538 (700)
.++|+||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 78999998 67999998753 3899999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH--------H
Q 005355 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF--------L 609 (700)
Q Consensus 539 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~--------~ 609 (700)
+...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+........ .
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence 9765322 223457889999999865 46789999999999999999999999765432211100000 0
Q ss_pred HHHHhcchhhhcchh------hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 610 EAMKENRLFEVLDAR------VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 610 ~~~~~~~~~~~~d~~------~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+........+... .........+..+.+++.+||+.+|++|||+.||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000000000 000001123567899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=267.91 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=201.8
Q ss_pred HhcCCCc-cceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEe----CCc
Q 005355 388 ATDNFNT-NRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLE----TEV 460 (700)
Q Consensus 388 ~~~~~~~-~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 460 (700)
.+++|++ .++||-|-.|.|.....+ .++++|+|++... ...++|+++--+. .|+|||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 4566665 357999999999998876 7899999987643 4567888876554 69999999998764 355
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC---CCCcEEEeecC
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFG 537 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~---~~~~~kl~DfG 537 (700)
+++|||.|+||.|+..+..... ..+++.++..|++||..|+.|||+.+ |.||||||+|+|.+ .|..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 6799999999999999988754 45999999999999999999999999 99999999999996 46679999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
+++.... .....+.+-|+.|.|||++...+|+...|+||+||++|-|++|.+||...... .+.--+...+..+..
T Consensus 210 FAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 210 FAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQY 284 (400)
T ss_pred cccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccCc
Confidence 9986432 33345567899999999999999999999999999999999999999754321 111123333333332
Q ss_pred hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. .+.+.....++...++|+.+|..+|.+|.|++++++
T Consensus 285 ~------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 285 E------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred c------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1 122233566778899999999999999999999886
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=275.90 Aligned_cols=265 Identities=23% Similarity=0.349 Sum_probs=206.9
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCC--C----ceeeEEeEEEeC
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINH--R----NVVKLLGCCLET 458 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~ 458 (700)
...+++|.+...+|+|+||.|....+. .+..||||+++...... +..+-|+++|.++.+ | -++++.++|.-.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYr-eAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYR-EAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHh-hHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 344889999999999999999998865 46899999998765543 667789999999842 2 377888899999
Q ss_pred CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC------------
Q 005355 459 EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD------------ 526 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~------------ 526 (700)
++.++|+|.+ +-|+.++|..+.. .+++..++..++.|++++++|||+.+ ++|.||||+|||+.
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCC
Confidence 9999999999 6699999987643 45899999999999999999999999 99999999999993
Q ss_pred --------CCCcEEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCc
Q 005355 527 --------DKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDS 598 (700)
Q Consensus 527 --------~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~ 598 (700)
.+..+||+|||.+...... ...++.|.-|.|||++.+-.|+.+.||||+||||+||.+|...|+..+.
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 2445899999999754322 2556789999999999999999999999999999999999999998875
Q ss_pred hhhhhHHHHHHHHHHhcchhhh----------cc---------------h-hh---hhccCHHHHHHHHHHHHHHhccCC
Q 005355 599 EEDKSLVGYFLEAMKENRLFEV----------LD---------------A-RV---LKEAKEEEIITVAMLAKRCLNMIG 649 (700)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~----------~d---------------~-~~---~~~~~~~~~~~l~~li~~cl~~~p 649 (700)
.|.....+.++..+....+... +| + .. .......+..+|.+|+++||..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 5543333322211111000000 00 0 00 001123455679999999999999
Q ss_pred CCCCCHHHHHH
Q 005355 650 KKRPTMKEAAF 660 (700)
Q Consensus 650 ~~RPs~~evl~ 660 (700)
.+|+|+.|+++
T Consensus 395 ~~RiTl~EAL~ 405 (415)
T KOG0671|consen 395 ARRITLREALS 405 (415)
T ss_pred cccccHHHHhc
Confidence 99999999986
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=274.98 Aligned_cols=236 Identities=32% Similarity=0.395 Sum_probs=193.9
Q ss_pred EeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCH
Q 005355 398 LGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 473 (700)
Q Consensus 398 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 473 (700)
||+|+||.||++... +++.+++|.+.... ....+.+..|+.++++++|+||+++++.+...+..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999976 58899999876432 23456889999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeeee
Q 005355 474 YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRV 553 (700)
Q Consensus 474 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~ 553 (700)
.+++.... .+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF 153 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence 99998654 3899999999999999999999999 9999999999999999999999999987653322 123344
Q ss_pred ecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHH
Q 005355 554 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEE 633 (700)
Q Consensus 554 ~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 633 (700)
.++..|+|||.+.+...+.++|+||||+++|+|++|..||...+..+ .........+ ..+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~----------~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-------IYEKILKDPL----------RFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHhcCCC----------CCCCCC
Confidence 57889999999998889999999999999999999999996554311 1111111111 112222
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHH
Q 005355 634 IITVAMLAKRCLNMIGKKRPTMKE 657 (700)
Q Consensus 634 ~~~l~~li~~cl~~~p~~RPs~~e 657 (700)
+..+.+++++||..+|++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 567889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=306.19 Aligned_cols=146 Identities=27% Similarity=0.393 Sum_probs=132.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|++.++||+|+||.||+|.+. .++.||||+++.. .......+.+|+.++..++|+||+++++.+...+..+||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367899999999999999999976 6889999987642 234457788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
|||+.+++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997653 3889999999999999999999999 9999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=276.51 Aligned_cols=260 Identities=28% Similarity=0.431 Sum_probs=203.3
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh-------hhHHHHHHHHHHHhhcCCCceeeEEeEEE-
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE-------SNIEQFINEVAILSQINHRNVVKLLGCCL- 456 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~- 456 (700)
....++|-++.+||+|||+.||+|.+- ..+.||||+-..... .-.+...+|..|-+.|.||.||++++++.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 344577888999999999999999954 678999998554221 12345678999999999999999999986
Q ss_pred eCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC---CCCcEEE
Q 005355 457 ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD---DKYRAKV 533 (700)
Q Consensus 457 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~---~~~~~kl 533 (700)
+.+..+-|+||+++.+|+-||+.+.. ++++++..|+.||+.||.||.... +||||-||||.||||- ..|.+||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEe
Confidence 56677899999999999999987754 999999999999999999999876 6799999999999994 4688999
Q ss_pred eecCCCcccccCCce------eeeeeecccccccccccc----cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhh
Q 005355 534 SDFGASRSVMIDQTH------LTTRVQGTFGYLDPEYFR----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKS 603 (700)
Q Consensus 534 ~DfGl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~----~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~ 603 (700)
+||||++.+..+... ......||++|++||.+- ....+.|+||||+|||+|..+.|++||.......+
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-- 692 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-- 692 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--
Confidence 999999977543222 344466999999999873 24578899999999999999999999986654332
Q ss_pred HHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 604 LVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...++.+.....-.. ...+....+..++|++||+..-++|....++..
T Consensus 693 -------ILqeNTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 -------ILQENTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -------HHhhhchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 222222222221111 112345567788999999999999998877654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-33 Score=267.69 Aligned_cols=257 Identities=25% Similarity=0.351 Sum_probs=199.1
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhh-cCCCceeeEEeEEEeCCcceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQ-INHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
++.+.+..||.|.||+|++..++ .|+..|||++.... ....++++.|.+...+ -+.||||+++|....++..++.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 34455578999999999999976 69999999987644 3566888999887655 479999999999999999999999
Q ss_pred eCCCCCHHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 467 FIPNGTLYQYIHDQ--TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 467 ~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
+| ..||+.+-... ..+..+++..+-.|+...+.||.||...-+ |+||||||+||||+..|.+||+|||++..+.
T Consensus 144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv- 219 (361)
T KOG1006|consen 144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLV- 219 (361)
T ss_pred HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHH-
Confidence 99 56776664321 122348999999999999999999987642 9999999999999999999999999997552
Q ss_pred CCceeeeeeeccccccccccccc--CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
.+...+...|-..|||||.+.. ..|+.+|||||||++|+|+.||..|+...+. ..+++.+... +....++.
T Consensus 220 -~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~-gdpp~l~~ 292 (361)
T KOG1006|consen 220 -DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVI-GDPPILLF 292 (361)
T ss_pred -HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHc-CCCCeecC
Confidence 2233344558889999999965 3589999999999999999999999976543 2222222222 22211111
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.....+....+..++.-||..|-..||...+++++
T Consensus 293 ----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 ----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 12224567789999999999999999999998763
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=279.83 Aligned_cols=264 Identities=27% Similarity=0.399 Sum_probs=207.9
Q ss_pred cceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCC
Q 005355 395 NRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 471 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 471 (700)
.+.||.|-||+||-|+++ +|+.||||++.. ....+..++++|+.||+++.||.||.+--.|+..+..+.|||-+ .|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 578999999999999976 799999998764 34555688999999999999999999999999999999999999 56
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEEEeecCCCcccccCCce
Q 005355 472 TLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD---KYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 472 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~---~~~~kl~DfGl~~~~~~~~~~ 548 (700)
+..+.|-.... ..|++.....++.||+.||.|||.++ |+|.||||+|||+.. -.++||+|||+++.+. +..
T Consensus 648 DMLEMILSsEk-gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--Eks 721 (888)
T KOG4236|consen 648 DMLEMILSSEK-GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--EKS 721 (888)
T ss_pred hHHHHHHHhhc-ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecc--hhh
Confidence 66666554322 23899999999999999999999999 999999999999954 4689999999999764 444
Q ss_pred eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhc
Q 005355 549 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE 628 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 628 (700)
....++||+.|+|||+++++.|...-|+||.|||+|--++|..||.....-. +.+.+..+ +- +..
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn---------dQIQNAaF---My---Pp~ 786 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN---------DQIQNAAF---MY---PPN 786 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh---------HHhhcccc---cc---CCC
Confidence 5567889999999999999999999999999999999999999996433211 11111111 11 112
Q ss_pred cCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH-----------HHHhchhhcCCCccCCCCCc
Q 005355 629 AKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF-----------ELGGIRASIGDSIMQHNCDD 680 (700)
Q Consensus 629 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~-----------~L~~l~~~~~~~~~~~~~~~ 680 (700)
...+......+||..+|+..-++|-|....+. -|+.+...+.+...-.+.+|
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~igeRyiThesDD 849 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIGERYITHESDD 849 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhCcceecCcchh
Confidence 22445567788999999999999999876543 35566655555544444443
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-33 Score=262.84 Aligned_cols=265 Identities=22% Similarity=0.324 Sum_probs=200.2
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe--------C
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLE--------T 458 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 458 (700)
+.|....+||+|.||.||+|+.+ .++.||+|+.... ...-....++|+.+|..+.|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 44555678999999999999966 5788999875432 22334567899999999999999999988753 2
Q ss_pred CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 005355 459 EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGA 538 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl 538 (700)
...+|||++++ -+|.-+|.....+ ++..++.+++.+++.||.|+|... |+|||+|+.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn~~vr--~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSNRKVR--FSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcCcccc--ccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 34689999995 4888888765433 899999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCce---eeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh
Q 005355 539 SRSVMIDQTH---LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE 614 (700)
Q Consensus 539 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 614 (700)
++.+...... ..+..+.|+.|++||.+.+ ..|+.+.|||.-|||+.||+++.+-+.+........++......+..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9876543322 2344567999999999876 57999999999999999999999998877655544444433322222
Q ss_pred cchhhhcchhhhhcc------------CHHH------HHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 615 NRLFEVLDARVLKEA------------KEEE------IITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 615 ~~~~~~~d~~~~~~~------------~~~~------~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+.|.....-.+.... -.+. .++..+|+.++|..||.+|+++.+++.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 222211111110000 0111 125778999999999999999988875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=267.36 Aligned_cols=220 Identities=25% Similarity=0.198 Sum_probs=177.1
Q ss_pred eCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCHHHHHhc
Q 005355 401 GGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHD 479 (700)
Q Consensus 401 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 479 (700)
|.||.||++.+. +++.||+|++.... .+.+|...+....|||++++++.+.+.+..+++|||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999975 68899999986532 234455555566799999999999999999999999999999999976
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeeeeeccccc
Q 005355 480 QTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY 559 (700)
Q Consensus 480 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y 559 (700)
.. .+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++++|||++...... .....++..|
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 53 3899999999999999999999999 999999999999999999999999987654321 1223356789
Q ss_pred ccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHH
Q 005355 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAM 639 (700)
Q Consensus 560 ~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 639 (700)
+|||.+....++.++||||+|++++||++|..|+....... .. ... .+.+......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~-----~~~----~~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT-----HTT----LNIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc-----ccc----cCCcccCCHHHHH
Confidence 99999988889999999999999999999998875322110 00 000 0112234457889
Q ss_pred HHHHHhccCCCCCCCHH
Q 005355 640 LAKRCLNMIGKKRPTMK 656 (700)
Q Consensus 640 li~~cl~~~p~~RPs~~ 656 (700)
++.+||+.||++||++.
T Consensus 208 li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 208 LLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHccCCHHHhcCCC
Confidence 99999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=283.68 Aligned_cols=239 Identities=23% Similarity=0.279 Sum_probs=197.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 466 (700)
++.|.....+|.|+|+.|-++... .++..+||++.... .+-.+|+.++... +|+||+++.+.+.+..+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 667888888999999999998865 67889999987642 2235677666665 79999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE-CCCCcEEEeecCCCcccccC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL-DDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl-~~~~~~kl~DfGl~~~~~~~ 545 (700)
.+.++-|.+.+..... ....+..|+.+|+.|+.|||.+| ++||||||+|||+ +..++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~----~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE----FCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcch----hHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999998888876542 33777889999999999999999 9999999999999 58899999999999876433
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
.....-|..|.|||++....+++++||||||++||+||+|+.||.....+. .+...+..++
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------ei~~~i~~~~--------- 530 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------EIHTRIQMPK--------- 530 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------HHHHhhcCCc---------
Confidence 223346889999999999999999999999999999999999998665441 1222222222
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+....+...++|+.+||+.||.+||+|.++..
T Consensus 531 ---~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 531 ---FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 22456677889999999999999999999876
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=286.09 Aligned_cols=257 Identities=25% Similarity=0.370 Sum_probs=210.1
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEE----
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCL---- 456 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---- 456 (700)
..+...++.|.+.+.||+|.+|.||+++.. +++.+|||+.......+ +++..|.++|+.. .|||++.++|++.
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 344455788999999999999999999954 78899999887654444 6778899999887 6999999999986
Q ss_pred -eCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEee
Q 005355 457 -ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535 (700)
Q Consensus 457 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~D 535 (700)
..++++|||||+.+||..|+++... ...+.|..+..|++.++.||.+||.+. ++|||||-.|||++.++.|||.|
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence 3578899999999999999998876 445999999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccccCCceeeeeeecccccccccccccC-----CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 005355 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS-----QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLE 610 (700)
Q Consensus 536 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 610 (700)
||++..+... .....+..||+.|||||++... .|+..+|+||||++..||.-|.+|+...-+.. +
T Consensus 167 FGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-------a-- 236 (953)
T KOG0587|consen 167 FGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-------A-- 236 (953)
T ss_pred eeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------h--
Confidence 9999876433 3334556799999999998653 46778999999999999999999986543321 1
Q ss_pred HHHhcchhhhc-chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 611 AMKENRLFEVL-DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 611 ~~~~~~~~~~~-d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
++.+. .+...-..+..-..++.++|..||..|-++||++.++++
T Consensus 237 ------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 ------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111 111112224566778999999999999999999999886
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=260.97 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=205.7
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcce
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL---VDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 462 (700)
..++|+++++||+|+|.+|..++++ ..+.+|+|+++. .+..+++-...|-.++.+. +||.+|.+..+|..+...+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3578999999999999999999975 678899998764 3455567778888888875 7999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+|.||+++|+|.-++.++++ ++++.+..+..+|.-||.|||++| |+.||||.+|+|||..|.+||+|+|+.+.-
T Consensus 328 fvieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 99999999999988887654 999999999999999999999999 999999999999999999999999999854
Q ss_pred ccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchh-hhhHHHHHHHHHHhcchhhhc
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE-DKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 621 (700)
. .....+.+.+||+.|.|||++.+..|...+|.|+|||+++||+.|+.||+....+. +.+...++.+.+-+.++
T Consensus 402 l-~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi---- 476 (593)
T KOG0695|consen 402 L-GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI---- 476 (593)
T ss_pred C-CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc----
Confidence 3 33445667889999999999999999999999999999999999999998554332 22333344444433322
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCC
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRP 653 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 653 (700)
..+...+.....+++.-|+.||.+|.
T Consensus 477 ------riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 ------RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ------cccceeehhhHHHHHHhhcCCcHHhc
Confidence 11223344556688999999999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=293.24 Aligned_cols=259 Identities=22% Similarity=0.280 Sum_probs=171.6
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-C----CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeE------EE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-N----GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGC------CL 456 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 456 (700)
..++|++.++||+|+||.||+|++. + +..||||++...... +.+..| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999976 4 689999987643221 111111 1112222222222211 24
Q ss_pred eCCcceEEEeeCCCCCHHHHHhccCCCC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 005355 457 ETEVPLLVYEFIPNGTLYQYIHDQTEEF-----------------PITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIK 519 (700)
Q Consensus 457 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~-----------------~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik 519 (700)
.....++|+||+++++|.+++....... ......+..++.||+.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 5567899999999999999997543110 1123446679999999999999999 9999999
Q ss_pred CCcEEECC-CCcEEEeecCCCcccccCCceeeeeeecccccccccccccC----------------------CCCcccce
Q 005355 520 SANILLDD-KYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS----------------------QFTEKSDV 576 (700)
Q Consensus 520 ~~NILl~~-~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksDV 576 (700)
|+|||+++ ++.+||+|||+++.+............+++.|+|||.+... .+..++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999986644444444556789999999965322 23456799
Q ss_pred ehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcc-----hhhhcchhhhhc------cCHHHHHHHHHHHHHHh
Q 005355 577 YSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR-----LFEVLDARVLKE------AKEEEIITVAMLAKRCL 645 (700)
Q Consensus 577 wSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~d~~~~~~------~~~~~~~~l~~li~~cl 645 (700)
|||||+||||+++..++.... . .+...+.... +...+.+....+ ..........+|+.+||
T Consensus 363 wSlGviL~el~~~~~~~~~~~----~----~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNL----I----QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHH----H----HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999766543210 0 1111111100 111111110000 00001123458999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 005355 646 NMIGKKRPTMKEAAFE 661 (700)
Q Consensus 646 ~~~p~~RPs~~evl~~ 661 (700)
+.||++|||++|+++.
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999984
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=284.81 Aligned_cols=261 Identities=20% Similarity=0.255 Sum_probs=182.8
Q ss_pred HhcCCCccceEeeeCCeEEEEEEE-----------------cCCcEEEEEEccccChhhHHHHH--------------HH
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGML-----------------TNGRIVAIKKSKLVDESNIEQFI--------------NE 436 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~~--------------~E 436 (700)
..++|++.++||+|+||.||+|.+ ..++.||||++........++|. .|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 477899999999999999999964 23567999998765443334443 46
Q ss_pred HHHHhhcCCCce-----eeEEeEEEe--------CCcceEEEeeCCCCCHHHHHhccCC---------------------
Q 005355 437 VAILSQINHRNV-----VKLLGCCLE--------TEVPLLVYEFIPNGTLYQYIHDQTE--------------------- 482 (700)
Q Consensus 437 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~E~~~~gsL~~~l~~~~~--------------------- 482 (700)
+.++.+++|.++ +++++++.. ....+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766554 667777643 3567999999999999999975321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeeeeecccccccc
Q 005355 483 EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDP 562 (700)
Q Consensus 483 ~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aP 562 (700)
...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 113567889999999999999999999 99999999999999999999999999975533222222223357899999
Q ss_pred cccccCC----------------------CCcccceehHHHHHHHHHhCCC-CCCCCCchhhh-----hHHHHHHHHHHh
Q 005355 563 EYFRSSQ----------------------FTEKSDVYSFGVVLVELLTGQK-PIRSTDSEEDK-----SLVGYFLEAMKE 614 (700)
Q Consensus 563 E~~~~~~----------------------~s~ksDVwSlG~il~elltg~~-p~~~~~~~~~~-----~~~~~~~~~~~~ 614 (700)
|.+.... ...+.||||+|+++++|+++.. |+......... .... .....+.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~-~~r~~~~ 458 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLN-RWRMYKG 458 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHH-HHHhhcc
Confidence 9875432 1235799999999999999875 66432211100 0000 0001111
Q ss_pred cchhhhcchhhhhccCHHHHHHHHHHHHHHhccCC---CCCCCHHHHHH
Q 005355 615 NRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIG---KKRPTMKEAAF 660 (700)
Q Consensus 615 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPs~~evl~ 660 (700)
... + -...........+|+.++|..+| .+|+|++|+++
T Consensus 459 ~~~----~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKY----D----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCC----C----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 110 0 01112335668889999999766 68999999986
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=261.54 Aligned_cols=238 Identities=30% Similarity=0.411 Sum_probs=194.9
Q ss_pred CCeEEEEEEEc-CCcEEEEEEccccChhh-HHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCHHHHHhc
Q 005355 402 GQGTVYKGMLT-NGRIVAIKKSKLVDESN-IEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHD 479 (700)
Q Consensus 402 ~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~ 479 (700)
+||.||+|++. +++.+++|++....... .+.+.+|++.+++++|+|++++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999987655444 68899999999999999999999999999999999999999999999976
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeeeeeccccc
Q 005355 480 QTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY 559 (700)
Q Consensus 480 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y 559 (700)
... +++..++.++.+++.++++||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 543 889999999999999999999999 9999999999999999999999999998654332 23345578899
Q ss_pred ccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHH
Q 005355 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAM 639 (700)
Q Consensus 560 ~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 639 (700)
++||.+....++.++|||+||+++++|++|..||......+ ............. ..........+.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~------~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL------ELFKKIGKPKPPF-------PPPEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH------HHHHHHhccCCCC-------ccccccCCHHHHH
Confidence 99999998889999999999999999999999997532211 1111111111110 0000004457889
Q ss_pred HHHHHhccCCCCCCCHHHHHH
Q 005355 640 LAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 640 li~~cl~~~p~~RPs~~evl~ 660 (700)
++.+||..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=276.66 Aligned_cols=243 Identities=25% Similarity=0.326 Sum_probs=204.8
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCCc-EEEEEEcc---ccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNGR-IVAIKKSK---LVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~vavK~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
..+++.+..||-|+||.|-++.....+ .+|+|+++ ..+..+.+.+..|-.||...+.+.||+++..|.+....|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 455666778999999999999976443 37777654 46677788999999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
||-+-+|.|+..|++... ++......++..+++|++|||+++ ||+|||||+|.+|+.+|-+||.|||+++.+..
T Consensus 499 mEaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 999999999999987654 899999999999999999999999 99999999999999999999999999997754
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
. ..+-+.+||+.|.|||++.+...+.++|.||||++++||++|.+||.+.++..-.+++ +.-+ |
T Consensus 573 g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I---LkGi---------d-- 636 (732)
T KOG0614|consen 573 G--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI---LKGI---------D-- 636 (732)
T ss_pred C--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH---Hhhh---------h--
Confidence 3 3455678999999999999999999999999999999999999999987764432222 1111 1
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCC
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPT 654 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs 654 (700)
..+.+........+|++++...+|.+|.-
T Consensus 637 -~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 -KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 12334445556778999999999999976
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=271.38 Aligned_cols=209 Identities=26% Similarity=0.402 Sum_probs=180.1
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEE-cCCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGML-TNGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
+....-|..++.||-|+||+|.++.. +....+|+|.+...+ ..+...++.|-.||..-..+.||+|+-.|.+.+.+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 33455688899999999999999984 446778999876533 45567788999999999999999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
|+||||+++|++..+|.+..- +.++.+..++.++..|+++.|+.| +|||||||+|||||.+|.+||+||||+.-
T Consensus 705 YFVMdYIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred EEEEeccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccc
Confidence 999999999999999988753 888899999999999999999999 99999999999999999999999999875
Q ss_pred cccCCc--------e---------------------------------eeeeeecccccccccccccCCCCcccceehHH
Q 005355 542 VMIDQT--------H---------------------------------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFG 580 (700)
Q Consensus 542 ~~~~~~--------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG 580 (700)
+..... + .....+||+.|+|||++....++...|.||.|
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g 858 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG 858 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence 531100 0 01124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCchh
Q 005355 581 VVLVELLTGQKPIRSTDSEE 600 (700)
Q Consensus 581 ~il~elltg~~p~~~~~~~~ 600 (700)
||||||+.|+.||....+.+
T Consensus 859 vil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHHHHhhCCCCccCCCCCc
Confidence 99999999999998777654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=237.68 Aligned_cols=210 Identities=26% Similarity=0.414 Sum_probs=174.4
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc-cChhhHHHHHHHHHHHhh-cCCCceeeEEeEEEeCCc
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL-VDESNIEQFINEVAILSQ-INHRNVVKLLGCCLETEV 460 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~ 460 (700)
.+++..+....+..||+|++|.|-+.++. +|...|+|++.. .+.+..++.++|+.+..+ ..+|.+|.++|.......
T Consensus 40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 36677777888889999999999888864 799999998775 344556778889988766 479999999999999999
Q ss_pred ceEEEeeCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 461 PLLVYEFIPNGTLYQYIHDQ-TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
.++.||.| ..||..+-++. .....+++..+-+|+..+++||.|||++-+ ++|||+||+||||+.+|++|++|||++
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccc
Confidence 99999999 56888776542 234569999999999999999999999753 999999999999999999999999999
Q ss_pred cccccCCceeeeeeeccccccccccccc----CCCCcccceehHHHHHHHHHhCCCCCCCCCc
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRS----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDS 598 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwSlG~il~elltg~~p~~~~~~ 598 (700)
..+.. +-..+...|-..|||||.+.. ..|+.|+||||||+++.||.+++.||+....
T Consensus 197 G~L~d--SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 197 GYLVD--SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred eeehh--hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 75421 112222457789999999854 4789999999999999999999999986554
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-31 Score=252.63 Aligned_cols=263 Identities=25% Similarity=0.320 Sum_probs=201.8
Q ss_pred CccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC-----cceEE
Q 005355 393 NTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETE-----VPLLV 464 (700)
Q Consensus 393 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv 464 (700)
+-.+.||.|+||.||..++. +|+.||+|++...- -...+.+.+|+++|..++|.|++..++.....+ +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34478999999999999964 89999999977532 234578999999999999999999998765443 44678
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
.|.| ..+|..+|-.. ..++.+.+.-+..||++||.|||+.+ |.||||||.|.|++.|-.+||+|||+++.-..
T Consensus 136 TELm-QSDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHH-HhhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 8888 44677766533 34899999999999999999999999 99999999999999999999999999997766
Q ss_pred CCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH-----HH---Hhc
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLE-----AM---KEN 615 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-----~~---~~~ 615 (700)
++...++..+.|..|.|||++.+ ..|+.+.||||.|||+.||+..+..|....+-+...++...+. .+ -++
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 66666777788999999999987 4699999999999999999999999987776665444433221 11 111
Q ss_pred chhhhcchhhhh---------ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005355 616 RLFEVLDARVLK---------EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662 (700)
Q Consensus 616 ~~~~~~d~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L 662 (700)
....++...... ..+...-.+...+...++..+|+.|.+..+.+..+
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111111111100 00112223456788889999999999999988765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=255.60 Aligned_cols=263 Identities=26% Similarity=0.330 Sum_probs=196.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-----C---CceeeEEeEEEe--
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQIN-----H---RNVVKLLGCCLE-- 457 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 457 (700)
..+|.+.++||.|.|++||++.+. +.+.||+|+.+..... .+....||++|++++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 478999999999999999999965 5788999998764332 366789999999983 3 469999999974
Q ss_pred --CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-------
Q 005355 458 --TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK------- 528 (700)
Q Consensus 458 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~------- 528 (700)
..+.+||+|++ +-+|..+|.....++ ++...+..|++||+.||.|||... .|||.||||+|||+..+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhh
Confidence 45789999999 778999998765544 999999999999999999999875 39999999999999300
Q ss_pred --------------------------------------------------------------------------------
Q 005355 529 -------------------------------------------------------------------------------- 528 (700)
Q Consensus 529 -------------------------------------------------------------------------------- 528 (700)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred -------------------------------------------------------------------------------C
Q 005355 529 -------------------------------------------------------------------------------Y 529 (700)
Q Consensus 529 -------------------------------------------------------------------------------~ 529 (700)
.
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 0
Q ss_pred cEEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCch---hhhhHHH
Q 005355 530 RAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSE---EDKSLVG 606 (700)
Q Consensus 530 ~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~---~~~~~~~ 606 (700)
++||+|||-+.-.. ..++..+.|..|+|||++.+..|+..+||||++|++|||+||...|+...-+ .+.+.+.
T Consensus 392 ~vKIaDlGNACW~~----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 392 RVKIADLGNACWVH----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred eEEEeeccchhhhh----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 13444444443221 1122334688899999999999999999999999999999999999755432 2222233
Q ss_pred HHHHHHHh-------------------cchhh-------hcchhhh--hccCHHHHHHHHHHHHHHhccCCCCCCCHHHH
Q 005355 607 YFLEAMKE-------------------NRLFE-------VLDARVL--KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658 (700)
Q Consensus 607 ~~~~~~~~-------------------~~~~~-------~~d~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ev 658 (700)
.+.+..-. +.+.. -+...+. -+.+.+...++.+++.-||+.+|++|||+.+.
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 22222211 11100 0111111 13467788899999999999999999999999
Q ss_pred HH
Q 005355 659 AF 660 (700)
Q Consensus 659 l~ 660 (700)
++
T Consensus 548 l~ 549 (590)
T KOG1290|consen 548 LK 549 (590)
T ss_pred hc
Confidence 96
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=276.98 Aligned_cols=245 Identities=27% Similarity=0.387 Sum_probs=189.4
Q ss_pred CCccceEeeeCCeE-EEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEEeeCC
Q 005355 392 FNTNRILGQGGQGT-VYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIP 469 (700)
Q Consensus 392 ~~~~~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~~ 469 (700)
|.-.+++|.|..|+ ||+|... ++.||||++-. ...+...+|+..|+.- +||||+++++.-.++...||..|.+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 45567799999985 7999986 88999998763 3335578999999987 6999999999999999999999999
Q ss_pred CCCHHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-----CCcEEEeecCCCcccc
Q 005355 470 NGTLYQYIHDQTEE-FPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD-----KYRAKVSDFGASRSVM 543 (700)
Q Consensus 470 ~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~-----~~~~kl~DfGl~~~~~ 543 (700)
..+|.+++...... ........+.+..|+++||++||+.+ ||||||||.||||+. ..+++|+|||+++...
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56999999874111 11121445778899999999999999 999999999999965 3579999999999887
Q ss_pred cCCcee--eeeeecccccccccccccCCCCcccceehHHHHHHHHHhC-CCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 544 IDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTG-QKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 544 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
.+.... .....||.+|+|||++.....+.++|||||||++|+.++| ..||...-..+. + +..+...
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-N--------Il~~~~~-- 731 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-N--------ILTGNYT-- 731 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-h--------hhcCccc--
Confidence 665443 3356799999999999999989999999999999999985 899975432211 0 1111100
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+. ..... .+. +..+||.+|++.+|..||++.+|+.
T Consensus 732 L~--~L~~~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 732 LV--HLEPL-PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ee--eeccC-chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00 00000 111 6778999999999999999999975
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=232.05 Aligned_cols=255 Identities=23% Similarity=0.316 Sum_probs=192.9
Q ss_pred hcCCCccceEeeeCCeEEEEEE-EcCCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeC--CcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQIN-HRNVVKLLGCCLET--EVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 464 (700)
.++|++.+++|+|.++.||.|. ..+.++++||+++. ...+.+.+|+.||..|. ||||+++++...+. ..+.||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 5788999999999999999999 45788999999984 44477899999999997 99999999998765 466799
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEeecCCCcccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGASRSVM 543 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~-~~~kl~DfGl~~~~~ 543 (700)
+||+.+.+...+... ++...+..++.++++||.|+|+.| |.|||+||.|++||.. ..++|+|+|++....
T Consensus 114 FE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 999988877666532 778889999999999999999999 9999999999999864 579999999998765
Q ss_pred cCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH--------HHHHHh
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF--------LEAMKE 614 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~ 614 (700)
+..... ..+.+..|--||.+-. +.|+..-|+|||||+|..|+..+.||....... ++++..+ ......
T Consensus 185 p~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHHHHhChHHHHHHHHH
Confidence 444332 2234566789998865 557788999999999999999998885333221 1111111 000000
Q ss_pred cchhhhcchhhhh----------------ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 615 NRLFEVLDARVLK----------------EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 615 ~~~~~~~d~~~~~----------------~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.. -.+|++... +...-..++..+|+.+.|..|..+|||++|...
T Consensus 262 Y~--i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 262 YQ--IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred Hc--cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 00 012221111 111122467889999999999999999999876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=232.09 Aligned_cols=210 Identities=38% Similarity=0.581 Sum_probs=183.8
Q ss_pred EeeeCCeEEEEEEEcC-CcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCHHH
Q 005355 398 LGQGGQGTVYKGMLTN-GRIVAIKKSKLVDES-NIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQ 475 (700)
Q Consensus 398 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 475 (700)
||+|.+|.||++...+ ++.+++|+....... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999998865443 45789999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEeecCCCcccccCCceeeeeee
Q 005355 476 YIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGASRSVMIDQTHLTTRVQ 554 (700)
Q Consensus 476 ~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~-~~~~kl~DfGl~~~~~~~~~~~~~~~~ 554 (700)
++.... ..+++..++.++.+++++|++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 998653 23899999999999999999999999 999999999999999 89999999999976543321 123345
Q ss_pred cccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHH
Q 005355 555 GTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEE 633 (700)
Q Consensus 555 gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 633 (700)
+...|++||.+... ..+.++|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78899999999887 888999999999999999
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 634 IITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 634 ~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 356779999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=256.01 Aligned_cols=197 Identities=24% Similarity=0.369 Sum_probs=170.4
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--------hhhHHHHHHHHHHHhhcC---CCceeeEEeEEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--------ESNIEQFINEVAILSQIN---HRNVVKLLGCCL 456 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 456 (700)
..+|..++.+|+|+||.|+.+.++ +...|+||.++... ....-.+-.|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 456888999999999999999987 46678999765421 111223556999999997 999999999999
Q ss_pred eCCcceEEEeeCC-CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEee
Q 005355 457 ETEVPLLVYEFIP-NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535 (700)
Q Consensus 457 ~~~~~~lv~E~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~D 535 (700)
+++..+|++|-.. +-+|.++|..+.+ +++.++..|++|++.|+++||+++ |||||||-+|++++.+|-+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 9999999999875 4589999988765 999999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccccCCceeeeeeecccccccccccccCCCC-cccceehHHHHHHHHHhCCCCCC
Q 005355 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKPIR 594 (700)
Q Consensus 536 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlG~il~elltg~~p~~ 594 (700)
||.+... .+.......||..|.|||++.+..|- ..-|||++|++||.++....||.
T Consensus 714 fgsaa~~---ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYT---KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhh---cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998755 34456677899999999999998874 56799999999999999999885
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=235.92 Aligned_cols=261 Identities=24% Similarity=0.339 Sum_probs=195.2
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC------C
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLET------E 459 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 459 (700)
..+|.-++.+|.|.- .|..+.+. .+++||+|+... .+....++..+|+.++..++|+|+++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777788899888 66666544 588999998654 3344467788999999999999999999998644 3
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
..++|||+| ..+|...+.-. ++-+.+..+..|++.|++|||+.+ |+||||||+||++..+..+||.|||++
T Consensus 95 e~y~v~e~m-~~nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILME-----LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 558999999 66899988722 778889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHH--------HHHHHH
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLV--------GYFLEA 611 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~--------~~~~~~ 611 (700)
+....+ ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|..-|.+.+.-..-... ..+...
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 854332 3456677888999999999999999999999999999999999998865522110000 000000
Q ss_pred HH-----------hc---chhhhcchhh-hh--ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 612 MK-----------EN---RLFEVLDARV-LK--EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 612 ~~-----------~~---~~~~~~d~~~-~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
+. +. .+.+.+...+ +. +.+.-......+++.+||..+|++|-+++++|..
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 00 0000000000 00 1111233457889999999999999999999873
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=249.68 Aligned_cols=268 Identities=20% Similarity=0.234 Sum_probs=208.6
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC------CCceeeEEeEEEe
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQIN------HRNVVKLLGCCLE 457 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~ 457 (700)
-+..-.+|.+.-..|+|-|++|.+|.+. -|..||||++...... .+.=+.|++||++|+ ..|.++++..|..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 3555678888889999999999999976 4789999999865433 355678999999995 3589999999999
Q ss_pred CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEeec
Q 005355 458 TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDF 536 (700)
Q Consensus 458 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~-~~~kl~Df 536 (700)
.++++||+|-+ ..+|.++|++...+..|....+..++.|+.-||..|...+ |+|.||||+|||+++. ..+||+||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence 99999999988 6799999999887777899999999999999999999999 9999999999999875 57899999
Q ss_pred CCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH-----HH
Q 005355 537 GASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL-----EA 611 (700)
Q Consensus 537 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-----~~ 611 (700)
|.|.....++ .+....+-.|.|||++.+..|+...|+||+||+||||.||+..|.+........+..... .+
T Consensus 582 GSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 582 GSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred cccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 9986543222 222334557999999999999999999999999999999999998776543222221111 11
Q ss_pred HHhcch---------------------------hhhcch------hh-----hhccCHHHHHHHHHHHHHHhccCCCCCC
Q 005355 612 MKENRL---------------------------FEVLDA------RV-----LKEAKEEEIITVAMLAKRCLNMIGKKRP 653 (700)
Q Consensus 612 ~~~~~~---------------------------~~~~d~------~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RP 653 (700)
+..+.+ ...+.+ .+ ..+........+.+|+.+||..||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 111100 001111 11 1112244566799999999999999999
Q ss_pred CHHHHHH
Q 005355 654 TMKEAAF 660 (700)
Q Consensus 654 s~~evl~ 660 (700)
|..++|.
T Consensus 739 t~nqAL~ 745 (752)
T KOG0670|consen 739 TVNQALK 745 (752)
T ss_pred CHHHHhc
Confidence 9999876
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=229.68 Aligned_cols=199 Identities=35% Similarity=0.550 Sum_probs=174.7
Q ss_pred CCccceEeeeCCeEEEEEEEcC-CcEEEEEEccccChh-hHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCC
Q 005355 392 FNTNRILGQGGQGTVYKGMLTN-GRIVAIKKSKLVDES-NIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIP 469 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~ 469 (700)
|++.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++.+......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999874 889999998865554 67889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee
Q 005355 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549 (700)
Q Consensus 470 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~ 549 (700)
+++|.+++...... +++..+..++.+++.++.+||+.+ ++|+||++.||+++.++.++|+|||.+..........
T Consensus 81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 99999999865432 789999999999999999999998 9999999999999999999999999998765432112
Q ss_pred eeeeeccccccccccc-ccCCCCcccceehHHHHHHHHHhCCCCCCC
Q 005355 550 TTRVQGTFGYLDPEYF-RSSQFTEKSDVYSFGVVLVELLTGQKPIRS 595 (700)
Q Consensus 550 ~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlG~il~elltg~~p~~~ 595 (700)
.....++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2344578899999998 667788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-28 Score=256.32 Aligned_cols=255 Identities=27% Similarity=0.374 Sum_probs=208.0
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
...++|.++..+|.|+||.|||+++. .++..|||.++........-+.+|+-+++..+|+||+.++|.+...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 34678999999999999999999965 68999999999888888888899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+.+|+|.+.-+... ++++.++....++.++||+|||+.+ -+|||||-.|||+++.+.+|++|||.+..+...
T Consensus 92 EycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 9999999999887654 4999999999999999999999999 789999999999999999999999998765322
Q ss_pred Cceeeeeeeccccccccccc---ccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 546 QTHLTTRVQGTFGYLDPEYF---RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~---~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
-.......||+.|||||+. +...|..+.|||++|+...|+---++|....-+.. ++.++..- ..+
T Consensus 166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~LmTkS----~~q 233 (829)
T KOG0576|consen 166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLMTKS----GFQ 233 (829)
T ss_pred -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------HHHHhhcc----CCC
Confidence 2234456799999999985 45678999999999999999988887754332211 11122111 111
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+.-+++ ...-.+.+.++++.+|..+|++||+++.+++
T Consensus 234 pp~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PPTLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCcccC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111111 2334556888999999999999999987765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=226.01 Aligned_cols=256 Identities=22% Similarity=0.293 Sum_probs=190.9
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeE-EEeCCcceEE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGC-CLETEVPLLV 464 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv 464 (700)
..+.|.+.+.||+|.||.+-++.++ ....+++|.+.. ......+|.+|..---.| .|.||+.-++. |...+..+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3578999999999999999999987 466788887654 234457899998776556 59999988875 5667788899
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC--CCCcEEEeecCCCccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD--DKYRAKVSDFGASRSV 542 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~--~~~~~kl~DfGl~~~~ 542 (700)
+||.+.|+|.+-+.... +-+..-.+++.|++.||.|||+.+ +||||||.+||||- +..++||+|||+.+..
T Consensus 101 qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999999887644 788888999999999999999999 99999999999993 3458999999998754
Q ss_pred ccCCceeeeeeecccccccccccccC-----CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSS-----QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
.. ......-+..|.+||..... ...+.+|||.||++++.+++|..||+. ....+...++|.. +..+..
T Consensus 174 g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~--w~~rk~ 246 (378)
T KOG1345|consen 174 GT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQ--WLKRKN 246 (378)
T ss_pred Cc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHH--HhcccC
Confidence 21 12223356689999987543 345679999999999999999999983 3333344444332 221111
Q ss_pred hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 618 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
+.++..+ ....+.+..+.++-|..++++|=-..++.++-..
T Consensus 247 -----~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 247 -----PALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred -----ccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 1221221 2344567788899999999999666666555433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=231.88 Aligned_cols=265 Identities=24% Similarity=0.357 Sum_probs=197.4
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEc----CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCC
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLT----NGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETE 459 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 459 (700)
+....+.|...++||+|.|++||++++. ..+.||+|.+..... ...+.+|+++|..+ .+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4455678899999999999999999954 367899998776433 35689999999998 5999999999999999
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEeecCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGA 538 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~-~~~~kl~DfGl 538 (700)
...+|+||++.....++... ++...+..+++.++.||+++|++| ||||||||.|+|.+. .+.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999998865 678899999999999999999999 999999999999975 46789999999
Q ss_pred Cccccc----------------C-----------------C----------ceeeeeeeccccccccccccc-CCCCccc
Q 005355 539 SRSVMI----------------D-----------------Q----------THLTTRVQGTFGYLDPEYFRS-SQFTEKS 574 (700)
Q Consensus 539 ~~~~~~----------------~-----------------~----------~~~~~~~~gt~~y~aPE~~~~-~~~s~ks 574 (700)
+..... . . ........||++|.|||++.. ...+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 872100 0 0 000112459999999999865 5688999
Q ss_pred ceehHHHHHHHHHhCCCCCCCCCchhhh--hHHHHHH------HHHHhcc--hh---------------hhcc-hhhhh-
Q 005355 575 DVYSFGVVLVELLTGQKPIRSTDSEEDK--SLVGYFL------EAMKENR--LF---------------EVLD-ARVLK- 627 (700)
Q Consensus 575 DVwSlG~il~elltg~~p~~~~~~~~~~--~~~~~~~------~~~~~~~--~~---------------~~~d-~~~~~- 627 (700)
||||.|||++.++++..||-....+-+. .++..+. -+.-.++ +. +-++ ..+.+
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 9999999999999999999644432111 0000000 0000111 00 0010 00000
Q ss_pred --------ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 628 --------EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 628 --------~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
......+..+.+|+.+||..||.+|.|++|.|+
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 001112236889999999999999999999987
|
|
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=195.01 Aligned_cols=101 Identities=37% Similarity=0.729 Sum_probs=85.6
Q ss_pred CCCcccCcCCeeccCCCCCCCCCCCCCCCeeeeCCCCCCCcceeccccceEEEeeccCCCceEEEeeeeeecccCCCCC-
Q 005355 13 EDLCQYSCGNVTINYPFGIGDGCYFDKRYEVICDDSSGSPKAFLAGVNNLELLNSDRYDGNLLRVNIPVISLKTTGHPN- 91 (700)
Q Consensus 13 ~~~C~~~CG~v~ipyPFg~~~~C~~~~~f~l~C~~~~~~p~~~l~~~~~~~v~~i~~~~~~~~~~~~~~~~~~~~~~~~- 91 (700)
+++||++||||+||||||||++|++.++|+|+|++++++|+|++.+. +++|++|++++ ++++|..|+++.+......
T Consensus 1 ~~~C~~~CGnv~IpYPFgi~~~C~~~~~F~L~C~~~~~~~~l~l~~~-~~~V~~I~~~~-~~i~v~~~~~~~~~~~~~~~ 78 (106)
T PF13947_consen 1 KPGCPSSCGNVSIPYPFGIGPGCGRDPGFELTCNNNTSPPKLLLSSG-NYEVLSISYEN-GTIRVSDPISSNCYSSSSSN 78 (106)
T ss_pred CCCCCCccCCEeecCCCccCCCCCCCCCcEEECCCCCCCceeEecCC-cEEEEEEecCC-CEEEEEeccccceecCCCCc
Confidence 47899999999999999999999995599999999888899999666 89999999999 9999999987764443221
Q ss_pred ----CcccCCCCeeeccCCceEEEeeccc
Q 005355 92 ----GVNLSGIPLTFSRWHNRFAAIGCRN 116 (700)
Q Consensus 92 ----~~~~~~~pf~~s~~~n~~~~~gC~~ 116 (700)
.+++.. ||.+|+++|+|+++||++
T Consensus 79 ~~~~~~~~~~-~~~~s~~~N~~~~~GC~t 106 (106)
T PF13947_consen 79 SSNSNLSLNG-PFFFSSSSNKFTVVGCNT 106 (106)
T ss_pred ccccEEeecC-CceEccCCcEEEEECCCC
Confidence 233444 899999999999999985
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=265.40 Aligned_cols=195 Identities=19% Similarity=0.213 Sum_probs=139.1
Q ss_pred hcCC-CceeeEEeEE-------EeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 005355 442 QINH-RNVVKLLGCC-------LETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPI 513 (700)
Q Consensus 442 ~l~h-~niv~l~~~~-------~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i 513 (700)
.++| +||+++++.+ .+.+..++++|++ +++|.++|.... ..+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4555 5788888876 3334567888987 669999997543 34899999999999999999999999 9
Q ss_pred eecCCCCCcEEECCC-------------------CcEEEeecCCCcccccCCc---------------eeeeeeeccccc
Q 005355 514 YHRDIKSANILLDDK-------------------YRAKVSDFGASRSVMIDQT---------------HLTTRVQGTFGY 559 (700)
Q Consensus 514 vH~Dik~~NILl~~~-------------------~~~kl~DfGl~~~~~~~~~---------------~~~~~~~gt~~y 559 (700)
+||||||+||||+.. +.+|++|||+++....... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 4556666666653210000 001113478889
Q ss_pred ccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHH
Q 005355 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAM 639 (700)
Q Consensus 560 ~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 639 (700)
||||++.+..++.++|||||||+||||++|..|+..... .. ..+.. ..+.+.. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~----~~~~~----~~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TM----SSLRH----RVLPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HH----HHHHH----hhcChhh-----hhcCHHHHH
Confidence 999999999999999999999999999998887642110 00 00110 0111111 112334567
Q ss_pred HHHHHhccCCCCCCCHHHHHH
Q 005355 640 LAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 640 li~~cl~~~p~~RPs~~evl~ 660 (700)
++.+||+.+|.+||++.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 889999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=206.71 Aligned_cols=170 Identities=22% Similarity=0.263 Sum_probs=128.0
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceee
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~ 550 (700)
|+|.++++.... .+++..++.++.|++.||+|||+++ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 689999986432 4999999999999999999999876 999999999999999 99987543221
Q ss_pred eeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccC
Q 005355 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAK 630 (700)
Q Consensus 551 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 630 (700)
..|++.|||||++.+..++.++||||||+++|||++|+.||....... .........+..... .+. ...
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~---~~~----~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADDP---RDR----SNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCCc---ccc----ccH
Confidence 258899999999999999999999999999999999999996443211 111111111111000 000 001
Q ss_pred HHHH--HHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 631 EEEI--ITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 631 ~~~~--~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
.... ..+.+++.+||+.+|++||++.|+++.+..+...
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 1222 2689999999999999999999999998776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-23 Score=218.09 Aligned_cols=262 Identities=22% Similarity=0.240 Sum_probs=199.8
Q ss_pred CCCccceEeeeCCeEEEEEEEcCC--cEEEEEEccccChhhHHHHHHHHHHHhhcCC----CceeeEEeEE-EeCCcceE
Q 005355 391 NFNTNRILGQGGQGTVYKGMLTNG--RIVAIKKSKLVDESNIEQFINEVAILSQINH----RNVVKLLGCC-LETEVPLL 463 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 463 (700)
+|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999997643 4789998765433333368889999988863 6899999988 47778899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-----CcEEEeecCC
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK-----YRAKVSDFGA 538 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~-----~~~kl~DfGl 538 (700)
||+.+ +.+|.++..... ...++....+.++.|++.+|.+||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 889999887665 345999999999999999999999999 9999999999999754 4699999999
Q ss_pred Cc--ccccCCce----e---eeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 005355 539 SR--SVMIDQTH----L---TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL 609 (700)
Q Consensus 539 ~~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 609 (700)
++ ........ . .....||..|.+++...+...+.+.|+||++.++.||+.|..||........... +.
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~---~~ 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK---FE 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH---HH
Confidence 99 33222211 1 2235599999999999999999999999999999999999999976553322111 11
Q ss_pred HHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 610 EAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 610 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
...... .... .....+..+.++...+-..+..++|....+...|+......
T Consensus 251 ~~~~~~----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 KDPRKL----LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHhhhh----cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 111111 1110 11122344555666666689999999999999987776554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=197.31 Aligned_cols=267 Identities=19% Similarity=0.232 Sum_probs=209.7
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEE-EcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCC-CceeeEEeEEEeCCcceE
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINH-RNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l 463 (700)
.+..+.|+++++||.|+||.+|.|. ..+|+.||||..+.. ....++..|..+.+.|++ ..|..+..+..+.+.-.+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 3456889999999999999999999 458999999986642 223567889999999975 678888888889999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC---CCCcEEEeecCCCc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGASR 540 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~---~~~~~kl~DfGl~~ 540 (700)
|||.+ +.+|.++..-..++ ++.+.++.++-|++.-++|+|.++ ++||||||+|+|.. ....+.++|||+++
T Consensus 89 VMdLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eeecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchh
Confidence 99999 88999998766544 888999999999999999999999 99999999999995 44579999999999
Q ss_pred ccccCCce------eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh
Q 005355 541 SVMIDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE 614 (700)
Q Consensus 541 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 614 (700)
........ ......||.+|.+-....+...+.+.|+-|+|.+|..+.-|..||++..........+.+.+....
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS 242 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence 77543222 234466999999998888888999999999999999999999999987765544333322221111
Q ss_pred cchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 615 NRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 615 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
. ..+......+.++...+.-|-...-++-|...-+.+.++-|...+
T Consensus 243 -----~----~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 243 -----T----PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred -----C----CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 0 111122334556777888888889999999888888776665443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=199.92 Aligned_cols=266 Identities=17% Similarity=0.218 Sum_probs=209.0
Q ss_pred HHhcCCCccceEeeeCCeEEEEEE-EcCCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcceEE
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 464 (700)
+..-.|++.++||+|.||.++.|+ +-+++.||||......+ ..+++.|.+.++.|. .+.|..++-+-.+..+-.||
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 346689999999999999999999 44799999998665333 356888999999984 79999999988899899999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-----CCcEEEeecCCC
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD-----KYRAKVSDFGAS 539 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~-----~~~~kl~DfGl~ 539 (700)
+|++ +.||+|+..-..+. ++.+.+..+|.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||++
T Consensus 103 idLL-GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhh-CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 9999 88999988655443 899999999999999999999999 999999999999953 346899999999
Q ss_pred cccccCCce------eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHH
Q 005355 540 RSVMIDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK 613 (700)
Q Consensus 540 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 613 (700)
+........ ......||.+||+-....+.+.+.+.|+-|||-+++..|-|..||.+...+..+...+.+.+...
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr 256 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR 256 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence 987544332 23456799999999999999999999999999999999999999998877665443332222111
Q ss_pred hcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 614 ENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 614 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
.-.+ .+.....+.+++.-+.-.-..+-.+-|..+-+...+..+...+
T Consensus 257 ~T~i---------~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 257 STPI---------EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred cCCH---------HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 1111 1122234445555555555678889999988888777766544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.6e-23 Score=215.25 Aligned_cols=168 Identities=20% Similarity=0.153 Sum_probs=131.6
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEc--CCcEEEEEEcccc-----ChhhHHHHHHHHHHHhhcCCCceee-EEeEE
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLT--NGRIVAIKKSKLV-----DESNIEQFINEVAILSQINHRNVVK-LLGCC 455 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~ 455 (700)
......++|++.+.||+|+||+||+|.++ +++.||||+.... .....+.|.+|+++|++++|+|++. +++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 34455788999999999999999999875 5777899986432 2234567999999999999999985 443
Q ss_pred EeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCcEEECCCCcEEEe
Q 005355 456 LETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDI-KSANILLDDKYRAKVS 534 (700)
Q Consensus 456 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Di-k~~NILl~~~~~~kl~ 534 (700)
.+..+|||||+++++|.. +.. .. ...++.|+++||.|||+++ |+|||| ||+|||++.++.+||+
T Consensus 90 --~~~~~LVmE~~~G~~L~~-~~~------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHL-ARP------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred --cCCcEEEEEccCCCCHHH-hCc------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEE
Confidence 246799999999999963 211 11 1467889999999999999 999999 9999999999999999
Q ss_pred ecCCCcccccCCce-------eeeeeecccccccccccccC
Q 005355 535 DFGASRSVMIDQTH-------LTTRVQGTFGYLDPEYFRSS 568 (700)
Q Consensus 535 DfGl~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~ 568 (700)
|||+++.+...... ......+++.|+|||++...
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999876432211 11345688899999998654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-24 Score=202.59 Aligned_cols=252 Identities=19% Similarity=0.329 Sum_probs=194.8
Q ss_pred CCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 391 NFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
...+..+|.+...|..|+|+|+ |..+++|++...+ .....+|.+|.-.|+.+.||||+.+++.|.....+.++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 3444567889999999999998 4555667665432 233467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
+.|+|+.+|+.... ..++..++.+++.++++|++|||+...+ |.---|.++.++||++.+++|+--. .+ + +.
T Consensus 270 p~gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad-~k-f----sf 341 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMAD-TK-F----SF 341 (448)
T ss_pred cchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheeccc-ce-e----ee
Confidence 99999999998643 3467889999999999999999998742 4444689999999999998875211 11 0 01
Q ss_pred eeeeeecccccccccccccCCC---CcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 549 LTTRVQGTFGYLDPEYFRSSQF---TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~~~---s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
........+.||+||.++..+- -.++|+|||.++||||.|...||....+.|..- .+.-..+
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm---------------kialegl 406 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM---------------KIALEGL 406 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh---------------hhhhccc
Confidence 1111234678999999987653 357999999999999999999998776554321 1122233
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
.-..++.....+..|+.-|++.||.+||.+..++-.|++++
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 34456667788999999999999999999999999998864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-20 Score=196.47 Aligned_cols=261 Identities=31% Similarity=0.401 Sum_probs=198.9
Q ss_pred CCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChh---hHHHHHHHHHHHhhcCCC-ceeeEEeEEEeCCcceEEEee
Q 005355 392 FNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDES---NIEQFINEVAILSQINHR-NVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~E~ 467 (700)
|.+.+.||.|+|+.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999987 78899987653322 467899999999999988 799999999777778999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEeecCCCcccccCC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~-~~kl~DfGl~~~~~~~~ 546 (700)
+.+++|.+++........++......++.|++.++.|+|+.+ ++|||+||+||+++... .+++.|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977765432124889999999999999999999999 99999999999999988 79999999998554333
Q ss_pred ce-----eeeeeeccccccccccccc---CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 547 TH-----LTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 547 ~~-----~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
.. ......++..|+|||.+.. .......|+|++|++++++++|..||...... .........+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 22 2456679999999999988 57889999999999999999999997655431 0001111111111100
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.................+.+++.+++..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223467889999999999999999887764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-22 Score=221.92 Aligned_cols=251 Identities=19% Similarity=0.259 Sum_probs=184.7
Q ss_pred CCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccC-hhhHHHHHHHHHH--HhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 391 NFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVD-ESNIEQFINEVAI--LSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
++...+.||.+.|=+|.+|++++|. |+||++-..+ .-....|.++++- ...++|||.+.+.-+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6778899999999999999998887 8889865433 3344445444443 4556899999998887777788899999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc--cC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM--ID 545 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~--~~ 545 (700)
+. -+|+|.|....- +..-+...|+.||+.||..+|..+ |.|||||.+||||+.-.-+.|+||.--+... .+
T Consensus 103 vk-hnLyDRlSTRPF---L~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VK-HNLYDRLSTRPF---LVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hh-hhhhhhhccchH---HHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 84 489998876543 778889999999999999999999 9999999999999999899999998665432 22
Q ss_pred Cc----eeeeeeecccccccccccccC----------C-CCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHH
Q 005355 546 QT----HLTTRVQGTFGYLDPEYFRSS----------Q-FTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFL 609 (700)
Q Consensus 546 ~~----~~~~~~~gt~~y~aPE~~~~~----------~-~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 609 (700)
+. ..+.+.....+|+|||.+... . .+++.||||+||++.||++ |++||.-. ++..
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~a--- 246 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLA--- 246 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHh---
Confidence 22 223333455689999987441 2 5778999999999999998 68888522 1111
Q ss_pred HHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 610 EAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 610 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
.+.+. .......++..+ ...++.|+..|++.||.+|.+++++|+.-+++
T Consensus 247 --Yr~~~--~~~~e~~Le~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 247 --YRSGN--ADDPEQLLEKIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred --HhccC--ccCHHHHHHhCc---CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 11111 001111111111 12577899999999999999999999985443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-22 Score=222.08 Aligned_cols=253 Identities=21% Similarity=0.283 Sum_probs=189.9
Q ss_pred CccceEeeeCCeEEEEEEEc-CCcEEEEEEcc-----ccChhh-HHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 393 NTNRILGQGGQGTVYKGMLT-NGRIVAIKKSK-----LVDESN-IEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 393 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~-----~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
...+++|.|.+|.|+..... ..+..+.|... ...... ...+..|+.+-..+.|+|++..+....+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999977777643 33444444322 111111 222667888888899999988888777776666669
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++ +|..++.... .+....+..++.|++.|++|||+.| |.|||+|++|++++.++.+||+|||.+..+..+
T Consensus 401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9999998752 2888899999999999999999999 999999999999999999999999999877544
Q ss_pred Cc---eeeeeeecccccccccccccCCCCc-ccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 546 QT---HLTTRVQGTFGYLDPEYFRSSQFTE-KSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 546 ~~---~~~~~~~gt~~y~aPE~~~~~~~s~-ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
.. .......|+..|+|||++.+..|.. ..||||.|+++..|++|+.||......+... . .+.......+.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~-~~~~~~~~~~~ 547 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----K-TNNYSDQRNIF 547 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----h-hhccccccccc
Confidence 33 4556678999999999999999876 6899999999999999999998665443321 0 01110000000
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. -........+.+...++.+||+.+|.+|.|+++|++
T Consensus 548 ~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 E--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred c--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0 011122344556788999999999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=184.70 Aligned_cols=173 Identities=12% Similarity=0.143 Sum_probs=135.6
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhh---HHH------HHHHHHHHhhcCCCceeeEEeEEE
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESN---IEQ------FINEVAILSQINHRNVVKLLGCCL 456 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~------~~~E~~~l~~l~h~niv~l~~~~~ 456 (700)
....++|+..++||.|+||.||+... ++..+|||.+....... ... +.+|+..+.+++|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 56689999999999999999999766 57789999986433222 222 578999999999999999998866
Q ss_pred eC--------CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC
Q 005355 457 ET--------EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK 528 (700)
Q Consensus 457 ~~--------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~ 528 (700)
.. ...+|+|||++|.+|.++.. ++. ....+++.+|..||+.+ ++|||++|.||+++++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 43 34689999999999988742 332 24569999999999999 9999999999999998
Q ss_pred CcEEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHH
Q 005355 529 YRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELL 587 (700)
Q Consensus 529 ~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ell 587 (700)
+ ++|+|||.......+... ..++....+..++|+|+||+++..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 8 999999988654221111 01344456678999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.9e-20 Score=177.43 Aligned_cols=139 Identities=19% Similarity=0.175 Sum_probs=107.7
Q ss_pred cceEeeeCCeEEEEEEEcCCcEEEEEEccccChh--h------------------------HHHHHHHHHHHhhcCCCce
Q 005355 395 NRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDES--N------------------------IEQFINEVAILSQINHRNV 448 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni 448 (700)
...||+|+||.||+|...+|+.||||+++..... . ......|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999987653211 0 1122359999999987776
Q ss_pred eeEEeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCCCCCcEEECC
Q 005355 449 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL-HSAASIPIYHRDIKSANILLDD 527 (700)
Q Consensus 449 v~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~ivH~Dik~~NILl~~ 527 (700)
....... ....+|||||+++++|...+... ..+++..+..++.|++.+|.+| |+.+ |+||||||+|||+++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~ 153 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD 153 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC
Confidence 4333222 22348999999988776553322 2488999999999999999999 6888 999999999999984
Q ss_pred CCcEEEeecCCCccc
Q 005355 528 KYRAKVSDFGASRSV 542 (700)
Q Consensus 528 ~~~~kl~DfGl~~~~ 542 (700)
+.++|+|||++...
T Consensus 154 -~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 -GKLYIIDVSQSVEH 167 (190)
T ss_pred -CcEEEEEccccccC
Confidence 78999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=9e-20 Score=183.85 Aligned_cols=233 Identities=21% Similarity=0.294 Sum_probs=151.5
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCC----------CceeeEEeEEE
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINH----------RNVVKLLGCCL 456 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~ 456 (700)
.+...+.||.|+++.||.+++. .++.+|||+..... ....+++++|......+.+ -.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455678999999999999987 58999999755422 2346777777765555322 12222222221
Q ss_pred ---------eC---C-----cceEEEeeCCCCCHHHHHhc---cCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 005355 457 ---------ET---E-----VPLLVYEFIPNGTLYQYIHD---QTE-EFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515 (700)
Q Consensus 457 ---------~~---~-----~~~lv~E~~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH 515 (700)
.. . ..+++|+-+ .++|.+++.. ... ...+....++.+..|+++.+++||+.| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11 1 225677777 6788888643 221 123455667778899999999999999 999
Q ss_pred cCCCCCcEEECCCCcEEEeecCCCcccccCCceeeeeeeccccccccccccc--------CCCCcccceehHHHHHHHHH
Q 005355 516 RDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS--------SQFTEKSDVYSFGVVLVELL 587 (700)
Q Consensus 516 ~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwSlG~il~ell 587 (700)
+||+|+|++++.+|.++|+||+....... . ......+..|.+||.... -.++.+.|.|+||+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~--~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT--R--YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE--E--EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc--e--eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999987654321 1 111335578999997643 25788999999999999999
Q ss_pred hCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCC
Q 005355 588 TGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKR 652 (700)
Q Consensus 588 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 652 (700)
++..||........... ...... +.++.+.+||..+|+.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999986644332111 223444 778889999999999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=193.36 Aligned_cols=219 Identities=25% Similarity=0.448 Sum_probs=167.5
Q ss_pred HhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-eecCC
Q 005355 440 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPI-YHRDI 518 (700)
Q Consensus 440 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i-vH~Di 518 (700)
|+.+.|.|+.+++|.+.+....+.|.+|+..|+|.|.+..... .+++.....+.++|++||+|||+.. | +|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~--~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI--KLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc--CccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 3578999999999999999999999999999999999988433 4899999999999999999999876 5 99999
Q ss_pred CCCcEEECCCCcEEEeecCCCccccc-CCceeeeeeecccccccccccccC-------CCCcccceehHHHHHHHHHhCC
Q 005355 519 KSANILLDDKYRAKVSDFGASRSVMI-DQTHLTTRVQGTFGYLDPEYFRSS-------QFTEKSDVYSFGVVLVELLTGQ 590 (700)
Q Consensus 519 k~~NILl~~~~~~kl~DfGl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDVwSlG~il~elltg~ 590 (700)
++.|.++|..+.+||+|||+...... .............-|.|||.+... ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999876532 111111222245679999998763 2467899999999999999999
Q ss_pred CCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 591 KPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 591 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
.||......+.. .+.+.. ++. .......+.+... .+..+.+..++.+||..+|.+||+++.+...++.+....
T Consensus 156 ~~~~~~~~~~~~--~eii~~-~~~-~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 156 GPFDLRNLVEDP--DEIILR-VKK-GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred CccccccccCCh--HHHHHH-HHh-cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 999875544432 111111 222 1111222222211 144447899999999999999999999999998876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.6e-19 Score=171.18 Aligned_cols=139 Identities=22% Similarity=0.210 Sum_probs=110.6
Q ss_pred cceEeeeCCeEEEEEEEcCCcEEEEEEccccChh--------------------------hHHHHHHHHHHHhhcCCCce
Q 005355 395 NRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDES--------------------------NIEQFINEVAILSQINHRNV 448 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni 448 (700)
.+.||+|+||.||+|...+|+.||||++...... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5789999999999999878999999987653211 01234578999999999987
Q ss_pred eeEEeEEEeCCcceEEEeeCCCCCHHHH-HhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEC
Q 005355 449 VKLLGCCLETEVPLLVYEFIPNGTLYQY-IHDQTEEFPITWEIRLRIAIEVSDALCYLHS-AASIPIYHRDIKSANILLD 526 (700)
Q Consensus 449 v~l~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dik~~NILl~ 526 (700)
.....+... ..+|||||++++++... +... .++......++.|++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~----~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV----PLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhc----cCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence 554443332 34899999998865443 3322 37888999999999999999999 89 99999999999999
Q ss_pred CCCcEEEeecCCCcccc
Q 005355 527 DKYRAKVSDFGASRSVM 543 (700)
Q Consensus 527 ~~~~~kl~DfGl~~~~~ 543 (700)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 7899999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-19 Score=203.07 Aligned_cols=202 Identities=22% Similarity=0.318 Sum_probs=165.5
Q ss_pred chHHHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcC---CCceeeEEeEEEe
Q 005355 381 TSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQIN---HRNVVKLLGCCLE 457 (700)
Q Consensus 381 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 457 (700)
...+.+.....|.+.+.||+|+||+||+|...+++.||+|..+...... |.--.+++.+|+ -+.|..+..+..-
T Consensus 689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 3445666778899999999999999999998889999999987655443 222233344443 3445555566667
Q ss_pred CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-------CCCc
Q 005355 458 TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD-------DKYR 530 (700)
Q Consensus 458 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~-------~~~~ 530 (700)
.+..+||+||.+.|+|.+++...+ .++|...+.++.|++..+.+||..+ |||+||||+|+||. ++.-
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred CCcceeeeeccccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccc
Confidence 788899999999999999998443 3999999999999999999999999 99999999999993 3456
Q ss_pred EEEeecCCCcccccC-CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCC
Q 005355 531 AKVSDFGASRSVMID-QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQK 591 (700)
Q Consensus 531 ~kl~DfGl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~ 591 (700)
++|+|||.+..+..- ........++|-.+-.+|+..+..|+..+|.|.|+.+++-||.|+.
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999999999876532 3345667789999999999999999999999999999999999964
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.8e-20 Score=195.63 Aligned_cols=225 Identities=26% Similarity=0.306 Sum_probs=179.5
Q ss_pred eEeeeCCeEEEEEE----EcCCcEEEEEEccccChhh--HHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcceEEEeeCC
Q 005355 397 ILGQGGQGTVYKGM----LTNGRIVAIKKSKLVDESN--IEQFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYEFIP 469 (700)
Q Consensus 397 ~lG~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~ 469 (700)
.+|+|.||.|++.. .+.+..+|+|.++...... ......|..++...+ ||.++++...+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999765 3346778888765422211 124566888888886 9999999999999999999999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee
Q 005355 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549 (700)
Q Consensus 470 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~ 549 (700)
+|.|...+..... .++.....+...++-|++++|+.+ |+|||+|++||+++.+|.+++.|||+++........
T Consensus 81 gg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 9999988876653 677777788889999999999999 999999999999999999999999999865433222
Q ss_pred eeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhcc
Q 005355 550 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEA 629 (700)
Q Consensus 550 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 629 (700)
+||..|||||++. .....+|.||||++++||++|..||.. +. . ..++... -..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~----~------------~~Il~~~--~~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DT----M------------KRILKAE--LEM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HH----H------------HHHhhhc--cCC
Confidence 7999999999998 677899999999999999999999975 11 0 0111111 123
Q ss_pred CHHHHHHHHHHHHHHhccCCCCCCCH
Q 005355 630 KEEEIITVAMLAKRCLNMIGKKRPTM 655 (700)
Q Consensus 630 ~~~~~~~l~~li~~cl~~~p~~RPs~ 655 (700)
+.+......+++.+++..+|..|.-.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 45666778889999999999999765
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-18 Score=164.98 Aligned_cols=187 Identities=16% Similarity=0.070 Sum_probs=139.1
Q ss_pred CccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhh----HHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcceEEEee
Q 005355 393 NTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESN----IEQFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 393 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.+...|++|+||+||.+.. .+.+++.+.+....... ...+.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3557899999999997766 57788877766544321 235789999999995 5889999886 446999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDI-KSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Di-k~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
+.+.+|.+.+.. . ...++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR---------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh---------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999888654321 1 1357789999999999999 999999 7999999999999999999998543222
Q ss_pred ce----e--------eeeeecccccccccccccC-CCC-cccceehHHHHHHHHHhCCCCCCCCC
Q 005355 547 TH----L--------TTRVQGTFGYLDPEYFRSS-QFT-EKSDVYSFGVVLVELLTGQKPIRSTD 597 (700)
Q Consensus 547 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~s-~ksDVwSlG~il~elltg~~p~~~~~ 597 (700)
.. . ......++.|++|+...-. ..+ ...+.++.|..+|.++|+..+.-...
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 10 0 0012256777777754322 223 56788999999999999988875544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-17 Score=163.75 Aligned_cols=137 Identities=16% Similarity=0.183 Sum_probs=107.5
Q ss_pred CCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhc-----CCCceeeEEeEEEeCC---c-ce
Q 005355 392 FNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQI-----NHRNVVKLLGCCLETE---V-PL 462 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~ 462 (700)
+.-.+.||+|+||.||. +......+||+.........+.+.+|+.+++.+ .||||+++++++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34457899999999996 433333479987765455567899999999999 5799999999998874 2 23
Q ss_pred EEEee--CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCcEEECC----CCcEEEee
Q 005355 463 LVYEF--IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDAL-CYLHSAASIPIYHRDIKSANILLDD----KYRAKVSD 535 (700)
Q Consensus 463 lv~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~~~~ivH~Dik~~NILl~~----~~~~kl~D 535 (700)
+|+|| ..+++|.+++.+.. +++. ..++.|++.++ +|||+++ |+||||||+|||++. +.+++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 55799999996632 5555 35678888777 9999999 999999999999974 34899999
Q ss_pred cCCC
Q 005355 536 FGAS 539 (700)
Q Consensus 536 fGl~ 539 (700)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5544
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.6e-19 Score=184.21 Aligned_cols=241 Identities=21% Similarity=0.305 Sum_probs=161.2
Q ss_pred CCccceEeeeCCeEEEEEEEcCC----cEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEe-------EE-----
Q 005355 392 FNTNRILGQGGQGTVYKGMLTNG----RIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLG-------CC----- 455 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-------~~----- 455 (700)
.++.+..+...++.+.......+ +.+..+..+...........+++-.+....|-+..-+.+ ..
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v 325 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV 325 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence 34445566666666665553322 233444444333233333444444444443333332222 11
Q ss_pred EeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEee
Q 005355 456 LETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535 (700)
Q Consensus 456 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~D 535 (700)
.....+++.|+++...+|.++|.+.......++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|
T Consensus 326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhh
Confidence 1133578999999999999999876555558889999999999999999 77 99999999999999999999999
Q ss_pred cCCCcccccCC-----ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHH
Q 005355 536 FGASRSVMIDQ-----THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFL 609 (700)
Q Consensus 536 fGl~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 609 (700)
||+........ ....+...||..||+||.+.+..|+.|+||||||++|+||+. =...+. ...+.
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~ 469 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATL 469 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhh
Confidence 99998765444 224456679999999999999999999999999999999998 222211 11122
Q ss_pred HHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHH
Q 005355 610 EAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657 (700)
Q Consensus 610 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~e 657 (700)
..+..+.+ ++....+.+ .=..|+.+++.+.|.+||++.+
T Consensus 470 ~d~r~g~i----p~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 470 TDIRDGII----PPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hhhhcCCC----ChHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 22222222 222222222 2345899999999999995444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.8e-17 Score=162.59 Aligned_cols=196 Identities=23% Similarity=0.258 Sum_probs=137.8
Q ss_pred CCCceeeEEeEEEe---------------------------CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 444 NHRNVVKLLGCCLE---------------------------TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAI 496 (700)
Q Consensus 444 ~h~niv~l~~~~~~---------------------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 496 (700)
+|||||+++++|.+ ....|+||... .-+|..++-... .+......++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC----CchHHHHHHHH
Confidence 59999999987753 22336788766 458888886554 56677778899
Q ss_pred HHHHHHHHHHhcCCCCeeecCCCCCcEEE--CC--CCcEEEeecCCCccccc-----CCceeeeeeeccccccccccccc
Q 005355 497 EVSDALCYLHSAASIPIYHRDIKSANILL--DD--KYRAKVSDFGASRSVMI-----DQTHLTTRVQGTFGYLDPEYFRS 567 (700)
Q Consensus 497 qi~~aL~~LH~~~~~~ivH~Dik~~NILl--~~--~~~~kl~DfGl~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~ 567 (700)
|+++|+.|||+++ |.|||+|++|||| |+ -..+.|+|||.+-.... +........-|.-.-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 33 34689999997643221 01111112336667899999854
Q ss_pred CC------CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHH
Q 005355 568 SQ------FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLA 641 (700)
Q Consensus 568 ~~------~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li 641 (700)
.+ ...|+|.|+.|.+.||++....||......- .+.. ...+.+ ....+...++.+.+|+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r-----~Yqe~q---------LPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTR-----TYQESQ---------LPALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echh-----hhhhhh---------CCCCcccCChHHHHHH
Confidence 32 2369999999999999999999997522110 0000 011111 1223445666788999
Q ss_pred HHHhccCCCCCCCHHHHHHHH
Q 005355 642 KRCLNMIGKKRPTMKEAAFEL 662 (700)
Q Consensus 642 ~~cl~~~p~~RPs~~evl~~L 662 (700)
...|+.||.+|++..-....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999987666555
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.2e-16 Score=156.44 Aligned_cols=134 Identities=23% Similarity=0.306 Sum_probs=113.7
Q ss_pred ceEeeeCCeEEEEEEEcCCcEEEEEEccccCh--------hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDE--------SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
+.||+|++|.||+|.+ .+..|+||+...... .....+.+|++++..++|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 6799999999999988 577899997543211 1234678899999999999988877777778888999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
+++++|.+++.... + .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 2 78899999999999999999 99999999999999 78999999998863
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=158.08 Aligned_cols=144 Identities=17% Similarity=0.134 Sum_probs=111.5
Q ss_pred hcCCCccceEeeeCCeEEEEEE--EcCCcEEEEEEccccChh------------------------hHHHHHHHHHHHhh
Q 005355 389 TDNFNTNRILGQGGQGTVYKGM--LTNGRIVAIKKSKLVDES------------------------NIEQFINEVAILSQ 442 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~ 442 (700)
..-|++.+.||+|+||.||+|. ..+|+.||||++...... ....+..|++++.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3357888999999999999998 457999999987643210 11235689999999
Q ss_pred cCCC--ceeeEEeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 005355 443 INHR--NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKS 520 (700)
Q Consensus 443 l~h~--niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~ 520 (700)
+.+. .+.++++. ...++||||+++.+|...+.... .+.......++.||+.+|++||+.+. ++||||||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp 177 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSE 177 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCCh
Confidence 9753 34444442 23589999999988876653221 25666778999999999999999873 99999999
Q ss_pred CcEEECCCCcEEEeecCCCccc
Q 005355 521 ANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 521 ~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 789999999988643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-17 Score=184.18 Aligned_cols=209 Identities=26% Similarity=0.355 Sum_probs=147.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
..+|..+++|-.|+||.||..+++ ..+.+|+|+-+.. .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee------------------
Confidence 578999999999999999999987 4667888543321 01110 22222233322
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC-
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ- 546 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~- 546 (700)
|+=...++... +++... +.+++|||+.+ |+|||+||+|.||+.-|.+|++|||+++......
T Consensus 136 ---gDc~tllk~~g---~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG---PLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcccCC---CCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 33333333222 244333 78999999999 9999999999999999999999999988542111
Q ss_pred -------------ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHH
Q 005355 547 -------------THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK 613 (700)
Q Consensus 547 -------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 613 (700)
......++||+.|.|||++..+.|...+|+|++|+|+||.+-|..||.+..+++....+ +.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v------is 272 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV------IS 272 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh------hh
Confidence 11123457999999999999999999999999999999999999999988777632211 11
Q ss_pred hcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCC
Q 005355 614 ENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT 654 (700)
Q Consensus 614 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs 654 (700)
.. ....+.....+.+.++++.++|+.+|..|.-
T Consensus 273 d~--------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 273 DD--------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hh--------ccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 10 0011223445667889999999999999953
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.1e-16 Score=152.12 Aligned_cols=141 Identities=22% Similarity=0.196 Sum_probs=110.6
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccCh----------------------hhHHHHHHHHHHHhhcC
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDE----------------------SNIEQFINEVAILSQIN 444 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~ 444 (700)
.....|.+.+.||+|+||.||++...+++.||||++..... .....+..|+.++..+.
T Consensus 12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 33334778899999999999999988899999997553221 01123677888999887
Q ss_pred CC--ceeeEEeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 005355 445 HR--NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSAN 522 (700)
Q Consensus 445 h~--niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~N 522 (700)
|+ .+...++ ....++||||+++++|.++... .....++.+++.++.++|+.+ ++||||||+|
T Consensus 92 ~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~N 155 (198)
T cd05144 92 EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFN 155 (198)
T ss_pred HcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCccc
Confidence 77 4444443 3455899999999998765421 234678899999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCCCcccc
Q 005355 523 ILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 523 ILl~~~~~~kl~DfGl~~~~~ 543 (700)
|++++++.++|+|||++....
T Consensus 156 ill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEEcCCCcEEEEECCccccCC
Confidence 999999999999999996553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.8e-16 Score=151.86 Aligned_cols=130 Identities=22% Similarity=0.334 Sum_probs=106.8
Q ss_pred eEeeeCCeEEEEEEEcCCcEEEEEEccccC--------hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 397 ILGQGGQGTVYKGMLTNGRIVAIKKSKLVD--------ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 397 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
.||+|+||.||+|.+. +..|++|...... ....+++.+|++++..++|+++.....+....+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999964 7889999754321 112356788999999999887665555566677779999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875431 1 78999999999999999 99999999999999 78999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.1e-16 Score=173.07 Aligned_cols=137 Identities=20% Similarity=0.287 Sum_probs=112.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCCcEEEEEE-cc-ccC------hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKK-SK-LVD------ESNIEQFINEVAILSQINHRNVVKLLGCCLETEV 460 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~-~~-~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 460 (700)
...|...++||+|+||+||+|.+.... +++|+ .. ... ....+.+.+|+++++.++|++++....+......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344567889999999999999986443 34432 21 111 1224568899999999999999988887777778
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.++||||+++++|.+++. ....++.+++++|.+||+.+ ++||||||+|||+ .++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999999885 34678999999999999999 9999999999999 57799999999996
Q ss_pred c
Q 005355 541 S 541 (700)
Q Consensus 541 ~ 541 (700)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 4
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-14 Score=139.96 Aligned_cols=135 Identities=21% Similarity=0.270 Sum_probs=98.0
Q ss_pred cceEeeeCCeEEEEEEEcCCcEEEEEEccccChh--hHHHH----------------------HHHHHHHhhcCCC--ce
Q 005355 395 NRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDES--NIEQF----------------------INEVAILSQINHR--NV 448 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~h~--ni 448 (700)
.+.||+|+||+||+|...+++.||||++...... ....+ ..|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 5689999999999999888999999986643211 11111 3466666666443 24
Q ss_pred eeEEeEEEeCCcceEEEeeCCCCCHHHH-HhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEEC
Q 005355 449 VKLLGCCLETEVPLLVYEFIPNGTLYQY-IHDQTEEFPITWEIRLRIAIEVSDALCYLHS-AASIPIYHRDIKSANILLD 526 (700)
Q Consensus 449 v~l~~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dik~~NILl~ 526 (700)
.+.++. ...++||||++++++... +.... .. .....++.+++.++.++|+ .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence 444443 346899999998543321 11111 11 5678899999999999999 88 99999999999999
Q ss_pred CCCcEEEeecCCCccc
Q 005355 527 DKYRAKVSDFGASRSV 542 (700)
Q Consensus 527 ~~~~~kl~DfGl~~~~ 542 (700)
++.++|+|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 889999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.4e-14 Score=132.08 Aligned_cols=135 Identities=24% Similarity=0.237 Sum_probs=114.1
Q ss_pred ccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCC--CceeeEEeEEEeCCcceEEEeeCCCC
Q 005355 394 TNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINH--RNVVKLLGCCLETEVPLLVYEFIPNG 471 (700)
Q Consensus 394 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~g 471 (700)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++......+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999864 7899998765433 4678999999999976 58999999888888899999999887
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 472 TLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 472 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++..+ +......++.+++++|++||......++|+|++|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77544 4566678899999999999986434499999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.4e-14 Score=141.25 Aligned_cols=135 Identities=19% Similarity=0.293 Sum_probs=105.9
Q ss_pred cceEe-eeCCeEEEEEEEcCCcEEEEEEccccC-------------hhhHHHHHHHHHHHhhcCCCce--eeEEeEEEeC
Q 005355 395 NRILG-QGGQGTVYKGMLTNGRIVAIKKSKLVD-------------ESNIEQFINEVAILSQINHRNV--VKLLGCCLET 458 (700)
Q Consensus 395 ~~~lG-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 458 (700)
...|| .|+.|+||++... +..++||++.... ......+.+|++++.+++|+++ ++.++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 8999999999875 7788998764311 1234567889999999998775 6777764433
Q ss_pred Cc----ceEEEeeCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEE
Q 005355 459 EV----PLLVYEFIPN-GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKV 533 (700)
Q Consensus 459 ~~----~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl 533 (700)
.. .++|+|++++ .+|.+++... .++.. .+.+|+.+|.+||+.| |+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 22 2599999997 6999988653 25544 3568999999999999 999999999999999889999
Q ss_pred eecCCCcc
Q 005355 534 SDFGASRS 541 (700)
Q Consensus 534 ~DfGl~~~ 541 (700)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.6e-16 Score=174.12 Aligned_cols=255 Identities=22% Similarity=0.290 Sum_probs=192.4
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc--CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcce
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT--NGRIVAIKKSKLVD--ESNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 462 (700)
....|.+.+.||+|.|+.|-..... ....+|+|...... ....+....|..+-..+. |+|++.+++...+.+..+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 3456778888999999999887753 24456777655443 333455566888877776 999999999999999999
Q ss_pred EEEeeCCCCCHHHHH-hccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeecCCCCCcEEECCCC-cEEEeecCCC
Q 005355 463 LVYEFIPNGTLYQYI-HDQTEEFPITWEIRLRIAIEVSDALCYLH-SAASIPIYHRDIKSANILLDDKY-RAKVSDFGAS 539 (700)
Q Consensus 463 lv~E~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~~ivH~Dik~~NILl~~~~-~~kl~DfGl~ 539 (700)
++.|+..++++.+.+ +.... ..+......++.|+..++.|+| ..+ +.|+||||+|.+++..+ .++++|||++
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred cccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhh
Confidence 999999999999988 43321 2666777789999999999999 888 99999999999999999 9999999999
Q ss_pred ccccc--CCceeeeeeec-ccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc
Q 005355 540 RSVMI--DQTHLTTRVQG-TFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN 615 (700)
Q Consensus 540 ~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 615 (700)
..+.. ..........| ++.|+|||...+. ......|+||.|+++.-+++|..||......... .. ..+...
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~----~~~~~~ 247 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YS----SWKSNK 247 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ce----eecccc
Confidence 88765 23333445568 9999999999885 4567899999999999999999999765543311 11 111110
Q ss_pred -chhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 616 -RLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 616 -~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
... ............+++.+++..+|..|.+.+++..
T Consensus 248 ~~~~--------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 GRFT--------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccc--------cCccccCChhhhhcccccccCCchhccccccccc
Confidence 000 1111223345667889999999999999888754
|
|
| >PF08488 WAK: Wall-associated kinase; InterPro: IPR013695 This domain is found together with the eukaryotic protein kinase domain IPR000719 from INTERPRO in plant wall-associated kinases (WAKs) and related proteins | Back alignment and domain information |
|---|
Probab=99.44 E-value=2e-13 Score=116.08 Aligned_cols=98 Identities=20% Similarity=0.488 Sum_probs=69.1
Q ss_pred CCCccCcccc--CCCCC-Ccccceeeeeccc-cCCCCCcceEEEEeecceecccccccccccCCCccceEEEEEeccCcc
Q 005355 143 SRGCYDFVCA--LPPNL-TQDFNASMLYHFS-QSIPQKCQSVLMVEENWLQSEFLTNANVLRDHQQFPAVLEFAEDRGNC 218 (700)
Q Consensus 143 ~~~C~g~gCc--~~~~~-~~~~~~~~~~~~~-~~~~~~c~~a~~~e~~~~~~~~~~~~~~~~~~~~~p~vLdWai~~~~C 218 (700)
+++|+|.+|| .||.+ ++.+++++..... .....+|.+|||||+.||.++ .+++......+.+||||||+|...+.
T Consensus 1 n~~CsG~~CCQt~iP~~~~qv~~~~i~~~~~~~~~~~~Ck~AFL~d~~~~~~n-~t~p~~~~~~~y~pv~L~W~i~t~~~ 79 (103)
T PF08488_consen 1 NSSCSGIGCCQTSIPSGLLQVFNVTIESTDGNNQTSNGCKVAFLVDEDWFSSN-ITDPEDFHAMGYVPVVLDWFIDTSDS 79 (103)
T ss_pred CCccCCcceeccCCCCCCceEEEEEeEecCCCcccCCCceEEEEecccccccc-CCChHHhccCCeeEEEEEEEEecCCc
Confidence 3579999999 67764 5778888774333 222379999999999999765 55556666778899999999975443
Q ss_pred ccccccccccccCCcccccCCCceeeecc
Q 005355 219 VEEYNSRTTCNKDNRCSIQLTSGYSCLCH 247 (700)
Q Consensus 219 ~~~~~~~~~C~s~s~c~~~~~~gy~C~C~ 247 (700)
. ....++|..... . ....+|.|+
T Consensus 80 ~--~~~s~~C~~~~~-y---~~~~~C~C~ 102 (103)
T PF08488_consen 80 S--FSNSLACKNNTE-Y---SSSNRCSCS 102 (103)
T ss_pred C--cCcCccCCCcee-c---cCCCcEeCC
Confidence 2 233478877744 2 122388886
|
WAKs are serine-threonine kinases which might be involved in signalling to the cytoplasm and are required for cell expansion []. ; GO: 0004674 protein serine/threonine kinase activity, 0016021 integral to membrane |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.5e-12 Score=140.49 Aligned_cols=140 Identities=20% Similarity=0.196 Sum_probs=100.8
Q ss_pred ceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhH----------------------------------------HHHHH
Q 005355 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNI----------------------------------------EQFIN 435 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 435 (700)
+.||.|++|.||+|++++|+.||||+.+....... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999998754321110 12455
Q ss_pred HHHHHhhcC----CCceeeEEeEE-EeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 005355 436 EVAILSQIN----HRNVVKLLGCC-LETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSD-ALCYLHSAA 509 (700)
Q Consensus 436 E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~-aL~~LH~~~ 509 (700)
|++.+.+++ |.+-+.+-..+ ......+|||||+++++|.++....... . .+..++.+++. .+..+|..|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhCC
Confidence 666666552 33323322222 2244579999999999999887543211 2 23456666666 478899999
Q ss_pred CCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 510 ~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
++|+|++|.||++++++++++.|||++..+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.4e-13 Score=134.35 Aligned_cols=202 Identities=20% Similarity=0.287 Sum_probs=141.2
Q ss_pred HHhhcCCCceeeEEeEEEeCC-----cceEEEeeCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005355 439 ILSQINHRNVVKLLGCCLETE-----VPLLVYEFIPNGTLYQYIHDQTE-EFPITWEIRLRIAIEVSDALCYLHSAASIP 512 (700)
Q Consensus 439 ~l~~l~h~niv~l~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ 512 (700)
-|-++-|.|||++..++.+.. ...++.|||..|+|..+|++... +..+......+|+.||+.||.|||+.. |+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 345567999999998876543 45789999999999999987643 345888889999999999999999987 66
Q ss_pred eeecCCCCCcEEECCCCcEEEeecCCCcccccC----CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh
Q 005355 513 IYHRDIKSANILLDDKYRAKVSDFGASRSVMID----QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 588 (700)
Q Consensus 513 ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt 588 (700)
|+|+++..+.|++..++-+|+.--.-.. .... .........+-++|.+||.=.....+.++|||+||...+||..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999999885321111 1100 0111122336789999998887888889999999999999988
Q ss_pred CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 589 GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 589 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
+..--..... ....+.... +.+. .+. -..-+.++.+|++..|..||+|++++..
T Consensus 278 lEiq~tnseS---~~~~ee~ia----~~i~-~le-----------n~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSES---KVEVEENIA----NVII-GLE-----------NGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcc---eeehhhhhh----hhee-ecc-----------CccccCcCcccccCCCCCCcchhhhhcC
Confidence 7643211111 000000000 0000 000 0112347999999999999999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=8.8e-13 Score=141.71 Aligned_cols=249 Identities=21% Similarity=0.248 Sum_probs=183.8
Q ss_pred hcCCCccceEee--eCCeEEEEEEE--c-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCc
Q 005355 389 TDNFNTNRILGQ--GGQGTVYKGML--T-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEV 460 (700)
Q Consensus 389 ~~~~~~~~~lG~--G~fg~Vy~~~~--~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 460 (700)
...|...+.+|. |.+|.||.+.. . ++..+|+|+-+... +.....=.+|+...+.+ .|+|.++....+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 456677788999 99999999987 3 57889999855422 23333334566666666 49999999999999999
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEee
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSD----ALCYLHSAASIPIYHRDIKSANILLDDK-YRAKVSD 535 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~~~~~ivH~Dik~~NILl~~~-~~~kl~D 535 (700)
.++-+|++ +.+|.++.+.... .++...++....+... ||.++|+.. ++|-|+||.||++..+ ...+++|
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred ceeeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 99999988 4788888776533 2677778888888888 999999999 9999999999999999 8899999
Q ss_pred cCCCcccccCCce----eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHH
Q 005355 536 FGASRSVMIDQTH----LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEA 611 (700)
Q Consensus 536 fGl~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 611 (700)
||+...+....-. ......+...|++||..+ ..++.++|+|++|.++.+-..+..+........
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~----------- 334 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS----------- 334 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC-----------
Confidence 9999877644321 122235778899999886 567889999999999999988776654321111
Q ss_pred HHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 612 MKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 612 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
|.++-...+..++.......+..++..|+..+|..|++.+++..
T Consensus 335 -----W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 -----WSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----ccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111111222333333445666899999999999999888766
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.9e-11 Score=130.16 Aligned_cols=166 Identities=17% Similarity=0.201 Sum_probs=129.9
Q ss_pred cCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHH
Q 005355 412 TNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIR 491 (700)
Q Consensus 412 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~ 491 (700)
.++.+|.|...+..+....+...+-++.|+.++||||+++++........|||+|-+ ..|..++.. +.....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHHH
Confidence 368888888887766655667788899999999999999999999999999999988 467777765 345667
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeeeeecccccccccccccCCCC
Q 005355 492 LRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFT 571 (700)
Q Consensus 492 ~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s 571 (700)
..-+.||+.||.|||+.+. ++|++|....|+++..|..||++|.++........ ......--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 7788999999999986653 99999999999999999999999988754321111 111111223566777665433
Q ss_pred cccceehHHHHHHHHHhCC
Q 005355 572 EKSDVYSFGVVLVELLTGQ 590 (700)
Q Consensus 572 ~ksDVwSlG~il~elltg~ 590 (700)
-..|.|.||++++|++.|.
T Consensus 182 ~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cchhhhhHHHHHHHHhCcc
Confidence 4569999999999999993
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.5e-11 Score=114.61 Aligned_cols=130 Identities=20% Similarity=0.146 Sum_probs=96.9
Q ss_pred cceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCcee-eEEeEEEeCCcceEEEeeCCCCCH
Q 005355 395 NRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVV-KLLGCCLETEVPLLVYEFIPNGTL 473 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~gsL 473 (700)
.+.|+.|.++.||+++.. ++.|++|....... ....+..|+.+++.+.+.+++ +++... ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 357889999999999876 78899998764332 223567899999988655543 455443 3345899999999887
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 474 YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA--SIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 474 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.+.. . ....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6430 1 11245679999999999987 22359999999999999 5689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.20 E-value=9.6e-11 Score=129.45 Aligned_cols=147 Identities=16% Similarity=0.133 Sum_probs=96.9
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcC-CcEEEEEEccccChh----------------------------------hHH
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTN-GRIVAIKKSKLVDES----------------------------------NIE 431 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~ 431 (700)
.....|+. +.||.|++|.||+|++++ |+.||||+....-.. ..+
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 33456776 789999999999999987 999999987642110 011
Q ss_pred ------HHHHHHHHHhhcC----CCceeeEEeEEEe-CCcceEEEeeCCCCCHHHHH--hccCC-CCCCCHHHHHHHHHH
Q 005355 432 ------QFINEVAILSQIN----HRNVVKLLGCCLE-TEVPLLVYEFIPNGTLYQYI--HDQTE-EFPITWEIRLRIAIE 497 (700)
Q Consensus 432 ------~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~E~~~~gsL~~~l--~~~~~-~~~l~~~~~~~i~~q 497 (700)
+|.+|+..+.+++ +.+.+.+=.++.+ ....+|||||++|++|.++. ..... ...+....+..++.|
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 2344555555542 3433433333332 45668999999999998753 22210 001222333333333
Q ss_pred HHHHHHHHHhcCCCCeeecCCCCCcEEECCCC----cEEEeecCCCccccc
Q 005355 498 VSDALCYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFGASRSVMI 544 (700)
Q Consensus 498 i~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~----~~kl~DfGl~~~~~~ 544 (700)
++..| ++|+|+||.||+++.++ ++++.|||++..+..
T Consensus 276 -------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34577 99999999999999888 999999999987643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.7e-10 Score=106.75 Aligned_cols=135 Identities=18% Similarity=0.147 Sum_probs=98.5
Q ss_pred ceEeeeCCeEEEEEEEcC-------CcEEEEEEcccc-------------C---------hhhHHHHH----HHHHHHhh
Q 005355 396 RILGQGGQGTVYKGMLTN-------GRIVAIKKSKLV-------------D---------ESNIEQFI----NEVAILSQ 442 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~~ 442 (700)
..||.|--+.||.|...+ +..+|||+.+.. + ....+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 478999964321 0 11123333 79999999
Q ss_pred cCC--CceeeEEeEEEeCCcceEEEeeCCCCCHHH-HHhccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCC
Q 005355 443 INH--RNVVKLLGCCLETEVPLLVYEFIPNGTLYQ-YIHDQTEEFPITWEIRLRIAIEVSDALCYL-HSAASIPIYHRDI 518 (700)
Q Consensus 443 l~h--~niv~l~~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~ivH~Di 518 (700)
+.. -++.+++++ ...+|||||+.+..+.. .+++. .++.+....+..+++.+|..| |+.+ |+|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 853 466666654 45689999997654322 22221 255566778889999999999 7888 999999
Q ss_pred CCCcEEECCCCcEEEeecCCCccc
Q 005355 519 KSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 519 k~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
++.|||+++ +.+.|+|||.+...
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeC
Confidence 999999974 58999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.14 E-value=8.8e-10 Score=115.98 Aligned_cols=168 Identities=23% Similarity=0.349 Sum_probs=129.0
Q ss_pred eEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEE----eCCcceEEEeeCCC-CCHHHHH
Q 005355 404 GTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL----ETEVPLLVYEFIPN-GTLYQYI 477 (700)
Q Consensus 404 g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~E~~~~-gsL~~~l 477 (700)
.+.|++... +|..+++|+++............-+++++++.|.|+|++.+++. .+...++||+|.++ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 578998854 89999999995433333334455678899999999999999987 33466899999985 5787775
Q ss_pred hccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 478 HDQT------------EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 478 ~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
.... .+...++..+|.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4321 1234788999999999999999999999 888999999999999999999999887665443
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCC
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p 592 (700)
.. |-+.. -.+-|.=.||.+++.|.+|..-
T Consensus 447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 31 11111 1256888899999999998543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.4e-10 Score=124.86 Aligned_cols=257 Identities=19% Similarity=0.225 Sum_probs=180.9
Q ss_pred ccchHH-HHHHhcCCCccceEeeeCCeEEEEEEEc--CCcEEEEEEccccChhhHHH--HHHHHHHHhhc-CCCceeeEE
Q 005355 379 LFTSME-LEMATDNFNTNRILGQGGQGTVYKGMLT--NGRIVAIKKSKLVDESNIEQ--FINEVAILSQI-NHRNVVKLL 452 (700)
Q Consensus 379 ~~~~~e-~~~~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~ 452 (700)
++...+ ......+|..+..||.|.|+.|+....+ ++..+++|.+...-.....+ -..|+.+...+ .|.++++.+
T Consensus 253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~ 332 (524)
T KOG0601|consen 253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN 332 (524)
T ss_pred eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence 333334 4445678999999999999999987744 57789999765433322222 24566666655 589999988
Q ss_pred eEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcE
Q 005355 453 GCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK-YRA 531 (700)
Q Consensus 453 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~-~~~ 531 (700)
..+......++--||++++++...+.-. ..+.+..++++..|++.++.++|+.. ++|+|+||+||++..+ +..
T Consensus 333 ~~W~~~r~~~ip~e~~~~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~ 406 (524)
T KOG0601|consen 333 SSWSQLRQGYIPLEFCEGGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFS 406 (524)
T ss_pred CCccccccccCchhhhcCcchhhhhHHH---HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhh
Confidence 8888888888999999999887776322 23788889999999999999999988 9999999999999876 788
Q ss_pred EEeecCCCcccccCCceeeeeeecccccc--cccccccCCCCcccceehHHHHHHHHHhCCCCCCC-CCchhhhhHHHHH
Q 005355 532 KVSDFGASRSVMIDQTHLTTRVQGTFGYL--DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRS-TDSEEDKSLVGYF 608 (700)
Q Consensus 532 kl~DfGl~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~-~~~~~~~~~~~~~ 608 (700)
++.|||....+.... . .....-+++ +++......+-.+.|++|||.-+.+.+++..--.. ....
T Consensus 407 ~~~~~~~~t~~~~~~---~-~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~--------- 473 (524)
T KOG0601|consen 407 KLGDFGCWTRLAFSS---G-VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL--------- 473 (524)
T ss_pred hccccccccccceec---c-cccccccccccchhhccccccccccccccccccccccccCcccCcccccce---------
Confidence 999999886421111 1 111223344 56666667888999999999999999998643211 1100
Q ss_pred HHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 609 LEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 609 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
.+..+. . ... ......+..+.+.++..++..||.+.++..+.+-.+
T Consensus 474 --~i~~~~--------~-p~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 474 --TIRSGD--------T-PNL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred --eeeccc--------c-cCC-CchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 011111 1 111 112256777889999999999999998887665543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.4e-09 Score=108.24 Aligned_cols=142 Identities=21% Similarity=0.263 Sum_probs=109.7
Q ss_pred ceEeeeCCeEEEEEEEcCCcEEEEEEccccCh-hhHHHHHHHHHHHhhcCC--CceeeEEeEEEeCC---cceEEEeeCC
Q 005355 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDE-SNIEQFINEVAILSQINH--RNVVKLLGCCLETE---VPLLVYEFIP 469 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~E~~~ 469 (700)
+.|+.|..+.||++...+|+.+++|....... .....+..|+++++.+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987678999998765332 134678899999999975 34577777766542 5689999999
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 005355 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA---------------------------------------- 509 (700)
Q Consensus 470 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---------------------------------------- 509 (700)
+.+|.+.+.. ..++...+..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888776532 12677778888888888888888521
Q ss_pred -------------CCCeeecCCCCCcEEECC--CCcEEEeecCCCcc
Q 005355 510 -------------SIPIYHRDIKSANILLDD--KYRAKVSDFGASRS 541 (700)
Q Consensus 510 -------------~~~ivH~Dik~~NILl~~--~~~~kl~DfGl~~~ 541 (700)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.7e-09 Score=100.18 Aligned_cols=131 Identities=23% Similarity=0.304 Sum_probs=101.5
Q ss_pred ceEeeeCCeEEEEEEEcCCcEEEEEE-ccc-c-C-----hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 396 RILGQGGQGTVYKGMLTNGRIVAIKK-SKL-V-D-----ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~~~~vavK~-~~~-~-~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
..+.+|+-+.+|.+.+. |..+++|. ... . . .-..+.-.+|+.++.+++--.|...+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999875 44566773 211 1 1 11234567899999998766666555566777888999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
+++..|.+++... ...++..+=..+.-||..+ |+|+||.++||++.... +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999998765 2457777888889999999 99999999999998874 99999999963
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=6.2e-09 Score=95.93 Aligned_cols=143 Identities=22% Similarity=0.264 Sum_probs=107.6
Q ss_pred ccceEeeeCCeEEEEEEEcCCcEEEEEEcc-c-------cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 394 TNRILGQGGQGTVYKGMLTNGRIVAIKKSK-L-------VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 394 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~-~-------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
.+.+|-||+-+.|+++.+. |+...||.-. . ...-...+..+|+++|.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999986 7777777421 1 11122456788999999986555555555566777778999
Q ss_pred eeCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC---CcEEEeecCCCcc
Q 005355 466 EFIPN-GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGASRS 541 (700)
Q Consensus 466 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~---~~~kl~DfGl~~~ 541 (700)
||+++ .++.+++....... ........++.+|=+.+.-||..+ |+|+||..+||+|..+ ..+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 48889887654432 333344788999999999999999 9999999999999543 3458999999863
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=8.4e-11 Score=132.74 Aligned_cols=252 Identities=23% Similarity=0.274 Sum_probs=177.9
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEV 460 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 460 (700)
.....+.+.+.+-+-.|.++.++.+.-. .+...++|..... ...+.+..+.+-.++-..++|-++....-+.-...
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 3455677888888999999999987744 3444444433221 12222333444444444456667666655666777
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
..|+++|..+++|...|+... ..+.+........+..++++||... +.|+|++|.|+|+..++..+++||+...
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccc
Confidence 899999999999999998765 2556666677788899999999987 8999999999999999999999998333
Q ss_pred cccc---------------------CC---------ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCC
Q 005355 541 SVMI---------------------DQ---------THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQ 590 (700)
Q Consensus 541 ~~~~---------------------~~---------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~ 590 (700)
.... .. ........+|+.|.+||...+......+|+|++|++++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 2110 00 00122345899999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHH
Q 005355 591 KPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMK 656 (700)
Q Consensus 591 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ 656 (700)
.||........ .+.+..+... ....+.+...+..+++.+.+..+|.+|..+.
T Consensus 1033 pp~na~tpq~~-------f~ni~~~~~~-------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQI-------FENILNRDIP-------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchhhh-------hhccccCCCC-------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99986654432 1111111110 1122345566788899999999999998876
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.2e-08 Score=104.81 Aligned_cols=273 Identities=17% Similarity=0.173 Sum_probs=169.2
Q ss_pred CccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhh-cCCCceeeEEeEE-------EeCCcceEE
Q 005355 393 NTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQ-INHRNVVKLLGCC-------LETEVPLLV 464 (700)
Q Consensus 393 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~-------~~~~~~~lv 464 (700)
...+.||+|+.+.+|-.--- +.. +.|+...-......+.. +.|.. -.||-+-.=+.+- ......-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh-hch-hheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 44678999999999864311 122 34555443333322222 22322 2455433311111 111224567
Q ss_pred EeeCCCC-CHHHHHhccCCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 465 YEFIPNG-TLYQYIHDQTEE---FPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 465 ~E~~~~g-sL~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
|..+++. .+..++.-..++ ....|..+++.++.++.+.+.||..| .+-+|++++|+|+++++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 7766553 233333322111 23689999999999999999999999 8999999999999999999999854332
Q ss_pred ccccCCceeeeeeecccccccccccc-----cCCCCcccceehHHHHHHHHHhC-CCCCCCCCchhhh-hHHHHHHHHHH
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTG-QKPIRSTDSEEDK-SLVGYFLEAMK 613 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlG~il~elltg-~~p~~~~~~~~~~-~~~~~~~~~~~ 613 (700)
.. .........+|...|++||... +..-+...|.|.||+++++|+.| +.||.+....... ... ...+.
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~---E~~Ia 240 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL---ETDIA 240 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc---hhhhh
Confidence 21 3333444566889999999754 34567789999999999999986 9999765421110 000 01111
Q ss_pred hcchhhhcchhh-----hhccC-HHHHHHHHHHHHHHhccC--CCCCCCHHHHHHHHHhchhhcCCCccCCCC
Q 005355 614 ENRLFEVLDARV-----LKEAK-EEEIITVAMLAKRCLNMI--GKKRPTMKEAAFELGGIRASIGDSIMQHNC 678 (700)
Q Consensus 614 ~~~~~~~~d~~~-----~~~~~-~~~~~~l~~li~~cl~~~--p~~RPs~~evl~~L~~l~~~~~~~~~~~~~ 678 (700)
.+.+...-+.+. ..+.+ .-.++.+..|..+|+..- +.-|||++.++..|..++.++.++.....+
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H 313 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMH 313 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccc
Confidence 122211111110 11111 223456777888888653 568999999999999999999988876554
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.8e-08 Score=96.61 Aligned_cols=125 Identities=25% Similarity=0.274 Sum_probs=83.3
Q ss_pred EEEEEEEcCCcEEEEEEccccCh--------------------------hhHHHHHHHHHHHhhcCCC--ceeeEEeEEE
Q 005355 405 TVYKGMLTNGRIVAIKKSKLVDE--------------------------SNIEQFINEVAILSQINHR--NVVKLLGCCL 456 (700)
Q Consensus 405 ~Vy~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 456 (700)
.||.|...++..+|||+.+.... .......+|.+.|.++... ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988899999996443100 1133467899999999765 566666442
Q ss_pred eCCcceEEEeeCC--CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeecCCCCCcEEECCCCcEEE
Q 005355 457 ETEVPLLVYEFIP--NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCY-LHSAASIPIYHRDIKSANILLDDKYRAKV 533 (700)
Q Consensus 457 ~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~~~~ivH~Dik~~NILl~~~~~~kl 533 (700)
...|||||++ +..+..+.... ++.+....++.+++..+.. +|..| |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 4489999998 55554443322 2233456677788886665 57888 9999999999999988 9999
Q ss_pred eecCCCccc
Q 005355 534 SDFGASRSV 542 (700)
Q Consensus 534 ~DfGl~~~~ 542 (700)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=7.4e-08 Score=97.99 Aligned_cols=139 Identities=15% Similarity=0.140 Sum_probs=98.8
Q ss_pred eEeeeCCeEEEEEEEcCCcEEEEEEccccChh-----------hHHHHHHHHHHHhhcCCCc--eeeEEeEEEe-----C
Q 005355 397 ILGQGGQGTVYKGMLTNGRIVAIKKSKLVDES-----------NIEQFINEVAILSQINHRN--VVKLLGCCLE-----T 458 (700)
Q Consensus 397 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~ 458 (700)
.+-.-....|++..+ +|+.+.||+....... ....+.+|...+.++...+ .+.++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333333344667666 4788999976432211 1124778999888874333 3344545433 2
Q ss_pred CcceEEEeeCCCC-CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-------CCc
Q 005355 459 EVPLLVYEFIPNG-TLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD-------KYR 530 (700)
Q Consensus 459 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~-------~~~ 530 (700)
...+||+|++++. +|.+++..... .+.+......++.+++..+.-||..| |+|+|+++.|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3468999999886 89999864321 23566777899999999999999999 999999999999975 578
Q ss_pred EEEeecCCCc
Q 005355 531 AKVSDFGASR 540 (700)
Q Consensus 531 ~kl~DfGl~~ 540 (700)
+.|+||+.+.
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 9999999885
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.4e-07 Score=90.13 Aligned_cols=134 Identities=22% Similarity=0.220 Sum_probs=97.3
Q ss_pred CCccceEeeeCCeEEEEEEEcCCcEEEEEEccccC----------------------hhhHHHHHHHHHHHhhcCCC--c
Q 005355 392 FNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVD----------------------ESNIEQFINEVAILSQINHR--N 447 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--n 447 (700)
..+..+||-|--+.||.|....|.++|||.-+... ...+....+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999999999999999432210 01234467899999998654 6
Q ss_pred eeeEEeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC
Q 005355 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD 527 (700)
Q Consensus 448 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~ 527 (700)
+.+.+++ +...+|||++++..|...- ++.+....++..|++-+.-+-..| |||+|+++-|||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 6666653 4557999999886665433 122233344555555555555778 999999999999999
Q ss_pred CCcEEEeecCCCc
Q 005355 528 KYRAKVSDFGASR 540 (700)
Q Consensus 528 ~~~~kl~DfGl~~ 540 (700)
+|.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999996554
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.1e-08 Score=109.79 Aligned_cols=151 Identities=22% Similarity=0.234 Sum_probs=105.3
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee--------eeeeecccccccccccc
Q 005355 495 AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL--------TTRVQGTFGYLDPEYFR 566 (700)
Q Consensus 495 ~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~ 566 (700)
+.+++.||.|||...+ +||++|.|++|.++.++..||..|+.+.......... ..-.+....|.|||++.
T Consensus 105 l~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3456699999998764 9999999999999999999999999876543321111 11133566899999999
Q ss_pred cCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHh
Q 005355 567 SSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCL 645 (700)
Q Consensus 567 ~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl 645 (700)
....+.++|+||+|++++-+.. |+.-+........... ....+..-......+.+.++.+=+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-------------~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-------------SRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-------------hhcccccccccccccCcHHHHHHHHHHh
Confidence 9899999999999999999995 4444433321111000 0011111111223456677888899999
Q ss_pred ccCCCCCCCHHHHHH
Q 005355 646 NMIGKKRPTMKEAAF 660 (700)
Q Consensus 646 ~~~p~~RPs~~evl~ 660 (700)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877665
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.1e-06 Score=82.77 Aligned_cols=139 Identities=19% Similarity=0.144 Sum_probs=103.1
Q ss_pred EeeeCCeEEEEEEEcCCcEEEEEEccc------cChhhHHHHHHHHHHHhhcCC--CceeeEEeEEEeC----CcceEEE
Q 005355 398 LGQGGQGTVYKGMLTNGRIVAIKKSKL------VDESNIEQFINEVAILSQINH--RNVVKLLGCCLET----EVPLLVY 465 (700)
Q Consensus 398 lG~G~fg~Vy~~~~~~~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~ 465 (700)
-|+||-+-|++.... |+.+-+|+... .-+.....|.+|+..|.++.. -.+.+++..-... -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 366888999997775 55788997542 113356789999999999853 2355555222221 2347999
Q ss_pred eeCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc--EEEeecCCCcc
Q 005355 466 EFIPN-GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR--AKVSDFGASRS 541 (700)
Q Consensus 466 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~--~kl~DfGl~~~ 541 (700)
|-+++ -+|.+++...... +.+...+..++.++++.++-||+.+ +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~-~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVS-PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcC-CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97754 5899988664321 3677888899999999999999999 999999999999986666 99999987654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.1e-06 Score=86.42 Aligned_cols=106 Identities=20% Similarity=0.249 Sum_probs=83.6
Q ss_pred HHHHHHHHHHHhhcC--CCceeeEEeEEEeCC----cceEEEeeCCCC-CHHHHHhccCCCCCCCHHHHHHHHHHHHHHH
Q 005355 430 IEQFINEVAILSQIN--HRNVVKLLGCCLETE----VPLLVYEFIPNG-TLYQYIHDQTEEFPITWEIRLRIAIEVSDAL 502 (700)
Q Consensus 430 ~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~----~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL 502 (700)
.....+|...+..+. .-.+.+.+++..... ..+||+|++++. +|.+++..... ++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 346778888887774 333455566655432 347999999874 89999986433 56667788999999999
Q ss_pred HHHHhcCCCCeeecCCCCCcEEECCCC---cEEEeecCCCcc
Q 005355 503 CYLHSAASIPIYHRDIKSANILLDDKY---RAKVSDFGASRS 541 (700)
Q Consensus 503 ~~LH~~~~~~ivH~Dik~~NILl~~~~---~~kl~DfGl~~~ 541 (700)
+-||..| |+|+|+++.|||++.+. .+.++||+.++.
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999998887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.5e-06 Score=95.87 Aligned_cols=147 Identities=19% Similarity=0.169 Sum_probs=97.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChh----------------------------------------
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDES---------------------------------------- 428 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------------------------------------- 428 (700)
...|.. +.|+.++-|.||+|++++|+.||||+....-..
T Consensus 125 F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~ 203 (517)
T COG0661 125 FSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR 203 (517)
T ss_pred HHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence 344443 679999999999999999999999976542110
Q ss_pred hHHHHHHHHHHHhhcC-----CCceeeEEeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHH-H
Q 005355 429 NIEQFINEVAILSQIN-----HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDA-L 502 (700)
Q Consensus 429 ~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~a-L 502 (700)
..-++.+|+..+.+++ .+++.-..=+..-....+|+|||++|..+.+........ ++.+. ++..++++ +
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~---ia~~~~~~f~ 278 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKE---LAELLVRAFL 278 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHH---HHHHHHHHHH
Confidence 0112445666655542 333332222233356679999999999999985433222 44333 33333332 2
Q ss_pred HHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 503 CYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 503 ~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
..+-..| ++|.|..|.||+++.++++-+.|||+...+..
T Consensus 279 ~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 279 RQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2333356 99999999999999999999999999987643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.27 E-value=8.2e-06 Score=79.05 Aligned_cols=139 Identities=17% Similarity=0.228 Sum_probs=92.9
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHH---------HHHHHHHhhcCC---CceeeEEe
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQF---------INEVAILSQINH---RNVVKLLG 453 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---~niv~l~~ 453 (700)
.....+|...+++-......|.+-..+ ++.+.+|..........+.| .+++..+.+++. .....++.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 455788888888888777777776664 78899997665433322222 223333333322 22222222
Q ss_pred E-----EEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC
Q 005355 454 C-----CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK 528 (700)
Q Consensus 454 ~-----~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~ 528 (700)
+ +.-....+|+|||++|..|.++.. +++ .++..+++++.-||+.| ++|+|..|.|++++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence 2 222344468999999988876642 332 35567788899999999 9999999999999966
Q ss_pred CcEEEeecCCCc
Q 005355 529 YRAKVSDFGASR 540 (700)
Q Consensus 529 ~~~kl~DfGl~~ 540 (700)
.+++.||+..+
T Consensus 172 -~i~iID~~~k~ 182 (229)
T PF06176_consen 172 -GIRIIDTQGKR 182 (229)
T ss_pred -cEEEEECcccc
Confidence 59999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1219 consensus Uncharacterized conserved protein, contains laminin, cadherin and EGF domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.3e-06 Score=103.99 Aligned_cols=79 Identities=24% Similarity=0.551 Sum_probs=66.1
Q ss_pred ccccCCcccccCCCceeeeccCCCcc---------ccCCcccccccccCCCCCcccCCCCCCccCCC-----CCCcccCC
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG---------LNDGYCVGDLLCDSASSPYNCSGCPNGYLLDD-----TDSCYQNT 292 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G---------~~~~~~~~~~~c~~~~~py~c~~c~~~~~~~~-----~d~C~~~~ 292 (700)
-|...++|.....+||.|+|+.-|-| |....|.-.++|.-..|.|.|. |++++.++. .++|..+.
T Consensus 3871 pCqhgG~C~~~~~ggy~CkCpsqysG~~CEi~~epC~snPC~~GgtCip~~n~f~Cn-C~~gyTG~~Ce~~Gi~eCs~n~ 3949 (4289)
T KOG1219|consen 3871 PCQHGGTCISQPKGGYKCKCPSQYSGNHCEIDLEPCASNPCLTGGTCIPFYNGFLCN-CPNGYTGKRCEARGISECSKNV 3949 (4289)
T ss_pred cccCCCEecCCCCCceEEeCcccccCcccccccccccCCCCCCCCEEEecCCCeeEe-CCCCccCceeeccccccccccc
Confidence 45555778777788999999999999 7788898889999999999996 888876653 57899887
Q ss_pred CC--CCcCCCCCCCCC
Q 005355 293 TA--KTDTISPSPSPY 306 (700)
Q Consensus 293 ~~--~~~~~~p~~~~~ 306 (700)
|. +.|.+.++.+.|
T Consensus 3950 C~~gg~C~n~~gsf~C 3965 (4289)
T KOG1219|consen 3950 CGTGGQCINIPGSFHC 3965 (4289)
T ss_pred ccCCceeeccCCceEe
Confidence 74 679999998888
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.8e-05 Score=78.82 Aligned_cols=138 Identities=17% Similarity=0.190 Sum_probs=84.4
Q ss_pred ceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCc--eeeEEeEEEeCCcceEEEeeCCCCC-
Q 005355 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRN--VVKLLGCCLETEVPLLVYEFIPNGT- 472 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~gs- 472 (700)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999983 25567888876422 2345788999999986433 4677777777777789999998863
Q ss_pred HHHHH---------------------hccCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHhc-CCCCeeecCC
Q 005355 473 LYQYI---------------------HDQTEEFPITWEIRL-RIAI----------EVSD-ALCYLHSA-ASIPIYHRDI 518 (700)
Q Consensus 473 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------qi~~-aL~~LH~~-~~~~ivH~Di 518 (700)
+...+ |..... ........ .+.. .+.+ ...+|... ..+.++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 22111 111000 01111100 0000 0111 12222211 1234789999
Q ss_pred CCCcEEECCCCcEEEeecCCCc
Q 005355 519 KSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 519 k~~NILl~~~~~~kl~DfGl~~ 540 (700)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999887 9999998774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.10 E-value=5.4e-05 Score=74.17 Aligned_cols=151 Identities=21% Similarity=0.210 Sum_probs=99.7
Q ss_pred cchHHHHHHhcCCCccceEe---eeCCeEEEEEEEcCCcEEEEEEccccChhh------------------------HHH
Q 005355 380 FTSMELEMATDNFNTNRILG---QGGQGTVYKGMLTNGRIVAIKKSKLVDESN------------------------IEQ 432 (700)
Q Consensus 380 ~~~~e~~~~~~~~~~~~~lG---~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------------------------~~~ 432 (700)
.+...+....++..+....| .|.-+.||+|...++..+|||+.+...... ...
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34556666666666666555 555668999998889999999866532111 011
Q ss_pred HHHHHHHHhhcC--CCceeeEEeEEEeCCcceEEEeeCCCCC-HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-c
Q 005355 433 FINEVAILSQIN--HRNVVKLLGCCLETEVPLLVYEFIPNGT-LYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS-A 508 (700)
Q Consensus 433 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~ 508 (700)
...|...|+++. +-.+.+.+.+. .-.|||||+...- -.-.|.+ .++..+....+..++++.+.-|-. .
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhc
Confidence 235666676663 33344444333 3379999996531 1111111 123444677788889999888887 6
Q ss_pred CCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 509 ~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+ +||+||+.-|||+. ++.+.|+||+-+...
T Consensus 187 ~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 187 G---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred C---cccccchhhheEEE-CCeEEEEECcccccc
Confidence 6 99999999999999 779999999988654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.4e-05 Score=76.31 Aligned_cols=143 Identities=23% Similarity=0.260 Sum_probs=85.1
Q ss_pred cceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCC--ceeeEEeEEEeC---CcceEEEeeCC
Q 005355 395 NRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHR--NVVKLLGCCLET---EVPLLVYEFIP 469 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~E~~~ 469 (700)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++...... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4679999999999999876 69999986654 4557788899998888533 356677644332 34589999999
Q ss_pred CCCHHH----------------HH---hcc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 005355 470 NGTLYQ----------------YI---HDQ-TEEFPITWEI---------RLRI------------AIEVSD-ALCYLHS 507 (700)
Q Consensus 470 ~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~qi~~-aL~~LH~ 507 (700)
+.++.. .+ +.. .......... .... ...+.+ .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 111 0111111100 0000 111222 2333332
Q ss_pred ----cCCCCeeecCCCCCcEEEC-CCCcEEEeecCCCc
Q 005355 508 ----AASIPIYHRDIKSANILLD-DKYRAKVSDFGASR 540 (700)
Q Consensus 508 ----~~~~~ivH~Dik~~NILl~-~~~~~kl~DfGl~~ 540 (700)
.....++|+|+.+.|||++ +++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1334499999999999999 66677899998774
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.02 E-value=2.3e-05 Score=75.53 Aligned_cols=104 Identities=26% Similarity=0.370 Sum_probs=82.5
Q ss_pred HHHHHHHhhcCC-CceeeEEeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005355 434 INEVAILSQINH-RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIP 512 (700)
Q Consensus 434 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ 512 (700)
..|.-+++.+++ +++++++|.| ..+++.|+.+.+++...-.....-...+|..+.+||.++++.+.+|++...-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888876 6999999999 34789999987766532111011123789999999999999999999865445
Q ss_pred eeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 513 IYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 513 ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
+...|++++|+-+++++++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 99999999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.99 E-value=7.6e-05 Score=75.49 Aligned_cols=139 Identities=17% Similarity=0.147 Sum_probs=85.7
Q ss_pred EeeeCC-eEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcceEEEeeCCCCCHHH
Q 005355 398 LGQGGQ-GTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQ 475 (700)
Q Consensus 398 lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~ 475 (700)
|-.|.. ..||+.... +..+.||+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 788998765 4788889876543 345678999988873 4456677877776667899999999887764
Q ss_pred HH-------------------hccCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----cC
Q 005355 476 YI-------------------HDQTE-EFPITW--EIRLRIAI--------------------EVSDALCYLHS----AA 509 (700)
Q Consensus 476 ~l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------qi~~aL~~LH~----~~ 509 (700)
.. +.... ..+... ...+.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 42 11110 001110 00000000 01111222211 12
Q ss_pred CCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 510 ~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2458999999999999998778999998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00018 Score=69.56 Aligned_cols=129 Identities=22% Similarity=0.280 Sum_probs=92.9
Q ss_pred ccceEeeeCCeEEEEEEEcCCcEEEEEEccccC----------------hhhHHHHHHHHHHHhhcC------CCceeeE
Q 005355 394 TNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVD----------------ESNIEQFINEVAILSQIN------HRNVVKL 451 (700)
Q Consensus 394 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l 451 (700)
....||+|+.=.||. +.+.....||+..... ....++..+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346799999999986 4556677888776544 223456677777666655 8899999
Q ss_pred EeEEEeCCcceEEEeeCCC------CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005355 452 LGCCLETEVPLLVYEFIPN------GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL 525 (700)
Q Consensus 452 ~~~~~~~~~~~lv~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl 525 (700)
+|....+..+-+|+|.+.+ .+|.+++.... ++. .... .+-+-..||-+++ |+.+|++|.||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~---~L~~f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQ---ALDEFKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHH---HHHHHHHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999998764 37888885543 554 3333 3344456777777 9999999999999
Q ss_pred CCC---C-cEEEee
Q 005355 526 DDK---Y-RAKVSD 535 (700)
Q Consensus 526 ~~~---~-~~kl~D 535 (700)
..+ . .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 532 2 577776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=5.3e-05 Score=70.18 Aligned_cols=129 Identities=21% Similarity=0.278 Sum_probs=90.1
Q ss_pred CCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCC
Q 005355 392 FNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 471 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~g 471 (700)
.+..+.|++|++|.||++.+. +..+|+|+-.. +.....+..|+++|..+.-.++-+=+-.+-+ .++.|||+.+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~ 97 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCc
Confidence 345678999999999999997 56889998664 3345778899999999886665543322222 24559999888
Q ss_pred CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC-C-CcEEECCCCcEEEeecCCCc
Q 005355 472 TLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIK-S-ANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 472 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik-~-~NILl~~~~~~kl~DfGl~~ 540 (700)
+|.+.-... +. +-...++++---|...| |-|+.|. | .||++.+ ..+.|+||.-+.
T Consensus 98 ~L~~~~~~~------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~-~~~~iIDFd~At 154 (201)
T COG2112 98 PLGKLEIGG------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVND-RDVYIIDFDSAT 154 (201)
T ss_pred chhhhhhcc------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecC-CcEEEEEccchh
Confidence 887776432 12 22334555545566667 9999998 4 4555554 499999998876
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.95 E-value=3.6e-05 Score=84.63 Aligned_cols=139 Identities=17% Similarity=0.152 Sum_probs=90.6
Q ss_pred ceEeeeCCeEEEEEEEcCCcEEEEEEccccChh-------------------------------------hHHHHHHHHH
Q 005355 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDES-------------------------------------NIEQFINEVA 438 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-------------------------------------~~~~~~~E~~ 438 (700)
+.||.-..|.||+|++++|+.||||+.+..-+. ..-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 679999999999999999999999975542110 0112445555
Q ss_pred HHhhc----CCCc------eeeEEeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHH-HHHh
Q 005355 439 ILSQI----NHRN------VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC-YLHS 507 (700)
Q Consensus 439 ~l~~l----~h~n------iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~-~LH~ 507 (700)
-..+. .|-+ |.+++.. -....+|+|||++|..+.|.-.-...+ ++...+.. .+.++.. -|-.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~~---~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRG--ISPHDILN---KLVEAYLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcC--CCHHHHHH---HHHHHHHHHHHh
Confidence 44443 3444 3333322 234568999999998777764322222 55554433 3333322 2223
Q ss_pred cCCCCeeecCCCCCcEEECC----CCcEEEeecCCCccccc
Q 005355 508 AASIPIYHRDIKSANILLDD----KYRAKVSDFGASRSVMI 544 (700)
Q Consensus 508 ~~~~~ivH~Dik~~NILl~~----~~~~kl~DfGl~~~~~~ 544 (700)
.| ++|.|=.|.||+++. ++.+.+.|||+......
T Consensus 320 ~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 56 999999999999983 67899999999986643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=8.8e-07 Score=96.07 Aligned_cols=183 Identities=19% Similarity=0.141 Sum_probs=130.3
Q ss_pred cceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCc-eeeEEeEEEeCCcceEEEeeCCCC-C
Q 005355 395 NRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRN-VVKLLGCCLETEVPLLVYEFIPNG-T 472 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~~~~g-s 472 (700)
..-++++++++++|.+....+....+..... ....-++++|.+++||| .+..++-+..++..++++++...+ +
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 3457889999999887543333334443322 44567899999999999 777777777778888999998776 2
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeee
Q 005355 473 LYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTR 552 (700)
Q Consensus 473 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~ 552 (700)
-...+... ...+..-+...+.+.-++++++||+.- =+|+| ||+..+ ...|..||+....+.... ....
T Consensus 322 ~~~~~~~s--e~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t 389 (829)
T KOG0576|consen 322 SALEMTVS--EIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRT 389 (829)
T ss_pred ccccCChh--hHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc--cccc
Confidence 21111111 111334455566677788999999864 48998 777766 588999999887654332 3445
Q ss_pred eecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCC
Q 005355 553 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIR 594 (700)
Q Consensus 553 ~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~ 594 (700)
..+++.++|||+.....+..+.|+|++++=-.+|.-|.+|-.
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 668999999999999999999999999987667776766543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.0013 Score=70.62 Aligned_cols=75 Identities=20% Similarity=0.245 Sum_probs=55.0
Q ss_pred ceEeeeCCeEEEEEEEcCC-cEEEEEEcccc-----C--hhhHHHHHHHHHHHhhcC---CCceeeEEeEEEeCCcceEE
Q 005355 396 RILGQGGQGTVYKGMLTNG-RIVAIKKSKLV-----D--ESNIEQFINEVAILSQIN---HRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 464 (700)
+.||.|.+..||++...+| +.|+||..... . +...+++..|.+.|+.+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5789999999999998776 58999974321 1 224567788888888863 3457777766 44567899
Q ss_pred EeeCCCCC
Q 005355 465 YEFIPNGT 472 (700)
Q Consensus 465 ~E~~~~gs 472 (700)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00023 Score=84.76 Aligned_cols=148 Identities=16% Similarity=0.232 Sum_probs=91.5
Q ss_pred cceEeeeCCeEEEEEEEcCC---cEEEEEEccccC-hhhHHHHHHHHHHHhhcC-CCce--eeEEeEEEeC---CcceEE
Q 005355 395 NRILGQGGQGTVYKGMLTNG---RIVAIKKSKLVD-ESNIEQFINEVAILSQIN-HRNV--VKLLGCCLET---EVPLLV 464 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 464 (700)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999887653 467778754322 122356889999999985 6654 7778877654 467899
Q ss_pred EeeCCCCCHHH--------------------H---HhccCCC--------CCCC--HHHHHHHHH---------------
Q 005355 465 YEFIPNGTLYQ--------------------Y---IHDQTEE--------FPIT--WEIRLRIAI--------------- 496 (700)
Q Consensus 465 ~E~~~~gsL~~--------------------~---l~~~~~~--------~~l~--~~~~~~i~~--------------- 496 (700)
|||+++..+.+ . ||..... .+.. ..++..+..
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 1 1111100 0001 111211111
Q ss_pred HHHHHHHHHHhcCC--------CCeeecCCCCCcEEECC-CCc-EEEeecCCCccc
Q 005355 497 EVSDALCYLHSAAS--------IPIYHRDIKSANILLDD-KYR-AKVSDFGASRSV 542 (700)
Q Consensus 497 qi~~aL~~LH~~~~--------~~ivH~Dik~~NILl~~-~~~-~kl~DfGl~~~~ 542 (700)
.+...+.+|..+-+ +.++|+|+++.|||++. +.. +-|.||+++..-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 12334566644321 34999999999999985 333 579999987643
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00072 Score=70.41 Aligned_cols=80 Identities=10% Similarity=0.048 Sum_probs=58.0
Q ss_pred CCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCC---CceeeEEeEEEe---CCcceEE
Q 005355 391 NFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINH---RNVVKLLGCCLE---TEVPLLV 464 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv 464 (700)
.....+.||.|..+.||+....++ .+.+|..+.. .....+..|.+.|+.+.- -.+.++++.+.. .+..+||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 334456799999999999876555 4666764431 123578899999998853 367888887754 3568999
Q ss_pred EeeCCCCCH
Q 005355 465 YEFIPNGTL 473 (700)
Q Consensus 465 ~E~~~~gsL 473 (700)
||++++.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00053 Score=68.93 Aligned_cols=73 Identities=18% Similarity=0.234 Sum_probs=45.8
Q ss_pred ceEeeeCCe-EEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCC---ceeeEEeEEEeC---CcceEEEeeC
Q 005355 396 RILGQGGQG-TVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHR---NVVKLLGCCLET---EVPLLVYEFI 468 (700)
Q Consensus 396 ~~lG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~E~~ 468 (700)
+.|+.|+.. .||+. +..+++|..... .....+.+|.+++..+... .+.++++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467777766 58874 235677865542 2345788999999887532 344444433322 2358899999
Q ss_pred CCCCHH
Q 005355 469 PNGTLY 474 (700)
Q Consensus 469 ~~gsL~ 474 (700)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00075 Score=67.77 Aligned_cols=140 Identities=21% Similarity=0.257 Sum_probs=80.4
Q ss_pred ceEeeeCCeEEEEEEEcC--CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCc-eeeEEeEEEeCCcceEEEeeCCCCC
Q 005355 396 RILGQGGQGTVYKGMLTN--GRIVAIKKSKLVDESNIEQFINEVAILSQINHRN-VVKLLGCCLETEVPLLVYEFIPNGT 472 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~~~~gs 472 (700)
+.|..|-...+|+....+ ++.|++|+....... .....+|+.+++.+.... ..++++... ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567778888999988664 678899976543221 123347888888885333 344444332 248999999876
Q ss_pred HHHH-----------------HhccCCCC--------CC-CHHHHHHHHH----------------------HHHHHHHH
Q 005355 473 LYQY-----------------IHDQTEEF--------PI-TWEIRLRIAI----------------------EVSDALCY 504 (700)
Q Consensus 473 L~~~-----------------l~~~~~~~--------~l-~~~~~~~i~~----------------------qi~~aL~~ 504 (700)
+... +|...... .. .++.+..+.. .+.+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5321 11111111 01 1222222211 11111122
Q ss_pred H----Hhc-CCCCeeecCCCCCcEEECC-CCcEEEeecCCCc
Q 005355 505 L----HSA-ASIPIYHRDIKSANILLDD-KYRAKVSDFGASR 540 (700)
Q Consensus 505 L----H~~-~~~~ivH~Dik~~NILl~~-~~~~kl~DfGl~~ 540 (700)
| ... ....++|+|+.+.|||+++ +..+.|+||..+.
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 2 211 2234899999999999998 5789999998774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00079 Score=64.70 Aligned_cols=125 Identities=29% Similarity=0.479 Sum_probs=89.9
Q ss_pred cCCCccceEeeeCC-eEEEEEEEcCCcEEEEEEccc---cCh------------------hhHHHHHHHHHHHhhcC---
Q 005355 390 DNFNTNRILGQGGQ-GTVYKGMLTNGRIVAIKKSKL---VDE------------------SNIEQFINEVAILSQIN--- 444 (700)
Q Consensus 390 ~~~~~~~~lG~G~f-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 444 (700)
.+++.++.||.|.. |.||+++.. |+.+|+|.++. ... .....|..|-+.+.+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 88999999999999 999999986 78999998222 100 11235778888877764
Q ss_pred CCce--eeEEeEEEeC-C-----------------cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 005355 445 HRNV--VKLLGCCLET-E-----------------VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCY 504 (700)
Q Consensus 445 h~ni--v~l~~~~~~~-~-----------------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~ 504 (700)
+.++ ++.+|+..=. + ...||.||++... .+. ..-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 5566 8889887422 0 1136777765432 122 3345677888899
Q ss_pred HHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 505 LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
||+.+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99999 999999999986 4588999854
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00057 Score=79.78 Aligned_cols=196 Identities=18% Similarity=0.188 Sum_probs=137.0
Q ss_pred HHHHHHHHhhcCCCceeeEEeEEEeCCcce----EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 005355 433 FINEVAILSQINHRNVVKLLGCCLETEVPL----LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508 (700)
Q Consensus 433 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 508 (700)
..-|++.+.++.|+|++.++.+-.+....- +..|++...++...+..... ++....+.+..++.+||+|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---IPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---cCHHHHHHHHHHHhhhHHHHHHh
Confidence 345666777889999999999887654332 44577778888888876543 88899999999999999999998
Q ss_pred CCCCeeecCCCCC---cEEECCCCcEEEe--ecCCCcccccCCceeeeeeecccccccccccccCCCCc--ccceehHHH
Q 005355 509 ASIPIYHRDIKSA---NILLDDKYRAKVS--DFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTE--KSDVYSFGV 581 (700)
Q Consensus 509 ~~~~ivH~Dik~~---NILl~~~~~~kl~--DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDVwSlG~ 581 (700)
. +.|.-+..+ +--.+..+.+.++ ||+.+.......... ...-+..+.+||......+.. +.|+|.+|.
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHH
Confidence 6 666555555 5555677778877 898887654333222 222455677888877665544 479999999
Q ss_pred HHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 582 VLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 582 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.+..+..|..+-..... ...+++. .....+.+...+|+..++++|+++.+++..
T Consensus 381 l~~~~~~~~~i~~~~~~------------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAV------------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHhhhhhcCcccccccc------------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 99999998655321110 0111111 111146678899999999999999999885
Q ss_pred H
Q 005355 662 L 662 (700)
Q Consensus 662 L 662 (700)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 4
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0006 Score=69.51 Aligned_cols=137 Identities=15% Similarity=0.149 Sum_probs=77.3
Q ss_pred EeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCce-eeEEeEEEeCCcceEEEeeCCCCCHHHH
Q 005355 398 LGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNV-VKLLGCCLETEVPLLVYEFIPNGTLYQY 476 (700)
Q Consensus 398 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gsL~~~ 476 (700)
+..|-...+|+... +++.+++|..........-...+|.++++.+....+ .+++... ...+|+||+++.++...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence 45577788998874 467888887554322211235778888888854323 3444432 13799999998665321
Q ss_pred -----------------HhccCC-CCCCCHH-HHHHHHHHH---------HHHHHHHHhc-----CCCCeeecCCCCCcE
Q 005355 477 -----------------IHDQTE-EFPITWE-IRLRIAIEV---------SDALCYLHSA-----ASIPIYHRDIKSANI 523 (700)
Q Consensus 477 -----------------l~~~~~-~~~l~~~-~~~~i~~qi---------~~aL~~LH~~-----~~~~ivH~Dik~~NI 523 (700)
||.... ..+++.. .+..+..++ ...+..+... ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 111111 1112221 111211111 1112222221 123489999999999
Q ss_pred EECCCCcEEEeecCCCc
Q 005355 524 LLDDKYRAKVSDFGASR 540 (700)
Q Consensus 524 Ll~~~~~~kl~DfGl~~ 540 (700)
++++++ +.|+||..+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999876 7899998775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.004 Score=65.16 Aligned_cols=140 Identities=24% Similarity=0.326 Sum_probs=82.0
Q ss_pred ceEeeeCCeEEEEEEEcC-------CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCc-eeeEEeEEEeCCcceEEEee
Q 005355 396 RILGQGGQGTVYKGMLTN-------GRIVAIKKSKLVDESNIEQFINEVAILSQINHRN-VVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E~ 467 (700)
+.|..|-...+|+....+ ++.+++|+...... ...+..+|.+++..+.... ..++++.+. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 455666667899888654 57899998665332 2245678888888875333 334555443 2468999
Q ss_pred CCCCCHHHH-----------------HhccCCCC--------CCCHHHHHH--------------------------HHH
Q 005355 468 IPNGTLYQY-----------------IHDQTEEF--------PITWEIRLR--------------------------IAI 496 (700)
Q Consensus 468 ~~~gsL~~~-----------------l~~~~~~~--------~l~~~~~~~--------------------------i~~ 496 (700)
++|.++... +|...... +.-+..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988765431 11111110 001111111 111
Q ss_pred HHHHHHHHHHh------cCCCCeeecCCCCCcEEECCC----CcEEEeecCCCc
Q 005355 497 EVSDALCYLHS------AASIPIYHRDIKSANILLDDK----YRAKVSDFGASR 540 (700)
Q Consensus 497 qi~~aL~~LH~------~~~~~ivH~Dik~~NILl~~~----~~~kl~DfGl~~ 540 (700)
++...+..|.. .....++|+|+.+.|||++++ +.+.++||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223334432 133458999999999999985 789999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.019 Score=60.45 Aligned_cols=142 Identities=14% Similarity=0.162 Sum_probs=75.6
Q ss_pred cceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCC--ceeeEEe------EEEeCCcceEEEe
Q 005355 395 NRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHR--NVVKLLG------CCLETEVPLLVYE 466 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~------~~~~~~~~~lv~E 466 (700)
.+.|..|....+|+....+| .+++|+...... +....|+.++..|... .+.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 34566777788999886655 688898753222 3333455555554211 1333332 1223456789999
Q ss_pred eCCCCCHH-----------HH---HhccCCC--------CCCCH-HHHHH------------HHHH-HHHHHHHHHhc--
Q 005355 467 FIPNGTLY-----------QY---IHDQTEE--------FPITW-EIRLR------------IAIE-VSDALCYLHSA-- 508 (700)
Q Consensus 467 ~~~~gsL~-----------~~---l~~~~~~--------~~l~~-~~~~~------------i~~q-i~~aL~~LH~~-- 508 (700)
|++|..+. +. +|..... ..+.| ..... ...+ +...++.+.+.
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99886431 11 1111111 01111 11111 1111 11222333211
Q ss_pred --CCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 509 --ASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 509 --~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
-...++|+|+.+.|||++++...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 12349999999999999977656899999875
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.005 Score=63.41 Aligned_cols=75 Identities=21% Similarity=0.252 Sum_probs=49.0
Q ss_pred CccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcC---CCceeeEEeEEEeCCcceEEEeeCC
Q 005355 393 NTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQIN---HRNVVKLLGCCLETEVPLLVYEFIP 469 (700)
Q Consensus 393 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~ 469 (700)
+..+.|+-|....+|+.. .+++.+.||.-. ......|..|++-|+.|. --.+.+++++....+..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 445678988899999977 568899999876 233356788888888873 4568889998888888899999998
Q ss_pred CC
Q 005355 470 NG 471 (700)
Q Consensus 470 ~g 471 (700)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 66
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.009 Score=62.66 Aligned_cols=143 Identities=19% Similarity=0.213 Sum_probs=80.6
Q ss_pred cceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCC--ceeeEEeE------EEeCCcceEEEe
Q 005355 395 NRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHR--NVVKLLGC------CLETEVPLLVYE 466 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~E 466 (700)
.+.++.|....+|+....++ .+++|+..... ..+....|++++..|... .+.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876544 57788765421 123455667777666322 23444432 122355689999
Q ss_pred eCCCCCHH-----------HH---HhccCCCC---------CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 005355 467 FIPNGTLY-----------QY---IHDQTEEF---------PITWEIRL------------RIAIEVSDALCYLHS---- 507 (700)
Q Consensus 467 ~~~~gsL~-----------~~---l~~~~~~~---------~l~~~~~~------------~i~~qi~~aL~~LH~---- 507 (700)
|++|.++. .. +|...... .-.|.... .....+.+.+++|..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885431 11 12111110 01111110 011223345555543
Q ss_pred cCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 508 ~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.-...++|+|+.+.||++++++.+.|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 112349999999999999998777899999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0018 Score=65.72 Aligned_cols=134 Identities=19% Similarity=0.206 Sum_probs=93.6
Q ss_pred CCccceEeeeCCeEEEEEEEcCCcEEEEEEccccCh------------------h----hHHHHHHHHHHHhhcCC--Cc
Q 005355 392 FNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDE------------------S----NIEQFINEVAILSQINH--RN 447 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~----~~~~~~~E~~~l~~l~h--~n 447 (700)
+.+.+.||-|.-+.+|.+-..+|++.++|.-..... . .+-...+|...|+.|.. --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 567889999999999999999999999984222100 0 01223567777777742 23
Q ss_pred eeeEEeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC
Q 005355 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD 527 (700)
Q Consensus 448 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~ 527 (700)
+.+.+++ +..++|||++.+-+|...-+-. . ...+...+..-+--|-.+| +||+|..--||++++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~------d---~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHVE------D---PPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeecC------C---hHHHHHHHHHHHHHHHHcC---ceecccchheeEEec
Confidence 4444433 4457899999887776654322 1 2234445555566777889 999999999999999
Q ss_pred CCcEEEeecCCCcc
Q 005355 528 KYRAKVSDFGASRS 541 (700)
Q Consensus 528 ~~~~kl~DfGl~~~ 541 (700)
+..++++||--...
T Consensus 238 d~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 238 DDKIVVIDFPQMVS 251 (465)
T ss_pred CCCEEEeechHhhc
Confidence 99999999965543
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.024 Score=59.02 Aligned_cols=142 Identities=18% Similarity=0.175 Sum_probs=84.0
Q ss_pred cceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCC--ceeeEEeE------EEeCCcceEEEe
Q 005355 395 NRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHR--NVVKLLGC------CLETEVPLLVYE 466 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~E 466 (700)
.+.|..|....+|+.... +..+++|+.... ..+....|++++..+.+. .+.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456777777899998765 457888987642 235566788888777433 24444431 223455689999
Q ss_pred eCCCCCHHH----H----------HhccCCC--------CCCCHHHHH----------HHHHHHHHHHHHHHhc----CC
Q 005355 467 FIPNGTLYQ----Y----------IHDQTEE--------FPITWEIRL----------RIAIEVSDALCYLHSA----AS 510 (700)
Q Consensus 467 ~~~~gsL~~----~----------l~~~~~~--------~~l~~~~~~----------~i~~qi~~aL~~LH~~----~~ 510 (700)
|++|..+.. . +|..... ....|.... .....+..++.++.+. -.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998866432 1 1111100 011121110 0111233445555531 12
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 511 IPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 511 ~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
..++|+|+.|.|||++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 348999999999999998777899998774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.018 Score=59.77 Aligned_cols=136 Identities=15% Similarity=0.228 Sum_probs=77.4
Q ss_pred EEEEEEEcCCcEEEEEEcc-ccChhhHHHHHHHHHHHhhcCC--CceeeEEeEEEeCC--cceEEEeeCCCCCHHHHHhc
Q 005355 405 TVYKGMLTNGRIVAIKKSK-LVDESNIEQFINEVAILSQINH--RNVVKLLGCCLETE--VPLLVYEFIPNGTLYQYIHD 479 (700)
Q Consensus 405 ~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~E~~~~gsL~~~l~~ 479 (700)
.+|..... ++++++++-. ...........+|.++++.+.- --+...++.+.++. .++.||+|+++..+.+.+..
T Consensus 40 ~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~ 118 (321)
T COG3173 40 DTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP 118 (321)
T ss_pred ceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence 44444443 6777777221 2233445667788888888743 34455666676665 67999999987322221111
Q ss_pred cCC-----------------------------------CCCCCHHHHHHHH--------HHHHHHHHHHHhcC-----CC
Q 005355 480 QTE-----------------------------------EFPITWEIRLRIA--------IEVSDALCYLHSAA-----SI 511 (700)
Q Consensus 480 ~~~-----------------------------------~~~l~~~~~~~i~--------~qi~~aL~~LH~~~-----~~ 511 (700)
... +..-.|....+.+ -....-..+|+.+. .+
T Consensus 119 ~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~ 198 (321)
T COG3173 119 ESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPP 198 (321)
T ss_pred ccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCc
Confidence 000 0000111111100 01222234444332 24
Q ss_pred CeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 512 PIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 512 ~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
.++|+|+.+.|++|+++..+-|.||+++..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 699999999999999988899999999864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.016 Score=59.71 Aligned_cols=31 Identities=23% Similarity=0.487 Sum_probs=25.4
Q ss_pred CCeeecCCCCCcEEECCCCc-EEEeecCCCcc
Q 005355 511 IPIYHRDIKSANILLDDKYR-AKVSDFGASRS 541 (700)
Q Consensus 511 ~~ivH~Dik~~NILl~~~~~-~kl~DfGl~~~ 541 (700)
+.++|+|+.+.|||++++++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999997555 56999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.25 Score=52.17 Aligned_cols=79 Identities=18% Similarity=0.194 Sum_probs=50.6
Q ss_pred eEeeeCCeEEEEEEEcCC-cEEEEEEccc----c---ChhhHHHHHHHHHHHhhcC--CC-ceeeEEeEEEeCCcceEEE
Q 005355 397 ILGQGGQGTVYKGMLTNG-RIVAIKKSKL----V---DESNIEQFINEVAILSQIN--HR-NVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 397 ~lG~G~fg~Vy~~~~~~~-~~vavK~~~~----~---~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 465 (700)
.||-|....||++...++ +.|+||.... . -+-..++..-|.+.|+... -| .+.+++. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 578899999999997654 6899996331 1 1334566667888887653 34 3444443 3445557999
Q ss_pred eeCCCC-CHHHHH
Q 005355 466 EFIPNG-TLYQYI 477 (700)
Q Consensus 466 E~~~~g-sL~~~l 477 (700)
|+++.. .|.+.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 998653 343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.019 Score=61.12 Aligned_cols=139 Identities=20% Similarity=0.231 Sum_probs=78.6
Q ss_pred eEeeeCCeEEEEEEEcC-----CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCce-eeEEeEEEeCCcceEEEeeCCC
Q 005355 397 ILGQGGQGTVYKGMLTN-----GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNV-VKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 397 ~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~ 470 (700)
.|-.|-.-.+|+..+.+ ++.|++|+.........+ -.+|..+++.+...++ .++++.+... .|.||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 34445666788877532 367889987654332222 3678888888854333 3455555322 58999987
Q ss_pred CCHHHH-----------------HhccCCC---CCCCHHHHHHHHHHH-----------------HHHHHHHH----h-c
Q 005355 471 GTLYQY-----------------IHDQTEE---FPITWEIRLRIAIEV-----------------SDALCYLH----S-A 508 (700)
Q Consensus 471 gsL~~~-----------------l~~~~~~---~~l~~~~~~~i~~qi-----------------~~aL~~LH----~-~ 508 (700)
.+|... +|..... ....++.+..+..++ ...+..|. . .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 665421 1211100 012233333333221 11122222 1 1
Q ss_pred CCCCeeecCCCCCcEEECC-CCcEEEeecCCCc
Q 005355 509 ASIPIYHRDIKSANILLDD-KYRAKVSDFGASR 540 (700)
Q Consensus 509 ~~~~ivH~Dik~~NILl~~-~~~~kl~DfGl~~ 540 (700)
....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 2234899999999999986 4689999998775
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.11 Score=55.62 Aligned_cols=74 Identities=15% Similarity=0.116 Sum_probs=49.9
Q ss_pred cceEeeeCCeEEEEEEEcC-CcEEEEEEccc---c---ChhhHHHHHHHHHHHhhcC--CC-ceeeEEeEEEeCCcceEE
Q 005355 395 NRILGQGGQGTVYKGMLTN-GRIVAIKKSKL---V---DESNIEQFINEVAILSQIN--HR-NVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~---~---~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv 464 (700)
.+.||-|.-..||++...+ ++.|+||.... . -+-..++..-|.+.|+... -| .+.+++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4578999999999999743 56899996321 1 1334667778888888763 34 45555543 44455788
Q ss_pred EeeCCC
Q 005355 465 YEFIPN 470 (700)
Q Consensus 465 ~E~~~~ 470 (700)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998864
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.00069 Score=80.76 Aligned_cols=162 Identities=14% Similarity=0.007 Sum_probs=116.4
Q ss_pred HHHHHHHHHHhhcCCCceeeEEeEEE--eCCcceEEEeeCCCCCHHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHHHh
Q 005355 431 EQFINEVAILSQINHRNVVKLLGCCL--ETEVPLLVYEFIPNGTLYQYIHDQTEE-FPITWEIRLRIAIEVSDALCYLHS 507 (700)
Q Consensus 431 ~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~ 507 (700)
+....|..-++...|+++.....-.. +....+..++++..|.+.+.|.+..++ ..+..........+.+.+..-.|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 33444555555567888776655443 234557899999999999998776443 234444444444444666666665
Q ss_pred cC--CCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHH
Q 005355 508 AA--SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVE 585 (700)
Q Consensus 508 ~~--~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~e 585 (700)
.. ....+|+++|+-|.+|..+.++|++++|+.+.. ...........+++-|++|+....-.++.++|+|..++-+|+
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk-np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK-NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCccccccccccccc-CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 32 234799999999999999999999999999832 222333444557888999999999999999999999999999
Q ss_pred HHhCCCCC
Q 005355 586 LLTGQKPI 593 (700)
Q Consensus 586 lltg~~p~ 593 (700)
+-.|..+|
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 98887765
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.031 Score=58.04 Aligned_cols=141 Identities=18% Similarity=0.206 Sum_probs=93.7
Q ss_pred CccceEeeeCCeEEEEEEEcCCcEEEEEEcccc-------Ch------------------hhHH-HHHHHHHHHhhcCCC
Q 005355 393 NTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLV-------DE------------------SNIE-QFINEVAILSQINHR 446 (700)
Q Consensus 393 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~-------~~------------------~~~~-~~~~E~~~l~~l~h~ 446 (700)
.+.-.|..|--+.||.+.-.+|..+|||+.+.. +. ...+ ....|++-|.+|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345578889999999999889999999975431 00 1111 123577777777543
Q ss_pred ceeeEEeEEEeCCcceEEEeeCCCCCH-HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005355 447 NVVKLLGCCLETEVPLLVYEFIPNGTL-YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL 525 (700)
Q Consensus 447 niv~l~~~~~~~~~~~lv~E~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl 525 (700)
.|.-.--.... ..+|||+|+....- .-.|+ ...++...+..+-.|++.-|.-|-+.. .+||.||+--|+|+
T Consensus 227 GIP~PePIlLk--~hVLVM~FlGrdgw~aPkLK----d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 227 GIPCPEPILLK--NHVLVMEFLGRDGWAAPKLK----DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred CCCCCCceeee--cceEeeeeccCCCCcCcccc----cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 33322111111 23799999953111 11111 223777788888889999999888765 39999999999998
Q ss_pred CCCCcEEEeecCCCccc
Q 005355 526 DDKYRAKVSDFGASRSV 542 (700)
Q Consensus 526 ~~~~~~kl~DfGl~~~~ 542 (700)
.+. .+.|+|-+-+...
T Consensus 299 hdG-~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 299 HDG-KLYIIDVSQSVEH 314 (520)
T ss_pred ECC-EEEEEEccccccC
Confidence 654 8999999877644
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.074 Score=57.14 Aligned_cols=80 Identities=16% Similarity=0.153 Sum_probs=53.0
Q ss_pred cceEeeeCCeEEEEEEEcCCcEEEEEEccc----cCh---hhHHHHHHHHHHHhhcC---CCceeeEEeEEEeCCcceEE
Q 005355 395 NRILGQGGQGTVYKGMLTNGRIVAIKKSKL----VDE---SNIEQFINEVAILSQIN---HRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~----~~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 464 (700)
.+.||.|....||+.... ++.++||+... ... -...+-..|++.|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 457899999999998764 56799997541 111 13344455677776653 357888888776 446889
Q ss_pred EeeCCC--CCHHHHH
Q 005355 465 YEFIPN--GTLYQYI 477 (700)
Q Consensus 465 ~E~~~~--gsL~~~l 477 (700)
||++++ ..+.+.+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 3344444
|
|
| >KOG1219 consensus Uncharacterized conserved protein, contains laminin, cadherin and EGF domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.013 Score=71.75 Aligned_cols=48 Identities=19% Similarity=0.517 Sum_probs=33.4
Q ss_pred CCcccccCCCceeeeccCCCcc----------ccCCcccccccccCCCCCcccCCCCCC
Q 005355 231 DNRCSIQLTSGYSCLCHRSFNG----------LNDGYCVGDLLCDSASSPYNCSGCPNG 279 (700)
Q Consensus 231 ~s~c~~~~~~gy~C~C~~Gy~G----------~~~~~~~~~~~c~~~~~py~c~~c~~~ 279 (700)
..+|... ++||.|+|+.||.| |-...|.-.++|.+..+-|+|.|.+++
T Consensus 3914 GgtCip~-~n~f~CnC~~gyTG~~Ce~~Gi~eCs~n~C~~gg~C~n~~gsf~CncT~g~ 3971 (4289)
T KOG1219|consen 3914 GGTCIPF-YNGFLCNCPNGYTGKRCEARGISECSKNVCGTGGQCINIPGSFHCNCTPGI 3971 (4289)
T ss_pred CCEEEec-CCCeeEeCCCCccCceeecccccccccccccCCceeeccCCceEeccChhH
Confidence 3455433 67999999999999 333345555888888888888755443
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.014 Score=62.92 Aligned_cols=50 Identities=16% Similarity=0.235 Sum_probs=40.2
Q ss_pred HHHHHHHHHHhhcCCCceeeEEeEEEeCC-cceEEEeeCCCCCHHHHHhccC
Q 005355 431 EQFINEVAILSQINHRNVVKLLGCCLETE-VPLLVYEFIPNGTLYQYIHDQT 481 (700)
Q Consensus 431 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~ 481 (700)
.++.....+++.+.|+|+...+++..... ...+|+|++ +.+|.+++....
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 56777888999999999999998876543 357889988 779999987654
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.44 Score=49.85 Aligned_cols=28 Identities=36% Similarity=0.434 Sum_probs=24.6
Q ss_pred CeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 512 PIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 512 ~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 4899999999999988 578999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.034 Score=54.71 Aligned_cols=29 Identities=28% Similarity=0.467 Sum_probs=20.7
Q ss_pred CeeecCCCCCcEEE-CCCCcEEEeecCCCc
Q 005355 512 PIYHRDIKSANILL-DDKYRAKVSDFGASR 540 (700)
Q Consensus 512 ~ivH~Dik~~NILl-~~~~~~kl~DfGl~~ 540 (700)
.+.|+|+.+.|||+ +.++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 37899999999999 888999999999885
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.16 Score=53.77 Aligned_cols=139 Identities=17% Similarity=0.214 Sum_probs=76.7
Q ss_pred eEeeeCCeEEEEEEEcC----CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCce-eeEEeEEEeCCcceEEEeeCCCC
Q 005355 397 ILGQGGQGTVYKGMLTN----GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNV-VKLLGCCLETEVPLLVYEFIPNG 471 (700)
Q Consensus 397 ~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~g 471 (700)
.|..|-.-.+|+....+ +..|++|+....... .-.-.+|..+++.+...++ .++++++. . .+|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~---G~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-N---GMIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-C---cEeehhhcCC
Confidence 44446666788876543 237888987653332 2233578888888864444 34555542 2 2588998776
Q ss_pred CHHH-------H----------HhccCC---CCCCCHHHHHHHHHHH----------------------HHHHHH----H
Q 005355 472 TLYQ-------Y----------IHDQTE---EFPITWEIRLRIAIEV----------------------SDALCY----L 505 (700)
Q Consensus 472 sL~~-------~----------l~~~~~---~~~l~~~~~~~i~~qi----------------------~~aL~~----L 505 (700)
+|.. . +|.... ..+-.+..+.++..++ .+-+.. +
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 5421 0 111110 0111233333322221 111222 2
Q ss_pred HhcC-CCCeeecCCCCCcEEECC-CCcEEEeecCCCc
Q 005355 506 HSAA-SIPIYHRDIKSANILLDD-KYRAKVSDFGASR 540 (700)
Q Consensus 506 H~~~-~~~ivH~Dik~~NILl~~-~~~~kl~DfGl~~ 540 (700)
.+.+ +..+.|+|+.+.|||+++ ++.++++||..+.
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1112 223789999999999975 5789999999875
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.41 Score=50.20 Aligned_cols=30 Identities=13% Similarity=0.235 Sum_probs=27.0
Q ss_pred CeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 512 PIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 512 ~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
.++|+|+.++|||+++++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999987753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.45 E-value=0.16 Score=49.20 Aligned_cols=103 Identities=16% Similarity=0.082 Sum_probs=64.6
Q ss_pred EEEEEEccccChh-hHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHH
Q 005355 416 IVAIKKSKLVDES-NIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI 494 (700)
Q Consensus 416 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i 494 (700)
...+|++...+-. ....|..+.+++.++. .|+++..- .....-++.|.+... ... ...+
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~---------------~i~-~~N~ 146 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI---------------KIN-FSNF 146 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc---------------ccc-hhHH
Confidence 3455655544333 4466788888888874 45555521 233445888877321 000 1112
Q ss_pred HHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 495 AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 495 ~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
+..=+++|.-.|+.. ...+|+|-.|+||+-|..|.+||.|-+..
T Consensus 147 i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 147 ITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 222246677788543 24999999999999999999999997643
|
The function of this family is unknown. |
| >PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.027 Score=37.90 Aligned_cols=25 Identities=24% Similarity=0.820 Sum_probs=17.6
Q ss_pred ccccCCcccccCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
.|..+..|.+..+ .|.|.|+.||.|
T Consensus 7 ~C~~nA~C~~~~~-~~~C~C~~Gy~G 31 (36)
T PF12947_consen 7 GCHPNATCTNTGG-SYTCTCKPGYEG 31 (36)
T ss_dssp GS-TTCEEEE-TT-SEEEEE-CEEEC
T ss_pred CCCCCcEeecCCC-CEEeECCCCCcc
Confidence 4666667776544 899999999999
|
; PDB: 2NPR_A 1N1I_C 1B9W_A 1YO8_A 2RHP_A. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=93.79 E-value=0.81 Score=44.85 Aligned_cols=74 Identities=19% Similarity=0.265 Sum_probs=51.4
Q ss_pred eEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhc---CCCceeeEEeEEEeCCcceEEEeeCCCCCH
Q 005355 397 ILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQI---NHRNVVKLLGCCLETEVPLLVYEFIPNGTL 473 (700)
Q Consensus 397 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 473 (700)
.+.-|.--..|...+ +...+.||.-. ......|..|+.-|..| +.-.+.+++.+-.+.++.++|+||++-+.+
T Consensus 23 ~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 23 EVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred ccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 343343344454433 35678888644 34456788888877776 446688899999999999999999998665
Q ss_pred H
Q 005355 474 Y 474 (700)
Q Consensus 474 ~ 474 (700)
.
T Consensus 99 d 99 (286)
T COG3001 99 D 99 (286)
T ss_pred C
Confidence 5
|
|
| >PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins | Back alignment and domain information |
|---|
Probab=93.61 E-value=0.028 Score=36.75 Aligned_cols=26 Identities=27% Similarity=0.787 Sum_probs=22.1
Q ss_pred ccccCCcccccCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
-|...++|.+....+|.|.|..||.|
T Consensus 5 ~C~n~g~C~~~~~~~y~C~C~~G~~G 30 (32)
T PF00008_consen 5 PCQNGGTCIDLPGGGYTCECPPGYTG 30 (32)
T ss_dssp SSTTTEEEEEESTSEEEEEEBTTEES
T ss_pred cCCCCeEEEeCCCCCEEeECCCCCcc
Confidence 47777888876578999999999999
|
The list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied. The functional significance of EGF domains in what appear to be unrelated proteins is not yet clear. However, a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase). The EGF domain includes six cysteine residues which have been shown (in EGF) to be involved in disulphide bonds. The main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet. Subdomains between the conserved cysteines vary in length.; GO: 0005515 protein binding; PDB: 1WHE_A 1CCF_A 1APO_A 1WHF_A 2VJ3_A 1TOZ_A 4D90_B 3CFW_A 1EDM_B 1IXA_A .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 700 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-48 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-47 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-34 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-28 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-28 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-28 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-27 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-27 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-26 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-24 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-24 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-24 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-24 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-24 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-24 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-24 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-23 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-23 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-23 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-23 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-23 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-23 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-23 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-23 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-23 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-23 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-23 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-23 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-23 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-23 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-23 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-23 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-23 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-23 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-23 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-23 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-23 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-23 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-23 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-23 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-23 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-23 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-23 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-23 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-22 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-22 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-22 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-22 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-21 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-21 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-21 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-20 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-20 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-20 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-20 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-19 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-19 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-19 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 7e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-19 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-18 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-18 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-18 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-18 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-18 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-18 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-18 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-18 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-18 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-17 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-17 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-17 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-17 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-17 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-17 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-17 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-17 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-17 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 7e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 355 bits (914), Expect = e-118
Identities = 108/298 (36%), Positives = 171/298 (57%), Gaps = 5/298 (1%)
Query: 367 SSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVD 426
SS+ ++ ++LE AT+NF+ ++G G G VYKG+L +G VA+K+
Sbjct: 16 LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75
Query: 427 ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHD-QTEEFP 485
IE+F E+ LS H ++V L+G C E +L+Y+++ NG L ++++
Sbjct: 76 SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 486 ITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI- 544
++WE RL I I + L YLH+ I HRD+KS NILLD+ + K++DFG S+
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSL 604
DQTHL+T V+GT GY+DPEYF + TEKSDVYSFGVVL E+L + I + E +L
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 605 VGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662
+ +E+ +L +++D + + + E + A +CL + + RP+M + ++L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 339 bits (873), Expect = e-112
Identities = 108/298 (36%), Positives = 176/298 (59%), Gaps = 7/298 (2%)
Query: 364 QQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSK 423
+++ + G K F+ EL++A+DNF+ ILG+GG G VYKG L +G +VA+K+ K
Sbjct: 7 EEDPEVHLGQ---LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLK 63
Query: 424 LVDESNIE-QFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTE 482
E QF EV ++S HRN+++L G C+ LLVY ++ NG++ + ++ E
Sbjct: 64 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 483 -EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541
+ P+ W R RIA+ + L YLH I HRD+K+ANILLD+++ A V DFG ++
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPI--RSTDSE 599
+ TH+TT V+GT G++ PEY + + +EK+DV+ +GV+L+EL+TGQ+ ++
Sbjct: 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 600 EDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657
+D L+ + +KE +L ++D + K+EE+ + +A C +RP M E
Sbjct: 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 332 bits (853), Expect = e-109
Identities = 104/315 (33%), Positives = 171/315 (54%), Gaps = 20/315 (6%)
Query: 366 ESSSNEGNSEKTKLFTSMELEMATDNFN------TNRILGQGGQGTVYKGMLTNGRIVAI 419
E+ S E + + F+ EL+ T+NF+ +G+GG G VYKG + N VA+
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 420 KKSKLVDESNIEQ----FINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQ 475
KK + + E+ F E+ ++++ H N+V+LLG + + LVY ++PNG+L
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 476 YIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535
+ P++W +R +IA ++ + +LH I HRDIKSANILLD+ + AK+SD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISD 176
Query: 536 FGASRSV-MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIR 594
FG +R+ QT +T+R+ GT Y+ PE R + T KSD+YSFGVVL+E++TG +
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 595 STDSEEDKSLVGYFLEAMKENR-LFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRP 653
+ L+ E E + + + +D + + +A + + +A +CL+ KRP
Sbjct: 236 EHREPQ--LLLDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 654 TMKEAAFELGGIRAS 668
+K+ L + AS
Sbjct: 293 DIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 5e-74
Identities = 64/323 (19%), Positives = 116/323 (35%), Gaps = 33/323 (10%)
Query: 363 LQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKS 422
+ + + + L + + +G G V+K L VA+K
Sbjct: 1 MGHHHHHHSSGVD----LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF 55
Query: 423 KLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGTLYQYIH 478
+ D+ + Q EV L + H N+++ +G L+ F G+L ++
Sbjct: 56 PIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114
Query: 479 DQTEEFPITWEIRLRIAIEVSDALCYLHSAASI-------PIYHRDIKSANILLDDKYRA 531
++W IA ++ L YLH I HRDIKS N+LL + A
Sbjct: 115 ANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170
Query: 532 KVSDFGASRSVMIDQTHL-TTRVQGTFGYLDPEYFRSS-----QFTEKSDVYSFGVVLVE 585
++DFG + ++ T GT Y+ PE + + D+Y+ G+VL E
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230
Query: 586 LLTGQKPIRSTDSE-----EDKSLVGYFLEAMKENRLFEVLDARVLKE-AKEEEIITVAM 639
L + E E++ LE M+E + + + K + +
Sbjct: 231 LASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCE 290
Query: 640 LAKRCLNMIGKKRPTMKEAAFEL 662
+ C + + R + +
Sbjct: 291 TIEECWDHDAEARLSAGCVGERI 313
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 1e-72
Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 36/284 (12%)
Query: 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCC 455
++G+G G V K + VAIK+ + ES + FI E+ LS++NH N+VKL G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 456 LETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIY 514
L P+ LV E+ G+LY +H T + ++ S + YLHS +
Sbjct: 71 LN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 515 HRDIKSANILLDDKYR-AKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 573
HRD+K N+LL K+ DFG + + QTH+T G+ ++ PE F S ++EK
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK-GSAAWMAPEVFEGSNYSEK 183
Query: 574 SDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEE 633
DV+S+G++L E++T +KP E R
Sbjct: 184 CDVFSWGIILWEVITRRKPF----DEIGGPAFRIMWAVHNGTRP---------------P 224
Query: 634 IIT-----VAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDS 672
+I + L RC + +RP+M+E + + +
Sbjct: 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 6e-72
Identities = 73/232 (31%), Positives = 116/232 (50%), Gaps = 5/232 (2%)
Query: 363 LQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKS 422
+ N ++++ + N +G G GTV++ +G VA+K
Sbjct: 10 MSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKIL 68
Query: 423 KLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ 480
D + +F+ EVAI+ ++ H N+V +G + +V E++ G+LY+ +H
Sbjct: 69 MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS 128
Query: 481 TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540
+ RL +A +V+ + YLH+ + PI HR++KS N+L+D KY KV DFG SR
Sbjct: 129 GAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187
Query: 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
+ + GT ++ PE R EKSDVYSFGV+L EL T Q+P
Sbjct: 188 -LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 8e-68
Identities = 69/209 (33%), Positives = 111/209 (53%), Gaps = 20/209 (9%)
Query: 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESN----IEQFINEVAILSQINHRNVVKL 451
I+G GG G VY+ G VA+K ++ + + IE E + + + H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 452 LGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASI 511
G CL+ LV EF G L + + + I +I + A++++ + YLH A +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 512 PIYHRDIKSANILLDDKYR--------AKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE 563
PI HRD+KS+NIL+ K K++DFG +R +T + G + ++ PE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSAA-GAYAWMAPE 184
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
R+S F++ SDV+S+GV+L ELLTG+ P
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-66
Identities = 73/212 (34%), Positives = 114/212 (53%), Gaps = 24/212 (11%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESN-------IEQFINEVAILSQINHRN 447
+ +G+GG G V+KG + + +VAIK L D ++F EV I+S +NH N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
+VKL G P +V EF+P G LY + D+ PI W ++LR+ ++++ + Y+ +
Sbjct: 85 IVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQN 140
Query: 508 AASIPIYHRDIKSANILLDDK-----YRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDP 562
+ PI HRD++S NI L AKV+DFG S+ H + + G F ++ P
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAP 195
Query: 563 EYF--RSSQFTEKSDVYSFGVVLVELLTGQKP 592
E +TEK+D YSF ++L +LTG+ P
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-64
Identities = 44/204 (21%), Positives = 87/204 (42%), Gaps = 16/204 (7%)
Query: 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLG 453
L + G ++KG G + +K K+ F E L +H NV+ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 454 CCLETEVPLL--VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASI 511
C P + ++P G+LY +H+ T F + ++ A++++ + +LH+
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTL-EP 132
Query: 512 PIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ-- 569
I + S ++++D+ A++S S + ++ PE +
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPED 186
Query: 570 -FTEKSDVYSFGVVLVELLTGQKP 592
+D++SF V+L EL+T + P
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVP 210
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 1e-60
Identities = 66/292 (22%), Positives = 121/292 (41%), Gaps = 33/292 (11%)
Query: 396 RILGQGGQGTVYKGML-TNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGC 454
+LG+G G K G ++ +K+ DE F+ EV ++ + H NV+K +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIY 514
+ + + E+I GTL I ++P W R+ A +++ + YLH S+ I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYP--WSQRVSFAKDIASGMAYLH---SMNII 130
Query: 515 HRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQ-------------GTFGYLD 561
HRD+ S N L+ + V+DFG +R ++ ++T G ++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 562 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621
PE + EK DV+SFG+VL E++ D + + + L +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYLPRTMDFGLNVRGFLDRYCPP 246
Query: 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSI 673
+ + + RC ++ +KRP+ + L +R + +
Sbjct: 247 NC----------PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-60
Identities = 62/277 (22%), Positives = 107/277 (38%), Gaps = 38/277 (13%)
Query: 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLG 453
++G+G G VY G +G VAI+ + +E ++ F EV Q H NVV +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPI 513
C+ ++ TLY + D +IA E+ + YLH + I
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD--VNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASR----SVMIDQTHLTTRVQGTFGYLDPEYFRSSQ 569
H+D+KS N+ D+ + ++DFG + G +L PE R
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 570 ---------FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620
F++ SDV++ G + EL + P ++ +E +G +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG-------TGMKPNL 263
Query: 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657
+ KE ++ + C ++RPT +
Sbjct: 264 SQIGMGKE--------ISDILLFCWAFEQEERPTFTK 292
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 4e-60
Identities = 71/327 (21%), Positives = 126/327 (38%), Gaps = 48/327 (14%)
Query: 380 FTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAI 439
+ E + DN ++G+G G VYKG L + R VA+K + + FINE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNI 58
Query: 440 --LSQINHRNVVKLLGCCLETEVP-----LLVYEFIPNGTLYQYIHDQTEEFPITWEIRL 492
+ + H N+ + + LLV E+ PNG+L +Y+ T W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114
Query: 493 RIAIEVSDALCYLHSAASI------PIYHRDIKSANILLDDKYRAKVSDFGASR------ 540
R+A V+ L YLH+ I HRD+ S N+L+ + +SDFG S
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 541 -SVMIDQTHLTTRVQGTFGYLDPEYFRSS-------QFTEKSDVYSFGVVLVELLTGQKP 592
++ + GT Y+ PE + ++ D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 593 IRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE-----------AKEEEIITVAMLA 641
+ +S + + F + + FE + V +E + ++
Sbjct: 235 LFPGESVPEYQMA--FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 642 KRCLNMIGKKRPTMKEAAFELGGIRAS 668
+ C + + R T + A + +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMI 319
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 2e-59
Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLG 453
+ +G G GTVYKG +G VA+K + ++ F NEV +L + H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 454 CCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIP 512
T L +V ++ +LY ++H +F + + IA + + + YLH+
Sbjct: 88 YS--TAPQLAIVTQWCEGSSLYHHLHASETKFE--MKKLIDIARQTARGMDYLHA---KS 140
Query: 513 IYHRDIKSANILLDDKYRAKVSDFGASR-SVMIDQTHLTTRVQGTFGYLDPEYFR---SS 568
I HRD+KS NI L + K+ DFG + +H ++ G+ ++ PE R S+
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 569 QFTEKSDVYSFGVVLVELLTGQKP 592
++ +SDVY+FG+VL EL+TGQ P
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLP 224
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-52
Identities = 59/295 (20%), Positives = 105/295 (35%), Gaps = 39/295 (13%)
Query: 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAI--LSQINHRNVVKLLG 453
+G+G G V++G G VA+K + + + E + + H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKI---FSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 454 CCLETEVP----LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA 509
+ + L+ + G+LY Y+ T + LRI + ++ L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 510 SI-----PIYHRDIKSANILLDDKYRAKVSDFGASR----SVMIDQTHLTTRVQGTFGYL 560
I HRD+KS NIL+ + ++D G + S RV GT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 184
Query: 561 DPE------YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSE----EDKSLVGYFLE 610
PE ++ D+++FG+VL E+ + D E
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 611 AMKENRLFEVLDAR-VLKEAKEEEIITVAM--LAKRCLNMIGKKRPTMKEAAFEL 662
M++ + R + + ++ L K C R T L
Sbjct: 245 DMRKVVCVD--QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-52
Identities = 61/303 (20%), Positives = 112/303 (36%), Gaps = 43/303 (14%)
Query: 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAI--LSQINHRNVVKLLG 453
+ +G+G G V+ G G VA+K +E + E I + H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIA 98
Query: 454 CCLETEVP----LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA 509
++ L+ ++ NG+LY Y+ T + + L++A LC+LH+
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 510 SI-----PIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL---TTRVQGTFGYLD 561
I HRD+KS NIL+ ++D G + + D + GT Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 562 PE------YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN 615
PE Q +D+YSFG++L E+ + + + + + +
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP-----YHDLVPSD 269
Query: 616 RLFEVLDARVLKE----------AKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665
+E + V + + +E + + L C R T L +
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
Query: 666 RAS 668
S
Sbjct: 330 SES 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 5e-51
Identities = 63/341 (18%), Positives = 123/341 (36%), Gaps = 51/341 (14%)
Query: 361 LLLQQESS-SNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAI 419
L+ +S S G + + + + +G+G G V++G G VA+
Sbjct: 19 LIYDMTTSGSGSGLPLLVQRTIARTIVLQ-------ESIGKGRFGEVWRGKW-RGEEVAV 70
Query: 420 KKSKLVDESNIEQFINEVAI--LSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGTL 473
K + E I + H N++ + + LV ++ +G+L
Sbjct: 71 KI---FSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL 127
Query: 474 YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAAS-----IPIYHRDIKSANILLDDK 528
+ Y++ T +T E +++A+ + L +LH I HRD+KS NIL+
Sbjct: 128 FDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 183
Query: 529 YRAKVSDFGASR----SVMIDQTHLTTRVQGTFGYLDPEYFRSS------QFTEKSDVYS 578
++D G + + RV GT Y+ PE S + +++D+Y+
Sbjct: 184 GTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMAPEVLDDSINMKHFESFKRADIYA 242
Query: 579 FGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE---------A 629
G+V E+ + + + Y+ + + E+ ++
Sbjct: 243 MGLVFWEIARRCSIGGIHEDYQ----LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ 298
Query: 630 KEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670
E + +A + + C G R T L + G
Sbjct: 299 SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 73/283 (25%), Positives = 121/283 (42%), Gaps = 27/283 (9%)
Query: 383 MELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKL--VDESNIEQFINEVAI 439
M +++ +G G G K ++G+I+ K+ + E+ + ++EV +
Sbjct: 1 MPSRA--EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNL 58
Query: 440 LSQINHRNVVKLLGCCLETEVPLL--VYEFIPNGTLYQYIHDQTEE-FPITWEIRLRIAI 496
L ++ H N+V+ ++ L V E+ G L I T+E + E LR+
Sbjct: 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 497 EVSDALCYLHS--AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQ 554
+++ AL H + HRD+K AN+ LD K K+ DFG +R + D + T V
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV- 177
Query: 555 GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE 614
GT Y+ PE + EKSD++S G +L EL P + +E L
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIR 229
Query: 615 NRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657
F + R E E + R LN+ RP+++E
Sbjct: 230 EGKFRRIPYRYSDELNE--------IITRMLNLKDYHRPSVEE 264
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 66/203 (32%), Positives = 99/203 (48%), Gaps = 14/203 (6%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIK--KSKLV-DESNIEQFINEVAILSQINHRNVVKL 451
LG GG TVY VAIK E +++F EV SQ++H+N+V +
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 452 LGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASI 511
+ E + LV E+I TL +YI P++ + + ++ D + + H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR-- 131
Query: 512 PIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTT--RVQGTFGYLDPEYFRSSQ 569
I HRDIK NIL+D K+ DFG ++++ +T LT V GT Y PE +
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 570 FTEKSDVYSFGVVLVELLTGQKP 592
E +D+YS G+VL E+L G+ P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 9/208 (4%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKK---SKLVDESNIEQFINEVAILSQINH 445
NF + +G+G VY+ L +G VA+KK L+D I E+ +L Q+NH
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEF-PITWEIRLRIAIEVSDALCY 504
NV+K +E +V E G L + I ++ I + +++ AL +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEY 564
+HS + HRDIK AN+ + K+ D G R T + V GT Y+ PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 565 FRSSQFTEKSDVYSFGVVLVELLTGQKP 592
+ + KSD++S G +L E+ Q P
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 59/232 (25%), Positives = 98/232 (42%), Gaps = 14/232 (6%)
Query: 364 QQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKS 422
SS + F SM + + + +G+G G +GR IK+
Sbjct: 4 HHHHSSGVDLGTENLYFQSM------EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI 57
Query: 423 KL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ 480
+ + E+ EVA+L+ + H N+V+ E +V ++ G L++ I+ Q
Sbjct: 58 NISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ 117
Query: 481 TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540
+ L +++ AL ++H I HRDIKS NI L ++ DFG +R
Sbjct: 118 KGV-LFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIAR 173
Query: 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
+ + GT YL PE + + KSD+++ G VL EL T +
Sbjct: 174 VLNSTVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-42
Identities = 66/290 (22%), Positives = 122/290 (42%), Gaps = 35/290 (12%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRI-VAIKKSK-LVDESNIEQFINEVAILSQI 443
+ ++ +G+G G V+ G L VA+K + + +F+ E IL Q
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY 169
Query: 444 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC 503
+H N+V+L+G C + + +V E + G ++ + + + L++ + + +
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGME 227
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY--LD 561
YL S I HRD+ + N L+ +K K+SDFG SR D + +
Sbjct: 228 YLESKCCI---HRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTA 283
Query: 562 PEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLV--GYFLEAMKE--NR 616
PE +++ +SDV+SFG++L E + G P + +++ + V G L + +
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDA 343
Query: 617 LFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666
+F + M +C +RP+ EL IR
Sbjct: 344 VFRL------------------ME--QCWAYEPGQRPSFSTIYQELQSIR 373
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-42
Identities = 63/230 (27%), Positives = 102/230 (44%), Gaps = 12/230 (5%)
Query: 367 SSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLV 425
S+ EG+ E L E D +LG+G G VY G L+N +AIK+
Sbjct: 3 RSTEEGDCESDLLEYDYEY----DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER 58
Query: 426 DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFP 485
D + E+A+ + H+N+V+ LG E + E +P G+L + +
Sbjct: 59 DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118
Query: 486 ITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGASRSVMI 544
+ ++ + L YLH I HRDIK N+L++ K+SDFG S+ +
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175
Query: 545 DQTHLTTRVQGTFGYLDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKP 592
T GT Y+ PE + + +D++S G ++E+ TG+ P
Sbjct: 176 INPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 73/310 (23%), Positives = 122/310 (39%), Gaps = 73/310 (23%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRN 447
+F +LGQG G V K + R AIKK + E + ++EV +L+ +NH+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 448 VVKLLGCCLETEVPL-------------LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI 494
VV+ LE + + E+ NGTLY IH + E R+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD-EYW-RL 121
Query: 495 AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV------------ 542
++ +AL Y+HS I HRD+K NI +D+ K+ DFG +++V
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 543 --MIDQTHLTTRVQGTFGYLDPEYFR-SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSE 599
+LT+ + GT Y+ E + + EK D+YS G++ E++
Sbjct: 179 NLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---------- 227
Query: 600 EDKSLVGYFLEAMKENRLFEVL-----------DARVLKEAKEEEIITVAMLAKRCLNMI 648
F M+ + + L D +K K+ + + ++
Sbjct: 228 --------FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKK--------IIRLLIDHD 271
Query: 649 GKKRPTMKEA 658
KRP +
Sbjct: 272 PNKRPGARTL 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-42
Identities = 68/207 (32%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIK--KSKLV-DESNIEQFINEVAILSQINHRNVVKL 451
ILG GG V+ L + R VA+K ++ L D S +F E + +NH +V +
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 452 L--GC--CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
G +P +V E++ TL +H E P+T + + + + AL + H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQ 134
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTT--RVQGTFGYLDPEYF 565
I HRD+K ANI++ KV DFG +R++ +T V GT YL PE
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 566 RSSQFTEKSDVYSFGVVLVELLTGQKP 592
R +SDVYS G VL E+LTG+ P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 55/203 (27%), Positives = 83/203 (40%), Gaps = 14/203 (6%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIK--KSKLV-DESNIEQFINEVAILSQINHRNVVKL 451
R++G+GG G VY+ RIVA+K L D + E ++ +VV +
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 452 LGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASI 511
+ I L + + P+ + I ++ AL H+A
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAAG-- 154
Query: 512 PIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTT--RVQGTFGYLDPEYFRSSQ 569
HRD+K NIL+ A + DFG + + LT GT Y+ PE F S
Sbjct: 155 -ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 570 FTEKSDVYSFGVVLVELLTGQKP 592
T ++D+Y+ VL E LTG P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-42
Identities = 68/304 (22%), Positives = 128/304 (42%), Gaps = 35/304 (11%)
Query: 364 QQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKS 422
Q+E + + + E+ + ++ + + +G+G TVYKG+ VA +
Sbjct: 1 QEERNQQQDDIEELET-KAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCEL 59
Query: 423 KLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGTLYQY 476
+ +S ++F E +L + H N+V+ T +LV E + +GTL Y
Sbjct: 60 QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY 119
Query: 477 IHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY-RAKVSD 535
+ + ++ ++ L +LH+ + PI HRD+K NI + K+ D
Sbjct: 120 L---KRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGD 175
Query: 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRS 595
G + + + V GT ++ PE + ++ E DVY+FG+ ++E+ T + P
Sbjct: 176 LGLAT---LKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYP--- 228
Query: 596 TDSEEDKSLVGYFL--EAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRP 653
SE + Y +K +V E K EII + C+ +R
Sbjct: 229 -YSECQNAAQIYRRVTSGVKPASFDKVAI----PEVK--EII------EGCIRQNKDERY 275
Query: 654 TMKE 657
++K+
Sbjct: 276 SIKD 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-41
Identities = 69/290 (23%), Positives = 120/290 (41%), Gaps = 58/290 (20%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNV 448
+F ++G GG G V+K +G+ IK+ K N E+ EV L++++H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDHVNI 66
Query: 449 VKLLGCCLETEVPL----------------LVYEFIPNGTLYQYIHDQTEEFPITWEIRL 492
V GC + + EF GTL Q+I + E + + L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLAL 125
Query: 493 RIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTR 552
+ +++ + Y+HS + +RD+K +NI L D + K+ DFG + TR
Sbjct: 126 ELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT--SLKNDGKRTR 180
Query: 553 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAM 612
+GT Y+ PE S + ++ D+Y+ G++L ELL A
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT------------------AF 222
Query: 613 KENRLFEVLDARVL-----KEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657
+ ++ F L ++ K+ K L ++ L+ + RP E
Sbjct: 223 ETSKFFTDLRDGIISDIFDKKEKT--------LLQKLLSKKPEDRPNTSE 264
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-41
Identities = 71/266 (26%), Positives = 120/266 (45%), Gaps = 12/266 (4%)
Query: 353 NFFKRNGGLL---LQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKG 409
+ L L + + + EM + LG G G VY+G
Sbjct: 180 HHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEG 239
Query: 410 MLTNGRI-VAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468
+ + VA+K K D +E+F+ E A++ +I H N+V+LLG C ++ EF+
Sbjct: 240 VWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298
Query: 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK 528
G L Y+ + ++ + L +A ++S A+ YL I HR++ + N L+ +
Sbjct: 299 TYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFI---HRNLAARNCLVGEN 354
Query: 529 YRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 588
+ KV+DFG SR + D + + PE ++F+ KSDV++FGV+L E+ T
Sbjct: 355 HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
Query: 589 -GQKPIRSTDSEEDKSLV--GYFLEA 611
G P D + L+ Y +E
Sbjct: 415 YGMSPYPGIDLSQVYELLEKDYRMER 440
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 67/313 (21%), Positives = 128/313 (40%), Gaps = 44/313 (14%)
Query: 364 QQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIK--- 420
SS + F SM ++ ++ + +G GG V++ + +I AIK
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKG--RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 61
Query: 421 KSKLVDESNIEQFINEVAILSQINHRN--VVKLLGCCLETEVPLLVYEFIPNGTLYQYIH 478
+ D ++ + NE+A L+++ + +++L + + +V E N L ++
Sbjct: 62 LEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK 119
Query: 479 DQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGA 538
+ + WE + + +A+ +H I H D+K AN L+ D K+ DFG
Sbjct: 120 KK-KSIDP-WERK-SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGI 172
Query: 539 SRSVMIDQT--HLTTRVQGTFGYLDPE-----------YFRSSQFTEKSDVYSFGVVLVE 585
+ + D T ++V GT Y+ PE S+ + KSDV+S G +L
Sbjct: 173 ANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231
Query: 586 LLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCL 645
+ G+ P + ++ K L A+ + K+ ++ + K CL
Sbjct: 232 MTYGKTPFQQIINQISK------LHAIIDPNHEIEFPDIPEKDLQD--------VLKCCL 277
Query: 646 NMIGKKRPTMKEA 658
K+R ++ E
Sbjct: 278 KRDPKQRISIPEL 290
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 54/207 (26%), Positives = 106/207 (51%), Gaps = 18/207 (8%)
Query: 396 RILGQGGQGTVYKGMLT----NGRI-VAIKKSKL-VDESNIEQFINEVAILSQINHRNVV 449
++LG G GTVYKG+ +I VAIK+ + ++ ++E +++ +++ +V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA 509
+LLG CL + V L+ + +P G L Y+ + + + L ++++ + YL
Sbjct: 81 RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLEDRR 137
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGT---FGYLDPEYFR 566
+ HRD+ + N+L+ K++DFG ++ + ++ +G ++ E
Sbjct: 138 LV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESIL 192
Query: 567 SSQFTEKSDVYSFGVVLVELLT-GQKP 592
+T +SDV+S+GV + EL+T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 75/333 (22%), Positives = 144/333 (43%), Gaps = 52/333 (15%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTNG----RIVAIK--KSKLVDESNIEQFINEV 437
++ + F R+LG+G G+V + L VA+K K+ ++ S+IE+F+ E
Sbjct: 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 438 AILSQINHRNVVKLLGCCLETE------VPLLVYEFIPNGTLYQYI---HDQTEEFPITW 488
A + + +H +V KL+G L + +P+++ F+ +G L+ ++ F +
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 489 EIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548
+ +R ++++ + YL +S HRD+ + N +L + V+DFG SR + +
Sbjct: 137 QTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY 193
Query: 549 LTTRVQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDK 602
QG L E + +T SDV++FGV + E++T GQ P ++ E
Sbjct: 194 ----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 603 SLV--GYFLEAMKE--NRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
+ + G L+ E ++++ M +C + K+RP+
Sbjct: 250 NYLIGGNRLKQPPECMEEVYDL------------------MY--QCWSADPKQRPSFTCL 289
Query: 659 AFELGGIRASIGDSIMQHNCDDIDFVAGHNTGH 691
EL I + + I+ H+ H
Sbjct: 290 RMELENILGHLSVLSTSQDPLYINIERAHHHHH 322
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-40
Identities = 64/246 (26%), Positives = 119/246 (48%), Gaps = 19/246 (7%)
Query: 353 NFFKRNGGLLLQQ--ESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGM 410
+ + L + + EG F + + +G+G G V G
Sbjct: 154 EHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD 213
Query: 411 LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIP 469
G VA+K K +++ + F+ E ++++Q+ H N+V+LLG +E + L +V E++
Sbjct: 214 Y-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270
Query: 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY 529
G+L Y+ + + + L+ +++V +A+ YL + HRD+ + N+L+ +
Sbjct: 271 KGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDN 326
Query: 530 RAKVSDFGASRSVMIDQTHLTTRVQGTFGY--LDPEYFRSSQFTEKSDVYSFGVVLVELL 587
AKVSDFG ++ +T+ G PE R +F+ KSDV+SFG++L E+
Sbjct: 327 VAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 380
Query: 588 T-GQKP 592
+ G+ P
Sbjct: 381 SFGRVP 386
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-40
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 11/210 (5%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINH 445
E+ + + LG G G V G VA+K K + ++F E + +++H
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSH 62
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
+VK G C + +V E+I NG L Y+ ++ + L + +V + + +L
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY--LDPE 563
S I HRD+ + N L+D KVSDFG +R V+ DQ + V F PE
Sbjct: 121 ESHQFI---HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPE 175
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
F +++ KSDV++FG+++ E+ + G+ P
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 62/226 (27%), Positives = 114/226 (50%), Gaps = 17/226 (7%)
Query: 371 EGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNI 430
G+ F + + +G+G G V G G VA+K K +++
Sbjct: 2 GGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATA 58
Query: 431 EQFINEVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWE 489
+ F+ E ++++Q+ H N+V+LLG +E + L +V E++ G+L Y+ + + +
Sbjct: 59 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGD 117
Query: 490 IRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549
L+ +++V +A+ YL + HRD+ + N+L+ + AKVSDFG ++
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEA------S 168
Query: 550 TTRVQGTFGY--LDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
+T+ G PE R +F+ KSDV+SFG++L E+ + G+ P
Sbjct: 169 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-40
Identities = 61/293 (20%), Positives = 116/293 (39%), Gaps = 46/293 (15%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRN 447
+F + LG+GG G V++ + AIK+ +L + E E+ + EV L+++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 448 VVKLLGCCLE---------TEVPLLVY---EFIPNGTLYQYIHDQTEEFPITWEIRLRIA 495
+V+ LE + + +Y + L +++ + + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 496 IEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQ- 554
+++++A+ +LHS + HRD+K +NI KV DFG ++ D+ T
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 555 ----------GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSL 604
GT Y+ PE + ++ K D++S G++L ELL P +
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF------STQME 232
Query: 605 VGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657
L ++ + F L + + + L+ +RP
Sbjct: 233 RVRTLTDVRNLK-FPPLFTQKYPCEYV--------MVQDMLSPSPMERPEAIN 276
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-40
Identities = 61/229 (26%), Positives = 108/229 (47%), Gaps = 27/229 (11%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTNGR----IVAIK--KSKLVDESNIEQFINEV 437
++ + + +ILG+G G+V +G L VA+K K + IE+F++E
Sbjct: 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEA 87
Query: 438 AILSQINHRNVVKLLGCCLETE-----VPLLVYEFIPNGTLYQYI---HDQTEEFPITWE 489
A + +H NV++LLG C+E P+++ F+ G L+ Y+ +T I +
Sbjct: 88 ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147
Query: 490 IRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549
L+ ++++ + YL ++ HRD+ + N +L D V+DFG S+ + +
Sbjct: 148 TLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY- 203
Query: 550 TTRVQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
QG + E +T KSDV++FGV + E+ T G P
Sbjct: 204 ---RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-40
Identities = 68/277 (24%), Positives = 131/277 (47%), Gaps = 13/277 (4%)
Query: 341 IVERRRVIKLKQ--NFFKRNGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRIL 398
I R + L+Q ++ ++ L + ++ + +T+ E+ ++ L
Sbjct: 133 ITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKL 192
Query: 399 GQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLET 458
GQG G V+ G VAIK K + E F+ E ++ ++ H +V+L +
Sbjct: 193 GQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--S 249
Query: 459 EVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRD 517
E P+ +V E++ G+L ++ +T ++ + + +A +++ + Y+ + HRD
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 305
Query: 518 IKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVY 577
+++ANIL+ + KV+DFG +R + ++ + + PE +FT KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 578 SFGVVLVELLT-GQKPIRSTDSEEDKSLV--GYFLEA 611
SFG++L EL T G+ P + E V GY +
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 402
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 68/211 (32%), Positives = 108/211 (51%), Gaps = 11/211 (5%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRI-VAIKKSKLVDESNIEQFINEVAILSQIN 444
EM + LG G G VY+G+ + VA+K K D +E+F+ E A++ +I
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIK 67
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCY 504
H N+V+LLG C ++ EF+ G L Y+ + + ++ + L +A ++S A+ Y
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEY 126
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY--LDP 562
L I HRD+ + N L+ + + KV+DFG SR + D T F P
Sbjct: 127 LEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAP 181
Query: 563 EYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
E ++F+ KSDV++FGV+L E+ T G P
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 63/313 (20%), Positives = 112/313 (35%), Gaps = 40/313 (12%)
Query: 364 QQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKS 422
+ G F + + ++ + LG+GG V L +G A+K+
Sbjct: 5 HHHHHHSSGRENL--YFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI 62
Query: 423 KLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP----LLVYEFIPNGTLYQYI- 477
++ + E+ E + NH N+++L+ CL L+ F GTL+ I
Sbjct: 63 LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIE 122
Query: 478 --HDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535
D+ +I L + + + L +H+ HRD+K NILL D+ + + D
Sbjct: 123 RLKDKGNFLT-EDQI-LWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMD 177
Query: 536 FGASRSVMIDQTHLTTRVQ--------GTFGYLDPEYF---RSSQFTEKSDVYSFGVVLV 584
G+ I + T Y PE F E++DV+S G VL
Sbjct: 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLY 237
Query: 585 ELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRC 644
++ G+ P + G + +N+L R + L
Sbjct: 238 AMMFGEGPY------DMVFQKGDSVALAVQNQLSIPQSPRHSSALWQ--------LLNSM 283
Query: 645 LNMIGKKRPTMKE 657
+ + +RP +
Sbjct: 284 MTVDPHQRPHIPL 296
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 60/206 (29%), Positives = 111/206 (53%), Gaps = 15/206 (7%)
Query: 395 NRILGQGGQGTVYKGMLTNGRI---VAIK--KSKLVDESNIEQFINEVAILSQINHRNVV 449
++ LG G GTV KG ++ VA+K K++ D + ++ + E ++ Q+++ +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA 509
+++G C E +LV E G L +Y+ + + + + +VS + YL +
Sbjct: 82 RMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 137
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDPEYFRS 567
+ HRD+ + N+LL ++ AK+SDFG S+++ D+ + + G + + PE
Sbjct: 138 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 568 SQFTEKSDVYSFGVVLVELLT-GQKP 592
+F+ KSDV+SFGV++ E + GQKP
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 63/233 (27%), Positives = 111/233 (47%), Gaps = 15/233 (6%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINH 445
E+ + LG G G V+ G VA+K K + + F+ E ++ Q+ H
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQH 67
Query: 446 RNVVKLLGCCLETEVPLL-VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCY 504
+ +V+L T+ P+ + E++ NG+L ++ +T L +A ++++ + +
Sbjct: 68 QRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAF 124
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY--LDP 562
+ I HRD+++ANIL+ D K++DFG +R +I+ T R F P
Sbjct: 125 IEERNYI---HRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAP 179
Query: 563 EYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLV--GYFLEAM 612
E FT KSDV+SFG++L E++T G+ P + E + GY +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINH 445
E+ + + LG G G V G VAIK K + ++FI E ++ ++H
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSH 78
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
+V+L G C + ++ E++ NG L Y+ + + L + +V +A+ YL
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY--LDPE 563
S + HRD+ + N L++D+ KVSDFG SR V+ D+ T+ V F PE
Sbjct: 137 ESKQFL---HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPE 191
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
S+F+ KSD+++FGV++ E+ + G+ P
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 69/233 (29%), Positives = 115/233 (49%), Gaps = 21/233 (9%)
Query: 373 NSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGR----IVAIKKSK-LVDE 427
N E + + + ++ + N ++G+G G VY G L + A+K + D
Sbjct: 8 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 67
Query: 428 SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL-VYEFIPNGTLYQYIHDQTEEFPI 486
+ QF+ E I+ +H NV+ LLG CL +E L V ++ +G L +I + E
Sbjct: 68 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNP 125
Query: 487 TWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546
T + + ++V+ + YL S + HRD+ + N +LD+K+ KV+DFG +R + +
Sbjct: 126 TVKDLIGFGLQVAKGMKYLASKKFV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182
Query: 547 THLTTRVQGTFGYL------DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
+ V G E ++ +FT KSDV+SFGV+L EL+T G P
Sbjct: 183 YY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 396 RILGQGGQGTVYKGMLTNGRI----VAIKKSK---LVDESNIEQFINEVAILSQINHRNV 448
LG G G V +G VA+K K L ++ FI EV + ++HRN+
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 449 VKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
++L G L P+ +V E P G+L + F + R A++V++ + YL S
Sbjct: 84 IRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYLES 139
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY--LDPEYF 565
I HRD+ + N+LL + K+ DFG R++ + H + + PE
Sbjct: 140 KRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 566 RSSQFTEKSDVYSFGVVLVELLT-GQKP 592
++ F+ SD + FGV L E+ T GQ+P
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 69/210 (32%), Positives = 106/210 (50%), Gaps = 11/210 (5%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINH 445
+ + +G G G V+ G N VAIK + + E FI E ++ +++H
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSH 62
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
+V+L G CLE LV EF+ +G L Y+ Q F E L + ++V + + YL
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYL 120
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY--LDPE 563
A I HRD+ + N L+ + KVSDFG +R V+ DQ T+ F PE
Sbjct: 121 EEACVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPE 175
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
F S+++ KSDV+SFGV++ E+ + G+ P
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 17/217 (7%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINH 445
++F R LG+G G VY + I+A+K K++L Q EV I S + H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 446 RNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLR-IAIEVSDALC 503
N+++L G + L+ E+ P GT+Y+ + + +F E R E+++AL
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTVYREL-QKLSKFD---EQRTATYITELANALS 123
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE 563
Y HS + HRDIK N+LL K++DFG SV + T GT YL PE
Sbjct: 124 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLC-GTLDYLPPE 177
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
EK D++S GV+ E L G+ P + +E
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-39
Identities = 67/238 (28%), Positives = 105/238 (44%), Gaps = 20/238 (8%)
Query: 396 RILGQGGQGTVYKGMLTN-----GRIVAIKKSK-LVDESNIEQFINEVAILSQINHRNVV 449
R LG+G G V G +VA+K K + + E+ IL + H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 450 KLLGCCLETEVP--LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
K GCC + LV E++P G+L Y+ + I L A ++ + + YLH+
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHA 152
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDPEYF 565
I HRD+ + N+LLD+ K+ DFG +++V + R G + PE
Sbjct: 153 QHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 566 RSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622
+ +F SDV+SFGV L ELLT + + M RL E+L+
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ--GQMTVLRLTELLE 265
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-39
Identities = 68/277 (24%), Positives = 131/277 (47%), Gaps = 13/277 (4%)
Query: 341 IVERRRVIKLKQ--NFFKRNGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRIL 398
I R + L+Q ++ ++ L + ++ + +T+ E+ ++ L
Sbjct: 216 ITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKL 275
Query: 399 GQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLET 458
GQG G V+ G VAIK K + E F+ E ++ ++ H +V+L +
Sbjct: 276 GQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--S 332
Query: 459 EVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRD 517
E P+ +V E++ G+L ++ +T ++ + + +A +++ + Y+ + HRD
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRD 388
Query: 518 IKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVY 577
+++ANIL+ + KV+DFG +R + ++ + + PE +FT KSDV+
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 578 SFGVVLVELLT-GQKPIRSTDSEEDKSLV--GYFLEA 611
SFG++L EL T G+ P + E V GY +
Sbjct: 449 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 485
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-39
Identities = 68/236 (28%), Positives = 111/236 (47%), Gaps = 14/236 (5%)
Query: 396 RILGQGGQGTVYKGMLT-----NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVK 450
+ LG+G G+V G +VA+KK + E ++ F E+ IL + H N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 451 LLGCCLET-EVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
G C L L+ E++P G+L Y+ E L+ ++ + YL +
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK--LLQYTSQICKGMEYLGTK 133
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDPEYFR 566
I HRD+ + NIL++++ R K+ DFG ++ + D+ + G + PE
Sbjct: 134 RYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 567 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622
S+F+ SDV+SFGVVL EL T + +S +E + + M L E+L
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-39
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINH 445
++F +LG+G VY+ + G VAIK K + +++ NEV I Q+ H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 446 RNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAI-EVSDALC 503
++++L E + LV E NG + +Y+ ++ + F E R + ++ +
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS---ENEARHFMHQIITGML 126
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE 563
YLHS I HRD+ +N+LL K++DFG + + + T + GT Y+ PE
Sbjct: 127 YLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE 182
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
S +SDV+S G + LL G+ P
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-39
Identities = 76/283 (26%), Positives = 129/283 (45%), Gaps = 14/283 (4%)
Query: 396 RILGQGGQGTVYKGMLT-----NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVK 450
+ LG+G G+V G +VA+KK + E ++ F E+ IL + H N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 451 LLGCCLET-EVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
G C L L+ E++P G+L Y+ E L+ ++ + YL +
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK--LLQYTSQICKGMEYLGTK 164
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDPEYFR 566
I HRD+ + NIL++++ R K+ DFG ++ + D+ + + G + PE
Sbjct: 165 RYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 567 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626
S+F+ SDV+SFGVVL EL T + +S +E + + M L E+L
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 281
Query: 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669
+ + M+ C N +RP+ ++ A + IR +
Sbjct: 282 LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-39
Identities = 63/237 (26%), Positives = 109/237 (45%), Gaps = 17/237 (7%)
Query: 396 RILGQGGQGTVYKGMLT-----NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVK 450
LG+G G+V G +VA+K+ + F E+ IL ++ +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 451 LLGCCLET-EVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
G L LV E++P+G L ++ + L + ++ + YL S
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR--LLLYSSQICKGMEYLGSR 146
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDPEYFR 566
+ HRD+ + NIL++ + K++DFG ++ + +D+ + R G + PE
Sbjct: 147 RCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 567 SSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622
+ F+ +SDV+SFGVVL EL T K + S E ++G + +RL E+L+
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELLE 258
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-38
Identities = 47/205 (22%), Positives = 82/205 (40%), Gaps = 23/205 (11%)
Query: 396 RILGQGGQGTVYKG--MLTNGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLL 452
+ GG G +Y NGR V +K D + E L+++ H ++V++
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 453 -----GCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
V +V E++ +L + + + +E+ AL YLHS
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS 200
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS 567
+ + D+K NI+L ++ + K+ D GA I+ + GT G+ PE R+
Sbjct: 201 I---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR--INSFGY---LYGTPGFQAPEIVRT 251
Query: 568 SQFTEKSDVYSFGVVLVELLTGQKP 592
T +D+Y+ G L L
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDLPT 275
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 396 RILGQGGQGTVYKGMLT---NGRI-VAIKKSKL-VDESNIEQFINEVAILSQINHRNVVK 450
+I+G G G V G L + VAIK K E F++E +I+ Q +H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 451 LLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAAS 510
L G + ++V E++ NG+L ++ +T + T + + V + YL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYL--DPEYFRSS 568
+ HRD+ + N+L+D KVSDFG SR + D T G PE
Sbjct: 173 V---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 569 QFTEKSDVYSFGVVLVELLT-GQKP 592
F+ SDV+SFGVV+ E+L G++P
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERP 254
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 55/265 (20%), Positives = 96/265 (36%), Gaps = 25/265 (9%)
Query: 336 GRLHEIVERRRVIKLKQNFFKRNGGLLLQQESSSNEGNSEKTKLF-TSMELEMATDNFNT 394
G+ H + + +R L E+ NEG KL E
Sbjct: 8 GQAHSLASLAKTWSSGSAKLQR-----LGPETEDNEGVLLTEKLKPVDYEYREEVHWMTH 62
Query: 395 NRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLG 453
+G+G G V++ G A+KK V E+ + ++ +V L G
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKK---VRLEVFRV--EELVACAGLSSPRIVPLYG 117
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLR-IAIEVSDALCYLHSAASIP 512
E + E + G+ + ++ E R + + L YLH+ +
Sbjct: 118 AVREGPWVNIFMELLEGGS----LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL- 172
Query: 513 IYHRDIKSANILLDDK-YRAKVSDFGASRSVMIDQTHLTTR----VQGTFGYLDPEYFRS 567
H D+K+ N+LL RA + DFG + + D + + GT ++ PE
Sbjct: 173 --HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 568 SQFTEKSDVYSFGVVLVELLTGQKP 592
K D++S +++ +L G P
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 57/273 (20%), Positives = 101/273 (36%), Gaps = 33/273 (12%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKL--VDESNIEQFINEVAILSQI-NH 445
+F LG G G V+K +GR+ A+K+S + + + EV ++ H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLR-IAIEVSDALCY 504
V+L E + L E +L Q+ P E ++ + AL +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLP---EAQVWGYLRDTLLALAH 172
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEY 564
LHS + H D+K ANI L + R K+ DFG + +G Y+ PE
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLV--ELGTAGAGEVQEGDPRYMAPEL 227
Query: 565 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624
+ + +DV+S G+ ++E+ + + + +++ L A
Sbjct: 228 LQ-GSYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPPEFTAG 276
Query: 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657
+ E + + L K R T +
Sbjct: 277 LSSELRS--------VLVMMLEPDPKLRATAEA 301
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 396 RILGQGGQGTVYKGMLTNGR----IVAIKKSK-LVDESNIEQFINEVAILSQINHRNVVK 450
R++G+G G VY G + AIK + + +E F+ E ++ +NH NV+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 451 LLGCCLETE-VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA 509
L+G L E +P ++ ++ +G L Q+I ++ + T + + ++V+ + YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYL-----DPEY 564
+ HRD+ + N +LD+ + KV+DFG +R I + Q L E
Sbjct: 145 FV---HRDLAARNCMLDESFTVKVADFGLAR--DILDREYYSVQQHRHARLPVKWTALES 199
Query: 565 FRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
++ +FT KSDV+SFGV+L ELLT G P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 61/217 (28%), Positives = 110/217 (50%), Gaps = 16/217 (7%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRI-----VAIK--KSKLVDESNIEQFINEVA 438
E+ +++G G G VYKGML VAIK K+ ++ ++ F+ E
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAG 98
Query: 439 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEV 498
I+ Q +H N+++L G + + +++ E++ NG L +++ + ++ + + + +
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGI 156
Query: 499 SDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFG 558
+ + YL + + HRD+ + NIL++ KVSDFG SR + D T G
Sbjct: 157 AAGMKYLANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 559 Y--LDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
PE +FT SDV+SFG+V+ E++T G++P
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 63/285 (22%), Positives = 119/285 (41%), Gaps = 40/285 (14%)
Query: 391 NFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINH--R 446
++ + +G GG V++ + +I AIK L D ++ + NE+A L+++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH 506
+++L + + +V E N L ++ + + WE + + +A+ +H
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK-KSIDP-WERK-SYWKNMLEAVHTIH 125
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT--HLTTRVQGTFGYLDPE- 563
I H D+K AN L+ D K+ DFG + + D T ++V GT Y+ PE
Sbjct: 126 QHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEA 180
Query: 564 ----------YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK 613
S+ + KSDV+S G +L + G+ P + ++ K L A+
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK------LHAII 234
Query: 614 ENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
+ K+ ++ + K CL K+R ++ E
Sbjct: 235 DPNHEIEFPDIPEKDLQD--------VLKCCLKRDPKQRISIPEL 271
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 69/232 (29%), Positives = 114/232 (49%), Gaps = 19/232 (8%)
Query: 373 NSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGR----IVAIKKSK-LVDE 427
N E + + + ++ + N ++G+G G VY G L + A+K + D
Sbjct: 72 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 131
Query: 428 SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL-VYEFIPNGTLYQYIHDQTEEFPI 486
+ QF+ E I+ +H NV+ LLG CL +E L V ++ +G L +I + E
Sbjct: 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNP 189
Query: 487 TWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546
T + + ++V+ + +L AS HRD+ + N +LD+K+ KV+DFG +R + +
Sbjct: 190 TVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246
Query: 547 THLTTRVQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
T L E ++ +FT KSDV+SFGV+L EL+T G P
Sbjct: 247 FDSVH--NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-38
Identities = 63/311 (20%), Positives = 124/311 (39%), Gaps = 40/311 (12%)
Query: 364 QQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSK 423
+ +K + + + ++ + +G GG V++ + +I AIK
Sbjct: 30 MDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 89
Query: 424 L--VDESNIEQFINEVAILSQINH--RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHD 479
L D ++ + NE+A L+++ +++L + + +V E N L ++
Sbjct: 90 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK 148
Query: 480 QTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539
+ + WE + + +A+ +H I H D+K AN L+ D K+ DFG +
Sbjct: 149 K-KSIDP-WERK-SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIA 201
Query: 540 RSVMIDQT--HLTTRVQGTFGYLDPE-----------YFRSSQFTEKSDVYSFGVVLVEL 586
+ D T ++V G Y+ PE S+ + KSDV+S G +L +
Sbjct: 202 NQMQPDTTSVVKDSQV-GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 260
Query: 587 LTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLN 646
G+ P + ++ K L A+ + K+ ++ + K CL
Sbjct: 261 TYGKTPFQQIINQISK------LHAIIDPNHEIEFPDIPEKDLQD--------VLKCCLK 306
Query: 647 MIGKKRPTMKE 657
K+R ++ E
Sbjct: 307 RDPKQRISIPE 317
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 53/231 (22%), Positives = 105/231 (45%), Gaps = 25/231 (10%)
Query: 372 GNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLT----NGRI-VAIKKSK-LV 425
++F EL ++LG G GTV+KG+ + +I V IK +
Sbjct: 2 AMKVLARIFKETELRK-------LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS 54
Query: 426 DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFP 485
+ + + + + ++H ++V+LLG C LV +++P G+L ++
Sbjct: 55 GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALG 113
Query: 486 ITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545
++ L ++++ + YL + HR++ + N+LL + +V+DFG + + D
Sbjct: 114 P--QLLLNWGVQIAKGMYYLEEHGMV---HRNLAARNVLLKSPSQVQVADFGVADLLPPD 168
Query: 546 QTHLTTRVQGT---FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
L ++ E ++T +SDV+S+GV + EL+T G +P
Sbjct: 169 DKQLLY--SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 53/207 (25%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 396 RILGQGGQGTVYKGMLT----NGRI-VAIKKSKL-VDESNIEQFINEVAILSQINHRNVV 449
++LG G GTVYKG+ +I VAIK+ + ++ ++E +++ +++ +V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA 509
+LLG CL L+ + +P G L Y+ + + + L ++++ + YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLEDRR 137
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGT---FGYLDPEYFR 566
+ HRD+ + N+L+ K++DFG ++ + ++ +G ++ E
Sbjct: 138 LV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESIL 192
Query: 567 SSQFTEKSDVYSFGVVLVELLT-GQKP 592
+T +SDV+S+GV + EL+T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINH 445
+ + ILGQG V++G G + AIK + ++ + E +L ++NH
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 446 RNVVKLLGC--CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC 503
+N+VKL T +L+ EF P G+LY + + + + + L + +V +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 504 YLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY 559
+L I HR+IK NI+ D + K++DFGA+R + D + GT Y
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLY-GTEEY 181
Query: 560 LDPEYFRSS--------QFTEKSDVYSFGVVLVELLTGQKP 592
L P+ + + ++ D++S GV TG P
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-38
Identities = 63/202 (31%), Positives = 112/202 (55%), Gaps = 13/202 (6%)
Query: 398 LGQGGQGTVYKGMLT--NGRI-VAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLG 453
LG G G+V +G+ +I VAIK K ++++ E+ + E I+ Q+++ +V+L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPI 513
C + +LV E G L++++ + EE + +VS + YL +
Sbjct: 78 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEEKNFV-- 132
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDPEYFRSSQFT 571
HRD+ + N+LL +++ AK+SDFG S+++ D ++ T R G + + PE +F+
Sbjct: 133 -HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 572 EKSDVYSFGVVLVELLT-GQKP 592
+SDV+S+GV + E L+ GQKP
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKP 213
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 18/238 (7%)
Query: 396 RILGQGGQGTVYKGMLT-----NGRIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVV 449
R LG+G G V G VA+K K ++I E+ IL + H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 450 KLLGCCLETEV-PL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
K G C E + L+ EF+P+G+L +Y+ + I + +L+ A+++ + YL S
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--GYLDPEYF 565
+ HRD+ + N+L++ +++ K+ DFG ++++ D+ + T + + PE
Sbjct: 145 RQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 566 RSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622
S+F SDV+SFGV L ELLT + M RL L
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH--GQMTVTRLVNTLK 257
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-38
Identities = 64/229 (27%), Positives = 108/229 (47%), Gaps = 27/229 (11%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTNGR------IVAIKKSK-LVDESNIEQFINE 436
E E+A + +R LGQG G VY+G+ VAIK +F+NE
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 437 VAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQY-------IHDQTEEFPITWE 489
+++ + N +VV+LLG + + L++ E + G L Y + + P +
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 490 IRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549
+++A E++D + YL + HRD+ + N ++ + + K+ DFG +R + +
Sbjct: 139 KMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY- 194
Query: 550 TTRVQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
+G G L PE + FT SDV+SFGVVL E+ T ++P
Sbjct: 195 ---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-38
Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 19/219 (8%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINH 445
+ R LG+GG ++ + A K KS L+ E+ E++I + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 446 RNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSDA 501
++VV G E + +V E +L + + TE E R ++
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEP-----EAR-YYLRQIVLG 153
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
YLH + HRD+K N+ L++ K+ DFG + V D + GT Y+
Sbjct: 154 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIA 209
Query: 562 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
PE + + DV+S G ++ LL G+ P ++ +E
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 248
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 19/219 (8%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINH 445
+ R LG+GG ++ + A K KS L+ E+ E++I + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 446 RNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSDA 501
++VV G E + +V E +L + + TE E R ++
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEP-----EAR-YYLRQIVLG 127
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
YLH + HRD+K N+ L++ K+ DFG + V D GT Y+
Sbjct: 128 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIA 183
Query: 562 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
PE + + DV+S G ++ LL G+ P ++ +E
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 222
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRI----VAIK--KSKLVDESNIEQFINEVAI 439
+A ++ NRILG+G G VY+G+ TN + VA+K K ++ + F++E I
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-FMSEAVI 66
Query: 440 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVS 499
+ ++H ++VKL+G E E ++ E P G L Y+ + + ++++
Sbjct: 67 MKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQIC 123
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGT--- 556
A+ YL S + HRDI NIL+ K+ DFG SR + + + T
Sbjct: 124 KAMAYLESINCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLP 177
Query: 557 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
++ PE +FT SDV+ F V + E+L+ G++P
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-37
Identities = 67/280 (23%), Positives = 126/280 (45%), Gaps = 18/280 (6%)
Query: 341 IVERRRVIKLKQ--NFFKRNGGLLLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRIL 398
I R L++ + +K+ L Q+ S +S+ K + E+ ++ + L
Sbjct: 138 ISPRSTFSTLQELVDHYKKGNDGLCQK-LSVPCMSSKPQKPWEKDAWEIPRESLKLEKKL 196
Query: 399 GQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLET 458
G G G V+ VA+K K ++E F+ E ++ + H +VKL T
Sbjct: 197 GAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV--T 253
Query: 459 EVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRD 517
+ P+ ++ EF+ G+L ++ + + ++++ + ++ I HRD
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRNYI---HRD 309
Query: 518 IKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY--LDPEYFRSSQFTEKSD 575
+++ANIL+ K++DFG +R + ++ T R F PE FT KSD
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 576 VYSFGVVLVELLT-GQKPIRSTDSEEDKSLV--GYFLEAM 612
V+SFG++L+E++T G+ P + E + GY +
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRP 407
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 69/209 (33%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 390 DNFNTNRILGQGGQGTVYKG-MLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINH 445
D+F+ R LG+G G VY N I+A+K KS+L E Q E+ I S + H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 446 RNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLR-IAIEVSDALC 503
N++++ + L+ EF P G LY+ + + F E R E++DAL
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQ-KHGRFD---EQRSATFMEELADALH 128
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE 563
Y H + HRDIK N+L+ K K++DFG SV T + GT YL PE
Sbjct: 129 YCHERK---VIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRRT-MCGTLDYLPPE 182
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
EK D++ GV+ E L G P
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-37
Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 15/216 (6%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGR----IVAIK--KSKLVDESNIEQFINEVAI 439
E+ N + ++++G G G V G L VAIK K ++ + F+ E +I
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASI 99
Query: 440 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVS 499
+ Q +H N+++L G +++ ++V E++ NG+L ++ +F T + + ++
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIA 157
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY 559
+ YL + HRD+ + NIL++ KVSDFG R + D T G
Sbjct: 158 SGMKYLSDMGYV---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI 214
Query: 560 L--DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
PE +FT SDV+S+G+VL E+++ G++P
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-37
Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINH 445
+ + ILGQG V++G G + AIK + ++ + E +L ++NH
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 446 RNVVKLLGC--CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC 503
+N+VKL T +L+ EF P G+LY + + + + + L + +V +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 504 YLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY 559
+L I HR+IK NI+ D + K++DFGA+R + D + GT Y
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLY-GTEEY 181
Query: 560 LDPEYFRSS--------QFTEKSDVYSFGVVLVELLTGQKP 592
L P+ + + ++ D++S GV TG P
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-37
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 16/215 (7%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLT---NGRI-VAIKKSKL-VDESNIEQFINEVAIL 440
E+ + R +G+G G V++G+ N + VAIK K +S E+F+ E +
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 441 SQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSD 500
Q +H ++VKL+G E ++ E G L ++ Q ++ + + A ++S
Sbjct: 71 RQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLST 127
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF--G 558
AL YL S + HRDI + N+L+ K+ DFG SR + +G
Sbjct: 128 ALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPIK 182
Query: 559 YLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
++ PE +FT SDV+ FGV + E+L G KP
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-37
Identities = 59/281 (20%), Positives = 111/281 (39%), Gaps = 37/281 (13%)
Query: 391 NFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQIN-HRNVV 449
+F +LG G +GT+ + + R VA+K+ + EV +L + + H NV+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR---ILPECFSFADREVQLLRESDEHPNVI 81
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA 509
+ + + + E TL +Y+ + ++F + + + + L +LHS
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 510 SIPIYHRDIKSANILLDDK-----YRAKVSDFGASRSVMIDQTHLTTR--VQGTFGYLDP 562
I HRD+K NIL+ +A +SDFG + + + + + R V GT G++ P
Sbjct: 139 ---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 563 EYFRSSQF---TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619
E T D++S G V +++ + + +
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACSLD 248
Query: 620 VLD--ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
L A+E L ++ + M +KRP+ K
Sbjct: 249 CLHPEKHEDVIARE--------LIEKMIAMDPQKRPSAKHV 281
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-37
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 18/219 (8%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKK-SKLVDESNIEQFINEVAILSQINHR 446
+ LG GG G V + + G VAIK+ + + N E++ E+ I+ ++NH
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 447 NVVKLLGCCLETE-------VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVS 499
NVV + +PLL E+ G L +Y++ + + ++S
Sbjct: 73 NVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 500 DALCYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGASRSVMIDQTHLTTRVQGT 556
AL YLH I HRD+K NI+L + K+ D G ++ + T V GT
Sbjct: 132 SALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQGELCTEFV-GT 186
Query: 557 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRS 595
YL PE ++T D +SFG + E +TG +P
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 1e-36
Identities = 63/202 (31%), Positives = 112/202 (55%), Gaps = 13/202 (6%)
Query: 398 LGQGGQGTVYKGMLT--NGRI-VAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLG 453
LG G G+V +G+ +I VAIK K ++++ E+ + E I+ Q+++ +V+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPI 513
C + +LV E G L++++ + EE P + +VS + YL +
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQVSMGMKYLEEKNFV-- 458
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY--LDPEYFRSSQFT 571
HR++ + N+LL +++ AK+SDFG S+++ D ++ T R G + PE +F+
Sbjct: 459 -HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 572 EKSDVYSFGVVLVELLT-GQKP 592
+SDV+S+GV + E L+ GQKP
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP 539
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTNGRI--------VAIKKSKLVDESNIEQFINEVAILS 441
++ N LGQG ++KG+ V +K + E F +++S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 442 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDA 501
+++H+++V G C+ + +LV EF+ G+L Y+ I W+ L +A +++ A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAA 125
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYR--------AKVSDFGASRSVMIDQTHLTTRV 553
+ +L I H ++ + NILL + K+SD G S +V+ + L R+
Sbjct: 126 MHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL-PKDILQERI 181
Query: 554 QGTFGYLDPE---YFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
PE + +D +SFG L E+ + G KP
Sbjct: 182 PWV----PPECIENPK--NLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 32/222 (14%)
Query: 396 RILGQGGQGTVYKGMLTNGR------IVAIKKSKLVDESNIEQFINEVAILSQINHRNVV 449
R LG+G G V+ N +VA+K K + + F E +L+ + H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHDQTEEFPITWEIRLRIAI 496
K G C + + ++V+E++ +G L ++ + + + L IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 497 EVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGT 556
+++ + YL AS HRD+ + N L+ K+ DFG SR V + RV G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVGGH 194
Query: 557 FGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
L PE +FT +SDV+SFGV+L E+ T G++P
Sbjct: 195 -TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 396 RILGQGGQGTVYKGMLTNGR------IVAIKKSKLVDESNIEQFINEVAILSQINHRNVV 449
LG+G G V+ N +VA+K K ES + F E +L+ + H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQY------------IHDQTEEFPITWEIRLRIAIE 497
+ G C E L+V+E++ +G L ++ + P+ L +A +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 498 VSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF 557
V+ + YL A + HRD+ + N L+ K+ DFG SR + RV G
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYRVGGR- 219
Query: 558 GYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
L PE +FT +SDV+SFGVVL E+ T G++P
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 36/299 (12%), Positives = 67/299 (22%), Gaps = 52/299 (17%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKL 451
L G + V+ + A+K S +E+ +++ + +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 452 LGCCLETEVP--------------------------LLVYEFIPNGTLYQYIHD----QT 481
LL+ + L
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYV 186
Query: 482 EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541
+ ++ L S + H N+ + R + D A
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 542 VMIDQTHLTTRVQGTFGYLDPEYFRSS--QFTEKSDVYSFGVVLVELLTGQKPIRSTDSE 599
V Y E+ +S FT + + G+ + + P
Sbjct: 244 V----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 600 EDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
S L + L + K L R LN ++R EA
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT--------LIGRFLNFDRRRRLLPLEA 350
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 27/229 (11%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTNGR------IVAIKKSK-LVDESNIEQFINE 436
E+ N R LG G G VY+G ++ VA+K + E + F+ E
Sbjct: 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 83
Query: 437 VAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYI----HDQTEEFPITWEIRL 492
I+S+ NH+N+V+ +G L++ ++ E + G L ++ ++ + L
Sbjct: 84 ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143
Query: 493 RIAIEVSDALCYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGASRSVMIDQTHL 549
+A +++ YL HRDI + N LL AK+ DFG +R +
Sbjct: 144 HVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--- 197
Query: 550 TTRVQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
R G L PE F FT K+D +SFGV+L E+ + G P
Sbjct: 198 YYRKGGC-AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 41/243 (16%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTNGR------IVAIKKSK-LVDESNIEQFINE 436
+ E N + LG+G G V K + + VA+K K S + ++E
Sbjct: 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSE 76
Query: 437 VAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------------- 476
+L Q+NH +V+KL G C + LL+ E+ G+L +
Sbjct: 77 FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136
Query: 477 -IHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535
D +E +T + A ++S + YL A + + HRD+ + NIL+ + + K+SD
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 536 FGASRSVMIDQTHLTTRVQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-G 589
FG SR V + ++ V+ + G + E +T +SDV+SFGV+L E++T G
Sbjct: 194 FGLSRDVYEEDSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249
Query: 590 QKP 592
P
Sbjct: 250 GNP 252
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-35
Identities = 72/281 (25%), Positives = 122/281 (43%), Gaps = 37/281 (13%)
Query: 389 TDNFNTNRILGQGGQGTVYKG-MLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQIN 444
+D + R+LG+G G V G+ A+K K ++ +++ E + EV +L Q++
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSDA 501
H N++KL + LV E G L+ I + +E + RI +V
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----DAA-RIIRQVLSG 138
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGASRSVMIDQTHLTTRVQGTFG 558
+ Y+H I HRD+K N+LL+ K ++ DFG S + + GT
Sbjct: 139 ITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST--HFEASKKMKDKIGTAY 193
Query: 559 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618
Y+ PE + + EK DV+S GV+L LL+G P + + K F
Sbjct: 194 YIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFN------GANEYDILKKVEKGKYTF 246
Query: 619 EVLD-ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
E+ +V + AK+ L ++ L + R + ++A
Sbjct: 247 ELPQWKKVSESAKD--------LIRKMLTYVPSMRISARDA 279
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 69/237 (29%), Positives = 104/237 (43%), Gaps = 35/237 (14%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTN------GRIVAIKKSK-LVDESNIEQFINE 436
+ E D + LG+G G V + R VA+K K S ++E
Sbjct: 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 80
Query: 437 VAILSQI-NHRNVVKLLGCCLETEVPLLV-YEFIPNGTL-------------YQYIHDQT 481
+ IL I +H NVV LLG C + PL+V EF G L Y+ +
Sbjct: 81 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 482 EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541
+ +T E + + +V+ + +L AS HRD+ + NILL +K K+ DFG +R
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 542 VMIDQTHLTTRVQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
+ D + V+ L PE +T +SDV+SFGV+L E+ + G P
Sbjct: 198 IYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 69/299 (23%), Positives = 120/299 (40%), Gaps = 50/299 (16%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNV 448
+ + +ILG G GTV GR VA+K+ + + + E+ +L++ +H NV
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR---MLIDFCDIALMEIKLLTESDDHPNV 71
Query: 449 VKLLGCCLETEVPL-LVYEFIPNGTLYQYI---HDQTEEFPITWEIRLRIAI-EVSDALC 503
++ C T+ L + E N L + + E + E + +++ +
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 504 YLHSAASIPIYHRDIKSANILLDDK-------------YRAKVSDFGASRSVMIDQTHLT 550
+LH S+ I HRD+K NIL+ R +SDFG + + Q+
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 551 TRVQ---GTFGYLDPEYFRSSQF-------TEKSDVYSFGVVLVELLT-GQKPIRSTDSE 599
T + GT G+ PE S T D++S G V +L+ G+ P S
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 600 EDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
E + G F + + + D ++ EA + L + ++ KRPT +
Sbjct: 247 ESNIIRGIF----SLDEMKCLHDRSLIAEATD--------LISQMIDHDPLKRPTAMKV 293
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 29/230 (12%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTNGR------IVAIK--KSKLVDESNIEQFIN 435
E+ N R LG G G VY+G ++ VA+K ++ ++ F+
Sbjct: 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLM 123
Query: 436 EVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYI----HDQTEEFPITWEIR 491
E I+S+ NH+N+V+ +G L++ ++ E + G L ++ ++ +
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 492 LRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGASRSVMIDQTH 548
L +A +++ YL HRDI + N LL AK+ DFG +R +
Sbjct: 184 LHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-- 238
Query: 549 LTTRVQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
R G L PE F FT K+D +SFGV+L E+ + G P
Sbjct: 239 -YYRKGGC-AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 44/290 (15%)
Query: 340 EIVERRRVIKLKQNFFKRNGGLLLQQESSSNEGNSEKTKLFTSMELEMATD--------N 391
I RR+V ++ N L + ++ ++ L E E+ D
Sbjct: 23 RIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDK 82
Query: 392 FNTNRILGQGGQGTVYKGMLTNGR--------IVAIKKSK-LVDESNIEQFINEVAILSQ 442
+ LG+G G V VA+K K E ++ ++E+ ++
Sbjct: 83 LTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM 142
Query: 443 I-NHRNVVKLLGCCLETEVPLLVYEFIPNGTL-------------YQYIHDQTEEFPITW 488
I H+N++ LLG C + ++ E+ G L Y Y ++ E +T+
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 489 EIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548
+ + +++ + YL AS HRD+ + N+L+ + K++DFG +R + +
Sbjct: 203 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 549 LTTRVQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
+ T G L PE +T +SDV+SFGV++ E+ T G P
Sbjct: 260 ----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-34
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 12/215 (5%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLT---NGRI-VAIKKSKL-VDESNIEQFINEVA 438
+ E+ + R +G+G G V++G+ N + VAIK K +S E+F+ E
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 439 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEV 498
+ Q +H ++VKL+G E V ++ E G L ++ Q +F + + A ++
Sbjct: 444 TMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQL 500
Query: 499 SDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFG 558
S AL YL S + HRDI + N+L+ K+ DFG SR + + ++ +
Sbjct: 501 STALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 559 YLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
++ PE +FT SDV+ FGV + E+L G KP
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 58/238 (24%), Positives = 103/238 (43%), Gaps = 36/238 (15%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTNGR--------IVAIKKSK-LVDESNIEQFI 434
+ E D + LG+G G V VA+K K E ++ +
Sbjct: 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV 88
Query: 435 NEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTL-------------YQYIHDQ 480
+E+ ++ I H+N++ LLG C + ++ E+ G L Y Y ++
Sbjct: 89 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 481 TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540
E +T++ + +++ + YL AS HRD+ + N+L+ + K++DFG +R
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 541 SVMIDQTHLTTRVQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
+ + + T G L PE +T +SDV+SFGV++ E+ T G P
Sbjct: 206 DINNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 33/223 (14%)
Query: 396 RILGQGGQGTVYKGMLTNGR------IVAIKKSK-LVDESNIEQFINEVAILSQINHRNV 448
LG+ G VYKG L VAIK K + E+F +E + +++ H NV
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 449 VKLLGCCLETEVPLLVYEFIPNGTLYQY-------------IHDQTEEFPITWEIRLRIA 495
V LLG + + +++ + +G L+++ D+T + + + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 496 IEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG 555
+++ + YL +S + H+D+ + N+L+ DK K+SD G R V ++ G
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD---YYKLLG 188
Query: 556 TFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
L PE +F+ SD++S+GVVL E+ + G +P
Sbjct: 189 N-SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 11/206 (5%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRN 447
+ +GQG GTVY M + G+ VAI++ L + E INE+ ++ + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLH 506
+V L L + +V E++ G+L + + +E I + E AL +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLH 133
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR 566
S I HRDIKS NILL K++DFG + +Q+ +T V GT ++ PE
Sbjct: 134 SNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVT 189
Query: 567 SSQFTEKSDVYSFGVVLVELLTGQKP 592
+ K D++S G++ +E++ G+ P
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 132 bits (332), Expect = 1e-33
Identities = 51/289 (17%), Positives = 91/289 (31%), Gaps = 33/289 (11%)
Query: 360 GLLLQQESSSN--EGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGM------L 411
GL S N E + + E ++ + + +LG+G VY+
Sbjct: 33 GLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDA 92
Query: 412 TNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNG 471
N + +K K + + L +K L +LV E G
Sbjct: 93 KNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYG 152
Query: 472 TLYQYIHD--QTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY 529
TL I+ T E + + + A+ + + +H I H DIK N +L + +
Sbjct: 153 TLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGF 209
Query: 530 RA-----------KVSDFGASR--SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDV 576
+ D G S + T T + T G+ E + + + D
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDY 268
Query: 577 YSFGVVLVELLTGQKPIRSTDSEE---DKSLVGYF-LEAMKENRLFEVL 621
+ + +L G + E + L+ E F V+
Sbjct: 269 FGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNE--FFHVM 315
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 52/228 (22%), Positives = 99/228 (43%), Gaps = 32/228 (14%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIK---KSKLV--------------DESNIEQ 432
+++ R L QG + + + A+K KS L +S +
Sbjct: 31 NDYRIIRTLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 433 FINEVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIH-----DQTEEFPI 486
F NE+ I++ I + + G + + ++YE++ N ++ ++ D+ I
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 487 TWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546
++ I V ++ Y+H+ +I HRD+K +NIL+D R K+SDFG S +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNI--CHRDVKPSNILMDKNGRVKLSDFGE--SEYMVD 204
Query: 547 THLTTRVQGTFGYLDPEYFRSSQFT--EKSDVYSFGVVLVELLTGQKP 592
+ GT+ ++ PE+F + K D++S G+ L + P
Sbjct: 205 KKIKGSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-33
Identities = 76/314 (24%), Positives = 124/314 (39%), Gaps = 47/314 (14%)
Query: 364 QQESSSNEGNSEKTK-------LFTSMELEMATDNFNTNRILGQGGQGTVYKG-MLTNGR 415
SS N +F + + ++ + + LG G G V
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 416 IVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGT 472
AIK K+ + + + + EVA+L ++H N++KL + LV E G
Sbjct: 64 ERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122
Query: 473 LYQYIHDQ---TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK- 528
L+ I + E + I +V + YLH I HRD+K N+LL+ K
Sbjct: 123 LFDEIIHRMKFNEV-----DAA-VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKE 173
Query: 529 --YRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVEL 586
K+ DFG S + + GT Y+ PE R + EK DV+S GV+L L
Sbjct: 174 KDALIKIVDFGL--SAVFENQKKMKERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFIL 230
Query: 587 LTGQKPIRSTDSEEDKSLVGYFLEAMKENRL-FEVLD-ARVLKEAKEEEIITVAMLAKRC 644
L G P +E L +++ + F+ + V + AK+ L K+
Sbjct: 231 LAGYPPFGGQTDQE-------ILRKVEKGKYTFDSPEWKNVSEGAKD--------LIKQM 275
Query: 645 LNMIGKKRPTMKEA 658
L ++R + ++A
Sbjct: 276 LQFDSQRRISAQQA 289
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 58/243 (23%), Positives = 107/243 (44%), Gaps = 41/243 (16%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTNGR------IVAIKKSK-LVDESNIEQFINE 436
LE +N R +G+G G V++ +VA+K K F E
Sbjct: 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 100
Query: 437 VAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQY-------------------- 476
A++++ ++ N+VKLLG C + L++E++ G L ++
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160
Query: 477 -IHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535
P++ +L IA +V+ + YL + HRD+ + N L+ + K++D
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIAD 217
Query: 536 FGASRSVMIDQTHLTTRVQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-G 589
FG SR++ + + G + PE +++T +SDV+++GVVL E+ + G
Sbjct: 218 FGLSRNIYSADYY---KADGN-DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273
Query: 590 QKP 592
+P
Sbjct: 274 LQP 276
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 9/205 (4%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRN 447
++ +G+G G V +GR VA+K L + E NEV I+ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
VV++ L E ++ EF+ G L D + + E + V AL YLH+
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS 567
I HRDIKS +ILL R K+SDFG + D + V GT ++ PE
Sbjct: 160 QGVI---HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISR 215
Query: 568 SQFTEKSDVYSFGVVLVELLTGQKP 592
S + + D++S G++++E++ G+ P
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 49/229 (21%), Positives = 91/229 (39%), Gaps = 33/229 (14%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKL--VDESNIEQFINEVAILSQI-N 444
T F+ +G G G+V+K + +G I AIK+SK + + + EV + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLR-IAIEVSDALC 503
H +VV+ E + L+ E+ G+L I + E L+ + ++V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 504 YLHSAASIPIYHRDIKSANILLD-------------------DKYRAKVSDFGASRSVMI 544
Y+HS + + H DIK +NI + +K K+ D G +
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 545 DQTHLTTRVQGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKP 592
Q +G +L E + + K+D+++ + +V +
Sbjct: 187 PQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 61/238 (25%), Positives = 101/238 (42%), Gaps = 36/238 (15%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTN--------GRIVAIKKSK-LVDESNIEQFI 434
E+ D + LG+G G V VA+K K E ++ I
Sbjct: 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 122
Query: 435 NEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTL-------------YQYIHDQ 480
+E+ ++ I H+N++ LLG C + ++ E+ G L Y Y
Sbjct: 123 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 481 TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540
E ++ + + A +V+ + YL AS HRD+ + N+L+ + K++DFG +R
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
Query: 541 SVMIDQTHLTTRVQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
+ + + T G L PE +T +SDV+SFGV+L E+ T G P
Sbjct: 240 DIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 36/226 (15%)
Query: 396 RILGQGGQGTVYKGMLTNGR------IVAIKKSK-LVDESNIEQFINEVAILSQI-NHRN 447
+ LG G G V + VA+K K + E ++E+ +LS + NH N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQY---------------IHDQTEEFPITWEIRL 492
+V LLG C L++ E+ G L + + +E + E L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 493 RIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTR 552
+ +V+ + +L AS HRD+ + NILL K+ DFG +R + D +
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY---- 201
Query: 553 VQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
V L PE + +T +SDV+S+G+ L EL + G P
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 396 RILGQGGQGTVYKGMLTNG---RIVAIKKSK-LVDESNIEQFINEVAILSQI-NHRNVVK 450
++G+G G V K + AIK+ K + + F E+ +L ++ +H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 451 LLGCCLETEVPLLVYEFIPNGTLYQY-------------IHDQTEEFPITWEIRLRIAIE 497
LLG C L E+ P+G L + + ++ + L A +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 498 VSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF 557
V+ + YL + HRD+ + NIL+ + Y AK++DFG SR + V+ T
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVY-----VKKTM 200
Query: 558 GYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
G L E S +T SDV+S+GV+L E+++ G P
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRN 447
+ F+ LG+G G+VYK + G+IVAIK+ + ES++++ I E++I+ Q + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPH 85
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGT---LYQYIHDQTEEFPITWEIRLRIAIEVSDALCY 504
VVK G + +V E+ G+ + + + E I ++ L Y
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ-----STLKGLEY 140
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEY 564
LH I HRDIK+ NILL+ + AK++DFG + + T + GT ++ PE
Sbjct: 141 LHFMRKI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEV 196
Query: 565 FRSSQFTEKSDVYSFGVVLVELLTGQKP 592
+ + +D++S G+ +E+ G+ P
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 60/256 (23%), Positives = 108/256 (42%), Gaps = 32/256 (12%)
Query: 362 LLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLT------NGR 415
+++ ++ + T+L + + E +N + LG G G V +
Sbjct: 18 IIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVL 77
Query: 416 IVAIKKSK-LVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTL 473
VA+K K E ++E+ I+S + H N+V LLG C L++ E+ G L
Sbjct: 78 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 474 YQYIHD-----------QTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSAN 522
++ + L + +V+ + +L AS HRD+ + N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARN 194
Query: 523 ILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYL-----DPEYFRSSQFTEKSDVY 577
+LL + + AK+ DFG +R +M D + + L PE +T +SDV+
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNY----IVKGNARLPVKWMAPESIFDCVYTVQSDVW 250
Query: 578 SFGVVLVELLT-GQKP 592
S+G++L E+ + G P
Sbjct: 251 SYGILLWEIFSLGLNP 266
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 41/231 (17%)
Query: 396 RILGQGGQGTVYKGMLTNGR------IVAIKKSK-LVDESNIEQFINEVAILSQI-NHRN 447
++LG G G V VA+K K D S E ++E+ +++Q+ +H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQY--------------------IHDQTEEFPIT 487
+V LLG C + L++E+ G L Y + ++ + +T
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 488 WEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547
+E L A +V+ + +L HRD+ + N+L+ K+ DFG +R +M D
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 548 HLTTRVQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592
+ V L PE +T KSDV+S+G++L E+ + G P
Sbjct: 228 Y----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKL-VDESNIEQFINEVAILSQINHR 446
+ F +G+G G V+KG+ ++VAIK L E IE E+ +LSQ +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYL 505
V K G L+ ++ E++ G+ + +E I +R E+ L YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYL 135
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF 565
HS I HRDIK+AN+LL + K++DFG + + Q T V GT ++ PE
Sbjct: 136 HSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 191
Query: 566 RSSQFTEKSDVYSFGVVLVELLTGQKP 592
+ S + K+D++S G+ +EL G+ P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 38/293 (12%), Positives = 82/293 (27%), Gaps = 59/293 (20%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQ--------- 442
+LGQ + G + ++ + I+Q EV L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 443 -------------INHRNVVKLLGCCLETEVPLLVYEFI----PNGTLYQYI----HDQT 481
+ K++ L+ ++ F L + +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 482 EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541
+ RL++ ++V L LH + H ++ +I+LD + ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQ-----FTEKSDVYSFGVVLVELLTGQKPIRST 596
R Q T D ++ G+ + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 597 D---------------SEEDKSLVGYFLEAMKENRL--FEVLDARVLKEAKEE 632
+ ++L+ FL KE+RL + ++ ++ + E
Sbjct: 321 AALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 373
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-32
Identities = 84/321 (26%), Positives = 129/321 (40%), Gaps = 53/321 (16%)
Query: 364 QQESSSNEGNSEKTKLFTSMELEMATDNFNTN----RILGQGGQGTVYKG-MLTNGRIVA 418
S + + M + + R LG G G V A
Sbjct: 6 HHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKA 65
Query: 419 IK---KSKLVD----------ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465
IK KS+ E E+ NE+++L ++H N++KL + + LV
Sbjct: 66 IKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVT 125
Query: 466 EFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSAN 522
EF G L++ I ++ E + I ++ +CYLH I HRDIK N
Sbjct: 126 EFYEGGELFEQIINRHKFDEC-----DAA-NIMKQILSGICYLHKHN---IVHRDIKPEN 176
Query: 523 ILLDDK---YRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSF 579
ILL++K K+ DFG S D L R+ GT Y+ PE + + EK DV+S
Sbjct: 177 ILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRL-GTAYYIAPEVLKKK-YNEKCDVWSC 233
Query: 580 GVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL-FEVLD-ARVLKEAKEEEIITV 637
GV++ LL G P + ++ ++ +++ + F+ D + EAKE
Sbjct: 234 GVIMYILLCGYPPFGGQNDQD-------IIKKVEKGKYYFDFNDWKNISDEAKE------ 280
Query: 638 AMLAKRCLNMIGKKRPTMKEA 658
L K L KR T +EA
Sbjct: 281 --LIKLMLTYDYNKRCTAEEA 299
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-32
Identities = 71/283 (25%), Positives = 122/283 (43%), Gaps = 42/283 (14%)
Query: 389 TDNFNTNRILGQGGQGTVYKG-MLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQIN 444
+ +N +LG+G G V K + A+K K+ ++ + + EV +L +++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD 79
Query: 445 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSD 500
H N++KL E +V E G L+ I + +E + RI +V
Sbjct: 80 HPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-----DAA-RIIKQVFS 132
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGASRSVMIDQTHLTTRVQGTF 557
+ Y+H I HRD+K NILL+ K K+ DFG S + + R+ GT
Sbjct: 133 GITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTA 187
Query: 558 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617
Y+ PE R + + EK DV+S GV+L LL+G P + + L+ ++ +
Sbjct: 188 YYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKY 239
Query: 618 -FEVLD-ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
F++ + +AK+ L ++ L R T +
Sbjct: 240 AFDLPQWRTISDDAKD--------LIRKMLTFHPSLRITATQC 274
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 18/213 (8%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRN 447
+ + LG G G VYK G + A K + E +E +I E+ IL+ +H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAI---EVSDALCY 504
+VKLLG ++ EF P G + + + I + ++ +AL +
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-----IQVVCRQMLEALNF 132
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE- 563
LHS I HRD+K+ N+L+ + +++DFG S + + + GT ++ PE
Sbjct: 133 LHSKRII---HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEV 188
Query: 564 ----YFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
+ + + K+D++S G+ L+E+ + P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 53/253 (20%), Positives = 100/253 (39%), Gaps = 24/253 (9%)
Query: 363 LQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKK 421
+ S + F +E+ R+L +GG VY+ + +GR A+K+
Sbjct: 1 MAGPGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKR 60
Query: 422 SKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVP-------LLVYEFIPNGTL 473
+E I EV + ++ H N+V+ + L+ + G L
Sbjct: 61 LLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQL 120
Query: 474 YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKV 533
+++ P++ + L+I + A+ ++H PI HRD+K N+LL ++ K+
Sbjct: 121 VEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKL 179
Query: 534 SDFGASRSVMIDQTHLTTRVQ-----------GTFGYLDPEYFRSSQ---FTEKSDVYSF 579
DFG++ ++ + + + T Y PE EK D+++
Sbjct: 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWAL 239
Query: 580 GVVLVELLTGQKP 592
G +L L Q P
Sbjct: 240 GCILYLLCFRQHP 252
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 13/295 (4%)
Query: 363 LQQESSSNEGNSEKTKLFTSME--LEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAI 419
L++ + T + E+ D+F LG G G V+K +G ++A
Sbjct: 4 LEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMAR 63
Query: 420 KKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIH 478
K L + + Q I E+ +L + N +V G + E + G+L Q +
Sbjct: 64 KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK 123
Query: 479 DQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGA 538
I +I +++I V L YL I HRD+K +NIL++ + K+ DFG
Sbjct: 124 KAG---RIPEQILGKVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGV 178
Query: 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDS 598
S + + + V GT Y+ PE + + ++ +SD++S G+ LVE+ G+ PI D+
Sbjct: 179 SG--QLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235
Query: 599 EEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRP 653
+E + + G +E + M L+ I + P
Sbjct: 236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD-SRPPMAIFELLDYIVNEPP 289
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 17/216 (7%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKL-VDESNIEQFINEVAILSQINHRN 447
D++ ++G G V VAIK+ L ++++++ + E+ +SQ +H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 448 VVKLLGCCLETEVPLLVYEFIPNG---TLYQYIHDQTEEFPITWEIRLRIAI---EVSDA 501
+V + + LV + + G + ++I + E + IA EV +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREVLEG 133
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF-G-- 558
L YLH I HRD+K+ NILL + +++DFG S + +V+ TF G
Sbjct: 134 LEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 559 -YLDPEYF-RSSQFTEKSDVYSFGVVLVELLTGQKP 592
++ PE + + K+D++SFG+ +EL TG P
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 43/212 (20%), Positives = 77/212 (36%), Gaps = 25/212 (11%)
Query: 398 LGQGGQ--GTVYKGM-LTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLL 452
+G+G + TV G V +++ L + E+ + NH N+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 453 GCCLETEVPLLVYEFIPNGTLYQYI-HDQTEEFPITWEIRLRIAI---EVSDALCYLHSA 508
+ +V F+ G+ I + IA V AL Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVLKALDYIHHM 147
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQ------GTFGYLDP 562
+ HR +K+++IL+ + +S ++ S++ +L P
Sbjct: 148 GYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 563 EYFRSSQ--FTEKSDVYSFGVVLVELLTGQKP 592
E + + + KSD+YS G+ EL G P
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 59/218 (27%), Positives = 87/218 (39%), Gaps = 32/218 (14%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDES---NIEQFINEVAILSQIN 444
F+ R +G G G VY + N +VAIKK + + I EV L ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNG--TLYQYIHDQTEEFPITWEIRLRIAIEVSDAL 502
H N ++ GC L LV E+ L + +E I L
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH-----GALQGL 167
Query: 503 CYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS-----RSVMIDQTHLTTRVQGTF 557
YLHS I HRD+K+ NILL + K+ DFG++ + + GT
Sbjct: 168 AYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV----------GTP 214
Query: 558 GYLDPE---YFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
++ PE Q+ K DV+S G+ +EL + P
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 74/290 (25%), Positives = 121/290 (41%), Gaps = 44/290 (15%)
Query: 382 SMELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEV 437
SM+ F +LG G V+ G++ A+K KS +S++E NE+
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEI 57
Query: 438 AILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLR 493
A+L +I H N+V L E+ LV + + G L+ I ++ TE+ +
Sbjct: 58 AVLKKIKHENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILERGVYTEK-----DAS-L 110
Query: 494 IAIEVSDALCYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGASRSVMIDQTHLT 550
+ +V A+ YLH I HRD+K N+L ++ + ++DFG S M ++
Sbjct: 111 VIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGL--SKMEQNGIMS 165
Query: 551 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLE 610
T GT GY+ PE +++ D +S GV+ LL G P + E
Sbjct: 166 TAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-------LFE 217
Query: 611 AMKENRL-FEVLD-ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
+KE FE + + AK+ L +R T ++A
Sbjct: 218 KIKEGYYEFESPFWDDISESAKD--------FICHLLEKDPNERYTCEKA 259
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 64/293 (21%), Positives = 119/293 (40%), Gaps = 34/293 (11%)
Query: 379 LFTSMELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDES--NIEQ 432
L + + + D + ++G+G V + + G+ A+K +K + E
Sbjct: 13 LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 433 FINEVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIR 491
E +I + H ++V+LL ++ L +V+EF+ L I + + + E
Sbjct: 73 LKREASICHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 492 LRIAI-EVSDALCYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGASRSVMIDQT 547
+ ++ +AL Y H I HRD+K +LL K + K+ FG + +
Sbjct: 132 ASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 188
Query: 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGY 607
RV GT ++ PE + + + DV+ GV+L LL+G P T
Sbjct: 189 VAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL------- 240
Query: 608 FLEAMKENRL-FEVLD-ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
E + + + + + + AK+ L +R L + +R T+ EA
Sbjct: 241 -FEGIIKGKYKMNPRQWSHISESAKD--------LVRRMLMLDPAERITVYEA 284
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 66/206 (32%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 396 RILGQGGQGTVYKG--MLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVK 450
+ +G+G V +LT GR VAIK K++L + +++++ EV I+ +NH N+VK
Sbjct: 21 KTIGKGNFAKVKLARHILT-GREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVK 78
Query: 451 LLGCCLETEVPL-LVYEFIPNGTLYQYI--HDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
L +ETE L L+ E+ G ++ Y+ H + +E E R ++ A+ Y H
Sbjct: 79 LFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EAR-SKFRQIVSAVQYCHQ 132
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS 567
I HRD+K+ N+LLD K++DFG S + L G Y PE F+
Sbjct: 133 KR---IVHRDLKAENLLLDADMNIKIADFGFS-NEFTVGGKLDAFC-GAPPYAAPELFQG 187
Query: 568 SQFT-EKSDVYSFGVVLVELLTGQKP 592
++ + DV+S GV+L L++G P
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-29
Identities = 69/299 (23%), Positives = 114/299 (38%), Gaps = 64/299 (21%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLV-----DESNIEQFINEVAI 439
D + ++ LG G G V + VAI+ K K + E+ I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 440 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAI 496
L ++NH ++K+ + E +V E + G L+ + E +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-LYFY 246
Query: 497 EVSDALCYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGASRSVMIDQTHLTTRV 553
++ A+ YLH I HRD+K N+LL + K++DFG S+ ++ + + + T
Sbjct: 247 QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTLC 302
Query: 554 QGTFGYLDPEYFRSSQF---TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLE 610
GT YL PE S D +S GV+L L+G P F E
Sbjct: 303 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---------------FSE 346
Query: 611 AMKENRLFE-VLDAR----------VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
+ L + + + V ++A + L K+ L + K R T +EA
Sbjct: 347 HRTQVSLKDQITSGKYNFIPEVWAEVSEKALD--------LVKKLLVVDPKARFTTEEA 397
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 31/242 (12%), Positives = 71/242 (29%), Gaps = 53/242 (21%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQI-------- 443
+LGQ + G + ++ + I+Q EV L +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 444 -----------------NHRNVVKLLGCCLETEVPLLVYEF-IPNGTLYQYI----HDQT 481
+ ++++ + V + + L + +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 482 EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541
+ RL++ ++V L LH + H ++ +I+LD + ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254
Query: 542 VMIDQTHLTTRVQGTFGYLDPEYF-----------RSSQFTEKSDVYSFGVVLVELLTGQ 590
+ + G+ PE R + T D ++ G+V+ +
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 591 KP 592
P
Sbjct: 311 LP 312
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 58/225 (25%), Positives = 108/225 (48%), Gaps = 19/225 (8%)
Query: 385 LEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL-VDESNIEQFINEVAI-LS 441
+E+ D+ LG+G G V K +G+I+A+K+ + V+ ++ + ++ I +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 442 QINHRNVVKLLGCCL-ETEVPLLVYEFIPNGT--LYQYIHDQTEEFPITWEIRL-RIAIE 497
++ V G E +V + E + Y+ + D+ + P E L +IA+
Sbjct: 62 TVDCPFTVTFYGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIP---EDILGKIAVS 117
Query: 498 VSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF 557
+ AL +LHS S+ I HRD+K +N+L++ + K+ DFG S ++D G
Sbjct: 118 IVKALEHLHSKLSV-I-HRDVKPSNVLINALGQVKMCDFGISG-YLVDDVAKDIDA-GCK 173
Query: 558 GYLDPE----YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDS 598
Y+ PE ++ KSD++S G+ ++EL + P S +
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 64/338 (18%), Positives = 121/338 (35%), Gaps = 91/338 (26%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRN 447
+F + +G+GG G V++ + AIK+ +L + E E+ + EV L+++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 448 VVKLLGCCLETEVPLL-------------------------------------------- 463
+V+ LET
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 464 -VYEFIPNGTLY------------QYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAAS 510
+ P LY +++ + + L I I++++A+ +LHS
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184
Query: 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT-----------TRVQGTFGY 559
+ HRD+K +NI KV DFG ++ D+ T T GT Y
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619
+ PE + ++ K D++S G++L ELL ST E + + ++ +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSF----STQMERVR-----IITDVRNLKFPL 293
Query: 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657
+ + +E ++ + L+ +RP +
Sbjct: 294 LFTQKYPQEHM---MV------QDMLSPSPTERPEATD 322
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 71/282 (25%), Positives = 125/282 (44%), Gaps = 40/282 (14%)
Query: 389 TDNFNTNRILGQGGQGTVYKG-MLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQIN 444
+ +N +LG+G G V K + A+K K+ ++ + + EV +L +++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD 79
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSDA 501
H N++KL ++ +V E G L+ I + +E + RI +V
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH-----DAA-RIIKQVFSG 133
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGASRSVMIDQTHLTTRVQGTFG 558
+ Y+H I HRD+K NILL+ K + K+ DFG S T + R+ GT
Sbjct: 134 ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKMKDRI-GTAY 188
Query: 559 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL- 617
Y+ PE R + + EK DV+S GV+L LL+G P + + + L+ ++ +
Sbjct: 189 YIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPF---YGKNEYDI----LKRVETGKYA 240
Query: 618 FEVLD-ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
F++ + +AK+ L ++ L R T +
Sbjct: 241 FDLPQWRTISDDAKD--------LIRKMLTFHPSLRITATQC 274
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 63/283 (22%), Positives = 109/283 (38%), Gaps = 44/283 (15%)
Query: 389 TDNFNTNRILGQGGQGTVYKG-MLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQIN 444
+ +G+G G V A K K + ++++F E+ I+ ++
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLD 64
Query: 445 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSD 500
H N+++L E + LV E G L++ + + E + RI +V
Sbjct: 65 HPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRES-----DAA-RIMKDVLS 117
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGASRSVMIDQTHLTTRVQGTF 557
A+ Y H + HRD+K N L K+ DFG + + T+V GT
Sbjct: 118 AVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMMRTKV-GTP 172
Query: 558 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617
Y+ P+ + + D +S GV++ LL G P + D + + ++E
Sbjct: 173 YYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPF---SAPTDSEV----MLKIREGTF 224
Query: 618 -FEVLD-ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
F D V +A+ L +R L K+R T +A
Sbjct: 225 TFPEKDWLNVSPQAES--------LIRRLLTKSPKQRITSLQA 259
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 11/219 (5%)
Query: 390 DNFNTNRILGQGGQGTVYKGML-TNGRIVAIK---KSKLVDESNIEQFINEVAILSQINH 445
D F R+LG+GG G V+ + G++ A K K +L + + E IL++++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 446 RNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALC 503
R +V L ET+ L LV + G + +I++ E+ P E R ++ L
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE 563
+LH I +RD+K N+LLDD ++SD G + + QT GT G++ PE
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE 359
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDK 602
++ D ++ GV L E++ + P R+ + +
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 60/241 (24%), Positives = 102/241 (42%), Gaps = 15/241 (6%)
Query: 367 SSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKG-MLTNGRIVAIK---KS 422
S + + ++F +ILG+G TV L R AIK K
Sbjct: 7 EPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR 66
Query: 423 KLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQT 481
++ E+ + E ++S+++H VKL + + L + NG L +YI +
Sbjct: 67 HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYIR-KI 124
Query: 482 EEFPITWEIRLRI-AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540
F E R E+ AL YLH I HRD+K NILL++ +++DFG ++
Sbjct: 125 GSFD---ETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAK 178
Query: 541 SVMIDQTHLTTR-VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSE 599
+ + GT Y+ PE + SD+++ G ++ +L+ G P R+ +
Sbjct: 179 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 238
Query: 600 E 600
Sbjct: 239 L 239
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 65/307 (21%), Positives = 124/307 (40%), Gaps = 45/307 (14%)
Query: 368 SSNEGNSEKTKLFTSME-LEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL- 424
SS + L + + ++ +G G G V+K G ++A+K+ +
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS 61
Query: 425 VDESNIEQFINEVAIL-SQINHRNVVKLLGCCL-ETEVPLLVYEFIPNGT--LYQYIHDQ 480
++ ++ + ++ ++ + +V+ G + T+V + E + L + +
Sbjct: 62 GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQGP 120
Query: 481 TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540
E + ++ + + AL YL + I HRD+K +NILLD++ + K+ DFG S
Sbjct: 121 IPERILG-----KMTVAIVKALYYLKEKHGV-I-HRDVKPSNILLDERGQIKLCDFGIS- 172
Query: 541 SVMIDQTHLTTRVQGTFGYLDPE-----YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRS 595
++D G Y+ PE + ++DV+S G+ LVEL TGQ P ++
Sbjct: 173 GRLVDDKAKDRSA-GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231
Query: 596 TDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEA---KEEEIITVAM--LAKRCLNMIGK 650
++ FEVL + +E + K CL +
Sbjct: 232 CKTD------------------FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHR 273
Query: 651 KRPTMKE 657
KRP +
Sbjct: 274 KRPKYNK 280
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 72/279 (25%), Positives = 114/279 (40%), Gaps = 32/279 (11%)
Query: 389 TDNFNTNRILGQGGQGTVYKG-MLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQIN 444
D F R LG G G V+ ++G IK K + + +EQ E+ +L ++
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLD 78
Query: 445 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIR-LRIAIEVSDAL 502
H N++K+ E + +V E G L + I E + ++ +AL
Sbjct: 79 HPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 503 CYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGASRSVMIDQTHLTTRVQGTFGY 559
Y HS + H+D+K NIL D K+ DFG + + H T GT Y
Sbjct: 138 AYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHSTNAA-GTALY 192
Query: 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619
+ PE F+ T K D++S GVV+ LLTG P SL +A + +
Sbjct: 193 MAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPF------TGTSLEEVQQKATYKEPNYA 245
Query: 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
V + +A + L K+ L ++RP+ +
Sbjct: 246 VECRPLTPQAVD--------LLKQMLTKDPERRPSAAQV 276
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 64/236 (27%), Positives = 110/236 (46%), Gaps = 16/236 (6%)
Query: 373 NSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKL-VDESNI 430
+S K K+ + ++ +G+G G+V K + +G+I+A+K+ + VDE
Sbjct: 5 SSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ 64
Query: 431 EQFINEVAI-LSQINHRNVVKLLGCCL-ETEVPLLVYEFIPNG--TLYQYIHDQTEEFPI 486
+Q + ++ + + + +V+ G E + + E + Y+Y++ ++ I
Sbjct: 65 KQLLMDLDVVMRSSDCPYIVQFYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDD-VI 122
Query: 487 TWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546
EI +I + AL +L I HRDIK +NILLD K+ DFG S ++D
Sbjct: 123 PEEILGKITLATVKALNHLKENLKI--IHRDIKPSNILLDRSGNIKLCDFGIS-GQLVDS 179
Query: 547 THLTTRVQGTFGYLDPEYFRSSQ----FTEKSDVYSFGVVLVELLTGQKPIRSTDS 598
T G Y+ PE S + +SDV+S G+ L EL TG+ P +S
Sbjct: 180 IAKTRDA-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 25/207 (12%), Positives = 59/207 (28%), Gaps = 40/207 (19%)
Query: 398 LGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKLLG 453
G ++ + R VA+ ++ + +++ ++ LS+I+ V ++L
Sbjct: 39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD 98
Query: 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPI 513
L+V E+I G+L + + +R ++ A H A +
Sbjct: 99 VVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA---GV 150
Query: 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 573
+ + + + + +
Sbjct: 151 ALSIDHPSRVRVSIDGDVVL---------------------AYPATMPDA-------NPQ 182
Query: 574 SDVYSFGVVLVELLTGQKPIRSTDSEE 600
D+ G L LL + P+
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRS 209
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 63/243 (25%), Positives = 101/243 (41%), Gaps = 27/243 (11%)
Query: 367 SSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLV 425
S +++ + L F ++G G G VYKG + G++ AIK +
Sbjct: 1 SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV- 59
Query: 426 DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPL------LVYEFIPNGT---LYQ 475
E+ E+ +L + +HRN+ G ++ P LV EF G+ L +
Sbjct: 60 TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 476 YIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVS 534
T +E I + R E+ L +LH I HRDIK N+LL + K+
Sbjct: 120 NTKGNTLKEEWIAYICR-----EILRGLSHLHQHKVI---HRDIKGQNVLLTENAEVKLV 171
Query: 535 DFGASRSVMIDQTHLTTRVQGTFGYLDPE-----YFRSSQFTEKSDVYSFGVVLVELLTG 589
DFG S + T + GT ++ PE + + KSD++S G+ +E+ G
Sbjct: 172 DFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
Query: 590 QKP 592
P
Sbjct: 231 APP 233
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 70/292 (23%), Positives = 119/292 (40%), Gaps = 59/292 (20%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQIN 444
+DN++ LG+G V + + T G A K KL + ++ E I ++
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ 63
Query: 445 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSD 500
H N+V+L + E LV++ + G L++ I + +E + ++ +
Sbjct: 64 HPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFYSEA-----DAS-HCIQQILE 116
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGASRSVMIDQTHLTTRVQGTF 557
++ Y HS I HR++K N+LL K + K++DFG + + D GT
Sbjct: 117 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWHGFA-GTP 171
Query: 558 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617
GYL PE + +++ D+++ GV+L LL G P D ++RL
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----------------QHRL 215
Query: 618 FE-VLDAR----------VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
+ + V EAK L L + KKR T +A
Sbjct: 216 YAQIKAGAYDYPSPEWDTVTPEAKS--------LIDSMLTVNPKKRITADQA 259
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 70/299 (23%), Positives = 115/299 (38%), Gaps = 64/299 (21%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLV-----DESNIEQFINEVAI 439
D + ++ LG G G V + VAIK K K + E+ I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 440 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAI 496
L ++NH ++K+ + E +V E + G L+ + E +
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-LYFY 121
Query: 497 EVSDALCYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGASRSVMIDQTHLTTRV 553
++ A+ YLH I HRD+K N+LL + K++DFG S+ ++ + + + T
Sbjct: 122 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTLC 177
Query: 554 QGTFGYLDPEYFRSSQ---FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLE 610
GT YL PE S + D +S GV+L L+G P F E
Sbjct: 178 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---------------FSE 221
Query: 611 AMKENRLFE-VLDAR----------VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
+ L + + + V ++A + L K+ L + K R T +EA
Sbjct: 222 HRTQVSLKDQITSGKYNFIPEVWAEVSEKALD--------LVKKLLVVDPKARFTTEEA 272
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 66/283 (23%), Positives = 114/283 (40%), Gaps = 40/283 (14%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQIN 444
T+ + LG+G V + + + G+ A KL + ++ E I +
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK 68
Query: 445 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSD 500
H N+V+L E L+++ + G L++ I + +E + ++ +
Sbjct: 69 HPNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVAREYYSEA-----DAS-HCIQQILE 121
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGASRSVMIDQTHLTTRVQGTF 557
A+ + H + HR++K N+LL K + K++DFG + V +Q GT
Sbjct: 122 AVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTP 177
Query: 558 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617
GYL PE R + + D+++ GV+L LL G P D + +K
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-------LYQQIKAGAY 230
Query: 618 -FEVLD-ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
F + V EAK+ L + L + KR T EA
Sbjct: 231 DFPSPEWDTVTPEAKD--------LINKMLTINPSKRITAAEA 265
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 60/252 (23%), Positives = 102/252 (40%), Gaps = 20/252 (7%)
Query: 362 LLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKG-MLTNGRIVAIK 420
L Q + ++ + + E+ + D+F +++G+G V M G++ A+K
Sbjct: 33 LAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMK 92
Query: 421 ---KSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQY 476
K ++ + F E +L + R + +L + E L LV E+ G L
Sbjct: 93 IMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTL 151
Query: 477 IHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535
+ E P R E+ A+ +H + HRDIK NILLD +++D
Sbjct: 152 LSKFGERIP---AEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLAD 205
Query: 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVY-------SFGVVLVELLT 588
FG+ + D T + GT YL PE ++ + Y + GV E+
Sbjct: 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
Query: 589 GQKPIRSTDSEE 600
GQ P + + E
Sbjct: 266 GQTPFYADSTAE 277
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 61/281 (21%), Positives = 112/281 (39%), Gaps = 39/281 (13%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVA---IKKSKLVDESNIEQFINEVAILSQIN 444
D ++ LG G G V++ + GR+ I +D NE++I++Q++
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLH 106
Query: 445 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC 503
H ++ L E + + L+ EF+ G L+ I E++ ++ + + + L
Sbjct: 107 HPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLK 163
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
++H + I H DIK NI+ + K + K+ DFG + ++ + T +
Sbjct: 164 HMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLAT--KLNPDEIVKVTTATAEFAA 218
Query: 562 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621
PE +D+++ GV+ LL+G P F L V
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSP---------------FAGEDDLETLQNVK 263
Query: 622 DARVLKEAKEEEIITVAMLAK----RCLNMIGKKRPTMKEA 658
E E+ +V+ AK L +KR T+ +A
Sbjct: 264 RCDW--EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 19/205 (9%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKL 451
LG G G V G G VA+K + K+ + + E+ L H +++KL
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 452 LGCCLETEVPL-LVYEFIPNGTLYQYI--HDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
+ T +V E++ G L+ YI H + EE E R R+ ++ A+ Y H
Sbjct: 77 YQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM----EAR-RLFQQILSAVDYCHRH 130
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS 568
+ HRD+K N+LLD AK++DFG S ++M D L T G+ Y PE
Sbjct: 131 M---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GSPNYAAPEVISGR 185
Query: 569 QFT-EKSDVYSFGVVLVELLTGQKP 592
+ + D++S GV+L LL G P
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLP 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 56/217 (25%), Positives = 108/217 (49%), Gaps = 15/217 (6%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQF----INEVAILSQINH 445
+ + +G+G G VYK + GRIVA+K+ +L ++ E I E+++L +++H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL--DAEDEGIPSTAIREISLLKELHH 78
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
N+V L+ LV+EF+ L + + + + +I++ ++ + +
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDS-QIKI-YLYQLLRGVAHC 135
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEY- 564
H I HRD+K N+L++ K++DFG +R+ I T V T Y P+
Sbjct: 136 HQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVL 191
Query: 565 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
S +++ D++S G + E++TG KP+ +++D
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVTDDD 227
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 64/245 (26%), Positives = 111/245 (45%), Gaps = 29/245 (11%)
Query: 364 QQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK-- 420
+ + + TKL E E + +LG GG G+VY G+ +++ VAIK
Sbjct: 17 RGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV 76
Query: 421 -KSKLVDESNIEQFIN---EVAILSQINHR--NVVKLLGCCLETEVPL-LVYEFI-PNGT 472
K ++ D + EV +L +++ V++LL E L+ E P
Sbjct: 77 EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQD 135
Query: 473 LYQYIHDQ---TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD-DK 528
L+ +I ++ EE R +V +A+ + H+ + HRDIK NIL+D ++
Sbjct: 136 LFDFITERGALQEE-----LAR-SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNR 186
Query: 529 YRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFT-EKSDVYSFGVVLVELL 587
K+ DFG+ ++ T T GT Y PE+ R ++ + V+S G++L +++
Sbjct: 187 GELKLIDFGSGA--LLKDTVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243
Query: 588 TGQKP 592
G P
Sbjct: 244 CGDIP 248
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-27
Identities = 75/251 (29%), Positives = 116/251 (46%), Gaps = 20/251 (7%)
Query: 363 LQQESSSNEGNSEKTKLFTS---MELEMAT-DNFNTNRILGQGGQGTVYKGML-TNGRIV 417
L ++ +S F +E + T + F R+LG+GG G V + G++
Sbjct: 153 LSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMY 212
Query: 418 AIK---KSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTL 473
A K K ++ +NE IL ++N R VV L ET+ L LV + G L
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDL 271
Query: 474 YQYIHDQTEE-FPITWEIRLRI-AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRA 531
+I+ + FP E R A E+ L LH I +RD+K NILLDD
Sbjct: 272 KFHIYHMGQAGFP---EARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHI 325
Query: 532 KVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQK 591
++SD G + V QT + RV GT GY+ PE ++ ++T D ++ G +L E++ GQ
Sbjct: 326 RISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
Query: 592 PIRSTDSEEDK 602
P + + +
Sbjct: 384 PFQQRKKKIKR 394
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 69/283 (24%), Positives = 116/283 (40%), Gaps = 41/283 (14%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQIN 444
+DN++ LG+G V + + T G A K KL ++ E I ++
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQ 86
Query: 445 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSD 500
H N+V+L + E LV++ + G L++ I + +E + ++ +
Sbjct: 87 HPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFYSEA-----DAS-HCIQQILE 139
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGASRSVMIDQTHLTTRVQGTF 557
++ Y HS I HR++K N+LL K + K++DFG + + D GT
Sbjct: 140 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWHGFA-GTP 194
Query: 558 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617
GYL PE + +++ D+++ GV+L LL G P D +K
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAY 247
Query: 618 -FEVLD-ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
+ + V EAK L L + KKR T +A
Sbjct: 248 DYPSPEWDTVTPEAKS--------LIDSMLTVNPKKRITADQA 282
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 67/275 (24%), Positives = 113/275 (41%), Gaps = 31/275 (11%)
Query: 394 TNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKL 451
++ LG+G K + + + A+K ++ + E+ L H N+VKL
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 452 LGCCLETEVPLLVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSDALCYLHSA 508
+ LV E + G L++ I + +E E I ++ A+ ++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET-----EAS-YIMRKLVSAVSHMHDV 125
Query: 509 ASIPIYHRDIKSANILLDDKYRA---KVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF 565
+ HRD+K N+L D+ K+ DFG +R D L T T Y PE
Sbjct: 126 G---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELL 181
Query: 566 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL-FEVLD-A 623
+ + E D++S GV+L +L+GQ P +S D + ++ +K+ FE
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK 241
Query: 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
V +EAK+ L + L + KR M
Sbjct: 242 NVSQEAKD--------LIQGLLTVDPNKRLKMSGL 268
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 12/216 (5%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFIN--EVAILSQINHR 446
+ + +G+G G V+K G+IVAIKK ++ + + I E+ +L Q+ H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH 506
N+V LL LV+E+ + T+ + P ++ I + A+ + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEH-LVK-SITWQTLQAVNFCH 119
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEY-F 565
HRD+K NIL+ K+ DFG +R + + V T Y PE
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLV 175
Query: 566 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
+Q+ DV++ G V ELL+G P+ S+ D
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVD 210
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 51/218 (23%), Positives = 98/218 (44%), Gaps = 15/218 (6%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQF----INEVAILSQIN 444
+ +G+G GTV+K IVA+K+ +L D+ E + E+ +L ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELK 59
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCY 504
H+N+V+L + LV+EF L +Y + ++ ++ L +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPE-IVKS-FLFQLLKGLGF 116
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEY 564
HS + HRD+K N+L++ K+++FG +R+ I + V T Y P+
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDV 172
Query: 565 -FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
F + ++ D++S G + EL +P+ + +D
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 67/323 (20%), Positives = 117/323 (36%), Gaps = 72/323 (22%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKL--VDESNIEQFINEVAILSQ 442
++ +GQG G V + I AIK K+K+ ++ ++E+ EV ++ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 443 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRL--------- 492
++H N+ +L E E + LV E G L ++ ++ + +
Sbjct: 85 LHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 493 ----------------------------RIAIEVSDALCYLHSAASIPIYHRDIKSANIL 524
I ++ AL YLH+ I HRDIK N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFL 200
Query: 525 LDDK--YRAKVSDFGASRSV----MIDQTHLTTRVQGTFGYLDPEYFRSSQ--FTEKSDV 576
+ K+ DFG S+ + +TT+ GT ++ PE ++ + K D
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDA 259
Query: 577 YSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD-ARVLKEAKEEEII 635
+S GV+L LL G P + + + + FE + + A++
Sbjct: 260 WSAGVLLHLLLMGAVPF------PGVNDADTISQVLNKKLCFENPNYNVLSPLARD---- 309
Query: 636 TVAMLAKRCLNMIGKKRPTMKEA 658
L LN +R A
Sbjct: 310 ----LLSNLLNRNVDERFDAMRA 328
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 65/242 (26%), Positives = 108/242 (44%), Gaps = 18/242 (7%)
Query: 364 QQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKS 422
SS + F SME + ++G+G G V K GRIVAIKK
Sbjct: 5 HHHHSSGVDLGTENLYFQSME------KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF 58
Query: 423 KLVDESNIEQFIN--EVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ 480
D+ + + I E+ +L Q+ H N+V LL C + + LV+EF+ + T+ +
Sbjct: 59 LESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELF 117
Query: 481 TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540
++ + ++ + + + HS I HRDIK NIL+ K+ DFG +R
Sbjct: 118 PNGLDYQ-VVQ-KYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 172
Query: 541 SVMIDQTHLTTRVQGTFGYLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSE 599
++ V T Y PE ++ + DV++ G ++ E+ G +P+ DS+
Sbjct: 173 TLAAPGEVYDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGDSD 230
Query: 600 ED 601
D
Sbjct: 231 ID 232
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 27/219 (12%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVA---IKKSKLVDESN---IEQFINEVAILS 441
D ++ LG G V K + G A IKK + E+ EV+IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 442 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIE 497
Q+ H NV+ L E + L+ E + G L+ ++ + +EE E +
Sbjct: 71 QVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEE-----EAT-SFIKQ 123
Query: 498 VSDALCYLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGASRSVMIDQTHLTTRV 553
+ D + YLH+ I H D+K NI+L K+ DFG + + D
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIF 179
Query: 554 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
GT ++ PE ++D++S GV+ LL+G P
Sbjct: 180 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 15/217 (6%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQF----INEVAILSQINH 445
+ ++ +G+G G VYK G A+KK +L E E I E++IL ++ H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--EGIPSTTIREISILKELKH 59
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
N+VKL + +LV+E + L + + + +++ + + Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESV-TAKS-FLLQLLNGIAYC 116
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEY- 564
H + HRD+K N+L++ + K++DFG +R+ I T + T Y P+
Sbjct: 117 HDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVL 172
Query: 565 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
S +++ D++S G + E++ G P+ SE D
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVSEAD 208
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 391 NFNTNRILGQGGQGTVYKGM-LTNGRIVA---IKKSKLVDESNIEQFINEVAILSQINHR 446
+ ILG G G V+K G +A IK + D E+ NE+++++Q++H
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHA 146
Query: 447 NVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPIT-WEIRLRIAIEVSDALCY 504
N+++L E++ + LV E++ G L+ I D++ T + ++ + + +
Sbjct: 147 NLIQLYD-AFESKNDIVLVMEYVDGGELFDRIIDESYNL--TELDTI-LFMKQICEGIRH 202
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGASRSVMIDQTHLTTRVQGTFGYLDP 562
+H I H D+K NIL ++ K+ DFG +R + L GT +L P
Sbjct: 203 MHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNF-GTPEFLAP 257
Query: 563 EYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
E + +D++S GV+ LL+G P
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 77/289 (26%), Positives = 121/289 (41%), Gaps = 48/289 (16%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVA---IKKSKLVDE---SNIEQFINEVAILS 441
D ++T LG G V K + G A IKK + + E EV+IL
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 442 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIE 497
+I H NV+ L E + + L+ E + G L+ ++ ++ TEE E +
Sbjct: 70 EIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEE-----EAT-EFLKQ 122
Query: 498 VSDALCYLHSAASIPIYHRDIKSANILLDDKYRA----KVSDFGASRSVMIDQTHLTTRV 553
+ + + YLHS I H D+K NI+L D+ K+ DFG + ID + +
Sbjct: 123 ILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNI 177
Query: 554 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK 613
GT ++ PE ++D++S GV+ LL+G P FL K
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP---------------FLGDTK 222
Query: 614 ENRLFEVLDARVLKEAKEEEIITVAMLAK----RCLNMIGKKRPTMKEA 658
+ L V E ++E + LAK R L KKR T++++
Sbjct: 223 QETLANVSAVNY--EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 31/221 (14%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFIN---EVAILSQ 442
+ +LG+GG GTV+ G LT+ VAIK +++++ S + + EVA+L +
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 443 IN----HRNVVKLLGCCLETEVPL-LVYEF-IPNGTLYQYIHDQ---TEEFPITWEIRLR 493
+ H V++LL ET+ LV E +P L+ YI ++ E R
Sbjct: 91 VGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEG-----PSR-C 143
Query: 494 IAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGASRSVMIDQTHLTTR 552
+V A+ + HS + HRDIK NIL+D + AK+ DFG+ ++ T
Sbjct: 144 FFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGA--LLHDEPYTDF 198
Query: 553 VQGTFGYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKP 592
GT Y PE+ Q+ + V+S G++L +++ G P
Sbjct: 199 D-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 25/216 (11%)
Query: 391 NFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKL-----VDESNIEQFINEVAILS 441
++T LG G G V+ + + V +K K K+ +++ + + E+AILS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 442 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGT-LYQYI--HDQTEEFPITWEIRLRIAIE 497
++ H N++K+L E + LV E +G L+ +I H + +E I +
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP----LAS-YIFRQ 138
Query: 498 VSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF 557
+ A+ YL I HRDIK NI++ + + K+ DFG++ + + T GT
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA-AYLERGKLFYTFC-GTI 193
Query: 558 GYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKP 592
Y PE + + + +++S GV L L+ + P
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 71/290 (24%), Positives = 122/290 (42%), Gaps = 58/290 (20%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKK-SKLVDESNIEQFINEVAILSQINHR 446
+D F LG+G VY+ + A+K K VD+ + E+ +L +++H
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR---TEIGVLLRLSHP 108
Query: 447 NVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSDAL 502
N++KL ET + LV E + G L+ I ++ +E + ++ +A+
Sbjct: 109 NIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGYYSER-----DAA-DAVKQILEAV 161
Query: 503 CYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGASRSVMIDQTHLTTRVQGTFGY 559
YLH I HRD+K N+L K++DFG S+ ++ Q + T GT GY
Sbjct: 162 AYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMKTVC-GTPGY 216
Query: 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619
PE R + + D++S G++ LL G +P F + + +F
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIITYILLCGFEP---------------FYDERGDQFMFR 261
Query: 620 -VLDAR----------VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
+L+ V AK+ L ++ + + KKR T +A
Sbjct: 262 RILNCEYYFISPWWDEVSLNAKD--------LVRKLIVLDPKKRLTTFQA 303
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-26
Identities = 58/282 (20%), Positives = 101/282 (35%), Gaps = 41/282 (14%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVA---IKKSKLVDESNIEQFINEVAILSQIN 444
D+++ + LG G G V++ G A + D E E+ +S +
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLR 212
Query: 445 HRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAI-EVSDAL 502
H +V L E + + ++YEF+ G L++ + D+ + E + +V L
Sbjct: 213 HPTLVNLHDAF-EDDNEMVMIYEFMSGGELFEKVADEHNKMS---EDEAVEYMRQVCKGL 268
Query: 503 CYLHSAASIPIYHRDIKSANILLDDK--YRAKVSDFGASRSVMIDQTHLTTRVQGTFGYL 560
C++H H D+K NI+ K K+ DFG + +D GT +
Sbjct: 269 CHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTA--HLDPKQSVKVTTGTAEFA 323
Query: 561 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620
PE +D++S GV+ LL+G P F + L V
Sbjct: 324 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSP---------------FGGENDDETLRNV 368
Query: 621 LDARVLKEAKEEEIITVAMLAK----RCLNMIGKKRPTMKEA 658
+ ++ K + L R T+ +A
Sbjct: 369 KSCDW--NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 408
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 63/208 (30%), Positives = 90/208 (43%), Gaps = 24/208 (11%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKL 451
+ LG+G G V + VA+K + VD E E+ I +NH NVVK
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKF 70
Query: 452 LGCCLETEVPL-LVYEFIPNGTLYQYI--HDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
G L E+ G L+ I E + + R ++ + YLH
Sbjct: 71 YGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQ-RFFHQLMAGVVYLHGI 124
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT---HLTTRVQGTFGYLDPEYF 565
I HRDIK N+LLD++ K+SDFG + +V L GT Y+ PE
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKMC-GTLPYVAPELL 179
Query: 566 RSSQFT-EKSDVYSFGVVLVELLTGQKP 592
+ +F E DV+S G+VL +L G+ P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 69/290 (23%), Positives = 112/290 (38%), Gaps = 50/290 (17%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVA---IKKSKLVDESN---IEQFINEVAILS 441
D++ LG G V K G+ A IKK +L E+ EV IL
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 442 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIE 497
+I H N++ L E + + L+ E + G L+ ++ ++ TE+ E + +
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTED-----EAT-QFLKQ 116
Query: 498 VSDALCYLHSAASIPIYHRDIKSANILLDDKYRA----KVSDFGASRSVMIDQTHLTTRV 553
+ D + YLHS I H D+K NI+L DK K+ DFG + +
Sbjct: 117 ILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEFKNIF 172
Query: 554 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK 613
GT ++ PE ++D++S GV+ LL+G P
Sbjct: 173 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET---------------- 215
Query: 614 ENRLFE-VLDARVLKEAKEEEIITVAMLAK----RCLNMIGKKRPTMKEA 658
+ + + EE + LAK R L K+R T+ ++
Sbjct: 216 KQETLTNISAVNY--DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQS 263
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 21/210 (10%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFIN-EVAILSQINHRNVVK 450
+LG+G G V + + A+K K KL N E + E+ +L ++ H+NV++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 451 LLG-CCLETEVPL-LVYEFIPNGT--LYQYI-HDQTEEFPITWEIRLRIAIEVSDALCYL 505
L+ E + + +V E+ G + + + + ++ D L YL
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV----CQAH-GYFCQLIDGLEYL 125
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFG-ASRSVMIDQTHLTTRVQGTFGYLDPEY 564
HS I H+DIK N+LL K+S G A QG+ + PE
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 565 FRSSQFTE--KSDVYSFGVVLVELLTGQKP 592
K D++S GV L + TG P
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 27/219 (12%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVA---IKKSKLVDE---SNIEQFINEVAILS 441
D ++ LG G V K + G A IKK + E+ EV+IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 442 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIE 497
Q+ H N++ L E + L+ E + G L+ ++ + +EE E +
Sbjct: 71 QVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEE-----EAT-SFIKQ 123
Query: 498 VSDALCYLHSAASIPIYHRDIKSANILLDDK----YRAKVSDFGASRSVMIDQTHLTTRV 553
+ D + YLH+ I H D+K NI+L DK K+ DFG + I+ +
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKNI 178
Query: 554 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
GT ++ PE ++D++S GV+ LL+G P
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 54/253 (21%), Positives = 107/253 (42%), Gaps = 24/253 (9%)
Query: 362 LLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGML----TNGRIV 417
L ++++ K ++ + ++F +++G+G G V + ++
Sbjct: 46 LRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEV---AVVKLKNADKVF 102
Query: 418 AIK---KSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTL 473
A+K K +++ + F E +L + + + L + + L LV ++ G L
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDL 161
Query: 474 YQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAK 532
+ + P E R E+ A+ +H + HRDIK NIL+D +
Sbjct: 162 LTLLSKFEDRLP---EEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIR 215
Query: 533 VSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKS-----DVYSFGVVLVELL 587
++DFG+ +M D T ++ GT Y+ PE ++ + + D +S GV + E+L
Sbjct: 216 LADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275
Query: 588 TGQKPIRSTDSEE 600
G+ P + E
Sbjct: 276 YGETPFYAESLVE 288
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 73/314 (23%), Positives = 120/314 (38%), Gaps = 65/314 (20%)
Query: 388 ATDNFNTN---------RILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFI 434
+TD+F+ +LG+G V + L + A+K K S +
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF--- 58
Query: 435 NEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ---TEEFPITWEI 490
EV +L Q HRNV++L+ E + LV+E + G++ +IH + E E
Sbjct: 59 REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-----EA 113
Query: 491 RLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGASRSV----- 542
+ +V+ AL +LH+ I HRD+K NIL + + K+ DF +
Sbjct: 114 S-VVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169
Query: 543 --MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKS-----DVYSFGVVLVELLTGQKPIRS 595
I L T G+ Y+ PE + D++S GV+L LL+G P
Sbjct: 170 CSPISTPELLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228
Query: 596 TDSEEDKSLVGYFLEAMKENRLFE-VLDAR----------VLKEAKEEEIITVAMLAKRC 644
D +N LFE + + + + AK+ L +
Sbjct: 229 -RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKD--------LISKL 279
Query: 645 LNMIGKKRPTMKEA 658
L K+R + +
Sbjct: 280 LVRDAKQRLSAAQV 293
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 62/241 (25%), Positives = 107/241 (44%), Gaps = 19/241 (7%)
Query: 362 LLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYK-GMLTNGRIVAIK 420
L + ++ N + K + +L M +++ +++G+G G V + ++ A+K
Sbjct: 41 LRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMK 100
Query: 421 ---KSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQY 476
K +++ S+ F E I++ N VV+L + + L +V E++P G L
Sbjct: 101 LLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNL 159
Query: 477 IHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535
+ + P E R EV AL +HS + HRD+K N+LLD K++D
Sbjct: 160 M--SNYDVP---EKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 211
Query: 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS----SQFTEKSDVYSFGVVLVELLTGQK 591
FG + + GT Y+ PE +S + + D +S GV L E+L G
Sbjct: 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
Query: 592 P 592
P
Sbjct: 272 P 272
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 66/245 (26%), Positives = 107/245 (43%), Gaps = 20/245 (8%)
Query: 365 QESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGML----TNGRIVAIK 420
S N G E + + + F ++LG+G G V +L GR A+K
Sbjct: 123 GSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMK 179
Query: 421 ---KSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQY 476
K +V + + + E +L H + L +T L V E+ G L+ +
Sbjct: 180 ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFH 238
Query: 477 IHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535
+ + F E R R E+ AL YLHS ++ +Y RD+K N++LD K++D
Sbjct: 239 LS-RERVFS---EDRARFYGAEIVSALDYLHSEKNV-VY-RDLKLENLMLDKDGHIKITD 292
Query: 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRS 595
FG + + D + T GT YL PE + + D + GVV+ E++ G+ P +
Sbjct: 293 FGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351
Query: 596 TDSEE 600
D E+
Sbjct: 352 QDHEK 356
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 17/218 (7%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQF----INEVAILSQIN 444
+ + LG+G TVYKG +VA+K+ +L E E I EV++L +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLK 58
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCY 504
H N+V L + LV+E++ L QY+ D + ++L ++ L Y
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMH-NVKL-FLFQLLRGLAY 115
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEY 564
H + HRD+K N+L++++ K++DFG +R+ I V T Y P+
Sbjct: 116 CHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDI 171
Query: 565 -FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
S+ ++ + D++ G + E+ TG +P+ + E+
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATG-RPLFPGSTVEE 208
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 63/208 (30%), Positives = 90/208 (43%), Gaps = 24/208 (11%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKL 451
+ LG+G G V + VA+K + VD E E+ I +NH NVVK
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKF 70
Query: 452 LGCCLETEVPL-LVYEFIPNGTLYQYI--HDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
G L E+ G L+ I E + + R ++ + YLH
Sbjct: 71 YGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQ-RFFHQLMAGVVYLHGI 124
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT---HLTTRVQGTFGYLDPEYF 565
I HRDIK N+LLD++ K+SDFG + +V L GT Y+ PE
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLA-TVFRYNNRERLLNKMC-GTLPYVAPELL 179
Query: 566 RSSQFT-EKSDVYSFGVVLVELLTGQKP 592
+ +F E DV+S G+VL +L G+ P
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 74/293 (25%), Positives = 120/293 (40%), Gaps = 50/293 (17%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNI------EQFINEVA 438
+N+ ILG+G V + + + A+K + S E + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 439 ILSQIN-HRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLR 493
IL +++ H N+++L ET LV++ + G L+ Y+ ++ +E+ E R +
Sbjct: 76 ILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSEK-----ETR-K 128
Query: 494 IAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRV 553
I + + +C LH I HRD+K NILLDD K++DFG S + L
Sbjct: 129 IMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKLREVC 184
Query: 554 QGTFGYLDPEYFRSSQF------TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGY 607
GT YL PE S ++ D++S GV++ LL G P + +
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF---WHRKQMLM--- 237
Query: 608 FLEAMKENRL-FEVLD-ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
L + F + K+ L R L + +KR T +EA
Sbjct: 238 -LRMIMSGNYQFGSPEWDDYSDTVKD--------LVSRFLVVQPQKRYTAEEA 281
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 63/245 (25%), Positives = 112/245 (45%), Gaps = 26/245 (10%)
Query: 363 LQQESSSNEGNSEKTKLFT-----SMELEMATDNFNTNRILGQGGQGTVYKG-MLTNGRI 416
L+ + S+K F + + + ++F+ +RI+G+GG G VY G++
Sbjct: 157 LRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKM 216
Query: 417 VAIK---KSKLVDESNIEQFINEVAILSQIN---HRNVVKLLGCCLETEVPL-LVYEFIP 469
A+K K ++ + +NE +LS ++ +V + T L + + +
Sbjct: 217 YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMN 275
Query: 470 NGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAASIPIYHRDIKSANILLDDK 528
G L+ ++ Q F E +R A E+ L ++H+ + +RD+K ANILLD+
Sbjct: 276 GGDLHYHLS-QHGVFS---EADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEH 328
Query: 529 YRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKS-DVYSFGVVLVELL 587
++SD G + + H V GT GY+ PE + + S D +S G +L +LL
Sbjct: 329 GHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
Query: 588 TGQKP 592
G P
Sbjct: 386 RGHSP 390
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKL-----VDESNIEQFINEVAI 439
++ ++G+G V + + G A+K + E E E I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 440 LSQI-NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRI 494
L Q+ H +++ L+ E+ + LV++ + G L+ Y+ ++ +E+ E R I
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSEK-----ETR-SI 205
Query: 495 AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQ 554
+ +A+ +LH+ I HRD+K NILLDD + ++SDFG S + L
Sbjct: 206 MRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSC-HLEPGEKLRELC- 260
Query: 555 GTFGYLDPEYFRSSQF------TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF 608
GT GYL PE + S ++ D+++ GV+L LL G P +
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF---WHRRQILM---- 313
Query: 609 LEAMKENRL-FEVLD-ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
L + E + F + K+ L R L + + R T ++A
Sbjct: 314 LRMIMEGQYQFSSPEWDDRSSTVKD--------LISRLLQVDPEARLTAEQA 357
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-25
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 19/205 (9%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKL 451
LG G G V G G VA+K + K+ + + E+ L H +++KL
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 452 LGCCLETEVPL-LVYEFIPNGTLYQYI--HDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
+ T + +V E++ G L+ YI + + +E E R R+ ++ + Y H
Sbjct: 82 YQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK----ESR-RLFQQILSGVDYCHRH 135
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS 568
+ HRD+K N+LLD AK++DFG S ++M D L T G+ Y PE
Sbjct: 136 M---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSC-GSPNYAAPEVISGR 190
Query: 569 QFT-EKSDVYSFGVVLVELLTGQKP 592
+ + D++S GV+L LL G P
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLP 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 51/214 (23%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK--KSKLVDESNIEQFINEVAILSQINH 445
+ + LG+G G V++ + ++ + K K K D+ ++ E++IL+ H
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARH 60
Query: 446 RNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ----TEEFPITWEIRLRIAIEVSD 500
RN++ L E+ L +++EFI +++ I+ E EI +V +
Sbjct: 61 RNILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNER-----EIV-SYVHQVCE 113
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGASRSVMIDQTHLTTRVQGTFG 558
AL +LHS I H DI+ NI+ + + K+ +FG +R + +
Sbjct: 114 ALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR--QLKPGDNFRLLFTAPE 168
Query: 559 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
Y PE + + +D++S G ++ LL+G P
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 68/234 (29%), Positives = 107/234 (45%), Gaps = 44/234 (18%)
Query: 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFIN-EVAILSQINHRN 447
+ +++G G G V++ L VAIKK D ++F N E+ I+ + H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-D----KRFKNRELQIMRIVKHPN 93
Query: 448 VVKLLGCCLET-----EVPL-LVYEFIPNGTLYQYIHD---QTEEFPITWEIR------L 492
VV L EV L LV E++P T+Y+ + P+ I+ L
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPML-LIKLYMYQLL 151
Query: 493 RIAIEVSDALCYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGASRSVMIDQ--TH- 548
R +L Y+HS I HRDIK N+LLD K+ DFG+++ ++ +
Sbjct: 152 R-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY 201
Query: 549 LTTRVQGTFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
+ +R Y PE F ++ +T D++S G V+ EL+ GQ P+ +S D
Sbjct: 202 ICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGID 249
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 59/284 (20%), Positives = 106/284 (37%), Gaps = 43/284 (15%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQ-I 443
TD + +G G + + A+K KSK E+ IL +
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT-------EEIEILLRYG 73
Query: 444 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLRIAIEVSD 500
H N++ L + + +V E + G L I Q +E E + ++
Sbjct: 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER-----EAS-AVLFTITK 127
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRA----KVSDFGASRSVMIDQTHLTTRVQGT 556
+ YLH+ + HRD+K +NIL D+ ++ DFG ++ + + L T T
Sbjct: 128 TVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YT 183
Query: 557 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR 616
++ PE + D++S GV+L +LTG P + + + + L + +
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI----LARIGSGK 239
Query: 617 L-FEVLD-ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
V AK+ L + L++ +R T
Sbjct: 240 FSLSGGYWNSVSDTAKD--------LVSKMLHVDPHQRLTAALV 275
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 71/235 (30%), Positives = 114/235 (48%), Gaps = 45/235 (19%)
Query: 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFIN-EVAILSQINHR 446
++ +++G G G VY+ L +G +VAIKK ++F N E+ I+ +++H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 447 NVVKLLGCCLET-----EVPL-LVYEFIPNGTLYQYIHD---QTEEFPITWEIR------ 491
N+V+L + EV L LV +++P T+Y+ + P+ ++
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVI-YVKLYMYQL 165
Query: 492 LRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGASRSVMIDQ--TH 548
R +L Y+HS I HRDIK N+LLD D K+ DFG+++ ++ +
Sbjct: 166 FR-------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 549 -LTTRVQGTFGYLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
+ +R Y PE F ++ +T DV+S G VL ELL GQ PI DS D
Sbjct: 216 YICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVD 264
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 18/223 (8%)
Query: 388 ATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQF----INEVAILSQ 442
++ F LG G TVYKG+ T G VA+K+ KL E E I E++++ +
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKE 59
Query: 443 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEF---PITWEIRLRIAIEVS 499
+ H N+V+L LV+EF+ N L +Y+ +T + + ++
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY 559
L + H I HRD+K N+L++ + + K+ DFG +R+ I ++ V T Y
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWY 174
Query: 560 LDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
P+ S ++ D++S G +L E++TG KP+ ++E+
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTNDEE 216
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 66/227 (29%), Positives = 104/227 (45%), Gaps = 15/227 (6%)
Query: 382 SMELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFIN----- 435
+++++ + LG+G TVYK +IVAIKK KL S + IN
Sbjct: 2 ALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61
Query: 436 EVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIA 495
E+ +L +++H N++ LL LV++F+ L I D + + I+
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPS-HIKA-YM 118
Query: 496 IEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG 555
+ L YLH I HRD+K N+LLD+ K++DFG ++S T +V
Sbjct: 119 LMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV- 174
Query: 556 TFGYLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
T Y PE F + + D+++ G +L ELL P DS+ D
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDSDLD 220
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 4e-24
Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 25/234 (10%)
Query: 390 DNFNTNRILGQGGQGTVY----KGMLTNGRIVAIK---KSKLVDESNIEQFINEVAILSQ 442
D+F R +G+G G V ++ A+K K K V+ + + E+ I+
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 443 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSD 500
+ H +V L + E + +V + + G L ++ Q F E +++ E+
Sbjct: 72 LEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFK---EETVKLFICELVM 126
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYL 560
AL YL + I HRD+K NILLD+ ++DF + + + T + GT Y+
Sbjct: 127 ALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYM 181
Query: 561 DPEYFRSSQFTEKS---DVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEA 611
PE F S + S D +S GV ELL G++P S K +V F
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT 235
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 70/304 (23%), Positives = 118/304 (38%), Gaps = 45/304 (14%)
Query: 374 SEKTKLFTSMELEMATDNFN-----TNRILGQGGQGTVYKGM-LTNGRIVA---IKKSKL 424
S L T + +NFN T++ LG+G V + + + G+ A +KK +
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR 67
Query: 425 VDESNIEQFINEVAILSQINHR-NVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTE 482
+ + ++E+A+L V+ L E + L+ E+ G ++ +
Sbjct: 68 -GQDCRAEILHEIAVLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELA 125
Query: 483 EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY---RAKVSDFGAS 539
E ++ R+ ++ + + YLH I H D+K NILL Y K+ DFG S
Sbjct: 126 EMVSENDVI-RLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181
Query: 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSE 599
R I + GT YL PE T +D+++ G++ LLT P
Sbjct: 182 R--KIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP------- 232
Query: 600 EDKSLVGYFLEAMKENRLFE-VLDARVLKEAKEEEIITVAMLAK----RCLNMIGKKRPT 654
F+ + + V + EE +V+ LA L +KRPT
Sbjct: 233 --------FV-GEDNQETYLNISQVNV--DYSEETFSSVSQLATDFIQSLLVKNPEKRPT 281
Query: 655 MKEA 658
+
Sbjct: 282 AEIC 285
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 46/232 (19%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIK---KSKLV-----------------------DES 428
+G+G G V + A+K K KL+
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 429 NIEQFINEVAILSQINHRNVVKL---LGCCLETEVPLLVYEFIPNGTLYQYIHDQ--TEE 483
IEQ E+AIL +++H NVVKL L E + +V+E + G + + + +E+
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSED 137
Query: 484 FPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543
+ R ++ + YLH I HRDIK +N+L+ + K++DFG S
Sbjct: 138 -----QAR-FYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFT---EKSDVYSFGVVLVELLTGQKP 592
L+ V GT ++ PE ++ + DV++ GV L + GQ P
Sbjct: 189 GSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 62/230 (26%), Positives = 103/230 (44%), Gaps = 28/230 (12%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQF----INEVAILSQIN 444
+ +GQG G V+K G+ VA+KK + +E E F + E+ IL +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLK 74
Query: 445 HRNVVKLLGCCLETEVPL--------LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAI 496
H NVV L+ C P LV++F + L + + +F ++ EI+ R+
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS-EIK-RVMQ 131
Query: 497 EVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS----VMIDQTHLTTR 552
+ + L Y+H I HRD+K+AN+L+ K++DFG +R+ T R
Sbjct: 132 MLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 553 VQGTFGYLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
V T Y PE + D++ G ++ E+ T PI ++E+
Sbjct: 189 VV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNTEQH 236
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 22/229 (9%)
Query: 387 MATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFIN-----EVAIL 440
MAT + +G G GTVYK +G VA+K ++ + + EVA+L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 441 SQIN---HRNVVKLLGCCLETEVPL-----LVYEFIPNGTLYQYIHDQTEEFPITWEIRL 492
++ H NVV+L+ C + LV+E + L Y+ I+
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK- 123
Query: 493 RIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTR 552
+ + L +LH+ I HRD+K NIL+ K++DFG +R LT
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPV 179
Query: 553 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
V T Y PE S + D++S G + E+ KP+ +SE D
Sbjct: 180 VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPLFCGNSEAD 226
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 22/223 (9%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQF----INEVAILSQIN 444
D + LG+G G VYK + VAIK+ +L E E I EV++L ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE--EGVPGTAIREVSLLKELQ 91
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCY 504
HRN+++L L++E+ N L +Y+ D+ + + I+ ++ + + +
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-DKNPDVSMR-VIK-SFLYQLINGVNF 147
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRA-----KVSDFGASRSVMIDQTHLTTRVQGTFGY 559
HS HRD+K N+LL + K+ DFG +R+ I T + T Y
Sbjct: 148 CHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWY 203
Query: 560 LDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
PE S ++ D++S + E+L P+ DSE D
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPLFPGDSEID 245
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINHRNVVKL 451
LG+G G V + VA+K + L + E++ L + H +++KL
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 452 LGCCLETEVPL-LVYEFIPNGTLYQYI--HDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
+ T + +V E+ G L+ YI + E E R R ++ A+ Y H
Sbjct: 75 YDV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTED----EGR-RFFQQIICAIEYCHRH 127
Query: 509 ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS 568
I HRD+K N+LLDD K++DFG S ++M D L T G+ Y PE
Sbjct: 128 K---IVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSC-GSPNYAAPEVINGK 182
Query: 569 QFT-EKSDVYSFGVVLVELLTGQKP 592
+ + DV+S G+VL +L G+ P
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 32/217 (14%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHR 446
D++ R LG+G V++ + +TN V +K K V + I E+ IL +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGP 91
Query: 447 NVVKLLGCCL--ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIR------LRIAIEV 498
N++ L + P LV+E + N Q T+ +IR L+
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY-----DIRFYMYEILK----- 141
Query: 499 SDALCYLHSAASIPIYHRDIKSANILLDDKYRA-KVSDFGASRSVMIDQTHLTTRVQGTF 557
AL Y HS I HRD+K N+++D ++R ++ D+G + RV +
Sbjct: 142 --ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-HPGQEYNVRV-ASR 194
Query: 558 GYLDPEYFRSSQFTEKS-DVYSFGVVLVELLTGQKPI 593
+ PE Q + S D++S G +L ++ ++P
Sbjct: 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 24/220 (10%)
Query: 390 DNFNTNRILGQGGQGTVYKGML----TNGRIVAIK---KSKLVDESNIEQFINEVAILSQ 442
D F+ + LG G G V ML +G A+K K K+V IE +NE IL
Sbjct: 41 DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 443 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSD 500
+N +VKL + L +V E++ G ++ ++ F E R A ++
Sbjct: 98 VNFPFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRI-GRFS---EPHARFYAAQIVL 152
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYL 560
YLHS + +RD+K N+L+D + +V+DFG ++ V T + GT L
Sbjct: 153 TFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEAL 205
Query: 561 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
PE S + + D ++ GV++ E+ G P + +
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 21/220 (9%)
Query: 390 DNFNTNRILGQGGQGTVYKGML----TNGRIVAIK---KSKLVDESNIEQFINEVAILSQ 442
++F+ ++LG+G G V +L GR A+K K ++ + + + E +L
Sbjct: 5 NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 443 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSD 500
H + L +T L V E+ G L+ ++ + F E R R E+
Sbjct: 62 TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS-RERVFT---EERARFYGAEIVS 116
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYL 560
AL YLHS + +RDIK N++LD K++DFG + + D + T GT YL
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYL 172
Query: 561 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
PE + + D + GVV+ E++ G+ P + D E
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 24/226 (10%)
Query: 390 DNFNTNRILGQGGQGTVYKG--MLTNGRIVAIKKSKLVDESNIEQF----INEVAILSQI 443
+ +G+G G V+K + GR VA+K+ ++ ++ E I EVA+L +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVLRHL 68
Query: 444 N---HRNVVKLLGCCLETEVPL-----LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIA 495
H NVV+L C + LV+E + L Y+ E T I+ +
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK-DMM 126
Query: 496 IEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG 555
++ L +LHS + HRD+K NIL+ + K++DFG +R LT+ V
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVV- 181
Query: 556 TFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
T Y PE S + D++S G + E+ KP+ S+ D
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPLFRGSSDVD 226
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 27/222 (12%)
Query: 382 SMELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEV 437
M + +D ++ + +G G G +VA+K + +DE N+++ E+
Sbjct: 12 DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQR---EI 67
Query: 438 AILSQINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQ---TEEFPITWEIRLR 493
+ H N+V+ + T L ++ E+ G LY+ I + +E+ E R
Sbjct: 68 INHRSLRHPNIVRFKEV-ILTPTHLAIIMEYASGGELYERICNAGRFSED-----EAR-F 120
Query: 494 IAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY--RAKVSDFGASRSVMIDQTHLTT 551
++ + Y HS I HRD+K N LLD R K+ DFG S + + +
Sbjct: 121 FFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKS 176
Query: 552 RVQGTFGYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKP 592
V GT Y+ PE ++ + +DV+S GV L +L G P
Sbjct: 177 TV-GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 4e-22
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 390 DNFNTNRILGQGGQGTVY----KGMLTNGRIVAIK---KSKLVDESN-IEQFINEVAILS 441
+ F R+LG+GG G V+ G+I A+K K+ +V + E IL
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 442 QINHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVS 499
++ H +V L+ +T L L+ E++ G L+ + + F E E+S
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE-REGIFM---EDTACFYLAEIS 131
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY 559
AL +LH I +RD+K NI+L+ + K++DFG + I +T GT Y
Sbjct: 132 MALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEY 187
Query: 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
+ PE S D +S G ++ ++LTG P + ++
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK 228
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 5e-22
Identities = 59/243 (24%), Positives = 106/243 (43%), Gaps = 29/243 (11%)
Query: 398 LGQGGQGTVYKGM---LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGC 454
+G+G G VYK + + A+K+ + E+A+L ++ H NV+ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 86
Query: 455 CLE-TEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVS------DALCYLH 506
L + + L++++ + L+ I ++L + S D + YLH
Sbjct: 87 FLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 507 SAASIPIYHRDIKSANILLDDKYRA----KVSDFGASRSVMI---DQTHLTTRVQGTFGY 559
+ + HRD+K ANIL+ + K++D G +R L V TF Y
Sbjct: 146 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201
Query: 560 LDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618
PE + +T+ D+++ G + ELLT +PI E+ K+ Y + + +R+F
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPYHHDQL--DRIF 258
Query: 619 EVL 621
V+
Sbjct: 259 NVM 261
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 69/252 (27%), Positives = 112/252 (44%), Gaps = 21/252 (8%)
Query: 365 QESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVY----KGMLTNGRIVAIK 420
E + +T T ++ +NF ++LG G G V+ G++ A+K
Sbjct: 29 GEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK 88
Query: 421 ---KSKLVDESN-IEQFINEVAILSQINHRN-VVKLLGCCLETEVPL-LVYEFIPNGTLY 474
K+ +V ++ E E +L I +V L +TE L L+ ++I G L+
Sbjct: 89 VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELF 147
Query: 475 QYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKV 533
++ Q E F E ++I E+ AL +LH I +RDIK NILLD +
Sbjct: 148 THLS-QRERFT---EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVL 200
Query: 534 SDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQK 591
+DFG S+ + D+T GT Y+ P+ R + D +S GV++ ELLTG
Sbjct: 201 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
Query: 592 PIRSTDSEEDKS 603
P + ++
Sbjct: 261 PFTVDGEKNSQA 272
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 67/219 (30%), Positives = 107/219 (48%), Gaps = 17/219 (7%)
Query: 390 DNFNTNRILGQGGQGTVY----KGMLTNGRIVAIK--KSKLVDESNIEQFINEVAILSQI 443
F ++LGQG G V+ ++ A+K K + + + E IL ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 444 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSDA 501
NH +VKL +TE L L+ +F+ G L+ + + F E ++ E++ A
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFT---EEDVKFYLAELALA 138
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
L +LHS I +RD+K NILLD++ K++DFG S+ ID GT Y+
Sbjct: 139 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMA 194
Query: 562 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
PE T+ +D +SFGV++ E+LTG P + D +E
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 63/284 (22%), Positives = 113/284 (39%), Gaps = 50/284 (17%)
Query: 394 TNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQI-NHRNV 448
+ ++LG G G V + G+ A+K S + EV Q ++
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ--------EVDHHWQASGGPHI 84
Query: 449 VKLLGCCLETEVP----LLVYEFIPNGTLYQYIHDQ-----TEEFPITWEIRLRIAIEVS 499
V +L L++ E + G L+ I ++ TE E I ++
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER-----EAA-EIMRDIG 138
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGASRSVMIDQTHLTTRVQGT 556
A+ +LHS I HRD+K N+L K + K++DFG ++ Q L T T
Sbjct: 139 TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPC-YT 192
Query: 557 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR 616
Y+ PE ++ + D++S GV++ LL G P S +++ ++ +
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFY---SNTGQAISPGMKRRIRLGQ 249
Query: 617 L-FEVLD-ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
F + + V ++AK+ L + L +R T+ +
Sbjct: 250 YGFPNPEWSEVSEDAKQ--------LIRLLLKTDPTERLTITQF 285
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 71/240 (29%), Positives = 114/240 (47%), Gaps = 22/240 (9%)
Query: 371 EGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGML----TNGRIVAIK---KSK 423
E + E + + + DNF R+LG+G G V ML G + A+K K
Sbjct: 4 ESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKV---MLARVKETGDLYAVKVLKKDV 60
Query: 424 LVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQT 481
++ + ++E + E ILS NH + +L CC +T L V EF+ G L +I ++
Sbjct: 61 ILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ-KS 118
Query: 482 EEFPITWEIRLRI-AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540
F E R R A E+ AL +LH I +RD+K N+LLD + K++DFG +
Sbjct: 119 RRFD---EARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172
Query: 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
+ + T GT Y+ PE + + D ++ GV+L E+L G P + + ++
Sbjct: 173 EGICNGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 7e-21
Identities = 64/224 (28%), Positives = 107/224 (47%), Gaps = 32/224 (14%)
Query: 390 DNFNTNRILGQGGQGTVYKGML----TNGRIVAIK---KSKLVDESNIEQFINEVAILSQ 442
+F R LG G G V L NGR A+K K +V +E +E +LS
Sbjct: 6 QDFQILRTLGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 443 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSD 500
+ H ++++ G + + ++ ++I G L+ + +++ FP + A EV
Sbjct: 63 VTHPFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLR-KSQRFP---NPVAKFYAAEVCL 117
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF-G- 558
AL YLHS I +RD+K NILLD K++DFG ++ V D T+ T G
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTY-------TLCGT 166
Query: 559 --YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
Y+ PE + + + D +SFG+++ E+L G P +++ +
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 7e-21
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 390 DNFNTNRILGQGGQGTVYKGML----TNGRIVAIK---KSKLVDESNIEQFINEVAILSQ 442
+F+ R++G+G V +L RI A+K K + D+ +I+ E + Q
Sbjct: 9 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 443 I-NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVS 499
NH +V L C +TE L V E++ G L ++ + + P E R + E+S
Sbjct: 66 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLP---EEHARFYSAEIS 120
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY 559
AL YLH I +RD+K N+LLD + K++D+G + + T+ GT Y
Sbjct: 121 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCGTPNY 176
Query: 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
+ PE R + D ++ GV++ E++ G+ P
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 65/249 (26%), Positives = 110/249 (44%), Gaps = 22/249 (8%)
Query: 362 LLQQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGML----TNGRIV 417
L+ + S++ L S +F+ +++G+G G V +L
Sbjct: 10 LMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKV---LLARHKAEEVFY 66
Query: 418 AIK---KSKLVDESNIEQFINEVAILSQ-INHRNVVKLLGCCLETEVPL-LVYEFIPNGT 472
A+K K ++ + + ++E +L + + H +V L +T L V ++I G
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGE 125
Query: 473 LYQYIHDQTEEFPITWEIRLRI-AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRA 531
L+ ++ + F E R R A E++ AL YLHS I +RD+K NILLD +
Sbjct: 126 LFYHLQ-RERCFL---EPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHI 178
Query: 532 KVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQK 591
++DFG + + + T+ GT YL PE + D + G VL E+L G
Sbjct: 179 VLTDFGLCKENIEHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
Query: 592 PIRSTDSEE 600
P S ++ E
Sbjct: 238 PFYSRNTAE 246
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRN 447
D F R+ GQG GTV G G VAIKK + D + + + L+ ++H N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLHHPN 80
Query: 448 VVKLL------GCCLETEVPL-LVYEFIPNGTLYQYI-HDQTEEFPITWE-IR------L 492
+V+L G ++ L +V E++P+ TL++ + + I+ +
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 493 RIAIEVSDALCYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGASRSVMIDQTH--- 548
R ++ LH S+ + HRDIK N+L++ K+ DFG+++ + + +
Sbjct: 140 R-------SIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 549 LTTRVQGTFGYLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
+ +R Y PE F + +T D++S G + E++ G+ PI
Sbjct: 192 ICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 2e-20
Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 390 DNFNTNRILGQGGQGTVYKGML----TNGRIVAIK---KSKLVDESNIEQFINEVAILSQ 442
+FN +LG+G G V ML + A+K K ++ + ++E + E +L+
Sbjct: 341 TDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 443 INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVSD 500
+ L C +T L V E++ G L +I Q F E A E++
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFK---EPHAVFYAAEIAI 453
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYL 560
L +L S I +RD+K N++LD + K++DFG + + D T GT Y+
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYI 509
Query: 561 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
PE + + D ++FGV+L E+L GQ P D +E
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 58/221 (26%), Positives = 89/221 (40%), Gaps = 38/221 (17%)
Query: 396 RILGQGGQGTVYKGMLTNGRIVAIKK--SKLVDESNIEQFIN---------EVAILSQIN 444
R + G G V G+ + G VAIK+ + + D + + E+ +L+ +
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 445 HRNVVKLLGCCLETEVPL-----LVYEFIPNGTLYQYIHDQ----TEEF--PITWEIRLR 493
H N++ L + E P LV E + L Q IHDQ + + + I L
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHI-LL 145
Query: 494 IAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRV 553
L LH A + HRD+ NILL D + DF +R D + T V
Sbjct: 146 -------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA-NKTHYV 194
Query: 554 QGTFGYLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
Y PE + FT+ D++S G V+ E+ K +
Sbjct: 195 T-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 390 DNFNTNRILGQGGQGTVYKGML----TNGRIVAIK---KSKLVDESNIEQFINEVAILSQ 442
+F+ R++G+G V +L RI A++ K + D+ +I+ E + Q
Sbjct: 52 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 443 I-NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVS 499
NH +V L C +TE L V E++ G L ++ + + P E R + E+S
Sbjct: 109 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLP---EEHARFYSAEIS 163
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY 559
AL YLH I +RD+K N+LLD + K++D+G + + T+ GT Y
Sbjct: 164 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCGTPNY 219
Query: 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 592
+ PE R + D ++ GV++ E++ G+ P
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 22/221 (9%)
Query: 390 DNFNTNRILGQGGQGTVYKGML----TNGRIVAIK---KSKLVDESNIEQFINEVAILSQ 442
+FN +LG+G G V ML + A+K K ++ + ++E + E +L+
Sbjct: 20 TDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 443 I-NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVS 499
+ +L C +T L V E++ G L +I Q F E A E++
Sbjct: 77 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFK---EPHAVFYAAEIA 131
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY 559
L +L S I +RD+K N++LD + K++DFG + + D T GT Y
Sbjct: 132 IGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDY 187
Query: 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
+ PE + + D ++FGV+L E+L GQ P D +E
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 390 DNFNTNRILGQGGQGTVYKGML----TNGRIVAIK---KSKLVDESNIEQFINEVAILSQ 442
++F +++LG+G G V L + AIK K ++ + ++E + E +LS
Sbjct: 17 EDFILHKMLGKGSFGKV---FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 443 -INHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRI-AIEVS 499
H + + C +T+ L V E++ G L +I +F R A E+
Sbjct: 74 AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFD---LSRATFYAAEII 128
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY 559
L +LHS I +RD+K NILLD K++DFG + M+ T GT Y
Sbjct: 129 LGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDY 184
Query: 560 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
+ PE ++ D +SFGV+L E+L GQ P D EE
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 8e-20
Identities = 65/294 (22%), Positives = 106/294 (36%), Gaps = 69/294 (23%)
Query: 394 TNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQI-NHRNV 448
T+++LG G G V + A+K EV + + ++
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHI 117
Query: 449 VKLLGCCLETEVP-----LLVYEFIPNGTLYQYIHDQ-----TEEFPITWEIRLRIAIEV 498
V+++ E L+V E + G L+ I D+ TE E I +
Sbjct: 118 VRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-----EAS-EIMKSI 170
Query: 499 SDALCYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGASRSVMIDQTHLTTRVQG 555
+A+ YLHS I I HRD+K N+L K K++DFG ++ + LTT
Sbjct: 171 GEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-Y 225
Query: 556 TFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN 615
T Y+ PE ++ + D++S GV++ LL G P S
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------SP 273
Query: 616 RLFE-VLDAR----------VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
+ + + V +E K L + L +R T+ E
Sbjct: 274 GMKTRIRMGQYEFPNPEWSEVSEEVKM--------LIRNLLKTEPTQRMTITEF 319
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 53/259 (20%), Positives = 102/259 (39%), Gaps = 74/259 (28%)
Query: 385 LEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFIN-EVAILSQ 442
LE ++ ++ + LG G G V + +G+ A+KK ++ N E+ I+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL-----QDPRYKNRELDIMKV 56
Query: 443 INHRNVVKLLGC-------------------------------------CLETEVPL-LV 464
++H N++KL+ L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 465 YEFIPNGTLYQYI-HDQTEEFPITWE-IR------LRIAIEVSDALCYLHSAASIPIYHR 516
E++P+ TL++ + I I R A+ ++HS I HR
Sbjct: 117 MEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHSLG---ICHR 165
Query: 517 DIKSANILLD-DKYRAKVSDFGASRSVMIDQTH---LTTRVQGTFGYLDPE-YFRSSQFT 571
DIK N+L++ K+ DFG+++ ++ + + +R Y PE ++++T
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYT 220
Query: 572 EKSDVYSFGVVLVELLTGQ 590
D++S G V EL+ G+
Sbjct: 221 PSIDLWSIGCVFGELILGK 239
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 61/254 (24%), Positives = 101/254 (39%), Gaps = 50/254 (19%)
Query: 364 QQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKS 422
++ + ++ + +G+G G V N VAIKK
Sbjct: 4 HHHMAAAAAAGPEMVRGQVFDV---GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK- 59
Query: 423 KLVDESNIEQFIN---------EVAILSQINHRNVVKLLGCCLETEVPL-----LVYEFI 468
I F + E+ IL + H N++ + + +V + +
Sbjct: 60 -------ISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 469 PNGT-LYQYIHDQ--TEEFP--ITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANI 523
T LY+ + Q + + ++I LR L Y+HSA + HRD+K +N+
Sbjct: 113 --ETDLYKLLKTQHLSNDHICYFLYQI-LR-------GLKYIHSAN---VLHRDLKPSNL 159
Query: 524 LLDDKYRAKVSDFGASRSVMIDQTH---LTTRVQGTFGYLDPEY-FRSSQFTEKSDVYSF 579
LL+ K+ DFG +R D H LT V T Y PE S +T+ D++S
Sbjct: 160 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSV 218
Query: 580 GVVLVELLTGQKPI 593
G +L E+L+ +PI
Sbjct: 219 GCILAEMLSN-RPI 231
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 27/217 (12%)
Query: 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIE--QFINEVAILSQINH 445
+ + +G G QG V R VAIKK ++ + E+ ++ +NH
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 446 RNVVKLLGCCLETEVPL------LVYEFIPNGTLYQYIH-DQTEEF--PITWEIRLRIAI 496
+N++ LL + +V E + L Q I + E + +++ L
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQM-LC--- 138
Query: 497 EVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGT 556
+ +LHSA I HRD+K +NI++ K+ DFG +R+ +T V T
Sbjct: 139 ----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYV-VT 189
Query: 557 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
Y PE + E D++S G ++ E++ G +
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL 225
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-18
Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 33/213 (15%)
Query: 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIE--QFINEVAILSQINHRNVVKLL 452
+ +G G G V + G VAIKK +S + + E+ +L + H NV+ LL
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 453 GCCLETEVPL------LVYEFIPNGTLYQYIHDQ--TEEF--PITWEIRLRIAIEVSDAL 502
E LV F+ L + + + E+ + +++ L+ L
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQM-LK-------GL 141
Query: 503 CYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT-HLTTRVQGTFGYLD 561
Y+H+A I HRD+K N+ +++ K+ DFG +R + T ++ TR Y
Sbjct: 142 RYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YRA 193
Query: 562 PEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
PE ++T+ D++S G ++ E++TG K +
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 9e-18
Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 44/227 (19%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIK--KSKLVDESNIEQFINEVAILSQINHR------ 446
+++G+G G V K + VA+K +++ + Q E+ IL + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 447 NVVKLLGC-------CLETEVPLL---VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAI 496
NV+ +L C+ E LL +YE I +Q F + +R + A
Sbjct: 160 NVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNK-FQG-------FSLP-LVR-KFAH 207
Query: 497 EVSDALCYLHSAASIPIYHRDIKSANILLDDKYRA--KVSDFGASRSVMIDQTHLTTRVQ 554
+ L LH I H D+K NILL + R+ KV DFG S + + T +Q
Sbjct: 208 SILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQ 261
Query: 555 GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
F Y PE +++ D++S G +L ELLTG P+ + E D
Sbjct: 262 SRF-YRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGD 306
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIE--QFINEVAILSQINH 445
+ + +G G G+V + +G VAIKK +S I + E+ +L + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 446 RNVVKLLGCCLETEVPL------LVYEFIPNGTLYQYIHDQ-TEEF--PITWEIRLRIAI 496
NV+ LL LV F+ L + + + +EE + +++ L+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQM-LK--- 137
Query: 497 EVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQG 555
L Y+HSA + HRD+K N+ +++ K+ DFG +R + T + TR
Sbjct: 138 ----GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-- 188
Query: 556 TFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
Y PE + + D++S G ++ E+LTG K +
Sbjct: 189 ---YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 33/220 (15%)
Query: 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIE--QFINEVAILSQINH 445
+ + +G G G+V T G VA+KK +S I + E+ +L + H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 446 RNVVKLLGCCLETEVPL------LVYEFIPNGTLYQYIHDQ--TEEF--PITWEIRLRIA 495
NV+ LL LV + L + Q T++ + ++I LR
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQI-LR-- 143
Query: 496 IEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT-HLTTRVQ 554
L Y+HSA I HRD+K +N+ +++ K+ DFG +R + T ++ TR
Sbjct: 144 -----GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW- 194
Query: 555 GTFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
Y PE + + D++S G ++ ELLTG + +
Sbjct: 195 ----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 56/228 (24%), Positives = 90/228 (39%), Gaps = 52/228 (22%)
Query: 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFIN---------EVAILSQINH 445
+LG+G G V G IVAIKK IE F E+ IL H
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIKILKHFKH 68
Query: 446 RNVVKLLGCCLETEVPL-----LVYEFIPNGT-LYQYIHDQ--TEEFP--ITWEIRLRIA 495
N++ + ++ E + T L++ I Q +++ ++ LR
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQYFIYQT-LR-- 123
Query: 496 IEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG 555
A+ LH + + HRD+K +N+L++ KV DFG +R + +
Sbjct: 124 -----AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 556 TFG---------YLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
G Y PE S++++ DV+S G +L EL +PI
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPI 222
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 40/223 (17%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLL-- 452
+ LG GG G V+ + + VAIKK L D +++ + E+ I+ +++H N+VK+
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 453 ----GCCLETEVPL--------LVYEFIPNGT-LYQYIHDQ--TEEFP--ITWEIRLRIA 495
G L +V +V E++ T L + EE +++ LR
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPLLEEHARLFMYQL-LR-- 131
Query: 496 IEVSDALCYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGASRSVMIDQTH---LTT 551
L Y+HSA + HRD+K AN+ ++ + K+ DFG +R + +H L+
Sbjct: 132 -----GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 552 RVQGTFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
+ T Y P + +T+ D+++ G + E+LTG K +
Sbjct: 184 GLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL 224
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 64/329 (19%), Positives = 116/329 (35%), Gaps = 88/329 (26%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIK--KSKLVDESNIEQFINEVAILSQIN-------- 444
R LG G TV+ + N VA+K + + E +E+ +L ++N
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 445 ---HRNVVKLLGC-----------CLETEVPLL---VYEFIPNGTLYQYIHDQTEEFPIT 487
+++KLL + E +L + I Y++ P+
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALI---KKYEH-----RGIPLI 131
Query: 488 WEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRA------KVSDFGASRS 541
+ ++ +I+ ++ L Y+H I I H DIK N+L++ K++D G +
Sbjct: 132 Y-VK-QISKQLLLGLDYMHRRCGI-I-HTDIKPENVLMEIVDSPENLIQIKIADLG---N 184
Query: 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
H T +Q Y PE + + +D++S ++ EL+TG + D
Sbjct: 185 ACWYDEHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDEGHS 242
Query: 602 KS-----------LVG----YFLEAMKENRLF-----EVLDARVLKEAKEEEIITVAM-- 639
+ L+G Y L K R F + + LK E+++T
Sbjct: 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 302
Query: 640 ----------LAKRCLNMIGKKRPTMKEA 658
L + +KR
Sbjct: 303 SKDEAKEISDFLSPMLQLDPRKRADAGGL 331
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 5e-17
Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 25/216 (11%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIE--QFINEVAILSQINH 445
+ + +G G QG V R VAIKK ++ + E+ ++ +NH
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 446 RNVVKLL-----GCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEI--RLRIAIE 497
+N++ LL LE + LV E + L Q I + + +++ + L
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLC---- 175
Query: 498 VSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF 557
+ +LHSA I HRD+K +NI++ K+ DFG +R+ +T V T
Sbjct: 176 ---GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYV-VTR 227
Query: 558 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
Y PE + E D++S G ++ E++ K +
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KIL 262
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 65/260 (25%), Positives = 105/260 (40%), Gaps = 46/260 (17%)
Query: 365 QESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSK 423
+ N+G + + E D + + ++G+G G V K VAIK K
Sbjct: 29 ERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK 88
Query: 424 LVDESNIEQF----INEVAILSQINHR------NVVKLLGC-------CLETEVPLL--- 463
N + F EV +L +N +V L CL E +L
Sbjct: 89 -----NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYN 141
Query: 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANI 523
+Y+ + N T ++ + R + A ++ AL +L + + I H D+K NI
Sbjct: 142 LYDLLRN-TNFRGVSLNL--------TR-KFAQQMCTALLFLATP-ELSIIHCDLKPENI 190
Query: 524 LLDDKYRA--KVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGV 581
LL + R+ K+ DFG S + +Q F Y PE + D++S G
Sbjct: 191 LLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGC 246
Query: 582 VLVELLTGQKPIRSTDSEED 601
+LVE+ TG +P+ S +E D
Sbjct: 247 ILVEMHTG-EPLFSGANEVD 265
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 48/239 (20%), Positives = 90/239 (37%), Gaps = 49/239 (20%)
Query: 396 RILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIE--QFINEVAILSQINHRNVVKLL 452
++G+G G VY + VAIKK + E I+ + + E+ IL+++ +++L
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 453 GCCLETEVPL-----LVYEFIPNGT-LYQYIHDQ---TEEF--PITWEIRLRIAIEVSDA 501
+ ++ +V E + L + TEE I + + L
Sbjct: 92 DLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEEHIKTILYNL-LL-------G 141
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
++H + I HRD+K AN LL+ KV DFG +R++ ++
Sbjct: 142 ENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 562 P----------EY------------FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDS 598
P + +T+ D++S G + ELL + + +
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 7e-16
Identities = 60/284 (21%), Positives = 108/284 (38%), Gaps = 71/284 (25%)
Query: 364 QQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKK- 421
+++ S++ + + + ++ D + ++G G G V + R+VAIKK
Sbjct: 30 RKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI 86
Query: 422 ----SKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL-----LVYEFIPNGT 472
L+D I + E+AIL+++NH +VVK+L + +V +V E +
Sbjct: 87 LRVFEDLIDCKRI---LREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DS 141
Query: 473 -LYQYI---------HDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSAN 522
+ H +T + + + L + Y+HSA I HRD+K AN
Sbjct: 142 DFKKLFRTPVYLTELHIKT----LLYNL-LV-------GVKYVHSAG---ILHRDLKPAN 186
Query: 523 ILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDP---------------EY--- 564
L++ KV DFG +R+V + + +
Sbjct: 187 CLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVT 246
Query: 565 ---------FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSE 599
+TE DV+S G + ELL K + ++
Sbjct: 247 RWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 9e-16
Identities = 36/125 (28%), Positives = 60/125 (48%), Gaps = 13/125 (10%)
Query: 474 YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKV 533
+ + + +T E + + +V+ + +L AS HRD+ + NILL +K K+
Sbjct: 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 234
Query: 534 SDFGASRSVMIDQTHLTTRVQGTFGYLD-----PEYFRSSQFTEKSDVYSFGVVLVELLT 588
DFG +R + D + V+ L PE +T +SDV+SFGV+L E+ +
Sbjct: 235 CDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
Query: 589 -GQKP 592
G P
Sbjct: 291 LGASP 295
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 59/239 (24%), Positives = 101/239 (42%), Gaps = 64/239 (26%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIKK-----SKLVDESNIEQFINEVAILSQIN-HRNV 448
+ LG+G G V+K + G +VA+KK D E+ IL++++ H N+
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT---FREIMILTELSGHENI 71
Query: 449 VKLLGCCLETEVPL--------LVYEFIPNGT-LYQYIHDQ--TEEF--PITWEIRLRIA 495
V LL V LV++++ T L+ I + +++ ++
Sbjct: 72 VNLL------NVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQL-IK-- 120
Query: 496 IEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQG 555
+ YLHS + HRD+K +NILL+ + KV+DFG SRS + +
Sbjct: 121 -----VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 556 TFGYLDP---------EY------------FRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
+ +Y S+++T+ D++S G +L E+L G KPI
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI 230
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 71/333 (21%), Positives = 123/333 (36%), Gaps = 96/333 (28%)
Query: 396 RILGQGGQGTVYKG--MLTNGRIVAIKKSKLVDESNIEQFIN----EVAILSQINHR--- 446
LG+G G V + GR VA+K K N++++ E+ +L +N
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVK-----NVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 447 ---NVVKLLGC-------CLETEVPLL---VYEFI-PNGTLYQYIHDQTEEFPITWEIRL 492
V++L C+ E LL Y+FI NG + F + IR
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENG--FLP-------FRLD-HIR- 121
Query: 493 RIAIEVSDALCYLHSAASIPIYHRDIKSANILL-DDKYRA------------------KV 533
++A ++ ++ +LHS H D+K NIL Y KV
Sbjct: 122 KMAYQICKSVNFLHSNKLT---HTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 534 SDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPI 593
DFG S D H +T V Y PE + +++ DV+S G +L+E G +
Sbjct: 179 VDFG---SATYDDEHHSTLVSTRH-YRAPEVILALGWSQPCDVWSIGCILIEYYLG-FTV 233
Query: 594 RSTDSEED-----KSLVG----YFLEAMKENRLFEVLDARVLKEAKEEEIITVAM----- 639
T ++ + ++G + ++ ++ + F + + ++ A
Sbjct: 234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKE 293
Query: 640 --------------LAKRCLNMIGKKRPTMKEA 658
L ++ L KR T++EA
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLREA 326
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 54/247 (21%), Positives = 88/247 (35%), Gaps = 66/247 (26%)
Query: 396 RILGQGGQGTVYKGM--LTNGRIVAIKKSKLVDESNIEQFIN----EVAILSQINHR--- 446
LG+G G V + + VA+K + N+ ++ E+ +L +I +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIR-----NVGKYREAARLEINVLKKIKEKDKE 79
Query: 447 ---NVVKLLGC-------CLETEVPLL---VYEFIPNGTLYQYIHDQTEEFPITWEIRLR 493
V + C+ E LL +EF+ +Q +P+ +R
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKENN-FQP-------YPLP-HVR-H 127
Query: 494 IAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRA-------------------KVS 534
+A ++ AL +LH H D+K NIL + +V+
Sbjct: 128 MAYQLCHALRFLHENQLT---HTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 535 DFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIR 594
DFG S D H TT V Y PE + + DV+S G +L E G +
Sbjct: 185 DFG---SATFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYRG-FTLF 239
Query: 595 STDSEED 601
T +
Sbjct: 240 QTHENRE 246
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 57/292 (19%), Positives = 93/292 (31%), Gaps = 90/292 (30%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQI-NHRNVVK 450
++LG G G V + A+K EV + + ++V+
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVR 75
Query: 451 LLGCCLETEVP-----LLVYEFIPNGTLYQYIHDQ-----TEEFPITWEIRLRIAIEVSD 500
++ E L+V E + G L+ I D+ TE E I + +
Sbjct: 76 IVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-----EAS-EIMKSIGE 128
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRA---KVSDFGASRSVMIDQTHLTTRVQGTF 557
A+ YLHS I HRD+K N+L K K++DFG
Sbjct: 129 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG-------------------- 165
Query: 558 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617
E ++ + D++S GV++ LL G P S +
Sbjct: 166 --FAKE-TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------SPGM 210
Query: 618 FE-VLDAR----------VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
+ + V +E K L + L +R T+ E
Sbjct: 211 KTRIRMGQYEFPNPEWSEVSEEVKM--------LIRNLLKTEPTQRMTITEF 254
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 79/378 (20%), Positives = 120/378 (31%), Gaps = 126/378 (33%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK--KSKLVDESNIEQFINEVAILSQ 442
++ ++ R LG G TV+ + + VA+K KS E E ++E+ +L
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKS 89
Query: 443 I--------NHRNVVKLLGC-----------CLETEVPLLVYEFIPNG-TLYQYIHDQTE 482
+ N VV+LL C+ V+E G L ++I
Sbjct: 90 VRNSDPNDPNREMVVQLLDDFKISGVNGTHICM-------VFE--VLGHHLLKWIIKS-N 139
Query: 483 EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL----------------- 525
+ +I +V L YLH+ I H DIK NILL
Sbjct: 140 YQGLPLPCVKKIIQQVLQGLDYLHTKCRII--HTDIKPENILLSVNEQYIRRLAAEATEW 197
Query: 526 --------------------------------DDKYRAKVSDFGASRSVMIDQTHLTTRV 553
+K + K++D G + V H T +
Sbjct: 198 QRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV---HKHFTEDI 254
Query: 554 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKS---------- 603
Q T Y E S + +D++S + EL TG EE
Sbjct: 255 Q-TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE 313
Query: 604 LVG---------------YF--------LEAMKENRLFEVLDARVLKEAKEEEIITVAML 640
L+G +F + +K LFEVL + E +EE
Sbjct: 314 LLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY--EWSQEEAAGFTDF 371
Query: 641 AKRCLNMIGKKRPTMKEA 658
L +I +KR T E
Sbjct: 372 LLPMLELIPEKRATAAEC 389
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 65/252 (25%), Positives = 92/252 (36%), Gaps = 72/252 (28%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFIN----EVAILSQINHR---- 446
R +G G G V + N + A+K + NI+++ E IL +I +
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVR-----NIKKYTRSAKIEADILKKIQNDDINN 95
Query: 447 -NVVKLLGC-------CLETEVPLL---VYEFI-PNGTLYQYIHDQTEEFPITWEIRLRI 494
N+VK G CL E L +YE I N Y F I +I+
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNN--YNG-------FHIE-DIK-LY 142
Query: 495 AIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRA----------------------- 531
IE+ AL YL + H D+K NILLDD Y
Sbjct: 143 CIEILKALNYLRKMSLT---HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 532 --KVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTG 589
K+ DFG + + + Y PE + + SD++SFG VL EL TG
Sbjct: 200 GIKLIDFG---CATFKSDYHGSIINTRQ-YRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
Query: 590 QKPIRSTDSEED 601
+ T +
Sbjct: 256 -SLLFRTHEHME 266
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 60/261 (22%), Positives = 104/261 (39%), Gaps = 41/261 (15%)
Query: 382 SMELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAIL 440
SMEL + + + R +G G G +Y G + G VAIK + ++ Q E I
Sbjct: 2 SMELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIY 58
Query: 441 SQINH-RNVVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHDQTEEFPITWEIRLRIAIEV 498
+ + + C E + ++V E + P+ L + + +F + + L +A ++
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPS--LEDLFNFCSRKFSL--KTVLLLADQM 114
Query: 499 SDALCYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGASRSVMIDQT--HLTTR- 552
+ Y+HS I HRD+K N L+ + DFG ++ +T H+ R
Sbjct: 115 ISRIEYIHSKNFI---HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171
Query: 553 ---VQGTFGY------LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP---IRSTDSEE 600
+ GT Y L E R + D+ S G VL+ G P +++ +
Sbjct: 172 NKNLTGTARYASINTHLGIEQSR------RDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 225
Query: 601 DKSLVGYFLEAMKENRLFEVL 621
+ K + EVL
Sbjct: 226 KYERIS----EKKMSTPIEVL 242
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 57/260 (21%), Positives = 104/260 (40%), Gaps = 41/260 (15%)
Query: 383 MELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILS 441
ME + + F R +G G G +Y G + VAIK + ++ Q + E I
Sbjct: 1 MEPRVG-NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYR 57
Query: 442 QIN-HRNVVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHDQTEEFPITWEIRLRIAIEVS 499
+ + + +E + +LV + + P+ L + + + + + L +A ++
Sbjct: 58 ILQGGTGIPNVRWFGVEGDYNVLVMDLLGPS--LEDLFNFCSRKLSL--KTVLMLADQMI 113
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAK---VSDFGASRSVMIDQT--HLTTR-- 552
+ + ++HS + + HRDIK N L+ RA + DFG ++ T H+ R
Sbjct: 114 NRVEFVHSKSFL---HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN 170
Query: 553 --VQGTFGY------LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP---IRSTDSEED 601
+ GT Y L E R + D+ S G VL+ L G P +++ ++
Sbjct: 171 KNLTGTARYASVNTHLGIEQSR------RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224
Query: 602 KSLVGYFLEAMKENRLFEVL 621
+ K E L
Sbjct: 225 YEKIS----EKKVATSIEAL 240
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 45/215 (20%), Positives = 68/215 (31%), Gaps = 41/215 (19%)
Query: 364 QQESSSNEGNSEKTKLFTSM-ELEMATDNFNTN----RILGQGGQGTVYKGM-LTNGRIV 417
S + G E ++ D + +G GG G +Y
Sbjct: 6 HHSSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKD 65
Query: 418 AIKKSK--------LVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY--EF 467
A K L E Q + + + + R + LG +PL
Sbjct: 66 ARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG------IPLFYGSGLT 119
Query: 468 IPNGTLY------------QYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515
G Y Q I Q F L++ I + D L Y+H + H
Sbjct: 120 EFKGRSYRFMVMERLGIDLQKISGQNGTFKK--STVLQLGIRMLDVLEYIHENEYV---H 174
Query: 516 RDIKSANILLDDKYRAKV--SDFGASRSVMIDQTH 548
DIK+AN+LL K +V +D+G S + H
Sbjct: 175 GDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 49/255 (19%), Positives = 96/255 (37%), Gaps = 42/255 (16%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRN 447
++ R +G+G G +++G L N + VAIK S+ Q +E +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 67
Query: 448 VVKLLGCCLETEVPLLVYEFI-PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH 506
+ + E +LV + + P+ L + +F + + A ++ + +H
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLGPS--LEDLLDLCGRKFSV--KTVAMAAKQMLARVQSIH 123
Query: 507 SAASIPIYHRDIKSANILLDDKYRAK-----VSDFGASRS--VMIDQTHLTTR----VQG 555
+ + +RDIK N L+ V DFG + + + H+ R + G
Sbjct: 124 EKSLV---YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 556 TFGY------LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP---IRSTDSEEDKSLVG 606
T Y L E R + D+ + G V + L G P +++ +++ +G
Sbjct: 181 TARYMSINTHLGREQSR------RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234
Query: 607 YFLEAMKENRLFEVL 621
K++ L
Sbjct: 235 ----EKKQSTPLREL 245
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.7 bits (146), Expect = 5e-10
Identities = 31/214 (14%), Positives = 63/214 (29%), Gaps = 54/214 (25%)
Query: 387 MATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDE--------SNIEQFINEVA 438
+ T+ +G+G G V++ + + VAIK + E+ + E+
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 439 ILSQI---------NHRNVVKLLGCCL----------------------ETEVPL----- 462
I ++ + L + P
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 463 ---LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIK 519
+V EF G + + + + I +++ +L + S+ HRD+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLH 189
Query: 520 SANILLDDKYRAKVSDFGASRSVMIDQTHLTTRV 553
N+LL K+ +S I L +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 55/254 (21%), Positives = 94/254 (37%), Gaps = 42/254 (16%)
Query: 391 NFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNV 448
NF + +G G G + G L VAIK + +S Q E Q+ + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGI 67
Query: 449 VKLLGCCLETEVPLLVYEFI-PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
++ + +V E + P+ L F + + L IAI++ + Y+HS
Sbjct: 68 PQVYYFGPCGKYNAMVLELLGPS--LEDLFDLCDRTFSL--KTVLMIAIQLISRMEYVHS 123
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVS-----DFGASRSVMIDQT--HLTTR----VQGT 556
I +RD+K N L+ DF ++ + +T H+ R + GT
Sbjct: 124 KNLI---YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180
Query: 557 FGY------LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP---IRSTDSEEDKSLVGY 607
Y L E R + D+ + G + + L G P +++ +E +G
Sbjct: 181 ARYMSINTHLGKEQSR------RDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG- 233
Query: 608 FLEAMKENRLFEVL 621
K EVL
Sbjct: 234 ---DTKRATPIEVL 244
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 39/267 (14%), Positives = 85/267 (31%), Gaps = 60/267 (22%)
Query: 396 RILGQGGQGTVYKGMLTNGRI---------VAIK----KSKLVDESNIEQFINEVAILSQ 442
+ QG +Y+ T+ ++K +L +E N Q + +++
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 443 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLY-----------QYIHDQTEEFPITWEIR 491
LL +P + + Q D + + ++
Sbjct: 108 WKKLYSTPLLA------IPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV 161
Query: 492 LRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKV--SDFGASRSVMIDQTHL 549
L++A + DAL +LH + H ++ + NI +D + +++V + +G + H+
Sbjct: 162 LQVACRLLDALEFLHENEYV---HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
Query: 550 TTRVQ------GTFGY------LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP---IR 594
G + R +SD+ S G +++ L G P
Sbjct: 219 AYVEGSRSPHEGDLEFISMDLHKGCGPSR------RSDLQSLGYCMLKWLYGFLPWTNCL 272
Query: 595 STDSEEDKSLVGYFLEAMKENRLFEVL 621
+ K + + + F
Sbjct: 273 PNTEDIMKQKQKF----VDKPGPFVGP 295
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 45/265 (16%), Positives = 82/265 (30%), Gaps = 56/265 (21%)
Query: 396 RILGQGGQGTVYKGMLTNGRIVAIKK-----------SKLVDESNIEQFINEVAILSQIN 444
+GQGG G +Y + + V L E Q + + +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 445 HRNVVKLLG-----CCLETEVPLLVYEFI------PNGTLYQYIHDQTEEFPITWEIRLR 493
+K LG + Y F+ + L + + F + L+
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSD--LQKIYEANAKRFSR--KTVLQ 156
Query: 494 IAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKV--SDFGASRSVMIDQTHL-- 549
+++ + D L Y+H + H DIK++N+LL+ K +V D+G + + H
Sbjct: 157 LSLRILDILEYIHEHEYV---HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY 213
Query: 550 ----TTRVQGTFGY------LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP---IRST 596
GT + R + D+ G +++ LTG P
Sbjct: 214 AADPKRCHDGTIEFTSIDAHNGVAPSR------RGDLEILGYCMIQWLTGHLPWEDNLKD 267
Query: 597 DSEEDKSLVGYFLEAMKENRLFEVL 621
S + Y +
Sbjct: 268 PKYVRDSKIRY----RENIASLMDK 288
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 1e-06
Identities = 52/358 (14%), Positives = 96/358 (26%), Gaps = 104/358 (29%)
Query: 22 NV----TINYPFGIGDGCYFDK-----RYEVICDDSSGSPKAFLAGVNNLELLNSDRYDG 72
NV N F + C K R++ + D S + ++ ++ L D
Sbjct: 252 NVQNAKAWNA-FNLS--C---KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS 305
Query: 73 NLLR-VNIPVISLK---TTGHPNGVNLSGIPLTF----SRWHNRFAAIGCRNYNTIVKRA 124
LL+ ++ L T +P LS I + + W + + + C TI++
Sbjct: 306 LLLKYLDCRPQDLPREVLTTNP--RRLSIIAESIRDGLATW-DNWKHVNCDKLTTIIES- 361
Query: 125 NDSTVFGGCLTISTCALSS---RGCYDFVCAL-------PPNLTQDFNASMLYHFSQSIP 174
L L R +D ++ P L ++ +
Sbjct: 362 --------SLN----VLEPAEYRKMFD-RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVV 408
Query: 175 QKCQSVLMVEENW---------LQSEFLTNANVLRD-HQQFPAVLEFAEDRGNCVEEYN- 223
K +VE+ + E H+ V+ YN
Sbjct: 409 NKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSI-------------VDHYNI 455
Query: 224 SRTTCNKDNRCSIQLTSGYSC--LCH--------RSFNGLNDGYCVGDL------LCDSA 267
+T + D Y + H + D +
Sbjct: 456 PKTFDSDD--LIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL--DFRFLEQKIRHD- 510
Query: 268 SSPYNCSGCPNGYLLD---------DTDSCYQNTTAKTDTISPSPSPYEVVHENSNVL 316
S+ +N SG L D D Y+ P + + +++L
Sbjct: 511 STAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLL 568
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 4e-06
Identities = 72/545 (13%), Positives = 150/545 (27%), Gaps = 159/545 (29%)
Query: 160 DFNASMLYHFSQSIPQKCQSVLMVEENWLQSEFLTNANVLRDHQQFP-AVLEFAEDRGNC 218
DF + + + +L V + F+ N + +D Q P ++L E
Sbjct: 8 DFETGEHQY-------QYKDILSV----FEDAFVDNFDC-KDVQDMPKSILSKEE----- 50
Query: 219 VEE-YNSRTTCNKDNRCSIQLTSGYSCLCHRSFNG-LNDGYCVGDLLCDSASSPYNCSGC 276
++ S+ + R L S + + L Y L +
Sbjct: 51 IDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY---KFLMSPIKTEQRQ--- 104
Query: 277 PNGYLLDDTDSCYQNTTAKTDTISPSPSPYEV-----VHENSNVL-------FIII---- 320
P+ T Y + + + Y V + L ++I
Sbjct: 105 PSM----MTRM-YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVL 159
Query: 321 GC--SVGAG-----------LPFFLFMI--GRLHEIVERRRVIKLKQNFFKRNGGLLLQQ 365
G + A + F +F + + V+++ Q + +
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPET---VLEMLQKLLYQ-----IDP 211
Query: 366 ESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLV 425
+S +S KL + R+L + Y+ L LV
Sbjct: 212 NWTSRSDHSSNIKL----RIHSIQAELR--RLL----KSKPYENCL------------LV 249
Query: 426 -----DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ 480
+ F IL + V L T + L + D+
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISL---DHHSMT----LTPDE 302
Query: 481 TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS- 539
+ + + + D +P R++ + N +S S
Sbjct: 303 VKSLLLKY-----LDCRPQD----------LP---REVLTTNPRR-------LSIIAESI 337
Query: 540 ----------RSVMIDQTHLTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFGVVLV 584
+ V D+ LTT ++ + L+P +R S F + + + ++L
Sbjct: 338 RDGLATWDNWKHVNCDK--LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT--ILLS 393
Query: 585 EL---LTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLA 641
+ + + + SL +E + + + + K E L
Sbjct: 394 LIWFDVIKSDVMVVVNKLHKYSL----VEKQPKESTISIPSIYLELKVKLENEYA---LH 446
Query: 642 KRCLN 646
+ ++
Sbjct: 447 RSIVD 451
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 700 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.9 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.89 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.61 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.38 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.35 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.15 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.03 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.82 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.72 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.69 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.38 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.37 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.92 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.91 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.79 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.76 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.75 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.63 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.6 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.54 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.39 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.8 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.24 | |
| 1yo8_A | 634 | Thrombospondin-2; EGF, Ca(2+)-binding domains, lec | 94.74 | |
| 2vj3_A | 135 | Neurogenic locus notch homolog protein 1; transcri | 94.32 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 94.18 | |
| 1dx5_I | 118 | Thrombomodulin; serine proteinase, EGF-like domain | 93.16 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.91 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 92.44 | |
| 3h5c_B | 317 | Vitamin K-dependent protein Z; protein Z-protein Z | 91.93 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 91.63 | |
| 3p5b_L | 400 | Low density lipoprotein receptor variant; B-propel | 91.13 | |
| 2bou_A | 143 | EGF-like module containing mucin-like hormone rece | 90.77 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 90.53 | |
| 2w2n_E | 107 | LDL receptor, low-density lipoprotein receptor; hy | 89.45 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.38 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 88.33 | |
| 1k36_A | 46 | Epiregulin; EGF-like fold, hormone/growth factor c | 86.74 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 86.74 | |
| 4d90_A | 143 | EGF-like repeat and discoidin I-like domain-conta | 86.23 | |
| 1egf_A | 53 | Epidermal growth factor; NMR {Mus musculus} SCOP: | 86.04 | |
| 1a3p_A | 45 | Epidermal growth factor; disulfide connectivities, | 86.02 | |
| 3v65_B | 386 | Low-density lipoprotein receptor-related protein; | 85.94 | |
| 2k2s_B | 61 | Micronemal protein 6; microneme protein complex, c | 85.71 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.28 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 84.98 | |
| 3u7u_G | 55 | Neuregulin 1; signaling protein, transferase-trans | 84.32 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 84.0 | |
| 2vj3_A | 135 | Neurogenic locus notch homolog protein 1; transcri | 83.84 | |
| 1gl4_A | 285 | Nidogen-1, entactin; immunoglobulin-like domain, e | 83.65 | |
| 1z1y_A | 186 | Ookinete surface protein PVS25; four EGF-like doma | 83.43 | |
| 1hae_A | 63 | Heregulin-alpha; growth factor; NMR {Homo sapiens} | 83.3 | |
| 1aut_L | 114 | Activated protein C; serine proteinase, plasma cal | 82.62 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.34 | |
| 1nql_B | 53 | Epidermal growth factor; cell surface receptor, ty | 82.33 | |
| 1tpg_A | 91 | T-plasminogen activator F1-G; plasminogen activati | 81.15 | |
| 3ca7_A | 52 | Protein spitz; argos, EGF, developmental protein, | 80.78 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=440.69 Aligned_cols=262 Identities=26% Similarity=0.436 Sum_probs=220.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
.++|.+.+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||++++++.+.+..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 467888999999999999999874 36789999998877777889999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEE
Q 005355 463 LVYEFIPNGTLYQYIHDQT----------EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAK 532 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~k 532 (700)
|||||+++|+|.++|+... ....++|.+++.++.||+.||+|||+++ |+||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999997642 2345999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHH
Q 005355 533 VSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLE 610 (700)
Q Consensus 533 l~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 610 (700)
|+|||+++........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||......+ +..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~~ 241 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIE 241 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHH
Confidence 9999999865443332 2334569999999999999999999999999999999998 899998665432 222
Q ss_pred HHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 611 AMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 611 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
.+..+... ..+...+.++.+|+.+||+.||++|||++||++.|+++.+..
T Consensus 242 ~i~~~~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 242 CITQGRVL---------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp HHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 23322221 123344567899999999999999999999999999987643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-53 Score=442.32 Aligned_cols=261 Identities=26% Similarity=0.446 Sum_probs=214.2
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
.++|.+.++||+|+||+||+|+++ +++.||||+++..+....++|.+|+++|++++|||||++++++.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 466788899999999999999975 37889999998887888889999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc
Q 005355 463 LVYEFIPNGTLYQYIHDQTE------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR 530 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~ 530 (700)
|||||+++|+|.++|+.... ..+++|.+++.|+.||+.||+|||+++ |+||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999986532 246999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHH
Q 005355 531 AKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYF 608 (700)
Q Consensus 531 ~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~ 608 (700)
+||+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+ +
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~ 269 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------A 269 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-------H
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-------H
Confidence 99999999986643332 23345679999999999999999999999999999999999 899998655432 1
Q ss_pred HHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 609 LEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 609 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
...+..+.. .+.+...++++.+|+.+||+.||++|||++||+++|+.+.+.
T Consensus 270 ~~~i~~g~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 270 IDCITQGRE---------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHHTCC---------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHcCCC---------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 222222211 112234456789999999999999999999999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=433.84 Aligned_cols=267 Identities=26% Similarity=0.420 Sum_probs=213.1
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
+++..+++++.++||+|+||+||+|+++ ..||||+++.. +....+.|.+|++++++++|||||++++++.+ +..+
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 3455678899999999999999999975 35999998753 44567889999999999999999999998764 5689
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
|||||+++|+|.++|+.... .+++.+++.|+.||+.||+|||+++ |+||||||+||||++++.+||+|||+++..
T Consensus 108 iVmEy~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 99999999999999986543 4999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCC-ceeeeeeeccccccccccccc---CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 543 MIDQ-THLTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 543 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
.... ........||+.|||||++.+ ..++.++|||||||+||||++|+.||........ +...+..+...
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------~~~~~~~~~~~ 256 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------IIFMVGRGYAS 256 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHTTCCC
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCCC
Confidence 4322 223445679999999999864 4589999999999999999999999976543321 11222222111
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
+.+ ...+...+..+.+|+.+||+.||++|||+.||++.|+.|+..+.
T Consensus 257 ----p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 257 ----PDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp ----CCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred ----CCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 111 12233455678999999999999999999999999999987654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=436.31 Aligned_cols=259 Identities=24% Similarity=0.394 Sum_probs=215.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
..++++.++||+|+||+||+|++. +++.||||+++.. .....++|.+|+.++++++|||||+++|++.+.+..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 355677899999999999999973 4678999998753 334467899999999999999999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC
Q 005355 462 LLVYEFIPNGTLYQYIHDQTE-------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK 528 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~ 528 (700)
+|||||+++|+|.++|+.... ...++|..++.++.||+.||+|||+++ |+||||||+||||+++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCC
Confidence 999999999999999975421 235899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHH
Q 005355 529 YRAKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVG 606 (700)
Q Consensus 529 ~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~ 606 (700)
+++||+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |..||.+....+
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~------ 255 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------ 255 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH------
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH------
Confidence 9999999999987644332 23445679999999999999999999999999999999998 899998765432
Q ss_pred HHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 607 YFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 607 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
+...+..+... ..+...+..+.+|+.+||+.||++|||++||++.|+...
T Consensus 256 -~~~~i~~~~~~---------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 256 -VVEMIRNRQVL---------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp -HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -HHHHHHcCCCC---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 22233333221 123345567899999999999999999999999998753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=428.61 Aligned_cols=249 Identities=25% Similarity=0.388 Sum_probs=211.4
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
..|++.++||+|+||+||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..+|||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56899999999999999999986 68999999987655555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
++|+|.+++.+.. +++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.... .
T Consensus 154 ~gg~L~~~l~~~~----l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 225 (346)
T 4fih_A 154 EGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 225 (346)
T ss_dssp TTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-C
T ss_pred CCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-C
Confidence 9999999997643 999999999999999999999999 9999999999999999999999999998664332 2
Q ss_pred eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhc
Q 005355 549 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE 628 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 628 (700)
......||+.|||||++.+..|+.++|||||||+||||++|+.||......+. ...+..+..... .
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-------~~~i~~~~~~~~-------~ 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDNLPPRL-------K 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHSSCCCC-------S
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-------HHHHHcCCCCCC-------C
Confidence 34556799999999999999999999999999999999999999976543321 122222111110 1
Q ss_pred cCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 629 AKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 629 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.....++++.+|+.+||+.||++|||++|+++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11234567889999999999999999999876
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=430.39 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=206.4
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
.++|++++.||+|+||+||+|++. +++.||||++.. ......+.+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 368999999999999999999976 689999999764 34556788999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++|+|.++|.... ...+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 103 Ey~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999997653 234799999999999999999999999 999999999999999999999999999865322
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
........||+.|||||++.+..|+.++|||||||+||||++|+.||......+ ....+..+...
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~~------- 243 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-------LVLKIISGSFP------- 243 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCC-------
T ss_pred -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHHHcCCCC-------
Confidence 122344679999999999999999999999999999999999999998654332 11222222211
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 244 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 --PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112334567899999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=430.43 Aligned_cols=271 Identities=28% Similarity=0.430 Sum_probs=224.4
Q ss_pred cchHHHHHHhcCCCccceEeeeCCeEEEEEEEcC------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCC-CceeeE
Q 005355 380 FTSMELEMATDNFNTNRILGQGGQGTVYKGMLTN------GRIVAIKKSKLV-DESNIEQFINEVAILSQINH-RNVVKL 451 (700)
Q Consensus 380 ~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l 451 (700)
+...++++..++|++.+.||+|+||+||+|.+.. ++.||||+++.. .....+.|.+|+++|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4556788889999999999999999999999653 358999998753 34456789999999999965 899999
Q ss_pred EeEEEeC-CcceEEEeeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 005355 452 LGCCLET-EVPLLVYEFIPNGTLYQYIHDQTE-------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRD 517 (700)
Q Consensus 452 ~~~~~~~-~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~D 517 (700)
+|++.+. +..+|||||+++|+|.++|+.... ...+++..++.++.|||+||+|||+++ |+|||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999765 567999999999999999976421 235899999999999999999999999 99999
Q ss_pred CCCCcEEECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCC
Q 005355 518 IKSANILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRS 595 (700)
Q Consensus 518 ik~~NILl~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~ 595 (700)
|||+||||++++.+||+|||+++....+... ......||+.|||||++.+..++.++|||||||+||||+| |+.||.+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544333 3445679999999999999999999999999999999998 9999987
Q ss_pred CCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 596 TDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
....+. +...+..+... ..+...++++.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus 291 ~~~~~~------~~~~i~~g~~~---------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 291 VKIDEE------FCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCCSHH------HHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHH------HHHHHHcCCCC---------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 654331 22223322211 12233456788999999999999999999999999987653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=420.15 Aligned_cols=257 Identities=21% Similarity=0.231 Sum_probs=211.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.+.|++.++||+|+||+||+|+++ +|+.||||+++.... ..+|+.++++++|||||++++++.+.+..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456888899999999999999986 689999999875321 24799999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEeecCCCcccccCC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~-~~kl~DfGl~~~~~~~~ 546 (700)
+++|+|.++|++.. .+++..+..++.||+.||+|||+++ |+||||||+||||+.++ ++||+|||+++.+..+.
T Consensus 132 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999998754 3999999999999999999999999 99999999999999987 69999999998764332
Q ss_pred ce----eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 547 TH----LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 547 ~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
.. ......||+.|||||++.+..++.++|||||||+||||++|+.||......+.. ..+..+..
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-------~~i~~~~~----- 273 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-------LKIASEPP----- 273 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH-------HHHHHSCC-----
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-------HHHHcCCC-----
Confidence 21 123357999999999999999999999999999999999999999865543321 11111111
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
...+.+...++.+.+|+.+||+.||++|||+.|+++.|........
T Consensus 274 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 274 --PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp --GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred --CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 0112334456678999999999999999999999999987766543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=418.48 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=211.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+++|++++|||||++++++.+.+..+||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 357999999999999999999976 6899999998642 234467899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++|+|.++|.+.. .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 111 mEy~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999998754 3999999999999999999999999 99999999999999999999999999987653
Q ss_pred CC-ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 545 DQ-THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 545 ~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
.. .......+||+.|||||++.+..++.++|||||||+||||++|+.||...+..+ ....+..+.+
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i~~~~~------ 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-------IFAKIIKLEY------ 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCC------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC------
Confidence 32 233456789999999999999999999999999999999999999997654332 1222222221
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+...++++.+|+.+||+.||++|||++|++.
T Consensus 252 ----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 252 ----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ----CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 112234557889999999999999999998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=430.01 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=212.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.+.|++.++||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 367999999999999999999986 6899999998876666667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++|+|.+++.... +++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 230 ~~gG~L~~~i~~~~----l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 99999999997643 999999999999999999999999 9999999999999999999999999998664332
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
.......||+.|||||++.+..|+.++|||||||+||||++|+.||......+. ...+..+.... +
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-------~~~i~~~~~~~-----~-- 367 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDNLPPR-----L-- 367 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHSCCCC-----C--
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-------HHHHHcCCCCC-----C--
Confidence 334556799999999999999999999999999999999999999976543321 12222211110 0
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
......+..+.+|+.+||+.||++|||+.|+++
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111234567889999999999999999999876
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=410.87 Aligned_cols=246 Identities=23% Similarity=0.381 Sum_probs=199.9
Q ss_pred CccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe----CCcceEEE
Q 005355 393 NTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLE----TEVPLLVY 465 (700)
Q Consensus 393 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 465 (700)
++.++||+|+||+||+|.+. +++.||||++.. ......+.|.+|++++++++|||||++++++.+ .+..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999986 688999998764 345556789999999999999999999999875 34578999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-CCCcEEEeecCCCccccc
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~-~~~~~kl~DfGl~~~~~~ 544 (700)
||+++|+|.++|.+.. .+++..+..++.||+.||+|||+++ ++|+||||||+||||+ +++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~- 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 183 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC-
Confidence 9999999999998754 3999999999999999999999987 3599999999999997 47999999999997532
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
........||+.|||||++.+ .++.++|||||||+||||++|+.||....... .+...+..+....
T Consensus 184 --~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~------~~~~~i~~~~~~~----- 249 (290)
T 3fpq_A 184 --ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPA----- 249 (290)
T ss_dssp --TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCG-----
T ss_pred --CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH------HHHHHHHcCCCCC-----
Confidence 223445679999999999875 69999999999999999999999997543322 1122222221111
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+...++++.+|+.+||+.||++|||++|+++
T Consensus 250 ---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 ---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122346889999999999999999999976
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=415.31 Aligned_cols=267 Identities=21% Similarity=0.319 Sum_probs=203.5
Q ss_pred cCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHH--HHHHHHhhcCCCceeeEEeEEEeCC----cceE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFI--NEVAILSQINHRNVVKLLGCCLETE----VPLL 463 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 463 (700)
++|.+.++||+|+||+||+|+++ |+.||||+++.... +.+. .|+..+.+++|||||++++++.+.+ ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~---~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch---hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 45788899999999999999985 89999999875332 3344 4555556789999999999998765 4689
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCcEEECCCCcEEEeecCC
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA-----SIPIYHRDIKSANILLDDKYRAKVSDFGA 538 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----~~~ivH~Dik~~NILl~~~~~~kl~DfGl 538 (700)
||||+++|+|.++|+... ++|+.+++++.|++.||+|||++. .++|+||||||+||||+.++++||+|||+
T Consensus 79 V~Ey~~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCCcHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999998653 999999999999999999999871 23499999999999999999999999999
Q ss_pred CcccccCCcee---eeeeecccccccccccccC------CCCcccceehHHHHHHHHHhCCCCCCCCCchhh--------
Q 005355 539 SRSVMIDQTHL---TTRVQGTFGYLDPEYFRSS------QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED-------- 601 (700)
Q Consensus 539 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~-------- 601 (700)
++......... .....||+.|||||++.+. .++.++|||||||+||||++|..||......+.
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 98664433222 2345799999999999764 467899999999999999999887754332110
Q ss_pred hhHHHHHHHHHHhcchhhhcchhhhh-ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 602 KSLVGYFLEAMKENRLFEVLDARVLK-EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
...............+ ++.+.. ....+.+..+.+|+.+||+.||++||||.||++.|++|...
T Consensus 235 ~~~~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cchHHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0111122222222221 222211 12345667899999999999999999999999999998753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=403.87 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=194.0
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999975 6899999987642 2334578999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+ +|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+||||++++++||+|||+++....
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD- 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC-
Confidence 999 689999998654 3999999999999999999999999 99999999999999999999999999976532
Q ss_pred CceeeeeeecccccccccccccCCC-CcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
........||+.|||||++.+..+ +.++|||||||+||||++|+.||......+ ....+..+..
T Consensus 165 -~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-------~~~~i~~~~~------- 229 (275)
T 3hyh_A 165 -GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-------LFKNISNGVY------- 229 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCC-------
T ss_pred -CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCC-------
Confidence 223345679999999999998876 579999999999999999999997654322 1222222221
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+...++++.+|+.+||+.||++|||++|+++
T Consensus 230 ---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 ---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 112234567889999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=409.51 Aligned_cols=243 Identities=27% Similarity=0.344 Sum_probs=196.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc----CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT----NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
.++|++.+.||+|+||+||+|+.. .++.||||+++.. .......+.+|+++|++++|||||++++++.+.+..+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 367999999999999999999863 4689999987642 2223456889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
|||||+++|+|.++|.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999998754 3999999999999999999999999 999999999999999999999999999864
Q ss_pred ccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
.... .......||+.|||||++.+..++.++|||||||+||||++|+.||.+.+..+. ...+.....
T Consensus 177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-------~~~i~~~~~----- 243 (304)
T 3ubd_A 177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-------MTMILKAKL----- 243 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC-----
T ss_pred cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH-------HHHHHcCCC-----
Confidence 3322 233456799999999999999999999999999999999999999986554331 122222221
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCH
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTM 655 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~ 655 (700)
..+...++++.+|+.+||+.||++|||+
T Consensus 244 -----~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 -----GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -----CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1122345678899999999999999984
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=397.37 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=192.1
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc-------
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEV------- 460 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------- 460 (700)
++|++++.||+|+||+||+|+++ +++.||||+++... ....+.+.+|+++|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45899999999999999999976 68999999987533 4456789999999999999999999999876553
Q ss_pred -----ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEee
Q 005355 461 -----PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535 (700)
Q Consensus 461 -----~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~D 535 (700)
.++||||+++|+|.+++.........++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 5899999999999999987654334677888999999999999999999 99999999999999999999999
Q ss_pred cCCCcccccCCce-----------eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhH
Q 005355 536 FGASRSVMIDQTH-----------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSL 604 (700)
Q Consensus 536 fGl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~ 604 (700)
||+++........ ..+...||+.|||||++.+..|+.++|||||||+||||++ ||.... +.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~--- 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ER--- 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HH---
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HH---
Confidence 9999876433221 1234569999999999999999999999999999999996 764211 11
Q ss_pred HHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 605 VGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 605 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. ............. ......+.+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~-~~~~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 V-RTLTDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H-HHHHHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-HHHHHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 1111122211111 11233445678999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=398.48 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=204.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC------C
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLET------E 459 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 459 (700)
.++|++++.||+|+||+||+|++. +|+.||||+++.. .....+.+.+|+++|++++|||||++++++... +
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999976 6999999998653 344567889999999999999999999997643 5
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
..+|||||++ |+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 6799999995 78999997653 4999999999999999999999999 999999999999999999999999999
Q ss_pred cccccC---CceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc
Q 005355 540 RSVMID---QTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN 615 (700)
Q Consensus 540 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 615 (700)
+.+... .........||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+....+ .......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I---~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI---MMVLGTP 282 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH---HHHHCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhcCCC
Confidence 866432 12234456799999999998875 5689999999999999999999999876543321111 1111000
Q ss_pred c---h--------hhhc---ch---hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 616 R---L--------FEVL---DA---RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 616 ~---~--------~~~~---d~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. + ...+ .. ............++.+|+.+||+.||++|||++|+++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 0 0000 00 0000011123456889999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=385.56 Aligned_cols=286 Identities=37% Similarity=0.625 Sum_probs=249.9
Q ss_pred cchHHHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC
Q 005355 380 FTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETE 459 (700)
Q Consensus 380 ~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 459 (700)
+...+++..+++|++.+.||+|+||.||+|.+++++.||||+.........+.+.+|++++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44556667889999999999999999999998889999999988776777788999999999999999999999999999
Q ss_pred cceEEEeeCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTE-EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGA 538 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl 538 (700)
..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999976532 235899999999999999999999999 99999999999999999999999999
Q ss_pred CcccccC-CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 539 SRSVMID-QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 539 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
+...... .........||+.|+|||++.+..++.++||||||+++|||++|+.||......+......+.......+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 9764322 222234456899999999999999999999999999999999999999877766666666666666666677
Q ss_pred hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 618 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
...+++.+........+..+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 777777777777888999999999999999999999999999999988653
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=384.11 Aligned_cols=199 Identities=20% Similarity=0.356 Sum_probs=171.1
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc----CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcce
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT----NGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 462 (700)
..++|++.++||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|+.+ +||||+++++++.+.+..+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4678999999999999999999864 46789999876533 345688999999998 6999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEeecCCCcc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGASRS 541 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~-~~~kl~DfGl~~~ 541 (700)
+||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999994 2899999999999999999999999 9999999999999876 7999999999975
Q ss_pred cccCCc---------------------------eeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCC
Q 005355 542 VMIDQT---------------------------HLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPI 593 (700)
Q Consensus 542 ~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~ 593 (700)
...... .......||+.|||||++.+. .++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 432211 112335699999999999775 5899999999999999999999999
Q ss_pred CCCC
Q 005355 594 RSTD 597 (700)
Q Consensus 594 ~~~~ 597 (700)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 6544
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=380.97 Aligned_cols=287 Identities=38% Similarity=0.653 Sum_probs=245.3
Q ss_pred cccccchHHHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCceeeEEeE
Q 005355 376 KTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDE-SNIEQFINEVAILSQINHRNVVKLLGC 454 (700)
Q Consensus 376 ~~~~~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~ 454 (700)
..+.++..++....++|++.+.||+|+||.||+|.+.+++.||||++..... .....+.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 3456888999999999999999999999999999988899999999875432 223468999999999999999999999
Q ss_pred EEeCCcceEEEeeCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhc---CCCCeeecCCCCCcEEECCCCc
Q 005355 455 CLETEVPLLVYEFIPNGTLYQYIHDQTE-EFPITWEIRLRIAIEVSDALCYLHSA---ASIPIYHRDIKSANILLDDKYR 530 (700)
Q Consensus 455 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~~~~ivH~Dik~~NILl~~~~~ 530 (700)
+.+.+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||++ + |+||||||+|||++.++.
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFE 172 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCC
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCC
Confidence 9999999999999999999999987543 34599999999999999999999999 7 999999999999999999
Q ss_pred EEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCC--chhhhhHHHHH
Q 005355 531 AKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD--SEEDKSLVGYF 608 (700)
Q Consensus 531 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~--~~~~~~~~~~~ 608 (700)
+||+|||++...............||+.|+|||++.+..++.++||||||+++|+|++|..||.... .........+.
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 9999999998765555555555669999999999999999999999999999999999999996321 11223344444
Q ss_pred HHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 609 LEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 609 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
...........+.+..+........+..+.+|+.+||+.||.+|||++||+++|++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 455555666677777777777888999999999999999999999999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=405.69 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=213.2
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.++|++.+.||+|+||.||+|+.+ +|+.||||++........+.+.+|+++|+.++||||+++++++.+.+..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999986 6899999998877777778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC--CcEEEeecCCCcccccC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK--YRAKVSDFGASRSVMID 545 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~--~~~kl~DfGl~~~~~~~ 545 (700)
+++|+|.++|..... .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999975432 3999999999999999999999999 9999999999999854 89999999999876433
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
.......||+.|||||++.+..|+.++|||||||+||||++|..||.+....+. ...+....+. ..
T Consensus 311 --~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-------~~~i~~~~~~--~~--- 376 (573)
T 3uto_A 311 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-------LRNVKSCDWN--MD--- 376 (573)
T ss_dssp --SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHTTCCC--CC---
T ss_pred --CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-------HHHHHhCCCC--CC---
Confidence 234456799999999999999999999999999999999999999986654331 2222222110 01
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.......+..+.+|+.+||+.||.+|||+.|+++
T Consensus 377 -~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 377 -DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111223456889999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=399.03 Aligned_cols=249 Identities=21% Similarity=0.278 Sum_probs=201.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhh---HHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESN---IEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
.++|++.++||+|+||+||+|+.+ +|+.||||++.... ... ....+.++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 477999999999999999999976 68999999875321 112 22334456677778999999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
+|||||+++|+|.++|.+.. .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999998754 3999999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
.... .....+||+.|||||++.. ..|+.++|||||||+||||++|..||........ .. ....+.....
T Consensus 342 ~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~-i~~~i~~~~~--- 411 (689)
T 3v5w_A 342 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HE-IDRMTLTMAV--- 411 (689)
T ss_dssp CSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HH-HHHHHHHCCC---
T ss_pred cCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HH-HHHhhcCCCC---
Confidence 5432 2345679999999999964 5799999999999999999999999975433221 11 1111111111
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT-----MKEAAF 660 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~ 660 (700)
..+...+.++.+|+.+||+.||.+|++ ++||++
T Consensus 412 -------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 -------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 122334567889999999999999998 677765
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=367.34 Aligned_cols=264 Identities=24% Similarity=0.400 Sum_probs=219.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.++|++.++||+|+||+||+|.+. +++.||+|++...+....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 567889999999999999999986 6899999998877778889999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999987533 3999999999999999999999999 99999999999999999999999999986543222
Q ss_pred ee-------------eeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh
Q 005355 548 HL-------------TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE 614 (700)
Q Consensus 548 ~~-------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 614 (700)
.. .....||+.|+|||++.+..++.++||||||+++|||++|..|+............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~--------- 234 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--------- 234 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB---------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh---------
Confidence 11 11456999999999999999999999999999999999999998754433211000
Q ss_pred cchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCC
Q 005355 615 NRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGD 671 (700)
Q Consensus 615 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~ 671 (700)
..... .....+...+..+.+|+.+||+.||++|||+.|+++.|+.++..+..
T Consensus 235 -~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 235 -NVRGF----LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp -CHHHH----HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred -hhhcc----ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 00000 11111233345688899999999999999999999999999887654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.68 Aligned_cols=284 Identities=35% Similarity=0.581 Sum_probs=231.3
Q ss_pred cccccchHHHHHHhcCCCcc------ceEeeeCCeEEEEEEEcCCcEEEEEEcccc----ChhhHHHHHHHHHHHhhcCC
Q 005355 376 KTKLFTSMELEMATDNFNTN------RILGQGGQGTVYKGMLTNGRIVAIKKSKLV----DESNIEQFINEVAILSQINH 445 (700)
Q Consensus 376 ~~~~~~~~e~~~~~~~~~~~------~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h 445 (700)
....|+..++..++++|... +.||+|+||.||+|.+ +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34568889999999999877 8999999999999987 4889999987642 23456789999999999999
Q ss_pred CceeeEEeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005355 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL 525 (700)
Q Consensus 446 ~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl 525 (700)
|||+++++++.+.+..++||||+++++|.+++.......++++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999986554556999999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhH
Q 005355 526 DDKYRAKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSL 604 (700)
Q Consensus 526 ~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~ 604 (700)
+.++.+||+|||++........ .......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 9999999999999976543222 22334568999999998875 588999999999999999999999986554332111
Q ss_pred HHHHHHHHH--hcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 605 VGYFLEAMK--ENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 605 ~~~~~~~~~--~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
. ..... ...+...++..+ ...+...+..+.+++.+||+.+|.+|||++++++.|++++++
T Consensus 246 ~---~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 246 I---KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp H---HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred H---HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 1 11111 112233333322 334567788899999999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=366.59 Aligned_cols=271 Identities=30% Similarity=0.424 Sum_probs=211.4
Q ss_pred chHHHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC
Q 005355 381 TSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLET 458 (700)
Q Consensus 381 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 458 (700)
...++....++|++.+.||+|+||+||+|++. ++.||||++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 33445566788999999999999999999874 889999997653 345567899999999999999999999999999
Q ss_pred CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 005355 459 EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGA 538 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl 538 (700)
+..++||||+++++|.+++........+++..++.++.||+.||+|||+++ ++|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 999999999999999999987543334899999999999999999999987 3499999999999999999999999999
Q ss_pred CcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 539 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
++..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. ........
T Consensus 186 a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~-------~~~~~~~~- 256 (309)
T 3p86_A 186 SRLKAST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV-------AAVGFKCK- 256 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-------HHHHHSCC-
T ss_pred Ccccccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhcCC-
Confidence 9754322 22233456999999999999999999999999999999999999999765543211 11110000
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
....+...+..+.+|+.+||+.+|++|||+.++++.|+.+.+..
T Consensus 257 -------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 257 -------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred -------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 01122334557889999999999999999999999999887654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=357.91 Aligned_cols=261 Identities=25% Similarity=0.386 Sum_probs=217.0
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
..++|++.+.||+|+||.||+|.++++..||||++...... .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 46789999999999999999999988889999998754333 36799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999987532 3899999999999999999999999 99999999999999999999999999986654443
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+..+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~--------- 223 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-------VLKVSQGHR--------- 223 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-------HHHHHTTCC---------
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-------HHHHHcCCC---------
Confidence 33444556778999999999999999999999999999999 9999976554321 111111110
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
...+...+..+.+|+.+||+.+|++|||+.|+++.|+.++...+
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~k 267 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC---
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhccC
Confidence 01112234568899999999999999999999999999976543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=357.61 Aligned_cols=259 Identities=29% Similarity=0.451 Sum_probs=216.6
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
..++|++.+.||+|+||.||+|.+.+++.||||++...... .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 35789999999999999999999988999999998754333 36799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp CTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999999976543 4899999999999999999999999 99999999999999999999999999986543333
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
.......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+..+..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~-------~~~~~~~~~--------- 225 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VEDISTGFR--------- 225 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTTCC---------
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH-------HHHHhcCcc---------
Confidence 33334456778999999999999999999999999999999 9999976544321 111221110
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
...+...+..+.+|+.+||+.+|++|||++|+++.|+++.++
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 111222345688999999999999999999999999998764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=357.27 Aligned_cols=264 Identities=27% Similarity=0.407 Sum_probs=212.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL---VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|++.+.||+|+||.||++.+. .++.||+|++.. ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 578999999999999999999976 688999998754 2344567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++++|.+++.... ++++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999998754 3999999999999999999999999 99999999999999999999999999986644
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
..........||+.|+|||++.+..++.++||||||+++|+|++|+.||......+. ....... .. +.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~-~~-----~~ 231 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQD-SV-----PN 231 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSS-CC-----CC
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhc-cC-----CC
Confidence 433334456699999999999999999999999999999999999999976543321 1111111 11 11
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhchhhcC
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRP-TMKEAAFELGGIRASIG 670 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~l~~~~~ 670 (700)
.........+..+.+++.+||+.||.+|| +++++.+.|+.+.....
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 11122333456789999999999999998 89999999988765443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=357.91 Aligned_cols=250 Identities=27% Similarity=0.423 Sum_probs=210.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.++|++.+.||+|+||+||+|... +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 468999999999999999999964 6899999998766556668899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++.... +++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 99999999998653 899999999999999999999999 99999999999999999999999999976543322
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......||+.|+|||++.+..++.++||||||+++|||++|..||........ .......... ..
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~~-~~------- 236 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP-EL------- 236 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSC-CC-------
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC-CC-------
Confidence 23445699999999999999999999999999999999999999976543321 1111111110 00
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+...+..+.+|+.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 011233456889999999999999999999987
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=370.08 Aligned_cols=264 Identities=25% Similarity=0.429 Sum_probs=217.8
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEe
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT--------NGRIVAIKKSKLV-DESNIEQFINEVAILSQI-NHRNVVKLLGCCLE 457 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 457 (700)
..++|++.+.||+|+||.||+|++. ++..||||+++.. .....+.+.+|+++++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4578999999999999999999863 3457999998754 344567899999999999 89999999999999
Q ss_pred CCcceEEEeeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 005355 458 TEVPLLVYEFIPNGTLYQYIHDQTE-------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANIL 524 (700)
Q Consensus 458 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NIL 524 (700)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999987532 234899999999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhh
Q 005355 525 LDDKYRAKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDK 602 (700)
Q Consensus 525 l~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~ 602 (700)
|+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~- 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-
Confidence 99999999999999986543222 12223446789999999999999999999999999999999 9999987654331
Q ss_pred hHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 603 SLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
...+..+.. ...+...+..+.+|+.+||+.+|++||++.|+++.|+++.....
T Consensus 315 ------~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 315 ------FKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp ------HHHHHTTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ------HHHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 112222211 11223345678999999999999999999999999999876543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=363.47 Aligned_cols=262 Identities=27% Similarity=0.404 Sum_probs=214.9
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc----CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT----NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
..++|++.+.||+|+||.||+|.+. .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 4578899999999999999999975 3456999998764 4555678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+||||+++++|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 127 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999976533 3999999999999999999999999 999999999999999999999999999866
Q ss_pred ccCCce--eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 543 MIDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 543 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+. ...+..+..
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~~~~~~~-- 272 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-------ISSVEEGYR-- 272 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------HHHHHTTCC--
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHHcCCC--
Confidence 433222 2223346778999999999999999999999999999999 9999976544321 111221111
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
...+...+..+.+|+.+||+.||++|||++|+++.|+.+.....
T Consensus 273 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 273 -------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred -------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 11223345678899999999999999999999999999876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=365.24 Aligned_cols=269 Identities=28% Similarity=0.455 Sum_probs=212.7
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-----CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC--Cc
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-----NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLET--EV 460 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 460 (700)
..++|++.+.||+|+||.||++++. +++.||||++........+.+.+|++++++++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 3578999999999999999999852 5889999999887777788999999999999999999999998654 56
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.++||||+++++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 7999999999999999987543 3899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCce--eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchh---------hhhHHHHHH
Q 005355 541 SVMIDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE---------DKSLVGYFL 609 (700)
Q Consensus 541 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~---------~~~~~~~~~ 609 (700)
........ ......++..|+|||++.+..++.++||||||+++|||++|..|+....... .........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 65433221 1223346778999999999999999999999999999999999986432110 000011111
Q ss_pred HHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 610 EAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 610 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
.....+ .....+...+..+.+|+.+||+.||++|||++|+++.|++++..+.
T Consensus 243 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 243 ELLKNN---------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHTT---------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHhcc---------CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 111111 1112233455679999999999999999999999999999987653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=366.57 Aligned_cols=272 Identities=23% Similarity=0.305 Sum_probs=213.7
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc----c
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEV----P 461 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~ 461 (700)
....++|++.++||+|+||+||+|++. ++.||||++..... ....+.+|+.++++++||||+++++++.+... .
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 344688999999999999999999986 79999999875433 33556678999999999999999999987554 5
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeeecCCCCCcEEECCCCcE
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA----------ASIPIYHRDIKSANILLDDKYRA 531 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------~~~~ivH~Dik~~NILl~~~~~~ 531 (700)
++||||+++|+|.+++.... +++..++.++.||+.||+|||+. + |+||||||+|||++.++.+
T Consensus 98 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCE
T ss_pred EEEEecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeE
Confidence 89999999999999997653 99999999999999999999998 8 9999999999999999999
Q ss_pred EEeecCCCcccccCCce-eeeeeeccccccccccccc-----CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHH
Q 005355 532 KVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLV 605 (700)
Q Consensus 532 kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~ 605 (700)
||+|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||............
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 99999999765433222 2233568999999999986 35667899999999999999999999765432211111
Q ss_pred ---------HHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 606 ---------GYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 606 ---------~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
...............+.... .....+..+.+|+.+||+.||++|||+.|+++.|++|+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111111111111111111 12345667999999999999999999999999999998653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=359.87 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=210.0
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
..++|++.+.||+|+||.||+|.+. +++.||||++... +....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3578999999999999999999984 7899999997643 455667899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++++|.+++..... +++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999999977543 999999999999999999999999 99999999999999999999999999976543
Q ss_pred CCceeeeeeecccccccccccccCCCC-cccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
. .......||+.|+|||++.+..+. .++||||||+++|+|++|+.||......+ ....+..+..
T Consensus 167 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~i~~~~~------ 231 (328)
T 3fe3_A 167 G--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-------LRERVLRGKY------ 231 (328)
T ss_dssp S--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC------
T ss_pred C--CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC------
Confidence 2 223445699999999999888775 79999999999999999999998665332 1122222211
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..+...+..+.+|+.+||+.||.+|||++|+++.
T Consensus 232 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122234568899999999999999999999873
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=372.72 Aligned_cols=263 Identities=24% Similarity=0.409 Sum_probs=216.6
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
+....++|++.+.||+|+||.||+|.+. +++.||||+++.. .....+.|.+|++++++++||||+++++++.+.+..+
T Consensus 109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 3445678999999999999999999987 7899999998753 3344567899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+||||+++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 189 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999999999999986432 3899999999999999999999999 999999999999999999999999999754
Q ss_pred ccCCceee-eeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 543 MIDQTHLT-TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 543 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
........ ....++..|+|||++.+..++.++||||||+++|||++ |..||......+. ...+..+..
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~--- 333 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-------REFVEKGGR--- 333 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-------HHHHHTTCC---
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC---
Confidence 32211111 12335778999999999999999999999999999998 9999976554321 112222111
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
...+...+..+.+|+.+||+.||++|||++++++.|+.+++.
T Consensus 334 ------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 334 ------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 111223455788999999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=368.27 Aligned_cols=260 Identities=25% Similarity=0.419 Sum_probs=204.4
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc----CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT----NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
..++|++.+.||+|+||.||+|++. .+..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 4578999999999999999999875 4678999998754 4455678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+||||+++++|.++++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999986533 4999999999999999999999999 999999999999999999999999999866
Q ss_pred ccCCcee--eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 543 MIDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 543 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
....... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+..+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------~~~~i~~~~--- 267 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIKAVDEGY--- 267 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-------HHHHHHTTE---
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC---
Confidence 4332221 122235778999999999999999999999999999998 999997654322 111222111
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
....+...+..+.+|+.+||+.+|++||++++++++|+++...
T Consensus 268 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 268 ------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 1111233456789999999999999999999999999998654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=380.97 Aligned_cols=265 Identities=22% Similarity=0.386 Sum_probs=219.1
Q ss_pred hHHHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 382 SMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 382 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
..++++..++|++.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+.++++++||||+++++++. .+..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 445667788999999999999999999999888999999987643 34688999999999999999999999986 6678
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++||||+++|+|.++++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred EEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 999999999999999985421 23889999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
.............++..|+|||++....++.++||||||++||||++ |+.||......+. ...+..+..
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~-------~~~i~~~~~--- 403 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-------IRALERGYR--- 403 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-------HHHHHHTCC---
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC---
Confidence 54332222233446788999999999999999999999999999999 9999986554321 111221111
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
...+...+..+.+|+.+||+.||++|||+++|++.|+.+...
T Consensus 404 ------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 404 ------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 111233456789999999999999999999999999988654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=354.08 Aligned_cols=261 Identities=26% Similarity=0.372 Sum_probs=215.6
Q ss_pred ccchHHHHHHhcC----------CCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCc
Q 005355 379 LFTSMELEMATDN----------FNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRN 447 (700)
Q Consensus 379 ~~~~~e~~~~~~~----------~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 447 (700)
.++..+++.+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4666777666654 677789999999999999987 79999999988766666788999999999999999
Q ss_pred eeeEEeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC
Q 005355 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD 527 (700)
Q Consensus 448 iv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~ 527 (700)
|+++++++...+..++||||+++++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 999999999999999999999999999998754 3999999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHH
Q 005355 528 KYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGY 607 (700)
Q Consensus 528 ~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 607 (700)
++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~------ 249 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------ 249 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------
T ss_pred CCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------
Confidence 99999999999976543322 23445699999999999999999999999999999999999999976543221
Q ss_pred HHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 608 FLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 608 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
...+......... .....+..+.+|+.+||+.||++|||++|+++.
T Consensus 250 -~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 -MKRLRDSPPPKLK-------NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp -HHHHHHSSCCCCT-------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HHHHhcCCCCCcC-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111110000 011234568899999999999999999999873
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=354.65 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=214.1
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
+...++|++.+.||+|+||.||++.+.++..||||++...... .+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 4457889999999999999999999998889999998764333 367899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 99 EYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999987433 3999999999999999999999999 999999999999999999999999999865433
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
.........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+. ...+..+..
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-------~~~~~~~~~------- 239 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------AEHIAQGLR------- 239 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-------HHHHHTTCC-------
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-------HHHHhcccC-------
Confidence 3222333446788999999999999999999999999999998 9999976554321 111111110
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
...+...+..+.+|+.+||+.+|.+|||++|+++.|+++...
T Consensus 240 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 240 --LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 111122345788999999999999999999999999988653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=367.31 Aligned_cols=273 Identities=27% Similarity=0.416 Sum_probs=222.6
Q ss_pred ccchHHHHHHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCceee
Q 005355 379 LFTSMELEMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLV-DESNIEQFINEVAILSQI-NHRNVVK 450 (700)
Q Consensus 379 ~~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~ 450 (700)
.+...+++...++|++.+.||+|+||.||+|.+. +++.||||+++.. .....+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3556777888999999999999999999999842 3578999998763 344567899999999999 7999999
Q ss_pred EEeEEEeCCc-ceEEEeeCCCCCHHHHHhccCC-----------------------------------------------
Q 005355 451 LLGCCLETEV-PLLVYEFIPNGTLYQYIHDQTE----------------------------------------------- 482 (700)
Q Consensus 451 l~~~~~~~~~-~~lv~E~~~~gsL~~~l~~~~~----------------------------------------------- 482 (700)
+++++.+.+. .++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 8999999999999999987542
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 483 ----------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 483 ----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122899999999999999999999999 9999999999999999999999999998654332
Q ss_pred c-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 547 T-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 547 ~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
. .......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+. +...+..+..
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~------- 314 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTR------- 314 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCC-------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCCC-------
Confidence 2 23344568999999999999999999999999999999998 9999976654331 1112222111
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
...+...+..+.+|+.+||+.||.+|||++|++++|+.+.+..
T Consensus 315 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 315 --MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 1112234457889999999999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=366.71 Aligned_cols=270 Identities=26% Similarity=0.432 Sum_probs=222.0
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEc--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCceeeEEeE
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLT--------NGRIVAIKKSKLV-DESNIEQFINEVAILSQI-NHRNVVKLLGC 454 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 454 (700)
++...++|++.+.||+|+||.||+|++. .+..||||+++.. .....+.+.+|+++++++ +||||++++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 3455789999999999999999999963 2357999998753 345567899999999999 89999999999
Q ss_pred EEeCCcceEEEeeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 005355 455 CLETEVPLLVYEFIPNGTLYQYIHDQTE-------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSA 521 (700)
Q Consensus 455 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~ 521 (700)
+.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 220 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 220 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcc
Confidence 9999999999999999999999987542 234899999999999999999999999 999999999
Q ss_pred cEEECCCCcEEEeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCch
Q 005355 522 NILLDDKYRAKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSE 599 (700)
Q Consensus 522 NILl~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~ 599 (700)
||||+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986543222 22333457889999999999999999999999999999999 99999765533
Q ss_pred hhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCCc
Q 005355 600 EDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSI 673 (700)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~ 673 (700)
+ ....+..+.. ...+...+..+.+|+.+||+.+|++|||++|+++.|+++........
T Consensus 301 ~-------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 301 E-------LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp H-------HHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred H-------HHHHHHcCCC---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 2 1222222211 11122345578899999999999999999999999999987665443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=377.00 Aligned_cols=266 Identities=26% Similarity=0.376 Sum_probs=213.4
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
..+++..++|++.+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|++++++++||||+++++++.+ +..+
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 344566788999999999999999999998888899999876433 34789999999999999999999999876 6789
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 255 iv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEehhhcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceec
Confidence 99999999999999975321 23899999999999999999999999 999999999999999999999999999866
Q ss_pred ccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
............++..|+|||++....++.++||||||++||||++ |+.||......+ ....+..+..
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~---- 399 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYR---- 399 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC----
T ss_pred CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC----
Confidence 4333333334457789999999999999999999999999999999 999997655432 1122222111
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
...+...+..+.+|+.+||+.+|++|||++++++.|+.+.....
T Consensus 400 -----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 400 -----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 11123445678899999999999999999999999998865543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=352.31 Aligned_cols=261 Identities=26% Similarity=0.407 Sum_probs=203.6
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEcC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLTN----GRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEV 460 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 460 (700)
+...++|++.+.||+|+||.||+|.+.. +..||+|+.... .....+.+.+|+.++++++||||+++++++. .+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 3446789999999999999999999753 457999998753 3445678999999999999999999999984 567
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.++||||+++++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 8999999999999999986532 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
..............+++.|+|||++.+..++.++||||||+++|||++ |..||......+. ...+..+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~-------~~~i~~~~~~- 236 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRIENGERL- 236 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTCCC-
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH-------HHHHHcCCCC-
Confidence 664433333334457789999999999999999999999999999997 9999986654331 1112221111
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
..+...+..+.+|+.+||+.||++|||+.|+++.|+++...
T Consensus 237 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 237 --------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11233456788999999999999999999999999988654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=347.81 Aligned_cols=259 Identities=29% Similarity=0.442 Sum_probs=215.5
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
..++|++.+.||+|+||.||++.+.+++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 35788999999999999999999988899999998764433 36799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++++|.+++..... .+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CTTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999999986543 4899999999999999999999999 99999999999999999999999999976543222
Q ss_pred eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 548 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+..+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~i~~~~~--------- 223 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VEDISTGFR--------- 223 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTTCC---------
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH-------HHHHhcCCc---------
Confidence 22233446788999999999999999999999999999999 8999976543321 111221110
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
...+...+..+.+|+.+||+.+|++|||++++++.|+++.++
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 011222345788999999999999999999999999998753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.73 Aligned_cols=267 Identities=27% Similarity=0.413 Sum_probs=220.1
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEE
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCC 455 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 455 (700)
.+++...++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|++++++++||||+++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 344556788999999999999999999862 3578999998753 345568899999999999999999999999
Q ss_pred EeCCcceEEEeeCCCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 005355 456 LETEVPLLVYEFIPNGTLYQYIHDQTE---------------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIY 514 (700)
Q Consensus 456 ~~~~~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iv 514 (700)
.+.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iv 172 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LV 172 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 999999999999999999999987542 234899999999999999999999999 99
Q ss_pred ecCCCCCcEEECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCC
Q 005355 515 HRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592 (700)
Q Consensus 515 H~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p 592 (700)
||||||+|||++.++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|||++ |..|
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999865433322 2233457788999999999999999999999999999999 9999
Q ss_pred CCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 593 IRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
|......+. ...+..+.. ...+...+..+.+|+.+||+.||++||++.|+++.|+++...
T Consensus 253 ~~~~~~~~~-------~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 253 YPGIPPERL-------FNLLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp STTCCGGGH-------HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCHHHH-------HHHhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 987654431 112222111 112233456788999999999999999999999999988653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=361.45 Aligned_cols=269 Identities=24% Similarity=0.425 Sum_probs=219.2
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEcC------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEE
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLTN------GRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCC 455 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 455 (700)
..+....++|++.+.||+|+||.||+|++.+ ++.||||+++.. .....+.+.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3445567899999999999999999999752 478999998754 344567899999999999999999999999
Q ss_pred EeCCcceEEEeeCCCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 005355 456 LETEVPLLVYEFIPNGTLYQYIHDQTE---------------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIY 514 (700)
Q Consensus 456 ~~~~~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iv 514 (700)
.+.+..++||||+++++|.+++..... ...+++..++.++.||++||+|||+++ |+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 999999999999999999999987431 145899999999999999999999999 99
Q ss_pred ecCCCCCcEEECCCCcEEEeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCC
Q 005355 515 HRDIKSANILLDDKYRAKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 592 (700)
Q Consensus 515 H~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p 592 (700)
||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |..|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999976533221 22234557889999999999999999999999999999999 9999
Q ss_pred CCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 593 IRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 593 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
|......+ ....+..+... ..+...+..+.+|+.+||+.+|++||++.++++.|+++.....
T Consensus 277 ~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 277 YYGMAHEE-------VIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TTTSCHHH-------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCCCChHH-------HHHHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 97654332 12222222221 1122345578899999999999999999999999999876654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=373.35 Aligned_cols=263 Identities=20% Similarity=0.288 Sum_probs=213.2
Q ss_pred chHHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEE
Q 005355 381 TSMELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCL 456 (700)
Q Consensus 381 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 456 (700)
...+++...++|++.++||+|+||+||+|+++ +++.||||++.... ....+.+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34556667899999999999999999999987 47899999986421 122344889999999999999999999999
Q ss_pred eCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeec
Q 005355 457 ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 536 (700)
Q Consensus 457 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~Df 536 (700)
+.+..++||||+++|+|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999987432 3999999999999999999999999 999999999999999999999999
Q ss_pred CCCcccccCCceeeeeeecccccccccccc-----cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHH
Q 005355 537 GASRSVMIDQTHLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEA 611 (700)
Q Consensus 537 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 611 (700)
|+++..............||+.|+|||++. ...++.++||||||+++|||++|+.||......+.. ...
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~------~~i 293 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKI 293 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH------Hhh
Confidence 999876555444455567999999999987 567899999999999999999999999865543321 111
Q ss_pred HHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHH
Q 005355 612 MKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKK--RPTMKEAAF 660 (700)
Q Consensus 612 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~ 660 (700)
+.... ...- .......+..+.+|+++||..+|++ ||+++|+++
T Consensus 294 ~~~~~--~~~~----p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 294 MNHKE--RFQF----PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HTHHH--HCCC----CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhccc--cccC----CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11000 0000 0001124557889999999988888 999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=354.04 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=209.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|++.+.||+|+||+||+++.. +++.||||+++.. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999976 6899999998642 233457789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999998654 3899999999999999999999999 99999999999999999999999999975432
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
. ........||+.|+|||++.+..++.++||||||+++|||++|..||...+..+ ....+.....
T Consensus 158 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~------- 222 (337)
T 1o6l_A 158 D-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI------- 222 (337)
T ss_dssp T-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-------
T ss_pred C-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC-------
Confidence 2 223345679999999999999999999999999999999999999997654322 1111111111
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRP-----TMKEAAFE 661 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~ 661 (700)
..+...+..+.+|+.+||+.||++|| +++|+++.
T Consensus 223 ---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11223456788999999999999999 89999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=349.68 Aligned_cols=270 Identities=25% Similarity=0.377 Sum_probs=216.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC--cceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETE--VPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 464 (700)
.++|++.++||+|+||+||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467899999999999999999987 58999999987533 334677889999999999999999999998765 67899
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----CCCCcEEEeecCCCc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGASR 540 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl----~~~~~~kl~DfGl~~ 540 (700)
|||+++++|.+++........+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999987655555999999999999999999999999 9999999999999 788889999999998
Q ss_pred ccccCCceeeeeeecccccccccccc--------cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHH
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFR--------SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAM 612 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 612 (700)
...... ......||+.|+|||++. +..++.++||||||+++|||++|+.||............ +....
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~ 240 (319)
T 4euu_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV--MYKII 240 (319)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH--HHHHH
T ss_pred ecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH--HHHHh
Confidence 654332 233456899999999986 578899999999999999999999999765443222111 11111
Q ss_pred Hhcc---hhhhc-----------chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 613 KENR---LFEVL-----------DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 613 ~~~~---~~~~~-----------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
.... +..+. +..............+.+|+.+||+.||++|||++|+++...+-
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1110 00000 00111234567788899999999999999999999999988654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=346.63 Aligned_cols=267 Identities=16% Similarity=0.176 Sum_probs=217.4
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 465 (700)
..++|++.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.+++++ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 3578999999999999999999974 78999999876432 234688999999999 7999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc-----EEEeecCCCc
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR-----AKVSDFGASR 540 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~-----~kl~DfGl~~ 540 (700)
||+ +++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++.
T Consensus 86 e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 9999999987543 3999999999999999999999999 999999999999987766 9999999998
Q ss_pred ccccCCce------eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh
Q 005355 541 SVMIDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE 614 (700)
Q Consensus 541 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 614 (700)
........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 66433221 234456999999999999999999999999999999999999999876543332222222211111
Q ss_pred cchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCC
Q 005355 615 NRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGD 671 (700)
Q Consensus 615 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~ 671 (700)
... .......+..+.+|+.+||+.+|++||++++|++.|+++...+..
T Consensus 240 ~~~---------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 240 TPL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp SCH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ccH---------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 111 111123456789999999999999999999999999999876653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=349.39 Aligned_cols=262 Identities=21% Similarity=0.344 Sum_probs=205.4
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhh--cCCCceeeEEeEEEeC----Ccc
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQ--INHRNVVKLLGCCLET----EVP 461 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~ 461 (700)
..++|++.+.||+|+||+||+|++ +++.||||++... ..+.+.+|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 357899999999999999999998 5899999998643 34566777887777 7999999999987653 457
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCcEEECCCCcEEE
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH--------SAASIPIYHRDIKSANILLDDKYRAKV 533 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~~ivH~Dik~~NILl~~~~~~kl 533 (700)
++||||+++|+|.++++.. .+++..++.++.||+.||+||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 8999999999999999654 3999999999999999999999 778 999999999999999999999
Q ss_pred eecCCCcccccCCcee---eeeeecccccccccccccC------CCCcccceehHHHHHHHHHhC----------CCCCC
Q 005355 534 SDFGASRSVMIDQTHL---TTRVQGTFGYLDPEYFRSS------QFTEKSDVYSFGVVLVELLTG----------QKPIR 594 (700)
Q Consensus 534 ~DfGl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlG~il~elltg----------~~p~~ 594 (700)
+|||+++......... .....||+.|+|||++.+. .++.++||||||+++|||++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999997654333222 2234699999999999876 455799999999999999999 88886
Q ss_pred CCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 595 STDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
........ ................+.. .......+..+.+|+.+||+.||++|||+.|+++.|++|
T Consensus 235 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPS--FEDMRKVVCVDQQRPNIPN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCC--HHHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcc--hhhhhHHHhccCCCCCCCh---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 54332211 1111111111111111111 112345677899999999999999999999999999886
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=352.12 Aligned_cols=262 Identities=21% Similarity=0.330 Sum_probs=205.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.++|++.++||+|+||+||+|++.+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 57899999999999999999999889999999986432 3345778999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|++ ++|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FME-KDLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCS-EEHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCC-CCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 997 588888876543 3899999999999999999999999 9999999999999999999999999998653222
Q ss_pred ceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcc---hhh---
Q 005355 547 THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR---LFE--- 619 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~--- 619 (700)
.......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+... .......... +..
T Consensus 174 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 174 -RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP---KIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp -C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH---HHHHHHCCCCTTTSGGGTT
T ss_pred -ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHHCCCChHHhhhhhc
Confidence 22334568999999999876 568999999999999999999999998765443221 1111111100 000
Q ss_pred ----------hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 620 ----------VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 620 ----------~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
................++.+|+.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000001111223457889999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=349.39 Aligned_cols=265 Identities=23% Similarity=0.405 Sum_probs=217.2
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
+++...++|++.+.||+|+||.||+|.+.+++.||||++..... ..+.+.+|++++++++||||+++++++. .+..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 44556688999999999999999999998888999999875432 3578999999999999999999999886 456899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++++|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++....
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 9999999999999975421 13899999999999999999999999 9999999999999999999999999998665
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
...........++..|+|||++.+..++.++||||||++++||++ |..||......+ ....+..+..
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~----- 228 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------VIQNLERGYR----- 228 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC-----
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-------HHHHHhcccC-----
Confidence 443333334456789999999998899999999999999999999 999997654332 1112221110
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
...+...+..+.+|+.+||+.+|++|||+.++++.|+.+.....
T Consensus 229 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 229 ----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ----CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 11122344678899999999999999999999999999876654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=379.10 Aligned_cols=261 Identities=28% Similarity=0.440 Sum_probs=218.6
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLTN-GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
++...++|++.++||+|+||.||+|.+.. +..||||+++.... ..+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 34456789999999999999999999874 88999999876433 45789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 294 v~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceecc
Confidence 9999999999999986532 34899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
...........++..|+|||++....++.++||||||++||||++ |..||......+. ...+..+.
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~------ 436 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKDY------ 436 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------HHHHHTTC------
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCC------
Confidence 433333333456789999999999999999999999999999999 9999987654331 11111111
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
....+...+..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 437 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 ---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11222344567889999999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=345.48 Aligned_cols=255 Identities=31% Similarity=0.502 Sum_probs=200.6
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccCh----hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDE----SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
..++|++.+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 3578999999999999999999986 88999998765332 235778999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC--------CCcEEEee
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD--------KYRAKVSD 535 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~--------~~~~kl~D 535 (700)
||||+++++|.+++... .+++..++.++.|++.||+|||+++..+|+||||||+|||++. ++.+||+|
T Consensus 84 v~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999999643 3999999999999999999999998556889999999999986 77899999
Q ss_pred cCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc
Q 005355 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN 615 (700)
Q Consensus 536 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 615 (700)
||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .......
T Consensus 160 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~ 229 (271)
T 3dtc_A 160 FGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-------AYGVAMN 229 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-------HHHHHTS
T ss_pred CCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHhhhcC
Confidence 99997553222 2244689999999999999999999999999999999999999976543321 1111111
Q ss_pred chhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 616 RLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 616 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
... ...+...+..+.+|+.+||+.+|++|||+.|+++.|++|
T Consensus 230 ~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 KLA--------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCC--------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111 112233456788999999999999999999999999865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=353.31 Aligned_cols=270 Identities=26% Similarity=0.409 Sum_probs=221.3
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEE------cCCcEEEEEEccccC-hhhHHHHHHHHHHHhhc-CCCceeeEEeEE
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGML------TNGRIVAIKKSKLVD-ESNIEQFINEVAILSQI-NHRNVVKLLGCC 455 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 455 (700)
+++...++|++.+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 3455678899999999999999999985 246789999987543 34567899999999999 999999999999
Q ss_pred EeCCcceEEEeeCCCCCHHHHHhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 005355 456 LETEVPLLVYEFIPNGTLYQYIHDQTE---------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKS 520 (700)
Q Consensus 456 ~~~~~~~lv~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~ 520 (700)
.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp 173 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCcc
Confidence 999999999999999999999987542 124899999999999999999999999 99999999
Q ss_pred CcEEECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCc
Q 005355 521 ANILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDS 598 (700)
Q Consensus 521 ~NILl~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~ 598 (700)
+|||++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999999999999999999866543322 2334557889999999999999999999999999999999 9999976554
Q ss_pred hhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCC
Q 005355 599 EEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGD 671 (700)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~ 671 (700)
... ......... ....+...+..+.+|+.+||+.||.+|||+.|+++.|+++.....+
T Consensus 254 ~~~------~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 254 DSK------FYKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp SHH------HHHHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC
T ss_pred hhH------HHHHhccCC---------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhc
Confidence 321 111111111 0111223456788999999999999999999999999998776544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=352.41 Aligned_cols=264 Identities=28% Similarity=0.439 Sum_probs=222.2
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
+++...++|++.+.||+|+||.||+|.+. +++.||||++... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 34456788999999999999999999987 4889999998754 334578999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+||||+++++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999987533 34899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
............+++.|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+...
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~-------~~~~~~~------ 228 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKD------ 228 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------HHHHHTT------
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhcc------
Confidence 5554444555667889999999999999999999999999999999 9999987654432 1111111
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
.....+...+..+.+|+.+||+.||.+|||+.|+++.|+.+...
T Consensus 229 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 229 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 11112233456789999999999999999999999999887654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=369.34 Aligned_cols=256 Identities=26% Similarity=0.443 Sum_probs=213.2
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC-cceEE
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETE-VPLLV 464 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv 464 (700)
+...++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++|
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 445678999999999999999999986 7899999987643 4578999999999999999999999987765 68999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 266 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 999999999999987532 23799999999999999999999999 99999999999999999999999999975422
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
. .....++..|+|||++.+..++.++||||||++||||++ |..||......+. ...+..+..
T Consensus 342 ~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-------~~~i~~~~~------ 404 (450)
T 1k9a_A 342 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGYK------ 404 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH-------HHHHHTTCC------
T ss_pred c----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC------
Confidence 1 122357889999999999999999999999999999998 9999986654331 112222211
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
...+...+..+.+|+.+||+.||.+|||+.++++.|+.++..
T Consensus 405 ---~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 405 ---MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 112234456789999999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.06 Aligned_cols=264 Identities=17% Similarity=0.196 Sum_probs=214.2
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.++|++.+.||+|+||.||+|+.. +++.||||++..... .+.+.+|+++++++ +|+||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 578999999999999999999974 789999998765332 24688999999999 99999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc-----EEEeecCCCcc
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR-----AKVSDFGASRS 541 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~-----~kl~DfGl~~~ 541 (700)
|+ +++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 9999999987532 4999999999999999999999999 999999999999998887 99999999986
Q ss_pred cccCCce------eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc
Q 005355 542 VMIDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN 615 (700)
Q Consensus 542 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 615 (700)
....... ......||+.|+|||++.+..++.++||||||+++|||++|..||......+...............
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 5433221 1235679999999999999999999999999999999999999998765443322222211111100
Q ss_pred chhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 616 RLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 616 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
... ......+ .+.+|+.+||+.+|.+||++++|++.|+++.....
T Consensus 240 ------~~~---~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 240 ------PIE---VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp ------CHH---HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ------CHH---HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 000 0011123 78999999999999999999999999998877654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=355.56 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=208.2
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh------hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE------SNIEQFINEVAILSQINHRNVVKLLGCCLETEV 460 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 460 (700)
..+.|++.+.||+|+||.||++... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3578999999999999999999986 689999998765332 135789999999999999999999999999999
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC----cEEEeec
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDF 536 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~----~~kl~Df 536 (700)
.++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999997643 4999999999999999999999999 99999999999998876 7999999
Q ss_pred CCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcc
Q 005355 537 GASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR 616 (700)
Q Consensus 537 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 616 (700)
|++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||......+. ...+....
T Consensus 164 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-------~~~i~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANITAVS 234 (361)
T ss_dssp SSCEECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHTTC
T ss_pred CCceEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhcC
Confidence 999865432 223445699999999999999999999999999999999999999976543321 11222211
Q ss_pred hhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 617 LFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 617 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. ..+.... ...+..+.+|+.+||..||++|||+.|+++
T Consensus 235 ~--~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 Y--DFDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp C--CCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred C--CCCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 0111111 123456889999999999999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=359.21 Aligned_cols=269 Identities=25% Similarity=0.436 Sum_probs=216.4
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCceeeEEeEE
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLV-DESNIEQFINEVAILSQI-NHRNVVKLLGCC 455 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 455 (700)
+++...++|++.+.||+|+||.||+|.+. .++.||||++... .....+.+.+|+.+++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 45567789999999999999999999962 3568999998753 233457899999999999 899999999999
Q ss_pred EeCCcceEEEeeCCCCCHHHHHhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 005355 456 LETEVPLLVYEFIPNGTLYQYIHDQTEE--------------------FPITWEIRLRIAIEVSDALCYLHSAASIPIYH 515 (700)
Q Consensus 456 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH 515 (700)
...+..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+++ |+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 9999999999999999999999875432 23799999999999999999999999 999
Q ss_pred cCCCCCcEEECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCC
Q 005355 516 RDIKSANILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPI 593 (700)
Q Consensus 516 ~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~ 593 (700)
|||||+||||+.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999866443322 2334567889999999999999999999999999999998 99999
Q ss_pred CCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 594 RSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
......+. +...+..+. ....+...+..+.+|+.+||+.||.+|||+.|+++.|+.+.....
T Consensus 276 ~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 276 PGIPVDAN------FYKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp TTCCCSHH------HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred ccCCcHHH------HHHHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 76654321 111222111 111122345678899999999999999999999999998876544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.68 Aligned_cols=251 Identities=23% Similarity=0.322 Sum_probs=208.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.++|++.+.||+|+||.||++.+. +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 578999999999999999999976 58899999887543 3456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC--CCcEEEeecCCCcccccC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD--KYRAKVSDFGASRSVMID 545 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~--~~~~kl~DfGl~~~~~~~ 545 (700)
+++++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++......
T Consensus 83 ~~g~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999976432 4899999999999999999999999 999999999999987 789999999999865432
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
.......+|+.|+|||++.+..++.++||||||+++|+|++|..||......+ ....+...... .+...
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~--~~~~~ 226 (321)
T 1tki_A 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYT--FDEEA 226 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC--CCHHH
T ss_pred --CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-------HHHHHHcCCCC--CChhh
Confidence 23345679999999999999889999999999999999999999997654332 11112211110 11111
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. ...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 227 ~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 227 F----KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp H----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 123457889999999999999999999998
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=356.02 Aligned_cols=258 Identities=24% Similarity=0.469 Sum_probs=205.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCc----EEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGR----IVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
.++|++.++||+|+||+||+|++. +++ +||+|.+... .....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467899999999999999999965 343 4688887543 3345678999999999999999999999998765 68
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+|+||+.+|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999987543 3999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 543 MIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 543 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+. ...+..+..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~~~~~~~--- 237 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGER--- 237 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTCC---
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-------HHHHHcCCC---
Confidence 433222 2233456889999999999999999999999999999999 9999987654432 111211111
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
...+...+..+.+|+.+||+.+|++||+++|+++.|+.+...
T Consensus 238 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 238 ------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 111233455788999999999999999999999999887653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=356.08 Aligned_cols=266 Identities=26% Similarity=0.422 Sum_probs=202.1
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEcC-C---cEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLTN-G---RIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLET 458 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 458 (700)
+....++|++.+.||+|+||.||+|.+.. + ..||||+++.. .....+.+.+|++++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 34456789999999999999999999763 3 27999998753 445578899999999999999999999999877
Q ss_pred Ccc------eEEEeeCCCCCHHHHHhccCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC
Q 005355 459 EVP------LLVYEFIPNGTLYQYIHDQTE---EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY 529 (700)
Q Consensus 459 ~~~------~lv~E~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~ 529 (700)
+.. ++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCC
Confidence 665 899999999999999975422 225899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHH
Q 005355 530 RAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGY 607 (700)
Q Consensus 530 ~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~ 607 (700)
.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |..||......+.
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~------ 248 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI------ 248 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH------
Confidence 9999999999865433221 2223446788999999999999999999999999999999 9999987654431
Q ss_pred HHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 608 FLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 608 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
...+..+.. ...+...+..+.+|+.+||+.||++|||+.++++.|+++....
T Consensus 249 -~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 249 -YNYLIGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -HHHHHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -HHHHhcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111111111 1112334567899999999999999999999999999987654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=357.04 Aligned_cols=250 Identities=26% Similarity=0.378 Sum_probs=203.7
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcc
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 461 (700)
...++|++.++||+|+||+||+++++ +++.||||+++.. .....+.+.+|..+++.+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 44688999999999999999999976 5899999998642 234456788999999988 799999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++||||+++|+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRR---FDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence 999999999999999987543 999999999999999999999999 99999999999999999999999999975
Q ss_pred cccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
.... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+..+..
T Consensus 174 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~---- 241 (353)
T 3txo_A 174 GICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEV---- 241 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC----
T ss_pred cccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC----
Confidence 3322 223445679999999999999999999999999999999999999998665432 1122222211
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCH------HHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTM------KEAAF 660 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~------~evl~ 660 (700)
..+......+.+|+.+||+.||.+||++ +|+++
T Consensus 242 ------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1122244568899999999999999998 67765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=362.59 Aligned_cols=262 Identities=26% Similarity=0.380 Sum_probs=214.3
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEV 460 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 460 (700)
..++|++.+.||+|+||.||+|++. .++.||||++... .......+.+|+.++++++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3578999999999999999999953 4668999998653 44556789999999999999999999999999999
Q ss_pred ceEEEeeCCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC---cEEE
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTE----EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY---RAKV 533 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~---~~kl 533 (700)
.++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999987532 234899999999999999999999999 99999999999999554 5999
Q ss_pred eecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHH
Q 005355 534 SDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEA 611 (700)
Q Consensus 534 ~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 611 (700)
+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+ ....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-------~~~~ 298 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEF 298 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHH
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHH
Confidence 99999975432221 22233457889999999999999999999999999999998 999997654332 1222
Q ss_pred HHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 612 MKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 612 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
+..+.. ...+...+..+.+|+.+||+.+|++|||+.+|++.|+.+...
T Consensus 299 i~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 299 VTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHcCCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 222211 111223445688999999999999999999999999988764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=365.73 Aligned_cols=259 Identities=23% Similarity=0.319 Sum_probs=211.3
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLET 458 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 458 (700)
.+++...++|++.++||+|+||+||++++. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 455666789999999999999999999987 58899999876421 12234588999999999999999999999999
Q ss_pred CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 005355 459 EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGA 538 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl 538 (700)
+..++||||+++|+|.+++.... +++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~~----~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999997643 899999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCceeeeeeecccccccccccccCC----CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh
Q 005355 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ----FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE 614 (700)
Q Consensus 539 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 614 (700)
++..............||+.|+|||++.+.. ++.++||||||++||||++|+.||......+. +.....
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~- 287 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMN- 287 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHT-
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH------HHHHHh-
Confidence 9876544433445667999999999998765 78999999999999999999999986543321 111111
Q ss_pred cchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 005355 615 NRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKK--RPTMKEAAFE 661 (700)
Q Consensus 615 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPs~~evl~~ 661 (700)
.... +........+..+.+|+.+||+.+|.+ ||+++|+++.
T Consensus 288 ~~~~------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 288 HKNS------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHH------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cccc------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0000 000001123457889999999999988 9999999974
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=343.54 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=209.2
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTN----GRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
..++|++.+.||+|+||.||+|.+.. +..||||++... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 46789999999999999999998653 346999998754 44556889999999999999999999999765 4568
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+||||+++++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999986543 3899999999999999999999999 999999999999999999999999999866
Q ss_pred ccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
............+++.|+|||++.+..++.++||||||+++|||++ |+.||......+.. ..+..+...
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~-------~~~~~~~~~--- 233 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-------GVLEKGDRL--- 233 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH-------HHHHHTCCC---
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH-------HHHhcCCCC---
Confidence 4433333344557889999999999999999999999999999998 99999765443311 111111110
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
..+...+..+.+|+.+||+.+|++|||+.|+++.|+.+...
T Consensus 234 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 234 ------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 11122345688999999999999999999999999988654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=354.63 Aligned_cols=270 Identities=26% Similarity=0.439 Sum_probs=220.4
Q ss_pred ccchHHHHHHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeE
Q 005355 379 LFTSMELEMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKL 451 (700)
Q Consensus 379 ~~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l 451 (700)
.+...+++...++|++.+.||+|+||.||+|.+. .++.||||++... .......+.+|+.++++++|+||+++
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3445566777899999999999999999999865 3678999998753 33455679999999999999999999
Q ss_pred EeEEEeCCcceEEEeeCCCCCHHHHHhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 005355 452 LGCCLETEVPLLVYEFIPNGTLYQYIHDQT-------EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANIL 524 (700)
Q Consensus 452 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NIL 524 (700)
++++.+.+..++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIl 170 (322)
T 1p4o_A 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 170 (322)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEE
Confidence 999999999999999999999999997632 1134799999999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhh
Q 005355 525 LDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDK 602 (700)
Q Consensus 525 l~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~ 602 (700)
++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 248 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 248 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--
T ss_pred EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--
Confidence 999999999999999865433221 2223457889999999999999999999999999999999 899997654332
Q ss_pred hHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 603 SLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
....+..+... ..+...+..+.+|+.+||+.+|.+|||+.|+++.|+++..
T Consensus 249 -----~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 249 -----VLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -----HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -----HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11222222111 1122345678899999999999999999999999988754
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=340.74 Aligned_cols=255 Identities=22% Similarity=0.343 Sum_probs=209.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC--CcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLET--EVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 464 (700)
.++|++.+.||+|+||.||+|+++ ++.||||++... .....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 578999999999999999999986 889999998753 345567899999999999999999999999877 778999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++++|.+++..... ..+++..++.++.||+.||+|||+++ .+|+||||||+|||++.++.++|.|||+......
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999999987532 35899999999999999999999976 3499999999999999999999999988754322
Q ss_pred CCceeeeeeecccccccccccccCCCCc---ccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTE---KSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
....+|+.|+|||++.+..++. ++||||||+++|||++|+.||......+. .......+..
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~---- 229 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVALEGLR---- 229 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHHSCCC----
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHhcCCC----
Confidence 2235789999999998765554 79999999999999999999976543321 1111111111
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
...+...+..+.+++.+||+.||++|||++|+++.|++++.
T Consensus 230 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 -----PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11223345578899999999999999999999999998864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=380.39 Aligned_cols=265 Identities=26% Similarity=0.378 Sum_probs=217.4
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
..+++..++|++.++||+|+||.||+|.+.++..||||+++.... ..+.|.+|+++|++++|+||+++++++.+ +..+
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 345566788999999999999999999998888899999876443 34789999999999999999999999876 6789
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
|||||+++|+|.++|..... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 338 lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred EeeehhcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 99999999999999975321 23899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
............++..|+|||++....++.++||||||++||||++ |+.||......+ ....+..+..
T Consensus 414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~~---- 482 (535)
T 2h8h_A 414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYR---- 482 (535)
T ss_dssp CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHHTTCC----
T ss_pred CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC----
Confidence 4322222223346788999999999999999999999999999999 999997654432 1122222211
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
...+...+..+.+|+.+||+.||++|||+++|+++|+.+....
T Consensus 483 -----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 483 -----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 1112234567889999999999999999999999999886543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=356.86 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=202.7
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcce
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 462 (700)
..++|++.++||+|+||+||+++++ +++.||||+++.. .....+.+.+|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4578999999999999999999986 5789999987643 233345688999999887 8999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 130 lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999998754 3999999999999999999999999 999999999999999999999999999753
Q ss_pred ccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhh--hhHHHHHHHHHHhcchhhh
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED--KSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 620 (700)
... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ..........+.....
T Consensus 204 ~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 279 (396)
T 4dc2_A 204 LRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 279 (396)
T ss_dssp CCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---
T ss_pred ccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---
Confidence 222 2234456799999999999999999999999999999999999999975432221 1111112222222211
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTM 655 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~ 655 (700)
..+...+..+.+|+.+||+.||++||++
T Consensus 280 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 -------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1223345678899999999999999995
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.35 Aligned_cols=261 Identities=21% Similarity=0.324 Sum_probs=202.0
Q ss_pred cCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDE--SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
++|++.+.||+|+||.||+|+..+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57899999999999999999998899999999865332 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++ +|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 975 99999976533 3899999999999999999999999 9999999999999999999999999987653222
Q ss_pred eeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc---chhh----
Q 005355 548 HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN---RLFE---- 619 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~---- 619 (700)
.......+|+.|+|||++.+ ..++.++||||||+++|||++|..||......+. ........... .+..
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGS
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCCChhhchhhhcc
Confidence 22234468999999999976 4589999999999999999999999986543321 11111111100 0000
Q ss_pred -hcchhh-------hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 620 -VLDARV-------LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 620 -~~d~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..++.. ........+..+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 01111234567889999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=350.80 Aligned_cols=266 Identities=25% Similarity=0.439 Sum_probs=217.9
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc--------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCceeeEEeEE
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT--------NGRIVAIKKSKLV-DESNIEQFINEVAILSQI-NHRNVVKLLGCC 455 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 455 (700)
....++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+++++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 445689999999999999999999863 4678999998754 344567899999999999 899999999999
Q ss_pred EeCCcceEEEeeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 005355 456 LETEVPLLVYEFIPNGTLYQYIHDQTE-------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSAN 522 (700)
Q Consensus 456 ~~~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~N 522 (700)
.+.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 999999999999999999999986542 124899999999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchh
Q 005355 523 ILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600 (700)
Q Consensus 523 ILl~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~ 600 (700)
||++.++.+||+|||++......... ......+++.|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 99999999999999999865433222 2233456788999999998899999999999999999999 999997654332
Q ss_pred hhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 601 DKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
....+..+.. ...+...+..+.+|+.+||+.+|.+|||+.|+++.|+++.....
T Consensus 268 -------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 268 -------LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp -------HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -------HHHHHhcCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 1112222111 11122345578899999999999999999999999999977554
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=352.33 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=204.2
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh-hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE-SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 789999999764332 334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999997543 3999999999999999999999999 9999999999999999999999999998654332
Q ss_pred c-eeeeeeecccccccccccccCCC-CcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 547 T-HLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 547 ~-~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
. .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||......... +. .+...... ..
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-----~~-~~~~~~~~--~~-- 229 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----YS-DWKEKKTY--LN-- 229 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-----HH-HHHTTCTT--ST--
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-----HH-HHhccccc--CC--
Confidence 2 22334579999999999988775 77999999999999999999999765433211 11 11111110 00
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
........+.+|+.+||+.||++|||++|+++.
T Consensus 230 ----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 ----PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 012234567889999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=356.30 Aligned_cols=272 Identities=24% Similarity=0.333 Sum_probs=214.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEE-----cCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEE--eCCcc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGML-----TNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL--ETEVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 461 (700)
.++|++.+.||+|+||.||++++ ..++.||||++........+.+.+|++++++++|+||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 47889999999999999999985 257899999998877777788999999999999999999999987 44567
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++||||+++++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 899999999999999986432 3899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCce--eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhh--------hhHHHHHHHH
Q 005355 542 VMIDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED--------KSLVGYFLEA 611 (700)
Q Consensus 542 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~~ 611 (700)
....... ......+|..|+|||++.+..++.++||||||+++|+|++|..||........ ..........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433322 22334578889999999999999999999999999999999999864322110 0000111111
Q ss_pred HHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCCcc
Q 005355 612 MKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSIM 674 (700)
Q Consensus 612 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~ 674 (700)
.. .......+...+..+.+|+.+||+.||++|||++|+++.|+.+.........
T Consensus 257 ~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 310 (327)
T 3lxl_A 257 LE---------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310 (327)
T ss_dssp HH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred hh---------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence 11 1111122334566789999999999999999999999999999776654443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=351.68 Aligned_cols=271 Identities=28% Similarity=0.406 Sum_probs=212.6
Q ss_pred CCccceEeeeCCeEEEEEEEc-----CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC--CcceE
Q 005355 392 FNTNRILGQGGQGTVYKGMLT-----NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLET--EVPLL 463 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 463 (700)
|++.+.||+|+||+||++.++ +++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 489999999999999998753 57899999987543 45567899999999999999999999999874 56789
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++++|.+++.... +++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999997654 899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCce--eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 544 IDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 544 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
..... ......+|..|+|||++.+..++.++||||||+++|+|++|..||........ ..............+...+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHH
Confidence 43322 22334578889999999999999999999999999999999999864321100 0000000000000111111
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
........+...+..+.+|+.+||+.||++|||++|+++.|+.+.+...
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 1111122234455689999999999999999999999999999987664
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=347.46 Aligned_cols=258 Identities=29% Similarity=0.462 Sum_probs=205.4
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
.++|++.+.||+|+||.||++++. ++.||||++.. ....+.+.+|++++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 467889999999999999999986 78999999864 344578999999999999999999999876 4579999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh---cCCCCeeecCCCCCcEEECCCCc-EEEeecCCCccccc
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS---AASIPIYHRDIKSANILLDDKYR-AKVSDFGASRSVMI 544 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~~~~ivH~Dik~~NILl~~~~~-~kl~DfGl~~~~~~ 544 (700)
++++|.+++........+++..++.++.|+++||+|||+ ++ |+||||||+|||++.++. +||+|||++.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999999876543447899999999999999999999 66 999999999999988876 79999999975432
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......... .......+...
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~~~~~~------ 223 (307)
T 2eva_A 159 H----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-----IMWAVHNGTRP------ 223 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-----HHHHHHTTCCC------
T ss_pred c----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-----HHHHHhcCCCC------
Confidence 1 22345899999999999999999999999999999999999999754432211 11111111111
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCC
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDS 672 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~ 672 (700)
......+..+.+|+.+||+.||++|||++|+++.|+.+.......
T Consensus 224 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 224 ---PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp ---CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred ---CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 111223456889999999999999999999999999998766543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=355.00 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=210.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.++|++.+.||+|+||.||+|... +++.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999976 6889999998876666667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC--CCcEEEeecCCCcccccC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD--KYRAKVSDFGASRSVMID 545 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~--~~~~kl~DfGl~~~~~~~ 545 (700)
+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++......
T Consensus 130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999999997643 24899999999999999999999999 999999999999974 578999999999865433
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
. ......||+.|+|||++.+..++.++||||||+++|||++|..||......+. ...+....+. .+
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-------~~~i~~~~~~--~~--- 270 (387)
T 1kob_A 205 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-------LQNVKRCDWE--FD--- 270 (387)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHHCCCC--CC---
T ss_pred c--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC--CC---
Confidence 2 23345699999999999999999999999999999999999999986543221 1112221111 01
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 271 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 -EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11112345578899999999999999999999873
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=349.32 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=206.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh------hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE------SNIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
.++|++.+.||+|+||.||++... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467899999999999999999986 689999998765322 2367899999999999999999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC----cEEEeecC
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFG 537 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~----~~kl~DfG 537 (700)
++||||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999997543 4999999999999999999999999 99999999999998877 89999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+. ...+.....
T Consensus 164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~~~~~~~ 234 (326)
T 2y0a_A 164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANVSAVNY 234 (326)
T ss_dssp TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHHTCC
T ss_pred CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-------HHHHHhcCC
Confidence 998654322 23345699999999999999999999999999999999999999976543321 111111111
Q ss_pred hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
....... ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 235 --~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 --EFEDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp --CCCHHHH----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CcCcccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111111 123456889999999999999999999987
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=348.94 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=202.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc------
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEV------ 460 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 460 (700)
.++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467899999999999999999987 7899999998753 34456889999999999999999999999876542
Q ss_pred ---------------------------------------------------ceEEEeeCCCCCHHHHHhccCCCCCCCHH
Q 005355 461 ---------------------------------------------------PLLVYEFIPNGTLYQYIHDQTEEFPITWE 489 (700)
Q Consensus 461 ---------------------------------------------------~~lv~E~~~~gsL~~~l~~~~~~~~l~~~ 489 (700)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 68999999999999999887655557888
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc-----------eeeeeeecccc
Q 005355 490 IRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT-----------HLTTRVQGTFG 558 (700)
Q Consensus 490 ~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~-----------~~~~~~~gt~~ 558 (700)
.++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999999 99999999999999999999999999987643321 12233569999
Q ss_pred cccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHH
Q 005355 559 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVA 638 (700)
Q Consensus 559 y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~ 638 (700)
|+|||++.+..++.++||||||+++|||++|..|+. +.. ........... ..........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~----~~~~~~~~~~~---------~~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERV----RIITDVRNLKF---------PLLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHH----HHHHHHHTTCC---------CHHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHH----HHHHHhhccCC---------CcccccCChhHH
Confidence 999999999999999999999999999999876642 110 01111111111 111133445678
Q ss_pred HHHHHHhccCCCCCCCHHHHHH
Q 005355 639 MLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 639 ~li~~cl~~~p~~RPs~~evl~ 660 (700)
+|+.+||+.||++|||++|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 9999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=342.17 Aligned_cols=265 Identities=26% Similarity=0.412 Sum_probs=216.8
Q ss_pred hcCCCccc-eEeeeCCeEEEEEEEc---CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 389 TDNFNTNR-ILGQGGQGTVYKGMLT---NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 389 ~~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
.++|.+.+ .||+|+||.||+|.+. .+..||||+++.. .....+.+.+|++++++++||||+++++++ +.+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45666666 9999999999999864 5788999998764 345678899999999999999999999999 5667899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHhCCc--cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999975432 4999999999999999999999999 9999999999999999999999999998664
Q ss_pred cCCcee--eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 544 IDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 544 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
...... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~i~~~~~--- 231 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFIEQGKR--- 231 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-------HHHHHTTCC---
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHhcCCc---
Confidence 333222 222346889999999998899999999999999999998 9999976554321 122222211
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCCccC
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSIMQ 675 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~~ 675 (700)
...+...+..+.+|+.+||+.+|++||++.++++.|+.+..+.......
T Consensus 232 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 232 ------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280 (287)
T ss_dssp ------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred ------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence 1122344567899999999999999999999999999998776544433
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=344.49 Aligned_cols=263 Identities=27% Similarity=0.470 Sum_probs=202.7
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
++..++|++.++||+|+||.||+|++. ..||||+++.. .....+.+.+|++++++++|+||++++++. .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 445788999999999999999999864 35999987653 345568899999999999999999999965 5567899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 97 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999999976533 4899999999999999999999999 9999999999999999999999999997553
Q ss_pred cC-Cceeeeeeecccccccccccc---cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 544 ID-QTHLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 544 ~~-~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
.. .........||+.|+|||++. +..++.++||||||+++|+|++|+.||......+. .......+....
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~ 245 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVGRGSLSP 245 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HHHHHHHTSCCC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HHHHhcccccCc
Confidence 22 222234456899999999986 56788899999999999999999999976554321 222222222111
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
.. .......+..+.+|+.+||+.+|++|||+.|++++|+++.+
T Consensus 246 ~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 DL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11 11123345678999999999999999999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=352.83 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=208.2
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
..++|++.+.||+|+||.||++.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3578999999999999999999976 6899999998643 345567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC---CcEEEeecCCCcc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGASRS 541 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~---~~~kl~DfGl~~~ 541 (700)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999997643 3899999999999999999999999 9999999999999765 4599999999986
Q ss_pred cccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
.... .......||+.|+|||++.+..++.++||||||+++|+|++|..||......+ ....+..+....
T Consensus 181 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------~~~~i~~~~~~~-- 249 (362)
T 2bdw_A 181 VNDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAYDY-- 249 (362)
T ss_dssp CTTC--CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC--
T ss_pred ecCC--cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCCC--
Confidence 5422 22334569999999999999999999999999999999999999997654322 122222222110
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
. .......+..+.+|+.+||+.||++||++.|+++.
T Consensus 250 ~----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 P----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp C----TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred C----cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00012234578899999999999999999998763
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=360.00 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=207.7
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
..++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3578999999999999999999975 68999999876533 34567789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC---CCCcEEEeecCCCcc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGASRS 541 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~---~~~~~kl~DfGl~~~ 541 (700)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 89 ~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999999998754 3999999999999999999999999 99999999999998 567899999999976
Q ss_pred cccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||......+ ....+..+.... .
T Consensus 163 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~-~ 233 (444)
T 3soa_A 163 VEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-------LYQQIKAGAYDF-P 233 (444)
T ss_dssp CCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCCC-C
T ss_pred ecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHhCCCCC-C
Confidence 54332 22344569999999999999999999999999999999999999997654332 122222222110 0
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 234 -----~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 234 -----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0111233457889999999999999999999987
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=345.84 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=198.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh--------------------------hhHHHHHHHHHHHh
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE--------------------------SNIEQFINEVAILS 441 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 441 (700)
.++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 578999999999999999999975 688999998764321 12356899999999
Q ss_pred hcCCCceeeEEeEEEe--CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 005355 442 QINHRNVVKLLGCCLE--TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIK 519 (700)
Q Consensus 442 ~l~h~niv~l~~~~~~--~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik 519 (700)
+++||||+++++++.+ .+..++||||+++++|.+++... .+++..++.++.||+.||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999998875432 4999999999999999999999999 9999999
Q ss_pred CCcEEECCCCcEEEeecCCCcccccCCceeeeeeecccccccccccccCC---CCcccceehHHHHHHHHHhCCCCCCCC
Q 005355 520 SANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ---FTEKSDVYSFGVVLVELLTGQKPIRST 596 (700)
Q Consensus 520 ~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlG~il~elltg~~p~~~~ 596 (700)
|+|||++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999998654332 2234456999999999998765 378899999999999999999999755
Q ss_pred CchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 597 DSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.... ....+....... ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~-------~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RIMC-------LHSKIKSQALEF--------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SHHH-------HHHHHHHCCCCC--------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cHHH-------HHHHHhcccCCC--------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 4321 111121111110 011223456889999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=345.59 Aligned_cols=245 Identities=27% Similarity=0.366 Sum_probs=206.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|++.+.||+|+||.||+++.. +++.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999976 68999999986422 23457788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999998654 3899999999999999999999999 99999999999999999999999999976432
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
......||+.|+|||++.+..++.++||||||+++|||++|..||......+. ...+.....
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~~------- 220 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------YEKILNAEL------- 220 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHCCC-------
T ss_pred ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC-------
Confidence 22345699999999999999999999999999999999999999976543221 111111111
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRP-----TMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~ 660 (700)
..+...+..+.+|+.+||+.||++|| +++|+++
T Consensus 221 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11223345788999999999999999 8888885
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=353.03 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=206.6
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCC
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQI-NHRNVVKLLGCCLETE 459 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 459 (700)
.....++|++.+.||+|+||.||+|+++ +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 3456789999999999999999999986 68899999986532 23456788999999886 9999999999999999
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999998654 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
+...... .......||+.|+|||++.+..++.++||||||+++|||++|..||......+ ....+..+..
T Consensus 166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~-- 235 (345)
T 1xjd_A 166 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNP-- 235 (345)
T ss_dssp BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC--
T ss_pred hhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHhCCC--
Confidence 7543222 22345679999999999999999999999999999999999999997654332 1112221111
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHH-HHH
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMK-EAA 659 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-evl 659 (700)
..+...+..+.+|+.+||+.||++||++. |++
T Consensus 236 --------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 --------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11222345788999999999999999997 665
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.33 Aligned_cols=271 Identities=24% Similarity=0.367 Sum_probs=209.7
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhc--CCCceeeEEeEEEeC--
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQI--NHRNVVKLLGCCLET-- 458 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~-- 458 (700)
.......++|++.+.||+|+||.||+|++. ++.||||++... ....+..|.+++..+ +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 334555689999999999999999999986 899999998643 234556667776654 899999999999887
Q ss_pred --CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCCeeecCCCCCcEEECCC
Q 005355 459 --EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA--------ASIPIYHRDIKSANILLDDK 528 (700)
Q Consensus 459 --~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~~~~ivH~Dik~~NILl~~~ 528 (700)
...++||||+++|+|.+++.... +++..++.++.|++.||+|||++ + |+||||||+|||++.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKN 178 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTT
T ss_pred CCCceEEEEeccCCCcHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCC
Confidence 67899999999999999997653 99999999999999999999998 7 9999999999999999
Q ss_pred CcEEEeecCCCcccccCCcee---eeeeecccccccccccccCCCCcc------cceehHHHHHHHHHhC----------
Q 005355 529 YRAKVSDFGASRSVMIDQTHL---TTRVQGTFGYLDPEYFRSSQFTEK------SDVYSFGVVLVELLTG---------- 589 (700)
Q Consensus 529 ~~~kl~DfGl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~k------sDVwSlG~il~elltg---------- 589 (700)
+.+||+|||++.......... .....||+.|+|||++.+...+.+ +||||||+++|||++|
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 999999999997654332221 123469999999999988776665 9999999999999999
Q ss_pred CCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 590 QKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 590 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
..||......... .................... ......+..+.+|+.+||+.||.+|||+.|+++.|+++..+.
T Consensus 259 ~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 259 QLPYHDLVPSDPS--YEDMREIVCIKKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CCTTTTTSCSSCC--HHHHHHHHTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred cccHhhhcCCCCc--hhhhHHHHhhhccCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 6666544322211 11111122111111111111 112356778999999999999999999999999999988754
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=353.62 Aligned_cols=267 Identities=24% Similarity=0.397 Sum_probs=217.7
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEcC------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCceeeEEeEE
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTN------GRIVAIKKSKLV-DESNIEQFINEVAILSQI-NHRNVVKLLGCC 455 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 455 (700)
+++...++|++.+.||+|+||.||+|.+.. ...||+|.+... .....+.+.+|+.+++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 456667899999999999999999999752 247999998754 344567899999999999 899999999999
Q ss_pred EeCCcceEEEeeCCCCCHHHHHhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 005355 456 LETEVPLLVYEFIPNGTLYQYIHDQTE-----------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANIL 524 (700)
Q Consensus 456 ~~~~~~~lv~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NIL 524 (700)
.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 999999999999999999999975421 234899999999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhh
Q 005355 525 LDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDK 602 (700)
Q Consensus 525 l~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~ 602 (700)
++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||........
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~- 275 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK- 275 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence 999999999999999865433322 2334557889999999999999999999999999999998 9999976543321
Q ss_pred hHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 603 SLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
+......+. ....+...+..+.+|+.+||+.||.+|||+.|+++.|+.+...
T Consensus 276 -----~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 276 -----FYKLVKDGY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp -----HHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHhcCC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 111111111 0111222345788999999999999999999999999987654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=355.33 Aligned_cols=267 Identities=18% Similarity=0.255 Sum_probs=208.7
Q ss_pred hcCCCccceEeee--CCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 389 TDNFNTNRILGQG--GQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 389 ~~~~~~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
.++|++.++||+| +||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 5789999999999 99999999987 6899999997643 34556788899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 9999999999999987532 23999999999999999999999999 9999999999999999999999999886543
Q ss_pred cCCce------eeeeeeccccccccccccc--CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc
Q 005355 544 IDQTH------LTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN 615 (700)
Q Consensus 544 ~~~~~------~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 615 (700)
..... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+... .... +
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~-----~ 252 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKLN-----G 252 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC--------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHhc-----C
Confidence 22111 1122368899999999987 679999999999999999999999997655433210 0000 0
Q ss_pred chhhhcch------------------------------------hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 005355 616 RLFEVLDA------------------------------------RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAA 659 (700)
Q Consensus 616 ~~~~~~d~------------------------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl 659 (700)
....+++. .............+.+|+.+||+.||++|||++|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 00000000 000011233456789999999999999999999998
Q ss_pred HH--HHhch
Q 005355 660 FE--LGGIR 666 (700)
Q Consensus 660 ~~--L~~l~ 666 (700)
+. |+++.
T Consensus 333 ~hp~f~~~~ 341 (389)
T 3gni_B 333 NHSFFKQIK 341 (389)
T ss_dssp TSGGGGGC-
T ss_pred cCHHHHHHh
Confidence 64 55544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=362.23 Aligned_cols=262 Identities=23% Similarity=0.287 Sum_probs=211.3
Q ss_pred chHHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEE
Q 005355 381 TSMELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCL 456 (700)
Q Consensus 381 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 456 (700)
...+++...++|++.++||+|+||+||+++.+ +++.||||++.... ....+.+.+|..++..++|+||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 44556667899999999999999999999986 68999999986422 223455889999999999999999999999
Q ss_pred eCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeec
Q 005355 457 ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 536 (700)
Q Consensus 457 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~Df 536 (700)
+.+..++||||+++|+|.+++.+... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999987532 3999999999999999999999999 999999999999999999999999
Q ss_pred CCCcccccCCceeeeeeecccccccccccc-------cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 005355 537 GASRSVMIDQTHLTTRVQGTFGYLDPEYFR-------SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL 609 (700)
Q Consensus 537 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 609 (700)
|+++..............||+.|+|||++. ...++.++||||||+++|||++|+.||......+.. .
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~ 280 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY------G 280 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------H
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH------H
Confidence 999876544443344567999999999987 457899999999999999999999999865543211 1
Q ss_pred HHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCC---CCHHHHHH
Q 005355 610 EAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKR---PTMKEAAF 660 (700)
Q Consensus 610 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Ps~~evl~ 660 (700)
....... ....+ ......+.++.+|+.+||. +|.+| |+++|+++
T Consensus 281 ~i~~~~~--~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 281 KIVHYKE--HLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHTHHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHhccc--CcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1111000 00000 0112345678899999999 99998 58999876
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=347.91 Aligned_cols=273 Identities=27% Similarity=0.422 Sum_probs=221.5
Q ss_pred cchHHHHHHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCceeeE
Q 005355 380 FTSMELEMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLV-DESNIEQFINEVAILSQI-NHRNVVKL 451 (700)
Q Consensus 380 ~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l 451 (700)
+...+++...++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 445566777899999999999999999999852 4678999998753 334567899999999999 79999999
Q ss_pred EeEEEeCC-cceEEEeeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 005355 452 LGCCLETE-VPLLVYEFIPNGTLYQYIHDQTE-------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRD 517 (700)
Q Consensus 452 ~~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~D 517 (700)
++++...+ ..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99988765 48999999999999999987543 123789999999999999999999999 99999
Q ss_pred CCCCcEEECCCCcEEEeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCC
Q 005355 518 IKSANILLDDKYRAKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRS 595 (700)
Q Consensus 518 ik~~NILl~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~ 595 (700)
|||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986543332 22334568899999999999999999999999999999998 9999976
Q ss_pred CCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 596 TDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
....+. +...+..+.. ...+...+..+.+++.+||+.||.+|||+.|+++.|+.+.....
T Consensus 254 ~~~~~~------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 254 VKIDEE------FCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CCCSHH------HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cchhHH------HHHHhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 554321 1122222111 11122234578899999999999999999999999999876543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=348.75 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=203.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 463 (700)
.++|++.+.||+|+||.||+++++ +++.||||++... .....+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 467899999999999999999986 5889999987643 344567788999999987 89999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999998654 3999999999999999999999999 9999999999999999999999999997543
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhh--hHHHHHHHHHHhcchhhhc
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDK--SLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 621 (700)
.. ........||+.|+|||++.+..++.++||||||+++|||++|+.||......... .........+.....
T Consensus 162 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 162 RP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp CT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CC-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 22 22334567999999999999999999999999999999999999999754322111 111112222222211
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTM 655 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~ 655 (700)
..+...+..+.+|+.+||+.||++||++
T Consensus 237 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1122345578899999999999999995
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=342.56 Aligned_cols=262 Identities=22% Similarity=0.332 Sum_probs=202.0
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
++|++.+.||+|+||+||+|.+. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999986 6899999987643 33445788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++ +|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9975 66666655332 3999999999999999999999999 9999999999999999999999999998653222
Q ss_pred ceeeeeeecccccccccccccCC-CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc---chhhhcc
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN---RLFEVLD 622 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d 622 (700)
.......+|+.|+|||++.+.. ++.++||||||+++|||++|..||....... ............. .+.....
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGG
T ss_pred -ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhcc
Confidence 2233456899999999998765 8999999999999999999888864333221 1111111111100 0000000
Q ss_pred ------------hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 623 ------------ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 623 ------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..............+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000111234567889999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=341.40 Aligned_cols=255 Identities=33% Similarity=0.574 Sum_probs=205.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhh-------HHHHHHHHHHHhhcCCCceeeEEeEEEeCCc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESN-------IEQFINEVAILSQINHRNVVKLLGCCLETEV 460 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 460 (700)
.++|++.+.||+|+||.||+|++. +++.||||++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 578999999999999999999985 78999999976533211 167899999999999999999999986544
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc-----EEEee
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR-----AKVSD 535 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~-----~kl~D 535 (700)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+++ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999999976543 4999999999999999999999987 34999999999999988776 99999
Q ss_pred cCCCcccccCCceeeeeeeccccccccccc--ccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHH
Q 005355 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYF--RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK 613 (700)
Q Consensus 536 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 613 (700)
||+++.... ......+|+.|+|||++ ....++.++||||||+++|||++|+.||......... ......
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-----FINMIR 243 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-----HHHHHH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-----HHHHHh
Confidence 999974322 23445689999999998 4456789999999999999999999999765543321 111111
Q ss_pred hcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 614 ENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 614 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
..... ...+...+..+.+|+.+||+.||++|||++|+++.|++|
T Consensus 244 ~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEGLR--------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSCCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCCC--------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11111 112233456789999999999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=340.05 Aligned_cols=269 Identities=19% Similarity=0.233 Sum_probs=210.5
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEE-EeCCcceEEE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCC-LETEVPLLVY 465 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 465 (700)
..++|++.+.||+|+||.||+|++. +++.||||+...... .+.+.+|++++++++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 3578999999999999999999974 788999998654322 24588899999999887766665554 6677889999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---CCCCcEEEeecCCCccc
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGASRSV 542 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl---~~~~~~kl~DfGl~~~~ 542 (700)
||+ +++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999999985433 3999999999999999999999999 9999999999999 78899999999999866
Q ss_pred ccCCc------eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcc
Q 005355 543 MIDQT------HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR 616 (700)
Q Consensus 543 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 616 (700)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 44322 122345689999999999999999999999999999999999999987654443333322221111111
Q ss_pred hhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCCc
Q 005355 617 LFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSI 673 (700)
Q Consensus 617 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~ 673 (700)
. .......+..+.+|+.+||+.+|++|||++++++.|+++........
T Consensus 239 ~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 239 I---------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp H---------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred h---------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 0 01111234578999999999999999999999999999988766443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=345.02 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=208.8
Q ss_pred hcCCCccceEeeeCCeEEEEEEE-----cCCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC--Cc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGML-----TNGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLET--EV 460 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 460 (700)
.++|++.+.||+|+||.||++++ .+++.||||++... .....+.+.+|++++++++||||+++++++.+. +.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 45689999999999999999984 25889999998743 334467899999999999999999999999876 66
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.++||||+++++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 7899999999999999966543 3899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCce--eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCch--------hhhhHHHHHHH
Q 005355 541 SVMIDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSE--------EDKSLVGYFLE 610 (700)
Q Consensus 541 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~--------~~~~~~~~~~~ 610 (700)
........ ......+|..|+|||++.+..++.++||||||+++|+|++|..|+...... ...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 66443322 223345788899999999999999999999999999999999886422110 00011111111
Q ss_pred HHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 611 AMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 611 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
....+. ....+...+..+.+|+.+||+.||.+|||+.|+++.|+.+.
T Consensus 255 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111 11123344567899999999999999999999999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=354.05 Aligned_cols=268 Identities=28% Similarity=0.453 Sum_probs=215.1
Q ss_pred HhcCCCccceEeeeCCeEEEEEEE-----cCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC--c
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGML-----TNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETE--V 460 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~ 460 (700)
..++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 356789999999999999999984 258899999998777777789999999999999999999999987654 7
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.++||||+++++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 7999999999999999987543 3899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCcee--eeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchh---------hhhHHHHHH
Q 005355 541 SVMIDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE---------DKSLVGYFL 609 (700)
Q Consensus 541 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~---------~~~~~~~~~ 609 (700)
......... .....++..|+|||++.+..++.++||||||+++|||++|..||....... .........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 764433221 223446778999999999899999999999999999999999875321100 000011111
Q ss_pred HHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 610 EAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 610 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
.....+. ....+...+..+.+|+.+||+.||++|||+.|+++.|++++..+
T Consensus 274 ~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 274 ELLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHhhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111 11122344567899999999999999999999999999998765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=344.48 Aligned_cols=254 Identities=24% Similarity=0.418 Sum_probs=206.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcC-C-------cEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTN-G-------RIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEV 460 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 460 (700)
.++|++.+.||+|+||.||+|.+.. + ..||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 5688999999999999999999652 3 4799999887767777899999999999999999999999999999
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc--------EE
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR--------AK 532 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~--------~k 532 (700)
.++||||+++++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999987532 3899999999999999999999999 999999999999998877 99
Q ss_pred EeecCCCcccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCC-CCCCCCCchhhhhHHHHHHH
Q 005355 533 VSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQ-KPIRSTDSEEDKSLVGYFLE 610 (700)
Q Consensus 533 l~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~-~p~~~~~~~~~~~~~~~~~~ 610 (700)
|+|||++...... ....+++.|+|||++.+ ..++.++||||||+++|||++|. +||........ ..
T Consensus 162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-------~~ 229 (289)
T 4fvq_A 162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-------LQ 229 (289)
T ss_dssp ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-------HH
T ss_pred eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-------HH
Confidence 9999998654221 23458899999999987 77999999999999999999955 45443322211 11
Q ss_pred HHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 611 AMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 611 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
...... ..+...+..+.+|+.+||+.||++|||++|+++.|+++.....
T Consensus 230 ~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 230 FYEDRH-----------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp HHHTTC-----------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred HhhccC-----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 111100 0111123457889999999999999999999999999876443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=355.09 Aligned_cols=271 Identities=22% Similarity=0.330 Sum_probs=200.4
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEe----
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQIN-HRNVVKLLGCCLE---- 457 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~---- 457 (700)
.++....+|++.++||+|+||.||++++. +++.||||++........+.+.+|+.+++++. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 34455678999999999999999999975 68999999987777777788999999999996 9999999999953
Q ss_pred ----CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEE
Q 005355 458 ----TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKV 533 (700)
Q Consensus 458 ----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl 533 (700)
....++|+||+. |+|.+++........+++..++.++.||+.||+|||+++ ++|+||||||+||||+.++.+||
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEB
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEE
Confidence 334689999995 799999977544456999999999999999999999986 34999999999999999999999
Q ss_pred eecCCCcccccCCcee-----------eeeeeccccccccccc---ccCCCCcccceehHHHHHHHHHhCCCCCCCCCch
Q 005355 534 SDFGASRSVMIDQTHL-----------TTRVQGTFGYLDPEYF---RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSE 599 (700)
Q Consensus 534 ~DfGl~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~ 599 (700)
+|||++.......... .....+|+.|+|||++ .+..++.++||||||+++|+|++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9999998654322211 1134589999999998 5677899999999999999999999999643321
Q ss_pred hhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCCccC
Q 005355 600 EDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSIMQ 675 (700)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~~ 675 (700)
.. .. +.. ...........+.+|+.+||+.||.+|||+.|+++.|+.+..........
T Consensus 260 ~~----------~~-~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 260 RI----------VN-GKY--------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp -----------------C--------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred Hh----------hc-Ccc--------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence 10 00 000 00111112234778999999999999999999999999998765544433
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=347.39 Aligned_cols=261 Identities=26% Similarity=0.417 Sum_probs=207.7
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcC-----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTN-----GRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
..++|++.+.||+|+||.||+|.+.. +..||||+++.. .......+.+|+.++++++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 35678888999999999999998653 246999998753 344567899999999999999999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++||||+++++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999986533 3899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCce--eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 542 VMIDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 542 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
....... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+ ....+..+..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~~- 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFR- 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCC-
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHCCCc-
Confidence 5433221 1222345778999999999999999999999999999999 999997654322 1122222111
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
...+...+..+.+|+.+||+.+|++||++.++++.|+++....
T Consensus 269 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 269 --------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp --------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred --------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0112234567889999999999999999999999999887543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=349.09 Aligned_cols=245 Identities=23% Similarity=0.295 Sum_probs=207.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467999999999999999999986 68999999976422 23457789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++|+|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999987543 899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
. .....||+.|+|||++.+..++.++||||||+++|||++|..||......+ ....+..+..
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~~~i~~~~~------- 255 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKV------- 255 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-------
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-------HHHHHHcCCC-------
Confidence 2 234569999999999999999999999999999999999999997654322 1122222221
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPT-----MKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~ 660 (700)
..+...+..+.+|+.+||+.||.+||+ ++|+++
T Consensus 256 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 112234557889999999999999998 788775
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=354.61 Aligned_cols=272 Identities=17% Similarity=0.219 Sum_probs=209.8
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcC------CcEEEEEEccccChhh-----------HHHHHHHHHHHhhcCCCcee
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTN------GRIVAIKKSKLVDESN-----------IEQFINEVAILSQINHRNVV 449 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv 449 (700)
...++|++.++||+|+||.||+|.+.. ++.||||++....... ...+..|+..++.++|+||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 346789999999999999999999864 4789999976544221 12234566677778899999
Q ss_pred eEEeEEEeC----CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005355 450 KLLGCCLET----EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL 525 (700)
Q Consensus 450 ~l~~~~~~~----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl 525 (700)
++++++... ...+|||||+ +++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+||||
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill 185 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL 185 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence 999998765 4579999999 9999999987532 4999999999999999999999999 9999999999999
Q ss_pred C--CCCcEEEeecCCCcccccCCcee------eeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCC
Q 005355 526 D--DKYRAKVSDFGASRSVMIDQTHL------TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 597 (700)
Q Consensus 526 ~--~~~~~kl~DfGl~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~ 597 (700)
+ .++.+||+|||+++......... .....||+.|+|||++.+..++.++||||||++||||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8 88999999999997654332211 133459999999999999999999999999999999999999997533
Q ss_pred chhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 598 SEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
.... ........ ....+..+++..+. ....+..+.+|+.+||+.+|++||++.+|++.|+++.....
T Consensus 266 ~~~~--~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 266 KDPK--YVRDSKIR-YRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp TCHH--HHHHHHHH-HHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCHH--HHHHHHHH-hhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 2221 11111111 11122233332221 12235678899999999999999999999999999877654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=353.88 Aligned_cols=273 Identities=25% Similarity=0.276 Sum_probs=211.6
Q ss_pred cccchHHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-----CCceeeE
Q 005355 378 KLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQIN-----HRNVVKL 451 (700)
Q Consensus 378 ~~~~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l 451 (700)
..++..+.....++|++.++||+|+||.||+|++. +++.||||++... ....+.+..|+++++.++ |+||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34555556667899999999999999999999985 6889999998743 344567888999999986 9999999
Q ss_pred EeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC----
Q 005355 452 LGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD---- 527 (700)
Q Consensus 452 ~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~---- 527 (700)
++++...+..++||||+ +++|.+++...... .+++..++.++.||+.||+|||+++ |+||||||+||||+.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 99999999999999999 99999999876432 3899999999999999999999999 999999999999975
Q ss_pred ---------------------CCcEEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHH
Q 005355 528 ---------------------KYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVEL 586 (700)
Q Consensus 528 ---------------------~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~el 586 (700)
++.+||+|||++..... ......||+.|+|||++.+..++.++||||||+++|+|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 78999999999975432 22345689999999999999999999999999999999
Q ss_pred HhCCCCCCCCCchhhhhHHHHHHHHHHhc--------chhhhcchhh------------------hh---ccCHHHHHHH
Q 005355 587 LTGQKPIRSTDSEEDKSLVGYFLEAMKEN--------RLFEVLDARV------------------LK---EAKEEEIITV 637 (700)
Q Consensus 587 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~d~~~------------------~~---~~~~~~~~~l 637 (700)
++|+.||......+............... .....++... .. .........+
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 99999998765433221111110000000 0000000000 00 0000112567
Q ss_pred HHHHHHHhccCCCCCCCHHHHHH
Q 005355 638 AMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 638 ~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.+|+.+||+.||++|||++|+++
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhcCChhhCCCHHHHhc
Confidence 89999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.88 Aligned_cols=263 Identities=22% Similarity=0.268 Sum_probs=203.6
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
..++|++.+.||+|+||.||++.+. +++.||||++... +....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3588999999999999999999976 6889999998753 23345789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
|+||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999998654 3899999999999999999999999 9999999999999999999999999997654
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
...........+++.|+|||++.+..++.++||||||+++|||++|+.||...... .....+..... .
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~----~- 253 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIP----R- 253 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCC----C-
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCC----C-
Confidence 43333334556899999999999999999999999999999999999999754322 11111111110 0
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhchhhcC
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRP-TMKEAAFELGGIRASIG 670 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~l~~~~~ 670 (700)
....+...+..+.+|+.+||+.||++|| +++++++.|++......
T Consensus 254 --~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 254 --PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp --GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred --ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0112233445788999999999999999 99999999988765543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=345.65 Aligned_cols=264 Identities=25% Similarity=0.388 Sum_probs=192.8
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999975 68999999886543 2334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 467 FIPNGTLYQYIHDQT---EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
|++ ++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999987542 1234899999999999999999999999 9999999999999999999999999998653
Q ss_pred cCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh---cchhh
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE---NRLFE 619 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 619 (700)
.... ......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||......+... .+...... ..+..
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK---LIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCTTTCGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCChhHhhh
Confidence 3222 2234468999999999976 468999999999999999999999998765433211 11111110 00000
Q ss_pred h-----------------cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 620 V-----------------LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 620 ~-----------------~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. +...+...........+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0000011111123457899999999999999999999886
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=345.13 Aligned_cols=262 Identities=26% Similarity=0.388 Sum_probs=212.0
Q ss_pred HHHhcCCCccc-eEeeeCCeEEEEEEEc---CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC
Q 005355 386 EMATDNFNTNR-ILGQGGQGTVYKGMLT---NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETE 459 (700)
Q Consensus 386 ~~~~~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 459 (700)
....++|++.+ .||+|+||.||+|.+. .++.||||++.... ....+.+.+|++++++++||||+++++++ +.+
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 33457788887 9999999999999653 46789999987532 33467899999999999999999999999 667
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
..++||||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CcEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 7899999999999999998754 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCcee--eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcc
Q 005355 540 RSVMIDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENR 616 (700)
Q Consensus 540 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 616 (700)
.......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+ ....+..+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~ 237 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGE 237 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTC
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC
Confidence 8664433322 222346788999999998889999999999999999999 999998655432 112222221
Q ss_pred hhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 617 LFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 617 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
. ...+...+..+.+++.+||+.||++||++.++++.|+++-....
T Consensus 238 ~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 238 R---------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp C---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred C---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1 11223345678999999999999999999999999999876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=353.30 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=206.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 478999999999999999999976 5889999987642 233457889999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.....
T Consensus 94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999998653 3999999999999999999999999 99999999999999999999999999986532
Q ss_pred CCceeeeeeeccccccccccccc---CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
. .......||+.|+|||++.. ..++.++||||||+++|||++|..||............ ..+....
T Consensus 168 ~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~----~~~~~~~----- 236 (384)
T 4fr4_A 168 E--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV----HTFETTV----- 236 (384)
T ss_dssp T--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH----HHHHHCC-----
T ss_pred C--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH----HHHhhcc-----
Confidence 2 23445679999999999974 45899999999999999999999999765433322111 1111111
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCC-HHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT-MKEAAF 660 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~evl~ 660 (700)
...+...+..+.+|+.+||+.||.+||+ ++++++
T Consensus 237 -----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 -----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1122334567889999999999999998 777664
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=346.93 Aligned_cols=265 Identities=25% Similarity=0.415 Sum_probs=212.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcE--EEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRI--VAIKKSKLV-DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 463 (700)
.++|++.+.||+|+||.||+|++. ++.. ||||++... .....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 478999999999999999999975 4554 499987643 334556789999999999 89999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc
Q 005355 464 VYEFIPNGTLYQYIHDQT-------------EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR 530 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~ 530 (700)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 999999999999998653 1235999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHH
Q 005355 531 AKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFL 609 (700)
Q Consensus 531 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~ 609 (700)
+||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||++ |..||......+ ..
T Consensus 181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~ 251 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY 251 (327)
T ss_dssp EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HH
T ss_pred EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HH
Confidence 999999998743211 11233446889999999998899999999999999999998 999997654332 11
Q ss_pred HHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCCcc
Q 005355 610 EAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSIM 674 (700)
Q Consensus 610 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~ 674 (700)
..+..+. ....+...+..+.+|+.+||+.+|.+|||+.|+++.|+++.........
T Consensus 252 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 307 (327)
T 1fvr_A 252 EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 307 (327)
T ss_dssp HHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBC
T ss_pred HHhhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCccc
Confidence 1222111 1112223456788999999999999999999999999998876654443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=352.16 Aligned_cols=254 Identities=23% Similarity=0.340 Sum_probs=205.8
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-----DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
.++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999976 6899999987532 1224578999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc---EEEeecCC
Q 005355 463 LVYEFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGA 538 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~---~kl~DfGl 538 (700)
+||||+++++|.+++.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998886542 2335899999999999999999999999 999999999999986654 99999999
Q ss_pred CcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 539 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
+....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... . ....+..+...
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~----~~~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----R----LFEGIIKGKYK 250 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----H----HHHHHHHTCCC
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----H----HHHHHHcCCCC
Confidence 98654322 223345699999999999999999999999999999999999999975321 1 11122211110
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+... ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 251 --~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 --MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111 123457889999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=336.43 Aligned_cols=266 Identities=19% Similarity=0.232 Sum_probs=212.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEE-cCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEE-EeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGML-TNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCC-LETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~E 466 (700)
.++|++.+.||+|+||.||+|++ .+++.||||++..... .+.+.+|+.+++.++|++++..+..+ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 57899999999999999999997 4789999998765332 24688999999999988766555554 66777899999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---CCCCcEEEeecCCCcccc
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl---~~~~~~kl~DfGl~~~~~ 543 (700)
|+ +++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999999985433 3999999999999999999999999 9999999999999 488899999999998664
Q ss_pred cCCce------eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 544 IDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 544 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-
Confidence 43321 12345699999999999999999999999999999999999999987554333322222221111100
Q ss_pred hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCC
Q 005355 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGD 671 (700)
Q Consensus 618 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~ 671 (700)
.+ ......+..+.+|+.+||+.||++|||++++++.|+++......
T Consensus 239 ----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 239 ----IE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp ----HH----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ----hH----HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 00 11122345788999999999999999999999999998876654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=339.04 Aligned_cols=262 Identities=26% Similarity=0.409 Sum_probs=209.4
Q ss_pred CCCccceEeeeCCeEEEEEEEcC-C---cEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc-eEE
Q 005355 391 NFNTNRILGQGGQGTVYKGMLTN-G---RIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP-LLV 464 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 464 (700)
.|+..++||+|+||.||+|.+.+ + ..||+|++... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999998642 2 37999988753 345568899999999999999999999999876655 999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
+||+.+++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999987433 4899999999999999999999999 99999999999999999999999999976533
Q ss_pred CCc---eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCC-CCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 545 DQT---HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP-IRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 545 ~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
... .......+++.|+|||.+.+..++.++||||||+++|+|++|..| |......+ ....+.....
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-------~~~~~~~~~~--- 246 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-------LTHFLAQGRR--- 246 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-------HHHHHHTTCC---
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-------HHHHhhcCCC---
Confidence 221 122334578899999999999999999999999999999995555 44333222 1111111111
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCCc
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSI 673 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~ 673 (700)
...+...+..+.+|+.+||+.+|.+|||++++++.|+++...+....
T Consensus 247 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 247 ------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred ------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 11122334578899999999999999999999999999987765443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=373.87 Aligned_cols=263 Identities=26% Similarity=0.405 Sum_probs=211.2
Q ss_pred hcCCCccc-eEeeeCCeEEEEEEEc---CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 389 TDNFNTNR-ILGQGGQGTVYKGMLT---NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 389 ~~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
.+++.+.+ .||+|+||.||+|.+. ++..||||+++.. .....+.|.+|+++|++++||||+++++++.. +..++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 44555555 7999999999999875 4567999998764 33456889999999999999999999999876 56899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 413 v~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999999999999997653 34999999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCcee--eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 544 IDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 544 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
...... .....+++.|+|||++.+..++.++||||||++||||++ |+.||......+ ....+..+..
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~--- 557 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKR--- 557 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCC---
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCC---
Confidence 332222 122335689999999999999999999999999999998 999998765443 1222222221
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCCc
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSI 673 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~ 673 (700)
...+...+..+.+|+.+||+.+|++||++.+|++.|+.+........
T Consensus 558 ------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 558 ------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp ------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred ------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 11223455678999999999999999999999999999887765444
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=350.32 Aligned_cols=246 Identities=23% Similarity=0.305 Sum_probs=203.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 478999999999999999999974 78999999876421 22245789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+ +|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 789999987654 3999999999999999999999999 99999999999999999999999999976533
Q ss_pred CCceeeeeeecccccccccccccCCC-CcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
. .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||......+.. ..+..
T Consensus 161 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~ 222 (336)
T 3h4j_B 161 G--NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNS 222 (336)
T ss_dssp S--BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCS
T ss_pred C--cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHc
Confidence 2 22344569999999999988776 68999999999999999999999765432210 00000
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. ....+...+..+.+|+.+||+.||.+|||++|+++
T Consensus 223 ~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 223 C-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp S-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred C-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0 01112234557889999999999999999999987
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=347.85 Aligned_cols=250 Identities=24% Similarity=0.319 Sum_probs=182.4
Q ss_pred cceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcceEEEeeCCCCC
Q 005355 395 NRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGT 472 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gs 472 (700)
.+.||+|+||.||++.+. +++.||||++.. .....+.+|+.+++.+. ||||+++++++.+....++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999986 689999999864 33467889999999997 9999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC---cEEEeecCCCcccccCCcee
Q 005355 473 LYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY---RAKVSDFGASRSVMIDQTHL 549 (700)
Q Consensus 473 L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~---~~kl~DfGl~~~~~~~~~~~ 549 (700)
|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..... ...
T Consensus 93 L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~ 165 (325)
T 3kn6_A 93 LFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQP 165 (325)
T ss_dssp HHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CCc
Confidence 999998754 3999999999999999999999999 99999999999997665 8999999999755332 222
Q ss_pred eeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhcc
Q 005355 550 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEA 629 (700)
Q Consensus 550 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 629 (700)
.....+|+.|+|||++.+..++.++||||||+++|+|++|..||..................+..+.... . .+.
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~--~----~~~ 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF--E----GEA 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC--C----SHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC--C----ccc
Confidence 3445689999999999999999999999999999999999999986543322111222223333222210 0 011
Q ss_pred CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 630 KEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 630 ~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
....+..+.+|+.+||+.||.+|||++|+++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 1224567889999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=348.11 Aligned_cols=258 Identities=24% Similarity=0.474 Sum_probs=204.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCc----EEEEEEccc-cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGR----IVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
.++|++.++||+|+||.||+|.+. +++ +||+|.+.. ......+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 578999999999999999999975 344 467787654 33445688999999999999999999999998765 78
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+|+|++.+|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999987543 3899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 543 MIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 543 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+. ...+..+..
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~~~~~~~--- 237 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGER--- 237 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTCC---
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCCC---
Confidence 433222 2223446788999999999999999999999999999999 9999987655432 111221111
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
...+...+..+.+|+.+||+.||.+||++.|+++.|+.+...
T Consensus 238 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 238 ------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 111223445688999999999999999999999999998753
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=346.67 Aligned_cols=269 Identities=25% Similarity=0.422 Sum_probs=207.1
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEc----CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEE
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLT----NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCL 456 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 456 (700)
.++....++|.+.+.||+|+||.||+|.+. .++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 344556788999999999999999999865 2458999998753 3455678999999999999999999999998
Q ss_pred eCCc-----ceEEEeeCCCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC
Q 005355 457 ETEV-----PLLVYEFIPNGTLYQYIHDQT---EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK 528 (700)
Q Consensus 457 ~~~~-----~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~ 528 (700)
+.+. .++||||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 7653 489999999999999995432 2345999999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHH
Q 005355 529 YRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVG 606 (700)
Q Consensus 529 ~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~ 606 (700)
+.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----- 258 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM----- 258 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-----
Confidence 99999999999865433221 2233457889999999999999999999999999999999 8999976654431
Q ss_pred HHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 607 YFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 607 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
...+..+.. ...+...+..+.+|+.+||+.+|.+|||++++++.|+++...+.
T Consensus 259 --~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 259 --YDYLLHGHR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp --HHHHHTTCC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred --HHHHHcCCC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 111111111 11122344578899999999999999999999999999987664
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.75 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=197.4
Q ss_pred HhcCCCccceEeeeCCeEEEEEEE----cCCcEEEEEEccccC----hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGML----TNGRIVAIKKSKLVD----ESNIEQFINEVAILSQINHRNVVKLLGCCLETE 459 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 459 (700)
..++|++.+.||+|+||.||+++. .+++.||||+++... ......+.+|+.++++++||||+++++++.+.+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 357899999999999999999997 368999999987532 234566889999999999999999999999999
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
..++||||+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999998654 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+.....
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~i~~~~~-- 238 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-------IDKILKCKL-- 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHTCC--
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhCCC--
Confidence 7543222 223345689999999999999999999999999999999999999976543321 111111111
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRP-----TMKEAAF 660 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~ 660 (700)
..+...+..+.+|+.+||+.||++|| ++.|+++
T Consensus 239 --------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 --------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11223445788999999999999999 7778876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.22 Aligned_cols=256 Identities=25% Similarity=0.433 Sum_probs=205.4
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC-CcceEEE
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLET-EVPLLVY 465 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 465 (700)
...++|++.+.||+|+||.||++.+. ++.||||+++... ..+.+.+|++++++++||||+++++++.+. +..++||
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 34678999999999999999999885 8899999987533 457899999999999999999999997655 4789999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++++|.+++..... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999976421 23789999999999999999999999 999999999999999999999999998754322
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
.....+++.|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+..+.
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-------~~~~~~~~-------- 231 (278)
T 1byg_A 171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGY-------- 231 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-------HHHHTTTC--------
T ss_pred ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhcCC--------
Confidence 223357889999999999999999999999999999998 9999976554321 11111111
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
....+...+..+.+++.+||+.||++|||+.|+++.|+.++...
T Consensus 232 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 232 -KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 11122334567889999999999999999999999999987643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=348.64 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=206.5
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcc
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 461 (700)
...++|++.+.||+|+||.||+++.+ +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 34678999999999999999999987 4789999998653 223457788999999987 799999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999998654 3999999999999999999999999 99999999999999999999999999975
Q ss_pred cccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
.... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+.....
T Consensus 171 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-------~~~~i~~~~~---- 238 (353)
T 2i0e_A 171 NIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNV---- 238 (353)
T ss_dssp CCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC----
T ss_pred cccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhCCC----
Confidence 4322 223345679999999999999999999999999999999999999997654332 1112222111
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT-----MKEAAF 660 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~ 660 (700)
..+...+..+.+|+.+||+.||.+||+ ++|+++
T Consensus 239 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 ------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 112234567889999999999999995 566665
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.96 Aligned_cols=266 Identities=25% Similarity=0.321 Sum_probs=202.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367999999999999999999986 58999999875433 334577889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999999887553 3899999999999999999999999 999999999999999999999999999765422
Q ss_pred Cceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH--------HHHHhcc
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL--------EAMKENR 616 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 616 (700)
. .......+|..|+|||++.+ ..++.++||||||+++|+|++|..||......+......... .......
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 S-DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c-cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 2 22334568999999999976 678999999999999999999999998765543322211110 0000000
Q ss_pred hhhhc---chh---hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 617 LFEVL---DAR---VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 617 ~~~~~---d~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..... ++. .........+..+.+|+.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 000 0000012345568899999999999999999999873
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=342.93 Aligned_cols=245 Identities=22% Similarity=0.264 Sum_probs=196.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|++.++||+|+||+||+|.+. +++.||||++... .......+..|+..+.++ +|+||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 468999999999999999999987 7899999987642 333445566666666555 899999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+ +++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 7799999887543 4999999999999999999999999 99999999999999999999999999876532
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
. .......||+.|+|||++.+ .++.++||||||+++|||++|..|+..... ...+..+. ..+.
T Consensus 210 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~----~~~~ 272 (311)
T 3p1a_A 210 A--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGY----LPPE 272 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTC----CCHH
T ss_pred C--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccC----CCcc
Confidence 2 22344568999999999876 789999999999999999999776643211 11111111 1111
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. +...+..+.+|+.+||+.||++|||++|+++
T Consensus 273 ~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 F----TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp H----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1 1223457899999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=343.39 Aligned_cols=260 Identities=27% Similarity=0.376 Sum_probs=202.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc---
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP--- 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 461 (700)
.++|++.+.||+|+||.||++++. +++.||||++... +....+.+.+|++++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 578999999999999999999974 7899999998753 334457889999999999999999999998876554
Q ss_pred -eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 462 -LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 462 -~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
++||||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 99999999999999998654 3899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCce--eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 541 SVMIDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 541 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCCCC
Confidence 65433221 22345689999999999999999999999999999999999999976543321 11112211110
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCC-HHHHHHHHHhchh
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT-MKEAAFELGGIRA 667 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~evl~~L~~l~~ 667 (700)
+ .......+..+.+|+.+||+.||++||+ ++++.+.|.++..
T Consensus 239 ----~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 239 ----P---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp ----H---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred ----c---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 0 1111224557889999999999999996 4555566665543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=342.80 Aligned_cols=270 Identities=24% Similarity=0.344 Sum_probs=206.4
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL---VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
..++|++.+.||+|+||.||+|... +++.||||++.. .+....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3467999999999999999999975 789999998864 345566789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 464 VYEFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999997532 2234899999999999999999999999 999999999999999999999999998765
Q ss_pred ccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
.... .......+++.|+|||++.+..++.++||||||+++|+|++|..||........ .....+.........
T Consensus 187 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~- 259 (310)
T 2wqm_A 187 SSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----SLCKKIEQCDYPPLP- 259 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-----HHHHHHHTTCSCCCC-
T ss_pred cCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-----HHHHHhhcccCCCCc-
Confidence 3322 222345689999999999999999999999999999999999999975432211 111122222211111
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCCcc
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSIM 674 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~ 674 (700)
....+..+.+|+.+||+.||++|||++++++.|+++++......+
T Consensus 260 -------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 260 -------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp -------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred -------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 122345788999999999999999999999999999988765543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=340.57 Aligned_cols=261 Identities=28% Similarity=0.451 Sum_probs=208.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcC----CcEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCceeeEEeEEE-eCCcce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTN----GRIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCCL-ETEVPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 462 (700)
..+|++.++||+|+||.||+|.+.+ ...||+|.+.. ......+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4568889999999999999999642 23689998775 34455688999999999999999999999865 456789
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+||||+++++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999976433 3899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCc---eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 543 MIDQT---HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 543 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ +.+||......+. ......+..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-------~~~~~~~~~- 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-------TVYLLQGRR- 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-------HHHHHTTCC-
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHHHhcCCC-
Confidence 43221 12233457789999999999999999999999999999999 5666655443321 111111111
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
...+...+..+.+++.+||+.+|++|||++|+++.|+.+.....
T Consensus 251 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 251 --------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 01112234568899999999999999999999999999877654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=349.13 Aligned_cols=271 Identities=24% Similarity=0.343 Sum_probs=202.2
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhh-HHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESN-IEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
++|++.+.||+|+||.||+|... +++.||||++....... ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999986 68999999887533222 22456899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
++ ++|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 96 699999887543 4899999999999999999999999 9999999999999999999999999987543222
Q ss_pred eeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh-
Q 005355 548 HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV- 625 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~- 625 (700)
.......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+................+........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 22334468999999999876 5689999999999999999999999987654432222111110000111111111000
Q ss_pred ------------hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH--HHHhchh
Q 005355 626 ------------LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF--ELGGIRA 667 (700)
Q Consensus 626 ------------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~~ 667 (700)
...........+.+|+.+||+.||++|||++|+++ .+..+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 00111223457889999999999999999999988 4454443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=355.21 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=200.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccc--cChhhHHHHHHHHHHHhhcC--CCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKL--VDESNIEQFINEVAILSQIN--HRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 464 (700)
.++|++.+.||+|+||.||++....++.||||++.. ......+.+.+|+.++++++ |+||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 456999999999999999999988899999998764 34556688999999999996 59999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|| +.+++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||||+ ++.+||+|||+++....
T Consensus 135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 56889999998754 4899999999999999999999999 99999999999996 57999999999987643
Q ss_pred CCce-eeeeeeccccccccccccc-----------CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHH
Q 005355 545 DQTH-LTTRVQGTFGYLDPEYFRS-----------SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAM 612 (700)
Q Consensus 545 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 612 (700)
.... ......||+.|+|||++.+ ..++.++||||||++||||++|+.||....... ..+..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~~~-- 279 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHA-- 279 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHHH--
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHHHH--
Confidence 3222 2344569999999999865 368899999999999999999999997543221 11111
Q ss_pred HhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 613 KENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 613 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
+++.......+......+.+|+.+||+.||++|||+.|+++.
T Consensus 280 -------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 280 -------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111111111122224568899999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=351.59 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=196.3
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
..++|++.+.||+|+||.||+++.. +++.||||++...... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3578999999999999999999986 7899999998754332 3678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc--EEEeecCCCccccc
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR--AKVSDFGASRSVMI 544 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~--~kl~DfGl~~~~~~ 544 (700)
|+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999997654 3999999999999999999999999 999999999999987765 99999999974322
Q ss_pred CCceeeeeeecccccccccccccCCCCcc-cceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEK-SDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
. .......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||......... .. ....+.....
T Consensus 171 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~-~~~~~~~~~~------ 239 (361)
T 3uc3_A 171 H--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RK-TIQRILSVKY------ 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HH-HHHHHHTTCC------
T ss_pred c--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HH-HHHHHhcCCC------
Confidence 2 22334569999999999988887665 89999999999999999999765432211 11 1111111111
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 240 --~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 --SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 000111234578899999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=353.91 Aligned_cols=261 Identities=28% Similarity=0.459 Sum_probs=201.7
Q ss_pred cCCCccceEeeeCCeEEEEEEEc--CC--cEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe-CCcceE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT--NG--RIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLE-TEVPLL 463 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 463 (700)
..|++.++||+|+||.||+|++. ++ ..||||.++.. .....+.|.+|+.++++++||||+++++++.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34677889999999999999964 22 36899988653 34567889999999999999999999998764 457899
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++|+|.+++..... .+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999986543 3889999999999999999999999 9999999999999999999999999998653
Q ss_pred cCCce---eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 544 IDQTH---LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 544 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |.+||......+.. ..+..+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~-------~~~~~~~~~- 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT-------VYLLQGRRL- 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH-------HHHHTTCCC-
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH-------HHHHcCCCC-
Confidence 32211 1233457788999999999999999999999999999999 77888765443311 111111110
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCC
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGD 671 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~ 671 (700)
..+...+..+.+|+.+||+.+|++|||++|+++.|+.+...+..
T Consensus 316 --------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 316 --------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 11223345788999999999999999999999999998876653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=349.70 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=199.9
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCC--CceeeEEeEEEeCCcceE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINH--RNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l 463 (700)
..++|++.+.||+|+||.||++...+++.||||++.. ......+.+.+|+.++++++| +||+++++++.+.+..++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 3567999999999999999999988899999998764 344556789999999999976 999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||| +.+++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||||+ ++.+||+|||+++...
T Consensus 87 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 56889999998754 3899999999999999999999999 99999999999997 5789999999998664
Q ss_pred cCCce-eeeeeeccccccccccccc-----------CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHH
Q 005355 544 IDQTH-LTTRVQGTFGYLDPEYFRS-----------SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEA 611 (700)
Q Consensus 544 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 611 (700)
..... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ..+..
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~- 232 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHA- 232 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHH-
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----HHHHH-
Confidence 33322 2334569999999999865 678899999999999999999999997543221 11111
Q ss_pred HHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 612 MKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 612 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
+++.......+......+.+|+.+||+.||.+|||+.|+++.
T Consensus 233 --------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 --------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111111112222234568899999999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.05 Aligned_cols=264 Identities=23% Similarity=0.355 Sum_probs=196.4
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCC--c
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQIN-HRNVVKLLGCCLETE--V 460 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 460 (700)
...++|++.+.||+|+||.||+|.+. +++.||||++.. ......+.+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34688999999999999999999975 689999998754 34455678889999999997 999999999998654 6
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.++||||++ ++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 799999997 6999999864 3899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccC--------------------Cceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCch
Q 005355 541 SVMID--------------------QTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSE 599 (700)
Q Consensus 541 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~ 599 (700)
..... .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 65321 1112334579999999999986 67899999999999999999999999876543
Q ss_pred hhhhHHHHHHHHHHhcch-----------hhhc---------------------chhh-hhccCHHHHHHHHHHHHHHhc
Q 005355 600 EDKSLVGYFLEAMKENRL-----------FEVL---------------------DARV-LKEAKEEEIITVAMLAKRCLN 646 (700)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~-----------~~~~---------------------d~~~-~~~~~~~~~~~l~~li~~cl~ 646 (700)
+..... ......... ...+ ...+ ...........+.+|+.+||+
T Consensus 238 ~~~~~i---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 238 NQLERI---IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp HHHHHH---HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred HHHHHH---HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 321111 111000000 0000 0000 000001234578899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 005355 647 MIGKKRPTMKEAAFE 661 (700)
Q Consensus 647 ~~p~~RPs~~evl~~ 661 (700)
.||++|||++|+++.
T Consensus 315 ~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 315 FNPNKRISANDALKH 329 (388)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred cCcccCCCHHHHhCC
Confidence 999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=341.37 Aligned_cols=272 Identities=22% Similarity=0.334 Sum_probs=215.4
Q ss_pred hHHHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhh--cCCCceeeEEeEEEeCC
Q 005355 382 SMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQ--INHRNVVKLLGCCLETE 459 (700)
Q Consensus 382 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~ 459 (700)
........++|++.+.||+|+||.||+|++. ++.||||++... ....+.+|++++.. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3444566789999999999999999999985 899999998643 34668889999987 78999999999998876
Q ss_pred ----cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeecCCCCCcEEECC
Q 005355 460 ----VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH--------SAASIPIYHRDIKSANILLDD 527 (700)
Q Consensus 460 ----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~~ivH~Dik~~NILl~~ 527 (700)
..++||||+++|+|.+++.... +++..++.++.|++.||+||| +.+ |+||||||+||||+.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK 182 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred CccceeEEEEeecCCCcHHHHHhccC----ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence 7899999999999999997643 899999999999999999999 778 999999999999999
Q ss_pred CCcEEEeecCCCcccccCCce---eeeeeecccccccccccccC------CCCcccceehHHHHHHHHHhC---------
Q 005355 528 KYRAKVSDFGASRSVMIDQTH---LTTRVQGTFGYLDPEYFRSS------QFTEKSDVYSFGVVLVELLTG--------- 589 (700)
Q Consensus 528 ~~~~kl~DfGl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlG~il~elltg--------- 589 (700)
++.+||+|||++......... ......||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 999999999999765443322 12345689999999999775 334789999999999999999
Q ss_pred -CCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 590 -QKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 590 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
..||......... ...+............+... ....+.+..+.+|+.+||+.||++|||++|+++.|+++...
T Consensus 263 ~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 263 YQLPYYDLVPSDPS--VEEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CCCTTTTTSCSSCC--HHHHHHHHTTSCCCCCCCGG---GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cccCccccCcCccc--HHHHHHHHHHHHhCCCCccc---ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 7788654332111 11122222222211111111 12345677899999999999999999999999999998765
Q ss_pred c
Q 005355 669 I 669 (700)
Q Consensus 669 ~ 669 (700)
.
T Consensus 338 ~ 338 (342)
T 1b6c_B 338 E 338 (342)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=351.65 Aligned_cols=251 Identities=25% Similarity=0.317 Sum_probs=202.2
Q ss_pred cceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCCCCH
Q 005355 395 NRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTL 473 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~gsL 473 (700)
.+.||+|+||.||+|... +++.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999975 6899999999877667778899999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE--CCCCcEEEeecCCCcccccCCceeee
Q 005355 474 YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL--DDKYRAKVSDFGASRSVMIDQTHLTT 551 (700)
Q Consensus 474 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl--~~~~~~kl~DfGl~~~~~~~~~~~~~ 551 (700)
.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...... ...
T Consensus 174 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~ 246 (373)
T 2x4f_A 174 FDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLK 246 (373)
T ss_dssp HHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCC
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccc
Confidence 99997643 24899999999999999999999999 9999999999999 677899999999998654332 223
Q ss_pred eeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCH
Q 005355 552 RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKE 631 (700)
Q Consensus 552 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 631 (700)
...||+.|+|||++.+..++.++||||||+++|||++|..||......+. ...+....+. . . .....
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~~~i~~~~~~-~-~----~~~~~ 313 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET-------LNNILACRWD-L-E----DEEFQ 313 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHTCCC-S-C----SGGGT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhccCC-C-C----hhhhc
Confidence 44699999999999999999999999999999999999999976543321 1111111110 0 0 01112
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCHHHHHH--HHHhc
Q 005355 632 EEIITVAMLAKRCLNMIGKKRPTMKEAAF--ELGGI 665 (700)
Q Consensus 632 ~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l 665 (700)
..+..+.+|+.+||+.||.+|||+.|+++ .|...
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 23457889999999999999999999998 45443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=343.64 Aligned_cols=264 Identities=25% Similarity=0.339 Sum_probs=201.2
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-----hhhHHHHHHHHHHHhhc---CCCceeeEEeEEEe
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-----ESNIEQFINEVAILSQI---NHRNVVKLLGCCLE 457 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~ 457 (700)
...++|++.++||+|+||+||+|++. +++.||||++.... ......+.+|+++++++ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 34689999999999999999999964 68999999876422 11234567777777766 49999999999987
Q ss_pred CC-----cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEE
Q 005355 458 TE-----VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAK 532 (700)
Q Consensus 458 ~~-----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~k 532 (700)
.. ..++||||+. ++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 65 4689999996 699999987643 23899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHH
Q 005355 533 VSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAM 612 (700)
Q Consensus 533 l~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 612 (700)
|+|||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.. .......
T Consensus 161 l~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~ 235 (308)
T 3g33_A 161 LADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDLI 235 (308)
T ss_dssp ECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH---HHHHHHH
T ss_pred EeeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHh
Confidence 9999999765322 2234456899999999999999999999999999999999999999866543321 1111111
Q ss_pred Hh---cchhhh----------cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 613 KE---NRLFEV----------LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 613 ~~---~~~~~~----------~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.. ..+... ..+........+....+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 10 000000 0000001111234567889999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.40 Aligned_cols=258 Identities=24% Similarity=0.426 Sum_probs=206.2
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCc----EEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGR----IVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
.++|++.++||+|+||.||+|.+. +++ +||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 467899999999999999999975 344 38888765432 333456788999999999999999999886 55688
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 9999999999999998653 24899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 543 MIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 543 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
...... ......++..|+|||++.+..++.++||||||+++|||++ |..||......+. ...+..+...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~-- 236 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV-------PDLLEKGERL-- 236 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-------HHHHHTTCBC--
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-------HHHHHcCCCC--
Confidence 443322 2344567889999999999999999999999999999999 9999987654332 1112211110
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
..+...+..+.+|+.+||+.||.+||+++|+++.|+++...
T Consensus 237 -------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 237 -------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp -------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred -------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11112334577899999999999999999999999988653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=334.17 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=207.7
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
..++|++.+.||+|+||.||+|.+. ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3577999999999999999999986 577999999876555667889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---CCCCcEEEeecCCCcccc
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl---~~~~~~kl~DfGl~~~~~ 543 (700)
|+++++|.+++..... +++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999999976543 899999999999999999999999 9999999999999 788999999999997654
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
... ......+|+.|+|||++.+. ++.++||||||+++|+|++|+.||......+. ...+..+... ...
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~--~~~ 228 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-------MLKIREGTFT--FPE 228 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC--CCH
T ss_pred Ccc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhCCCC--CCc
Confidence 322 23345689999999998754 89999999999999999999999976543321 1122222111 000
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 229 ~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDW----LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 123457889999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=350.33 Aligned_cols=267 Identities=19% Similarity=0.242 Sum_probs=203.2
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc----CCcEEEEEEccccChh-----------hHHHHHHHHHHHhhcCCCceeeEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT----NGRIVAIKKSKLVDES-----------NIEQFINEVAILSQINHRNVVKLLG 453 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 453 (700)
.++|++.+.||+|+||.||+|.+. .+..||||+....... ....+.+|+.+++.++|+||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 578999999999999999999986 4678999987654321 1234667888999999999999999
Q ss_pred EEEe----CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC
Q 005355 454 CCLE----TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY 529 (700)
Q Consensus 454 ~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~ 529 (700)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67889999999 999999998654 4999999999999999999999999 99999999999998877
Q ss_pred --cEEEeecCCCcccccCCce------eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhh
Q 005355 530 --RAKVSDFGASRSVMIDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601 (700)
Q Consensus 530 --~~kl~DfGl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~ 601 (700)
.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999865432211 11345689999999999999999999999999999999999999964322111
Q ss_pred hhHHHHHHHHHHhcchhhhcchhhhhcc-CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 602 KSLVGYFLEAMKENRLFEVLDARVLKEA-KEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
.......... ..+...+.... ....+..+.+|+.+||+.+|++||++++|++.|+++...+
T Consensus 269 --~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 269 --AVQTAKTNLL-----DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp --HHHHHHHHHH-----HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred --HHHHHHHhhc-----ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 1111111111 11111111100 1134557899999999999999999999999999876543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=354.49 Aligned_cols=272 Identities=24% Similarity=0.365 Sum_probs=216.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC--cceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETE--VPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 464 (700)
.++|++.++||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467899999999999999999987 58999999987533 334577889999999999999999999998765 67999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----CCCCcEEEeecCCCc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL----DDKYRAKVSDFGASR 540 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl----~~~~~~kl~DfGl~~ 540 (700)
|||+++++|.+++........+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999987655555999999999999999999999999 9999999999999 788889999999998
Q ss_pred ccccCCceeeeeeeccccccccccccc--------CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHH
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFRS--------SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAM 612 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 612 (700)
...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... ..+....
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~~~~~~ 240 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYKII 240 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HHHHHHH
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HHHHHHh
Confidence 653322 2334568999999999865 567889999999999999999999997544322211 1111222
Q ss_pred Hhcchhhhc---------------chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 613 KENRLFEVL---------------DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 613 ~~~~~~~~~---------------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
.. ...... +..............+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 241 ~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TG-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HS-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cC-CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 11 110000 00111233467788899999999999999999999999999887653
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=362.33 Aligned_cols=250 Identities=24% Similarity=0.314 Sum_probs=198.9
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
...++|++.++||+|+||.||++... +++.||||++... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 34578999999999999999999976 6899999988642 3344567889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
+||||+++++|.+++.... .+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++.
T Consensus 225 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp EEECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EEEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999999997654 38999999999999999999998 88 99999999999999999999999999975
Q ss_pred cccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
.... ........||+.|+|||++.+..++.++||||||++||||++|+.||......+. ...+.....
T Consensus 299 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~~~i~~~~~---- 366 (446)
T 4ejn_A 299 GIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEEI---- 366 (446)
T ss_dssp TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC----
T ss_pred ccCC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-------HHHHHhCCC----
Confidence 4322 2233456799999999999999999999999999999999999999976543321 111111111
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRP-----TMKEAAF 660 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~ 660 (700)
..+...+..+.+|+.+||+.||.+|| +++|+++
T Consensus 367 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 ------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11223345788999999999999999 9999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=348.72 Aligned_cols=260 Identities=24% Similarity=0.306 Sum_probs=204.8
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-----ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-----DESNIEQFINEVAILSQINHRNVVKLLGCCLET 458 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 458 (700)
+....++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4556788999999999999999999975 6889999987542 345567899999999999999999999999999
Q ss_pred CcceEEEeeCCCCCHHHHHhccC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 005355 459 EVPLLVYEFIPNGTLYQYIHDQT-------------------------------------EEFPITWEIRLRIAIEVSDA 501 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qi~~a 501 (700)
+..++||||+++|+|.+++.... ....+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999996311 01124678889999999999
Q ss_pred HHHHHhcCCCCeeecCCCCCcEEECCCC--cEEEeecCCCcccccCCc---eeeeeeeccccccccccccc--CCCCccc
Q 005355 502 LCYLHSAASIPIYHRDIKSANILLDDKY--RAKVSDFGASRSVMIDQT---HLTTRVQGTFGYLDPEYFRS--SQFTEKS 574 (700)
Q Consensus 502 L~~LH~~~~~~ivH~Dik~~NILl~~~~--~~kl~DfGl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~s~ks 574 (700)
|+|||+++ |+||||||+|||++.++ .+||+|||++........ .......||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 99999999999998776 899999999986543221 12345569999999999975 6789999
Q ss_pred ceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCC
Q 005355 575 DVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT 654 (700)
Q Consensus 575 DVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs 654 (700)
||||||+++|||++|+.||......+. ........... .. ......+..+.+|+.+||+.+|.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~~--~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKLCF--EN-----PNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCCT--TS-----GGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhccccc--CC-----cccccCCHHHHHHHHHHcCCChhHCCC
Confidence 999999999999999999976654321 11111111100 00 011123457889999999999999999
Q ss_pred HHHHHH
Q 005355 655 MKEAAF 660 (700)
Q Consensus 655 ~~evl~ 660 (700)
+.|+++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999987
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=332.57 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=207.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
.++|++.+.||+|+||.||+|.+. +++.||+|++.. ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999976 588999998764 34455678899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc---EEEeecCCCccc
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGASRSV 542 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~---~kl~DfGl~~~~ 542 (700)
||+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999999987654 3899999999999999999999999 999999999999976655 999999999765
Q ss_pred ccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||......+ ....+..+.... .
T Consensus 159 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~-~- 227 (284)
T 3kk8_A 159 NDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAYDY-P- 227 (284)
T ss_dssp CSS--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC-C-
T ss_pred ccC--ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-------HHHHHHhccccC-C-
Confidence 332 22334568999999999999999999999999999999999999997654332 111222221110 0
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 ----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ----TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0111223456889999999999999999999988
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.22 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=193.0
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
...++|++.+.||+|+||.||+|++. +++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34678999999999999999999987 57899999987532 3467889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEEEeecCCCccc
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD---KYRAKVSDFGASRSV 542 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~---~~~~kl~DfGl~~~~ 542 (700)
||+++++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 128 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999997643 3899999999999999999999999 999999999999975 889999999999765
Q ss_pred ccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
.. ........||+.|+|||++.+..++.++||||||+++|||++|..||......+. ....+...... ..
T Consensus 202 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~i~~~~~~-~~- 271 (349)
T 2w4o_A 202 EH--QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF------MFRRILNCEYY-FI- 271 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH------HHHHHHTTCCC-CC-
T ss_pred Cc--ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH------HHHHHHhCCCc-cC-
Confidence 32 2223445689999999999999999999999999999999999999975543321 11112211110 00
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 272 ----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 272 ----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111234557889999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.22 Aligned_cols=266 Identities=22% Similarity=0.325 Sum_probs=209.4
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe----CCcc
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLE----TEVP 461 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 461 (700)
...++|++.+.||+|+||.||++... +++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 34678999999999999999999974 789999999877777778899999999999999999999999873 3467
Q ss_pred eEEEeeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 462 LLVYEFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
++|+||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 89999999999999998632 2345999999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCce--------eeeeeecccccccccccccCC---CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 005355 541 SVMIDQTH--------LTTRVQGTFGYLDPEYFRSSQ---FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL 609 (700)
Q Consensus 541 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 609 (700)
........ ......||+.|+|||++.... ++.++||||||+++|||++|+.||........ ...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~---- 257 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVA---- 257 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHH----
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhh----
Confidence 54321110 011234689999999987654 68899999999999999999999853111110 000
Q ss_pred HHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 610 EAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 610 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
..... . .........+..+.+|+.+||+.||.+|||++|+++.|+.++...
T Consensus 258 ~~~~~-~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 258 LAVQN-Q--------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp HHHHC-C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred HHhhc-c--------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 01111 0 001111234567899999999999999999999999999886543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=343.82 Aligned_cols=260 Identities=23% Similarity=0.326 Sum_probs=201.8
Q ss_pred hcCCCcc-ceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEE
Q 005355 389 TDNFNTN-RILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 389 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 465 (700)
.+.|++. ++||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4667774 78999999999999965 6899999998776666678899999999985 7999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc---EEEeecCCCccc
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFGASRSV 542 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~---~kl~DfGl~~~~ 542 (700)
||+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999998754 3899999999999999999999999 999999999999988766 999999998765
Q ss_pred ccCCc------eeeeeeeccccccccccccc-----CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhh--------h
Q 005355 543 MIDQT------HLTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDK--------S 603 (700)
Q Consensus 543 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~--------~ 603 (700)
..... .......||+.|+|||++.. ..++.++||||||+++|||++|+.||......+.. .
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32211 11223458999999999875 56889999999999999999999999765432210 0
Q ss_pred HHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 604 LVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
........+..+... . ..... ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~i~~~~~~-~-~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEGKYE-F-PDKDW----AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHCCCC-C-CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccCcc-c-Cchhc----ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 011112222222110 0 00000 123457889999999999999999999987
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=347.33 Aligned_cols=247 Identities=26% Similarity=0.400 Sum_probs=202.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.+.|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 456889999999999999999974 78999999986432 33456789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+. |+|.+++..... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99996 789888865432 4899999999999999999999999 99999999999999999999999999976532
Q ss_pred CCceeeeeeecccccccccccc---cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
. ....||+.|+|||++. ...++.++||||||+++|||++|+.||......+. ...... +.....
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~-~~~~~~- 273 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ-NESPAL- 273 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH-SCCCCC-
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHh-cCCCCC-
Confidence 2 2346899999999984 56789999999999999999999999976543221 111111 111111
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.....+..+.+|+.+||+.+|++|||++++++.
T Consensus 274 -------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 274 -------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -------CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 112234568899999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=335.46 Aligned_cols=248 Identities=28% Similarity=0.406 Sum_probs=204.3
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4578999999999999999999976 57799999875422 2235678999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999998754 3899999999999999999999999 9999999999999999999999999886442
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
.. ......+++.|+|||++.+..++.++||||||+++|+|++|..||......+. ...+....
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~------- 223 (279)
T 3fdn_A 161 SS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-------YKRISRVE------- 223 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHTC-------
T ss_pred cc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-------HHHHHhCC-------
Confidence 22 22345689999999999999999999999999999999999999976543321 11111111
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
...+...+..+.+|+.+||+.+|++|||++|+++.
T Consensus 224 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 ---FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11122344568899999999999999999999974
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=356.40 Aligned_cols=261 Identities=23% Similarity=0.299 Sum_probs=198.8
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC------
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETE------ 459 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 459 (700)
.++|++.+.||+|+||+||+|.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999976 6889999998653 4555678999999999999999999999997654
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
..++||||+++ +|.+.+... +++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~~-----l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTSC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 45999999965 577777432 899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH----------
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL---------- 609 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~---------- 609 (700)
+.... ........||+.|+|||++.+..++.++||||||++||||++|+.||.+.+..+.........
T Consensus 212 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 212 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp -------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred eecCC--CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 86532 223445679999999999999999999999999999999999999998765433211110000
Q ss_pred ------HHHHhc------chhhhcchhhh---hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 610 ------EAMKEN------RLFEVLDARVL---KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 610 ------~~~~~~------~~~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...... .+.......+. .+........+.+|+.+||+.||++|||++|+++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 00000000000 0011223567899999999999999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=372.76 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=204.5
Q ss_pred ceEeeeCCeEEEEEEEc---CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLT---NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
+.||+|+||.||+|.+. .++.||||+++.. +....+.+.+|++++++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999764 4678999998753 3344688999999999999999999999986 4567899999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce--
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH-- 548 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~-- 548 (700)
|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999997653 3899999999999999999999999 999999999999999999999999999866433321
Q ss_pred eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 549 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......+|+.|+|||++.+..++.++||||||++||||++ |+.||......+ ....+..+.. .
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~---------~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGER---------M 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC---------C
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC---------C
Confidence 2233446789999999999999999999999999999998 999998765433 1222222211 1
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
..+...+..+.+|+.+||+.||++||++.+|++.|+.+...+.
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 1223345678999999999999999999999999999876554
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=350.31 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=197.5
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHH-HhhcCCCceeeEEeEEEeCCcce
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAI-LSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
..++|++.+.||+|+||.||+++.+ +++.||||++.... ......+.+|..+ ++.++||||+++++++.+.+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3578999999999999999999986 58899999876432 2334566777776 46789999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999998754 3899999999999999999999999 999999999999999999999999999754
Q ss_pred ccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
... ........||+.|+|||++.+..++.++||||||+++|||++|..||...+..+. ...+....+
T Consensus 190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-------~~~i~~~~~----- 256 (373)
T 2r5t_A 190 IEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-------YDNILNKPL----- 256 (373)
T ss_dssp BCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH-------HHHHHHSCC-----
T ss_pred ccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHhccc-----
Confidence 322 2234456799999999999999999999999999999999999999976543321 111111111
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L 662 (700)
..+...+..+.+|+.+||+.||.+||++.+.++.+
T Consensus 257 -----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 257 -----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp -----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 11223445788999999999999999986544444
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.73 Aligned_cols=275 Identities=24% Similarity=0.377 Sum_probs=202.8
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHh--hcCCCceeeEEeEEEeC-----Cc
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILS--QINHRNVVKLLGCCLET-----EV 460 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~-----~~ 460 (700)
..++|++.+.||+|+||.||+|++ +++.||||++.... ...+..|.+++. .++|+||+++++.+... ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 457899999999999999999987 58999999987433 344555555544 58999999999865432 24
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeeecCCCCCcEEECCCCcE
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA---------ASIPIYHRDIKSANILLDDKYRA 531 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---------~~~~ivH~Dik~~NILl~~~~~~ 531 (700)
.++||||+++|+|.+++.... .++..++.++.||+.||+|||+. + |+||||||+||||+.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 589999999999999997654 68999999999999999999999 8 9999999999999999999
Q ss_pred EEeecCCCcccccCC-------ceeeeeeeccccccccccccc-------CCCCcccceehHHHHHHHHHhCCCCCCCCC
Q 005355 532 KVSDFGASRSVMIDQ-------THLTTRVQGTFGYLDPEYFRS-------SQFTEKSDVYSFGVVLVELLTGQKPIRSTD 597 (700)
Q Consensus 532 kl~DfGl~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlG~il~elltg~~p~~~~~ 597 (700)
||+|||+++...... ........||+.|+|||++.+ ..++.++||||||+++|||++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 999999998654321 111223458999999999987 456779999999999999999977664333
Q ss_pred chhh-hhH----------HHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 598 SEED-KSL----------VGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 598 ~~~~-~~~----------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
.... ... ................+.... ......+..+.+|+.+||+.||++|||++|+++.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 2111 000 001111111111111111000 112346678999999999999999999999999999998
Q ss_pred hhcCCCccC
Q 005355 667 ASIGDSIMQ 675 (700)
Q Consensus 667 ~~~~~~~~~ 675 (700)
.........
T Consensus 318 ~~~~~~~~~ 326 (336)
T 3g2f_A 318 MIWERNKSV 326 (336)
T ss_dssp HCCCC----
T ss_pred HHHHhcccC
Confidence 776655433
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=336.32 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=207.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh------hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE------SNIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
.++|++.+.||+|+||.||++... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 567999999999999999999986 689999998765322 1367899999999999999999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC----cEEEeecC
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFG 537 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~----~~kl~DfG 537 (700)
++||||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999997643 3899999999999999999999999 99999999999999887 79999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+. ...+.....
T Consensus 165 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~i~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANITSVSY 235 (321)
T ss_dssp TCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHTTCC
T ss_pred cceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhccc
Confidence 997654322 23345689999999999999999999999999999999999999976543321 111211111
Q ss_pred hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+..... ..+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 --~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 --DFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --CCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --ccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11111111 23456889999999999999999999987
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=356.12 Aligned_cols=247 Identities=24% Similarity=0.354 Sum_probs=207.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|.+.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999986 78999999986432 23356789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999997543 4999999999999999999999999 99999999999999999999999999986533
Q ss_pred CCceeeeeeecccccccccccccCCC-CcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
. .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||......+ ....+..+..
T Consensus 169 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~------ 233 (476)
T 2y94_A 169 G--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-------LFKKICDGIF------ 233 (476)
T ss_dssp T--CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-------HHHHHHTTCC------
T ss_pred c--ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCc------
Confidence 2 22344569999999999988765 689999999999999999999998654332 1112222211
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+......+.+|+.+||+.||.+|||++|+++
T Consensus 234 ----~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 ----YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 111223456889999999999999999999997
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=361.41 Aligned_cols=254 Identities=27% Similarity=0.336 Sum_probs=209.6
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
..++|++.++||+|+||.||+++.. +++.||||++... .......+.+|+.+|++++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3577999999999999999999986 6899999997642 22345678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 262 VmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999999986542 34899999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
... ......||+.|+|||++.+..++.++||||||+++|||++|..||........... +...+....
T Consensus 338 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~---i~~~i~~~~------- 405 (576)
T 2acx_A 338 EGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKEVP------- 405 (576)
T ss_dssp TTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH---HHHHHHHCC-------
T ss_pred cCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH---HHHHhhccc-------
Confidence 332 23345799999999999999999999999999999999999999986543221111 111111111
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRP-----TMKEAAF 660 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~ 660 (700)
...+...+..+.+|+.+||+.||.+|| +++|+++
T Consensus 406 ---~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 ---EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 112233456788999999999999999 7888876
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=332.92 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=185.4
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 467999999999999999999974 78999999986432 22347789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999998653 24899999999999999999999999 99999999999999999999999999976542
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||......+.. ...... +.
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~------~~- 229 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------NKVVLA------DY- 229 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSS------CC-
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------HHHhhc------cc-
Confidence 222 223456899999999999999999999999999999999999999765432210 000000 00
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+...+..+.+|+.+||+.||++|||++++++
T Consensus 230 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 ---EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 112233457889999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=347.03 Aligned_cols=263 Identities=27% Similarity=0.428 Sum_probs=207.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.++|++.+.||+|+||.||++.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 567999999999999999999986 6899999998754 44556789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
|+++++|.+++.... .+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999998754 389999999999999999999996 8 999999999999999999999999999754221
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH---------------
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLE--------------- 610 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------------- 610 (700)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+..........
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 22345689999999999999999999999999999999999999987654332111100000
Q ss_pred --------HHHhcchhhhcchhhh----hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 611 --------AMKENRLFEVLDARVL----KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 611 --------~~~~~~~~~~~d~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
........+.++.... .......+..+.+|+.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000011111000 0011123457899999999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=335.46 Aligned_cols=253 Identities=27% Similarity=0.428 Sum_probs=206.4
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe---------
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLE--------- 457 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 457 (700)
..++|++.+.||+|+||.||+|.+. +++.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4577999999999999999999986 78999999987543 346789999999999999999998864
Q ss_pred -------CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc
Q 005355 458 -------TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR 530 (700)
Q Consensus 458 -------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~ 530 (700)
....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 345789999999999999997643 224899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 005355 531 AKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLE 610 (700)
Q Consensus 531 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 610 (700)
+||+|||++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..|+.. .. ....
T Consensus 161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~----~~~~ 229 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----TS----KFFT 229 (284)
T ss_dssp EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----HH----HHHH
T ss_pred EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----HH----HHHH
Confidence 9999999997654332 22344689999999999999999999999999999999999988631 10 1111
Q ss_pred HHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCC
Q 005355 611 AMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGD 671 (700)
Q Consensus 611 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~ 671 (700)
......+ +...+..+.+|+.+||+.||.+|||+.|+++.|+.++.....
T Consensus 230 ~~~~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 230 DLRDGII------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp HHHTTCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred Hhhcccc------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 1121111 112334678899999999999999999999999998866543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.39 Aligned_cols=264 Identities=23% Similarity=0.304 Sum_probs=196.0
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh--hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE--SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
....++|++.++||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345678999999999999999999976 688999999875432 33567889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE-----CCCCcEEEeecC
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL-----DDKYRAKVSDFG 537 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl-----~~~~~~kl~DfG 537 (700)
+||||++ ++|.+++..... +++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||
T Consensus 110 lv~e~~~-~~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCS-EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCC-CCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999997 599999987643 999999999999999999999999 9999999999999 455669999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh--
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE-- 614 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 614 (700)
++....... .......+|+.|+|||++.+. .++.++||||||+++|||++|..||......+... ........
T Consensus 183 ~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~~~~~~ 258 (329)
T 3gbz_A 183 LARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF---KIFEVLGLPD 258 (329)
T ss_dssp HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCC
T ss_pred CccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH---HHHHHhCCCc
Confidence 997653222 223345689999999999874 48999999999999999999999997655432211 11111100
Q ss_pred -cchh-------------hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 615 -NRLF-------------EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 615 -~~~~-------------~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+. ......+...........+.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 000000000111113457889999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=335.34 Aligned_cols=250 Identities=28% Similarity=0.419 Sum_probs=208.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.+.|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 466899999999999999999975 68899999986533 3456889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|.+++... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999999753 3899999999999999999999999 9999999999999999999999999997654322
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
.......+++.|+|||++.+..++.++||||||+++|+|++|..||......+. ...+.....
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~--------- 236 (303)
T 3a7i_A 174 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV-------LFLIPKNNP--------- 236 (303)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHSCC---------
T ss_pred -cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH-------HHHhhcCCC---------
Confidence 223345689999999999999999999999999999999999999976543221 111111111
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L 662 (700)
.......+..+.+|+.+||+.+|++|||+.|+++..
T Consensus 237 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 111223345688999999999999999999998853
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=335.34 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=205.6
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
..++|++.+.||+|+||.||+++.. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3577999999999999999999976 689999999886555556778999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---CCCCcEEEeecCCCcccc
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl---~~~~~~kl~DfGl~~~~~ 543 (700)
|+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999997654 3899999999999999999999999 9999999999999 788999999999987543
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||......+ ....+..+... ..
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~i~~~~~~--~~- 227 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-------LFEKIKEGYYE--FE- 227 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHCCCC--CC-
T ss_pred CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCC--CC-
Confidence 21 2233458999999999999999999999999999999999999997654322 11222222110 00
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.......+..+.+|+.+||+.||++|||++|+++
T Consensus 228 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 228 ---SPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ---TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111234567889999999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=333.73 Aligned_cols=254 Identities=25% Similarity=0.379 Sum_probs=203.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.++|....+||+|+||.||+|.+. +++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 344566679999999999999975 6889999998876666678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEeecCCCcccccCC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~-~~~~kl~DfGl~~~~~~~~ 546 (700)
+++++|.+++........+++..+..++.||+.||+|||+++ |+|+||||+|||++. ++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 999999999987655555789999999999999999999999 999999999999987 8999999999997653221
Q ss_pred ceeeeeeecccccccccccccCC--CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
.......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||......... ....... . .
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~-~-----~--- 243 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA----MFKVGMF-K-----V--- 243 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH----HHHHHHH-C-----C---
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH----HHhhccc-c-----c---
Confidence 2233456899999999997643 889999999999999999999999643322110 0000000 0 0
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
....+...+..+.+|+.+||+.||++||++.|+++
T Consensus 244 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 -HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11122334567889999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=330.48 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=205.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999986 6899999997643 23446789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|.+++.... .+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999987543 4899999999999999999999999 9999999999999999999999999997654322
Q ss_pred c-eeeeeeecccccccccccccCCC-CcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 547 T-HLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 547 ~-~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
. .......+++.|+|||++.+..+ +.++||||||+++|+|++|..||......... ...+...... ..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~--~~-- 229 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTY--LN-- 229 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH------HHHHHTTCTT--ST--
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHhhhcccc--cC--
Confidence 2 22334568999999999988765 78999999999999999999999765432211 1111111110 00
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.....+..+.+|+.+||+.||++|||++|+++
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 ----PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 01123456888999999999999999999976
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=332.04 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=208.4
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|.+.+.||+|+||.||++.+. +++.||+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 477899999999999999999986 5789999987542 345567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999987654 3899999999999999999999999 99999999999999999999999999976542
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
.. .......+++.|+|||++.+..++.++||||||+++|+|++|+.||......+. ...+.....
T Consensus 168 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~------- 232 (294)
T 2rku_A 168 DG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-------YLRIKKNEY------- 232 (294)
T ss_dssp TT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTCC-------
T ss_pred Cc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhhccC-------
Confidence 22 223345689999999999999999999999999999999999999976543321 111111111
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..+......+.+|+.+||+.||++|||++|+++.
T Consensus 233 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1112334568889999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.11 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=201.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc--CCc--EEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT--NGR--IVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
.++|++.+.||+|+||.||+|++. +++ .||||+++.. .....+.+.+|++++++++||||+++++++.+.+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 578999999999999999999864 233 6899987653 3445678999999999999999999999998765 7
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++|+||+++++|.+++..... .+++..++.++.||+.||+|||+++ |+|+||||+|||++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 899999999999999986532 3899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCce--eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 542 VMIDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 542 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||......+. ...+......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~~ 243 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-------LHKIDKEGER 243 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTSCCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH-------HHHHHccCCC
Confidence 6433322 1223457788999999998889999999999999999999 9999976653321 1111111110
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
...+...+..+.+++.+||+.+|++|||+.++++.|++++..
T Consensus 244 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 244 --------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred --------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 011223456789999999999999999999999999987654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.92 Aligned_cols=263 Identities=25% Similarity=0.389 Sum_probs=210.2
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETE 459 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 459 (700)
...++|++.+.||+|+||.||+|++. +++.||||++... .......+.+|+.++++++||||+++++++.+.+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 34688999999999999999999842 4678999998643 3455678999999999999999999999999999
Q ss_pred cceEEEeeCCCCCHHHHHhccCCC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEE
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEE----FPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD---KYRAK 532 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~---~~~~k 532 (700)
..++||||+++++|.+++...... ..+++..++.++.||+.||.|||+++ |+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999875421 34899999999999999999999999 999999999999984 45699
Q ss_pred EeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHH
Q 005355 533 VSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLE 610 (700)
Q Consensus 533 l~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~ 610 (700)
|+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+ ...
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~ 256 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLE 256 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-------HHH
Confidence 999999875432221 12233457889999999999999999999999999999998 999997654332 112
Q ss_pred HHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 611 AMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 611 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
.+..+... ..+...+..+.+|+.+||+.||.+||++.++++.|+.+...
T Consensus 257 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 257 FVTSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhcCCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 22221111 11223445788999999999999999999999999988653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=331.58 Aligned_cols=252 Identities=26% Similarity=0.329 Sum_probs=199.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467999999999999999999976 68899999876532 3346789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---CCCCcEEEeecCCCccc
Q 005355 467 FIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGASRSV 542 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl---~~~~~~kl~DfGl~~~~ 542 (700)
|+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999986531 1234999999999999999999999999 9999999999999 45688999999999765
Q ss_pred ccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
... .......+|+.|+|||++. ..++.++||||||+++|||++|..||......+. ..............
T Consensus 178 ~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~~~~~ 247 (285)
T 3is5_A 178 KSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-------QQKATYKEPNYAVE 247 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCCCCC-
T ss_pred CCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH-------HhhhccCCcccccc
Confidence 332 2234456899999999986 5688999999999999999999999986553321 11111111100000
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
....++.+.+|+.+||+.||++|||+.|+++
T Consensus 248 -------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 -------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp --------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0113456889999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.68 Aligned_cols=255 Identities=27% Similarity=0.336 Sum_probs=205.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEE----cCCcEEEEEEccccC----hhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCC
Q 005355 389 TDNFNTNRILGQGGQGTVYKGML----TNGRIVAIKKSKLVD----ESNIEQFINEVAILSQI-NHRNVVKLLGCCLETE 459 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 459 (700)
.++|++.++||+|+||.||+++. .+++.||||+++... ....+.+.+|+++++++ +|+||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 47899999999999999999997 368999999876422 22345678899999999 6999999999999999
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999998654 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeeccccccccccccc--CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
+..............||+.|+|||++.+ ..++.++||||||++||||++|+.||......... .. +........
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~-~~~~~~~~~- 282 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AE-ISRRILKSE- 282 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HH-HHHHHHHCC-
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HH-HHHHHhccC-
Confidence 8664444434445679999999999985 45789999999999999999999999755432211 11 111111110
Q ss_pred hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHHH
Q 005355 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRP-----TMKEAAFEL 662 (700)
Q Consensus 618 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~~L 662 (700)
...+...+..+.+|+.+||+.||++|| +++|+++..
T Consensus 283 ---------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ---------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ---------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 112233445688999999999999999 999998754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=338.84 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=208.4
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
..++|.+.+.||+|+||.||++.+. +++.||+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3578999999999999999999986 5789999987642 34566789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 119 v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999987653 3899999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||......+. . ..+.....
T Consensus 193 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~-~~~~~~~~------ 258 (335)
T 2owb_A 193 YDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------Y-LRIKKNEY------ 258 (335)
T ss_dssp STT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H-HHHHHTCC------
T ss_pred cCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------H-HHHhcCCC------
Confidence 222 223345689999999999999999999999999999999999999976543221 1 11111111
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+......+.+|+.+||+.||++|||++|+++
T Consensus 259 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 ----SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223456888999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=344.59 Aligned_cols=260 Identities=22% Similarity=0.312 Sum_probs=198.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC------
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLETE------ 459 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 459 (700)
.++|++.+.||+|+||.||+|.+. +++.||||++.. ......+.+.+|++++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 578999999999999999999975 689999999854 33445678899999999999999999999998663
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
..++||||+ +++|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 88999999864 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH--------H
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL--------E 610 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~--------~ 610 (700)
+..... .....+|..|+|||++.+ ..++.++||||||++++||++|+.||.+.+..+......... .
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 864322 234568999999999887 679999999999999999999999998765432211110000 0
Q ss_pred HHHhcchhhhc------chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 611 AMKENRLFEVL------DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 611 ~~~~~~~~~~~------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.+........+ ...............+.+|+.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00000000000 000001111233567899999999999999999999988
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=355.45 Aligned_cols=265 Identities=26% Similarity=0.342 Sum_probs=188.2
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC-----Cc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLET-----EV 460 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 460 (700)
.++|++.++||+|+||.||+|.+. +++.||||++.. .+....+.+.+|+++|++++|+||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999976 689999998764 3445567899999999999999999999998543 46
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.++||||+ +++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 79999998 579999997653 3999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCc--------------------------eeeeeeeccccccccccc-ccCCCCcccceehHHHHHHHHHh-----
Q 005355 541 SVMIDQT--------------------------HLTTRVQGTFGYLDPEYF-RSSQFTEKSDVYSFGVVLVELLT----- 588 (700)
Q Consensus 541 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlG~il~ellt----- 588 (700)
....... .......||+.|+|||++ ....++.++|||||||+||||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 6542211 123345689999999986 56679999999999999999999
Q ss_pred ------CCCCCCCCCchh-----------------hhhHHHHHHHHHHhcc---hhhhcch--------------hhhhc
Q 005355 589 ------GQKPIRSTDSEE-----------------DKSLVGYFLEAMKENR---LFEVLDA--------------RVLKE 628 (700)
Q Consensus 589 ------g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~---~~~~~d~--------------~~~~~ 628 (700)
|+++|.+..... .......+........ +..+... ....+
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 666665543110 0011111111100000 0000000 00001
Q ss_pred cCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 629 AKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 629 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
........+.+|+.+||+.||++|||++|+++
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11223567889999999999999999999998
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=346.90 Aligned_cols=268 Identities=14% Similarity=0.198 Sum_probs=209.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcC---------CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceee---------
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTN---------GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVK--------- 450 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 450 (700)
.++|++.+.||+|+||.||+|++.. ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4789999999999999999999763 789999998743 45889999999999999887
Q ss_pred ------EEeEEEe-CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 005355 451 ------LLGCCLE-TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANI 523 (700)
Q Consensus 451 ------l~~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NI 523 (700)
+++++.. .+..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 67889999999 999999998652 234999999999999999999999999 99999999999
Q ss_pred EECCCC--cEEEeecCCCcccccCCce------eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCC
Q 005355 524 LLDDKY--RAKVSDFGASRSVMIDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRS 595 (700)
Q Consensus 524 Ll~~~~--~~kl~DfGl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~ 595 (700)
|++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++||||||++||||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999865433221 11334689999999999999999999999999999999999999976
Q ss_pred CCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCC
Q 005355 596 TDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDS 672 (700)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~ 672 (700)
....... .......... ......+.... ....+..+.+|+.+||+.||++|||++++++.|+++.......
T Consensus 271 ~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 271 CLPNTED--IMKQKQKFVD-KPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp GTTCHHH--HHHHHHHHHH-SCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CCcCHHH--HHHHHHhccC-Chhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 5422211 1111111111 11111110000 0122457889999999999999999999999999998776543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=348.95 Aligned_cols=264 Identities=19% Similarity=0.260 Sum_probs=212.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCC-CceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINH-RNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 466 (700)
.++|++.++||+|+||.||+|++. +++.||||++..... .+++.+|+++++.++| +++..+..+..+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 578999999999999999999974 689999998765332 2458899999999976 566667777778888899999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---CCCCcEEEeecCCCcccc
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl---~~~~~~kl~DfGl~~~~~ 543 (700)
|+ +++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++...
T Consensus 84 ~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999986433 3999999999999999999999999 9999999999999 688999999999998764
Q ss_pred cCCce------eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 544 IDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 544 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
..... ......||+.|+|||++.+..++.++||||||++||||++|+.||..............+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 43321 122566999999999999999999999999999999999999999876654433332222211111111
Q ss_pred hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 618 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
. .+. ...+.++.+|+.+||+.+|++||++.+|+++|+.+....
T Consensus 238 ----~-~l~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 238 ----E-ALC----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp ----H-HHH----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ----H-HHh----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 1 111 123457899999999999999999999999999986644
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=342.54 Aligned_cols=252 Identities=20% Similarity=0.285 Sum_probs=203.0
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 465 (700)
..++|++.+.||+|+||.||++..+ +++.||||++..... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3577999999999999999999986 688999999865432 245788888887 7999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC----CcEEEeecCCCcc
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK----YRAKVSDFGASRS 541 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~----~~~kl~DfGl~~~ 541 (700)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||++..
T Consensus 96 E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999998654 3999999999999999999999999 9999999999998543 3599999999986
Q ss_pred cccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
..... .......+|+.|+|||++.+..++.++||||||+++|||++|..||......... .....+..+.+..
T Consensus 170 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~~~~i~~~~~~~-- 242 (342)
T 2qr7_A 170 LRAEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE----EILARIGSGKFSL-- 242 (342)
T ss_dssp CBCTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH----HHHHHHHHCCCCC--
T ss_pred CcCCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH----HHHHHHccCCccc--
Confidence 54332 2233456899999999999888999999999999999999999999754322211 1222232222210
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
........+..+.+|+.+||+.||++||++.|+++
T Consensus 243 ----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 243 ----SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ----CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111234567889999999999999999999987
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.49 Aligned_cols=243 Identities=23% Similarity=0.353 Sum_probs=203.5
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--------hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--------ESNIEQFINEVAILSQINHRNVVKLLGCCLET 458 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 458 (700)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3578999999999999999999975 68899999876532 11334678899999999999999999999999
Q ss_pred CcceEEEeeCCCC-CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 459 EVPLLVYEFIPNG-TLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 459 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
+..++||||+..| +|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9999998654 3999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccCCC-CcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcc
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR 616 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 616 (700)
++...... .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......
T Consensus 176 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------- 237 (335)
T 3dls_A 176 SAAYLERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------- 237 (335)
T ss_dssp TCEECCTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT----------------
T ss_pred cceECCCC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH----------------
Confidence 99765432 22344569999999999988876 789999999999999999999996422110
Q ss_pred hhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 617 LFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 617 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.... ..+...+..+.+|+.+||+.||++|||++|+++.
T Consensus 238 -~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 -EAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -TTCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -hhcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0111234568899999999999999999999984
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=342.21 Aligned_cols=265 Identities=25% Similarity=0.381 Sum_probs=203.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
.++|++.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 578999999999999999999986 5899999987543 3334567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999998876543 3999999999999999999999999 999999999999999999999999999765332
Q ss_pred CceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH--------HHHHHhcc
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF--------LEAMKENR 616 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 616 (700)
. .......+++.|+|||++.+. .++.++||||||+++|+|++|+.||......+........ ........
T Consensus 178 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 178 G-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred c-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 2 223345689999999999875 7899999999999999999999999876543321111000 00000000
Q ss_pred -hh-----hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 617 -LF-----EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 617 -~~-----~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.. ...............+..+.+|+.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 000000011111234567999999999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=330.29 Aligned_cols=258 Identities=25% Similarity=0.355 Sum_probs=207.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh------hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE------SNIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
.++|++.+.||+|+||.||++... +++.||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467899999999999999999987 689999998764321 2367899999999999999999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC----cEEEeecC
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFG 537 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~----~~kl~DfG 537 (700)
++||||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999997643 3899999999999999999999999 99999999999998877 89999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
++....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||......+. ...+.....
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-------LTNISAVNY 228 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTCC
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-------HHHhHhccc
Confidence 997653222 22345689999999999999999999999999999999999999976543221 111111111
Q ss_pred hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH--HHHhchh
Q 005355 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF--ELGGIRA 667 (700)
Q Consensus 618 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~~ 667 (700)
....... ...+..+.+|+.+||+.||++|||+.|+++ .++.++.
T Consensus 229 --~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 229 --DFDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp --CCCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred --CCcchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 0111111 123456889999999999999999999998 4555543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.58 Aligned_cols=246 Identities=28% Similarity=0.365 Sum_probs=206.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999986 57889999876422 22346789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999998754 3899999999999999999999999 99999999999999999999999999865432
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
. ......+++.|+|||++.+..++.++||||||+++|+|++|..||......+. ...+.....
T Consensus 167 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~------- 229 (284)
T 2vgo_A 167 L---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-------HRRIVNVDL------- 229 (284)
T ss_dssp S---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTCC-------
T ss_pred c---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-------HHHHhcccc-------
Confidence 2 22345689999999999999999999999999999999999999976543321 111111111
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+...+..+.+|+.+||+.||.+||+++|+++
T Consensus 230 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 ---KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 112233457889999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=340.12 Aligned_cols=259 Identities=22% Similarity=0.294 Sum_probs=206.1
Q ss_pred HHHHHhcCCCcc-ceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeC
Q 005355 384 ELEMATDNFNTN-RILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQI-NHRNVVKLLGCCLET 458 (700)
Q Consensus 384 e~~~~~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 458 (700)
..+...++|.+. +.||+|+||.||+|... +++.||||++... .......+.+|+.+++++ +||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 344556777777 89999999999999976 6899999987653 233467899999999998 569999999999999
Q ss_pred CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEEEee
Q 005355 459 EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD---KYRAKVSD 535 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~---~~~~kl~D 535 (700)
+..++||||+++++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECC
T ss_pred CeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEee
Confidence 99999999999999999986542 234999999999999999999999999 999999999999987 78999999
Q ss_pred cCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc
Q 005355 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN 615 (700)
Q Consensus 536 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 615 (700)
||+++..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||......+.. ..+...
T Consensus 178 fg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-------~~i~~~ 248 (327)
T 3lm5_A 178 FGMSRKIGHA--CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY-------LNISQV 248 (327)
T ss_dssp GGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHT
T ss_pred CccccccCCc--cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-------HHHHhc
Confidence 9999865322 2233456999999999999999999999999999999999999999765543211 111111
Q ss_pred chhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 616 RLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 616 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.. ..........+..+.+|+.+||+.||++|||++|+++.
T Consensus 249 ~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 NV------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CC------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cc------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 10 00111122345568899999999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.23 Aligned_cols=250 Identities=23% Similarity=0.374 Sum_probs=201.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe----CCcc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLE----TEVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 461 (700)
...|++.+.||+|+||.||+|.+. ++..||+|++.. ......+.+.+|+.++++++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345788889999999999999976 678999998764 345567889999999999999999999999875 3457
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-CCCcEEEeecCCCc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGASR 540 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~-~~~~~kl~DfGl~~ 540 (700)
++||||+++++|.+++.... .+++..++.++.||+.||+|||+.+ .+|+||||||+|||++ .++.+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 89999999999999998753 3899999999999999999999986 3499999999999997 78999999999996
Q ss_pred ccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||........ .......+....
T Consensus 181 ~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~- 249 (290)
T 1t4h_A 181 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPA- 249 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCG-
T ss_pred ccccc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH------HHHHHhccCCcc-
Confidence 54322 2334568999999998874 589999999999999999999999976443221 111122111111
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+...+..+.+|+.+||+.||++|||++|+++
T Consensus 250 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 -------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111122346889999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=342.48 Aligned_cols=267 Identities=24% Similarity=0.282 Sum_probs=199.7
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChh-----hHHHHHHHHHHHhhcCCCceeeEEeEEEeC
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDES-----NIEQFINEVAILSQINHRNVVKLLGCCLET 458 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 458 (700)
+....++|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|++++++++||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 3445688999999999999999999976 5899999998753221 124688999999999999999999999999
Q ss_pred CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 005355 459 EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGA 538 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl 538 (700)
+..++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred CceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccc
Confidence 999999999975 8999987653 24888999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc--
Q 005355 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN-- 615 (700)
Q Consensus 539 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 615 (700)
++...... .......+|+.|+|||++.+. .++.++||||||+++|||++|.+||......+. ...........
T Consensus 159 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~---~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 159 AKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTE 234 (346)
T ss_dssp GSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCT
T ss_pred ceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHcCCCCh
Confidence 98653322 223345689999999999764 588999999999999999999999976543321 11111111100
Q ss_pred -chhhhc---ch--------hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 616 -RLFEVL---DA--------RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 616 -~~~~~~---d~--------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.+.... +. ..........+..+.+|+.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000 00 00001112334678999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.15 Aligned_cols=253 Identities=23% Similarity=0.298 Sum_probs=194.2
Q ss_pred hcCCCcc-ceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhh-cCCCceeeEEeEEEe----CCcc
Q 005355 389 TDNFNTN-RILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQ-INHRNVVKLLGCCLE----TEVP 461 (700)
Q Consensus 389 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 461 (700)
.++|.+. ++||+|+||+||++.+. +++.||||++... ..+.+|++++.+ .+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3566665 78999999999999976 6889999998632 457788888754 589999999999875 5678
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEEEeecCC
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD---KYRAKVSDFGA 538 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~---~~~~kl~DfGl 538 (700)
++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+||||+. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 999999999999999987532 34899999999999999999999999 999999999999987 78999999999
Q ss_pred CcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 539 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
++..... .......||+.|+|||++.+..++.++||||||++||||++|..||........... ....+..+...
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~~i~~~~~~ 285 (400)
T 1nxk_A 211 AKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQYE 285 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS---HHHHHHHTCCC
T ss_pred ccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH---HHHHHHcCccc
Confidence 9854322 223455689999999999999999999999999999999999999976543321110 01111111110
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
. ........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 286 ~------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 F------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp C------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000112345578899999999999999999999974
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=341.98 Aligned_cols=266 Identities=22% Similarity=0.312 Sum_probs=202.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC-------
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLET------- 458 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 458 (700)
.++|++.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999985 78999999875432 23346788999999999999999999999874
Q ss_pred -CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 459 -EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 459 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
+..++||||++ ++|.+.+..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccC-CCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 45789999996 588888876543 3999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCC---ceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHH
Q 005355 538 ASRSVMIDQ---THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK 613 (700)
Q Consensus 538 l~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 613 (700)
+++...... ........||+.|+|||++.+ ..++.++||||||+++|||++|..||......+.............
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 998654221 222334568999999999876 4589999999999999999999999987654432222111110000
Q ss_pred hcchhhhcchhhhh--------ccC-------HHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 614 ENRLFEVLDARVLK--------EAK-------EEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 614 ~~~~~~~~d~~~~~--------~~~-------~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...+...-...... ... ......+.+|+.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00000000000000 000 011345889999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=349.43 Aligned_cols=253 Identities=25% Similarity=0.334 Sum_probs=194.2
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--------hhhHHHHHHHHHHHhhcCCCceeeEEeEEEe
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--------ESNIEQFINEVAILSQINHRNVVKLLGCCLE 457 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 457 (700)
...++|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45689999999999999999999976 57899999876421 122335889999999999999999999975
Q ss_pred CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC---CcEEEe
Q 005355 458 TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK---YRAKVS 534 (700)
Q Consensus 458 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~---~~~kl~ 534 (700)
.+..++||||+++++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 455799999999999999987653 3999999999999999999999999 9999999999999654 459999
Q ss_pred ecCCCcccccCCceeeeeeeccccccccccccc---CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHH
Q 005355 535 DFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEA 611 (700)
Q Consensus 535 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 611 (700)
|||+++.... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||........ ....
T Consensus 285 DFG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~------~~~~ 356 (419)
T 3i6u_A 285 DFGHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQ 356 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC------HHHH
T ss_pred ecccceecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH------HHHH
Confidence 9999986532 233345679999999999853 6788899999999999999999999976543221 1112
Q ss_pred HHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 612 MKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 612 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+..+... ..+... ...+..+.+|+.+||+.||++|||++|+++
T Consensus 357 i~~~~~~--~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKYN--FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCC--CCchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 2222111 011111 123457889999999999999999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=333.09 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=207.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe--CCcceE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLE--TEVPLL 463 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 463 (700)
.++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 478999999999999999999986 6899999987643 34556789999999999999999999998864 567899
Q ss_pred EEeeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 464 VYEFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAA--SIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997642 2334899999999999999999999976 2349999999999999999999999999987
Q ss_pred ccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
....... ......+++.|+|||++.+..++.++||||||+++|+|++|..||......+ ....+..+...
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~~~~~-- 234 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFR-- 234 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC--
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-------HHHHHhhcccc--
Confidence 6532221 1223458999999999999999999999999999999999999998654322 11222222221
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGG 664 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~ 664 (700)
..+...+..+.+|+.+||+.+|++||++.|+++.+..
T Consensus 235 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 235 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1122345678899999999999999999999986643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=367.52 Aligned_cols=264 Identities=26% Similarity=0.417 Sum_probs=212.4
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEcC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLTN----GRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLE 457 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 457 (700)
.+.+...++|++.+.||+|+||.||+|.+.. +..||||+.... .....+.+.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 4455567889999999999999999999752 467999998753 3445678999999999999999999999985
Q ss_pred CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 458 TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 458 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
.+..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 466899999999999999998653 24899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcc
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENR 616 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 616 (700)
+++..............+|+.|+|||++.+..++.++||||||+++|||++ |..||......+. ...+..+.
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-------~~~i~~~~ 609 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRIENGE 609 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHHTC
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHcCC
Confidence 998764433333334557789999999999999999999999999999997 9999986554321 11222211
Q ss_pred hhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 617 LFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 617 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
.. ..+...+..+.+|+.+||+.||++|||+.|+++.|+++...
T Consensus 610 ~~---------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 610 RL---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC---------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 11 11233456788999999999999999999999999988643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=349.12 Aligned_cols=198 Identities=26% Similarity=0.384 Sum_probs=167.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC-----Cc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLET-----EV 460 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 460 (700)
.++|++.+.||+|+||.||+|.+. +++.||||++.. ......+.+.+|+.+|++++|+||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 578999999999999999999976 588999999865 3344567899999999999999999999999876 56
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.++||||++ ++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999985 69999998653 3999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCc---------------------eeeeeeeccccccccccc-ccCCCCcccceehHHHHHHHHHhCCCCC
Q 005355 541 SVMIDQT---------------------HLTTRVQGTFGYLDPEYF-RSSQFTEKSDVYSFGVVLVELLTGQKPI 593 (700)
Q Consensus 541 ~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlG~il~elltg~~p~ 593 (700)
....... .......||+.|+|||++ ....++.++||||||+++|||++|..||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 6543221 123456789999999986 5667999999999999999999854444
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.41 Aligned_cols=260 Identities=17% Similarity=0.210 Sum_probs=210.0
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEE------EcCCcEEEEEEccccChhhHHHHHHHHHHHhhcC---CCceeeEEe
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGM------LTNGRIVAIKKSKLVDESNIEQFINEVAILSQIN---HRNVVKLLG 453 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~ 453 (700)
.+++...++|++.++||+|+||.||+|. ...++.||||++.... ...+..|++++++++ |+||+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3445567889999999999999999994 3468899999987544 346777888888776 999999999
Q ss_pred EEEeCCcceEEEeeCCCCCHHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC----
Q 005355 454 CCLETEVPLLVYEFIPNGTLYQYIHDQT--EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD---- 527 (700)
Q Consensus 454 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~---- 527 (700)
++...+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence 9999999999999999999999997532 2345999999999999999999999999 999999999999998
Q ss_pred -------CCcEEEeecCCCccccc-CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCch
Q 005355 528 -------KYRAKVSDFGASRSVMI-DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSE 599 (700)
Q Consensus 528 -------~~~~kl~DfGl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~ 599 (700)
++.+||+|||+++.... ..........||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 89999999999976532 2333445567999999999999999999999999999999999999998543221
Q ss_pred hhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCC-CCHHHHHHHHHhchhhc
Q 005355 600 EDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKR-PTMKEAAFELGGIRASI 669 (700)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Ps~~evl~~L~~l~~~~ 669 (700)
.. .....+. .. .....+.+++..||+.+|.+| |+++++.+.|+.+....
T Consensus 292 ~~--------------~~~~~~~-----~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 292 EC--------------KPEGLFR-----RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp EE--------------EECSCCT-----TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ce--------------eechhcc-----cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 10 0001100 00 124457789999999999998 67999999998876543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=326.49 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=199.1
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3578999999999999999999986 78999999876432 2335678999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+|+||||+|||++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999998654 3899999999999999999999999 9999999999999999999999999997653
Q ss_pred cCCceeeeeeecccccccccccccCCC-CcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
.. .......+++.|+|||++.+..+ +.++||||||+++|+|++|..||......+ ....+..+..
T Consensus 163 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~----- 228 (276)
T 2h6d_A 163 DG--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-------LFKKIRGGVF----- 228 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-----
T ss_pred CC--cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-------HHHHhhcCcc-----
Confidence 32 22234468999999999988765 689999999999999999999997644322 1112221111
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..+......+.+++.+||+.||++|||++|+++.
T Consensus 229 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 -----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0112234568899999999999999999999983
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=340.52 Aligned_cols=261 Identities=22% Similarity=0.327 Sum_probs=204.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC-----Ccc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLET-----EVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 461 (700)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 568999999999999999999976 6889999998753 344457899999999999999999999999765 357
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++|+||++ ++|.+++.... +++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~~----~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 89999996 69999997643 999999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCce--eeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcc--
Q 005355 542 VMIDQTH--LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR-- 616 (700)
Q Consensus 542 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 616 (700)
....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+..... ........
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH---HHHHCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---HHHhCCCCHH
Confidence 5433222 1234579999999998754 45899999999999999999999999876644422111 11110000
Q ss_pred -hhhhcchh--------------hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 617 -LFEVLDAR--------------VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 617 -~~~~~d~~--------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+....+.. ............+.+|+.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 000111223457889999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=342.30 Aligned_cols=269 Identities=24% Similarity=0.303 Sum_probs=202.9
Q ss_pred chHHHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEcccc-----------ChhhHHHHHHHHHHHhhcCCCcee
Q 005355 381 TSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLV-----------DESNIEQFINEVAILSQINHRNVV 449 (700)
Q Consensus 381 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~niv 449 (700)
...++....++|++.+.||+|+||.||+|...+++.||||++... +....+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 346778889999999999999999999999888999999987542 222347899999999999999999
Q ss_pred eEEeEEEeCC-----cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEE
Q 005355 450 KLLGCCLETE-----VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANIL 524 (700)
Q Consensus 450 ~l~~~~~~~~-----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NIL 524 (700)
++++++...+ ..++||||++ |+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 9999986533 4689999997 68999888643 34999999999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCCCcccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhh
Q 005355 525 LDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKS 603 (700)
Q Consensus 525 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~ 603 (700)
++.++.+||+|||++...... .......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999999754322 22334568999999999877 678999999999999999999999998765433211
Q ss_pred HHHHHHHHHHhcchhh-----------hc-------chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 604 LVGYFLEAMKENRLFE-----------VL-------DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 604 ~~~~~~~~~~~~~~~~-----------~~-------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
............. .+ ...............+.+|+.+||+.||++|||+.|+++
T Consensus 245 ---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 245 ---KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp ---HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 1111111100000 00 000001111223456889999999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=354.81 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=205.4
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|++.++||+|+||.||++++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 477899999999999999999986 68999999986422 23356789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 465 YEFIPNGTLYQYIHDQTE-EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
|||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999986532 345999999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... . .+...+.....
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~-~~~~~i~~~~~------ 410 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--K-ELKQRVLEQAV------ 410 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--H-HHHHHHHHCCC------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--H-HHHHHHhhccc------
Confidence 3322 233457999999999999999999999999999999999999999865432111 1 11111111111
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTM 655 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~ 655 (700)
..+...+..+.+|+.+||+.||++||++
T Consensus 411 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 ----TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ----CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 1223345678899999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=336.87 Aligned_cols=257 Identities=25% Similarity=0.420 Sum_probs=207.6
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--------hhhHHHHHHHHHHHhhc-CCCceeeEE
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--------ESNIEQFINEVAILSQI-NHRNVVKLL 452 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~ 452 (700)
.......++|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334555678999999999999999999986 69999999876432 12246788999999999 799999999
Q ss_pred eEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEE
Q 005355 453 GCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAK 532 (700)
Q Consensus 453 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~k 532 (700)
+++......++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999998653 3999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCcccccCCceeeeeeeccccccccccccc------CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHH
Q 005355 533 VSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS------SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVG 606 (700)
Q Consensus 533 l~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~ 606 (700)
|+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.......
T Consensus 241 l~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~------ 312 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL------ 312 (365)
T ss_dssp ECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------
T ss_pred EEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH------
Confidence 99999997654322 2334569999999999863 358889999999999999999999997644322
Q ss_pred HHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 607 YFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 607 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
....+..+... ...... ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 313 -~~~~i~~~~~~--~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 -MLRMIMEGQYQ--FSSPEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -HHHHHHHTCCC--CCHHHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHHHHHhCCCC--CCCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11112221111 000000 122356889999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.25 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=200.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|++.+.||+|+||.||+|.+. +++.||||++.. ........+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 577999999999999999999986 789999998775 3344567888999999998 999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC----------------
Q 005355 465 YEFIPNGTLYQYIHDQTE-EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD---------------- 527 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~---------------- 527 (700)
|||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976421 134899999999999999999999999 999999999999984
Q ss_pred ---CCcEEEeecCCCcccccCCceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhh
Q 005355 528 ---KYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKS 603 (700)
Q Consensus 528 ---~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~ 603 (700)
...+||+|||++....... ...+|+.|+|||++.+. .++.++||||||+++|+|++|.+++.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----
Confidence 4479999999997654322 23489999999999876 667899999999999999999877643211
Q ss_pred HHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 604 LVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...+..+... ..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 237 -----~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 -----WHEIRQGRLP---------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -----HHHHHTTCCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHHHcCCCC---------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1112222211 112233457889999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=336.98 Aligned_cols=266 Identities=23% Similarity=0.355 Sum_probs=189.6
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
.....++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 4556789999999999999999999964 68899999876533 334577889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 463 LVYEFIPNGTLYQYIHDQ-----TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
+||||+++++|.+++... .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999999752 12335899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCC----ceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHH
Q 005355 538 ASRSVMIDQ----THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAM 612 (700)
Q Consensus 538 l~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 612 (700)
++....... ........+|+.|+|||++.+ ..++.++||||||+++|+|++|..||......... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~ 240 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTL 240 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHH
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHHh
Confidence 987553221 112234568999999999876 56899999999999999999999999866543311 1111
Q ss_pred HhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 613 KENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 613 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.. ..................+..+.+|+.+||+.||.+|||+.|+++
T Consensus 241 ~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 QN-DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TS-SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cc-CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11 111110000001111223457889999999999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=333.15 Aligned_cols=253 Identities=24% Similarity=0.371 Sum_probs=202.0
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
..++|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3578999999999999999999986 588999999887666677889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++++|.+++..... .+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999999876433 3899999999999999999999999 999999999999999999999999987533211
Q ss_pred ceeeeeeeccccccccccc-----ccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 547 THLTTRVQGTFGYLDPEYF-----RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~-----~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
........+++.|+|||++ ....++.++||||||+++|+|++|..||......+. ....... ......
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~-~~~~~~ 243 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKS-DPPTLL 243 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHS-CCCCCS
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhcc-CCcccC
Confidence 1112334689999999998 467789999999999999999999999976543221 1111111 111110
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.+...+..+.+|+.+||+.||++|||+.++++
T Consensus 244 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 -------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11223456889999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=352.06 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=204.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
.++|++.++||+|+||+||++... +++.||||++... .......+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 577999999999999999999986 6899999997542 2334578999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC---CCCcEEEeecCCCccc
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGASRSV 542 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~---~~~~~kl~DfGl~~~~ 542 (700)
||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999997654 3999999999999999999999999 99999999999995 4567999999999765
Q ss_pred ccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+ ....+..+......
T Consensus 175 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~~- 243 (486)
T 3mwu_A 175 QQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAFDL- 243 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCSCS-
T ss_pred CCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCCCC-
Confidence 332 22344569999999999976 58999999999999999999999997654432 12222222221100
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
......+..+.+|+.+||+.+|.+|||+.|+++.
T Consensus 244 -----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 -----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0012234568899999999999999999999974
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=334.20 Aligned_cols=269 Identities=23% Similarity=0.347 Sum_probs=209.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEE-c-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCC------ceeeEEeEEEeCCc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGML-T-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHR------NVVKLLGCCLETEV 460 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~ 460 (700)
.++|++.+.||+|+||.||++.+ . +++.||||+++.. ....+.+.+|+++++.++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 57899999999999999999997 3 6889999998754 34457789999999998765 49999999999999
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-------------
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD------------- 527 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~------------- 527 (700)
.++||||+ +++|.+++..... .++++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 8999999987542 34899999999999999999999999 999999999999987
Q ss_pred ------CCcEEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhh
Q 005355 528 ------KYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601 (700)
Q Consensus 528 ------~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~ 601 (700)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|..||...+..+.
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 678999999999754322 2345689999999999999999999999999999999999999987655432
Q ss_pred hhHHHHHHHHH-----Hhcchhhh---------------------cch-hhhhccCHHHHHHHHHHHHHHhccCCCCCCC
Q 005355 602 KSLVGYFLEAM-----KENRLFEV---------------------LDA-RVLKEAKEEEIITVAMLAKRCLNMIGKKRPT 654 (700)
Q Consensus 602 ~~~~~~~~~~~-----~~~~~~~~---------------------~d~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs 654 (700)
........... ........ ..+ .............+.+|+.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 22211111000 00000000 000 0001112345678999999999999999999
Q ss_pred HHHHHHH--HHhchh
Q 005355 655 MKEAAFE--LGGIRA 667 (700)
Q Consensus 655 ~~evl~~--L~~l~~ 667 (700)
+.|+++. |+.++.
T Consensus 323 ~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 323 LREALKHPFFDLLKK 337 (339)
T ss_dssp HHHHTTSGGGGGGGC
T ss_pred HHHHhcCHHHHHHhc
Confidence 9999863 554443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=347.16 Aligned_cols=203 Identities=26% Similarity=0.334 Sum_probs=176.2
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc------CCCceeeEEeEEEeCC
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQI------NHRNVVKLLGCCLETE 459 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~ 459 (700)
....+|++.++||+|+||.||+|.+. +++.||||++... ....+.+.+|+++++.+ +|+||+++++.+...+
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 34578999999999999999999976 5889999998753 33446788898888887 5779999999999999
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc--EEEeecC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR--AKVSDFG 537 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~--~kl~DfG 537 (700)
..++||||+. ++|.+++...... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++. +||+|||
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEEeccC-CCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 9999999995 6999999875432 3899999999999999999999999 999999999999999887 9999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCch
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSE 599 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~ 599 (700)
++..... ......+|+.|+|||++.+..++.++||||||++||||++|..||......
T Consensus 248 ~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 248 SSCYEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp TCEETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cceecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 9965422 223456899999999999999999999999999999999999999876543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=367.27 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=208.2
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCc
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEV 460 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 460 (700)
....++|++.++||+|+||.||+|++. +++.||||+++.. .....+.+..|..++..+ +|++|+++++++.+.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 345678999999999999999999976 5889999998742 233456788999999987 79999999999999999
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.+|||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999998754 3999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
...... .......||+.|+|||++.+..++.++||||||++||||++|+.||...+..+ ....+.....
T Consensus 491 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-------~~~~i~~~~~--- 559 (674)
T 3pfq_A 491 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-------LFQSIMEHNV--- 559 (674)
T ss_dssp ECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHSSCC---
T ss_pred ccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-------HHHHHHhCCC---
Confidence 543222 23445679999999999999999999999999999999999999998654432 1222222211
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCH-----HHHHH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTM-----KEAAF 660 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~-----~evl~ 660 (700)
..+...+.++.+|+.+||+.||++||++ +||++
T Consensus 560 -------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 -------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1223345678999999999999999997 66654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=336.16 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=195.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC------
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLETE------ 459 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 459 (700)
.++|++.+.||+|+||.||+|... +++.||||++.. ......+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999976 688999999764 33455678899999999999999999999998665
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
..++||||++ ++|.+++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 6799999996 588888863 2899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHH-------------
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVG------------- 606 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~------------- 606 (700)
+.... ........||+.|+|||++.+..++.++||||||+++|||++|..||...+..+......
T Consensus 175 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 175 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred ccccc--ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 75432 222334568999999999999999999999999999999999999998765432110000
Q ss_pred ---HHHHHHHhc------chhhhcchhhh---hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 607 ---YFLEAMKEN------RLFEVLDARVL---KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 607 ---~~~~~~~~~------~~~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
......... .+......... .+........+.+|+.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000000 00000000000 0011234667999999999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=337.54 Aligned_cols=259 Identities=24% Similarity=0.371 Sum_probs=201.8
Q ss_pred chHHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEe-
Q 005355 381 TSMELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLE- 457 (700)
Q Consensus 381 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 457 (700)
+..++....++|++.+.||+|+||.||+|.+. +++.||||++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 34445556889999999999999999999985 689999999865433 347789999999998 79999999999987
Q ss_pred -----CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEE
Q 005355 458 -----TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAK 532 (700)
Q Consensus 458 -----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~k 532 (700)
.+..++||||+++++|.+++.... ...+++..++.++.||+.||+|||+++ |+|+||||+|||++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 467899999999999999998653 234899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCcccccCCceeeeeeecccccccccccc-----cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHH
Q 005355 533 VSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGY 607 (700)
Q Consensus 533 l~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 607 (700)
|+|||++....... .......+++.|+|||++. +..++.++||||||+++|+|++|..||........
T Consensus 170 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------ 242 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------ 242 (326)
T ss_dssp ECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------
T ss_pred EeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------
Confidence 99999997653221 1233456899999999987 56788999999999999999999999975543221
Q ss_pred HHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 608 FLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 608 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. ..+........ .....+..+.+|+.+||..||.+||++.++++
T Consensus 243 ~-~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 243 L-FLIPRNPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp H-HHHHHSCCCCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H-HHhhcCccccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1 11111111111 11223457889999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=343.01 Aligned_cols=258 Identities=24% Similarity=0.313 Sum_probs=186.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC------C
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLET------E 459 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 459 (700)
.++|++.+.||+|+||.||+|.+. +++.||||++.. ......+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 578999999999999999999975 689999999865 3344567889999999999999999999998754 5
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
..++|+|++ +++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 78999998753 3999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc---
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN--- 615 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 615 (700)
+.... ......+|..|+|||++.+ ..++.++||||||+++|||++|+.||.+.+..+.... ........
T Consensus 180 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~---i~~~~g~p~~~ 252 (367)
T 2fst_X 180 RHTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPGAE 252 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHH
T ss_pred ccccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCCHH
Confidence 76432 1334568999999999887 6789999999999999999999999987654332111 11111000
Q ss_pred chhhhcch--------------hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 616 RLFEVLDA--------------RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 616 ~~~~~~d~--------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.+..+... .............+.+|+.+||+.||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000000 00000011224568899999999999999999999873
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.59 Aligned_cols=250 Identities=16% Similarity=0.183 Sum_probs=195.3
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc---cChhhHHHHHHHHH---HHhhcCCCceeeEE-------e
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL---VDESNIEQFINEVA---ILSQINHRNVVKLL-------G 453 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~ 453 (700)
..++|++.+.||+|+||.||+|++. +++.||||++.. ......+.+.+|+. ++++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 4578999999999999999999964 689999999863 34456688999995 45556899999998 6
Q ss_pred EEEeCCc-----------------ceEEEeeCCCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 005355 454 CCLETEV-----------------PLLVYEFIPNGTLYQYIHDQTE----EFPITWEIRLRIAIEVSDALCYLHSAASIP 512 (700)
Q Consensus 454 ~~~~~~~-----------------~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ 512 (700)
++.+.+. .++||||+ +|+|.+++..... ...+++..++.++.||+.||+|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 6655432 78999999 6899999986421 123456888999999999999999999
Q ss_pred eeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeeeeecccccccccccccC-----------CCCcccceehHHH
Q 005355 513 IYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS-----------QFTEKSDVYSFGV 581 (700)
Q Consensus 513 ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwSlG~ 581 (700)
|+||||||+||||+.++.+||+|||+++... .......| +.|+|||++.+. .++.++||||||+
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999997532 23344557 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH-
Q 005355 582 VLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF- 660 (700)
Q Consensus 582 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~- 660 (700)
+||||++|+.||......+. ...+.. .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~---------------~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG---------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CC---------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccc---------------hhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999965432221 111111 01123457889999999999999999999996
Q ss_pred -HHHhchh
Q 005355 661 -ELGGIRA 667 (700)
Q Consensus 661 -~L~~l~~ 667 (700)
.++.++.
T Consensus 361 p~f~~~~~ 368 (377)
T 3byv_A 361 PEYEQLRT 368 (377)
T ss_dssp HHHHHHHH
T ss_pred hHHHHHHH
Confidence 4555544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=332.03 Aligned_cols=256 Identities=23% Similarity=0.317 Sum_probs=200.8
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEe--CCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQIN-HRNVVKLLGCCLE--TEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 464 (700)
.++|++.+.||+|+||.||+|... +++.||||+++... .+.+.+|++++++++ |+||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 477999999999999999999974 68999999987433 467899999999997 9999999999987 5678999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEeecCCCcccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGASRSVM 543 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~-~~kl~DfGl~~~~~ 543 (700)
|||+++++|.+++.. +++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999999853 889999999999999999999999 99999999999999776 89999999997654
Q ss_pred cCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||......... +. ..........+...++
T Consensus 183 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~-~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LV-RIAKVLGTEDLYDYID 258 (330)
T ss_dssp TTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HH-HHHHHHCHHHHHHHHH
T ss_pred CCC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HH-HHHHhcCCchhhhHHH
Confidence 322 2334568999999999977 67899999999999999999999999654332211 11 1111111000000000
Q ss_pred h-----------------------hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 623 A-----------------------RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 623 ~-----------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. ..........+..+.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0000111124567899999999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=332.40 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=190.4
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-h-hhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-E-SNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
...++|++.+.||+|+||.||++... +++.||||++.... . ...+.+.++...++.++||||+++++++.+.+..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 34678999999999999999999975 68999999987532 2 233444555556788899999999999999999999
Q ss_pred EEeeCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 464 VYEFIPNGTLYQYIHDQ-TEEFPITWEIRLRIAIEVSDALCYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
||||++ ++|.+++... .....+++..++.++.||+.||+|||++ + |+||||||+|||++.++.+||+|||++..
T Consensus 84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 999996 5888887652 1223599999999999999999999998 8 99999999999999999999999999976
Q ss_pred cccCCceeeeeeeccccccccccc----ccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYF----RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
.... .......||+.|+|||++ .+..++.++||||||+++|+|++|..||........ ...........
T Consensus 160 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~ 232 (290)
T 3fme_A 160 LVDD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-----QLKQVVEEPSP 232 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-----HHHHHHHSCCC
T ss_pred cccc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-----HHHHHhccCCC
Confidence 5332 222334689999999996 566789999999999999999999999975433221 11112221111
Q ss_pred hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.......+..+.+|+.+||+.||++|||+.|+++
T Consensus 233 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 ---------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0111223457889999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.14 Aligned_cols=269 Identities=23% Similarity=0.347 Sum_probs=207.4
Q ss_pred chHHHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC
Q 005355 381 TSMELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLET 458 (700)
Q Consensus 381 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 458 (700)
...+++...++|++.+.||+|+||.||+|.+.. .||+|+++.. .....+.+.+|+.++++++|+||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 345566678999999999999999999999863 4999987653 233346688999999999999999999999999
Q ss_pred CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 005355 459 EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGA 538 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl 538 (700)
+..++||||+++++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCC--CCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 999999999999999999976542 4899999999999999999999999 99999999999998 67999999999
Q ss_pred CcccccCC----ceeeeeeeccccccccccccc---------CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHH
Q 005355 539 SRSVMIDQ----THLTTRVQGTFGYLDPEYFRS---------SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLV 605 (700)
Q Consensus 539 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~ 605 (700)
+....... ........|++.|+|||++.. ..++.++||||||+++|||++|..||......+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---- 251 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI---- 251 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH----
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----
Confidence 87543211 112233458999999999864 4578899999999999999999999976543321
Q ss_pred HHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCC
Q 005355 606 GYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDS 672 (700)
Q Consensus 606 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~ 672 (700)
...+..+...... ....+..+.+|+.+||..+|++|||+.+++++|+.+.......
T Consensus 252 ---~~~~~~~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 252 ---IWQMGTGMKPNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp ---HHHHHTTCCCCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred ---HHHhccCCCCCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 1112221111111 1123346888999999999999999999999999998765543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=328.02 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=201.4
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
....++|++.+.||+|+||.||+|.+. +++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 345678999999999999999999986 58999999987533 346789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++++|.+++..... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EECCTTEEHHHHHHHHTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred eecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999999974332 3899999999999999999999999 99999999999999999999999999976533
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
.. .......+++.|+|||++.+..++.++||||||+++|+|++|..||........ .. ...........
T Consensus 178 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~-~~~~~~~~~~~--- 246 (314)
T 3com_A 178 TM-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IF-MIPTNPPPTFR--- 246 (314)
T ss_dssp TB-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HH-HHHHSCCCCCS---
T ss_pred hc-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HH-HHhcCCCcccC---
Confidence 22 223345689999999999999999999999999999999999999976543221 11 11111110000
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.+...+..+.+|+.+||+.||.+|||+.++++
T Consensus 247 ----~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 ----KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 01123456889999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=353.88 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=207.2
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
..++|++.++||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3567999999999999999999986 7899999987542 23456789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---CCCCcEEEeecCCCc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL---DDKYRAKVSDFGASR 540 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl---~~~~~~kl~DfGl~~ 540 (700)
||||+.+++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++.
T Consensus 104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999997654 3999999999999999999999999 9999999999999 567899999999997
Q ss_pred ccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
...... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+ ....+..+.....
T Consensus 178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKGKYTFE 247 (484)
T ss_dssp HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCCC
T ss_pred Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCCCC
Confidence 653222 2334569999999999876 68999999999999999999999998665432 1222222222110
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. ......+..+.+|+.+||+.+|.+|||+.|+++
T Consensus 248 ~------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 L------PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp S------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 001223457889999999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=352.33 Aligned_cols=251 Identities=29% Similarity=0.390 Sum_probs=204.0
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh-------------hhHHHHHHHHHHHhhcCCCceeeEEe
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE-------------SNIEQFINEVAILSQINHRNVVKLLG 453 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 453 (700)
..++|++.++||+|+||+||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4688999999999999999999986 578999998764321 23577899999999999999999999
Q ss_pred EEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC---c
Q 005355 454 CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY---R 530 (700)
Q Consensus 454 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~---~ 530 (700)
++.+....++||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999999997654 3999999999999999999999999 99999999999998775 6
Q ss_pred EEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 005355 531 AKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLE 610 (700)
Q Consensus 531 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 610 (700)
+||+|||++...... .......||+.|+|||++. ..++.++||||||+++|+|++|..||......+ ...
T Consensus 188 ~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~ 257 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------IIK 257 (504)
T ss_dssp EEECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHH
T ss_pred EEEEECCCCEEcCCC--CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHH
Confidence 999999999865432 2234456999999999987 468999999999999999999999998665432 222
Q ss_pred HHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 611 AMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 611 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.+..+.... +.... ...+..+.+|+.+||+.||.+|||++|+++
T Consensus 258 ~i~~~~~~~--~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 258 KVEKGKYYF--DFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHCCCCC--CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHcCCCCC--Ccccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 222222110 11111 123456889999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.52 Aligned_cols=251 Identities=22% Similarity=0.278 Sum_probs=200.8
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC----hhhHHHHHHHHHHHhhcCCCceeeEEeEEE--eCCcc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD----ESNIEQFINEVAILSQINHRNVVKLLGCCL--ETEVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 461 (700)
.++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++|+||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999975 68899999986532 234678999999999999999999999984 45578
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++||||++++ |.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999876 7777766432 34999999999999999999999999 99999999999999999999999999986
Q ss_pred cccC-CceeeeeeecccccccccccccCC--CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 542 VMID-QTHLTTRVQGTFGYLDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 542 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
.... .........+++.|+|||++.+.. ++.++||||||+++|||++|..||......+ ....+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~i~~~~~- 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-------LFENIGKGSY- 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCCC-
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-------HHHHHhcCCC-
Confidence 5432 222334456899999999997654 3779999999999999999999997654322 1122222211
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..+...+..+.+|+.+||+.||.+|||++|+++.
T Consensus 231 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ---------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1122334578899999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=351.75 Aligned_cols=251 Identities=27% Similarity=0.353 Sum_probs=201.6
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
..++|++.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567999999999999999999986 68899999876532 33457789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEEEeecCCCcc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD---KYRAKVSDFGASRS 541 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~---~~~~kl~DfGl~~~ 541 (700)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++..
T Consensus 115 ~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999987654 3899999999999999999999999 999999999999976 45599999999976
Q ss_pred cccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
.... .......||+.|+|||++. ..++.++||||||+++|+|++|..||......+ ....+..+....
T Consensus 189 ~~~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~-- 256 (494)
T 3lij_A 189 FENQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------ILRKVEKGKYTF-- 256 (494)
T ss_dssp CBTT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC--
T ss_pred CCCC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC--
Confidence 5432 2234456999999999986 568999999999999999999999998665432 122222222110
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.... ....+..+.+|+.+||+.+|.+|||+.|+++
T Consensus 257 ~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 DSPE----WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CSGG----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cchh----cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0000 1123456889999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=325.77 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=205.9
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---------hhhHHHHHHHHHHHhhcC-CCceeeEEeEEE
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---------ESNIEQFINEVAILSQIN-HRNVVKLLGCCL 456 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 456 (700)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999986 68899999986532 123567889999999995 999999999999
Q ss_pred eCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeec
Q 005355 457 ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 536 (700)
Q Consensus 457 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~Df 536 (700)
+.+..++||||+++++|.+++.... .+++..++.++.||+.||+|||+++ ++|+||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999998653 3899999999999999999999999 999999999999999999999999
Q ss_pred CCCcccccCCceeeeeeecccccccccccc------cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHH
Q 005355 537 GASRSVMIDQTHLTTRVQGTFGYLDPEYFR------SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLE 610 (700)
Q Consensus 537 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~ 610 (700)
|++....... ......+++.|+|||++. ...++.++||||||+++|+|++|..||......+ ...
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~ 239 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLR 239 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHH
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-------HHH
Confidence 9997654322 233456899999999985 4568899999999999999999999997654322 111
Q ss_pred HHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 611 AMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 611 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.+..+.... . .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~-~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGNYQF-G-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTCCCC-C-----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCCccc-C-----cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 222221110 0 0011234557889999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=340.26 Aligned_cols=262 Identities=25% Similarity=0.283 Sum_probs=204.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC--------CCceeeEEeEEE---
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQIN--------HRNVVKLLGCCL--- 456 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 456 (700)
.++|++.++||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 578999999999999999999975 6889999998743 344578899999999985 788999999987
Q ss_pred -eCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCC-----
Q 005355 457 -ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA-ASIPIYHRDIKSANILLDDKY----- 529 (700)
Q Consensus 457 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dik~~NILl~~~~----- 529 (700)
.....++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 456789999999 6677777665432 3499999999999999999999998 8 99999999999998775
Q ss_pred --------------------------------------------cEEEeecCCCcccccCCceeeeeeeccccccccccc
Q 005355 530 --------------------------------------------RAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF 565 (700)
Q Consensus 530 --------------------------------------------~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~ 565 (700)
.+||+|||++...... .....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999765322 2334689999999999
Q ss_pred ccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH---HHHHHh--------cchh-hhcc-----------
Q 005355 566 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF---LEAMKE--------NRLF-EVLD----------- 622 (700)
Q Consensus 566 ~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~--------~~~~-~~~d----------- 622 (700)
.+..++.++||||||++||||++|+.||......+........ ...... +... ....
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 9999999999999999999999999999866543322111111 111100 0000 0000
Q ss_pred ------hhh--hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 623 ------ARV--LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 623 ------~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+ ....+......+.+|+.+||+.||++|||++|+++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 01234667788999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=342.99 Aligned_cols=269 Identities=22% Similarity=0.293 Sum_probs=200.6
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC-----
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLET----- 458 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 458 (700)
++...++|++.+.||+|+||.||+|.+. +++.||||++..... ...+|+++++.++||||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 4556789999999999999999999975 789999998764322 234799999999999999999998543
Q ss_pred ---------------------------------CcceEEEeeCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHH
Q 005355 459 ---------------------------------EVPLLVYEFIPNGTLYQYIHDQ-TEEFPITWEIRLRIAIEVSDALCY 504 (700)
Q Consensus 459 ---------------------------------~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~ 504 (700)
...++||||++ ++|.+.+... .....+++..+..++.||+.||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 33789999997 5888887642 122359999999999999999999
Q ss_pred HHhcCCCCeeecCCCCCcEEEC-CCCcEEEeecCCCcccccCCceeeeeeecccccccccccccC-CCCcccceehHHHH
Q 005355 505 LHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVV 582 (700)
Q Consensus 505 LH~~~~~~ivH~Dik~~NILl~-~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~i 582 (700)
||+++ |+||||||+|||++ .++.+||+|||+++...... ......+|..|+|||++.+. .++.++||||||++
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999 99999999999997 68899999999998653332 23345689999999998775 58999999999999
Q ss_pred HHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcc---------------hhhhcchhhhhccCHHHHHHHHHHHHHHhcc
Q 005355 583 LVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR---------------LFEVLDARVLKEAKEEEIITVAMLAKRCLNM 647 (700)
Q Consensus 583 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~ 647 (700)
+|||++|+.||......+... .......... +............+...+..+.+|+.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~---~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLV---RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHHHHH---HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 999999999998765433211 1111110000 0000001111112233456789999999999
Q ss_pred CCCCCCCHHHHHH--HHHhch
Q 005355 648 IGKKRPTMKEAAF--ELGGIR 666 (700)
Q Consensus 648 ~p~~RPs~~evl~--~L~~l~ 666 (700)
||++|||+.|+++ .++.++
T Consensus 309 dP~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 309 EPDLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp SGGGSCCHHHHHTSGGGHHHH
T ss_pred ChhhCCCHHHHhcCHHHHHHH
Confidence 9999999999985 344444
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.94 Aligned_cols=261 Identities=25% Similarity=0.367 Sum_probs=197.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEE-----------
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCL----------- 456 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 456 (700)
.++|++.+.||+|+||.||+|.+. +++.||||++...+....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 478999999999999999999987 48999999988777777889999999999999999999999874
Q ss_pred ---eCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-CCCcEE
Q 005355 457 ---ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD-DKYRAK 532 (700)
Q Consensus 457 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~-~~~~~k 532 (700)
+....++||||++ |+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467789999997 6999999653 3899999999999999999999999 99999999999997 567999
Q ss_pred EeecCCCcccccCCc--eeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 005355 533 VSDFGASRSVMIDQT--HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL 609 (700)
Q Consensus 533 l~DfGl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 609 (700)
|+|||+++....... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.... ..
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~---~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL---IL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH---HH
Confidence 999999986532211 11233457889999998865 6789999999999999999999999987654322111 11
Q ss_pred HHHHh------cchhhhc----chhh------hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 610 EAMKE------NRLFEVL----DARV------LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 610 ~~~~~------~~~~~~~----d~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..... ..+...+ .... ........+..+.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 10000 0000000 0000 00111234567899999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=343.13 Aligned_cols=269 Identities=23% Similarity=0.298 Sum_probs=199.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc------ce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEV------PL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~ 462 (700)
..+|++.++||+|+||.||+|++..+..||+|++..... ...+|+++++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 467999999999999999999998777799998754322 22479999999999999999999965443 67
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-CCCcEEEeecCCCcc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGASRS 541 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~-~~~~~kl~DfGl~~~ 541 (700)
+||||++++.+............+++..+..++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999976544444332222345999999999999999999999999 99999999999999 799999999999986
Q ss_pred cccCCceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH--------HHH
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL--------EAM 612 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~~ 612 (700)
..... ......+|+.|+|||++.+. .++.++||||||+++|||++|+.||.+....+......... ..+
T Consensus 192 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 192 LIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 53332 23345689999999998765 58999999999999999999999998765433211111000 000
Q ss_pred Hh----cchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhch
Q 005355 613 KE----NRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE--LGGIR 666 (700)
Q Consensus 613 ~~----~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~--L~~l~ 666 (700)
.. ..+..+.............+..+.+|+.+||+.||.+|||+.|+++. ++.++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 00 00000000001111122345678999999999999999999999974 45444
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=331.89 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=198.1
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--------hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--------ESNIEQFINEVAILSQINHRNVVKLLGCCLET 458 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 458 (700)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3578999999999999999999976 57899999876422 12234688999999999999999999998765
Q ss_pred CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc---EEEee
Q 005355 459 EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR---AKVSD 535 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~---~kl~D 535 (700)
+ .++||||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 799999999999999997543 3899999999999999999999999 999999999999987654 99999
Q ss_pred cCCCcccccCCceeeeeeecccccccccccc---cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHH
Q 005355 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAM 612 (700)
Q Consensus 536 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~ 612 (700)
||++...... .......||+.|+|||++. ...++.++||||||+++|+|++|..||........ + ...+
T Consensus 161 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~----~~~~ 232 (322)
T 2ycf_A 161 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L----KDQI 232 (322)
T ss_dssp CTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--H----HHHH
T ss_pred Cccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--H----HHHH
Confidence 9999765322 2223456899999999974 56788999999999999999999999976543221 1 1111
Q ss_pred HhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 613 KENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 613 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+... ..+... ...+..+.+|+.+||+.||++||++.|+++
T Consensus 233 ~~~~~~--~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TSGKYN--FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCccc--cCchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 211111 011111 123457889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=337.42 Aligned_cols=274 Identities=21% Similarity=0.280 Sum_probs=196.3
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc-
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEV- 460 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 460 (700)
.......++|++.+.||+|+||.||+|++. +++.||||++.... .....+.+|++.+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 456677899999999999999999999986 68999999875432 223567788888999999999999999976443
Q ss_pred ------ceEEEeeCCCCCHHHHHhc-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeeecCCCCCcEEECC-CCc
Q 005355 461 ------PLLVYEFIPNGTLYQYIHD-QTEEFPITWEIRLRIAIEVSDALCYLH--SAASIPIYHRDIKSANILLDD-KYR 530 (700)
Q Consensus 461 ------~~lv~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~~~~ivH~Dik~~NILl~~-~~~ 530 (700)
.++||||+++ +|.+.+.. ......+++..+..++.|++.||.||| +++ |+||||||+||||+. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 6899999976 55554432 233345899999999999999999999 888 999999999999996 899
Q ss_pred EEEeecCCCcccccCCceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH
Q 005355 531 AKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL 609 (700)
Q Consensus 531 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 609 (700)
+||+|||++....... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+..... .
T Consensus 171 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~---~ 245 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI---V 245 (360)
T ss_dssp EEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H
T ss_pred EEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH---H
Confidence 9999999998654332 22344589999999998665 4899999999999999999999999876543321111 1
Q ss_pred HHHHhcc--hhhh----------------cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhch
Q 005355 610 EAMKENR--LFEV----------------LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE--LGGIR 666 (700)
Q Consensus 610 ~~~~~~~--~~~~----------------~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~--L~~l~ 666 (700)
....... .... .............+..+.+|+.+||+.||.+|||+.|+++. ++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 1100000 0000 00111111222346789999999999999999999999973 44443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=345.28 Aligned_cols=260 Identities=14% Similarity=0.064 Sum_probs=187.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhc--CCCceeeEE-------eEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQI--NHRNVVKLL-------GCC 455 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 455 (700)
..+|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456899999999999999999976 78999999987643 24456778886555555 699988755 444
Q ss_pred EeCC-----------------cceEEEeeCCCCCHHHHHhccCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 005355 456 LETE-----------------VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIR------LRIAIEVSDALCYLHSAASIP 512 (700)
Q Consensus 456 ~~~~-----------------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qi~~aL~~LH~~~~~~ 512 (700)
.... ..++||||++ ++|.+++..... .+++..+ +.++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 4332 3699999998 899999987522 2455555 788899999999999999
Q ss_pred eeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeeeeeccccccccccccc--CCCCcccceehHHHHHHHHHhCC
Q 005355 513 IYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQ 590 (700)
Q Consensus 513 ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlG~il~elltg~ 590 (700)
|+||||||+||||+.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++||||||++||||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999975421 1223457799999999987 78999999999999999999999
Q ss_pred CCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH--HHHhch
Q 005355 591 KPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF--ELGGIR 666 (700)
Q Consensus 591 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~ 666 (700)
.||.......... ......................+..+.+|+.+||+.||++|||+.|+++ .++++.
T Consensus 291 ~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 291 LPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp CSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 9998664332110 0000000000001111111234567899999999999999999999985 344443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=334.42 Aligned_cols=261 Identities=24% Similarity=0.305 Sum_probs=202.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC-----Ccc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLET-----EVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 461 (700)
.++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 578999999999999999999986 6889999998753 344567788999999999999999999988754 677
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++||||+. ++|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999996 6999999764 3999999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCce---------eeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHH
Q 005355 542 VMIDQTH---------LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEA 611 (700)
Q Consensus 542 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 611 (700)
....... ......||+.|+|||++.. ..++.++||||||+++|+|++|+.||......+..... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~ 238 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI---FGI 238 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HHH
Confidence 5432111 1123468999999998764 77899999999999999999999999876543221111 111
Q ss_pred HHhc----chhhhcchh--------------hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 612 MKEN----RLFEVLDAR--------------VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 612 ~~~~----~~~~~~d~~--------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.... ....+.... .........+..+.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000 000000000 000111234567889999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=336.30 Aligned_cols=257 Identities=24% Similarity=0.337 Sum_probs=199.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc----
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP---- 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 461 (700)
.++|.+.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 578999999999999999999976 6899999998753 344467889999999999999999999999877665
Q ss_pred --eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 462 --LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 462 --~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
++||||+. ++|.+++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999996 688888743 2899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc--c
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN--R 616 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 616 (700)
+..... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+.... ........ .
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~ 264 (371)
T 4exu_A 192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ---ILKVTGVPGTE 264 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCHH
T ss_pred cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCcHH
Confidence 754322 234568999999999987 7889999999999999999999999986654322111 11100000 0
Q ss_pred hhhhcch--------hh-------hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 617 LFEVLDA--------RV-------LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 617 ~~~~~d~--------~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
+...+.. .+ ........+..+.+|+.+||+.||++|||++|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000 00 000112235678999999999999999999999873
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=332.07 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=201.8
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccc--cChhhHHHHHHHHHHHhhcC--CCceeeEEeEEEeC
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKL--VDESNIEQFINEVAILSQIN--HRNVVKLLGCCLET 458 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 458 (700)
..+....++|++.+.||+|+||.||++...+++.||||++.. ......+.+.+|++++++++ |+||+++++++.+.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 344556788999999999999999999988899999998764 34456688999999999997 59999999999999
Q ss_pred CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 005355 459 EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGA 538 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl 538 (700)
+..++||| +.+++|.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||+++ +.+||+|||+
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred CEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence 99999999 56889999998654 3899999999999999999999999 999999999999965 7999999999
Q ss_pred CcccccCCce-eeeeeeccccccccccccc-----------CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHH
Q 005355 539 SRSVMIDQTH-LTTRVQGTFGYLDPEYFRS-----------SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVG 606 (700)
Q Consensus 539 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~ 606 (700)
+......... ......|++.|+|||++.+ ..++.++||||||+++|||++|..||........
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----- 247 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----- 247 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-----
Confidence 9865433222 2234568999999999875 4688899999999999999999999975432211
Q ss_pred HHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 607 YFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 607 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
.+.... +.......+...+..+.+|+.+||+.||++||++.|+++.
T Consensus 248 ~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 248 KLHAII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHH---------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111 1111111122224578899999999999999999999873
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=330.65 Aligned_cols=263 Identities=25% Similarity=0.371 Sum_probs=202.8
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEc--CCcEEEEEEccccC--hhhHHHHHHHHHHHhhc---CCCceeeEEeEEE----
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLT--NGRIVAIKKSKLVD--ESNIEQFINEVAILSQI---NHRNVVKLLGCCL---- 456 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 456 (700)
..++|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4588999999999999999999983 67899999876422 22234566777777766 8999999999987
Q ss_pred -eCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEee
Q 005355 457 -ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535 (700)
Q Consensus 457 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~D 535 (700)
.....++||||++ ++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567789999997 699999987543 24899999999999999999999999 99999999999999999999999
Q ss_pred cCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh-
Q 005355 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE- 614 (700)
Q Consensus 536 fGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 614 (700)
||++....... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||......+. ..........
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLP 238 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCC
Confidence 99997653222 23345689999999999999999999999999999999999999986654321 1111111110
Q ss_pred --cchhhh----------cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 615 --NRLFEV----------LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 615 --~~~~~~----------~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+... .............+..+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0000011122334567889999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.77 Aligned_cols=251 Identities=27% Similarity=0.467 Sum_probs=194.8
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe----------
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLE---------- 457 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 457 (700)
.++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 567899999999999999999975 7899999998643 4456789999999999999999999999865
Q ss_pred ---CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEe
Q 005355 458 ---TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVS 534 (700)
Q Consensus 458 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~ 534 (700)
.+..++||||+++++|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 346689999999999999998643 24888999999999999999999999 9999999999999999999999
Q ss_pred ecCCCcccccCC-------------ceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchh
Q 005355 535 DFGASRSVMIDQ-------------THLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600 (700)
Q Consensus 535 DfGl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~ 600 (700)
|||++....... ........+++.|+|||++.+. .++.++||||||+++|||++ ||.... +
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~ 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--E 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--H
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--h
Confidence 999997653221 1122345689999999999864 68999999999999999998 543211 1
Q ss_pred hhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 601 DKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.. .....+.... .......+...+..+.+|+.+||+.||.+|||+.++++
T Consensus 234 ~~----~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 RV----NILKKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HH----HHHHHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH----HHHHhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11 1111111111 11112233444567889999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.93 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=205.8
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
....++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 444678999999999999999999986 6899999987542 2345678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC---CcEEEeecCCC
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK---YRAKVSDFGAS 539 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~---~~~kl~DfGl~ 539 (700)
+|+||+++++|.+++.... .+++..++.++.||+.||+|||+++ ++||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999999987654 3899999999999999999999999 9999999999999754 47999999998
Q ss_pred cccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
....... ......+++.|+|||++.+ .++.++||||||+++|+|++|..||......+ ....+..+....
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~ 241 (287)
T 2wei_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAF 241 (287)
T ss_dssp GTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC
T ss_pred eeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCCC
Confidence 7653322 2233458999999999876 48999999999999999999999997654322 122222222111
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
... .....+..+.+|+.+||+.+|++|||+.|+++
T Consensus 242 ~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 DLP------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CSG------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cch------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000 01123456889999999999999999999997
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=341.19 Aligned_cols=266 Identities=23% Similarity=0.332 Sum_probs=184.7
Q ss_pred hcCCCc-cceEeeeCCeEEEEEEEc---CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe--CCcce
Q 005355 389 TDNFNT-NRILGQGGQGTVYKGMLT---NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLE--TEVPL 462 (700)
Q Consensus 389 ~~~~~~-~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 462 (700)
.+.|++ .++||+|+||+||+|++. +++.||||++..... ...+.+|+.+|++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 344555 568999999999999975 478999999875332 2568899999999999999999999965 56789
Q ss_pred EEEeeCCCCCHHHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE----CCCCcEE
Q 005355 463 LVYEFIPNGTLYQYIHDQT------EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL----DDKYRAK 532 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl----~~~~~~k 532 (700)
+||||++ ++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||| +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999996 58888876321 1234899999999999999999999999 9999999999999 6788999
Q ss_pred EeecCCCcccccCCc--eeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhh------hh
Q 005355 533 VSDFGASRSVMIDQT--HLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED------KS 603 (700)
Q Consensus 533 l~DfGl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~------~~ 603 (700)
|+|||+++....... .......||+.|+|||++.+. .++.++||||||++||||++|..||........ ..
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999986543221 223446789999999999874 589999999999999999999999976543210 01
Q ss_pred HHHHHHHHHHh---cchhhh------------cchhh---------hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 005355 604 LVGYFLEAMKE---NRLFEV------------LDARV---------LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAA 659 (700)
Q Consensus 604 ~~~~~~~~~~~---~~~~~~------------~d~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl 659 (700)
....+...+.. ..+..+ ..... ...........+.+|+.+||+.||.+|||++|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 11111111100 000000 00000 0000001134678999999999999999999999
Q ss_pred H
Q 005355 660 F 660 (700)
Q Consensus 660 ~ 660 (700)
+
T Consensus 333 ~ 333 (405)
T 3rgf_A 333 Q 333 (405)
T ss_dssp T
T ss_pred c
Confidence 8
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=343.90 Aligned_cols=265 Identities=25% Similarity=0.344 Sum_probs=197.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC------cc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETE------VP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~ 461 (700)
..+|++.+.||+|+||.||+|++. +++.||||++.... ..+.+|++++++++|+||+++++++.... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346889999999999999999986 58999999876432 22347999999999999999999986422 25
Q ss_pred eEEEeeCCCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEeecCCC
Q 005355 462 LLVYEFIPNGTLYQYIHDQ-TEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGAS 539 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~-~~~kl~DfGl~ 539 (700)
++||||+++ +|.+++... .....+++..++.++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 689999975 677666532 12335999999999999999999999999 9999999999999965 67899999999
Q ss_pred cccccCCceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc---
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN--- 615 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 615 (700)
+...... ......+|+.|+|||++.+. .++.++||||||++||||++|+.||......+.. .. ........
T Consensus 205 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l--~~-i~~~lg~p~~~ 279 (420)
T 1j1b_A 205 KQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VE-IIKVLGTPTRE 279 (420)
T ss_dssp EECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH-HHHHHCSCCHH
T ss_pred hhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHHHhCCCCHH
Confidence 8653322 22345689999999998764 7899999999999999999999999876533211 11 11110000
Q ss_pred -------chhhhcchh-----hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH--HHHhch
Q 005355 616 -------RLFEVLDAR-----VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF--ELGGIR 666 (700)
Q Consensus 616 -------~~~~~~d~~-----~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~ 666 (700)
...+...+. .........+.++.+|+.+||+.||.+|||+.|+++ .++.++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 000000000 001112233567899999999999999999999986 344443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=334.42 Aligned_cols=258 Identities=22% Similarity=0.344 Sum_probs=205.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChh-----------------hHHHHHHHHHHHhhcCCCceeeE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDES-----------------NIEQFINEVAILSQINHRNVVKL 451 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~l 451 (700)
.++|++.+.||+|+||.||+|.. +++.||||++...... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 57899999999999999999999 8999999987642211 12789999999999999999999
Q ss_pred EeEEEeCCcceEEEeeCCCCCHHHH------HhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEE
Q 005355 452 LGCCLETEVPLLVYEFIPNGTLYQY------IHDQTEEFPITWEIRLRIAIEVSDALCYLHS-AASIPIYHRDIKSANIL 524 (700)
Q Consensus 452 ~~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dik~~NIL 524 (700)
++++.+.+..++||||+++++|.++ +... ....+++..++.++.||+.||+|||+ ++ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999999 5442 13459999999999999999999999 88 999999999999
Q ss_pred ECCCCcEEEeecCCCcccccCCceeeeeeecccccccccccccC-CCCc-ccceehHHHHHHHHHhCCCCCCCCCchhhh
Q 005355 525 LDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSS-QFTE-KSDVYSFGVVLVELLTGQKPIRSTDSEEDK 602 (700)
Q Consensus 525 l~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDVwSlG~il~elltg~~p~~~~~~~~~~ 602 (700)
++.++.+||+|||++...... ......++..|+|||++.+. .++. ++||||||+++|||++|..||........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~- 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE- 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH-
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-
Confidence 999999999999999765332 33445689999999999887 6666 99999999999999999999986554211
Q ss_pred hHHHHHHHHHHhcchhhhcc---------hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 603 SLVGYFLEAMKENRLFEVLD---------ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~d---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
....+..+......+ ...........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 261 -----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 -----LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -----HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 122222221110000 00000011334567899999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=331.29 Aligned_cols=204 Identities=26% Similarity=0.360 Sum_probs=174.3
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CC-----ceeeEEeEEEeC
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQIN-HR-----NVVKLLGCCLET 458 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~ 458 (700)
+...++|++.++||+|+||+||+|... +++.||||+++.. ......+..|+.+++.++ |+ +++++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 334689999999999999999999976 6889999998743 344567888999988875 54 499999999999
Q ss_pred CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh--cCCCCeeecCCCCCcEEEC--CCCcEEEe
Q 005355 459 EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS--AASIPIYHRDIKSANILLD--DKYRAKVS 534 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~~~~ivH~Dik~~NILl~--~~~~~kl~ 534 (700)
+..++||||++ ++|.+++..... ..+++..+..++.||+.||.|||+ .+ |+||||||+||||+ .++.+||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEEC
T ss_pred CceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEE
Confidence 99999999995 599999987642 238999999999999999999995 56 99999999999994 57889999
Q ss_pred ecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCch
Q 005355 535 DFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSE 599 (700)
Q Consensus 535 DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~ 599 (700)
|||+++..... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 204 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 204 DFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp CCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999765322 23456899999999999999999999999999999999999999876543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=330.60 Aligned_cols=256 Identities=24% Similarity=0.333 Sum_probs=198.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc-----
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLETEV----- 460 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 460 (700)
.++|.+.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999976 6899999998653 34446788999999999999999999999987654
Q ss_pred -ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 461 -PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 461 -~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
.++||||++ ++|.+++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 399999996 688887743 2899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc--c
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN--R 616 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 616 (700)
...... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||......+. ........... .
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTE 246 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHH
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHH
Confidence 754322 234568999999999877 6789999999999999999999999986654321 11111110000 0
Q ss_pred hhhhc-ch-----------h---hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 617 LFEVL-DA-----------R---VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 617 ~~~~~-d~-----------~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+...+ +. . .........+..+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 00 0 001112234567899999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=331.19 Aligned_cols=262 Identities=20% Similarity=0.246 Sum_probs=201.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-----------CCceeeEEeEEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQIN-----------HRNVVKLLGCCL 456 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 456 (700)
.++|++.+.||+|+||.||+|++. +++.||||++.. +....+.+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 468999999999999999999975 689999999874 3344577889999999886 899999999988
Q ss_pred eCC----cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEEC-----
Q 005355 457 ETE----VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA-ASIPIYHRDIKSANILLD----- 526 (700)
Q Consensus 457 ~~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dik~~NILl~----- 526 (700)
..+ ..++|||++ +++|.+++..... ..+++..++.++.||+.||+|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 678999999 8999999987533 2489999999999999999999998 9 99999999999994
Q ss_pred -CCCcEEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHH
Q 005355 527 -DKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLV 605 (700)
Q Consensus 527 -~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~ 605 (700)
..+.+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|||++|..||............
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999765322 23346899999999999999999999999999999999999999865432211111
Q ss_pred HHHHHHHHh-cchhh-----------hc-----------------chhh--hhccCHHHHHHHHHHHHHHhccCCCCCCC
Q 005355 606 GYFLEAMKE-NRLFE-----------VL-----------------DARV--LKEAKEEEIITVAMLAKRCLNMIGKKRPT 654 (700)
Q Consensus 606 ~~~~~~~~~-~~~~~-----------~~-----------------d~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs 654 (700)
......... +.+.. .. ...+ ....+......+.+|+.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 111111110 00000 00 0000 11234677888999999999999999999
Q ss_pred HHHHHH
Q 005355 655 MKEAAF 660 (700)
Q Consensus 655 ~~evl~ 660 (700)
++|+++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=327.64 Aligned_cols=262 Identities=21% Similarity=0.305 Sum_probs=202.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CC-cEEEEEEccccChhhHHHHHHHHHHHhhcCCCc------eeeEEeEEEeCCc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NG-RIVAIKKSKLVDESNIEQFINEVAILSQINHRN------VVKLLGCCLETEV 460 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 460 (700)
.++|++.+.||+|+||+||+|... ++ +.||||+++.. ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 578999999999999999999975 34 68999998753 344577889999999987665 9999999999999
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE---------------
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL--------------- 525 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl--------------- 525 (700)
.++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 6777777766432 24899999999999999999999999 9999999999999
Q ss_pred ----CCCCcEEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhh
Q 005355 526 ----DDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601 (700)
Q Consensus 526 ----~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~ 601 (700)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|..||......+.
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56789999999999754322 2345689999999999999999999999999999999999999986654332
Q ss_pred hhHHHHHHHH-----HHhcchhhhc-----------------ch-----hhhhccCHHHHHHHHHHHHHHhccCCCCCCC
Q 005355 602 KSLVGYFLEA-----MKENRLFEVL-----------------DA-----RVLKEAKEEEIITVAMLAKRCLNMIGKKRPT 654 (700)
Q Consensus 602 ~~~~~~~~~~-----~~~~~~~~~~-----------------d~-----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs 654 (700)
.......... .......... .. .............+.+|+.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 2111111000 0000000000 00 0000112344668999999999999999999
Q ss_pred HHHHHH
Q 005355 655 MKEAAF 660 (700)
Q Consensus 655 ~~evl~ 660 (700)
+.|+++
T Consensus 328 ~~e~l~ 333 (355)
T 2eu9_A 328 LAEALL 333 (355)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.64 Aligned_cols=258 Identities=25% Similarity=0.368 Sum_probs=182.3
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHH-HHhhcCCCceeeEEeEEEeCCcce
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVA-ILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
....++|++.+.||+|+||.||+|... +++.||||++... .......+..|+. +++.++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 334688999999999999999999986 6899999998754 3344456666666 677789999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 463 LVYEFIPNGTLYQYIHDQ--TEEFPITWEIRLRIAIEVSDALCYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
+||||+++ +|.+++... .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 99999974 888887641 1123489999999999999999999998 9 999999999999999999999999999
Q ss_pred cccccCCceeeeeeeccccccccccc----ccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYF----RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN 615 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 615 (700)
+...... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||........ ...
T Consensus 174 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---------~~~-- 240 (327)
T 3aln_A 174 GQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------QLT-- 240 (327)
T ss_dssp CC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------C--
T ss_pred eeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH---------HHH--
Confidence 7653222 22334689999999998 456789999999999999999999999975432110 000
Q ss_pred chhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 616 RLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 616 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.......+.+........+..+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000000011111111234557899999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.29 Aligned_cols=246 Identities=29% Similarity=0.411 Sum_probs=191.9
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh------hhHHHHHHHHHHHhhc----CCCceeeE
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE------SNIEQFINEVAILSQI----NHRNVVKL 451 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l 451 (700)
.+.+...++|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+|+.++.++ +|+||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 344556789999999999999999999875 688999999865432 1234466799999998 89999999
Q ss_pred EeEEEeCCcceEEEee-CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-CCC
Q 005355 452 LGCCLETEVPLLVYEF-IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD-DKY 529 (700)
Q Consensus 452 ~~~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~-~~~ 529 (700)
++++.+.+..++|+|+ +.+++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++ .++
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCC
Confidence 9999999999999999 78999999998754 3899999999999999999999999 99999999999999 889
Q ss_pred cEEEeecCCCcccccCCceeeeeeecccccccccccccCCCC-cccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH
Q 005355 530 RAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF 608 (700)
Q Consensus 530 ~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 608 (700)
.+||+|||++....... .....++..|+|||++.+..+. .++||||||+++|||++|+.||.....
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------- 244 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---------- 244 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----------
Confidence 99999999998654322 2345589999999999877664 589999999999999999999963210
Q ss_pred HHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 609 LEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 609 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...... ..+......+.+|+.+||+.+|++|||++|+++
T Consensus 245 ---~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 ---ILEAEL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ---HHHTCC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---Hhhhcc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 112233456889999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=324.33 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=174.2
Q ss_pred HhcCCCccc-eEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe----CCcc
Q 005355 388 ATDNFNTNR-ILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLE----TEVP 461 (700)
Q Consensus 388 ~~~~~~~~~-~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 461 (700)
..++|++.+ +||+|+||.||+|.+. +++.||||++.... ....+....++.++|+||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 357888855 6999999999999987 68999999986421 112223334566799999999999876 4457
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEEEeecCC
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD---KYRAKVSDFGA 538 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~---~~~~kl~DfGl 538 (700)
++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 899999999999999987542 34999999999999999999999999 999999999999976 45599999999
Q ss_pred CcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 539 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
+..... .......+|+.|+|||++.+..++.++||||||+++|+|++|..||........... ....+.....
T Consensus 178 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~- 250 (336)
T 3fhr_A 178 AKETTQ---NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---MKRRIRLGQY- 250 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceeccc---cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---HHHhhhcccc-
Confidence 975432 222345689999999999988999999999999999999999999975543221100 0011110000
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..........+..+.+|+.+||+.||++|||++|+++
T Consensus 251 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 251 -----GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0001111234567889999999999999999999998
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.11 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=189.0
Q ss_pred cCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEEeeC
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
+.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 445567889999999998776667999999987642 335678999999886 8999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-------------CcE
Q 005355 469 PNGTLYQYIHDQTEEF----PITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK-------------YRA 531 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~-------------~~~ 531 (700)
+ |+|.+++....... ..++..++.++.||+.||+|||+++ |+||||||+||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999998654211 1133456789999999999999999 9999999999999654 589
Q ss_pred EEeecCCCcccccCCce---eeeeeeccccccccccccc-------CCCCcccceehHHHHHHHHHh-CCCCCCCCCchh
Q 005355 532 KVSDFGASRSVMIDQTH---LTTRVQGTFGYLDPEYFRS-------SQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600 (700)
Q Consensus 532 kl~DfGl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~ 600 (700)
||+|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++ |..||......+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876443222 1234569999999999976 678999999999999999999 999997543322
Q ss_pred hhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 601 DKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. .... +... .+..........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 248 ~--------~i~~-~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 S--------NIIR-GIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H--------HHHH-TCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H--------HHhc-CCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 0111 1100 000111123456778999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.09 Aligned_cols=248 Identities=25% Similarity=0.418 Sum_probs=200.1
Q ss_pred chHHHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh------hhHHHHHHHHHHHhhcC--CCceeeE
Q 005355 381 TSMELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE------SNIEQFINEVAILSQIN--HRNVVKL 451 (700)
Q Consensus 381 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l 451 (700)
...+.+...++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.++++++ |+||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 33455566789999999999999999999975 688999998764321 12345778999999996 5999999
Q ss_pred EeEEEeCCcceEEEeeCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-CCC
Q 005355 452 LGCCLETEVPLLVYEFIPN-GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD-DKY 529 (700)
Q Consensus 452 ~~~~~~~~~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~-~~~ 529 (700)
++++.+.+..++|+|++.+ ++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++ +++
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTT
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCC
Confidence 9999999999999999976 89999998653 3899999999999999999999999 99999999999999 789
Q ss_pred cEEEeecCCCcccccCCceeeeeeecccccccccccccCCC-CcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH
Q 005355 530 RAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF 608 (700)
Q Consensus 530 ~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 608 (700)
.+||+|||++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 188 ~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------- 254 (320)
T 3a99_A 188 ELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------- 254 (320)
T ss_dssp EEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------
T ss_pred CEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------
Confidence 9999999999765422 2234568999999999987766 6889999999999999999999963210
Q ss_pred HHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 609 LEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 609 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
... ... ..+...+..+.+|+.+||+.||++|||++|+++
T Consensus 255 --~~~-~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 --IIR-GQV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --HHH-CCC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --hhc-ccc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011 110 011223456889999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=334.33 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=189.8
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEE
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 465 (700)
....+|+..++||+|+||+|+.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+.+..++||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 34567899999999999997655556799999999865332 2356899999999 7999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-----CCcEEEeecCCCc
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD-----KYRAKVSDFGASR 540 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~-----~~~~kl~DfGl~~ 540 (700)
||++ |+|.+++...... +.+..++.++.||+.||+|||+++ |+||||||+||||+. ...+||+|||+++
T Consensus 98 E~~~-g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSSSCC--CCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhcCCC--ccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9995 6999999876432 455566789999999999999999 999999999999943 3468899999998
Q ss_pred ccccCCc--eeeeeeecccccccccccc---cCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHh
Q 005355 541 SVMIDQT--HLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKE 614 (700)
Q Consensus 541 ~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 614 (700)
....... .......||+.|+|||++. ...++.++||||||+++|||++ |..||........ ......
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~~~~~ 244 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NILLGA 244 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HHHTTC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HHHhcc
Confidence 6643322 2233456999999999997 4567889999999999999999 9999864432221 011111
Q ss_pred cchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 615 NRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 615 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
... ... .........+.+|+.+||+.||.+|||++|+++
T Consensus 245 ~~~-~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CSL-DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCC-TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCc-ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111 111 111234556789999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=316.36 Aligned_cols=253 Identities=23% Similarity=0.380 Sum_probs=182.6
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh-h-hHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE-S-NIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
...++|++.+.||+|+||.||+|.+. +++.||||++..... . ..+.+.++..+++.++||||+++++++.+.+..++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 34578999999999999999999986 689999999875432 2 23344555567788899999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA-ASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
||||+ ++.+..++.... ..+++..++.++.||+.||+|||++ + |+||||||+|||++.++.+||+|||++...
T Consensus 102 v~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp EECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 99999 556665555432 2489999999999999999999995 8 999999999999999999999999999755
Q ss_pred ccCCceeeeeeecccccccccccc-----cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
... .......+++.|+|||++. ...++.++||||||+++|||++|+.||........ .+..... +..
T Consensus 176 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~-~~~ 247 (318)
T 2dyl_A 176 VDD--KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-----VLTKVLQ-EEP 247 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHHHHHH-SCC
T ss_pred cCC--ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-----HHHHHhc-cCC
Confidence 332 2233456899999999984 45788999999999999999999999975433211 1111111 111
Q ss_pred hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.. .. .....+..+.+|+.+||+.||.+||+++|+++
T Consensus 248 ~~-----~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 PL-----LP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CC-----CC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CC-----CC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 00 01123456889999999999999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=345.60 Aligned_cols=273 Identities=25% Similarity=0.322 Sum_probs=206.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe------CCc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLE------TEV 460 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 460 (700)
.++|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999975 6899999987753 45556789999999999999999999998765 677
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc---EEEeecC
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR---AKVSDFG 537 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~---~kl~DfG 537 (700)
.++||||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7999999999999999988665556899999999999999999999999 999999999999987654 9999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||............. ..........
T Consensus 170 ~a~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i-~~~~~~~~~~ 246 (676)
T 3qa8_A 170 YAKELDQG--ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV-REKSNEHIVV 246 (676)
T ss_dssp CCCBTTSC--CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC-C------CCS
T ss_pred cccccccc--cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh-hcccchhhhh
Confidence 99865332 22344568999999999999999999999999999999999999997543211000000 0000000000
Q ss_pred hhhcch--------hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHH-----HHHHHHhchh
Q 005355 618 FEVLDA--------RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE-----AAFELGGIRA 667 (700)
Q Consensus 618 ~~~~d~--------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~e-----vl~~L~~l~~ 667 (700)
...... ..........+..+.+|+.+||..||++|||++| +.+.++.+..
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000000 0112233456778999999999999999999988 4556655544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=308.66 Aligned_cols=235 Identities=14% Similarity=0.100 Sum_probs=188.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++.+++|+||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 478999999999999999999986 48999999987532 34567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++++|.+++... .....+.+++.||+.||+|||+++ |+||||||+||||+.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999999542 455678899999999999999999 9999999999999999999998543
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
|++ .++.++||||||+++|||++|+.||......+..... ....... ..
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------~~~~~~~--~~ 223 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------ERDTAGQ--PI 223 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------CBCTTSC--BC
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------HHHhccC--CC
Confidence 333 3688999999999999999999999876543210000 0000000 00
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
.........+..+.+|+.+||+.||++| |+.|+++.|+++.....
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0111223345678999999999999999 99999999999876543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=343.99 Aligned_cols=240 Identities=22% Similarity=0.331 Sum_probs=196.6
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc--CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc-----
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT--NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEV----- 460 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 460 (700)
.++|++.+.||+|+||.||++.+. +++.||||++... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999986 5899999988643 34556788999999999999999999999987766
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.+|||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+||||+.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999988764 3999999999999999999999999 9999999999999986 99999999997
Q ss_pred ccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
..... ....||+.|+|||++.+.. +.++||||||++||+|++|..||........
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------------- 284 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------------- 284 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------------------
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-------------------
Confidence 65322 3456999999999987654 8899999999999999999988764221110
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhch
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRP-TMKEAAFELGGIR 666 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~l~ 666 (700)
.. ..........+.+|+.+||+.||++|| +++++.+.|..+.
T Consensus 285 ~~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 285 PE----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CT----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cc----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00 000112345688999999999999999 5777877777654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=327.95 Aligned_cols=246 Identities=15% Similarity=0.179 Sum_probs=183.6
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh---hhHHHHHHHHHHHhhcCC-Cce---------ee-
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE---SNIEQFINEVAILSQINH-RNV---------VK- 450 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~ni---------v~- 450 (700)
.....+|+..++||+|+||.||+|++. +++.||||++..... ...+.+.+|+.+++.++| +|. +.
T Consensus 74 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 334566888899999999999999965 689999999874332 235789999999999977 211 11
Q ss_pred -----------EEeEEEe-----CCcceEEEeeCCCCCHHHHHhcc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 005355 451 -----------LLGCCLE-----TEVPLLVYEFIPNGTLYQYIHDQ----TEEFPITWEIRLRIAIEVSDALCYLHSAAS 510 (700)
Q Consensus 451 -----------l~~~~~~-----~~~~~lv~E~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~ 510 (700)
++..... ....+++|+++ +++|.+++... ..+..+++..++.++.||+.||+|||+++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 231 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 231 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 1111111 12345666655 78999998521 12334889999999999999999999999
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeeeeeccccccccccc----------ccCCCCcccceehHH
Q 005355 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF----------RSSQFTEKSDVYSFG 580 (700)
Q Consensus 511 ~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDVwSlG 580 (700)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||||||
T Consensus 232 --iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 232 --LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp --EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred --cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 999999999999999999999999998754322 344567 999999999 556688999999999
Q ss_pred HHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 581 VVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 581 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+++|||++|+.||......+. ...++.. ....+..+.+|+.+||+.||++||++.++++
T Consensus 305 vil~elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGSC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHCCCCCCCcchhhh---------------HHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999999976543221 1111110 0123457899999999999999999888865
Q ss_pred H
Q 005355 661 E 661 (700)
Q Consensus 661 ~ 661 (700)
.
T Consensus 364 ~ 364 (413)
T 3dzo_A 364 T 364 (413)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.31 Aligned_cols=229 Identities=23% Similarity=0.325 Sum_probs=179.6
Q ss_pred hcCCCcc-ceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHH-hhcCCCceeeEEeEEEe----CCcc
Q 005355 389 TDNFNTN-RILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAIL-SQINHRNVVKLLGCCLE----TEVP 461 (700)
Q Consensus 389 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 461 (700)
.++|.+. +.||+|+||.||++... +++.||||++... ..+.+|++++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4667776 78999999999999975 6899999998642 4577889888 55699999999999987 6778
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEEEeecCC
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD---KYRAKVSDFGA 538 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~---~~~~kl~DfGl 538 (700)
++||||+++++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 999999999999999987542 34999999999999999999999999 999999999999998 78999999999
Q ss_pred CcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 539 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
+.... +..++.++||||||+++|||++|..||........ ......
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~ 212 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKT 212 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCC
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHH
Confidence 86431 24567899999999999999999999975432210 000000
Q ss_pred hhcchh--hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 619 EVLDAR--VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 619 ~~~d~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.+.... .........+..+.+|+.+||+.||++|||+.|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000 000000123567899999999999999999999997
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=311.79 Aligned_cols=243 Identities=16% Similarity=0.207 Sum_probs=187.1
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccC--------hhhHHHHHHHHHHHhhcC---------CCcee
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVD--------ESNIEQFINEVAILSQIN---------HRNVV 449 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv 449 (700)
...++|++.+.||+|+||+||+|++ +++.||||++.... ....+.+.+|+.++++++ |+||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3457799999999999999999998 58999999977532 233578899999998885 88888
Q ss_pred eEEeEEE------------------------------eCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHH
Q 005355 450 KLLGCCL------------------------------ETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVS 499 (700)
Q Consensus 450 ~l~~~~~------------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~ 499 (700)
++.+.+. +.+..++||||+++|++.+.+.+. .+++..++.++.||+
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLT 171 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----CCCHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----CCCHHHHHHHHHHHH
Confidence 8887753 267889999999999877777542 389999999999999
Q ss_pred HHHHHHH-hcCCCCeeecCCCCCcEEECCCC--------------------cEEEeecCCCcccccCCceeeeeeecccc
Q 005355 500 DALCYLH-SAASIPIYHRDIKSANILLDDKY--------------------RAKVSDFGASRSVMIDQTHLTTRVQGTFG 558 (700)
Q Consensus 500 ~aL~~LH-~~~~~~ivH~Dik~~NILl~~~~--------------------~~kl~DfGl~~~~~~~~~~~~~~~~gt~~ 558 (700)
.||+||| +++ |+||||||+||||+.++ .+||+|||+++.... ....||+.
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDV 242 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCC
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeec
Confidence 9999999 899 99999999999999887 899999999986532 13469999
Q ss_pred cccccccccCCCCcccceehHHHH-HHHHHhCCCCCCCCCchhhhhHHHHHHHHHH-hcchhhhcchhhhhccCHHHHHH
Q 005355 559 YLDPEYFRSSQFTEKSDVYSFGVV-LVELLTGQKPIRSTDSEEDKSLVGYFLEAMK-ENRLFEVLDARVLKEAKEEEIIT 636 (700)
Q Consensus 559 y~aPE~~~~~~~s~ksDVwSlG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~ 636 (700)
|+|||++.+.. +.++|||||+.+ .++++.|..||... .........+. ..... ...........+.+
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTFK----TKCNTPAMKQIKRK 311 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCCS----SCCCSHHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhccC----cccchhhhhhcCHH
Confidence 99999998776 889999998777 77788899887311 00011111111 11111 01111123456788
Q ss_pred HHHHHHHHhccCCCCCCCHHHHH
Q 005355 637 VAMLAKRCLNMIGKKRPTMKEAA 659 (700)
Q Consensus 637 l~~li~~cl~~~p~~RPs~~evl 659 (700)
+.+|+.+||+.| |++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999976 998887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-28 Score=274.74 Aligned_cols=182 Identities=19% Similarity=0.148 Sum_probs=128.8
Q ss_pred EeeeCCeEEEEEE-EcCCcEEEEEEcccc----------ChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceEEE
Q 005355 398 LGQGGQGTVYKGM-LTNGRIVAIKKSKLV----------DESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 398 lG~G~fg~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 465 (700)
.+.|++|.+..++ ...|+.+++|.+... .+...++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666555544 224888999987542 123456799999999999 6999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||++|++|.++|.... +++.. +|+.||+.||+|||++| ||||||||+||||++++++||+|||+++.....
T Consensus 322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999998654 36654 47899999999999999 999999999999999999999999999866433
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCC
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQ 590 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~ 590 (700)
. .......||+.|||||++.+ .+..++|+||+|+++++|.++.
T Consensus 393 ~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 393 C-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred C-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 2 23345679999999999976 4667899999999988876653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-25 Score=248.00 Aligned_cols=185 Identities=15% Similarity=0.208 Sum_probs=146.1
Q ss_pred CccceEeeeCCeEEEEEEEcCCcEEEEEEccccC--------hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 393 NTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVD--------ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 393 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
...++||+|+||.||++.. .++.+++|+..... ....+.+.+|++++++++||||+++..+....+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999955 47888998753311 11245689999999999999999666666678888999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||++. ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999975 4589999999999999999 999999999999999 999999999987643
Q ss_pred CCcee------eeeeeccccccccccccc--CCCCcccceehHHHHHHHHHhCCCCCC
Q 005355 545 DQTHL------TTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIR 594 (700)
Q Consensus 545 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlG~il~elltg~~p~~ 594 (700)
..... .....||+.|||||++.. ..|+.+.|+|+..+-..+.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32211 235679999999999987 678889999999998888888776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-22 Score=206.49 Aligned_cols=151 Identities=17% Similarity=0.139 Sum_probs=121.7
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccCh------------------hhHHHHHHHHHHHhhcCC
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDE------------------SNIEQFINEVAILSQINH 445 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h 445 (700)
.+......|++.+.||+|+||.||+|.+.+++.||||.++.... .....+.+|++++++++|
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~ 163 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 163 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence 34444566778899999999999999997799999999864321 235678999999999984
Q ss_pred CceeeEEeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005355 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL 525 (700)
Q Consensus 446 ~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl 525 (700)
+++.+++. .+..++||||+++++|.+ +.. .....++.|++.||.|||+++ |+||||||+||||
T Consensus 164 ---~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 164 ---LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp ---SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred ---CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 55555443 356799999999999998 421 124479999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCCcccccCCceeeeeeecccccccccccc
Q 005355 526 DDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR 566 (700)
Q Consensus 526 ~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 566 (700)
+ ++.+||+|||+++ .+..++|||++.
T Consensus 227 ~-~~~vkl~DFG~a~--------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSV--------------EVGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCE--------------ETTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCe--------------ECCCCCHHHHHH
Confidence 9 9999999999996 334578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.7e-18 Score=175.62 Aligned_cols=136 Identities=18% Similarity=0.189 Sum_probs=107.3
Q ss_pred CCccceEeeeCCeEEEEEEE-cCCcE--EEEEEccccCh------------------------hhHHHHHHHHHHHhhcC
Q 005355 392 FNTNRILGQGGQGTVYKGML-TNGRI--VAIKKSKLVDE------------------------SNIEQFINEVAILSQIN 444 (700)
Q Consensus 392 ~~~~~~lG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l~ 444 (700)
|++.+.||+|+||.||+|.+ .+|+. ||||+++.... .....+.+|+.++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56789999999999999998 67888 99998653211 11236789999999998
Q ss_pred CCce--eeEEeEEEeCCcceEEEeeCCC-C----CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeec
Q 005355 445 HRNV--VKLLGCCLETEVPLLVYEFIPN-G----TLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH-SAASIPIYHR 516 (700)
Q Consensus 445 h~ni--v~l~~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~~ivH~ 516 (700)
|+++ ..++.. +..+|||||+.+ | +|.+++.. .++..+..++.|++.||.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 7753 444432 366899999942 4 77776542 234467789999999999999 899 9999
Q ss_pred CCCCCcEEECCCCcEEEeecCCCccc
Q 005355 517 DIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 517 Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
||||+|||+++ .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.8e-16 Score=165.83 Aligned_cols=137 Identities=14% Similarity=0.179 Sum_probs=100.6
Q ss_pred cCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccCh--------------hhHH--------HHHHHHHHHhhcCCCc
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDE--------------SNIE--------QFINEVAILSQINHRN 447 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~h~n 447 (700)
.-|++.+.||+|+||.||+|...+|+.||||+++.... .... ....|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 33899999999999999999998899999997643100 0011 1234666777765444
Q ss_pred ee--eEEeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEE
Q 005355 448 VV--KLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILL 525 (700)
Q Consensus 448 iv--~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl 525 (700)
+. ..++. ...+|||||+++++|.++.. . .....++.||+.+|.+||+.+ ||||||||.||||
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl 238 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILI 238 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEE
Confidence 32 22222 23479999999988866532 1 123567899999999999999 9999999999999
Q ss_pred CCCC----------cEEEeecCCCccc
Q 005355 526 DDKY----------RAKVSDFGASRSV 542 (700)
Q Consensus 526 ~~~~----------~~kl~DfGl~~~~ 542 (700)
++++ .+.|+||+-+...
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred eCCCCcccccccccceEEEEeCCcccC
Confidence 8776 3899999977643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.8e-11 Score=123.92 Aligned_cols=146 Identities=14% Similarity=0.090 Sum_probs=114.5
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcceEE
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 464 (700)
......|++...++.|+.+.||+.... ++.+++|+...........+.+|+++++.+. +..+.+++++..+.+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344567888888898999999998754 6899999976422222346889999999884 67788999999988899999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA----------------------------------- 509 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----------------------------------- 509 (700)
|||++|.+|.+.+.. ......++.+++++|+.||+..
T Consensus 89 ~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999876421 1223478889999999999811
Q ss_pred ---------------------CCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 510 ---------------------SIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 510 ---------------------~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
...++|+|+++.|||++++..+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1338999999999999876666799998774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.02 E-value=2.9e-10 Score=114.60 Aligned_cols=137 Identities=15% Similarity=0.171 Sum_probs=100.3
Q ss_pred cCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCc--eeeEEeEEEeCCcceEEEee
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRN--VVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~E~ 467 (700)
..+.+..+.+.|..+.||+....+|+.+++|..... ....+.+|+++++.+.+.+ +.+++++....+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 344443333455569999998777788999987643 2245788999999886444 56688888887888999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA-------------------------------------- 509 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-------------------------------------- 509 (700)
+++.+|. ... .. ...++.++++.|+.||+..
T Consensus 97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998884 211 11 2256777888888888643
Q ss_pred -----------------CCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 510 -----------------SIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 510 -----------------~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.90 E-value=2.9e-09 Score=113.04 Aligned_cols=142 Identities=15% Similarity=0.219 Sum_probs=106.2
Q ss_pred ccceEeeeCCeEEEEEEEcCCcEEEEEEcc--ccC-hhhHHHHHHHHHHHhhcC--CCceeeEEeEEEeC---CcceEEE
Q 005355 394 TNRILGQGGQGTVYKGMLTNGRIVAIKKSK--LVD-ESNIEQFINEVAILSQIN--HRNVVKLLGCCLET---EVPLLVY 465 (700)
Q Consensus 394 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 465 (700)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++..+.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567899999999998875 4678888765 322 122356888999999986 45688899888776 3479999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA------------------------------------ 509 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------ 509 (700)
||+++.++.+... ..++...+..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999887754211 12778888999999999999999731
Q ss_pred -------------------CCCeeecCCCCCcEEECCCCc--EEEeecCCCcc
Q 005355 510 -------------------SIPIYHRDIKSANILLDDKYR--AKVSDFGASRS 541 (700)
Q Consensus 510 -------------------~~~ivH~Dik~~NILl~~~~~--~kl~DfGl~~~ 541 (700)
...++|+|+++.|||+++++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 235899999999999987653 69999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.89 E-value=1.2e-09 Score=113.19 Aligned_cols=185 Identities=20% Similarity=0.248 Sum_probs=122.8
Q ss_pred cceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCc--eeeEEeEEEeCC---cceEEEeeC
Q 005355 395 NRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQIN-HRN--VVKLLGCCLETE---VPLLVYEFI 468 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~E~~ 468 (700)
.+.++.|....||+.. ..+++|+... ......+.+|+++++.+. +.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999853 5688888553 234577899999998873 332 445555443333 458999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA--------------------------------------- 509 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------------------------------------- 509 (700)
++.+|.+.... .++.+++..++.++++.|+.||+..
T Consensus 99 ~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99888764432 2777888888999999999998621
Q ss_pred ----------------CCCeeecCCCCCcEEECC--CCcEEEeecCCCcccccCCceeeee--------------eeccc
Q 005355 510 ----------------SIPIYHRDIKSANILLDD--KYRAKVSDFGASRSVMIDQTHLTTR--------------VQGTF 557 (700)
Q Consensus 510 ----------------~~~ivH~Dik~~NILl~~--~~~~kl~DfGl~~~~~~~~~~~~~~--------------~~gt~ 557 (700)
.+.++|+|+++.||++++ ...+.|+||+.+...... ...... ....+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHc
Confidence 134799999999999998 556899999987643211 000000 00111
Q ss_pred cccc-ccccccCCCCcccceehHHHHHHHHHhCCCCC
Q 005355 558 GYLD-PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPI 593 (700)
Q Consensus 558 ~y~a-PE~~~~~~~s~ksDVwSlG~il~elltg~~p~ 593 (700)
+... |+.... .....+.|+++.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1112 222111 112358899999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=4.4e-06 Score=86.21 Aligned_cols=135 Identities=14% Similarity=0.175 Sum_probs=96.5
Q ss_pred cceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCC---ceeeEEeEEE-eCCcceEEEeeCCC
Q 005355 395 NRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHR---NVVKLLGCCL-ETEVPLLVYEFIPN 470 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~E~~~~ 470 (700)
.+.++.|....||+. +..+++|+.. .......+.+|.++|+.+.+. .+.+++.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888888899987 5678888843 234457889999999998642 3566676664 44567899999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA----------------------------------------- 509 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----------------------------------------- 509 (700)
.+|.+..... ++......++.++.+.|+.||+..
T Consensus 98 ~~l~~~~~~~-----l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMAV-----LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHTT-----SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhhh-----CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 8887643211 455556666666666666666422
Q ss_pred ----------------CCCeeecCCCCCcEEECC---CCc-EEEeecCCCc
Q 005355 510 ----------------SIPIYHRDIKSANILLDD---KYR-AKVSDFGASR 540 (700)
Q Consensus 510 ----------------~~~ivH~Dik~~NILl~~---~~~-~kl~DfGl~~ 540 (700)
.+.++|+|+++.|||+++ ++. +.|+||+.+.
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 224699999999999987 455 5899999775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.7e-06 Score=86.01 Aligned_cols=134 Identities=19% Similarity=0.196 Sum_probs=98.7
Q ss_pred eEeeeCCe-EEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcceEEEeeCCCCCH
Q 005355 397 ILGQGGQG-TVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTL 473 (700)
Q Consensus 397 ~lG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~gsL 473 (700)
.+..|..+ .||+.... ++..+++|+... .....+.+|..+|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68987765 466789998653 33466888999998874 44477889999999999999999999888
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 005355 474 YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA-------------------------------------------- 509 (700)
Q Consensus 474 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-------------------------------------------- 509 (700)
.+...... .....+..+++..|+-||+..
T Consensus 108 ~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 87764321 223356667777777777421
Q ss_pred -----------CCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 510 -----------SIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 510 -----------~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.+.++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137999999999999988777899999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=4.4e-06 Score=88.16 Aligned_cols=79 Identities=4% Similarity=-0.014 Sum_probs=54.8
Q ss_pred ceE-eeeCCeEEEEEEEc-------CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcC-C--CceeeEEeEEEeC---
Q 005355 396 RIL-GQGGQGTVYKGMLT-------NGRIVAIKKSKLVD---ESNIEQFINEVAILSQIN-H--RNVVKLLGCCLET--- 458 (700)
Q Consensus 396 ~~l-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--- 458 (700)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 77888899988754 26678899765422 001245778888888874 2 3577788877655
Q ss_pred CcceEEEeeCCCCCHH
Q 005355 459 EVPLLVYEFIPNGTLY 474 (700)
Q Consensus 459 ~~~~lv~E~~~~gsL~ 474 (700)
...++|||++++.+|.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=5.9e-05 Score=80.70 Aligned_cols=75 Identities=19% Similarity=0.188 Sum_probs=50.1
Q ss_pred cceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh-------hhHHHHHHHHHHHhhcCC--C-ceeeEEeEEEeCCcceE
Q 005355 395 NRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE-------SNIEQFINEVAILSQINH--R-NVVKLLGCCLETEVPLL 463 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l 463 (700)
.+.||.|..+.||++... +++.++||....... ...+.+..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 468899997543211 123456789999888742 3 34456543 4556789
Q ss_pred EEeeCCCC
Q 005355 464 VYEFIPNG 471 (700)
Q Consensus 464 v~E~~~~g 471 (700)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00011 Score=76.75 Aligned_cols=140 Identities=16% Similarity=0.179 Sum_probs=78.3
Q ss_pred ceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcC--CCceeeEEe------EEEeCCcceEEEee
Q 005355 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQIN--HRNVVKLLG------CCLETEVPLLVYEF 467 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~E~ 467 (700)
+.|+.|..+.||+....++ .+++|+.... . ..+..|+.+++.+. .-.+.+++. +....+..++++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4465567889999887644 5889987652 2 23344555555442 112333332 12345667899999
Q ss_pred CCCCCHH--------------HHHhccCCCC-----------CCCHHHH-------------------------------
Q 005355 468 IPNGTLY--------------QYIHDQTEEF-----------PITWEIR------------------------------- 491 (700)
Q Consensus 468 ~~~gsL~--------------~~l~~~~~~~-----------~l~~~~~------------------------------- 491 (700)
+++.++. ..+|...... .-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 1122211100 0122211
Q ss_pred HHHHHHHHHHHHHHHh--------c--CCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 492 LRIAIEVSDALCYLHS--------A--ASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 492 ~~i~~qi~~aL~~LH~--------~--~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
..+..++..++++|+. . ....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111234446667763 1 23459999999999999888899999999774
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00018 Score=73.21 Aligned_cols=79 Identities=15% Similarity=0.124 Sum_probs=58.4
Q ss_pred cCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCC---CceeeEEeEEEeCCcceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINH---RNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~E 466 (700)
..+...+.+|.|..+.||+.+..+|+.|+||+...........|..|++.|+.|.- --+.++++. +..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 44556678999999999999999999999998665444434568889999988742 234555554 23589999
Q ss_pred eCCCCC
Q 005355 467 FIPNGT 472 (700)
Q Consensus 467 ~~~~gs 472 (700)
|++.+.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.0011 Score=68.12 Aligned_cols=139 Identities=16% Similarity=0.136 Sum_probs=92.5
Q ss_pred ccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcC---CCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 394 TNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQIN---HRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 394 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
..+.|+.|....+|+... ++..++||+.... ....+..|.+.|+.+. ...+.+++......+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346789999999999876 4678889986532 3567889999998873 36688888888877889999999998
Q ss_pred CCHH--------H---HHhccCC--CC-----------------CCCHHHHH---HHH----------------HHHHHH
Q 005355 471 GTLY--------Q---YIHDQTE--EF-----------------PITWEIRL---RIA----------------IEVSDA 501 (700)
Q Consensus 471 gsL~--------~---~l~~~~~--~~-----------------~l~~~~~~---~i~----------------~qi~~a 501 (700)
..+. . .||.... .. .-+|.... ++. .++++.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 7542 1 2333221 00 12454321 111 112222
Q ss_pred H-HHHHh-cCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 502 L-CYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 502 L-~~LH~-~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
+ ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 23432 2245699999999999999887 8888873
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00089 Score=72.06 Aligned_cols=77 Identities=9% Similarity=0.056 Sum_probs=46.4
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCceeeeee-ecccccccccccccCC---CCcccceehHHHHHHHH
Q 005355 511 IPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRV-QGTFGYLDPEYFRSSQ---FTEKSDVYSFGVVLVEL 586 (700)
Q Consensus 511 ~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~---~s~ksDVwSlG~il~el 586 (700)
..++|+|+++.|||+++++ ++|+||+.+........ ..... .-...|++|+...... .....++......+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 3499999999999998876 99999998864321110 00000 0123466666553211 11234555777777777
Q ss_pred HhC
Q 005355 587 LTG 589 (700)
Q Consensus 587 ltg 589 (700)
+.+
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 664
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0032 Score=64.26 Aligned_cols=71 Identities=14% Similarity=0.113 Sum_probs=44.1
Q ss_pred cceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCce-eeEEeEEEeCCcceEEEeeC-CCCC
Q 005355 395 NRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNV-VKLLGCCLETEVPLLVYEFI-PNGT 472 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~-~~gs 472 (700)
.+.|+.|....+|+. +.+++|+........ ....+|+.+++.+....+ .++++. +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678999999999998 558888765432111 123467777777642222 455543 344457999999 6544
Q ss_pred H
Q 005355 473 L 473 (700)
Q Consensus 473 L 473 (700)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0055 Score=63.44 Aligned_cols=141 Identities=13% Similarity=0.111 Sum_probs=72.0
Q ss_pred ceEeeeCCeE-EEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCC--CceeeEEeEEEeCCcceEEEeeCCCCC
Q 005355 396 RILGQGGQGT-VYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINH--RNVVKLLGCCLETEVPLLVYEFIPNGT 472 (700)
Q Consensus 396 ~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~gs 472 (700)
+.|+.|.... +|+....+++.+++|....... +.+..|+.+++.+.. -.+.+++.+.. +.-+++||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 3455554444 5666553466777776543221 234456666666632 23556666532 33378999998777
Q ss_pred HHHHHhccC---------------------C-CC-CCCHHHHH-------H-H------------HHHHHHHHHHHHh--
Q 005355 473 LYQYIHDQT---------------------E-EF-PITWEIRL-------R-I------------AIEVSDALCYLHS-- 507 (700)
Q Consensus 473 L~~~l~~~~---------------------~-~~-~l~~~~~~-------~-i------------~~qi~~aL~~LH~-- 507 (700)
+.+.+.... . .. ..+..... . + ...+...++.|..
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 665443210 0 00 11111100 0 0 0111222233311
Q ss_pred -cCCCCeeecCCCCCcEEECCC----CcEEEeecCCCcc
Q 005355 508 -AASIPIYHRDIKSANILLDDK----YRAKVSDFGASRS 541 (700)
Q Consensus 508 -~~~~~ivH~Dik~~NILl~~~----~~~kl~DfGl~~~ 541 (700)
.....++|||+.+.|||++.+ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 122348999999999999874 6899999998863
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0018 Score=69.88 Aligned_cols=73 Identities=18% Similarity=0.205 Sum_probs=49.0
Q ss_pred cceEeeeCCeEEEEEEEcC--------CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCc-eeeEEeEEEeCCcceEEE
Q 005355 395 NRILGQGGQGTVYKGMLTN--------GRIVAIKKSKLVDESNIEQFINEVAILSQINHRN-VVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 465 (700)
.+.|+.|....+|+....+ ++.+++|+..... ..+.+.+|+.+++.+...+ ..++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3567888889999998753 4789999874321 1145568999988874333 3566665532 3899
Q ss_pred eeCCCCCH
Q 005355 466 EFIPNGTL 473 (700)
Q Consensus 466 E~~~~gsL 473 (700)
||+++.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0044 Score=59.04 Aligned_cols=101 Identities=17% Similarity=0.099 Sum_probs=67.2
Q ss_pred CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee
Q 005355 470 NGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL 549 (700)
Q Consensus 470 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~ 549 (700)
..+|.++|..... +++++++|.++.|.+.+|.-+-.... -..+=+.|..|+|..+|.|.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 3489999987654 59999999999999999877632221 11233457999999999998764 1110
Q ss_pred eeeeecccccccccccccCCCCcccceehHHHHHHHHHhC
Q 005355 550 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTG 589 (700)
Q Consensus 550 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg 589 (700)
.....+.+||... ...+.+.=|||||++||.-+-=
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1223466888764 4556788999999999998863
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0029 Score=66.81 Aligned_cols=140 Identities=19% Similarity=0.226 Sum_probs=82.1
Q ss_pred ceEeeeCCeEEEEEEEc--------CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcceEEEe
Q 005355 396 RILGQGGQGTVYKGMLT--------NGRIVAIKKSKLVDESNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 466 (700)
+.|..|-...+|+.... +++.+++|+..... .......+|.++++.+. +.-..++++.+.+ .+|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45666777888988764 24789999864321 23456678999998874 3223566666543 39999
Q ss_pred eCCCCCHHHH-----------------HhccCC--CCCC--CHHHHHHHHHHHHH-------------------HHHHHH
Q 005355 467 FIPNGTLYQY-----------------IHDQTE--EFPI--TWEIRLRIAIEVSD-------------------ALCYLH 506 (700)
Q Consensus 467 ~~~~gsL~~~-----------------l~~~~~--~~~l--~~~~~~~i~~qi~~-------------------aL~~LH 506 (700)
|+++.+|..- ||.... .... -+.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9997654311 121111 1112 24555555544322 233332
Q ss_pred ----hcC-CCCeeecCCCCCcEEECCC----CcEEEeecCCCc
Q 005355 507 ----SAA-SIPIYHRDIKSANILLDDK----YRAKVSDFGASR 540 (700)
Q Consensus 507 ----~~~-~~~ivH~Dik~~NILl~~~----~~~kl~DfGl~~ 540 (700)
... ...++|+|+.+.|||++++ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 222 2348999999999999876 789999998875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0062 Score=65.99 Aligned_cols=74 Identities=15% Similarity=0.032 Sum_probs=47.3
Q ss_pred cceEeeeCCeEEEEEEEcC-CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCce-eeEEeEEEeCCcceEEEeeCCCCC
Q 005355 395 NRILGQGGQGTVYKGMLTN-GRIVAIKKSKLVDESNIEQFINEVAILSQINHRNV-VKLLGCCLETEVPLLVYEFIPNGT 472 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~gs 472 (700)
.+.|+.|-...+|+....+ +..+++|+........ -.-.+|+.+++.+...++ .++++.+. + .+|+||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3568888889999998764 4788899864322111 112578888888864444 56777662 2 36999998754
Q ss_pred H
Q 005355 473 L 473 (700)
Q Consensus 473 L 473 (700)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.60 E-value=0.013 Score=60.09 Aligned_cols=158 Identities=13% Similarity=0.166 Sum_probs=85.5
Q ss_pred cchHHHHHHhcCCCc-----cceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCc--eeeEE
Q 005355 380 FTSMELEMATDNFNT-----NRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRN--VVKLL 452 (700)
Q Consensus 380 ~~~~e~~~~~~~~~~-----~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 452 (700)
++..++......|.+ .+.|+.|....+|+....++ .+++|+.... ...+.+..|+.+++.+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344555555555654 23466688889999887655 6788887642 11234556777777663212 23333
Q ss_pred eE------EEeCCcceEEEeeCCCCCHHH--------------HHhccCCCC------CC---CHHHHHH----------
Q 005355 453 GC------CLETEVPLLVYEFIPNGTLYQ--------------YIHDQTEEF------PI---TWEIRLR---------- 493 (700)
Q Consensus 453 ~~------~~~~~~~~lv~E~~~~gsL~~--------------~l~~~~~~~------~l---~~~~~~~---------- 493 (700)
.. ....+..+++++|+++..+.. .+|...... .. .|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 122355689999998754321 122211110 01 1222110
Q ss_pred --HHHHHHHHHHHHHhc----CCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 494 --IAIEVSDALCYLHSA----ASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 494 --i~~qi~~aL~~LH~~----~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
+...+.+.++.|++. ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455666532 12348999999999999987666899998774
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.54 E-value=0.015 Score=59.77 Aligned_cols=141 Identities=15% Similarity=0.151 Sum_probs=79.5
Q ss_pred ceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCC--ceeeEEeE-----EEeCCcceEEEeeC
Q 005355 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHR--NVVKLLGC-----CLETEVPLLVYEFI 468 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~E~~ 468 (700)
+.|+ |....||+....+|+.+++|...... ...+.+..|..+++.+... .+++++.. ....+..++++|++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 77889999877667789999876321 1235567788888776421 23444432 12244557899999
Q ss_pred CCCCHH-----H------H---Hhcc----C--CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc-
Q 005355 469 PNGTLY-----Q------Y---IHDQ----T--EEFPITWEIR----LRI---------------AIEVSDALCYLHSA- 508 (700)
Q Consensus 469 ~~gsL~-----~------~---l~~~----~--~~~~l~~~~~----~~i---------------~~qi~~aL~~LH~~- 508 (700)
++.++. . . +|.. . .....++... ..+ ...+-..++.|...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 1 1 1211 0 0011222211 000 11111223333221
Q ss_pred ---CCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 509 ---ASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 509 ---~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 223479999999999999 4 89999998775
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0049 Score=64.93 Aligned_cols=73 Identities=12% Similarity=0.108 Sum_probs=43.8
Q ss_pred ceEeeeCCeEEEEEEEcC---------CcEEEEEEccccChhhHHHHHHHHHHHhhcCCCc-eeeEEeEEEeCCcceEEE
Q 005355 396 RILGQGGQGTVYKGMLTN---------GRIVAIKKSKLVDESNIEQFINEVAILSQINHRN-VVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 465 (700)
+.|+.|....+|+....+ ++.+++|+....... ......|.++++.+...+ ..++++.. .-++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 456778788999988653 268889986543221 112357888888774333 44666544 237899
Q ss_pred eeCCCCCH
Q 005355 466 EFIPNGTL 473 (700)
Q Consensus 466 E~~~~gsL 473 (700)
||+++.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.24 E-value=0.093 Score=54.32 Aligned_cols=30 Identities=20% Similarity=0.393 Sum_probs=26.6
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 511 IPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 511 ~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
..++|+|+.+.||++++++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 348999999999999988889999998765
|
| >1yo8_A Thrombospondin-2; EGF, Ca(2+)-binding domains, lectin domain, disulfide, cell; HET: NAG MAN; 2.60A {Homo sapiens} PDB: 2rhp_A* | Back alignment and structure |
|---|
Probab=94.74 E-value=0.016 Score=64.46 Aligned_cols=80 Identities=19% Similarity=0.394 Sum_probs=54.7
Q ss_pred ccccCCcccccCCCceee-eccCCCcc----c------cCCc--ccccc---cccCCCCCcccCCCCCCccCC-------
Q 005355 227 TCNKDNRCSIQLTSGYSC-LCHRSFNG----L------NDGY--CVGDL---LCDSASSPYNCSGCPNGYLLD------- 283 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C-~C~~Gy~G----~------~~~~--~~~~~---~c~~~~~py~c~~c~~~~~~~------- 283 (700)
-|.....|.+..+..|+| .|..||+| | .... |.... .|.+..+.|.|.-|+.++.+.
T Consensus 10 PC~~gg~C~n~~~Gsy~C~~C~~GytGdg~~CeDiDEC~~~p~~C~~gg~~~~CvNt~gsY~C~~C~~Gy~G~~c~g~g~ 89 (634)
T 1yo8_A 10 PCFPGAQCSSFPDGSWSCGFCPVGFLGNGTHCEDLDECALVPDICFSTSKVPRCVNTQPGFHCLPCPPRYRGNQPVGVGL 89 (634)
T ss_dssp CSCTTCCEEECTTSCEEECCCCTTBCSCSSSCCBCCTTTTSCCCSCCCSSSCCEEECSSSEEECCCCTTEEECCCEESSS
T ss_pred CCCCCCEEecCCCCCeECCcCCCccCCCCCCccccccccCCCCcccCCccccceeeccCceecccCCCCcccCccccccc
Confidence 477667887754445999 99999998 2 2222 65555 788888889997577665433
Q ss_pred -----------CCCCccc--CCCC--CCcCCCC----CCCCC
Q 005355 284 -----------DTDSCYQ--NTTA--KTDTISP----SPSPY 306 (700)
Q Consensus 284 -----------~~d~C~~--~~~~--~~~~~~p----~~~~~ 306 (700)
+.++|.. ++|. +.|.+.+ +.+.|
T Consensus 90 ~~~~~dg~~C~dideC~~~~~pC~~~~~Cvnt~~~~~GsY~C 131 (634)
T 1yo8_A 90 EAAKTEKQVCEPENPCKDKTHNCHKHAECIYLGHFSDPMYKC 131 (634)
T ss_dssp HHHHSCCCCEEECCTTTTTCCCCCTTEEEEECCTTCSSSEEE
T ss_pred cccccCCCcccccccccCCCcccccCccccccccccccceee
Confidence 3577863 4664 5677777 77777
|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* | Back alignment and structure |
|---|
Probab=94.32 E-value=0.018 Score=50.94 Aligned_cols=78 Identities=19% Similarity=0.450 Sum_probs=51.4
Q ss_pred ccccCCcccccCCCceeeeccCCCcc---------ccCCcccccccccCCCCCcccCCCCCCccCC----CCCCcccCCC
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG---------LNDGYCVGDLLCDSASSPYNCSGCPNGYLLD----DTDSCYQNTT 293 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G---------~~~~~~~~~~~c~~~~~py~c~~c~~~~~~~----~~d~C~~~~~ 293 (700)
.|...+.|.+. ..+|+|.|..||.| +....|....+|.+..+.|.|. |+.++.+. +.|+|..++|
T Consensus 14 ~C~~~g~C~~~-~g~~~C~C~~Gy~G~~C~~~~~~C~~~~C~~~~~C~~~~g~~~C~-C~~G~~G~~C~~~~~~C~~~~C 91 (135)
T 2vj3_A 14 PCEHAGKCINT-LGSFECQCLQGYTGPRCEIDVNECVSNPCQNDATCLDQIGEFQCI-CMPGYEGVHCEVNTDECASSPC 91 (135)
T ss_dssp SSSTTCEEEEC-SSSEEEECCTTEESTTSCEECCTTTTCCCCSSCEEEECSSCEEEE-CCTTEESSSSCEECCTTTTCCS
T ss_pred CCCCCCEeECC-CCCEEEECCCCCcCCcccccCccCCCCCCCCCCEEeCCCCCceee-CCCCCcCCcceecCCcccCCCc
Confidence 36555677654 35799999999999 2233455667788877788885 56554443 3467766655
Q ss_pred C--CCcCCCCCCCCC
Q 005355 294 A--KTDTISPSPSPY 306 (700)
Q Consensus 294 ~--~~~~~~p~~~~~ 306 (700)
. +.+.+.++.+.|
T Consensus 92 ~~~g~C~~~~g~~~C 106 (135)
T 2vj3_A 92 LHNGRCLDKINEFQC 106 (135)
T ss_dssp TTTCEEEECSSCEEE
T ss_pred CCCCEeECCCCCeEE
Confidence 4 467777776666
|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.18 E-value=0.011 Score=47.98 Aligned_cols=54 Identities=19% Similarity=0.412 Sum_probs=35.5
Q ss_pred cccCCcccccCCCceeeeccCCCccccCCcccccccccCCCCCcccCCCCCCccCCCCCCcccCCCCCCcCCCCCCCCC
Q 005355 228 CNKDNRCSIQLTSGYSCLCHRSFNGLNDGYCVGDLLCDSASSPYNCSGCPNGYLLDDTDSCYQNTTAKTDTISPSPSPY 306 (700)
Q Consensus 228 C~s~s~c~~~~~~gy~C~C~~Gy~G~~~~~~~~~~~c~~~~~py~c~~c~~~~~~~~~d~C~~~~~~~~~~~~p~~~~~ 306 (700)
| ..+.|.+. ..+|+|.|..||+| ++.. ..|+++ |+|..++|.+.|.+.++.+.|
T Consensus 13 C-~~~~C~n~-~g~y~C~C~~G~~~----------------~~~g-~~C~di------deC~~~~C~~~C~n~~g~y~C 66 (87)
T 1z6c_A 13 C-GTAVCKNI-PGDFECECPEGYRY----------------NLKS-KSCEDI------DECSENMCAQLCVNYPGGYTC 66 (87)
T ss_dssp B-TTSSCCCB-TTBCCCSSSTTCEE----------------ETTT-TEEECC------CHHHHSCCSSEECCCSSSCCE
T ss_pred C-CCCEeECC-CCCEEEECCCCceE----------------CCCC-CcCCCc------CeeCCCCCCCEEEccCCCEEE
Confidence 6 44667654 35899999999997 3211 012333 777666666777777777777
|
| >1dx5_I Thrombomodulin; serine proteinase, EGF-like domains, anticoagulant complex, antifibrinolytic complex, hydrolase-hydrolase inhibitor COM; HET: AR7 NDG; 2.30A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 3gis_X 1dqb_A* 1zaq_A 1adx_A 2adx_A | Back alignment and structure |
|---|
Probab=93.16 E-value=0.021 Score=49.23 Aligned_cols=71 Identities=25% Similarity=0.600 Sum_probs=49.3
Q ss_pred CcccccCCCceeeeccCCCcccc-----------CCcccccccccCCCCCcccCCCCCCccC------CCCCCccc-CCC
Q 005355 232 NRCSIQLTSGYSCLCHRSFNGLN-----------DGYCVGDLLCDSASSPYNCSGCPNGYLL------DDTDSCYQ-NTT 293 (700)
Q Consensus 232 s~c~~~~~~gy~C~C~~Gy~G~~-----------~~~~~~~~~c~~~~~py~c~~c~~~~~~------~~~d~C~~-~~~ 293 (700)
+.|.+...++|+|.|..||+|.. .+.|. ..|.+ .+.|.|. |+.++.. .+.|+|.. ++|
T Consensus 14 ~~C~~~~~g~y~C~C~~Gy~g~~~~~~~C~~~C~~~~C~--~~C~~-~~~y~C~-C~~Gy~~~~g~~C~dideC~~~~~C 89 (118)
T 1dx5_I 14 YQCQPLDQTSYLCVCAEGFAPIPHEPHRCQMFCNQTACP--ADCDP-NTQASCE-CPEGYILDDGFICTDIDECENGGFC 89 (118)
T ss_dssp SEEEECSSSCEEEECCTTEEEETTEEEEEEECCCSSEEE--CEECT-TSTTCEE-CCTTEEEETTTEEEECCHHHHCSSC
T ss_pred CCCCCCCCCCEEeECCCCccccCCCCCccccccCCCCCC--CcccC-CCCeEeE-CCCCccCCCCCccccccccCCCCCC
Confidence 36766535689999999999921 22232 45666 4679985 6666541 25688875 788
Q ss_pred CCCcCCCCCCCCC
Q 005355 294 AKTDTISPSPSPY 306 (700)
Q Consensus 294 ~~~~~~~p~~~~~ 306 (700)
.+.+.+.++.+.|
T Consensus 90 ~~~C~n~~g~y~C 102 (118)
T 1dx5_I 90 SGVCHNLPGTFEC 102 (118)
T ss_dssp SSEEEECSSSEEE
T ss_pred cCeEEeCCCCEEE
Confidence 7788999998887
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.91 E-value=0.37 Score=51.32 Aligned_cols=140 Identities=14% Similarity=0.120 Sum_probs=82.6
Q ss_pred cceEeeeCCeEEEEEEEcC--------CcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcceEEE
Q 005355 395 NRILGQGGQGTVYKGMLTN--------GRIVAIKKSKLVDESNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 465 (700)
.+.|..|-...+|+....+ ++.+++|+........ -+..+|..+++.+. +.-..++++.+ .-++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 3567777788999988753 5789999865432211 12357888887774 32245555533 237899
Q ss_pred eeCCCCCHHH-------H----------Hhcc-------C---CCCCCCHHHHHHHHHHH-------------------H
Q 005355 466 EFIPNGTLYQ-------Y----------IHDQ-------T---EEFPITWEIRLRIAIEV-------------------S 499 (700)
Q Consensus 466 E~~~~gsL~~-------~----------l~~~-------~---~~~~l~~~~~~~i~~qi-------------------~ 499 (700)
||+++.+|.. . ||.. . ...+..+.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865321 0 1110 0 11112244444444322 2
Q ss_pred HHHHHHHh---------------------cCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 500 DALCYLHS---------------------AASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 500 ~aL~~LH~---------------------~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
..+..|.+ .....++|+|+.+.||+ +.++.+.|+||..+.
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 22333321 11234899999999999 778899999999885
|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.44 E-value=0.035 Score=49.49 Aligned_cols=79 Identities=20% Similarity=0.434 Sum_probs=48.7
Q ss_pred ccccCCcccccCC-CceeeeccCCCcc--cc-------------------CCccccccccc-------CCCCCcccCCCC
Q 005355 227 TCNKDNRCSIQLT-SGYSCLCHRSFNG--LN-------------------DGYCVGDLLCD-------SASSPYNCSGCP 277 (700)
Q Consensus 227 ~C~s~s~c~~~~~-~gy~C~C~~Gy~G--~~-------------------~~~~~~~~~c~-------~~~~py~c~~c~ 277 (700)
.|...+.|.+... .+|+|.|..||.| +. ...|.....|. +..+.|.|. |+
T Consensus 7 pC~~~g~C~~~~~~g~~~C~C~~G~~G~~C~~~~~~~~~~~~c~~~~~C~~~~C~~~g~C~~~~~~~~~~~~~~~C~-C~ 85 (143)
T 4d90_A 7 PCENGGICLPGLADGSFSCECPDGFTDPNCSSVVEVASDEEEPTSAGPCTPNPCHNGGTCEISEAYRGDTFIGYVCK-CP 85 (143)
T ss_dssp CCGGGCEEEC-----CCEEECCTTCCTTTTCSCCCCTTTTTSCCCCCTTSSCCCCTTCEEEECCCEETTEECCEEEE-CC
T ss_pred cCCCCCEeeCCCCCCCEEeECCCCCCCCCCccCccccccccccccCCcCCCCCCCCCCEecCCCccccCCCCCeEeE-Cc
Confidence 3666678876433 5899999999999 11 12355556676 445578884 56
Q ss_pred CCccCC----CCCCcccCCCC--CCcCCCCCCCCC
Q 005355 278 NGYLLD----DTDSCYQNTTA--KTDTISPSPSPY 306 (700)
Q Consensus 278 ~~~~~~----~~d~C~~~~~~--~~~~~~p~~~~~ 306 (700)
.++.+. +.|+|..++|. +.|.+.++.+.|
T Consensus 86 ~G~~G~~C~~~i~~C~~~~C~~~~~C~~~~g~~~C 120 (143)
T 4d90_A 86 RGFNGIHCQHNINECEVEPCKNGGICTDLVANYSC 120 (143)
T ss_dssp TTEESTTSCEECCTTTTCCSCTTCEEEEETTEEEE
T ss_pred CCCcCCCcccCCCcCCCCCCCCCCEeECCCCCeEe
Confidence 554333 45778766653 467777777766
|
| >3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.93 E-value=0.085 Score=54.00 Aligned_cols=58 Identities=31% Similarity=0.842 Sum_probs=36.5
Q ss_pred cccCCcccccCCCceeeeccCCCcc--cc-C---------CcccccccccCCCCCcccCCCCCCccCC-CCCCcc
Q 005355 228 CNKDNRCSIQLTSGYSCLCHRSFNG--LN-D---------GYCVGDLLCDSASSPYNCSGCPNGYLLD-DTDSCY 289 (700)
Q Consensus 228 C~s~s~c~~~~~~gy~C~C~~Gy~G--~~-~---------~~~~~~~~c~~~~~py~c~~c~~~~~~~-~~d~C~ 289 (700)
|...+.|.+. ..+|+|.|..||.| |- + ..|.. .|.+..+.|.|. |+.++.+. +...|.
T Consensus 13 C~~~g~C~~~-~~~~~C~C~~g~~g~~C~~~~~eC~~~~~~~C~~--~C~~~~g~~~C~-C~~g~~~~~~~~~C~ 83 (317)
T 3h5c_B 13 CLHNGSCQDS-IWGYTCTCSPGYEGSNCELAKNECHPERTDGCQH--FCLPGQESYTCS-CAQGYRLGEDHKQCV 83 (317)
T ss_dssp CTTTCCCCCC-SSSCCCCCSSSCCSSSSCCCSSSCCTTCTTSCSS--EEECCSSSCEEE-CCTTEECCTTSSCCE
T ss_pred CCCCCEeECC-CCCeEEECCCCCcCCccccCcccCCCCCCCCCcC--ccccCCCeeEEe-ccccccccccccccc
Confidence 7666778764 36899999999999 21 1 23332 566777778885 55554433 234454
|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* | Back alignment and structure |
|---|
Probab=91.63 E-value=0.13 Score=45.97 Aligned_cols=25 Identities=28% Similarity=0.820 Sum_probs=20.0
Q ss_pred ccccCCcccccCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
-|...+.|.+. .++|+|.|..||.|
T Consensus 55 pC~n~g~C~~~-~~~y~C~C~~G~~G 79 (146)
T 1x7a_L 55 PCLNGGLCKDD-INSYECWCQVGFEG 79 (146)
T ss_dssp SSCTTCEEEEC-SSCEEEECCSSEES
T ss_pred CCCCCCEeECC-CCCEEEecCCCCcC
Confidence 47666788765 45899999999999
|
| >3p5b_L Low density lipoprotein receptor variant; B-propellor, convertase, hydrolase-lipid binding P complex; 3.30A {Homo sapiens} PDB: 3p5c_L | Back alignment and structure |
|---|
Probab=91.13 E-value=0.11 Score=55.16 Aligned_cols=20 Identities=35% Similarity=0.806 Sum_probs=15.8
Q ss_pred CcccccCCCceeeeccCCCcc
Q 005355 232 NRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 232 s~c~~~~~~gy~C~C~~Gy~G 252 (700)
..|.+. ..||.|.|..||++
T Consensus 12 ~~C~~~-~~~y~C~C~~G~~~ 31 (400)
T 3p5b_L 12 HVCNDL-KIGYECLCPDGFQL 31 (400)
T ss_dssp SEEEEC-SSSEEEECCTTEEE
T ss_pred CEeECC-CCCeEEECCCCCCc
Confidence 466654 46899999999995
|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A | Back alignment and structure |
|---|
Probab=90.77 E-value=0.027 Score=50.32 Aligned_cols=23 Identities=13% Similarity=0.150 Sum_probs=15.2
Q ss_pred CCCCccc--CCCC--CCcCCCCCCCCC
Q 005355 284 DTDSCYQ--NTTA--KTDTISPSPSPY 306 (700)
Q Consensus 284 ~~d~C~~--~~~~--~~~~~~p~~~~~ 306 (700)
+.|+|.. ++|. +.|.+.++.+.|
T Consensus 95 dideC~~~~~~C~~~~~C~n~~g~y~C 121 (143)
T 2bou_A 95 DVDECSSGQHQCDSSTVCFNTVGSYSC 121 (143)
T ss_dssp ECCHHHHTCCCCCTTSEEEECSSCEEE
T ss_pred CccCccCcCCCCCCCCEEECCCCCEEe
Confidence 3477762 4554 567888888777
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
Probab=90.53 E-value=0.027 Score=45.40 Aligned_cols=24 Identities=17% Similarity=0.754 Sum_probs=17.6
Q ss_pred ccccCCcccccCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
.|. .+.|.+. .++|+|.|..||+|
T Consensus 12 ~C~-~g~C~n~-~g~y~C~C~~Gy~~ 35 (86)
T 1lmj_A 12 LCG-RGQCVNT-PGDFECKCDEGYES 35 (86)
T ss_dssp TTT-TSCEEEE-TTEEEECCCSSEEE
T ss_pred CCC-CCEEECC-CCCEEeeCCCCcCc
Confidence 363 3467664 35899999999997
|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A | Back alignment and structure |
|---|
Probab=89.45 E-value=0.08 Score=44.60 Aligned_cols=48 Identities=23% Similarity=0.424 Sum_probs=16.9
Q ss_pred cccccCCCceeeeccCCCccccCCcccccccccCCCCC-cccCCCCCCccCCCCCCcc-cCCCCCCcCCCCCCCCC
Q 005355 233 RCSIQLTSGYSCLCHRSFNGLNDGYCVGDLLCDSASSP-YNCSGCPNGYLLDDTDSCY-QNTTAKTDTISPSPSPY 306 (700)
Q Consensus 233 ~c~~~~~~gy~C~C~~Gy~G~~~~~~~~~~~c~~~~~p-y~c~~c~~~~~~~~~d~C~-~~~~~~~~~~~p~~~~~ 306 (700)
.|.+. ..+|+|.|..||+| .+ .. |+++ |+|. .++|.+.|.+.++.+.|
T Consensus 42 ~C~n~-~g~y~C~C~~Gy~g----------------~~g~~---C~di------deC~~~~~C~~~C~n~~gsy~C 91 (107)
T 2w2n_E 42 VCNDL-KIGYECLCPDGFQL----------------VAQRR---CEDI------DECQDPDTCSQLCVNLEGGYKC 91 (107)
T ss_dssp EEECC-SBSCEEECCTTCEE----------------ETTTE---EEC-----------------------------
T ss_pred EeEeC-CCCeEEECCCCccc----------------cCCCc---cccc------cccCCCCCcCCeeecCCCCEEE
Confidence 45443 45899999999999 21 22 2333 7775 35666778888888888
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.38 E-value=0.89 Score=48.02 Aligned_cols=28 Identities=36% Similarity=0.523 Sum_probs=24.3
Q ss_pred eeecCCCCCcEEE------CCCCcEEEeecCCCc
Q 005355 513 IYHRDIKSANILL------DDKYRAKVSDFGASR 540 (700)
Q Consensus 513 ivH~Dik~~NILl------~~~~~~kl~DfGl~~ 540 (700)
++|+|+.+.|||+ +++..+.++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456789999999885
|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
Probab=88.33 E-value=0.09 Score=41.82 Aligned_cols=20 Identities=20% Similarity=0.524 Sum_probs=15.6
Q ss_pred CcccccCCCceeeeccCCCcc
Q 005355 232 NRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 232 s~c~~~~~~gy~C~C~~Gy~G 252 (700)
+.|.+. .++|+|.|..||+|
T Consensus 17 g~C~n~-~g~y~C~C~~Gy~~ 36 (82)
T 1emn_A 17 GQCINT-DGSYRCECPFGYIL 36 (82)
T ss_dssp SEECCC-SSCCCEECCTTEEE
T ss_pred CEEEec-CCCEEEECCCCeEC
Confidence 566654 45899999999984
|
| >1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A | Back alignment and structure |
|---|
Probab=86.74 E-value=0.25 Score=34.34 Aligned_cols=25 Identities=24% Similarity=0.555 Sum_probs=19.7
Q ss_pred ccccCCccccc-CCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSIQ-LTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~-~~~gy~C~C~~Gy~G 252 (700)
-|.. ++|.+. ..++|.|.|..||.|
T Consensus 13 pC~n-G~C~~~~~~~~~~C~C~~GytG 38 (46)
T 1k36_A 13 YCLH-GQCIYLVDMSQNYCRCEVGYTG 38 (46)
T ss_dssp SCSS-EEEEEETTTTEEEEEECTTCSS
T ss_pred CCCC-CEeeccCCCCCEEEECCCCCcc
Confidence 3765 688763 347899999999999
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=86.74 E-value=0.29 Score=32.48 Aligned_cols=25 Identities=28% Similarity=0.800 Sum_probs=19.6
Q ss_pred ccccCCcccccCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
-|.....|.+. ..+|+|.|..||.|
T Consensus 10 pC~ngg~C~~~-~~~~~C~C~~G~~G 34 (39)
T 1edm_B 10 PCLNGGSCKDD-INSYECWCPFGFEG 34 (39)
T ss_dssp CCCTTCEEEEE-TTEEEEECCTTCCS
T ss_pred CCCCCCEeEcC-CCceEeECCCCCcC
Confidence 36656777664 46899999999999
|
| >4d90_A EGF-like repeat and discoidin I-like domain-conta protein 3; RGD finger, cell adhesion, innate immunity, extracellular MA protein; HET: NGA NAG FUC; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.23 E-value=0.37 Score=42.62 Aligned_cols=53 Identities=32% Similarity=0.870 Sum_probs=31.9
Q ss_pred cccCCccccc------CCCceeeeccCCCcc--c-------cCCcccccccccCCCCCcccCCCCCCcc
Q 005355 228 CNKDNRCSIQ------LTSGYSCLCHRSFNG--L-------NDGYCVGDLLCDSASSPYNCSGCPNGYL 281 (700)
Q Consensus 228 C~s~s~c~~~------~~~gy~C~C~~Gy~G--~-------~~~~~~~~~~c~~~~~py~c~~c~~~~~ 281 (700)
|.....|... ...+|+|.|..||.| + ....|....+|.+..+.|.|. |+.++.
T Consensus 60 C~~~g~C~~~~~~~~~~~~~~~C~C~~G~~G~~C~~~i~~C~~~~C~~~~~C~~~~g~~~C~-C~~G~~ 127 (143)
T 4d90_A 60 CHNGGTCEISEAYRGDTFIGYVCKCPRGFNGIHCQHNINECEVEPCKNGGICTDLVANYSCE-CPGEFM 127 (143)
T ss_dssp CCTTCEEEECCCEETTEECCEEEECCTTEESTTSCEECCTTTTCCSCTTCEEEEETTEEEEE-CCTTCB
T ss_pred CCCCCEecCCCccccCCCCCeEeECcCCCcCCCcccCCCcCCCCCCCCCCEeECCCCCeEeE-CCCCCc
Confidence 5555677642 235899999999999 1 122344445666666666663 444433
|
| >1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A | Back alignment and structure |
|---|
Probab=86.04 E-value=0.39 Score=34.47 Aligned_cols=26 Identities=23% Similarity=0.653 Sum_probs=20.7
Q ss_pred ccccCCcccc-cCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSI-QLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~-~~~~gy~C~C~~Gy~G 252 (700)
-|...++|.. ....+|.|.|..||.|
T Consensus 13 pC~ngg~C~~~~~~~~~~C~C~~G~~G 39 (53)
T 1egf_A 13 YCLNGGVCMHIESLDSYTCNCVIGYSG 39 (53)
T ss_dssp SSCSSCEEEEESSSSCEEEECCTTCCS
T ss_pred cCCCCcEEEeeCCCCCEEEECCCCCcC
Confidence 3766678874 4467899999999999
|
| >1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
Probab=86.02 E-value=0.31 Score=33.58 Aligned_cols=26 Identities=19% Similarity=0.503 Sum_probs=20.6
Q ss_pred ccccCCcccc-cCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSI-QLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~-~~~~gy~C~C~~Gy~G 252 (700)
-|...+.|.. ....+|+|.|..||.|
T Consensus 10 pC~ngg~C~~~~~~~~~~C~C~~G~~G 36 (45)
T 1a3p_A 10 YCLNGGVXMHIESLDSYTCNCVIGYSG 36 (45)
T ss_dssp CCSSSCEEEECTTTSSEEEECCTTEET
T ss_pred CCCCCCEEEeecCCCCEEEEcCCCCcC
Confidence 3766678864 4456899999999999
|
| >3v65_B Low-density lipoprotein receptor-related protein; laminin-G, beta-propeller, protein binding; 3.30A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=85.94 E-value=0.18 Score=53.15 Aligned_cols=19 Identities=21% Similarity=0.787 Sum_probs=0.0
Q ss_pred cccccCCCceeeeccCCCcc
Q 005355 233 RCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 233 ~c~~~~~~gy~C~C~~Gy~G 252 (700)
.|. ...++|+|.|..||+.
T Consensus 16 ~C~-~~~g~~~C~C~~G~~l 34 (386)
T 3v65_B 16 KCQ-MIRGAVQCTCHTGYRL 34 (386)
T ss_dssp --------------------
T ss_pred CCc-CCCCCcEeECCCCceE
Confidence 552 2344699999999994
|
| >2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A | Back alignment and structure |
|---|
Probab=85.71 E-value=0.25 Score=36.62 Aligned_cols=24 Identities=29% Similarity=0.945 Sum_probs=18.6
Q ss_pred cccC--CcccccCCCceeeeccCCCc-c
Q 005355 228 CNKD--NRCSIQLTSGYSCLCHRSFN-G 252 (700)
Q Consensus 228 C~s~--s~c~~~~~~gy~C~C~~Gy~-G 252 (700)
|... .+|.+. .++|.|.|..||. |
T Consensus 19 C~nga~gtC~~~-~g~y~C~C~~Gy~~G 45 (61)
T 2k2s_B 19 CGPEAAGTCKET-NSGYICRCNQGYRIS 45 (61)
T ss_dssp SCSSSCCEEEEC-SSEEEEECCTTEEEE
T ss_pred CcCCCccccccC-CCceEeECCCCCccC
Confidence 6544 577664 4589999999999 9
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.28 E-value=2.2 Score=40.56 Aligned_cols=84 Identities=11% Similarity=0.034 Sum_probs=60.8
Q ss_pred CCCceeeEEeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeeecCCCCCc
Q 005355 444 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC-YLHSAASIPIYHRDIKSAN 522 (700)
Q Consensus 444 ~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~-~LH~~~~~~ivH~Dik~~N 522 (700)
.||++ -..+-.+.+...+.|+.-+++.=...++. ++...+++++.+|+.... +++. -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57877 44444666766677776544433333432 788899999999888777 5554 5677889999
Q ss_pred EEECCCCcEEEeecCCCc
Q 005355 523 ILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 523 ILl~~~~~~kl~DfGl~~ 540 (700)
|+++.++.++|.-.|+-.
T Consensus 115 L~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp EEECTTCCEEESCCEETT
T ss_pred EEEeCCCcEEEEEcCCcc
Confidence 999999999998887654
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.98 E-value=0.34 Score=33.07 Aligned_cols=13 Identities=15% Similarity=0.036 Sum_probs=4.8
Q ss_pred ehhHHHHHHHHHH
Q 005355 320 IGCSVGAGLPFFL 332 (700)
Q Consensus 320 igi~v~~~~~~~l 332 (700)
.++..|+++++++
T Consensus 15 ~gVVgGv~~~~ii 27 (44)
T 2ks1_B 15 TGMVGALLLLLVV 27 (44)
T ss_dssp HHHHHHHHHHHHH
T ss_pred eehhHHHHHHHHH
Confidence 3333333333333
|
| >3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.32 E-value=0.37 Score=34.92 Aligned_cols=26 Identities=31% Similarity=0.751 Sum_probs=19.9
Q ss_pred ccccCCcccc----cCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSI----QLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~----~~~~gy~C~C~~Gy~G 252 (700)
-|...++|.. +...+|+|.|..||.|
T Consensus 15 pC~NgGtC~~~~~~d~~~~y~C~C~~g~~G 44 (55)
T 3u7u_G 15 FCVNGGECFMVKDLSNPSRYLCKCPNEFTG 44 (55)
T ss_dssp TSCTTCEEEEECCC--CCCEEEEECTTEES
T ss_pred CCCCCCCcCCCCccCCCCCEeEeCCCCCcC
Confidence 4766688864 2356999999999999
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=84.00 E-value=0.29 Score=33.27 Aligned_cols=8 Identities=50% Similarity=0.671 Sum_probs=3.9
Q ss_pred eeehhHHH
Q 005355 318 IIIGCSVG 325 (700)
Q Consensus 318 iiigi~v~ 325 (700)
.+++.++|
T Consensus 13 ~Ia~~vVG 20 (44)
T 2jwa_A 13 SIISAVVG 20 (44)
T ss_dssp HHHHHHHH
T ss_pred chHHHHHH
Confidence 34445555
|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* | Back alignment and structure |
|---|
Probab=83.84 E-value=0.54 Score=41.20 Aligned_cols=54 Identities=24% Similarity=0.736 Sum_probs=37.3
Q ss_pred ccccCCcccccCCCceeeeccCCCcc---------ccCCcccccccccCCCCCcccCCCCCCccC
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG---------LNDGYCVGDLLCDSASSPYNCSGCPNGYLL 282 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G---------~~~~~~~~~~~c~~~~~py~c~~c~~~~~~ 282 (700)
.|.....|.+. ..+|+|.|..||.| +....|...++|.+..+.|.|. |+.++.+
T Consensus 52 ~C~~~~~C~~~-~g~~~C~C~~G~~G~~C~~~~~~C~~~~C~~~g~C~~~~g~~~C~-C~~G~~G 114 (135)
T 2vj3_A 52 PCQNDATCLDQ-IGEFQCICMPGYEGVHCEVNTDECASSPCLHNGRCLDKINEFQCE-CPTGFTG 114 (135)
T ss_dssp CCCSSCEEEEC-SSCEEEECCTTEESSSSCEECCTTTTCCSTTTCEEEECSSCEEEE-CCTTEES
T ss_pred CCCCCCEEeCC-CCCceeeCCCCCcCCcceecCCcccCCCcCCCCEeECCCCCeEEE-CCCCCcC
Confidence 36555677664 35899999999999 2233466667888877888885 6666443
|
| >1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A | Back alignment and structure |
|---|
Probab=83.65 E-value=0.3 Score=48.31 Aligned_cols=25 Identities=24% Similarity=0.829 Sum_probs=20.7
Q ss_pred ccccCCcccccCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
.|..+..|.+. .++|.|.|+.||.|
T Consensus 14 ~C~~~a~C~Nt-~Gsy~C~C~~Gy~G 38 (285)
T 1gl4_A 14 QCSVHAECRDY-ATGFCCRCVANYTG 38 (285)
T ss_dssp GSCTTEEEEEC-SSCEEEEECTTEEE
T ss_pred CCCCCCEeEcC-CCCeEEEcCCCCCC
Confidence 57777777764 56899999999999
|
| >1z1y_A Ookinete surface protein PVS25; four EGF-like domains, cell adhesion; HET: MLY; 2.00A {Plasmodium vivax} PDB: 1z27_A 1z3g_A | Back alignment and structure |
|---|
Probab=83.43 E-value=0.13 Score=48.14 Aligned_cols=76 Identities=18% Similarity=0.429 Sum_probs=44.7
Q ss_pred cccCCcccccCCCceeeeccCCCccc-----------c----CCcccccccccCCC-----CCcccCCCCCCccCCC---
Q 005355 228 CNKDNRCSIQLTSGYSCLCHRSFNGL-----------N----DGYCVGDLLCDSAS-----SPYNCSGCPNGYLLDD--- 284 (700)
Q Consensus 228 C~s~s~c~~~~~~gy~C~C~~Gy~G~-----------~----~~~~~~~~~c~~~~-----~py~c~~c~~~~~~~~--- 284 (700)
|. +++|.+. .++|+|.|..||.|- . ...|.....|.+.. +.|.|. |+.++.+..
T Consensus 13 C~-ng~C~~~-~g~~~C~C~~G~~g~~~~~C~~id~C~~~~~~~~C~~~~~C~~~~~~~~~g~y~C~-C~~G~~g~~~~C 89 (186)
T 1z1y_A 13 CX-NGQLVQM-SNHFXCMCNEGLVHLSENTCEEXNECXXETLGXACGEFGQCIENPDPAQVNMYXCG-CIEGYTLXEDTC 89 (186)
T ss_dssp CB-TEEEEEC-SSCEEEEECTTEEEEETTEEEECCCCSGGGTTSEEETTEEEEECSSTTSSCSEEEE-ECTTEEEETTEE
T ss_pred CC-CCEeECC-CCCeEeECCCCCccCCCCccCCCCcccCCCCCCCCCCCCEeecCCCCcCCCCEECC-CCCCCccCCCCC
Confidence 54 3356554 347999999999882 1 12244445676666 678885 666654432
Q ss_pred -CCCcccCCCC--CCcC----CCCCCCCC
Q 005355 285 -TDSCYQNTTA--KTDT----ISPSPSPY 306 (700)
Q Consensus 285 -~d~C~~~~~~--~~~~----~~p~~~~~ 306 (700)
.|+|..++|. +.|. +.++.+.|
T Consensus 90 ~~d~C~~~~C~~~g~C~~~~~~~~g~~~C 118 (186)
T 1z1y_A 90 VLDVCQYXNCGESGECIVEYLSEIQSAGC 118 (186)
T ss_dssp EEGGGTTCCCCTTEEEEEEEETTEEEEEE
T ss_pred CCCcCcCCCCCCCCEEeeCCcCCCCCceE
Confidence 2566655553 4455 66666666
|
| >1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A | Back alignment and structure |
|---|
Probab=83.30 E-value=0.46 Score=35.46 Aligned_cols=26 Identities=31% Similarity=0.768 Sum_probs=20.7
Q ss_pred ccccCCcccc----cCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSI----QLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~----~~~~gy~C~C~~Gy~G 252 (700)
-|...++|.+ ....+|+|.|..||.|
T Consensus 13 pC~ngG~C~~~~~~~~~~~y~C~C~~Gf~G 42 (63)
T 1hae_A 13 FCVNGGECFMVKDLSNPSRYLCKCQPGFTG 42 (63)
T ss_dssp TSCTTCEEEEEESSSSSCCEEEECCTTEES
T ss_pred cCCCCcEEecCCccCCCCCEEEECCCCCcC
Confidence 3766678876 2457999999999999
|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* | Back alignment and structure |
|---|
Probab=82.62 E-value=0.29 Score=41.58 Aligned_cols=24 Identities=25% Similarity=0.729 Sum_probs=18.4
Q ss_pred cccCCcccccCCCceeeeccCCCcc
Q 005355 228 CNKDNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 228 C~s~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
|...++|.+. .++|+|.|..||.|
T Consensus 22 C~~~g~C~~~-~~~y~C~C~~G~~G 45 (114)
T 1aut_L 22 CCGHGTCIDG-IGSFSCDCRSGWEG 45 (114)
T ss_dssp TTTSEEECCC-SSCCCEEECTTEES
T ss_pred CCCcCCCCCC-CCCcEeeCCCCCcC
Confidence 5444677654 46899999999999
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.34 E-value=1.8 Score=41.05 Aligned_cols=116 Identities=10% Similarity=0.105 Sum_probs=75.3
Q ss_pred CCCceeeEEeEEEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcE
Q 005355 444 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANI 523 (700)
Q Consensus 444 ~h~niv~l~~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NI 523 (700)
.||+++.. .+-.+.+...+.|+.-+.+.=+..++. ++...+++++.+|+....+++. -+|--|.|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~------~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS------FTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG------SCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh------cCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 58888866 455555655555655442222222322 7889999999999998866654 46888999999
Q ss_pred EECCCCcEEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCC
Q 005355 524 LLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIR 594 (700)
Q Consensus 524 Ll~~~~~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~ 594 (700)
+++.++.+++.-.|+...+. |.- .++..=.-.+=+++..+++++..|.
T Consensus 111 ~f~~~~~p~i~~RGik~~l~------------------P~~-----~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVD------------------PLP-----VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTBS------------------CCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCCC------------------CCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999998877643321 110 0111112245677888888887763
|
| >1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C* | Back alignment and structure |
|---|
Probab=82.33 E-value=0.46 Score=34.09 Aligned_cols=26 Identities=27% Similarity=0.673 Sum_probs=21.0
Q ss_pred ccccCCcccc-cCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSI-QLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~-~~~~gy~C~C~~Gy~G 252 (700)
-|...++|.. ...++|.|.|..||.|
T Consensus 13 pC~nGG~C~~~~~~~~~~C~C~~GytG 39 (53)
T 1nql_B 13 YCLHDGVCMYIEALDKYACNCVVGYIG 39 (53)
T ss_dssp EECTTCEEEEETTTTEEEEEECTTEES
T ss_pred CCCCCeEEeeecCCCCEEEecCCCCcC
Confidence 4776788874 4466899999999999
|
| >1tpg_A T-plasminogen activator F1-G; plasminogen activation; NMR {Homo sapiens} SCOP: g.3.11.1 g.27.1.1 PDB: 1tpm_A 1tpn_A | Back alignment and structure |
|---|
Probab=81.15 E-value=0.34 Score=39.28 Aligned_cols=12 Identities=17% Similarity=0.337 Sum_probs=7.3
Q ss_pred CceeeeccCCCc
Q 005355 240 SGYSCLCHRSFN 251 (700)
Q Consensus 240 ~gy~C~C~~Gy~ 251 (700)
.+|.|.|..||.
T Consensus 30 ~~y~C~C~~G~~ 41 (91)
T 1tpg_A 30 RVEYCWCNSGRA 41 (91)
T ss_dssp CEEEEECSSSCC
T ss_pred CCcEeECCCCCc
Confidence 456666666664
|
| >3ca7_A Protein spitz; argos, EGF, developmental protein, differentiation, EGF-like domain, endoplasmic reticulum, glycoprotein, golgi apparatus; 1.50A {Drosophila melanogaster} PDB: 3c9a_C 3ltg_D | Back alignment and structure |
|---|
Probab=80.78 E-value=0.4 Score=34.23 Aligned_cols=26 Identities=35% Similarity=0.634 Sum_probs=20.3
Q ss_pred ccccCCccccc---CCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSIQ---LTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~---~~~gy~C~C~~Gy~G 252 (700)
-|...++|.+. ...+|.|.|..||.|
T Consensus 15 pC~NGGtC~~~~~~~~~~y~C~C~~Gf~G 43 (52)
T 3ca7_A 15 YCLNDAHCFAVKIADLPVYSCECAIGFMG 43 (52)
T ss_dssp TSCTTCEEEEEEETTEEEEEEECCTTEES
T ss_pred cCCCCCEEecCccCCCCCEEEECCCCCcC
Confidence 37666788762 345899999999999
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 700 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-66 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-66 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-63 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-63 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-62 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-62 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-59 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-58 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-56 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-54 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-53 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-53 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-52 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-50 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-47 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-47 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-46 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-46 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-45 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-44 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-38 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 4e-72
Identities = 69/290 (23%), Positives = 122/290 (42%), Gaps = 21/290 (7%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQI 443
+ E+ + +G G GTVYKG V + ++ F NEV +L +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 444 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC 503
H N++ +G ++ +V ++ +LY ++H E + IA + + +
Sbjct: 62 RHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMD 118
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV-MIDQTHLTTRVQGTFGYLDP 562
YLH+ I HRD+KS NI L + K+ DFG + +H ++ G+ ++ P
Sbjct: 119 YLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 563 EYFRSSQ---FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619
E R ++ +SDVY+FG+VL EL+TGQ P + ++ + + + L
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSP 229
Query: 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669
L K + L CL +RP + + + S+
Sbjct: 230 DLSKVRSNCPKA-----MKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 2e-71
Identities = 72/303 (23%), Positives = 130/303 (42%), Gaps = 37/303 (12%)
Query: 385 LEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKL-VDESNIEQFINEVAILSQ 442
+E+ D+F LG G G V+K +G ++A K L + + Q I E+ +L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 443 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDAL 502
N +V G + E + G+L Q + I +I +++I V L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117
Query: 503 CYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDP 562
YL I HRD+K +NIL++ + K+ DFG S ++ + GT Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 563 EYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED--------------------- 601
E + + ++ +SD++S G+ LVE+ G+ PI D++E
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 602 --KSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAK----RCLNMIGKKRPTM 655
+ L Y +++ +FE+LD V + + ++ + +CL +R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 656 KEA 658
K+
Sbjct: 293 KQL 295
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 5e-67
Identities = 61/279 (21%), Positives = 117/279 (41%), Gaps = 21/279 (7%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQI 443
E E+ + LG G G V+ G VA+K K + + F+ E ++ Q+
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQL 65
Query: 444 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC 503
H+ +V+L + + ++ E++ NG+L ++ +T L +A ++++ +
Sbjct: 66 QHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMA 123
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE 563
++ HRD+++ANIL+ D K++DFG +R + ++ + + PE
Sbjct: 124 FIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623
FT KSDV+SFG++L E++T + + + + E V
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------VIQNLERGYRMVRPD 233
Query: 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662
+E + L + C + RPT L
Sbjct: 234 NCPEELYQ--------LMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 2e-66
Identities = 74/279 (26%), Positives = 119/279 (42%), Gaps = 21/279 (7%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVV 449
+ +G G G V+ G N VAIK + + E FI E ++ +++H +V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA 509
+L G CLE LV+EF+ +G L Y+ Q E L + ++V + + YL A
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA- 120
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ 569
+ HRD+ + N L+ + KVSDFG +R V+ DQ +T + + PE F S+
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 570 FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEA 629
++ KSDV+SFGV++ E+ + K S + + E +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------------VVEDISTGFRLYK 223
Query: 630 KEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668
V + C + RP +L I S
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 5e-66
Identities = 67/284 (23%), Positives = 130/284 (45%), Gaps = 29/284 (10%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQI 443
L M + +G+G G V G G VA+K + +++ + F+ E ++++Q+
Sbjct: 3 ALNM--KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQL 57
Query: 444 NHRNVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDAL 502
H N+V+LLG +E + L +V E++ G+L Y+ + + + L+ +++V +A+
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAM 116
Query: 503 CYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDP 562
YL HRD+ + N+L+ + AKVSDFG ++ Q + + P
Sbjct: 117 EYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAP 169
Query: 563 EYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622
E R +F+ KSDV+SFG++L E+ + + +D + +++ + D
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPD 223
Query: 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666
E + K C ++ RP+ + +L I+
Sbjct: 224 -GCPPAVYE--------VMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 1e-65
Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 25/277 (9%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINHR 446
+++ +G G G K ++G+I+ K+ + E+ + ++EV +L ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 447 NVVKLLGCCLETE--VPLLVYEFIPNGTLYQYIHDQTEEF-PITWEIRLRIAIEVSDALC 503
N+V+ ++ +V E+ G L I T+E + E LR+ +++ AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 504 YLH--SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
H S + HRD+K AN+ LD K K+ DFG +R + D + GT Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMS 182
Query: 562 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621
PE + EKSD++S G +L EL P + +E ++E + F +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGK-FRRI 234
Query: 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
R E E + R LN+ RP+++E
Sbjct: 235 PYRYSDELNE--------IITRMLNLKDYHRPSVEEI 263
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 216 bits (551), Expect = 1e-65
Identities = 76/295 (25%), Positives = 130/295 (44%), Gaps = 23/295 (7%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTN-GRIVAIKKSKLVDESNIEQFINEVAILSQ 442
+ EM + LG G G VY+G+ VA+K K D +E+F+ E A++ +
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 69
Query: 443 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDAL 502
I H N+V+LLG C ++ EF+ G L Y+ + ++ + L +A ++S A+
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAM 128
Query: 503 CYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDP 562
YL HRD+ + N L+ + + KV+DFG SR + D + + P
Sbjct: 129 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 563 EYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622
E ++F+ KSDV++FGV+L E+ T + ++++E+L+
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLE 230
Query: 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI--RASIGDSIMQ 675
E E V L + C RP+ E + +SI D + +
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 3e-63
Identities = 63/279 (22%), Positives = 119/279 (42%), Gaps = 21/279 (7%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQI 443
E+ ++ LGQG G V+ G VAIK K + E F+ E ++ ++
Sbjct: 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKL 69
Query: 444 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC 503
H +V+L E + +V E++ G+L ++ +T ++ + +A +++ +
Sbjct: 70 RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLR-LPQLVDMAAQIASGMA 127
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPE 563
Y+ HRD+++ANIL+ + KV+DFG +R + ++ + + PE
Sbjct: 128 YVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623
+FT KSDV+SFG++L EL T + M + + ++
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVER 229
Query: 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662
E ++ L +C ++RPT + L
Sbjct: 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 6e-63
Identities = 74/302 (24%), Positives = 136/302 (45%), Gaps = 30/302 (9%)
Query: 384 ELEMATDNFN-TNRILGQGGQGTVYKGML---TNGRIVAIKK-SKLVDESNIEQFINEVA 438
+L + DN + LG G G+V +G+ VAIK + ++++ E+ + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 439 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEV 498
I+ Q+++ +V+L+G C + E +LV E G L++++ + EE P + +V
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQV 118
Query: 499 SDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTR--VQGT 556
S + YL HRD+ + N+LL +++ AK+SDFG S+++ D ++ T R +
Sbjct: 119 SMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 557 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKEN 615
+ PE +F+ +SDV+S+GV + E L+ GQKP + E + +++
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQG 228
Query: 616 RLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSIMQ 675
+ E E L C + RP + S+ +
Sbjct: 229 KRME-CPPECPPELYA--------LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279
Query: 676 HN 677
H+
Sbjct: 280 HH 281
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 6e-63
Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 30/277 (10%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIK---KSKLVDESNIEQFINEVAILS 441
+ A ++F R LG+G G VY + I+A+K K++L Q EV I S
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61
Query: 442 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDA 501
+ H N+++L G + L+ E+ P GT+Y+ + + + E+++A
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANA 118
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
L Y HS + HRDIK N+LL K++DFG S + + GT YL
Sbjct: 119 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLP 172
Query: 562 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621
PE EK D++S GV+ E L G+ P + +E + +
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEF--TF 223
Query: 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
V + A++ L R L +RP ++E
Sbjct: 224 PDFVTEGARD--------LISRLLKHNPSQRPMLREV 252
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 9e-63
Identities = 67/268 (25%), Positives = 115/268 (42%), Gaps = 21/268 (7%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVV 449
+ + LG G G V G VAIK K + ++FI E ++ ++H +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA 509
+L G C + ++ E++ NG L Y+ + F + L + +V +A+ YL S
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ--TQQLLEMCKDVCEAMEYLESK- 119
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ 569
HRD+ + N L++D+ KVSDFG SR V+ D+ + + + PE S+
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 570 FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEA 629
F+ KSD+++FGV++ E+ + K E + E + +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRLYR 222
Query: 630 KEEEIITVAMLAKRCLNMIGKKRPTMKE 657
V + C + +RPT K
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKI 250
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 1e-62
Identities = 60/272 (22%), Positives = 114/272 (41%), Gaps = 30/272 (11%)
Query: 395 NRILGQGGQGTVYKGMLT-NGRIVAIKK--SKLVDESNIEQFINEVAILSQINHRNVVKL 451
+ +G+G TVYKG+ T VA + + + +S ++F E +L + H N+V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 452 LGCCLET----EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
T + +LV E + +GTL Y+ + ++ ++ L +LH+
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT 130
Query: 508 AASIPIYHRDIKSANILLDDK-YRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR 566
+ PI HRD+K NI + K+ D G + + + V GT ++ PE +
Sbjct: 131 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPEMYE 186
Query: 567 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626
++ E DVY+FG+ ++E+ T + P + + D +
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPASFDKVAI 239
Query: 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
E KE + + C+ +R ++K+
Sbjct: 240 PEVKE--------IIEGCIRQNKDERYSIKDL 263
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 4e-62
Identities = 68/271 (25%), Positives = 119/271 (43%), Gaps = 23/271 (8%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRN 447
+ +GQG GTVY M + G+ VAI++ L + E INE+ ++ + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
+V L L + +V E++ G+L + + + + E AL +LHS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS 134
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS 567
+ HRDIKS NILL K++DFG + +Q+ +T V GT ++ PE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
Query: 568 SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627
+ K D++S G++ +E++ G+ P + + L+ ++
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNGTPELQNPEKLSA 244
Query: 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
++ RCL+M +KR + KE
Sbjct: 245 IFRD--------FLNRCLDMDVEKRGSAKEL 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 8e-62
Identities = 67/276 (24%), Positives = 105/276 (38%), Gaps = 26/276 (9%)
Query: 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRN 447
D + LG G G VYK + A K E +E ++ E+ IL+ +H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
+VKLL ++ EF G + + + E P+T + + DAL YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD 128
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS 567
I HRD+K+ NIL K++DFG S + + GT ++ PE
Sbjct: 129 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMC 184
Query: 568 SQ-----FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622
+ K+DV+S G+ L+E+ + P + L+ K
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSEPPTLAQP 238
Query: 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
+R K+ K+CL R T +
Sbjct: 239 SRWSSNFKD--------FLKKCLEKNVDARWTTSQL 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 205 bits (523), Expect = 2e-61
Identities = 65/311 (20%), Positives = 126/311 (40%), Gaps = 47/311 (15%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTN------GRIVAIKK-SKLVDESNIEQFINE 436
LE +N R +G+G G V++ +VA+K + F E
Sbjct: 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66
Query: 437 VAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEF------------ 484
A++++ ++ N+VKLLG C + L++E++ G L +++ +
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 485 ---------PITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535
P++ +L IA +V+ + YL HRD+ + N L+ + K++D
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIAD 183
Query: 536 FGASRSVM-IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIR 594
FG SR++ D ++ PE +++T +SDV+++GVVL E+ +
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 595 STDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT 654
+ E+ ++ V D +L E + + L + C + + RP+
Sbjct: 244 YGMAHEEV--------------IYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPS 288
Query: 655 MKEAAFELGGI 665
L +
Sbjct: 289 FCSIHRILQRM 299
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 3e-61
Identities = 58/298 (19%), Positives = 114/298 (38%), Gaps = 29/298 (9%)
Query: 396 RILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCC 455
+G+G G V++G G VA+K +E + E+ + H N++ +
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAAD 66
Query: 456 LETE----VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA-- 509
+ LV ++ +G+L+ Y++ + +T E +++A+ + L +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 510 ---SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL---TTRVQGTFGYLDPE 563
I HRD+KS NIL+ ++D G + + GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 564 YFRSS------QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE----DKSLVGYFLEAMK 613
S + +++D+Y+ G+V E+ + + D +E M+
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 614 ENRLFEVLDARVLKEAKEEEII-TVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670
+ + L + + E + +A + + C G R T L + G
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 5e-61
Identities = 78/295 (26%), Positives = 138/295 (46%), Gaps = 30/295 (10%)
Query: 393 NTNRILGQGGQGTVYKGMLTN----GRIVAIKK-SKLVDESNIEQFINEVAILSQINHRN 447
+ N ++G+G G VY G L + A+K +++ D + QF+ E I+ +H N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 448 VVKLLGCCLETE-VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH 506
V+ LLG CL +E PL+V ++ +G L +I ++T + + ++V+ + +L
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMKFLA 147
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV---MIDQTHLTTRVQGTFGYLDPE 563
S HRD+ + N +LD+K+ KV+DFG +R + D H T + ++ E
Sbjct: 148 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 564 YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623
++ +FT KSDV+SFGV+L EL+T P D + + ++ RL
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDITVYLLQGRRLL--QPE 257
Query: 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS-IGDSIMQHN 677
E + +C + + RP+ E + I ++ IG+ + N
Sbjct: 258 YCPDPLYE--------VMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 304
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 204 bits (519), Expect = 1e-60
Identities = 67/291 (23%), Positives = 109/291 (37%), Gaps = 36/291 (12%)
Query: 375 EKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNI 430
+ +LF + E F+ R +G G G VY + N +VAIK S
Sbjct: 3 DVAELFFKDDPE---KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 431 EQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEI 490
+ I EV L ++ H N ++ GC L LV E+ + P+
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVE 116
Query: 491 RLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT 550
+ L YLHS + HRD+K+ NILL + K+ DFG++
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSAS-----IMAPA 168
Query: 551 TRVQGTFGYLDPEYFRSS---QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGY 607
GT ++ PE + Q+ K DV+S G+ +EL + P+ + ++
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------ 222
Query: 608 FLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
L + +N + + + CL I + RPT +
Sbjct: 223 -LYHIAQNESPALQSGHWSEYFRN--------FVDSCLQKIPQDRPTSEVL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (517), Expect = 1e-60
Identities = 65/304 (21%), Positives = 114/304 (37%), Gaps = 38/304 (12%)
Query: 380 FTSMELEMATDNFNTN---------RILGQGGQGTVYKGMLT----NGRIVAIKK-SKLV 425
FT + A F +++G G G V G L VAIK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 426 DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFP 485
E F++E +I+ Q +H NV+ L G ++ +++ EF+ NG+L ++
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--Q 124
Query: 486 ITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545
T + + ++ + YL HRD+ + NIL++ KVSDFG SR + D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 546 QTHLTTR----VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
+ T + + PE + +FT SDV+S+G+V+ E+++ +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--------- 232
Query: 602 KSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661
M + ++ + + L C RP +
Sbjct: 233 ------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 662 LGGI 665
L +
Sbjct: 287 LDKM 290
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-60
Identities = 72/276 (26%), Positives = 125/276 (45%), Gaps = 31/276 (11%)
Query: 395 NRILGQGGQGTVYKGMLTN---GRIVAIK--KSKLVDESNIEQFINEVAILSQINHRNVV 449
++ LG G GTV KG + VA+K K++ D + ++ + E ++ Q+++ +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA 509
+++G C E E +LV E G L +Y+ + + + + +VS + YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES- 126
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTR--VQGTFGYLDPEYFRS 567
HRD+ + N+LL ++ AK+SDFG S+++ D+ + + + + PE
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 568 SQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626
+F+ KSDV+SFGV++ E + GQKP R E + AM E A
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------VTAMLEKGERMGCPAGCP 236
Query: 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662
+E + L C + RP L
Sbjct: 237 REMYD--------LMNLCWTYDVENRPGFAAVELRL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 3e-60
Identities = 66/273 (24%), Positives = 108/273 (39%), Gaps = 24/273 (8%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKK-SKLVDESNIEQFINEVAILSQINHRN 447
++++ + LG+G G V + VA+K E E+ I +NH N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
VVK G E + L E+ G L+ I + R ++ + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG 121
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID-QTHLTTRVQGTFGYLDPEYFR 566
I HRDIK N+LLD++ K+SDFG + + + L ++ GT Y+ PE +
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 567 SSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625
+F E DV+S G+VL +L G + S+ + KE + + ++
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQ-----EYSDWKEKKTYLNPWKKI 232
Query: 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
L + L R T+ +
Sbjct: 233 DSAPLA--------LLHKILVENPSARITIPDI 257
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 4e-60
Identities = 68/335 (20%), Positives = 129/335 (38%), Gaps = 50/335 (14%)
Query: 362 LLQQESSSNEGNS----EKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLTN---- 413
L + + + N + + ++ E +N ++LG G G V
Sbjct: 5 LQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKT 64
Query: 414 --GRIVAIKK-SKLVDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIP 469
VA+K + D S E ++E+ +++Q+ +H N+V LLG C + L++E+
Sbjct: 65 GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC 124
Query: 470 NGTLYQYIHDQTEEF--------------------PITWEIRLRIAIEVSDALCYLHSAA 509
G L Y+ + E+F +T+E L A +V+ + +L
Sbjct: 125 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK- 183
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT-TRVQGTFGYLDPEYFRSS 568
HRD+ + N+L+ K+ DFG +R +M D ++ + ++ PE
Sbjct: 184 --SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 241
Query: 569 QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE 628
+T KSDV+S+G++L E+ + + + +N +E
Sbjct: 242 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN------FYKLIQNGFKMDQPFYATEE 295
Query: 629 AKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663
+ + C +KRP+ LG
Sbjct: 296 IYI--------IMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 8e-59
Identities = 66/291 (22%), Positives = 123/291 (42%), Gaps = 28/291 (9%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLTNG-----RIVAIKK-SKLVDESNIEQFINEVAI 439
E+ +++G G G VYKGML VAIK E F+ E I
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 440 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVS 499
+ Q +H N+++L G + + +++ E++ NG L +++ ++ EF + + ++
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS--VLQLVGMLRGIA 120
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ--THLTTRVQGTF 557
+ YL + HRD+ + NIL++ KVSDFG SR + D T+ T+ +
Sbjct: 121 AGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 558 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617
+ PE +FT SDV+SFG+V+ E++T + + + +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELSNHEV 222
Query: 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668
+ ++ + + L +C +RP + L + +
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 199 bits (508), Expect = 1e-58
Identities = 58/274 (21%), Positives = 110/274 (40%), Gaps = 27/274 (9%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNV 448
D+++ + LG G G V++ G A K ES+ E E+ +S + H +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 449 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
V L + +++YEF+ G L++ + D+ ++ + + +V LC++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 509 ASIPIYHRDIKSANILLDDKY--RAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR 566
H D+K NI+ K K+ DFG + +D GT + PE
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTTGTAEFAAPEVAE 198
Query: 567 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN--RLFEVLDAR 624
+D++S GV+ LL+G P + +E L +K + + +
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWNMDDSAFSG 251
Query: 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
+ ++ K+ ++ L R T+ +A
Sbjct: 252 ISEDGKD--------FIRKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-58
Identities = 62/278 (22%), Positives = 113/278 (40%), Gaps = 28/278 (10%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILS 441
+ ++F +ILG+G TV L R AIK K ++ E+ + E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 442 QINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDA 501
+++H VKL + E + NG L +YI E+ A
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSA 120
Query: 502 LCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID-QTHLTTRVQGTFGYL 560
L YLH I HRD+K NILL++ +++DFG ++ + + + GT Y+
Sbjct: 121 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 561 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620
PE + SD+++ G ++ +L+ G P R+ + + + +
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLEY--D 228
Query: 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
+ +A++ L ++ L + KR +E
Sbjct: 229 FPEKFFPKARD--------LVEKLLVLDATKRLGCEEM 258
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-58
Identities = 66/315 (20%), Positives = 122/315 (38%), Gaps = 41/315 (13%)
Query: 375 EKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKK-SKLVDE 427
+ T+L + E + + + LG G G V + VA+K
Sbjct: 8 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL 67
Query: 428 SNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHD------- 479
+ E ++E+ +LS + NH N+V LLG C L++ E+ G L ++
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 480 --------QTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRA 531
+ +E + E L + +V+ + +L S HRD+ + NILL
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRIT 184
Query: 532 KVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQ 590
K+ DFG +R + D + + + ++ PE + +T +SDV+S+G+ L EL +
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 591 KPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGK 650
+ K ++++ + E + + K C +
Sbjct: 245 SSPYPGMPVDSK--------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPL 290
Query: 651 KRPTMKEAAFELGGI 665
KRPT K+ +
Sbjct: 291 KRPTFKQIVQLIEKQ 305
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 4e-58
Identities = 65/287 (22%), Positives = 114/287 (39%), Gaps = 26/287 (9%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTN----GRIVAIKK-SKLVDESNIEQFINEVA 438
+ E+ + R +G+G G V++G+ + VAIK +S E+F+ E
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 439 ILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEV 498
+ Q +H ++VKL+G E V ++ E G L ++ + + + + A ++
Sbjct: 61 TMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQL 117
Query: 499 SDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFG 558
S AL YL S HRDI + N+L+ K+ DFG SR + + ++ +
Sbjct: 118 STALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 559 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618
++ PE +FT SDV+ FGV + E+L D + ++
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERL 228
Query: 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665
+ L +C +RP E +L I
Sbjct: 229 P-MPPNCPPTLYS--------LMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 6e-57
Identities = 64/313 (20%), Positives = 119/313 (38%), Gaps = 38/313 (12%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTNG---RIVAIKK-SKLVDESNIEQFINEVAILSQI-N 444
++ ++G+G G V K + AIK+ + + + F E+ +L ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ-------------TEEFPITWEIR 491
H N++ LLG C L E+ P+G L ++ + ++ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 492 LRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTT 551
L A +V+ + YL HRD+ + NIL+ + Y AK++DFG SR + T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 552 RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEA 611
+ ++ E S +T SDV+S+GV+L E+++
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYCG 229
Query: 612 MKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGD 671
M L+E L E V L ++C +RP+ + L +
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
Query: 672 SIMQHNCDDIDFV 684
+ + +
Sbjct: 290 YVNTTLYEKFTYA 302
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-56
Identities = 61/277 (22%), Positives = 106/277 (38%), Gaps = 29/277 (10%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLT----NGRIVAIK---KSKLVDESNIEQFINEVAILSQ 442
+ LG G G V +G VA+K L ++ FI EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 443 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDAL 502
++HRN+++L G L + +V E P G+L + F R A++V++ +
Sbjct: 68 LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFL--LGTLSRYAVQVAEGM 124
Query: 503 CYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH--LTTRVQGTFGYL 560
YL S HRD+ + N+LL + K+ DFG R++ + H + + F +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 561 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620
PE ++ F+ SD + FGV L E+ T + + L + +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGERLP 235
Query: 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657
++ + +C + RPT
Sbjct: 236 RPEDCPQDIYN--------VMVQCWAHKPEDRPTFVA 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-56
Identities = 59/280 (21%), Positives = 121/280 (43%), Gaps = 28/280 (10%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTN-----GRIVAIKK-SKLVDESNIEQFINEVAILSQI 443
F ++LG G GTVYKG+ VAIK+ + ++ ++E +++ +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 444 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALC 503
++ +V +LLG CL + V L+ + +P G L Y+ + + + L ++++ +
Sbjct: 69 DNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAKGMN 125
Query: 504 YLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDP 562
YL + HRD+ + N+L+ K++DFG ++ + ++ + + ++
Sbjct: 126 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 563 EYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622
E +T +SDV+S+GV + EL+T + + + + +L+
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISSILE 227
Query: 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFEL 662
I V M+ +C + RP +E E
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 188 bits (479), Expect = 1e-54
Identities = 58/272 (21%), Positives = 108/272 (39%), Gaps = 23/272 (8%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNV 448
D ++ LG G G V++ + GR+ K + NE++I++Q++H +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 449 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
+ L + +L+ EF+ G L+ I + ++ ++ + + + L ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 509 ASIPIYHRDIKSANILLD--DKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR 566
I H DIK NI+ + K+ DFG + ++ + T + PE
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTTATAEFAAPEIVD 201
Query: 567 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626
+D+++ GV+ LL+G P D E V + E + V
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-----KRCDWEFDEDAFSSVS 256
Query: 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
EAK+ K L +KR T+ +A
Sbjct: 257 PEAKD--------FIKNLLQKEPRKRLTVHDA 280
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 4e-54
Identities = 74/297 (24%), Positives = 126/297 (42%), Gaps = 33/297 (11%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTN------GRIVAIKK-SKLVDESNIEQFINE 436
E E+A + +R LGQG G VY+G+ VAIK ++ +F+NE
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 437 VAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIH-------DQTEEFPITWE 489
+++ + N +VV+LLG + + L++ E + G L Y+ + P +
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 490 IRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM-IDQTH 548
+++A E++D + YL++ HRD+ + N ++ + + K+ DFG +R + D
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 549 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF 608
+ ++ PE + FT SDV+SFGVVL E+ T + S E
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------V 244
Query: 609 LEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665
L + E L + D E L + C K RP+ E +
Sbjct: 245 LRFVMEGGLLDKPD-NCPDMLFE--------LMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 184 bits (469), Expect = 5e-54
Identities = 74/290 (25%), Positives = 117/290 (40%), Gaps = 32/290 (11%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQIN 444
+D + ILG GG V+ L R VA+K D S +F E + +N
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 445 HRNVVKLLGCCLETE----VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSD 500
H +V + +P +V E++ TL +H + P+T + + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL--TTRVQGTFG 558
AL + H I HRD+K ANI++ KV DFG +R++ + T V GT
Sbjct: 123 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 559 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618
YL PE R +SDVYS G VL E+LTG+ P S V + ++E+ +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF------TGDSPVSVAYQHVREDPIP 233
Query: 619 -EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRP-TMKEAAFELGGIR 666
+ + + + L + R T E +L +
Sbjct: 234 PSARHEGLSADLDA--------VVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (469), Expect = 1e-53
Identities = 62/272 (22%), Positives = 105/272 (38%), Gaps = 20/272 (7%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKK-SKLVDESNIEQFINEVAILSQINHR 446
D ++ +LG G V ++VAIK +K E NE+A+L +I H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH 506
N+V L L+ + + G L+ I ++ T R+ +V DA+ YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLH 124
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR 566
+ + LD+ + +SDFG S+ M D + + GT GY+ PE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLSTACGTPGYVAPEVLA 182
Query: 567 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626
+++ D +S GV+ LL G P + + + E +
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-----LKAEYEFDSPYWDDIS 237
Query: 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
AK+ + + +KR T ++A
Sbjct: 238 DSAKD--------FIRHLMEKDPEKRFTCEQA 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-53
Identities = 58/273 (21%), Positives = 111/273 (40%), Gaps = 26/273 (9%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNV 448
+ + LG+G G V++ + ++ + K K+ ++ E++IL+ HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNI 63
Query: 449 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
+ L E ++++EFI +++ I+ F + + +V +AL +LHS
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH 121
Query: 509 ASIPIYHRDIKSANILLDDK--YRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR 566
I H DI+ NI+ + K+ +FG +R + + Y PE +
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQAR--QLKPGDNFRLLFTAPEYYAPEVHQ 176
Query: 567 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF-EVLDARV 625
+ +D++S G ++ LL+G P + +++ + M F E +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MNAEYTFDEEAFKEI 230
Query: 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
EA + R L K R T EA
Sbjct: 231 SIEAMD--------FVDRLLVKERKSRMTASEA 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 182 bits (462), Expect = 6e-53
Identities = 68/286 (23%), Positives = 115/286 (40%), Gaps = 38/286 (13%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKK---------SKLVDESNIEQFINEVAI 439
+N+ ILG+G V + + + A+K S + E + EV I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 440 LSQIN-HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEV 498
L +++ H N+++L LV++ + G L+ Y+ ++ ++ + +I +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRAL 119
Query: 499 SDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFG 558
+ +C LH I HRD+K NILLDD K++DFG S +D V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLREVCGTPS 174
Query: 559 YLDPEYFRSSQ------FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAM 612
YL PE S + ++ D++S GV++ LL G P ++
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-----MS 229
Query: 613 KENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
+ K+ L R L + +KR T +EA
Sbjct: 230 GNYQFGSPEWDDYSDTVKD--------LVSRFLVVQPQKRYTAEEA 267
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (461), Expect = 1e-52
Identities = 76/305 (24%), Positives = 122/305 (40%), Gaps = 40/305 (13%)
Query: 384 ELEMATDNFNTNRILGQGGQGTVYKGM------LTNGRIVAIKK-SKLVDESNIEQFINE 436
+ E D + LG+G G V + R VA+K + S ++E
Sbjct: 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66
Query: 437 VAILSQINHR-NVVKLLGCCLETEVPL-LVYEFIPNGTLYQYIHDQTEEF---------- 484
+ IL I H NVV LLG C + PL ++ EF G L Y+ + EF
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 485 ---PITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541
+T E + + +V+ + +L S HRD+ + NILL +K K+ DFG +R
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARD 183
Query: 542 VMIDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE 600
+ D ++ + ++ PE +T +SDV+SFGV+L E+ + +
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 601 DKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660
++ F +KE D E + C + +RPT E
Sbjct: 244 EE-----FCRRLKEGTRMRAPD-YTTPEMYQ--------TMLDCWHGEPSQRPTFSELVE 289
Query: 661 ELGGI 665
LG +
Sbjct: 290 HLGNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 8e-52
Identities = 67/306 (21%), Positives = 123/306 (40%), Gaps = 42/306 (13%)
Query: 386 EMATDNFNTNRILGQGGQGTVYKGMLT--------NGRIVAIKKSKL-VDESNIEQFINE 436
E+ D + LG+G G V VA+K K E ++ I+E
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 437 VAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ-------------TE 482
+ ++ I H+N++ LLG C + ++ E+ G L +Y+ +
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 483 EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542
E ++ + + A +V+ + YL S HRD+ + N+L+ + K++DFG +R +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 543 MIDQTHLTTRVQ-GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED 601
+ T ++ PE +T +SDV+SFGV+L E+ T
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--------- 236
Query: 602 KSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661
+ LF++L + + M+ + C + + +RPT K+ +
Sbjct: 237 ------PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 662 LGGIRA 667
L I A
Sbjct: 291 LDRIVA 296
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 8e-50
Identities = 69/277 (24%), Positives = 114/277 (41%), Gaps = 29/277 (10%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIK---KSKLVDESNIEQFINEVAILS-QIN 444
++F +++LG+G G V+ + AIK K ++ + ++E + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 445 HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCY 504
H + + E V E++ G L +I A E+ L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQF 118
Query: 505 LHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEY 564
LHS I +RD+K NILLD K++DFG + M+ T GT Y+ PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174
Query: 565 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624
++ D +SFGV+L E+L GQ P D EE +++ + F
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPF--YPRW 225
Query: 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661
+ KEAK+ L + +KR ++ +
Sbjct: 226 LEKEAKD--------LLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 170 bits (431), Expect = 1e-48
Identities = 57/283 (20%), Positives = 110/283 (38%), Gaps = 20/283 (7%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRN 447
+ ++ +G+G G VYK G A+KK +L DE I E++IL ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 448 VVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
+VKL + +LV+E + E + +++ + + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 508 AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRS 567
+ HRD+K N+L++ + K++DFG +R+ I T + + S
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 568 SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE------------DKSLVGYFLEAMKEN 615
+++ D++S G + E++ G + + E K +
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 616 RLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
F V + + + + L + L + +R T K+A
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 171 bits (433), Expect = 6e-48
Identities = 58/283 (20%), Positives = 113/283 (39%), Gaps = 31/283 (10%)
Query: 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIK---KSKLVDESNIEQFINEV---AI 439
+ ++F+ +RI+G+GG G VY G++ A+K K ++ + +NE ++
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 440 LSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVS 499
+S + +V + + + + + G L+ ++ + A E+
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEII 117
Query: 500 DALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY 559
L ++H+ + +RD+K ANILLD+ ++SD G + + H GT GY
Sbjct: 118 LGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGY 171
Query: 560 LDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618
+ PE + + +D +S G +L +LL G P R +++ + L E
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE---- 227
Query: 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661
L E + L + L +R +
Sbjct: 228 --LPDSFSPELRS--------LLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 169 bits (428), Expect = 1e-47
Identities = 64/273 (23%), Positives = 120/273 (43%), Gaps = 26/273 (9%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINH 445
+F R LG G G V+ NGR A+K K +V +E +E +LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
++++ G + + ++ ++I G L+ + + A EV AL YL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYL 120
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF 565
HS I +RD+K NILLD K++DFG ++ V +T + GT Y+ PE
Sbjct: 121 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVV 173
Query: 566 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625
+ + + D +SFG+++ E+L G P +++ + E + L
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-------TYEKILNAEL--RFPPFF 224
Query: 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
++ K ++++ ++ + +G + ++
Sbjct: 225 NEDVK--DLLS-RLITRDLSQRLGNLQNGTEDV 254
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-47
Identities = 60/274 (21%), Positives = 107/274 (39%), Gaps = 29/274 (10%)
Query: 394 TNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQI-NHRNVVKL 451
T+++LG G G V + A+K + + + EV + + ++V++
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRI 70
Query: 452 LGCC----LETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS 507
+ + L+V E + G L+ I D+ ++ T I + +A+ YLHS
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS 129
Query: 508 AASIPIYHRDIKSANILLDDKY---RAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEY 564
I HRD+K N+L K K++DFG ++ + T T Y+ PE
Sbjct: 130 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEV 184
Query: 565 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624
++ + D++S GV++ LL G P S + M + +
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPNPEWSE 243
Query: 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
V +E K L + L +R T+ E
Sbjct: 244 VSEEVKM--------LIRNLLKTEPTQRMTITEF 269
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 4e-47
Identities = 68/291 (23%), Positives = 115/291 (39%), Gaps = 25/291 (8%)
Query: 388 ATDNFNTNRILGQGGQGTVYKG--MLTNGRIVAIK--KSKLVDESNIEQFINEVAILSQI 443
A + +G+G G V+K + GR VA+K + + +E I EVA+L +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 444 ---NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQ---YIHDQTEEFPITWEIRLRIAIE 497
H NVV+L C + + + Q D+ E + E + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 498 VSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTF 557
+ L +LHS + HRD+K NIL+ + K++DFG +R T V T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 558 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIR-STDSEEDKSLVGYFLEAMKENR 616
Y PE S + D++S G + E+ + R S+D ++ ++ +E+
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 617 LFEVLDARVLKEAKEEEIITVAM---------LAKRCLNMIGKKRPTMKEA 658
+V R +K + I + L +CL KR + A
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 6e-47
Identities = 61/284 (21%), Positives = 106/284 (37%), Gaps = 20/284 (7%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINHR 446
+NF +G+G G VYK G +VA+KK +L E I E+++L ++NH
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH 506
N+VKLL LV+EF+ P + ++ L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP--LPLIKSYLFQLLQGLAFCH 119
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR 566
S + HRD+K N+L++ + K++DFG +R+ + T V +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 567 SSQFTEKSDVYSFGVVLVELLTGQKP------------IRSTDSEEDKSLVGYFLEAMKE 614
++ D++S G + E++T + I T D+ +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 615 NRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
F + + L + L+ KR + K A
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 8e-47
Identities = 64/281 (22%), Positives = 106/281 (37%), Gaps = 25/281 (8%)
Query: 396 RILGQGGQGTVYKGMLTN-GRIVAIKKSKL-----VDESNIEQFINEVAILSQINHRNVV 449
LG+G TVYK N +IVAIKK KL + + E+ +L +++H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 450 KLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA 509
LL LV++F+ + +T + L YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 510 SIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ 569
I HRD+K N+LLD+ K++DFG ++S T +V T Y PE ++
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 570 -FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE 628
+ D+++ G +L ELL + + + + L E + ++
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 629 AKEEEIITVAM-----------LAKRCLNMIGKKRPTMKEA 658
K I + L + R T +A
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-46
Identities = 68/280 (24%), Positives = 112/280 (40%), Gaps = 32/280 (11%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESN---IEQFINEVAILSQ 442
D ++T LG G V K + G A K K + E EV+IL +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 443 INHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDAL 502
I H NV+ L +L+ E + G L+ ++ ++ +T E ++ + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 126
Query: 503 CYLHSAASIPIYHRDIKSANILLDD----KYRAKVSDFGASRSVMIDQTHLTTRVQGTFG 558
YLHS I H D+K NI+L D K R K+ DFG + ID + + GT
Sbjct: 127 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIFGTPE 181
Query: 559 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618
++ PE ++D++S GV+ LL+G P +E +
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----LANVSAVNYEFE 236
Query: 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
+ + AK+ +R L KKR T++++
Sbjct: 237 DEYFSNTSALAKD--------FIRRLLVKDPKKRMTIQDS 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-46
Identities = 66/297 (22%), Positives = 113/297 (38%), Gaps = 44/297 (14%)
Query: 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNV 448
++ +++G G G VY+ L +G +VAIKK + E+ I+ +++H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNI 75
Query: 449 VKLLGCCLETEVP------LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDAL 502
V+L + LV +++P H + + ++ +L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 503 CYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLD 561
Y+HS I HRDIK N+LLD D K+ DFG+++ ++ + + +
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYRAP 191
Query: 562 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEE--------------------D 601
F ++ +T DV+S G VL ELL GQ + +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 602 KSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
+ + +K + +V R EA L R L R T EA
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIA--------LCSRLLEYTPTARLTPLEA 300
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-46
Identities = 55/289 (19%), Positives = 112/289 (38%), Gaps = 22/289 (7%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKK-SKLVDESNIEQFINEVAILSQINHR 446
+ +G+G G V N VAIKK S ++ ++ + E+ IL + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH 506
N++ + + + ++ + ++ + ++ + ++ L Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLT--TRVQGTFGYLDPEY 564
SA + HRD+K +N+LL+ K+ DFG +R D H T T Y PE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 565 FRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623
+S+ +T+ D++S G +L E+L+ + + + + L + + L +++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 624 RVLKEAKEEEIIT--------------VAMLAKRCLNMIGKKRPTMKEA 658
+ L + L KR +++A
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-45
Identities = 57/285 (20%), Positives = 113/285 (39%), Gaps = 22/285 (7%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINHR 446
+ +G+G GTV+K IVA+K+ +L DE + E+ +L ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH 506
N+V+L + LV+EF + + EI ++ L + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH 118
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR 566
S + HRD+K N+L++ K+++FG +R+ I + V + F
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 567 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEED-----KSLVGYFLE-------AMKE 614
+ ++ D++S G + EL +P+ + +D L+G E + +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 615 NRLFEVLDARVLKEAKEEEIITVAM-LAKRCLNMIGKKRPTMKEA 658
+ + + A ++ L + L +R + +EA
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-44
Identities = 65/276 (23%), Positives = 108/276 (39%), Gaps = 28/276 (10%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK---KSKLVDESNIEQFINEVAILSQINH 445
++F+ ++LG+G G V GR A+K K ++ + + + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
+ L + V E+ G L+ ++ E T E E+ AL YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYL 121
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF 565
HS + +RDIK N++LD K++DFG + + D + T GT YL PE
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 177
Query: 566 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625
+ + D + GVV+ E++ G+ P + D E E + + +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI--RFPRTL 228
Query: 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661
EAK L L K+R + +
Sbjct: 229 SPEAKS--------LLAGLLKKDPKQRLGGGPSDAK 256
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-44
Identities = 67/280 (23%), Positives = 117/280 (41%), Gaps = 42/280 (15%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKK------SKLVDESNIEQFINEVAILSQ 442
+ +LG GG G+VY G+ +++ VAIK S + N + EV +L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 443 IN--HRNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSD 500
++ V++LL + +L+ E TE + E+ +V +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 501 ALCYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGY 559
A+ + H+ + HRDIK NIL+D ++ K+ DFG+ ++ T T GT Y
Sbjct: 122 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA--LLKDTVYTDFD-GTRVY 175
Query: 560 LDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618
PE+ R ++ + V+S G++L +++ G P + E ++ F
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQVFF 223
Query: 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEA 658
RV E + L + CL + RPT +E
Sbjct: 224 ---RQRVSSECQH--------LIRWCLALRPSDRPTFEEI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 7e-44
Identities = 55/286 (19%), Positives = 97/286 (33%), Gaps = 29/286 (10%)
Query: 383 MELEMATDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILS 441
MEL + + + R +G G G +Y G + G VAIK + ++ Q E I
Sbjct: 1 MELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYK 57
Query: 442 QINHRNVVKLLG-CCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSD 500
+ + + C E + ++V E + + + + L +A ++
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMIS 114
Query: 501 ALCYLHSAASIPIYHRDIKSANIL---LDDKYRAKVSDFGASRSVMIDQTH------LTT 551
+ Y+HS HRD+K N L + DFG ++ +TH
Sbjct: 115 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 552 RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEA 611
+ GT Y + + + D+ S G VL+ G P + + + E
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE- 230
Query: 612 MKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657
K + EVL E C ++ +P
Sbjct: 231 KKMSTPIEVLCKGYPSEFAT--------YLNFCRSLRFDDKPDYSY 268
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (387), Expect = 9e-42
Identities = 59/245 (24%), Positives = 99/245 (40%), Gaps = 18/245 (7%)
Query: 364 QQESSSNEGNSEKTKLFTSMELEMAT----DNFNTNRILGQGGQGTVYKGM-LTNGRIVA 418
+QES K E D F+ + LG G G V +G A
Sbjct: 11 EQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYA 70
Query: 419 IK---KSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQ 475
+K K K+V IE +NE IL +N +VKL + +V E++ G ++
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 476 YIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSD 535
++ + A ++ YLHS + +RD+K N+L+D + +V+D
Sbjct: 131 HLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTD 184
Query: 536 FGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRS 595
FG ++ V + GT L PE S + + D ++ GV++ E+ G P +
Sbjct: 185 FGFAKRVKGRTWT----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 596 TDSEE 600
+
Sbjct: 241 DQPIQ 245
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-41
Identities = 54/287 (18%), Positives = 110/287 (38%), Gaps = 24/287 (8%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK--KSKLVDESNIEQFINEVAILSQINHR 446
+ + +G G G V + G VAIK E ++ E+ +L + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQ-TEEFPITWEIRLRIAIEVSDALCYL 505
NV+ LL E +F + + + + + ++ L Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYF 565
H+A I HRD+K N+ +++ K+ DFG +R + +T V +
Sbjct: 138 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVIL 191
Query: 566 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLV--------GYFLEAMKENRL 617
++T+ D++S G ++ E++TG+ + +D + + F++ ++ +
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 618 FEVLDARVLKEAKEEEIITVAM------LAKRCLNMIGKKRPTMKEA 658
+ E K+ I L ++ L + ++R T EA
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 5e-41
Identities = 60/299 (20%), Positives = 112/299 (37%), Gaps = 36/299 (12%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINHR 446
+ +GQG G V+K G+ VA+KK + E + E+ IL + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 447 NVVKLLGCCLETEVP--------LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEV 498
NVV L+ C P LV++F + + T R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQML 126
Query: 499 SDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT---HLTTRVQG 555
L L+ I HRD+K+AN+L+ K++DFG +R+ + + + T
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 556 TFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDSEE--------DKSLVG 606
T Y PE + + D++ G ++ E+ T ++ + S+
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 607 YFLEAMKENRLFEVLDARVLKEAKEEEIITVAM-------LAKRCLNMIGKKRPTMKEA 658
+ L+E L+ ++ K ++ + + L + L + +R +A
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 146 bits (370), Expect = 4e-40
Identities = 46/280 (16%), Positives = 92/280 (32%), Gaps = 28/280 (10%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNV 448
++ R +G+G G +++G L N + VAIK S+ Q +E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 62
Query: 449 VKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSA 508
+ + + + ++ + +L + +F + A ++ + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFS--VKTVAMAAKQMLARVQSIHEK 120
Query: 509 ASIPIYHRDIKSANILLDDKYR-----AKVSDFGASRSVMIDQT------HLTTRVQGTF 557
+ +RDIK N L+ V DFG + T + GT
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 558 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617
Y+ + + + D+ + G V + L G P + + +K E K++
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE-KKQSTP 236
Query: 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657
L A +E + N+ P
Sbjct: 237 LRELCAGFPEEFYK--------YMHYARNLAFDATPDYDY 268
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 142 bits (358), Expect = 5e-38
Identities = 55/298 (18%), Positives = 108/298 (36%), Gaps = 45/298 (15%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQIN-HRN 447
D++ R LG+G V++ + +TN V +K + ++ E+ IL + N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKILENLRGGPN 91
Query: 448 VVKLLGCCLE--TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
++ L + + P LV+E + N Q +T E+ AL Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145
Query: 506 HSAASIPIYHRDIKSANILLD-DKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEY 564
HS I HRD+K N+++D + + ++ D+G + Q + + + PE
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 200
Query: 565 FRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623
Q + D++S G +L ++ ++P D + + + L++ +D
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDK 258
Query: 624 RVLKEAKEEEIITVAM-----------------------LAKRCLNMIGKKRPTMKEA 658
++ I + L + R T +EA
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 6e-38
Identities = 70/309 (22%), Positives = 122/309 (39%), Gaps = 40/309 (12%)
Query: 364 QQESSSNEGNSEKTKLFTSMELEMATDNFNTNRILGQGGQGTVYKGMLT----NGRIVAI 419
+ +++ G++EK + +NF ++LG G G V+ G++ A+
Sbjct: 8 ELRTANLTGHAEKVGI----------ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAM 57
Query: 420 K---KSKLVDESN-IEQFINEVAILSQINHR-NVVKLLGCCLETEVPLLVYEFIPNGTLY 474
K K+ +V ++ E E +L I +V L L+ ++I G L+
Sbjct: 58 KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 117
Query: 475 QYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVS 534
++ + T E+ AL +LH I +RDIK NILLD ++
Sbjct: 118 THLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLT 171
Query: 535 DFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKP 592
DFG S+ + D+T GT Y+ P+ R + D +S GV++ ELLTG P
Sbjct: 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
Query: 593 IRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKR 652
+ ++ + + + + + AK+ L +R L KKR
Sbjct: 232 FTVDGEKNSQAEI-----SRRILKSEPPYPQEMSALAKD--------LIQRLLMKDPKKR 278
Query: 653 PTMKEAAFE 661
+
Sbjct: 279 LGCGPRDAD 287
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-35
Identities = 55/292 (18%), Positives = 106/292 (36%), Gaps = 32/292 (10%)
Query: 389 TDNFNTNRILGQGGQGTVYKGM-LTNGRIVAIK--KSKLVDESNIEQFINEVAILSQINH 445
+ + +G G G+V G VA+K + ++ E+ +L + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 446 RNVVKLLGCC-----LETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSD 500
NV+ LL LE + + + L + Q +T + + ++
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILR 132
Query: 501 ALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYL 560
L Y+HSA I HRD+K +N+ +++ K+ DFG + +T V +
Sbjct: 133 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRA 186
Query: 561 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLV--------GYFLEAM 612
+ + D++S G ++ ELLTG+ TD + L+ L+ +
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 613 KENRLFEVLDARVLKEAKEEEIITVAM------LAKRCLNMIGKKRPTMKEA 658
+ + + + L ++ L + KR T +A
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-35
Identities = 61/297 (20%), Positives = 111/297 (37%), Gaps = 33/297 (11%)
Query: 390 DNFNTNRILGQGGQGTVYKGM-LTNGRIVAIKK--SKLVDESNIEQFINEVAILSQINHR 446
+ + +G G QG V R VAIKK ++++ ++ E+ ++ +NH+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 447 NVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH 506
N++ LL + + L Q + + E + ++ + +LH
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 507 SAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFR 566
S I HRD+K +NI++ K+ DFG +R+ + + T T Y PE
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVIL 191
Query: 567 SSQFTEKSDVYSFGVVLVELLTGQKP---------------IRSTDSEEDKSLVGYFLEA 611
+ E D++S G ++ E++ + T E + +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 612 MKENRL------FEVLDARVLKEAKEEEIITVAMLAK----RCLNMIGKKRPTMKEA 658
ENR F L L A E A A+ + L + KR ++ +A
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (307), Expect = 6e-31
Identities = 57/314 (18%), Positives = 101/314 (32%), Gaps = 58/314 (18%)
Query: 396 RILGQGGQGTVYKGM-LTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGC 454
R LG G TV+ + N VA+K + D+ E +E+ +L ++N + K
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 455 CLETEVPLLVY--EFIPNGTLYQYIH-----------DQTEEFPITWEIRLRIAIEVSDA 501
+ LL + PNG + + E I +I+ ++
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 502 LCYLHSAASIPIYHRDIKSANILLD------DKYRAKVSDFGASRSVMIDQTHLTTRVQG 555
L Y+H I H DIK N+L++ + + K++D G + T+
Sbjct: 138 LDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN----SIQ 191
Query: 556 TFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVG--------- 606
T Y PE + + +D++S ++ EL+TG +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 607 ---------------YFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGK- 650
F + R L L++ E+ AK + +
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311
Query: 651 ------KRPTMKEA 658
KR
Sbjct: 312 LQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.9 bits (217), Expect = 1e-20
Identities = 30/202 (14%), Positives = 63/202 (31%), Gaps = 28/202 (13%)
Query: 396 RILGQGGQGTVYKGMLTNGRIVAIK----------KSKLVDESNIEQFINEVAILSQINH 445
+++G+G + V+ +K K K + F ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 446 RNVVKLLGCCLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYL 505
R + KL G + Y + N L + I + + + + +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 506 HSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV--MIDQTHLTTRVQGTFGYLDPE 563
+ I H D+ N+L+ + + DF S V + L V+
Sbjct: 120 YHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNI-----IT 170
Query: 564 YFRSSQFTEKSDVYSFGVVLVE 585
YF + + D+ S +++
Sbjct: 171 YFS-RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 700 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.43 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.77 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.31 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.32 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 96.08 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.03 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.73 | |
| d1tpga1 | 41 | Plasminogen activator (tissue-type), t-PA {Human ( | 92.73 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 92.56 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 92.49 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 92.15 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 91.85 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 91.5 | |
| d1q4ga2 | 42 | Prostaglandin H2 synthase-1, EGF-like module {Shee | 90.96 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 90.89 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 90.61 | |
| d1cvua2 | 41 | Prostaglandin H2 synthase-1, EGF-like module {Mous | 90.13 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 89.87 | |
| d1dx5i3 | 40 | Thrombomodulin, different EGF-like domains {Human | 88.67 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 88.51 | |
| d1nqlb_ | 48 | Epidermal growth factor, EGF {Human (Homo sapiens) | 87.59 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 86.69 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 85.92 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 85.14 | |
| d1haea_ | 63 | Heregulin-alpha, EGF-like domain {Human (Homo sapi | 84.45 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 80.18 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=416.85 Aligned_cols=258 Identities=29% Similarity=0.447 Sum_probs=205.2
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
.++|++.+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 46788999999999999999999888999999987643 33478999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++........
T Consensus 83 ~~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999999986543 4899999999999999999999999 999999999999999999999999999876544444
Q ss_pred eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhC-CCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 549 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTG-QKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......||+.|+|||++.+..++.++||||||++||||+++ .+||......+ +...+..+.. .
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~-------~~~~i~~~~~---------~ 221 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGFR---------L 221 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH-------HHHHHHHTCC---------C
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHhcCC---------C
Confidence 44456789999999999999999999999999999999995 55554333221 1122222211 1
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
..+...+.++.+|+.+||+.||++|||++||++.|++|+++
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 11223345788999999999999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-51 Score=416.16 Aligned_cols=266 Identities=26% Similarity=0.434 Sum_probs=212.4
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
++..++|++.+.||+|+||+||+|+++ ..||||+++. .+....+.|.+|++++++++||||+++++++.+ +..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 445788999999999999999999875 3599999864 345567889999999999999999999998754 56799
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++|+|.+++..... .+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 81 v~Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999976543 3999999999999999999999999 9999999999999999999999999998654
Q ss_pred cCC-ceeeeeeeccccccccccccc---CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 544 IDQ-THLTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 544 ~~~-~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
... ........||+.|||||++.+ ..++.++||||||++||||++|+.||........ +...+..+....
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~~~p 229 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSP 229 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTSCCC
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCCCC
Confidence 332 223445679999999999864 3578999999999999999999999986544321 112222221111
Q ss_pred hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 620 VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 620 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
. ....+...++.+.+|+.+||+.||++|||++|+++.|+.++.++.
T Consensus 230 ----~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 230 ----D-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp ----C-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ----c-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 0 112233445678999999999999999999999999999987654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.8e-51 Score=418.12 Aligned_cols=264 Identities=27% Similarity=0.401 Sum_probs=220.2
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
++++..++|++.+.||+|+||+||+|++. +++.||||+++... ...++|.+|+++|++++||||+++++++.+.+..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 34556788999999999999999999986 58899999987543 34578999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++..
T Consensus 90 iv~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred EEeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeec
Confidence 99999999999999976533 35999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
............|++.|+|||++.+..++.++||||||+++|||++|..||........ ....+..+.
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------~~~~i~~~~------ 233 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDY------ 233 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHTTC------
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH------HHHHHhcCC------
Confidence 55555555556789999999999999999999999999999999997766543322211 112222211
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
....+...+..+.+|+.+||+.||++|||++||++.|+.+.+
T Consensus 234 ---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 234 ---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ---CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112233445678999999999999999999999999988753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=413.49 Aligned_cols=263 Identities=22% Similarity=0.384 Sum_probs=215.1
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
++++..++|++.+.||+|+||+||+|.+++++.||||+++... ...+.|.+|++++++++||||+++++++.+ +..++
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 3445678899999999999999999999888899999987543 334789999999999999999999998754 56799
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++|+|.+++..... ..+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+++...
T Consensus 85 v~Ey~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEeCCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEcc
Confidence 9999999999998865432 23899999999999999999999999 9999999999999999999999999998775
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
...........||+.|||||++.+..++.++||||||++||||++|..|+........ ....+..+..
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~------~~~~i~~~~~------ 228 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGYR------ 228 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCC------
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCC------
Confidence 5544445556789999999999999999999999999999999996555433322211 1222222211
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
...+...+..+.+|+.+||+.||++|||++||++.|+.+-.
T Consensus 229 ---~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 229 ---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 11122345578999999999999999999999999988643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=402.66 Aligned_cols=255 Identities=26% Similarity=0.405 Sum_probs=217.4
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
.++|++.++||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 478999999999999999999998888999999876443 3478999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
++|+|.+++..... .+++..+++++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++........
T Consensus 82 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999999876544 3899999999999999999999999 999999999999999999999999999876555444
Q ss_pred eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 549 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
......+|+.|+|||.+.+..++.|+||||||+++|||++ |+.||......+. ...+..+.. .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-------~~~i~~~~~---------~ 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------AEHIAQGLR---------L 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------HHHHHTTCC---------C
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-------HHHHHhCCC---------C
Confidence 4445668999999999999999999999999999999998 8999987654431 122222211 1
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGI 665 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l 665 (700)
..+...+..+.+|+.+||+.||++|||++|+++.|.+|
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 11223345789999999999999999999999998654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-49 Score=410.60 Aligned_cols=258 Identities=25% Similarity=0.410 Sum_probs=204.4
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcC-C---cEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTN-G---RIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
.++|++.++||+|+||+||+|+++. + ..||||++.. ......+.|.+|+++|++++|||||++++++.+.+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 4567888999999999999999752 2 3689998765 345566789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++|+|.+++..... .+++.+++.++.||++||+|||+++ |+||||||+||||+.++++||+|||+++...
T Consensus 105 v~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999999886543 3999999999999999999999999 9999999999999999999999999998664
Q ss_pred cCCcee----eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 544 IDQTHL----TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 544 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
...... .....+|+.|||||++.+..++.++||||||++||||++ |+.||......+ ....+..+..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~- 251 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-------VINAIEQDYR- 251 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTTCC-
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC-
Confidence 332221 122457899999999999999999999999999999998 899997655432 1122222211
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
...+...+..+.+|+.+||+.||++|||+.||++.|+++.+
T Consensus 252 --------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 252 --------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11233455678999999999999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=405.22 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=210.5
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
++|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999975 68999999987655556688999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
++|+|.+++.+.. +++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++...... .
T Consensus 100 ~gg~L~~~~~~~~----l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (293)
T ss_dssp TTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred CCCcHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-c
Confidence 9999999987643 999999999999999999999999 9999999999999999999999999998764332 2
Q ss_pred eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhc
Q 005355 549 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKE 628 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 628 (700)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .......... .. .
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~~~-~~-------~ 237 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTP-EL-------Q 237 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSC-CC-------S
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHhCCCC-CC-------C
Confidence 33455699999999999999999999999999999999999999976543221 1111111111 11 1
Q ss_pred cCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 629 AKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 629 ~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.+...+..+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11233457889999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=400.73 Aligned_cols=245 Identities=28% Similarity=0.415 Sum_probs=208.5
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.+.||+|+||+||+|+++ +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999986 6889999987642 2334577899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++|+|.+++..... +++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~~~---l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999986543 999999999999999999999999 999999999999999999999999999765322
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
......||+.|||||++.+..++.++|||||||+||||++|+.||......+ ....+.....
T Consensus 160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~-------- 221 (263)
T d2j4za1 160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEF-------- 221 (263)
T ss_dssp ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCC--------
T ss_pred ---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC--------
Confidence 2344569999999999999999999999999999999999999997654332 1122222211
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+...++++.+|+.+||+.||++|||++|+++
T Consensus 222 --~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 112234567889999999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=404.88 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=204.3
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
++|++.+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57999999999999999999986 68999999976533 23456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.......
T Consensus 85 ~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999997543 4999999999999999999999999 99999999999999999999999999987654332
Q ss_pred -eeeeeeecccccccccccccCCC-CcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 548 -HLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 548 -~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
.......||+.|||||++.+..+ +.++||||||++||||++|+.||......... ...........
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~------~~~~~~~~~~~------ 226 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTYL------ 226 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH------HHHHHTTCTTS------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH------HHHHhcCCCCC------
Confidence 23445679999999999988876 57899999999999999999999755432211 11111111110
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
......+.++.+|+.+||+.||++|||++|+++
T Consensus 227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 --NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001123456788999999999999999999865
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=404.97 Aligned_cols=265 Identities=27% Similarity=0.423 Sum_probs=216.9
Q ss_pred hcCCCccce-EeeeCCeEEEEEEEc---CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 389 TDNFNTNRI-LGQGGQGTVYKGMLT---NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 389 ~~~~~~~~~-lG~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
.++|.+.+. ||+|+||+||+|.++ ++..||||+++.. .....+.|.+|+++|++++||||+++++++.+ +..+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 456666674 999999999999865 3557999998753 45557889999999999999999999999864 56799
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
||||+++|+|.+++..... .+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 86 vmE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999999865543 4999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCcee--eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 544 IDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 544 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
...... .....||+.|||||++.+..++.++||||||+++|||++ |+.||......+ +...+..+...
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~~-- 231 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRM-- 231 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCC--
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC--
Confidence 433322 233458899999999999999999999999999999998 899998655432 22223332211
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCCccC
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSIMQ 675 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~~~ 675 (700)
+.+...+.++.+|+.+||+.+|++|||+.+|++.|+.+..++......
T Consensus 232 -------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~~ 279 (285)
T d1u59a_ 232 -------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279 (285)
T ss_dssp -------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred -------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccch
Confidence 223344567899999999999999999999999999887766554433
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=405.74 Aligned_cols=263 Identities=24% Similarity=0.354 Sum_probs=209.6
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
+..++|++.+.||+|+||+||+|++++++.||||+++.... ..+.|.+|+.++++++|+|||++++++.+ +..++|||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 44678999999999999999999999888999999875433 34789999999999999999999999854 56799999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++|+|..++..... ..++|.+++.++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++......
T Consensus 92 y~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 92 YMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred ecCCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 9999999999876432 23999999999999999999999999 9999999999999999999999999998765444
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVL 626 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 626 (700)
........||+.|+|||++....++.++||||||++||||++|..|+........ ....+..+..
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~------~~~~i~~~~~--------- 232 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYR--------- 232 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCC---------
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCC---------
Confidence 4444556789999999999999999999999999999999997666544332221 1222222211
Q ss_pred hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 627 KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 627 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
...+...+.++.+|+.+||+.||++|||+++|+++|+....+..
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 11223345678999999999999999999999999998776554
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=403.30 Aligned_cols=251 Identities=25% Similarity=0.331 Sum_probs=209.4
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeC
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 468 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~ 468 (700)
+.|++.+.||+|+||+||+|++. +++.||||++........+.+.+|+++|++++||||+++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999976 68999999988766677788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
++|+|.+++.+... ++++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++...... .
T Consensus 92 ~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp TTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 99999999876432 4999999999999999999999999 9999999999999999999999999997543221 1
Q ss_pred eeeeeecccccccccccc-----cCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 549 LTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 549 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
......||+.|||||++. +..++.++|||||||+||||++|+.||......+. + ..+..+....+
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~-~~i~~~~~~~~--- 235 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------L-LKIAKSEPPTL--- 235 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------H-HHHHHSCCCCC---
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------H-HHHHcCCCCCC---
Confidence 233456999999999984 45688999999999999999999999987654432 1 11111111111
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 236 ----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 ----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111234567889999999999999999999876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=401.43 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=205.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcCC-----cEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTNG-----RIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 462 (700)
.+.|+..++||+|+||+||+|.++.. ..||||++.. ......++|.+|++++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 46688889999999999999997632 3799999865 34445668999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
+||||+.+++|.+++..... .+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999998876543 3999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCce--eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 543 MIDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 543 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
...... ......||+.|||||++.+..++.++||||||++||||+++..|+........ +...+..+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~------~~~~i~~~~---- 230 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDGF---- 230 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTC----
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH------HHHHHhccC----
Confidence 433222 22334589999999999999999999999999999999996666543322211 122222221
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
....+...+..+.+|+.+||+.||++|||+.||+++|+++.+.
T Consensus 231 -----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 -----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1122333456789999999999999999999999999987653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=402.20 Aligned_cols=255 Identities=26% Similarity=0.401 Sum_probs=198.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe--CCcceE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLE--TEVPLL 463 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 463 (700)
.++|++.+.||+|+||+||+|+.+ +|+.||||++... ++...+.+.+|++++++++||||+++++++.+ .+..++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 367999999999999999999976 6899999987653 45556789999999999999999999999875 456789
Q ss_pred EEeeCCCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 464 VYEFIPNGTLYQYIHDQT-EEFPITWEIRLRIAIEVSDALCYLHSAA--SIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
||||+++|+|.+++.+.. .+..+++..++.++.||+.||+|||+++ ..+|+||||||+||||+.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999997532 2335999999999999999999999865 1249999999999999999999999999998
Q ss_pred ccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
..... ........||+.|||||++.+..++.++||||||+++|||++|+.||......+ ....+..+...
T Consensus 163 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i~~~~~~-- 232 (269)
T d2java1 163 ILNHD-TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFR-- 232 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCC--
T ss_pred ecccC-CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCC--
Confidence 65432 223345679999999999999999999999999999999999999997654332 22223333221
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+...++++.+|+.+||+.||++|||+.|+++
T Consensus 233 -------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 -------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 112234557899999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=397.51 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=203.5
Q ss_pred ceEeeeCCeEEEEEEEcC---CcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEeeCCC
Q 005355 396 RILGQGGQGTVYKGMLTN---GRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIPN 470 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~ 470 (700)
++||+|+||+||+|.+++ ++.||||+++. .+....+.|.+|+++|++++||||+++++++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998753 46899999864 334456789999999999999999999999854 567899999999
Q ss_pred CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCcee-
Q 005355 471 GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTHL- 549 (700)
Q Consensus 471 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~~- 549 (700)
|+|.++++... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999998654 3999999999999999999999999 9999999999999999999999999998765443332
Q ss_pred -eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhh
Q 005355 550 -TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLK 627 (700)
Q Consensus 550 -~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 627 (700)
.....||+.|||||++.+..++.++||||||+++|||++ |+.||......+ ....+..+.. .
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~~---------~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGER---------M 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCC---------C
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcCCC---------C
Confidence 233568999999999999999999999999999999998 899998654332 1222222221 1
Q ss_pred ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 628 EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 628 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
..+...+.++.+|+.+||+.||++|||+++|++.|+..-.
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 1223345678899999999999999999999999987543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=409.16 Aligned_cols=261 Identities=26% Similarity=0.454 Sum_probs=212.7
Q ss_pred HHHHhcCCCccceEeeeCCeEEEEEEEcC-C-----cEEEEEEccc-cChhhHHHHHHHHHHHhhc-CCCceeeEEeEEE
Q 005355 385 LEMATDNFNTNRILGQGGQGTVYKGMLTN-G-----RIVAIKKSKL-VDESNIEQFINEVAILSQI-NHRNVVKLLGCCL 456 (700)
Q Consensus 385 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~-----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 456 (700)
+++..++|++.++||+|+||+||+|++.. + ..||||++.. ........+.+|+.++.++ +|||||++++++.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 34566889999999999999999999753 2 3699998764 3344457899999999998 8999999999999
Q ss_pred eCCcceEEEeeCCCCCHHHHHhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 005355 457 ETEVPLLVYEFIPNGTLYQYIHDQTE--------------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHR 516 (700)
Q Consensus 457 ~~~~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~ 516 (700)
+.+..++||||+++|+|.++|+.... ...+++..++.++.||++||+|||+++ |+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 99999999999999999999986532 134899999999999999999999999 9999
Q ss_pred CCCCCcEEECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCC
Q 005355 517 DIKSANILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIR 594 (700)
Q Consensus 517 Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~ 594 (700)
||||+|||++.++.+||+|||+++........ ......||+.|||||++.+..++.++|||||||+||||++ |..||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876544332 3345668999999999999999999999999999999998 899998
Q ss_pred CCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 005355 595 STDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELG 663 (700)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~ 663 (700)
+....+. +...+..+. ..+.+...++++.+|+.+||+.||++|||++||+++|.
T Consensus 269 ~~~~~~~------~~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDAN------FYKLIQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHH------HHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHH------HHHHHhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 6554331 112222211 11223334567899999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-49 Score=410.60 Aligned_cols=270 Identities=26% Similarity=0.409 Sum_probs=211.0
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
...++|++.++||+|+||+||+|++. +++.||||+++.. .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34678999999999999999999976 6899999998653 344567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS-AASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
|||+++|+|.+++.+.. .+++..+..++.||+.||+|||+ ++ |+||||||+||||+.++++||+|||+|+...
T Consensus 83 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 99999999999998654 39999999999999999999997 48 9999999999999999999999999998653
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHH-H---------
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAM-K--------- 613 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~--------- 613 (700)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+............ .
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 22 2334679999999999999999999999999999999999999998765433211100000000 0
Q ss_pred -------------hcchhhhcchhhhh----ccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH--HHHhc
Q 005355 614 -------------ENRLFEVLDARVLK----EAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF--ELGGI 665 (700)
Q Consensus 614 -------------~~~~~~~~d~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l 665 (700)
.....+.++..... ......+.++.+|+.+||+.||++|||++|+++ .|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00000000000000 000112457889999999999999999999998 35543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-48 Score=391.57 Aligned_cols=246 Identities=23% Similarity=0.383 Sum_probs=199.2
Q ss_pred CccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe----CCcceEEE
Q 005355 393 NTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLE----TEVPLLVY 465 (700)
Q Consensus 393 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 465 (700)
++.++||+|+||+||+|++. +++.||+|++.. ......+.|.+|+++|++++||||+++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999986 688999998764 345566789999999999999999999999875 34568999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC-CCCcEEEeecCCCccccc
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD-DKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~-~~~~~kl~DfGl~~~~~~ 544 (700)
||+++|+|.+++.+.. .+++..++.++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999998754 3999999999999999999999987 3499999999999996 578999999999975422
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
.......||+.|||||++.+ .++.++||||||++||||++|+.||........ ....+..+....
T Consensus 168 ---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~------~~~~i~~~~~~~----- 232 (270)
T d1t4ha_ 168 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPA----- 232 (270)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCG-----
T ss_pred ---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH------HHHHHHcCCCCc-----
Confidence 22345679999999999875 599999999999999999999999975443221 112222221111
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..+...++++.+|+.+||+.||++|||++|+++
T Consensus 233 ---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111223446889999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=396.69 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=204.8
Q ss_pred HHhcCCCccceEeeeCCeEEEEEEEcC----CcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 387 MATDNFNTNRILGQGGQGTVYKGMLTN----GRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 387 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
+..++|++.+.||+|+||.||+|++.. +..||||+++.. .....+.|.+|++++++++||||+++++++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 446789999999999999999999753 356899988653 4445678999999999999999999999985 4678
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++||||+++|+|.+++..... .+++..++.++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999999876543 4899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
.............||+.|+|||++.+..++.++||||||+++|||++ |.+||......+. ...+..+...
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~-------~~~i~~~~~~-- 228 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRIENGERL-- 228 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTCCC--
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCCC--
Confidence 65444444555678999999999999999999999999999999998 8999987655431 1222222211
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
..+...+..+.+|+.+||+.||++|||++||++.|+.+.+.
T Consensus 229 -------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 -------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 12234456789999999999999999999999999987643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-48 Score=401.60 Aligned_cols=267 Identities=24% Similarity=0.413 Sum_probs=219.2
Q ss_pred hHHHHHHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeE
Q 005355 382 SMELEMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGC 454 (700)
Q Consensus 382 ~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~ 454 (700)
+.+++.+.++|++.+.||+|+||+||+|+++ +++.||||+++... ....++|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3456677889999999999999999999974 35789999987533 3446789999999999999999999999
Q ss_pred EEeCCcceEEEeeCCCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 005355 455 CLETEVPLLVYEFIPNGTLYQYIHDQTE---------------------EFPITWEIRLRIAIEVSDALCYLHSAASIPI 513 (700)
Q Consensus 455 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i 513 (700)
+.+.+..+++|||+++|+|.++++.... ...+++..++.++.||+.||+|||+++ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 9999999999999999999999975321 124899999999999999999999999 9
Q ss_pred eecCCCCCcEEECCCCcEEEeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCC-C
Q 005355 514 YHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQ-K 591 (700)
Q Consensus 514 vH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~-~ 591 (700)
+||||||+||||+.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||++||||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999986543322 2334456889999999999999999999999999999999985 5
Q ss_pred CCCCCCchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 592 PIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 592 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
||......+ ....+..+... ..+...+.++.+|+.+||+.+|++||||.||+++|++|.+
T Consensus 242 p~~~~~~~e-------~~~~v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 242 PYYGMAHEE-------VIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTTTSCHHH-------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCCCHHH-------HHHHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 676554433 12223333221 1223344578999999999999999999999999999863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=398.37 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=207.1
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.+.||+|+||+||+|++. +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 67999999999999999999985 6899999987642 2344578999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||||++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999988654 3999999999999999999999999 999999999999999999999999999876433
Q ss_pred C-ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 546 Q-THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 546 ~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
. ........||+.|||||++.+..++.++|||||||+||||++|+.||...+..+ ....+....+
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~------- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLEY------- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHTTCC-------
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-------HHHHHHcCCC-------
Confidence 2 223345679999999999999999999999999999999999999998654332 1122222211
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..+...++++.+|+.+||+.||++|||++|+++.
T Consensus 228 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1122345578899999999999999999997653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-47 Score=401.77 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=212.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.++|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.+|++++||||+++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999975 6899999999877777778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC--CCCcEEEeecCCCcccccC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD--DKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~--~~~~~kl~DfGl~~~~~~~ 545 (700)
+++|+|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+++.....
T Consensus 105 ~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999975432 3999999999999999999999999 99999999999995 4678999999999865433
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
.......||+.|||||++.+..++.++|||||||++|||++|+.||.+....+. ...+...... ...
T Consensus 180 --~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~~~~--~~~-- 246 (350)
T d1koaa2 180 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-------LRNVKSCDWN--MDD-- 246 (350)
T ss_dssp --SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCC--SCC--
T ss_pred --cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC--CCc--
Confidence 234456799999999999999999999999999999999999999976543321 1222222110 011
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
......+.++.+|+.+||+.||++|||++|+++.
T Consensus 247 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 --SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112234568899999999999999999999884
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.8e-47 Score=402.09 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=213.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++||||+++++++.+.+..+|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999975 6999999998876666677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC--CCCcEEEeecCCCcccccC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD--DKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~--~~~~~kl~DfGl~~~~~~~ 545 (700)
+++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||++......
T Consensus 108 ~~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999998875432 3999999999999999999999999 99999999999997 6789999999999876433
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
.......||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+. ...+...... .
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------~~~i~~~~~~------~ 247 (352)
T d1koba_ 183 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-------LQNVKRCDWE------F 247 (352)
T ss_dssp --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHHCCCC------C
T ss_pred --CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC------C
Confidence 234456799999999999999999999999999999999999999976544321 1222222111 1
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
........+.++.+|+.+||+.||.+|||++|+++.
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223345678899999999999999999999873
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-47 Score=396.98 Aligned_cols=245 Identities=26% Similarity=0.387 Sum_probs=203.1
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
+.|+.++.||+|+||+||+|++. +++.||||++.... ....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45899999999999999999975 68899999876532 344577999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++|+|..++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999987766543 3999999999999999999999999 99999999999999999999999999975432
Q ss_pred Cceeeeeeeccccccccccccc---CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcc
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLD 622 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 622 (700)
.....||+.|||||++.+ ..++.++|||||||++|||++|..||......+. +.. +..+......
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~-i~~~~~~~~~- 235 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH-IAQNESPALQ- 235 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHH-HHHSCCCCCS-
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH------HHH-HHhCCCCCCC-
Confidence 233569999999999864 4589999999999999999999999976543221 111 1111111111
Q ss_pred hhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 623 ARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 623 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+...++.+.+|+.+||+.||++|||++|+++
T Consensus 236 -------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 -------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1223457889999999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=391.15 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=204.0
Q ss_pred HhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC-CcceEEEe
Q 005355 388 ATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLET-EVPLLVYE 466 (700)
Q Consensus 388 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E 466 (700)
..++|++.+.||+|+||.||+|.++ |+.||||+++.. ...+.|.+|++++++++||||+++++++.+. +..++|||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 3567888999999999999999996 789999998753 3457899999999999999999999998654 56799999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+++|+|.++|..... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 y~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-- 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 155 (262)
T ss_dssp CCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC--
Confidence 9999999999976421 23899999999999999999999999 99999999999999999999999999985432
Q ss_pred ceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
......++..|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+..+..
T Consensus 156 --~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~-------~~~i~~~~~-------- 218 (262)
T d1byga_ 156 --TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGYK-------- 218 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-------HHHHTTTCC--------
T ss_pred --CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCCC--------
Confidence 2233457899999999999999999999999999999998 7888876544331 122222211
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
.+.+...++++.+|+.+||+.||++|||+.|++++|++++.
T Consensus 219 -~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 219 -MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 12233345678899999999999999999999999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-47 Score=395.30 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=193.2
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC-hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD-ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
.+.|++.+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999986 68999999876432 2334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC---CCCcEEEeecCCCcccc
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGASRSVM 543 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~---~~~~~kl~DfGl~~~~~ 543 (700)
|+++|+|.++|.... .+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999997643 3999999999999999999999999 99999999999994 57899999999998553
Q ss_pred cCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcch
Q 005355 544 IDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDA 623 (700)
Q Consensus 544 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 623 (700)
. ........||+.|||||++.+..++.++|||||||+||||++|+.||......+ ....+......
T Consensus 162 ~--~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~~~i~~~~~~----- 227 (307)
T d1a06a_ 162 P--GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAEYE----- 227 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHTTCCC-----
T ss_pred C--CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHhccCCC-----
Confidence 2 223345679999999999999999999999999999999999999997654332 11122221110
Q ss_pred hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 624 RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 624 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.........++.+.+|+.+||+.||++|||++|+++
T Consensus 228 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 -FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 011112234567899999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=395.96 Aligned_cols=257 Identities=25% Similarity=0.473 Sum_probs=207.0
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCc----EEEEEEccc-cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGR----IVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 463 (700)
.+|+++++||+|+||+||+|.+. +|+ +||||+++. .+....+.|.+|++++++++||||+++++++.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46999999999999999999975 343 689998764 3344568899999999999999999999999865 5678
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVM 543 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~ 543 (700)
++|++.+++|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999999887543 4999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCcee-eeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchhhhc
Q 005355 544 IDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVL 621 (700)
Q Consensus 544 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (700)
...... .....||+.|+|||++.+..++.++||||||++||||++ |..||......+. ...+..+..
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-------~~~i~~~~~---- 231 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGER---- 231 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-------HHHHHHTCC----
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCCC----
Confidence 443332 334568999999999999999999999999999999998 8899876654432 112222211
Q ss_pred chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 622 DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 622 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
...+...+..+.+|+.+||+.||++|||++|+++.|+.+...
T Consensus 232 -----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 232 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 112233456788999999999999999999999999887643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=387.43 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=207.9
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC------hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD------ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
.++|++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999985 68999999875321 22367899999999999999999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC----cEEEeecC
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY----RAKVSDFG 537 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~----~~kl~DfG 537 (700)
+|||||+++|+|.++|.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999998754 3999999999999999999999999 99999999999998776 59999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
++...... .......+|+.|+|||++.+..++.++||||||++||||++|+.||.+....+. ...+.....
T Consensus 163 ~a~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-------~~~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANVSAVNY 233 (293)
T ss_dssp TCEECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHTTCC
T ss_pred hhhhcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-------HHHHHhcCC
Confidence 99865332 223445689999999999999999999999999999999999999986553321 112222111
Q ss_pred hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. ..... ....+..+.+|+++||+.||++|||++|+++
T Consensus 234 ~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 E--FEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C--CCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--CCchh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 01111 1123456889999999999999999999976
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=390.73 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=210.8
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 464 (700)
.++|++++.||+|+||.||+|+.+ +++.||||+++.. .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999975 7899999998642 234467889999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++|+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 84 ~ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999987653 899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
.. .......||+.|+|||++.+..++.++|||||||+||||++|+.||...+..+ ....+..+.+
T Consensus 158 ~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~i~~~~~------- 222 (337)
T d1o6la_ 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEI------- 222 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-------
T ss_pred CC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-------HHHHHhcCCC-------
Confidence 22 23445679999999999999999999999999999999999999998765432 1222222221
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPT-----MKEAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~ 660 (700)
..+...+.++.+|+.+||+.||.+||+ ++|+++
T Consensus 223 ---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 112334567889999999999999995 788876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=390.41 Aligned_cols=270 Identities=27% Similarity=0.417 Sum_probs=209.2
Q ss_pred chHHHHHHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccc-cChhhHHHHHHHHHHHhhc-CCCceeeEE
Q 005355 381 TSMELEMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKL-VDESNIEQFINEVAILSQI-NHRNVVKLL 452 (700)
Q Consensus 381 ~~~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~ 452 (700)
+..++++..++|++.++||+|+||.||+|++. +++.||||+++. ......+.+.+|..++.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34556667789999999999999999999964 246899999875 3344567788888888876 689999999
Q ss_pred eEEEeCC-cceEEEeeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 005355 453 GCCLETE-VPLLVYEFIPNGTLYQYIHDQTE-------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDI 518 (700)
Q Consensus 453 ~~~~~~~-~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Di 518 (700)
+++.+.+ ..++||||+++|+|.++|+.... ...+++..++.++.||++||+|||+++ |+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence 9987654 57899999999999999975421 234899999999999999999999999 999999
Q ss_pred CCCcEEECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhC-CCCCCCC
Q 005355 519 KSANILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTG-QKPIRST 596 (700)
Q Consensus 519 k~~NILl~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg-~~p~~~~ 596 (700)
||+||||++++.+||+|||+++........ ......||+.|||||++.+..++.++||||||+++|||++| ..||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999865433322 23446799999999999999999999999999999999986 5677655
Q ss_pred CchhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 597 DSEEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
...+. +...+..+... ..+...++++.+|+.+||+.||++|||++|++++|+++.++
T Consensus 241 ~~~~~------~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 241 KIDEE------FCRRLKEGTRM---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCSHH------HHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHH------HHHHHhcCCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 43321 22222222211 12223455788999999999999999999999999987643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=390.48 Aligned_cols=264 Identities=25% Similarity=0.406 Sum_probs=210.4
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCc--EEEEEEccc-cChhhHHHHHHHHHHHhhc-CCCceeeEEeEEEeCCcceE
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGR--IVAIKKSKL-VDESNIEQFINEVAILSQI-NHRNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 463 (700)
.++|++.++||+|+||+||+|+++ ++. .||||+++. ......+.|.+|+++|+++ +||||+++++++.+.+..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 378889999999999999999976 344 578888754 3444567899999999998 79999999999999999999
Q ss_pred EEeeCCCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCc
Q 005355 464 VYEFIPNGTLYQYIHDQT-------------EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYR 530 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~ 530 (700)
||||+++|+|.++|+... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence 999999999999997642 2345999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCC-CCCCCCCchhhhhHHHHHH
Q 005355 531 AKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQ-KPIRSTDSEEDKSLVGYFL 609 (700)
Q Consensus 531 ~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~-~p~~~~~~~~~~~~~~~~~ 609 (700)
+||+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|. +||......+ +.
T Consensus 166 ~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~~ 236 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY 236 (309)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HH
T ss_pred eEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-------HH
Confidence 9999999997543222 223345899999999999999999999999999999999975 5676544322 12
Q ss_pred HHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcCCCc
Q 005355 610 EAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIGDSI 673 (700)
Q Consensus 610 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~~~~ 673 (700)
..+..+.. .+.+...++++.+|+.+||+.||++||||+||++.|+++........
T Consensus 237 ~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~ 291 (309)
T d1fvra_ 237 EKLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291 (309)
T ss_dssp HHGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred HHHHhcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCCC
Confidence 22222211 12223345679999999999999999999999999999876554433
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=385.96 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=201.0
Q ss_pred hcCCCccceEeeeCCeEEEEEEEcC--C--cEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLTN--G--RIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
.++|++.+.||+|+||.||+|++.. + ..||||+++.. .....+.|.+|+.+|++++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3678999999999999999998642 2 37899987642 34456789999999999999999999999965 467
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 899999999999998876543 3999999999999999999999999 99999999999999999999999999997
Q ss_pred cccCCce--eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 542 VMIDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 542 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
....... ......++..|+|||++.+..++.++||||||+++|||++ |..||......+. .....+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~------~~~i~~~~~~- 233 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGER- 233 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSCCC-
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH------HHHHHhCCCC-
Confidence 6544332 2234457889999999999999999999999999999998 8999976654431 1111121111
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhch
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIR 666 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~ 666 (700)
.+.+...+..+.+|+.+||+.||++|||+.||++.|++.+
T Consensus 234 --------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 234 --------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 1112334457889999999999999999999999998753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.5e-46 Score=381.41 Aligned_cols=259 Identities=28% Similarity=0.382 Sum_probs=207.2
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCc----
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEV---- 460 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 460 (700)
.++|++.+.||+|+||+||+|++. +++.||||+++.. +....+.|.+|++++++++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 477999999999999999999975 7899999998642 34456789999999999999999999999986543
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.+|||||+++++|.+++.... .+++.+++.++.||+.||+|||+++ |+||||||+||||+.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 689999999999999997764 3999999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCc--eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 541 SVMIDQT--HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 541 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+...+......
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCCCC
Confidence 5533222 23445679999999999999999999999999999999999999997654332 122222222111
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhch
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRP-TMKEAAFELGGIR 666 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~evl~~L~~l~ 666 (700)
........+..+.+|+.+||+.||++|| |++++++.|.+++
T Consensus 234 -------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 -------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1111223456788999999999999999 8999999998875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=388.82 Aligned_cols=267 Identities=26% Similarity=0.414 Sum_probs=218.4
Q ss_pred HHHHHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEccc-cChhhHHHHHHHHHHHhhc-CCCceeeEEeEE
Q 005355 384 ELEMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKL-VDESNIEQFINEVAILSQI-NHRNVVKLLGCC 455 (700)
Q Consensus 384 e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 455 (700)
++++..++|++.++||+|+||.||+|++. .++.||||+++. ........|.+|+.+++++ +||||+++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 44566789999999999999999999863 356899999875 3345567899999999998 699999999999
Q ss_pred EeCCcceEEEeeCCCCCHHHHHhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 005355 456 LETEVPLLVYEFIPNGTLYQYIHDQTE---------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKS 520 (700)
Q Consensus 456 ~~~~~~~lv~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~ 520 (700)
.+.+..++||||+++|+|.++++.... ...+++..++.++.||+.||+|||+++ ++||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence 999999999999999999999986532 235899999999999999999999999 99999999
Q ss_pred CcEEECCCCcEEEeecCCCcccccCCc-eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCc
Q 005355 521 ANILLDDKYRAKVSDFGASRSVMIDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDS 598 (700)
Q Consensus 521 ~NILl~~~~~~kl~DfGl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~ 598 (700)
+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |.+||.....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654333 33345678999999999999999999999999999999999 5555654443
Q ss_pred hhhhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 599 EEDKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
.+. +...+..+. ....+...+..+.+|+.+||+.||++|||++||+++|+++...
T Consensus 254 ~~~------~~~~i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 254 DSK------FYKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SHH------HHHHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH------HHHHHhcCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 321 111222211 1122233456789999999999999999999999999876543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.5e-46 Score=386.21 Aligned_cols=244 Identities=27% Similarity=0.369 Sum_probs=207.4
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++.+.||+|+||+||+|+++ +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999985 6899999998642 2334678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+++|+|..++..... +++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999999987653 889999999999999999999999 999999999999999999999999999865322
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
.....||+.|||||++.+..++.++|||||||+||||++|+.||...+..+. ...+..+..
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~i~~~~~-------- 218 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------YEKILNAEL-------- 218 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHCCC--------
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-------HHHHHcCCC--------
Confidence 3346799999999999999999999999999999999999999986543321 111221111
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRP-----TMKEAAF 660 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~ 660 (700)
..+...+.++.+++.+||+.||.+|| |++|+++
T Consensus 219 --~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11223345688999999999999996 8999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=382.79 Aligned_cols=256 Identities=28% Similarity=0.453 Sum_probs=206.9
Q ss_pred cceEeeeCCeEEEEEEEcCC----cEEEEEEccc-cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC-CcceEEEeeC
Q 005355 395 NRILGQGGQGTVYKGMLTNG----RIVAIKKSKL-VDESNIEQFINEVAILSQINHRNVVKLLGCCLET-EVPLLVYEFI 468 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~E~~ 468 (700)
.++||+|+||+||+|++.++ ..||||+++. .+....++|.+|+++|++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999997532 3689999874 4566678899999999999999999999998764 5789999999
Q ss_pred CCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCce
Q 005355 469 PNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQTH 548 (700)
Q Consensus 469 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~~ 548 (700)
++|+|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999987544 3788999999999999999999999 999999999999999999999999999876433222
Q ss_pred ---eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 549 ---LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 549 ---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
......||+.|+|||.+....++.++||||||++||||++|..||.......+ ....+..+...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~------~~~~i~~g~~~------- 253 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGRRL------- 253 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTCCC-------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCCC-------
Confidence 22235689999999999999999999999999999999998888764332211 11122222211
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
..+...+..+.+|+.+||+.||++||+++||++.|+++.....
T Consensus 254 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 254 --LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred --CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 1122334578899999999999999999999999999987543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-46 Score=383.45 Aligned_cols=264 Identities=27% Similarity=0.444 Sum_probs=212.9
Q ss_pred HHHhcCCCccceEeeeCCeEEEEEEEcC--------CcEEEEEEcccc-ChhhHHHHHHHHHHHhhc-CCCceeeEEeEE
Q 005355 386 EMATDNFNTNRILGQGGQGTVYKGMLTN--------GRIVAIKKSKLV-DESNIEQFINEVAILSQI-NHRNVVKLLGCC 455 (700)
Q Consensus 386 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 455 (700)
++..++|++.+.||+|+||.||+|+... +..||||+++.. ......++.+|...+.++ +||||+++++++
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 3456789999999999999999998642 247999998753 345568899999999888 899999999999
Q ss_pred EeCCcceEEEeeCCCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCc
Q 005355 456 LETEVPLLVYEFIPNGTLYQYIHDQTE-------------EFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSAN 522 (700)
Q Consensus 456 ~~~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~N 522 (700)
.+.+..++||||+++|+|.++|..... ...+++..++.++.||+.||+|||+++ |+||||||+|
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~N 165 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 165 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccc
Confidence 999999999999999999999976532 235899999999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCCCcccccCCce-eeeeeecccccccccccccCCCCcccceehHHHHHHHHHh-CCCCCCCCCchh
Q 005355 523 ILLDDKYRAKVSDFGASRSVMIDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDSEE 600 (700)
Q Consensus 523 ILl~~~~~~kl~DfGl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~ellt-g~~p~~~~~~~~ 600 (700)
||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 99999999999999999876543322 2344568999999999999999999999999999999998 788887655432
Q ss_pred hhhHHHHHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 601 DKSLVGYFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
....+..+... ..+...+..+.+|+.+||+.||++|||+.||++.|++|.+.
T Consensus 246 -------~~~~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 -------LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp -------HHHHHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HHHHHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 12222222211 12223456789999999999999999999999999998653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=384.80 Aligned_cols=266 Identities=27% Similarity=0.427 Sum_probs=218.1
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEc------CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEE
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLT------NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCC 455 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 455 (700)
+++++..++|++.+.||+|+||+||+|.+. .++.||||+++.. .......|.+|++++++++||||+++++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 345666789999999999999999999864 2578999998753 444556799999999999999999999999
Q ss_pred EeCCcceEEEeeCCCCCHHHHHhccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC
Q 005355 456 LETEVPLLVYEFIPNGTLYQYIHDQT-------EEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK 528 (700)
Q Consensus 456 ~~~~~~~lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~ 528 (700)
...+..++||||+++|+|.+++.... ....+++..+..++.|+++||.|||+++ |+||||||+||||+.+
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCC
Confidence 99999999999999999999987531 2234799999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCCcccccCCcee-eeeeecccccccccccccCCCCcccceehHHHHHHHHHhCC-CCCCCCCchhhhhHHH
Q 005355 529 YRAKVSDFGASRSVMIDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQ-KPIRSTDSEEDKSLVG 606 (700)
Q Consensus 529 ~~~kl~DfGl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~-~p~~~~~~~~~~~~~~ 606 (700)
+++||+|||+++......... .....+|+.|+|||.+.+..++.++||||||++||||++|. .||......+
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~------ 243 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------ 243 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH------
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH------
Confidence 999999999998664433322 33346899999999999999999999999999999999984 7776544332
Q ss_pred HHHHHHHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchh
Q 005355 607 YFLEAMKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRA 667 (700)
Q Consensus 607 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~ 667 (700)
....+..+.... .+...+..+.+|+.+||+.+|++|||+++|+++|++..+
T Consensus 244 -~~~~i~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 -VLRFVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -HHHHHHhCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 122222222211 122344679999999999999999999999999987643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-45 Score=387.10 Aligned_cols=244 Identities=23% Similarity=0.298 Sum_probs=207.7
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 465 (700)
++|++++.||+|+||.||+|+++ +|+.||||++... .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999986 6999999987642 2334577899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccC
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMID 545 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~ 545 (700)
||+.+|+|.+++..... +++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999999987643 999999999999999999999999 999999999999999999999999999865322
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
.....||+.|||||++.+..++.++|||||||+||||++|+.||......+ ....+..+..
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~~~i~~~~~-------- 255 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKV-------- 255 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC--------
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-------HHHHHhcCCC--------
Confidence 334679999999999999999999999999999999999999997654322 1122222211
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRP-----TMKEAAF 660 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----s~~evl~ 660 (700)
..+...+.++.+|+.+||+.||.+|+ |++|+++
T Consensus 256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11223456788999999999999994 8999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.5e-45 Score=373.35 Aligned_cols=251 Identities=27% Similarity=0.409 Sum_probs=206.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---------hhhHHHHHHHHHHHhhcC-CCceeeEEeEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---------ESNIEQFINEVAILSQIN-HRNVVKLLGCCLE 457 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 457 (700)
.++|++.+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999975 78999999876432 122456889999999997 9999999999999
Q ss_pred CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 458 TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 458 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
.+..+|||||+++|+|.++|.... .+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999997654 4999999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCceeeeeeeccccccccccccc------CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHH
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRS------SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEA 611 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 611 (700)
+++..... .......||+.|+|||++.+ ..++.++||||+|++||||++|+.||......+ ....
T Consensus 156 ~a~~~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~ 226 (277)
T d1phka_ 156 FSCQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRM 226 (277)
T ss_dssp TCEECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHH
T ss_pred heeEccCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHH
Confidence 99866432 22344679999999999853 356889999999999999999999998665332 1122
Q ss_pred HHhcchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 612 MKENRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 612 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
+..+... .........++++.+|+.+||+.||++|||++|+++
T Consensus 227 i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 227 IMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2222211 001111234567889999999999999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=381.44 Aligned_cols=251 Identities=23% Similarity=0.326 Sum_probs=208.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.++|++.+.||+|+||+||+|.+. +++.||||+++.... ....+.+|+++|++++||||+++++++.+.+..+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 478999999999999999999986 688999999876543 346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC--CCcEEEeecCCCcccccC
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD--KYRAKVSDFGASRSVMID 545 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~--~~~~kl~DfGl~~~~~~~ 545 (700)
+++|+|.++|..... .+++.++..++.||+.||+|||+++ |+||||||+|||++. ...+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999976532 3999999999999999999999999 999999999999984 458999999999865332
Q ss_pred CceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 546 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 546 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
.......+|+.|+|||.+.+..++.++|||||||++|+|++|..||......+ ....+..+.. ..+...
T Consensus 158 --~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-------~~~~i~~~~~--~~~~~~ 226 (321)
T d1tkia_ 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEY--TFDEEA 226 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCC--CCCHHH
T ss_pred --CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCC--CCChhh
Confidence 23445668999999999999999999999999999999999999998665432 1122222111 011111
Q ss_pred hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 626 LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 626 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.. ..+.++.+|+.+||+.||++|||++|+++
T Consensus 227 ~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 FK----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 23456889999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=380.23 Aligned_cols=268 Identities=21% Similarity=0.303 Sum_probs=202.9
Q ss_pred cCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHH--HHhhcCCCceeeEEeEEEeCC----cceE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVA--ILSQINHRNVVKLLGCCLETE----VPLL 463 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~--~l~~l~h~niv~l~~~~~~~~----~~~l 463 (700)
.+|.+.+.||+|+||+||+|+++ |+.||||+++... .+.+..|.+ .+.+++||||+++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 56778899999999999999975 8999999986432 234444555 445689999999999998764 4689
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCcEEECCCCcEEEeecCC
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAA-----SIPIYHRDIKSANILLDDKYRAKVSDFGA 538 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----~~~ivH~Dik~~NILl~~~~~~kl~DfGl 538 (700)
||||+++|+|.++|++.. ++|..++.++.|++.||+|||+.. ..+|+||||||+||||+.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~~----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999998753 999999999999999999999741 12399999999999999999999999999
Q ss_pred CcccccCCce---eeeeeecccccccccccccCC------CCcccceehHHHHHHHHHhCCCCCCCCCchhh--------
Q 005355 539 SRSVMIDQTH---LTTRVQGTFGYLDPEYFRSSQ------FTEKSDVYSFGVVLVELLTGQKPIRSTDSEED-------- 601 (700)
Q Consensus 539 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwSlG~il~elltg~~p~~~~~~~~~-------- 601 (700)
++........ ......||+.|+|||++.+.. ++.|+||||||++||||++|..||......+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9876543332 233467999999999987643 57799999999999999999888754332111
Q ss_pred hhHHHHHHHHHHhcchhhhcchhhhhc-cCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhc
Q 005355 602 KSLVGYFLEAMKENRLFEVLDARVLKE-AKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASI 669 (700)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~ 669 (700)
.............+.. ++.+... ...+....+.+|+.+||+.||++|||+.||++.|+++....
T Consensus 235 ~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 0111112222222221 1111111 12345667999999999999999999999999999987643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=381.71 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=205.7
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc---ChhhHHHHHHHHHHHh-hcCCCceeeEEeEEEeCCcceEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV---DESNIEQFINEVAILS-QINHRNVVKLLGCCLETEVPLLV 464 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 464 (700)
++|++.+.||+|+||+||+|++. +++.||||+++.. .....+.+..|..++. .++||||+++++++.+.+..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999986 6899999998642 2334566777777765 68999999999999999999999
Q ss_pred EeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccccc
Q 005355 465 YEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMI 544 (700)
Q Consensus 465 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~ 544 (700)
|||+++|+|.+++..... +++.+++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999987543 899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDAR 624 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 624 (700)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ ....+..+..
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~------- 220 (320)
T d1xjda_ 156 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNP------- 220 (320)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-------
T ss_pred cc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC-------
Confidence 32 33444679999999999999999999999999999999999999998655432 1222222211
Q ss_pred hhhccCHHHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 005355 625 VLKEAKEEEIITVAMLAKRCLNMIGKKRPTMK-EAAF 660 (700)
Q Consensus 625 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~-evl~ 660 (700)
..+...+.++.+|+.+||+.||++||++. |+++
T Consensus 221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11223355788999999999999999996 6764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-44 Score=384.21 Aligned_cols=249 Identities=21% Similarity=0.285 Sum_probs=200.8
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC---hhhHHHHH---HHHHHHhhcCCCceeeEEeEEEeCCcc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD---ESNIEQFI---NEVAILSQINHRNVVKLLGCCLETEVP 461 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~ 461 (700)
.++|++.++||+|+||.||+|++. +|+.||||++.... ......+. +|+.+++.++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 468999999999999999999976 68999999875311 11223333 456777778899999999999999999
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcc
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRS 541 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~ 541 (700)
++||||+++|+|.++|..... +++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhccc---ccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999987643 899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhh
Q 005355 542 VMIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEV 620 (700)
Q Consensus 542 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (700)
.... ......||+.|+|||++.. ..++.++|||||||+||||++|+.||......+... .........
T Consensus 157 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~~~~~~~~~---- 225 (364)
T d1omwa3 157 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMA---- 225 (364)
T ss_dssp CSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH----HHHHSSSCC----
T ss_pred cCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcccCC----
Confidence 5432 2334569999999999975 568999999999999999999999998655433111 111111000
Q ss_pred cchhhhhccCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 005355 621 LDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT-----MKEAAF 660 (700)
Q Consensus 621 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~ 660 (700)
...+...++++.+|+.+||+.||++||| ++|+++
T Consensus 226 ------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 ------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1112234567899999999999999999 688875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=377.79 Aligned_cols=257 Identities=24% Similarity=0.258 Sum_probs=196.0
Q ss_pred ccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChh-----hHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 394 TNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDES-----NIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 394 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
.+++||+|+||+||+|++. +++.||||+++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999975 6899999998653322 134688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+.++++..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9888777665433 24899999999999999999999999 99999999999999999999999999986543322
Q ss_pred eeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh---cchhhhc--
Q 005355 548 HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE---NRLFEVL-- 621 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-- 621 (700)
......||+.|+|||++.. ..++.++|||||||++|||++|..||......+. .......... ..+....
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTTSS
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChhhccchhcc
Confidence 2334569999999999865 4679999999999999999999999976654332 1111111100 0000000
Q ss_pred ---------chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 622 ---------DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 622 ---------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..............++.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000111123457899999999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=378.61 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=199.6
Q ss_pred hcCCCccc-eEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhh-cCCCceeeEEeEEEe----CCcc
Q 005355 389 TDNFNTNR-ILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQ-INHRNVVKLLGCCLE----TEVP 461 (700)
Q Consensus 389 ~~~~~~~~-~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 461 (700)
.++|.+.. +||+|+||+||+|++. +++.||||+++.. +.+.+|++++.+ .+||||+++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788764 6999999999999975 6899999998642 457789998765 589999999999875 4567
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC---CCcEEEeecCC
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD---KYRAKVSDFGA 538 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~---~~~~kl~DfGl 538 (700)
++||||+++|+|.++|..... ..+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 999999999999999986432 34999999999999999999999999 999999999999975 56799999999
Q ss_pred CcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 539 SRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 539 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
++...... ......||+.|||||++.+..++.++|||||||+||+|++|+.||.+....+... .....+.....
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~~- 234 (335)
T d2ozaa1 161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQY- 234 (335)
T ss_dssp CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS-
T ss_pred eeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhcCCC-
Confidence 98654332 2345569999999999999999999999999999999999999997654332110 01111111110
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
..........++++.+|+.+||+.||++|||+.|+++
T Consensus 235 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -----SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0011111344567899999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=373.56 Aligned_cols=261 Identities=25% Similarity=0.372 Sum_probs=200.7
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
++|+++++||+|+||+||+|++. +++.||||+++... ....+.+.+|+++|++++||||+++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999975 68999999986532 2335789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
|+.+ .+.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCC-chhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9965 5555554332 224999999999999999999999999 9999999999999999999999999997654322
Q ss_pred ceeeeeeecccccccccccccCC-CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhhhcchhh
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFEVLDARV 625 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 625 (700)
.......||+.|+|||++.... ++.++||||||+++|+|++|+.||...+..+. +.. ..... +...+...+..
T Consensus 157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~-i~~~~--~~~~~~~~~~~ 230 (298)
T d1gz8a_ 157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFR-IFRTL--GTPDEVVWPGV 230 (298)
T ss_dssp -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHH--CCCCTTTSTTG
T ss_pred -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHH-HHHhc--CCCchhhcccc
Confidence 2334456999999999877665 57899999999999999999999986543321 111 11110 00000000000
Q ss_pred -----------------hhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 626 -----------------LKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 626 -----------------~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..........++.+|+.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000111234578899999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.7e-44 Score=370.05 Aligned_cols=261 Identities=21% Similarity=0.305 Sum_probs=201.6
Q ss_pred cCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccC--hhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEee
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVD--ESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 467 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E~ 467 (700)
++|+++++||+|+||+||+|++++++.||||+++... ....+.+.+|+.+|++++||||+++++++.+.+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999999999999986533 33357899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCCc
Q 005355 468 IPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQT 547 (700)
Q Consensus 468 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~~ 547 (700)
+.++.+..+..... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 98776666665443 3999999999999999999999999 9999999999999999999999999997653322
Q ss_pred eeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcc---hhh----
Q 005355 548 HLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR---LFE---- 619 (700)
Q Consensus 548 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~---- 619 (700)
.......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+. ............ +..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGS
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCChhhccchhhh
Confidence 223344589999999998764 568999999999999999999999976543221 111111111000 000
Q ss_pred --------hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 620 --------VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 620 --------~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
...+.............+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000001112223457889999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-44 Score=369.55 Aligned_cols=263 Identities=24% Similarity=0.333 Sum_probs=199.1
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-C-CcEEEEEEcccc--ChhhHHHHHHHHHHHhhc---CCCceeeEEeEEEe----
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-N-GRIVAIKKSKLV--DESNIEQFINEVAILSQI---NHRNVVKLLGCCLE---- 457 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 457 (700)
.++|+++++||+|+||+||+|++. + ++.||||+++.. .......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999974 3 677999987642 222234566777777665 79999999999863
Q ss_pred -CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeec
Q 005355 458 -TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDF 536 (700)
Q Consensus 458 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~Df 536 (700)
....++++|+++++.+......... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~--~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhccCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 2467899999988777655544333 3899999999999999999999999 999999999999999999999999
Q ss_pred CCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHh--
Q 005355 537 GASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKE-- 614 (700)
Q Consensus 537 Gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 614 (700)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... ........
T Consensus 161 g~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~ 235 (305)
T d1blxa_ 161 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG---KILDVIGLPG 235 (305)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCC
T ss_pred hhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH---HHHHhhCCCc
Confidence 998754322 23445679999999999999999999999999999999999999998665433211 11111100
Q ss_pred -cchhh----------hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 615 -NRLFE----------VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 615 -~~~~~----------~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
..+.. ...............+.+.+|+.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 000000111122334578899999999999999999999873
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=367.98 Aligned_cols=240 Identities=25% Similarity=0.416 Sum_probs=196.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccCh------hhHHHHHHHHHHHhhcC--CCceeeEEeEEEeCC
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDE------SNIEQFINEVAILSQIN--HRNVVKLLGCCLETE 459 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 459 (700)
.++|++.++||+|+||+||+|+.. +++.||||++..... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 467999999999999999999975 689999998764211 12244678999999986 899999999999999
Q ss_pred cceEEEeeCCC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-CCcEEEeecC
Q 005355 460 VPLLVYEFIPN-GTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD-KYRAKVSDFG 537 (700)
Q Consensus 460 ~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~-~~~~kl~DfG 537 (700)
..++||||+.+ +++.+++.... .+++..+..++.||++||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999975 68888887654 3999999999999999999999999 999999999999985 4799999999
Q ss_pred CCcccccCCceeeeeeecccccccccccccCCC-CcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcc
Q 005355 538 ASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENR 616 (700)
Q Consensus 538 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 616 (700)
+++.... .......||+.|+|||++.+..+ +.++||||||++||||++|+.||.... .+..+.
T Consensus 157 ~a~~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i~~~~ 220 (273)
T d1xwsa_ 157 SGALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQ 220 (273)
T ss_dssp TCEECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCC
T ss_pred cceeccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------HHhhcc
Confidence 9975432 22345679999999999987765 567899999999999999999996421 011111
Q ss_pred hhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 617 LFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 617 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. ..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 221 ~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 V----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1 011223457889999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=363.57 Aligned_cols=266 Identities=22% Similarity=0.284 Sum_probs=197.5
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEe--------
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLE-------- 457 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 457 (700)
.++|+++++||+|+||+||+|++. +|+.||||++... .....+++.+|+++|++++|+|++++++.+..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999975 7899999987543 33445778999999999999999999999865
Q ss_pred CCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 005355 458 TEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFG 537 (700)
Q Consensus 458 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfG 537 (700)
.+..++||||+.++.+..+..... .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 345789999998776665544332 3899999999999999999999999 9999999999999999999999999
Q ss_pred CCcccccCCc---eeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHH
Q 005355 538 ASRSVMIDQT---HLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMK 613 (700)
Q Consensus 538 l~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 613 (700)
+++....... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+.............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9976543222 122335699999999998765 689999999999999999999999986554332222111110000
Q ss_pred hcchhhhcch--------hhhhccC-------HHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 614 ENRLFEVLDA--------RVLKEAK-------EEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 614 ~~~~~~~~d~--------~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.......... ....... ....+.+.+|+.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0000000000 0000000 111345778999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-42 Score=356.94 Aligned_cols=263 Identities=19% Similarity=0.229 Sum_probs=202.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCc-eeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRN-VVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~E 466 (700)
.++|++.+.||+|+||.||+|++. +++.||||++..... .+++..|++++++++|+| |+.+..+..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 367999999999999999999975 689999998765332 245789999999998766 5555666778888899999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEEC---CCCcEEEeecCCCcccc
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLD---DKYRAKVSDFGASRSVM 543 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~---~~~~~kl~DfGl~~~~~ 543 (700)
|+ +++|.+.+..... .+++..++.++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+++...
T Consensus 84 ~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred Ec-CCchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 99 5677777665433 3999999999999999999999999 99999999999985 45679999999998764
Q ss_pred cCCce------eeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch
Q 005355 544 IDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL 617 (700)
Q Consensus 544 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 617 (700)
..... ......||+.|||||++.+..++.++||||||+++|||++|+.||......................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-- 235 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-- 235 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS--
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC--
Confidence 33221 2344579999999999999999999999999999999999999998765544322221111110000
Q ss_pred hhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhh
Q 005355 618 FEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRAS 668 (700)
Q Consensus 618 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~ 668 (700)
.. .......+.++.+|+.+||+.+|++||+++++.+.|+.+...
T Consensus 236 ---~~----~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 236 ---PI----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ---CH----HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---Ch----hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 00 111223446788999999999999999999999999887543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.6e-42 Score=353.35 Aligned_cols=265 Identities=17% Similarity=0.175 Sum_probs=212.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCC-CceeeEEeEEEeCCcceEEEe
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINH-RNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~E 466 (700)
.++|++.++||+|+||+||+|++. +++.||||++.... ..+.+.+|+++++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 578999999999999999999976 68999999875432 22457889999999965 899999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECC-----CCcEEEeecCCCcc
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDD-----KYRAKVSDFGASRS 541 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~-----~~~~kl~DfGl~~~ 541 (700)
|+ +++|.+++..... .+++..+..++.|++.||+|||+++ |+||||||+||||+. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 7899999876543 3899999999999999999999999 999999999999964 57899999999987
Q ss_pred cccCCc------eeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc
Q 005355 542 VMIDQT------HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN 615 (700)
Q Consensus 542 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 615 (700)
...... .......||+.|||||++.+..++.++||||||+++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 643221 12334579999999999999999999999999999999999999998665543322222211111111
Q ss_pred chhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhchhhcC
Q 005355 616 RLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFELGGIRASIG 670 (700)
Q Consensus 616 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~L~~l~~~~~ 670 (700)
.. .+.....++++.+++..|+..+|++||+++.+.+.|+++.....
T Consensus 236 ~~---------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 236 PL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp CH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred Ch---------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 11 11112234578899999999999999999999999988765543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=365.91 Aligned_cols=266 Identities=21% Similarity=0.303 Sum_probs=199.7
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc-ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC----cce
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV-DESNIEQFINEVAILSQINHRNVVKLLGCCLETE----VPL 462 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 462 (700)
+++|+++++||+|+||+||+|... +++.||||++... .....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467999999999999999999975 7999999998653 3445678999999999999999999999997654 235
Q ss_pred EEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCccc
Q 005355 463 LVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSV 542 (700)
Q Consensus 463 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~ 542 (700)
++++++.+|+|.+++.... +++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~~----l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQH----LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcCC----CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 5666777999999997643 999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCce--eeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchhh
Q 005355 543 MIDQTH--LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLFE 619 (700)
Q Consensus 543 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (700)
...... ......||+.|+|||++.. ..++.++||||+|++++||++|+.||......+...................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 433222 2344669999999999854 5678999999999999999999999976654322111111000000000000
Q ss_pred h-----------c---chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 620 V-----------L---DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 620 ~-----------~---d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
. . ..............++.+|+.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0 0000000111223468899999999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=368.15 Aligned_cols=269 Identities=25% Similarity=0.324 Sum_probs=199.2
Q ss_pred CCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC------CcceE
Q 005355 391 NFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNVVKLLGCCLET------EVPLL 463 (700)
Q Consensus 391 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 463 (700)
+|+..++||+|+||+||+|++. +++.||||++..... .+.+|+++|++++|+||+++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888899999999999999986 689999999865432 234799999999999999999998643 24689
Q ss_pred EEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCC-cEEEeecCCCccc
Q 005355 464 VYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKY-RAKVSDFGASRSV 542 (700)
Q Consensus 464 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~-~~kl~DfGl~~~~ 542 (700)
||||++++.+..+.........+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987654444433333445999999999999999999999999 99999999999999775 8999999999865
Q ss_pred ccCCceeeeeeeccccccccccccc-CCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH-----HHHHh--
Q 005355 543 MIDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL-----EAMKE-- 614 (700)
Q Consensus 543 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~-- 614 (700)
.... ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+......... ..+..
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 4332 2334569999999998765 578999999999999999999999997665332211110000 00000
Q ss_pred -----cchhhhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH--HHHhchhh
Q 005355 615 -----NRLFEVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF--ELGGIRAS 668 (700)
Q Consensus 615 -----~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~--~L~~l~~~ 668 (700)
..+................++++.+|+.+||+.||++|||+.|+++ .|+.++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 0000000000011112234557889999999999999999999997 36666543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-42 Score=362.67 Aligned_cols=266 Identities=22% Similarity=0.310 Sum_probs=199.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCC------
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLETE------ 459 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 459 (700)
.++|+++++||+|+||+||+|.+. +|+.||||+++. ......+.+.+|+++|++++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 578999999999999999999976 699999999874 34445678999999999999999999999998665
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
..++||||+ +.+|..+++... +++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~~----l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 458999999 667888776543 999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHH-----HHHH
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFL-----EAMK 613 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~ 613 (700)
+..... .+...+|+.|+|||++.+. .++.++|||||||++|||++|+.||...+............ ....
T Consensus 169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 865322 3445699999999998764 57899999999999999999999998765432211111000 0000
Q ss_pred hcch------hh---hcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhch
Q 005355 614 ENRL------FE---VLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE--LGGIR 666 (700)
Q Consensus 614 ~~~~------~~---~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~--L~~l~ 666 (700)
.... .. ...............+.+.+|+.+||+.||++|||++|+++. |+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000 00 000000011112234567899999999999999999999984 55543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=350.72 Aligned_cols=262 Identities=21% Similarity=0.310 Sum_probs=204.8
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeCCcceEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 466 (700)
++|+++++||+|+||+||+|++. +++.||||+++. ......+++.+|+.+|+.++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999975 788999999754 334457889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCcccccCC
Q 005355 467 FIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASRSVMIDQ 546 (700)
Q Consensus 467 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~~~~~~~ 546 (700)
++.+++|..++.... .+++..+..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988887553 3899999999999999999999999 9999999999999999999999999998654332
Q ss_pred ceeeeeeecccccccccccccCC-CCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhc---chh---h
Q 005355 547 THLTTRVQGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKEN---RLF---E 619 (700)
Q Consensus 547 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~---~ 619 (700)
. ......++..|+|||++.... ++.++||||||+++|||++|+.||........ ....+....... .+. .
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGG
T ss_pred c-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhh
Confidence 2 233345778899999987665 68999999999999999999999754332221 111111111100 000 0
Q ss_pred hc---------chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 620 VL---------DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 620 ~~---------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
.. ...............+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000001112233456889999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=357.67 Aligned_cols=252 Identities=26% Similarity=0.332 Sum_probs=205.5
Q ss_pred cCCCccceEeeeCCeEEEEEEEc----CCcEEEEEEcccc----ChhhHHHHHHHHHHHhhcCC-CceeeEEeEEEeCCc
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT----NGRIVAIKKSKLV----DESNIEQFINEVAILSQINH-RNVVKLLGCCLETEV 460 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 460 (700)
++|++.+.||+|+||+||+|+.. +|+.||||+++.. +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999863 4789999987642 22335678899999999976 899999999999999
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.+++|||+.+|+|.+++..... +++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999987654 788999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCceeeeeeecccccccccccccC--CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcchh
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSS--QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRLF 618 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (700)
.+............|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+.... .........
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~---i~~~~~~~~-- 252 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---ISRRILKSE-- 252 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---HHHHHHHCC--
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcccCC--
Confidence 7655444445556799999999999764 467899999999999999999999976654332111 111111111
Q ss_pred hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 005355 619 EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPT-----MKEAAF 660 (700)
Q Consensus 619 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-----~~evl~ 660 (700)
...+...+.++.+|+.+||+.||.+||| ++|+++
T Consensus 253 --------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 --------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1122345668899999999999999994 788876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.7e-41 Score=352.11 Aligned_cols=255 Identities=22% Similarity=0.298 Sum_probs=197.1
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeC--CcceEEE
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQIN-HRNVVKLLGCCLET--EVPLLVY 465 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 465 (700)
++|+++++||+|+||+||+|++. +++.||||+++... .+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 67999999999999999999975 68999999987543 467889999999995 99999999999754 5678999
Q ss_pred eeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCC-CcEEEeecCCCccccc
Q 005355 466 EFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDK-YRAKVSDFGASRSVMI 544 (700)
Q Consensus 466 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~-~~~kl~DfGl~~~~~~ 544 (700)
||+++++|..+.+ .+++..+..++.||+.||+|||+++ |+||||||+||||+.+ ..+||+|||+++....
T Consensus 112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999977642 3899999999999999999999999 9999999999999865 4699999999986543
Q ss_pred CCceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHH---------Hh
Q 005355 545 DQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAM---------KE 614 (700)
Q Consensus 545 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~ 614 (700)
.. ......+|+.|+|||.+.+. .++.++||||+|++++||++|+.||........... ...... ..
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~--~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV--RIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH--HHHHHHCHHHHHHHHHH
T ss_pred CC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHH--HHHHHHCCchhhhhhhh
Confidence 32 23445689999999998765 479999999999999999999999976554322110 010000 00
Q ss_pred cch------hhhc--------chhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 615 NRL------FEVL--------DARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 615 ~~~------~~~~--------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
... .... ..............++.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000 000000111223456889999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=353.64 Aligned_cols=262 Identities=22% Similarity=0.293 Sum_probs=193.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccc--cChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC------C
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKL--VDESNIEQFINEVAILSQINHRNVVKLLGCCLET------E 459 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 459 (700)
.++|+++++||+|+||+||+|.+. +|+.||||++.. .+....+.+.+|+.++++++||||+++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999986 699999999864 3455567899999999999999999999999643 5
Q ss_pred cceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCC
Q 005355 460 VPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGAS 539 (700)
Q Consensus 460 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~ 539 (700)
..++||||+.++ |.+.+.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 779999999654 5555532 2899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHH------------
Q 005355 540 RSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGY------------ 607 (700)
Q Consensus 540 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~------------ 607 (700)
+.... ........+|+.|+|||++.+..++.++||||+|++++||++|+.||.+............
T Consensus 167 ~~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hcccc--ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 76532 2334455689999999999999999999999999999999999999976653321111100
Q ss_pred ----HHHHHHhc------chhhhcchhhh---hccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 005355 608 ----FLEAMKEN------RLFEVLDARVL---KEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAFE 661 (700)
Q Consensus 608 ----~~~~~~~~------~~~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~~ 661 (700)
........ ........... .......+..+.+|+.+||..||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 00000000000 01123456778999999999999999999999863
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-41 Score=355.80 Aligned_cols=257 Identities=23% Similarity=0.299 Sum_probs=197.3
Q ss_pred hcCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEcccc--ChhhHHHHHHHHHHHhhcCCCceeeEEeEEEeC-----Cc
Q 005355 389 TDNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLV--DESNIEQFINEVAILSQINHRNVVKLLGCCLET-----EV 460 (700)
Q Consensus 389 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 460 (700)
.++|+++++||+|+||+||+|++. +|+.||||+++.. +....+.+.+|+++|++++|+|++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 578999999999999999999975 7999999998753 344567889999999999999999999998643 34
Q ss_pred ceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 461 PLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 461 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
.+++++++.+|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 46778888899999999654 3999999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCceeeeeeecccccccccccccC-CCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHHHHHHHhcch--
Q 005355 541 SVMIDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYFLEAMKENRL-- 617 (700)
Q Consensus 541 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 617 (700)
.... ......|++.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+........ .........
T Consensus 170 ~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i---~~~~~~~~~~~ 242 (348)
T d2gfsa1 170 HTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGAEL 242 (348)
T ss_dssp CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCHHH
T ss_pred ccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCChHH
Confidence 5422 23345689999999987665 4688999999999999999999999876543221111 111000000
Q ss_pred h----------------hhcchhhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 005355 618 F----------------EVLDARVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKEAAF 660 (700)
Q Consensus 618 ~----------------~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~evl~ 660 (700)
. ....... ..........+.+|+.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCH-HHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccchhhhhhhhhcccCCCcch-hhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 0000000 0001123456889999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-36 Score=321.99 Aligned_cols=263 Identities=20% Similarity=0.192 Sum_probs=192.5
Q ss_pred cCCCccceEeeeCCeEEEEEEEc-CCcEEEEEEccccChhhHHHHHHHHHHHhhcC-----------CCceeeEEeEEEe
Q 005355 390 DNFNTNRILGQGGQGTVYKGMLT-NGRIVAIKKSKLVDESNIEQFINEVAILSQIN-----------HRNVVKLLGCCLE 457 (700)
Q Consensus 390 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 457 (700)
++|+++++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45999999999999999999975 78999999987543 33467888999988875 5789999988764
Q ss_pred C--CcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeecCCCCCcEEECCCC-----
Q 005355 458 T--EVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHS-AASIPIYHRDIKSANILLDDKY----- 529 (700)
Q Consensus 458 ~--~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~Dik~~NILl~~~~----- 529 (700)
. ...++++++...+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4556777776655544444444444458999999999999999999998 77 99999999999997654
Q ss_pred -cEEEeecCCCcccccCCceeeeeeecccccccccccccCCCCcccceehHHHHHHHHHhCCCCCCCCCchhhhhHHHHH
Q 005355 530 -RAKVSDFGASRSVMIDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDSEEDKSLVGYF 608 (700)
Q Consensus 530 -~~kl~DfGl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG~il~elltg~~p~~~~~~~~~~~~~~~~ 608 (700)
.+|++|||.+..... ......||+.|+|||++....++.++||||+|+++++|++|+.||...............
T Consensus 169 ~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 499999999975432 234456999999999999999999999999999999999999999755432211111111
Q ss_pred HHHHHh-cc----------h-hhh-----------------cch--hhhhccCHHHHHHHHHHHHHHhccCCCCCCCHHH
Q 005355 609 LEAMKE-NR----------L-FEV-----------------LDA--RVLKEAKEEEIITVAMLAKRCLNMIGKKRPTMKE 657 (700)
Q Consensus 609 ~~~~~~-~~----------~-~~~-----------------~d~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~e 657 (700)
...+.. +. . ... ... .............+.+|+.+||..||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 111100 00 0 000 000 0011234567788999999999999999999999
Q ss_pred HHH
Q 005355 658 AAF 660 (700)
Q Consensus 658 vl~ 660 (700)
+++
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.6e-22 Score=193.39 Aligned_cols=165 Identities=18% Similarity=0.200 Sum_probs=121.9
Q ss_pred CccceEeeeCCeEEEEEEEcCCcEEEEEEccccC------------------hhhHHHHHHHHHHHhhcCCCceeeEEeE
Q 005355 393 NTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVD------------------ESNIEQFINEVAILSQINHRNVVKLLGC 454 (700)
Q Consensus 393 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~~~ 454 (700)
.+.++||+|+||+||+|+..+|+.||||+++... .........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4578999999999999998889999999754311 0112345678889999999999988865
Q ss_pred EEeCCcceEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCcEEECCCCcEEEe
Q 005355 455 CLETEVPLLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAASIPIYHRDIKSANILLDDKYRAKVS 534 (700)
Q Consensus 455 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~Dik~~NILl~~~~~~kl~ 534 (700)
. ..+++|||+++..+.+ +++.....++.|++++|+|||+++ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 3479999998765533 344456689999999999999999 9999999999999976 58999
Q ss_pred ecCCCcccccCCceeeeeeecccccccc--c---ccccCCCCcccceehHHHHHH
Q 005355 535 DFGASRSVMIDQTHLTTRVQGTFGYLDP--E---YFRSSQFTEKSDVYSFGVVLV 584 (700)
Q Consensus 535 DfGl~~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~s~ksDVwSlG~il~ 584 (700)
|||++......... .|+.. + .+....|+.++|+||+.--+.
T Consensus 145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 99999765322211 11111 0 012356788999999865443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.43 E-value=3.2e-07 Score=89.96 Aligned_cols=149 Identities=15% Similarity=0.107 Sum_probs=103.7
Q ss_pred HHHHHHhcCCCccceEeeeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcc
Q 005355 383 MELEMATDNFNTNRILGQGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVP 461 (700)
Q Consensus 383 ~e~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 461 (700)
.+++.....|+..+..+-+....||+... +++.++||+...........+.+|..++..+. +--+.+++.+..+.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45666667777666544444578998865 46667888876544444456778888887774 44467788888888889
Q ss_pred eEEEeeCCCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-------------------------------
Q 005355 462 LLVYEFIPNGTLYQYIHDQTEEFPITWEIRLRIAIEVSDALCYLHSAAS------------------------------- 510 (700)
Q Consensus 462 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~------------------------------- 510 (700)
++||+++++.++.+...... ....++.++++.++.||+...
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~--------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ--------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS--------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEecccccccccccccc--------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 99999999988866543211 123345566666666664210
Q ss_pred -------------------------CCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 511 -------------------------IPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 511 -------------------------~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
..++|+|+.+.|||++++...-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127899999999999987666799998774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.77 E-value=2.7e-05 Score=75.28 Aligned_cols=130 Identities=17% Similarity=0.155 Sum_probs=84.8
Q ss_pred eEeeeCC-eEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcC--CCceeeEEeEEEeCCcceEEEeeCCCCCH
Q 005355 397 ILGQGGQ-GTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQIN--HRNVVKLLGCCLETEVPLLVYEFIPNGTL 473 (700)
Q Consensus 397 ~lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~E~~~~gsL 473 (700)
.+..|.. ..||+...+++..+++|....... ..+..|...++.+. .-.+.+++.+..+.+..++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444543 678999888788899998664433 34677888877764 33467788888888889999999987655
Q ss_pred HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 005355 474 YQYIHDQTEEFPITWEIRLRIAIEVSDALCYLH----------------------------------------------- 506 (700)
Q Consensus 474 ~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----------------------------------------------- 506 (700)
.+.. ... ...+.++.+.|+-||
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3210 110 011122222333333
Q ss_pred ----hcC----CCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 507 ----SAA----SIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 507 ----~~~----~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
... .+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 211 1237999999999999987667899998774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.31 E-value=0.00036 Score=71.87 Aligned_cols=76 Identities=21% Similarity=0.231 Sum_probs=49.1
Q ss_pred cceEeeeCCeEEEEEEEc-CCcEEEEEEccc----cC---hhhHHHHHHHHHHHhhcC-C--CceeeEEeEEEeCCcceE
Q 005355 395 NRILGQGGQGTVYKGMLT-NGRIVAIKKSKL----VD---ESNIEQFINEVAILSQIN-H--RNVVKLLGCCLETEVPLL 463 (700)
Q Consensus 395 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~----~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 463 (700)
.+.||.|....||+.... +++.|+||.... .. +...++...|.+.|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 346899999999999865 467899996432 11 112344567888887763 2 345666644 5566789
Q ss_pred EEeeCCCCC
Q 005355 464 VYEFIPNGT 472 (700)
Q Consensus 464 v~E~~~~gs 472 (700)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.32 E-value=0.007 Score=60.04 Aligned_cols=67 Identities=13% Similarity=0.082 Sum_probs=44.2
Q ss_pred eEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCCCce--eeEE-----eEEEeCCcceEEEeeCCCC
Q 005355 404 GTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINHRNV--VKLL-----GCCLETEVPLLVYEFIPNG 471 (700)
Q Consensus 404 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lv~E~~~~g 471 (700)
-.||++...+|+.+++|+.... ....+++..|+..+..|....+ +..+ .........+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 5899999989999999987643 2234667888888877642221 1111 1223456678899998763
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.08 E-value=0.00075 Score=43.85 Aligned_cols=25 Identities=24% Similarity=0.829 Sum_probs=21.0
Q ss_pred ccccCCcccccCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
.|..+..|.+. ..+|.|.|+.||.|
T Consensus 8 ~C~~~A~C~Nt-~Gsy~C~C~~Gy~G 32 (40)
T d1gl4a2 8 QCSVHAECRDY-ATGFCCRCVANYTG 32 (40)
T ss_dssp GSCTTEEEEEC-SSCEEEEECTTEEE
T ss_pred CCCCCCEeecC-CCCeEeECCCCCcC
Confidence 58777888875 45799999999999
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.03 E-value=0.0059 Score=62.38 Aligned_cols=72 Identities=18% Similarity=0.197 Sum_probs=48.0
Q ss_pred ceEeeeCCeEEEEEEEcC--------CcEEEEEEccccChhhHHHHHHHHHHHhhcC-CCceeeEEeEEEeCCcceEEEe
Q 005355 396 RILGQGGQGTVYKGMLTN--------GRIVAIKKSKLVDESNIEQFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYE 466 (700)
Q Consensus 396 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 466 (700)
+.|+-|-.-.+|+....+ .+.|.+++... ... .....+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 567777788999988653 35677777553 222 234568899988874 4334567776642 68999
Q ss_pred eCCCCCH
Q 005355 467 FIPNGTL 473 (700)
Q Consensus 467 ~~~~gsL 473 (700)
|+++.+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.73 E-value=0.11 Score=50.65 Aligned_cols=158 Identities=11% Similarity=0.041 Sum_probs=80.2
Q ss_pred cchHHHHHHhcCCCccceEe-----eeCCeEEEEEEEcCCcEEEEEEccccChhhHHHHHHHHHHHhhcCC-----Ccee
Q 005355 380 FTSMELEMATDNFNTNRILG-----QGGQGTVYKGMLTNGRIVAIKKSKLVDESNIEQFINEVAILSQINH-----RNVV 449 (700)
Q Consensus 380 ~~~~e~~~~~~~~~~~~~lG-----~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv 449 (700)
.+..+++....+|.+.+... .|---+.|+.+..+| .+++|+..... ..+.+..|++++..+.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 45678888888898765543 444567899887655 48889875421 12334455666665532 2111
Q ss_pred eEE-e--EEEeCCcceEEEeeCCCCCHH--------------HHHhccCC----C--CCC------------------CH
Q 005355 450 KLL-G--CCLETEVPLLVYEFIPNGTLY--------------QYIHDQTE----E--FPI------------------TW 488 (700)
Q Consensus 450 ~l~-~--~~~~~~~~~lv~E~~~~gsL~--------------~~l~~~~~----~--~~l------------------~~ 488 (700)
... | ..........++.++.+.... ..++.... . ... ..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110 0 112234445566666543211 11111000 0 000 00
Q ss_pred HHHHHHHHHHHHHHHHHHhcC-CCCeeecCCCCCcEEECCCCcEEEeecCCCc
Q 005355 489 EIRLRIAIEVSDALCYLHSAA-SIPIYHRDIKSANILLDDKYRAKVSDFGASR 540 (700)
Q Consensus 489 ~~~~~i~~qi~~aL~~LH~~~-~~~ivH~Dik~~NILl~~~~~~kl~DfGl~~ 540 (700)
......+..+...+.-.+... +..++|+|+.++||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111122222233333332211 2238999999999999998777899999874
|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Plasminogen activator (tissue-type), t-PA species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.73 E-value=0.027 Score=36.54 Aligned_cols=26 Identities=27% Similarity=0.719 Sum_probs=21.5
Q ss_pred ccccCCcccc-cCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSI-QLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~-~~~~gy~C~C~~Gy~G 252 (700)
-|....+|.+ ....+|+|.|..||.|
T Consensus 5 PC~ngG~C~~~~~~~~y~C~C~~g~~G 31 (41)
T d1tpga1 5 RCFNGGTCQQALYFSDFVCQCPEGFAG 31 (41)
T ss_dssp CSCTTCEEEEESSSSCEEEECCTTCBS
T ss_pred CCCCCCEEecCCCCCCeEECCCCCCCC
Confidence 3766788887 4567999999999999
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.56 E-value=0.033 Score=35.67 Aligned_cols=25 Identities=28% Similarity=0.800 Sum_probs=20.7
Q ss_pred ccccCCcccccCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
-|...++|.+. ..+|.|.|..||.|
T Consensus 10 PC~ngg~C~~~-~~~y~C~C~~g~~G 34 (39)
T d1edmb_ 10 PCLNGGSCKDD-INSYECWCPFGFEG 34 (39)
T ss_dssp CCCTTCEEEEE-TTEEEEECCTTCCS
T ss_pred CCCCCcEEEcC-CCCEEEECCCCCCC
Confidence 47777888764 56999999999999
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.49 E-value=0.023 Score=36.40 Aligned_cols=25 Identities=28% Similarity=0.886 Sum_probs=20.8
Q ss_pred ccccCCcccccCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
-|...+.|.+. ..+|+|.|..||.|
T Consensus 8 PC~n~g~C~~~-~~~y~C~C~~G~~G 32 (39)
T d2vj3a2 8 PCQNDATCLDQ-IGEFQCICMPGYEG 32 (39)
T ss_dssp CCCSSCEEEEC-SSCEEEECCTTEES
T ss_pred CCCCCCEEECC-CCCEEEeCCCCCcc
Confidence 47777888864 56999999999999
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.15 E-value=0.026 Score=35.16 Aligned_cols=25 Identities=28% Similarity=0.824 Sum_probs=20.7
Q ss_pred ccccCCcccccCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
-|...++|.+. ..+|.|.|..||.|
T Consensus 7 PC~ngg~C~~~-~~~y~C~C~~g~~G 31 (35)
T d2vj3a3 7 PCLHNGRCLDK-INEFQCECPTGFTG 31 (35)
T ss_dssp CSTTTCEEEEC-SSCEEEECCTTEES
T ss_pred CCCCCcEEECC-CCCeEEECCCCCCC
Confidence 47777888764 45899999999999
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.85 E-value=0.026 Score=36.13 Aligned_cols=25 Identities=28% Similarity=0.888 Sum_probs=20.3
Q ss_pred ccccCCcccccCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
-|...++|.+. ..+|.|.|..||.|
T Consensus 7 PC~ngg~C~~~-~~~y~C~C~~G~~G 31 (39)
T d1xkba1 7 PCQNQGKCKDG-LGEYTCTCLEGFEG 31 (39)
T ss_dssp CCCSSCEECCC-SSSCCEECCTTEET
T ss_pred CCCCCcEEECC-CCCEEEECCCCCCc
Confidence 36666788764 56899999999999
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=91.50 E-value=0.029 Score=35.44 Aligned_cols=25 Identities=32% Similarity=0.893 Sum_probs=20.3
Q ss_pred ccccCCcccccCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
-|...++|.+. ..+|.|.|..||.|
T Consensus 9 PC~ngg~C~~~-~~~y~C~C~~g~~G 33 (37)
T d2c4fl1 9 PCQNGGSCKDQ-LQSYICFCLPAFEG 33 (37)
T ss_dssp CCCTTCEEEEE-TTEEEEECCTTEES
T ss_pred CCCCCCEEECC-CCCeEEECCCCCcC
Confidence 36666788763 56899999999999
|
| >d1q4ga2 g.3.11.1 (A:32-73) Prostaglandin H2 synthase-1, EGF-like module {Sheep (Ovis aries) [TaxId: 9940]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Prostaglandin H2 synthase-1, EGF-like module species: Sheep (Ovis aries) [TaxId: 9940]
Probab=90.96 E-value=0.036 Score=36.12 Aligned_cols=26 Identities=27% Similarity=0.712 Sum_probs=21.3
Q ss_pred ccccCCcccccCCCceeeeccC-CCcc
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHR-SFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~-Gy~G 252 (700)
-|...++|.+....+|.|.|+. ||.|
T Consensus 9 PC~ngG~C~~~~~~~y~C~C~~~G~~G 35 (42)
T d1q4ga2 9 PCQHQGICVRFGLDRYQCDCTRTGYSG 35 (42)
T ss_dssp CCCTTCEEEEETTTEEEEECTTSSEET
T ss_pred CCCCCCEeeeCCCCCEEEECCCCCcCC
Confidence 4777789987556799999986 9999
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.89 E-value=0.042 Score=35.83 Aligned_cols=25 Identities=20% Similarity=0.816 Sum_probs=20.4
Q ss_pred ccccCCcccccCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
-|...++|.+. ..+|+|.|..||.|
T Consensus 12 pC~n~g~C~n~-~g~y~C~C~~G~~G 36 (42)
T d2vj3a1 12 PCEHAGKCINT-LGSFECQCLQGYTG 36 (42)
T ss_dssp SSSTTCEEEEC-SSSEEEECCTTEES
T ss_pred CCCCCcEeECC-CCCEEeECCCCCcC
Confidence 47666788774 55799999999999
|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.61 E-value=0.033 Score=35.67 Aligned_cols=25 Identities=28% Similarity=0.894 Sum_probs=20.3
Q ss_pred ccccCCcccccCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
-|...++|.+. ..+|.|.|..||.|
T Consensus 8 pC~ngg~C~~~-~~~~~C~C~~g~~G 32 (39)
T d1g1ta2 8 SCSGHGECVET-INNYTCKCDPGFSG 32 (39)
T ss_dssp GGGGSEEEEEE-TTEEEEEECTTEES
T ss_pred cCCCCcEEECC-CCCEEEeCCCCCcC
Confidence 36666788764 56899999999999
|
| >d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Prostaglandin H2 synthase-1, EGF-like module species: Mouse (Mus musculus) [TaxId: 10090]
Probab=90.13 E-value=0.037 Score=35.82 Aligned_cols=26 Identities=31% Similarity=0.752 Sum_probs=20.6
Q ss_pred ccccCCcccccCCCceeeeccC-CCcc
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHR-SFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~-Gy~G 252 (700)
-|...++|.+....+|+|.|+. ||.|
T Consensus 8 PC~ngG~C~~~~~~~y~C~C~~~gy~G 34 (41)
T d1cvua2 8 PCQNRGECMSTGFDQYKCDCTRTGFYG 34 (41)
T ss_dssp CCCTTCEEEEEETTEEEEECTTSSEET
T ss_pred CCCCCCEEEECCCCCEEEeCcCCCcCC
Confidence 3766788877545689999975 9999
|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.87 E-value=0.048 Score=35.04 Aligned_cols=25 Identities=32% Similarity=0.872 Sum_probs=19.8
Q ss_pred ccccCCcccccCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
-|...+.|.+. ..+|+|.|..||.|
T Consensus 8 pC~ngg~C~~~-~~~y~C~C~~g~~G 32 (40)
T d1g1sa2 8 SCSKQGECLET-IGNYTCSCYPGFYG 32 (40)
T ss_dssp GGGGSEEEEEC-SSSEEEEECTTEES
T ss_pred cCCCCcEEECC-CCCeEEeCCCCccC
Confidence 36666778664 56899999999999
|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.67 E-value=0.069 Score=34.14 Aligned_cols=20 Identities=15% Similarity=0.443 Sum_probs=15.8
Q ss_pred CcccccCCCceeeeccCCCcc
Q 005355 232 NRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 232 s~c~~~~~~gy~C~C~~Gy~G 252 (700)
..|.+. .++|+|.|..||++
T Consensus 13 ~~C~N~-~Gsy~C~C~~Gy~l 32 (40)
T d1dx5i3 13 GVCHNL-PGTFECICGPDSAL 32 (40)
T ss_dssp SEEEEC-SSSEEEEECSSSSC
T ss_pred CEeeCC-CCCeEeECCCCCee
Confidence 345543 66999999999998
|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Mouse (Mus musculus) [TaxId: 10090]
Probab=88.51 E-value=0.11 Score=35.62 Aligned_cols=26 Identities=23% Similarity=0.653 Sum_probs=21.9
Q ss_pred ccccCCcccc-cCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSI-QLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~-~~~~gy~C~C~~Gy~G 252 (700)
-|...++|.. ....+|.|.|..||.|
T Consensus 13 ~C~NgG~C~~~~~~~~~~C~C~~gy~G 39 (53)
T d3egfa_ 13 YCLNGGVCMHIESLDSYTCNCVIGYSG 39 (53)
T ss_dssp CSCSSCEEEEESSSSCEEEECCTTCCS
T ss_pred CCCCCcEeeccCCCCCeEeECCCCCcC
Confidence 4877789976 4567999999999999
|
| >d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.59 E-value=0.09 Score=35.26 Aligned_cols=26 Identities=27% Similarity=0.673 Sum_probs=22.1
Q ss_pred ccccCCcccc-cCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSI-QLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~-~~~~gy~C~C~~Gy~G 252 (700)
.|...++|.. ....+|.|.|..||.|
T Consensus 11 ~C~ngG~C~~~~~~~~~~C~C~~gy~G 37 (48)
T d1nqlb_ 11 YCLHDGVCMYIEALDKYACNCVVGYIG 37 (48)
T ss_dssp EECTTCEEEEETTTTEEEEEECTTEES
T ss_pred CCCCCcEEeeeCCCCCeEEeCCCCccc
Confidence 4877789976 4567999999999999
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.69 E-value=0.13 Score=33.75 Aligned_cols=21 Identities=14% Similarity=0.694 Sum_probs=16.9
Q ss_pred CCcccccCCCceeeeccCCCcc
Q 005355 231 DNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 231 ~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
.+.|.+. -++|+|.|..||+|
T Consensus 15 ~~~C~Nt-~Gsy~C~C~~Gy~~ 35 (44)
T d1lmja1 15 RGQCVNT-PGDFECKCDEGYES 35 (44)
T ss_dssp TSCEEEE-TTEEEECCCSSEEE
T ss_pred CCEeEcC-CCCeEEeCCCCCcc
Confidence 3567665 56999999999999
|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement protease C1R species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.92 E-value=0.18 Score=34.48 Aligned_cols=20 Identities=25% Similarity=0.673 Sum_probs=15.9
Q ss_pred CcccccCCCceeeeccCCCcc
Q 005355 232 NRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 232 s~c~~~~~~gy~C~C~~Gy~G 252 (700)
..|.+. .++|+|.|..||+.
T Consensus 24 ~~C~Nt-~GsY~C~C~~Gy~l 43 (53)
T d1apqa_ 24 HLCHNY-VGGYFCSCRPGYEL 43 (53)
T ss_dssp SEEEEE-TTEEEEECSTTCEE
T ss_pred CEeEcC-CCCeEeECCCCCeE
Confidence 456654 56999999999986
|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.14 E-value=0.11 Score=34.79 Aligned_cols=23 Identities=26% Similarity=0.811 Sum_probs=17.9
Q ss_pred cccCCcccccCCCceeeeccCCCcc
Q 005355 228 CNKDNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 228 C~s~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
|.. ++|.+. .++|+|.|+.||.|
T Consensus 16 C~n-G~C~~~-~~~y~C~C~~G~~G 38 (48)
T d1autl1 16 CGH-GTCIDG-IGSFSCDCRSGWEG 38 (48)
T ss_dssp TTS-EEECCC-SSCCCEEECTTEES
T ss_pred CCC-CEEECC-CCCCeEeCCCCCcC
Confidence 542 677754 45899999999999
|
| >d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Heregulin-alpha, EGF-like domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.45 E-value=0.18 Score=35.89 Aligned_cols=26 Identities=31% Similarity=0.768 Sum_probs=20.8
Q ss_pred ccccCCcccc----cCCCceeeeccCCCcc
Q 005355 227 TCNKDNRCSI----QLTSGYSCLCHRSFNG 252 (700)
Q Consensus 227 ~C~s~s~c~~----~~~~gy~C~C~~Gy~G 252 (700)
-|...++|.. +...+|.|.|..||.|
T Consensus 13 ~C~NgG~C~~~~~~~~~~~y~C~C~~gy~G 42 (63)
T d1haea_ 13 FCVNGGECFMVKDLSNPSRYLCKCQPGFTG 42 (63)
T ss_dssp TSCTTCEEEEEESSSSSCCEEEECCTTEES
T ss_pred cCCCCCEEeecccccCCCCEEeECCCCCCC
Confidence 4777788854 3456999999999999
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.18 E-value=0.29 Score=31.77 Aligned_cols=21 Identities=19% Similarity=0.506 Sum_probs=16.2
Q ss_pred CCcccccCCCceeeeccCCCcc
Q 005355 231 DNRCSIQLTSGYSCLCHRSFNG 252 (700)
Q Consensus 231 ~s~c~~~~~~gy~C~C~~Gy~G 252 (700)
.+.|.+. .++|.|.|..||.+
T Consensus 16 ~~~C~Nt-~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 16 HGQCINT-DGSYRCECPFGYIL 36 (43)
T ss_dssp SSCCCCC-SSCCCCCCCTTEEE
T ss_pred CCEeECC-CCCeEeECCCCccc
Confidence 3556654 46899999999987
|